Citrus Sinensis ID: 016544
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 387 | 2.2.26 [Sep-21-2011] | |||||||
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.457 | 0.106 | 0.382 | 1e-33 | |
| Q54H46 | 642 | Probable serine/threonine | yes | no | 0.519 | 0.313 | 0.380 | 4e-33 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.514 | 0.288 | 0.393 | 6e-33 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.514 | 0.213 | 0.403 | 2e-32 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.532 | 0.159 | 0.391 | 2e-31 | |
| Q5UQG7 | 1651 | Putative serine/threonine | N/A | no | 0.452 | 0.105 | 0.394 | 2e-31 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.470 | 0.112 | 0.384 | 2e-31 | |
| Q54IP4 | 653 | Dual specificity protein | no | no | 0.534 | 0.316 | 0.357 | 2e-31 | |
| P18160 | 2410 | Dual specificity protein | no | no | 0.560 | 0.090 | 0.384 | 5e-31 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.457 | 0.215 | 0.427 | 5e-31 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function desciption |
|---|
Score = 144 bits (362), Expect = 1e-33, Method: Composition-based stats.
Identities = 70/183 (38%), Positives = 121/183 (66%), Gaps = 6/183 (3%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
W+ + VA+KK ++ I D++ + R+E+A L+K+ HPN++ +GA + + IVTEY+
Sbjct: 1418 WKNVDVAIKKFIKQKI-DENHLLGIREEIAFLKKLHHPNIITMVGASLKKPNICIVTEYM 1476
Query: 233 PKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
KG+LR ++ L+ ++ ++IA+G++YLH P PIIHRD++PSNIL D++ N
Sbjct: 1477 AKGNLRDAMRTCTPKLEWHQKIKILVNIAKGISYLHSFDP-PIIHRDIKPSNILIDENWN 1535
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
+K+ADFG ++ +KE+ + + + + APE+ +N+ YD KVDVFSF +++ E++
Sbjct: 1536 VKIADFGFAR---IKEENAIMTRCGTPCWTAPEIIRNDIYDEKVDVFSFGIVMWEVLTCK 1592
Query: 352 PPF 354
PF
Sbjct: 1593 EPF 1595
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 142 bits (358), Expect = 4e-33, Method: Compositional matrix adjust.
Identities = 83/218 (38%), Positives = 129/218 (59%), Gaps = 17/218 (7%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
+ID H++ V I KG + L WRG QVAVKKL I +++ ++ F E+ L++
Sbjct: 368 DIDIHQIKI--GVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNI-NENILKEFHREINLMK 424
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMN 264
+RHPNV+QFLG+ + I TEY+P+G L + L + L+ S ++ +D A+G+
Sbjct: 425 NLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVI 484
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YLH + PV I+HRDL+ N+L D++ +KVADFG+S + ++ +T T C + +PE
Sbjct: 485 YLHNSTPV-ILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPC-WTSPE 540
Query: 325 VFKNEEYDTKVDVFSFALILQEMIE------GCPPFTM 356
V +++ Y K DV+SF +IL E G PPF +
Sbjct: 541 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQV 578
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 142 bits (357), Expect = 6e-33, Method: Compositional matrix adjust.
Identities = 85/216 (39%), Positives = 126/216 (58%), Gaps = 17/216 (7%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
+ID ++ V I KG F L WRG QVAVKKL I +++ ++ F E+ L++
Sbjct: 385 DIDTQQIKI--GVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNI-NENILKEFHREINLMK 441
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMN 264
+RHPNV+QFLG+ S + I TEY+P+G L + L K + S R +D A+G+
Sbjct: 442 NLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGII 501
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YLH + PV I+HRDL+ N+L D++ +KVADFG+S + ++ +T T C + +PE
Sbjct: 502 YLHGSTPV-ILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPC-WTSPE 557
Query: 325 VFKNEEYDTKVDVFSFALILQEMIE------GCPPF 354
V +++ Y K DV+SF +IL E G PPF
Sbjct: 558 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPF 593
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 140 bits (352), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 84/208 (40%), Positives = 128/208 (61%), Gaps = 9/208 (4%)
Query: 144 EVPEYEIDPHELDFTNSVEI-TKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
+V E EI ++L + + + G A W G +VAVKK ++ S + FR E+
Sbjct: 658 DVGECEIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGA-ALAEFRSEVR 716
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIAR 261
+++++RHPNVV FLGAVT+ + IVTE+LP+G L L R K + ++ ALD+A
Sbjct: 717 IMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAM 776
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--R 319
GMN LH + P I+HRDL+ N+L D++ N+KV DFG+S+L K + L+ + T+
Sbjct: 777 GMNCLHTSTPT-IVHRDLKTPNLLVDNNWNVKVGDFGLSRL---KHNTFLSSKSTAGTPE 832
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEM 347
++APEV +NE + K DV+SF +IL E+
Sbjct: 833 WMAPEVLRNEPSNEKCDVYSFGVILWEL 860
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 137 bits (345), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 83/212 (39%), Positives = 115/212 (54%), Gaps = 6/212 (2%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
G WRG +VAVK L + + + + R E+ LL K+RHPN+V F+GA T+ S
Sbjct: 863 GQVFRGSWRGTEVAVKMLFNDNV-NLKLISDLRKEVDLLCKLRHPNIVLFMGACTEPSSP 921
Query: 226 MIVTEYLPKGDL-RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
IVTEYL +G L L + ++ D ARGM YLH P+ IIHRDL+ N+
Sbjct: 922 CIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYLHSRNPI-IIHRDLKTDNL 980
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
L DDS +KVADFG L TVK + +VAPEV E Y K DV+S+A++L
Sbjct: 981 LVDDSWQVKVADFG---LATVKSHTFAKTMCGTTGWVAPEVLAEEGYTEKADVYSYAIVL 1037
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376
E++ P+ K+ +V ++ +R P A
Sbjct: 1038 WELLTRLIPYAGKNTMQVVRSIDRGERLPMPA 1069
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1 | Back alignment and function description |
|---|
Score = 137 bits (345), Expect = 2e-31, Method: Composition-based stats.
Identities = 73/185 (39%), Positives = 117/185 (63%), Gaps = 10/185 (5%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
W+ I VAVKK ++ I D+ ++ FR E+A L ++RHP+++ +GA + + IVTE++
Sbjct: 1413 WKNINVAVKKFVKQKI-DEKQMLEFRAEIAFLSQLRHPHIILMIGACLKRPNICIVTEFM 1471
Query: 233 PKGDLRAFLKRKGALKPSTAVRFAL--DIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
G LR +K KP ++ + A G+ YLH + P+ IIHRD++PSNIL DDS
Sbjct: 1472 GNGSLRNVIK---TTKPEWKLKIKMLYQTALGIGYLHNSDPI-IIHRDIKPSNILVDDSM 1527
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
N+K+ADFG +++ +E+ +T T C + APE+ + E+Y KVDVFSF +++ E++
Sbjct: 1528 NVKIADFGFARI--KEENSVMTRCGTPC-WTAPEIIRGEKYTEKVDVFSFGIVMWEVLTC 1584
Query: 351 CPPFT 355
PF+
Sbjct: 1585 KEPFS 1589
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 137 bits (344), Expect = 2e-31, Method: Composition-based stats.
Identities = 78/203 (38%), Positives = 125/203 (61%), Gaps = 21/203 (10%)
Query: 162 EITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
+I G++ + F W+G+ VAVKK ++ +S+ ++ FR E+A L +++H N+V F+GA
Sbjct: 1369 QIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSET-QLLEFRAEMAFLSELKHSNIVTFIGA 1427
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI------ARGMNYLHENKPV 272
+ + IVTEY+ G+LR LK P + FA + A G++YLH + P+
Sbjct: 1428 CIKKPNICIVTEYMRMGNLRDVLK-----NPDIKITFANKLKLLYGAAMGIDYLHSSNPM 1482
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEY 331
I+HRD++P+NIL D+ N+K+ADFG ++ +KED +T T C + APEV + E+Y
Sbjct: 1483 -IVHRDIKPANILVDEHFNVKIADFGFAR---IKEDNTTMTRCGTPC-WTAPEVIRGEKY 1537
Query: 332 DTKVDVFSFALILQEMIEGCPPF 354
K DVFSF +++ E++ G PF
Sbjct: 1538 CEKADVFSFGVVMWEVLTGKEPF 1560
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 137 bits (344), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 78/218 (35%), Positives = 129/218 (59%), Gaps = 11/218 (5%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
E+ +EID +E+ + ++ G F + RG +VA+KKL + V +++ + F+ E
Sbjct: 161 EIIRWEIDRNEISYNREAKLGSGAFGSVYKGIVRGKEVAIKKLTQTVF-EENTMNEFKKE 219
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
++L+ K+R+P+++ F+GA T + IVTE +PKG + + L+ K + A+ IA
Sbjct: 220 VSLMAKLRNPHLLLFMGACTAPEDLSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILIA 279
Query: 261 R----GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
R GM +LH + I+H DL+P+N+L D + +KVADFG+SK + L Q
Sbjct: 280 RDTVLGMTWLHASN---ILHLDLKPANLLVDQNWVVKVADFGLSKYMKPDSKDKLLGQAG 336
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
S Y+APE+ N+ YD KVDVFSF+++L E++ P+
Sbjct: 337 SPLYMAPEMLVNQPYDGKVDVFSFSILLWELLTKQEPY 374
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 135 bits (340), Expect = 5e-31, Method: Composition-based stats.
Identities = 98/255 (38%), Positives = 131/255 (51%), Gaps = 38/255 (14%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
EYEID +EL+F + I KG F +WR VA+K + + + F++E+ +
Sbjct: 2107 EYEIDFNELEFGQT--IGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVMFQNEVGI 2164
Query: 204 LQKIRHPNVVQFLGAVTQSSP--MMIVTEYLPKGDLRAFLKRKGAL---KPSTAVRFALD 258
L K+RHPNVVQFLGA T IVTE++ G LR FL L P ++ ALD
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRD---DSGN----------LKVADFGVSKLLTV 305
IA+GMNYLH P PI+HRDL NIL D D N K++DFG+S+L
Sbjct: 2225 IAKGMNYLHGWTP-PILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKM- 2282
Query: 306 KEDRPLTCQDTSC-RYVAPEVFKNEEYDTKVDVFSFALILQEMI------EGCPPFTMKH 358
E Q C Y+APEVFK + K DV+S+ ++L E++ + P M H
Sbjct: 2283 -EQASQMTQSVGCIPYMAPEVFKGDSNSEKSDVYSYGMVLFELLTSDEPQQDMKPMKMAH 2341
Query: 359 DNEVPKAYAARQRPP 373
AY + RPP
Sbjct: 2342 ----LAAYES-YRPP 2351
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 135 bits (340), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 80/187 (42%), Positives = 113/187 (60%), Gaps = 10/187 (5%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
GT A W G VAVK L E+ + RV F E+A+++++RHPN+V F+GAVTQ +
Sbjct: 563 GTVHRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 621
Query: 226 MIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
IVTEYL +G L L + GA L + A D+A+GMNYLH P PI+HRDL+
Sbjct: 622 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRDLKSP 680
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--RYVAPEVFKNEEYDTKVDVFSF 340
N+L D +KV DFG+S+L K L+ + + ++APEV ++E + K DV+SF
Sbjct: 681 NLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF 737
Query: 341 ALILQEM 347
+IL E+
Sbjct: 738 GVILWEL 744
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 387 | ||||||
| 356555470 | 456 | PREDICTED: probable serine/threonine-pro | 0.992 | 0.842 | 0.795 | 0.0 | |
| 255562560 | 466 | protein kinase, putative [Ricinus commun | 0.997 | 0.828 | 0.793 | 0.0 | |
| 225443668 | 462 | PREDICTED: dual specificity protein kina | 1.0 | 0.837 | 0.785 | 1e-178 | |
| 356549162 | 455 | PREDICTED: probable serine/threonine-pro | 0.989 | 0.841 | 0.788 | 1e-177 | |
| 449459316 | 458 | PREDICTED: serine/threonine-protein kina | 0.976 | 0.825 | 0.808 | 1e-177 | |
| 224076914 | 423 | predicted protein [Populus trichocarpa] | 0.968 | 0.886 | 0.797 | 1e-177 | |
| 255558750 | 401 | Serine/threonine-protein kinase HT1, put | 0.979 | 0.945 | 0.773 | 1e-168 | |
| 356499380 | 454 | PREDICTED: dual specificity protein kina | 0.974 | 0.830 | 0.758 | 1e-166 | |
| 102139950 | 467 | protein kinase, putative [Musa balbisian | 1.0 | 0.828 | 0.725 | 1e-165 | |
| 104295003 | 467 | protein kinase family protein [Musa acum | 1.0 | 0.828 | 0.722 | 1e-164 |
| >gi|356555470|ref|XP_003546054.1| PREDICTED: probable serine/threonine-protein kinase drkB-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 642 bits (1655), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 308/387 (79%), Positives = 346/387 (89%), Gaps = 3/387 (0%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
ME+K P R TL KQSSLAP+R KEAEL DGE + RLM+ A E DV+GI+E L
Sbjct: 1 MESKNPARFTLGKQSSLAPERHNKEAELQ---KDGEAVDQGVRLMYSAFEGDVDGIREAL 57
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
+SG+ VN++DIDNRTALHVAAC+GFT+VV LLL++GA+VDPKDRWGSTPL DAI+YK ++
Sbjct: 58 ESGVSVNYKDIDNRTALHVAACEGFTDVVDLLLQKGAEVDPKDRWGSTPLADAIFYKKND 117
Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
VIKLLEKHGAKPLMAPMHV HAREVPEYEI+P ELDFTNSVEITKGTF A WRG +VAV
Sbjct: 118 VIKLLEKHGAKPLMAPMHVNHAREVPEYEINPKELDFTNSVEITKGTFCSALWRGTKVAV 177
Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
KKLGE+VISD+++V+AFRDELAL QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR F
Sbjct: 178 KKLGEDVISDEEKVKAFRDELALFQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRDF 237
Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
+KRKGALKPSTAVRFALDIARG+ YLHENKP PIIHRDLEPSNILRDDSG+LKVADFGVS
Sbjct: 238 MKRKGALKPSTAVRFALDIARGVGYLHENKPSPIIHRDLEPSNILRDDSGHLKVADFGVS 297
Query: 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360
KLL VKED+PLTCQDTSCRYVAPEVF+ EEYDTKVDVFSFALILQEMIEGCPPF+ K D+
Sbjct: 298 KLLAVKEDKPLTCQDTSCRYVAPEVFRQEEYDTKVDVFSFALILQEMIEGCPPFSAKQDD 357
Query: 361 EVPKAYAARQRPPFKAPAKLYARGLKE 387
EVPK YAA++RPPF+APAK Y+ G++E
Sbjct: 358 EVPKVYAAKERPPFQAPAKRYSHGIRE 384
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255562560|ref|XP_002522286.1| protein kinase, putative [Ricinus communis] gi|223538539|gb|EEF40144.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 641 bits (1653), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 316/398 (79%), Positives = 348/398 (87%), Gaps = 12/398 (3%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEE-----------IKPEFRLMFLAN 49
ME K VR TL KQSSLAP+R R+E N ++ E+ I P RLM+ +
Sbjct: 1 MEGKSSVRFTLGKQSSLAPERSREEDVSNDQEEGSEDMSNDPEEELEDIHPGVRLMYSCH 60
Query: 50 ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
E D++GI+ELLDSGIDVNFRDIDNRTALH+AACQG+T+VV+LLL GA+ DPKDRWGSTP
Sbjct: 61 EGDLDGIRELLDSGIDVNFRDIDNRTALHLAACQGYTDVVALLLNNGAETDPKDRWGSTP 120
Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFI 169
L DAIYYKNH+VIKLLEK GAKPLMAPMHV HAREVPEYEI+PHELDFTNSVEITKGTF
Sbjct: 121 LADAIYYKNHDVIKLLEKRGAKPLMAPMHVNHAREVPEYEINPHELDFTNSVEITKGTFH 180
Query: 170 LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
LA WRGIQVAVKKLGE+VISD+D+VRAF DELALLQKIRHPNVVQFLGAVTQSSPMMIVT
Sbjct: 181 LASWRGIQVAVKKLGEDVISDEDKVRAFSDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 240
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
EYL KGDLRAFLK+KGAL+P TAVRF LDIARG+NYLHENKP PIIHRDLEPSNILRDDS
Sbjct: 241 EYLHKGDLRAFLKKKGALRPGTAVRFGLDIARGLNYLHENKP-PIIHRDLEPSNILRDDS 299
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
G+LKVADFGVSKLLTVKED+PLTCQDTSCRYVAPEVFK+EEYDTKVDVFSFALILQEMIE
Sbjct: 300 GHLKVADFGVSKLLTVKEDKPLTCQDTSCRYVAPEVFKHEEYDTKVDVFSFALILQEMIE 359
Query: 350 GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387
GCPPF+ K D EVPK+YAA++RPPF+AP K Y GLK+
Sbjct: 360 GCPPFSAKQDLEVPKSYAAKERPPFRAPTKHYPHGLKD 397
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225443668|ref|XP_002263226.1| PREDICTED: dual specificity protein kinase shkB [Vitis vinifera] gi|297740576|emb|CBI30758.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1625), Expect = e-178, Method: Compositional matrix adjust.
Identities = 307/391 (78%), Positives = 347/391 (88%), Gaps = 4/391 (1%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
+E+K VR TL KQSSLAP+R R EA G D E I P RLM+LANE D+EG++ELL
Sbjct: 3 VESKTAVRFTLGKQSSLAPERARDEALTEGEQGDVEGIDPRVRLMYLANEGDLEGLRELL 62
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
DSG+DVNFRDIDNRTALHVAACQGF++VV LL+ GA++D +DRWGSTPL DAI+YKNH+
Sbjct: 63 DSGMDVNFRDIDNRTALHVAACQGFSDVVEFLLKNGAEIDLEDRWGSTPLADAIHYKNHD 122
Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
VIKLLEKHGA+ LMAPMHV +AREVPEYEIDP ELDFTNSV+ITKGT+ +A WRGIQVAV
Sbjct: 123 VIKLLEKHGAQHLMAPMHVNNAREVPEYEIDPKELDFTNSVDITKGTYRIASWRGIQVAV 182
Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
K+LG+EVI D+D+V+AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL AF
Sbjct: 183 KRLGDEVIIDEDKVKAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLHAF 242
Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
LKRKGALK +TAV+FALDIARGMNYLHE++P IIHRDLEPSNILRDDSG+LKVADFGVS
Sbjct: 243 LKRKGALKTATAVKFALDIARGMNYLHEHRPEAIIHRDLEPSNILRDDSGHLKVADFGVS 302
Query: 301 KLL----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356
KLL TVKED PL CQ+TSCRY+APEVFKNE YDTKVDVFSFALILQEMIEGCPPF+
Sbjct: 303 KLLKVANTVKEDYPLICQETSCRYLAPEVFKNEAYDTKVDVFSFALILQEMIEGCPPFSA 362
Query: 357 KHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387
K +NEVPK YAA++RPPF+AP+KLY+ GLKE
Sbjct: 363 KPENEVPKVYAAQERPPFRAPSKLYSHGLKE 393
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549162|ref|XP_003542966.1| PREDICTED: probable serine/threonine-protein kinase drkA-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 628 bits (1620), Expect = e-177, Method: Compositional matrix adjust.
Identities = 305/387 (78%), Positives = 343/387 (88%), Gaps = 4/387 (1%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
ME+K P R TL KQSSLAP+R KEAEL +DGE + RLM+ A E DV+GI E L
Sbjct: 1 MESKNPARFTLGKQSSLAPERHNKEAELQ---NDGEVVDQGVRLMYSAFEGDVDGICEAL 57
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
+ G+ VN++DIDNRTALHVA C+GFT+VV LLL++GA+VDPKDRWGSTPL DAI+YK ++
Sbjct: 58 EFGVSVNYKDIDNRTALHVAVCEGFTDVVDLLLQKGAEVDPKDRWGSTPLADAIFYKKND 117
Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
VIKLLEKHGAK LMAPMHV HAREVPEYEI+P ELDFTNSVEITKGTF +A WRG +VAV
Sbjct: 118 VIKLLEKHGAKLLMAPMHVNHAREVPEYEINPKELDFTNSVEITKGTFCIALWRGTEVAV 177
Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
KKLGE+VISD+++V+AFRDELAL QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR F
Sbjct: 178 KKLGEDVISDEEKVKAFRDELALFQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRDF 237
Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
LKRKGALKPSTAVRFALDIARG+ YLHENKP PIIHRDLEPSNILRDDSG+LKVADFGVS
Sbjct: 238 LKRKGALKPSTAVRFALDIARGVGYLHENKPSPIIHRDLEPSNILRDDSGHLKVADFGVS 297
Query: 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360
KLL VKED+PLTC DTSCRYVAPEVF+ +EYDTKVDVFSFALILQEMIEGCPPF+ K DN
Sbjct: 298 KLLAVKEDKPLTCHDTSCRYVAPEVFR-QEYDTKVDVFSFALILQEMIEGCPPFSAKQDN 356
Query: 361 EVPKAYAARQRPPFKAPAKLYARGLKE 387
EVPK YAA++RPPF+APAK Y+ G++E
Sbjct: 357 EVPKVYAAKERPPFRAPAKHYSYGIRE 383
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449459316|ref|XP_004147392.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1613), Expect = e-177, Method: Compositional matrix adjust.
Identities = 308/381 (80%), Positives = 334/381 (87%), Gaps = 3/381 (0%)
Query: 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV 66
VR L KQSS+APDR+ +EAEL +DGEEI P RLM+LANE D+EGIKELLDSGIDV
Sbjct: 11 VRFLLGKQSSMAPDRQPEEAELA---EDGEEIDPGVRLMYLANEGDLEGIKELLDSGIDV 67
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
NF DIDNRTALH+AACQG E+V LLL RGA++DPKDRWGSTPL DAI+YKNHEVIKLLE
Sbjct: 68 NFHDIDNRTALHIAACQGCNEIVDLLLRRGAEIDPKDRWGSTPLADAIFYKNHEVIKLLE 127
Query: 127 KHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEE 186
K GAK LMAPMHVKHAREVPEYEIDP E DFTNSV +TKGTF LA WRGIQVAVK+L E+
Sbjct: 128 KRGAKHLMAPMHVKHAREVPEYEIDPKEFDFTNSVNLTKGTFHLASWRGIQVAVKELPED 187
Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA 246
VIS++D+V AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL L +KG
Sbjct: 188 VISEEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLCQLLHKKGP 247
Query: 247 LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
LKP AV+FALDIARGMNYLHENKP PIIHRDLEPSNILRDD+GNLKVADFGVSKLLTVK
Sbjct: 248 LKPIVAVKFALDIARGMNYLHENKPAPIIHRDLEPSNILRDDTGNLKVADFGVSKLLTVK 307
Query: 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366
ED+PLTCQDT+CRYVAPEVFKN YDTKVDVFSFALILQEMIEG PPF+ K +N + K Y
Sbjct: 308 EDKPLTCQDTACRYVAPEVFKNNGYDTKVDVFSFALILQEMIEGQPPFSNKKENAICKGY 367
Query: 367 AARQRPPFKAPAKLYARGLKE 387
AA RPPFKAPAK YA G+KE
Sbjct: 368 AAGMRPPFKAPAKCYAHGIKE 388
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076914|ref|XP_002305047.1| predicted protein [Populus trichocarpa] gi|222848011|gb|EEE85558.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 625 bits (1613), Expect = e-177, Method: Compositional matrix adjust.
Identities = 303/380 (79%), Positives = 342/380 (90%), Gaps = 5/380 (1%)
Query: 8 RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVN 67
R TL KQSSLAP+R+R+E+++ D DG + P RLM+LANE ++EGIKEL++S +DVN
Sbjct: 1 RFTLGKQSSLAPERDREESDV---DMDG--VDPGVRLMYLANEGNLEGIKELVNSDVDVN 55
Query: 68 FRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
FRDID RTALH+A+CQG T+VV LLL+ GA++DPKDRWGSTPL DAI+YKNH+VIKLLEK
Sbjct: 56 FRDIDGRTALHIASCQGLTQVVDLLLDHGAEIDPKDRWGSTPLADAIFYKNHDVIKLLEK 115
Query: 128 HGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEV 187
GAKPLMAPMHVKHAREVPEYEI+P ELDFTNSVE+TKGTF +A WRGIQVAVKKLGEEV
Sbjct: 116 RGAKPLMAPMHVKHAREVPEYEINPDELDFTNSVELTKGTFCVALWRGIQVAVKKLGEEV 175
Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
+SD+D+VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE+LPKGD AFLKRKGAL
Sbjct: 176 LSDEDKVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEFLPKGDFCAFLKRKGAL 235
Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
KP AVR ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG+LKVADFG+SKLLTVKE
Sbjct: 236 KPIAAVRLALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGHLKVADFGISKLLTVKE 295
Query: 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367
++PL D S RYVAPEVFKNEEYDTKVD+FSFALILQEMIEGCPPF+ K ++EVP AYA
Sbjct: 296 EKPLISLDNSWRYVAPEVFKNEEYDTKVDIFSFALILQEMIEGCPPFSAKQEHEVPSAYA 355
Query: 368 ARQRPPFKAPAKLYARGLKE 387
A++RPPF+AP K YA GLKE
Sbjct: 356 AKERPPFRAPTKSYAHGLKE 375
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558750|ref|XP_002520399.1| Serine/threonine-protein kinase HT1, putative [Ricinus communis] gi|223540446|gb|EEF42015.1| Serine/threonine-protein kinase HT1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 596 bits (1537), Expect = e-168, Method: Compositional matrix adjust.
Identities = 300/388 (77%), Positives = 336/388 (86%), Gaps = 9/388 (2%)
Query: 5 VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKE-LLDSG 63
P R TL KQSSL P+R+R E E + G I P RLM+LA+E D++GI E LL+SG
Sbjct: 18 TPARFTLGKQSSLKPERDRHEEEEEEEEVAG--IDPRVRLMYLASEGDIDGINEVLLESG 75
Query: 64 IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
DVNF+DID RTALHVAACQG T+V+ LLL+RGA++DPKDRWGSTPL DAIYYKNH+VIK
Sbjct: 76 TDVNFKDIDGRTALHVAACQGLTDVLQLLLDRGAEIDPKDRWGSTPLADAIYYKNHDVIK 135
Query: 124 LLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKL 183
LLE HGAKP +APMHV++AREVPEYEIDP+ELDF+NSV+ITKGTF A WRGIQVAVK L
Sbjct: 136 LLEIHGAKPPIAPMHVQNAREVPEYEIDPNELDFSNSVDITKGTFRSASWRGIQVAVKTL 195
Query: 184 GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 243
GEEV +D+D+V+AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL A+LK
Sbjct: 196 GEEVFTDEDKVKAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLCAYLKL 255
Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
KGALKP AV+FALDIARGMNYLHE+KP IIHRDLEPSNILRDDSG+LKVADFGVSKLL
Sbjct: 256 KGALKPRVAVKFALDIARGMNYLHEHKPEAIIHRDLEPSNILRDDSGHLKVADFGVSKLL 315
Query: 304 ----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359
TVKEDRP CQDTS RYVAPEV++NEEYDTKVDVFSFALILQEMIEG PPF+ + D
Sbjct: 316 KVTKTVKEDRP--CQDTSWRYVAPEVYRNEEYDTKVDVFSFALILQEMIEGSPPFSTRQD 373
Query: 360 NEVPKAYAARQRPPFKAPAKLYARGLKE 387
NEVPKAYAA +RPPF+APAK Y+ GLKE
Sbjct: 374 NEVPKAYAANERPPFRAPAKRYSHGLKE 401
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356499380|ref|XP_003518519.1| PREDICTED: dual specificity protein kinase pyk1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 589 bits (1519), Expect = e-166, Method: Compositional matrix adjust.
Identities = 295/389 (75%), Positives = 330/389 (84%), Gaps = 12/389 (3%)
Query: 4 KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEE-IKPEFRLMFLANERDVEGIKELLDS 62
K+ R +L +QSSLAP+R G D E + P RLM+LANE D +GIKELLD+
Sbjct: 5 KLQPRFSLGRQSSLAPER-------GGCGGDASEALDPAVRLMYLANEGDSDGIKELLDA 57
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G DVNF DID RTALHVAACQG T+VV LLL RGADVDP+DRWGSTPL DA+YYKNH+V+
Sbjct: 58 GSDVNFTDIDGRTALHVAACQGRTDVVGLLLRRGADVDPQDRWGSTPLVDAMYYKNHDVV 117
Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
KLLEKHGA+P MAPMHV++AREVPEYEIDP ELDFTNSV ITKGTF +A WRG QVAVK
Sbjct: 118 KLLEKHGARPPMAPMHVQNAREVPEYEIDPSELDFTNSVCITKGTFRIALWRGTQVAVKT 177
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
LGEE+ +DDD+V+AF DEL LL+KIRHPNVVQFLGAVTQS+PMMIVTEYLP+GDLRA+LK
Sbjct: 178 LGEELFTDDDKVKAFHDELTLLEKIRHPNVVQFLGAVTQSTPMMIVTEYLPQGDLRAYLK 237
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
RKGALKP TAV+FALDIARGMNYLHE+KP IIHRDLEPSNILRDDSG+LKVADFGVSKL
Sbjct: 238 RKGALKPVTAVKFALDIARGMNYLHEHKPEAIIHRDLEPSNILRDDSGHLKVADFGVSKL 297
Query: 303 L----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358
L TVKED+P+T DTS RYVAPEV+KNEEYDTKVDVFSFALILQEMIEGCPPF K
Sbjct: 298 LKVAKTVKEDKPVTSLDTSWRYVAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFYEKP 357
Query: 359 DNEVPKAYAARQRPPFKAPAKLYARGLKE 387
+NEVPKAY +RPPF+A KLYA GLK+
Sbjct: 358 ENEVPKAYVENERPPFRASPKLYAYGLKQ 386
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|102139950|gb|ABF70090.1| protein kinase, putative [Musa balbisiana] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1515), Expect = e-165, Method: Compositional matrix adjust.
Identities = 301/415 (72%), Positives = 337/415 (81%), Gaps = 28/415 (6%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAE-LNGLDDDG----EEIKPEFRLMFLANERDVEG 55
ME K R TL KQSSLAPDR+ E + L D DG EE+ RLM+LANE D+ G
Sbjct: 1 MEAKSTGRFTLGKQSSLAPDRDDGELQALRSGDLDGLQVPEEVDANIRLMYLANEGDLAG 60
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST------- 108
I+E L SG+DVNFRDID+RTALHVAACQGF +VV LLL+RGA VDP+DRWGST
Sbjct: 61 IEETLASGVDVNFRDIDDRTALHVAACQGFADVVQLLLDRGAQVDPEDRWGSTSNFITIA 120
Query: 109 ----PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEIT 164
PL DA++YKNHEVIKL EKHGAK + PM V++AREVPEYEIDP ELDFTNSV IT
Sbjct: 121 PAKQPLADAVHYKNHEVIKLFEKHGAKLRVTPMRVENAREVPEYEIDPSELDFTNSVNIT 180
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRV--------RAFRDELALLQKIRHPNVVQFL 216
KGTFI+A WRGIQVAVKK ++V++D+D++ RAFRDELALLQ+IRHPNVVQFL
Sbjct: 181 KGTFIIAKWRGIQVAVKKFNDDVMADEDKLWDFFIFCRRAFRDELALLQQIRHPNVVQFL 240
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
GAVTQSSPMMIVTEYL KGDLRA+L RK L+PS+AV FALDIARGMNYLHE+KP IIH
Sbjct: 241 GAVTQSSPMMIVTEYLRKGDLRAYLNRKRTLRPSSAVLFALDIARGMNYLHEHKPEAIIH 300
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLL----TVKEDRPLTCQDTSCRYVAPEVFKNEEYD 332
RDLEPSNILRDDSG+LKVADFGVSKLL TVKE+RPLTC DT+CRYVAPEVF NEEYD
Sbjct: 301 RDLEPSNILRDDSGHLKVADFGVSKLLKVAKTVKEERPLTCLDTACRYVAPEVFLNEEYD 360
Query: 333 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387
TKVDVFSFALILQEMIEGCPPF+ K DNEVPKAY ++QRPPF+AP K YA GLKE
Sbjct: 361 TKVDVFSFALILQEMIEGCPPFSYKQDNEVPKAYVSKQRPPFRAPPKQYAHGLKE 415
|
Source: Musa balbisiana Species: Musa balbisiana Genus: Musa Family: Musaceae Order: Zingiberales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|104295003|gb|ABF72018.1| protein kinase family protein [Musa acuminata] | Back alignment and taxonomy information |
|---|
Score = 585 bits (1508), Expect = e-164, Method: Compositional matrix adjust.
Identities = 300/415 (72%), Positives = 335/415 (80%), Gaps = 28/415 (6%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAE-LNGLDDDG----EEIKPEFRLMFLANERDVEG 55
ME K R TL KQSSLAPDR+ E + L D DG EE+ RLM+LANE D+ G
Sbjct: 1 MEAKSTGRFTLGKQSSLAPDRDDGELQALRSGDLDGLQVLEEVDANIRLMYLANEGDLAG 60
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST------- 108
I+E L SG+DVNFRDID+RTALHVAACQGF +VV LLL+RGA VDP+DRWGST
Sbjct: 61 IEETLASGVDVNFRDIDDRTALHVAACQGFADVVQLLLDRGALVDPEDRWGSTSNFITIA 120
Query: 109 ----PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEIT 164
PL DA++YKNHEVIKL EKHGAK + PM V++AREVPEYEIDP ELDFTNSV IT
Sbjct: 121 PAKQPLADAVHYKNHEVIKLFEKHGAKLQVTPMRVENAREVPEYEIDPSELDFTNSVNIT 180
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRV--------RAFRDELALLQKIRHPNVVQFL 216
KGTFI+A WRGIQVAVKK ++V++D+D++ AFRDELALLQ+IRHPNVVQFL
Sbjct: 181 KGTFIIAKWRGIQVAVKKFSDDVMADEDKLWDFFIFCRSAFRDELALLQQIRHPNVVQFL 240
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
GAVTQSSPMMIVTEYL KGDLRA+L RK L+PS+AV FALDIARGMNYLHE+KP IIH
Sbjct: 241 GAVTQSSPMMIVTEYLRKGDLRAYLNRKRTLRPSSAVLFALDIARGMNYLHEHKPEAIIH 300
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLL----TVKEDRPLTCQDTSCRYVAPEVFKNEEYD 332
RDLEPSNILRDDSG+LKVADFGVSKLL TVKE+RPLTC DTSCRYVAPEVF NEEYD
Sbjct: 301 RDLEPSNILRDDSGHLKVADFGVSKLLKVAKTVKEERPLTCLDTSCRYVAPEVFLNEEYD 360
Query: 333 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387
TKVDVFSFALILQEMIEGCPPF+ K DNEVPKAY ++QRPPF+AP K Y GLKE
Sbjct: 361 TKVDVFSFALILQEMIEGCPPFSYKQDNEVPKAYVSKQRPPFRAPPKQYGHGLKE 415
|
Source: Musa acuminata Species: Musa acuminata Genus: Musa Family: Musaceae Order: Zingiberales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 387 | ||||||
| TAIR|locus:2117129 | 459 | AT4G18950 [Arabidopsis thalian | 0.979 | 0.825 | 0.729 | 2.2e-146 | |
| TAIR|locus:2098999 | 471 | AT3G58760 [Arabidopsis thalian | 1.0 | 0.821 | 0.689 | 5.6e-139 | |
| TAIR|locus:2044034 | 479 | AT2G43850 [Arabidopsis thalian | 0.979 | 0.791 | 0.488 | 1.2e-90 | |
| TAIR|locus:2045258 | 476 | AT2G31800 [Arabidopsis thalian | 0.981 | 0.798 | 0.475 | 4.1e-88 | |
| TAIR|locus:2080517 | 477 | AT3G59830 [Arabidopsis thalian | 0.984 | 0.798 | 0.478 | 2.4e-85 | |
| TAIR|locus:2014849 | 438 | VIK "VH1-interacting kinase" [ | 0.850 | 0.751 | 0.480 | 1.9e-74 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.720 | 0.510 | 0.352 | 3.5e-36 | |
| WB|WBGene00016030 | 850 | C24A1.3 [Caenorhabditis elegan | 0.516 | 0.235 | 0.393 | 6.1e-36 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.524 | 0.356 | 0.393 | 1.7e-35 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.509 | 0.257 | 0.409 | 3.6e-33 |
| TAIR|locus:2117129 AT4G18950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1430 (508.4 bits), Expect = 2.2e-146, P = 2.2e-146
Identities = 278/381 (72%), Positives = 320/381 (83%)
Query: 8 RTTLLKQSSLAPDR--ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
R T+ +QSS+AP++ E + +DGEEI RLM+LANE D+EGIKEL+DSGID
Sbjct: 9 RFTIGRQSSMAPEKIPEPSVHSEEEVFEDGEEIDGGVRLMYLANEGDIEGIKELIDSGID 68
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
N+RDID+RTALHVAACQG +VV LLL+R A+VDPKDRWGSTP DAI+YKN +VIK+L
Sbjct: 69 ANYRDIDDRTALHVAACQGLKDVVELLLDRKAEVDPKDRWGSTPFADAIFYKNIDVIKIL 128
Query: 126 EKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGE 185
E HGAK MAPMHVK AREVPEYEI+P ELDFT S EITKGT+ +A WRGIQVAVKKL +
Sbjct: 129 EIHGAKHPMAPMHVKTAREVPEYEINPSELDFTQSKEITKGTYCMAMWRGIQVAVKKLDD 188
Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG 245
EV+SDDD+VR F DELALLQ++RHPN+VQFLGAVTQS+PMMIVTEYLP+GDLR LKRKG
Sbjct: 189 EVLSDDDQVRKFHDELALLQRLRHPNIVQFLGAVTQSNPMMIVTEYLPRGDLRELLKRKG 248
Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
LKP+TAVR+ALDIARGM+YLHE K PIIHRDLEPSNILRDDSG+LKVADFGVSKL+TV
Sbjct: 249 QLKPATAVRYALDIARGMSYLHEIKGDPIIHRDLEPSNILRDDSGHLKVADFGVSKLVTV 308
Query: 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365
KED+P TCQD SCRY+APEVF +EEYDTK DVFSFALI+QEMIEG PF K D+E +A
Sbjct: 309 KEDKPFTCQDISCRYIAPEVFTSEEYDTKADVFSFALIVQEMIEGRMPFAEKEDSEASEA 368
Query: 366 YAARQRPPFKAPAKLYARGLK 386
YA + RP FKAP+K Y GLK
Sbjct: 369 YAGKHRPLFKAPSKNYPHGLK 389
|
|
| TAIR|locus:2098999 AT3G58760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1360 (483.8 bits), Expect = 5.6e-139, P = 5.6e-139
Identities = 275/399 (68%), Positives = 315/399 (78%)
Query: 1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIK-------PEFRLMFLANERDV 53
++ K P R L +QSSLAP+ L +DD P RLM+LANE D+
Sbjct: 3 IKPKSPARFKLGRQSSLAPESRTPIDTLTEDEDDDLAAAATAGIGDPTIRLMYLANEGDI 62
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
+GI ++LDSG +V++RDID RTALHVAACQG T+VV LLL RGA VD KDRWGSTPL DA
Sbjct: 63 DGINKMLDSGTNVDYRDIDARTALHVAACQGRTDVVELLLSRGAKVDTKDRWGSTPLADA 122
Query: 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW 173
+YYKNH+VIKLLEKHGAKP +APMHV +EVPEYEI P ELDF+NSV+I+KGTF A W
Sbjct: 123 VYYKNHDVIKLLEKHGAKPTIAPMHVLTDKEVPEYEIHPTELDFSNSVKISKGTFNKASW 182
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
RGI VAVK GEE+ +D+D+V AFRDELALLQKIRHPNVVQFLGAVTQS+PMMIVTEYLP
Sbjct: 183 RGIDVAVKTFGEEMFTDEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 242
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
KGDLR +L RKG L P+ AV+FAL+IARGMNYLHE+KP IIH DLEP NILRDDSG+LK
Sbjct: 243 KGDLRQYLDRKGPLMPAHAVKFALEIARGMNYLHEHKPEAIIHCDLEPPNILRDDSGHLK 302
Query: 294 VADFGVSKLL----TVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
VADFGVSKLL TVK+DRP+ TC D+S RY+APEV++NEEYDTKVDVFSFALILQEMI
Sbjct: 303 VADFGVSKLLVVKKTVKKDRPVVTCLDSSWRYMAPEVYRNEEYDTKVDVFSFALILQEMI 362
Query: 349 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387
EGC PF D EVPKAY +RPPF AP K Y GL+E
Sbjct: 363 EGCEPFHEIEDREVPKAYIEDERPPFNAPTKSYPFGLQE 401
|
|
| TAIR|locus:2044034 AT2G43850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 904 (323.3 bits), Expect = 1.2e-90, P = 1.2e-90
Identities = 193/395 (48%), Positives = 257/395 (65%)
Query: 7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPE-----FRLMFLANERDVEGIKELLD 61
+R + +QSSL P R ++ + DD+ PE +L+F+A++ DV GI+ELLD
Sbjct: 42 MRFSFGRQSSLDPIRRSPDSSKS--DDEPHMSVPENLDSTMQLLFMASKGDVRGIEELLD 99
Query: 62 SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
GIDVN D+D RTALH+AAC+G VV LL R A++D +DRWGST DA YY N +V
Sbjct: 100 EGIDVNSIDLDGRTALHIAACEGHLGVVKALLSRRANIDARDRWGSTAAADAKYYGNLDV 159
Query: 122 IKLLEKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQV 178
LL+ GAK P PM V + REVPEYE++P E+ S I+KG + +A W G +V
Sbjct: 160 YNLLKARGAKVPKTRKTPMTVSNPREVPEYELNPLEVQVRKSDGISKGAYQVAKWNGTRV 219
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
+VK L ++ SD +R+ AFR EL LL+K+RHPNV+QF+GAVTQ+ PMMIV EY PKGDL
Sbjct: 220 SVKILDKDSYSDPERINAFRHELTLLEKVRHPNVIQFVGAVTQNIPMMIVVEYNPKGDLS 279
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+L++KG L PS A+RFALDIARGMNYLHE KP PIIH DL+P NIL D G LK++ FG
Sbjct: 280 VYLQKKGRLSPSKALRFALDIARGMNYLHECKPDPIIHCDLKPKNILLDRGGQLKISGFG 339
Query: 299 VSKLLTVKEDRPLTCQ-----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
+ +L + +D+ D S Y+APEV+K+E +D +VD SF +IL E+ EG P
Sbjct: 340 MIRLSKISQDKAKVANHKAHIDLSNYYIAPEVYKDEIFDLRVDAHSFGVILYEITEGVPV 399
Query: 354 FTMKHDNEVPKAYAAR-QRPPFKAPAKLYARGLKE 387
F + EV + +RP FK ++ Y +KE
Sbjct: 400 FHPRPPEEVARMMCLEGKRPVFKTKSRSYPPDIKE 434
|
|
| TAIR|locus:2045258 AT2G31800 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 880 (314.8 bits), Expect = 4.1e-88, P = 4.1e-88
Identities = 186/391 (47%), Positives = 252/391 (64%)
Query: 7 VRTTLLKQSSLAPDRERKEAELNGLD-DDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
+R + +QSSL P R + NG + + +L+F+A DVEG+++LLD GID
Sbjct: 42 MRFSFGRQSSLDPIRRSPDGS-NGPQLAVPDNLDATMQLLFVACRGDVEGVQDLLDEGID 100
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
VN D+D RTALH+AAC+G +VV LLL R A++D +DRWGST DA YY N +V +L
Sbjct: 101 VNSIDLDGRTALHIAACEGHVDVVKLLLTRKANIDARDRWGSTAAADAKYYGNMDVFNIL 160
Query: 126 EKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
+ GAK P PM V + REVPEYE++P EL + I+KG + +A W G +V+VK
Sbjct: 161 KARGAKVPKTKRTPMVVANPREVPEYELNPQELQVRKADGISKGIYQVAKWNGTKVSVKI 220
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
L +++ D D + AF+ EL L +K+RHPNVVQF+GAVTQ+ PMMIV+EY PKGDL ++L+
Sbjct: 221 LDKDLYKDSDTINAFKHELTLFEKVRHPNVVQFVGAVTQNVPMMIVSEYHPKGDLGSYLQ 280
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
+KG L P+ +RFALDIARGMNYLHE KP P+IH DL+P NI+ D G+LKVA FG+
Sbjct: 281 KKGRLSPAKVLRFALDIARGMNYLHECKPEPVIHCDLKPKNIMLDSGGHLKVAGFGLISF 340
Query: 303 LTVKEDRPLTCQ-----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
+ D+ D S +APEV+K+E +D VD +SF ++L EMIEG PF K
Sbjct: 341 AKLSSDKSKILNHGAHIDPSNYCMAPEVYKDEIFDRSVDSYSFGVVLYEMIEGVQPFHPK 400
Query: 358 HDNEVPKAYAAR-QRPPFKAPAKLYARGLKE 387
E K +RP FKA +K + ++E
Sbjct: 401 PPEEAVKLMCLEGRRPSFKAKSKSCPQEMRE 431
|
|
| TAIR|locus:2080517 AT3G59830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 854 (305.7 bits), Expect = 2.4e-85, P = 2.4e-85
Identities = 187/391 (47%), Positives = 248/391 (63%)
Query: 7 VRTTLLKQSSLAPDRERKEA-ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
+R + +QSSL P R E+ E + +L+F+A++ DV G++ELL+ GID
Sbjct: 42 MRFSFGRQSSLDPIRRSPESLSCEPHMSVPENLDSTMQLLFMASKGDVNGVEELLNEGID 101
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
VN D+D RTALH+A+C+G +VV +LL R A++D +DRWGST DA YY N EV LL
Sbjct: 102 VNSIDLDGRTALHIASCEGHYDVVKVLLSRRANIDARDRWGSTAAVDAKYYGNVEVYNLL 161
Query: 126 EKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
+ GAK P PM V + +EVPEYE++P EL I+KGT+ +A W G +V+VK
Sbjct: 162 KARGAKAPKTRKTPMTVGNPKEVPEYELNPLELQVRKVDGISKGTYQVAKWNGTRVSVKI 221
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
++ SD +RV AF +EL LL K RHPN+VQF+GAVTQ+ PMMIV E PKGDL +L+
Sbjct: 222 FDKDSYSDPERVNAFTNELTLLAKARHPNIVQFVGAVTQNLPMMIVVECNPKGDLSVYLQ 281
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
+KG L PS A+RFALDIARGMNYLHE KP PIIH +L P NIL D G LK++ FG+ KL
Sbjct: 282 KKGRLSPSKALRFALDIARGMNYLHECKPDPIIHCELMPKNILLDRGGQLKISGFGLIKL 341
Query: 303 LTVKEDRPLTCQ-----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
+ ED D S Y+APE++K+E +D + DV SF +IL E+ EG F K
Sbjct: 342 SKIGEDSAKVVNHEAQIDKSNYYIAPEIYKDEVFDKRADVHSFGVILYELTEGVSLFHPK 401
Query: 358 HDNEVPKAYAAR-QRPPFKAPAKLYARGLKE 387
EV ++ +RP + +K Y LKE
Sbjct: 402 PPEEVAESICIEGKRPTIRTKSKSYPPELKE 432
|
|
| TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 751 (269.4 bits), Expect = 1.9e-74, P = 1.9e-74
Identities = 169/352 (48%), Positives = 230/352 (65%)
Query: 44 LMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
+++ A++ D +++LL+ V+ RD D RT LHVA+ G+ +VV LLE GADV+ +
Sbjct: 41 ILWHAHQNDAAAVRKLLEEDPTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQ 100
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH--AREVP-------EYEIDPH 153
DRW +TPL DA + ++I+LL+ HG L + H + VP ++EI+P
Sbjct: 101 DRWKNTPLADAEGARKQKMIELLKSHGG--LSYGQNGSHFEPKPVPPPIPKKCDWEIEPA 158
Query: 154 ELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRV-RAFRDELALLQKIRH 209
ELDF+N+ I KG+F + A+WRG VAVK++ +SDD V + FR E+ LL K+RH
Sbjct: 159 ELDFSNAAMIGKGSFGEIVKAYWRGTPVAVKRILPS-LSDDRLVIQDFRHEVDLLVKLRH 217
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
PN+VQFLGAVT+ P+M++TEYL GDL +LK KG L P+TAV FALDIARGM YLH N
Sbjct: 218 PNIVQFLGAVTERKPLMLITEYLRGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLH-N 276
Query: 270 KPVPIIHRDLEPSNILRDDSG--NLKVADFGVSKLLTVKEDRP---LTCQDTSCRYVAPE 324
+P IIHRDL+P N+L +S +LKV DFG+SKL+ V+ +T + S RY+APE
Sbjct: 277 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 336
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376
VFK+ YD KVDVFSFA+IL EM+EG PPF E K + RP F++
Sbjct: 337 VFKHRRYDKKVDVFSFAMILYEMLEGEPPFANHEPYEAAKHVSDGHRPTFRS 388
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 390 (142.3 bits), Expect = 3.5e-36, P = 3.5e-36
Identities = 110/312 (35%), Positives = 177/312 (56%)
Query: 98 DVDPKDRWGSTP---LGDAIYYKNHEVIKLLEKHGAKPLMAPM--HVKHARE-VPE-YEI 150
DV D W L DA+ + E++KL ++ G+K H K + E +P EI
Sbjct: 215 DVFVVDGWSQEETDGLRDAL---SKEILKLKDQPGSKQKSISFFEHDKSSNELIPACIEI 271
Query: 151 -----DPHELDFTN-SVE--ITKGTFILAFWRGI----QVAVKKLGEEVISDDDRVRAFR 198
D E+D T +E + G++ RG +VA+K L + ++++ +R F
Sbjct: 272 PTDGTDEWEIDVTQLKIEKKVASGSYG-DLHRGTYCSQEVAIKFLKPDRVNNE-MLREFS 329
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
E+ +++K+RH NVVQFLGA T+S + IVTE++ +G + FL K+K A K T ++ AL
Sbjct: 330 QEVFIMRKVRHKNVVQFLGACTRSPTLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVAL 389
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
D+A+GM+YLH+N IIHRDL+ +N+L D+ G +KVADFGV+++ E +T + +
Sbjct: 390 DVAKGMSYLHQNN---IIHRDLKTANLLMDEHGLVKVADFGVARVQI--ESGVMTAETGT 444
Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
R++APEV +++ Y+ K DVFS+A++L E++ G P+ + + P K P
Sbjct: 445 YRWMAPEVIEHKPYNHKADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQKGLRP-KIP 503
Query: 378 AKLY--ARGLKE 387
K + +GL E
Sbjct: 504 KKTHPKVKGLLE 515
|
|
| WB|WBGene00016030 C24A1.3 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 333 (122.3 bits), Expect = 6.1e-36, Sum P(2) = 6.1e-36
Identities = 83/211 (39%), Positives = 119/211 (56%)
Query: 154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
E++F S I G+F + +RG VAVK+ E+++L ++ HP
Sbjct: 515 EIEFQES--IGSGSFGKVYKGTYRGKLVAVKRYRAMAFGCKSETDMLCREVSILSRLAHP 572
Query: 211 NVVQFLG-AVTQSSPMMIVTEYLPKGDL--RAFLKRKG--ALKPSTAVRFALDIARGMNY 265
NVV F+G ++ S I+TE++ G L R +RK + P+ +R +LD+ARGM Y
Sbjct: 573 NVVAFVGTSLDDPSQFAIITEFVENGSLFRRENGERKNYRVMDPAFRLRISLDVARGMRY 632
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
LHE+ P+IHRDL NIL G VADFG S+ + +ED LT Q + R++APEV
Sbjct: 633 LHESAAKPVIHRDLNSHNILIHADGRSVVADFGESRFVCQREDENLTKQPGNLRWMAPEV 692
Query: 326 FKNE-EYDTKVDVFSFALILQEMIEGCPPFT 355
F +YD KVDVFSFAL++ E+ PF+
Sbjct: 693 FSQSGKYDRKVDVFSFALVIWEIHTAELPFS 723
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 385 (140.6 bits), Expect = 1.7e-35, P = 1.7e-35
Identities = 83/211 (39%), Positives = 136/211 (64%)
Query: 147 EYEIDPHELDFTNSVEI-TKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
E+EID +L V + G + +VA+K L E ++ + +R F E+ +++
Sbjct: 284 EWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKILKPERVNAE-MLREFSQEVYIMR 342
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMN 264
K+RH NVVQF+GA T+S + IVTE++ +G + FL K KG K + ++ ALD+++GMN
Sbjct: 343 KVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMN 402
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YLH+N IIHRDL+ +N+L D+ +KVADFGV+++ T E +T + + R++APE
Sbjct: 403 YLHQNN---IIHRDLKTANLLMDEHEVVKVADFGVARVQT--ESGVMTAETGTYRWMAPE 457
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
V +++ YD + DVFS+A++L E++ G P++
Sbjct: 458 VIEHKPYDHRADVFSYAIVLWELLTGELPYS 488
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 370 (135.3 bits), Expect = 3.6e-33, P = 3.6e-33
Identities = 84/205 (40%), Positives = 126/205 (61%)
Query: 147 EYEIDPHELDFTNSV-EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
+YEI +L + + + GT W G VAVK ++ S++ + +F+ E++L++
Sbjct: 479 DYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSEEI-ITSFKQEVSLMK 537
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMN 264
++RHPNV+ F+GAV + IVTE+LP+G L L+R K L + A DIARGMN
Sbjct: 538 RLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARGMN 597
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC-RYVAP 323
YLH P PIIHRDL+ SN+L D + +KVADFG+S+ +K + LT +++AP
Sbjct: 598 YLHHCSP-PIIHRDLKSSNLLVDRNWTVKVADFGLSR---IKHETYLTTNGRGTPQWMAP 653
Query: 324 EVFKNEEYDTKVDVFSFALILQEMI 348
EV +NE D K DV+SF ++L E++
Sbjct: 654 EVLRNEAADEKSDVYSFGVVLWELV 678
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.IV.2537.1 | hypothetical protein (423 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 387 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-55 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-54 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-53 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-52 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-50 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-39 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-37 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-37 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-35 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-34 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-34 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-34 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-33 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-33 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-30 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-30 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-29 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-28 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-28 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-28 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-27 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-27 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-27 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-26 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-24 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-24 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-24 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-24 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-23 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-23 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-23 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-23 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 5e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-23 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-22 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 1e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-22 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-22 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-21 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-21 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-21 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-21 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-20 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 3e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-19 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-19 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-19 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-19 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-19 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-19 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-19 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-19 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-18 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-18 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-17 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-17 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-16 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-16 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-16 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-16 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-16 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-15 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-15 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 3e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-14 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-14 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-13 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-12 | |
| PTZ00322 | 664 | PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fruct | 4e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-11 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 1e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-11 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-10 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 3e-09 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 3e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-09 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 5e-09 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 6e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-09 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 1e-08 | |
| PLN03192 | 823 | PLN03192, PLN03192, Voltage-dependent potassium ch | 1e-08 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 3e-08 | |
| pfam00023 | 33 | pfam00023, Ank, Ankyrin repeat | 3e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 2e-07 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 2e-07 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 3e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-07 | |
| pfam13857 | 56 | pfam13857, Ank_5, Ankyrin repeats (many copies) | 4e-07 | |
| PLN03192 | 823 | PLN03192, PLN03192, Voltage-dependent potassium ch | 9e-07 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 2e-06 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 2e-06 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 2e-06 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-06 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 2e-05 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| pfam13606 | 30 | pfam13606, Ank_3, Ankyrin repeat | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-05 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 5e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-05 | |
| smart00248 | 30 | smart00248, ANK, ankyrin repeats | 5e-05 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 7e-05 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 5e-04 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 0.001 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| PHA02946 | 446 | PHA02946, PHA02946, ankyin-like protein; Provision | 0.001 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.001 | |
| TIGR00870 | 743 | TIGR00870, trp, transient-receptor-potential calci | 0.001 | |
| PHA02716 | 764 | PHA02716, PHA02716, CPXV016; CPX019; EVM010; Provi | 0.001 | |
| PHA02798 | 489 | PHA02798, PHA02798, ankyrin-like protein; Provisio | 0.002 | |
| PHA02736 | 154 | PHA02736, PHA02736, Viral ankyrin protein; Provisi | 0.002 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 6e-55
Identities = 72/237 (30%), Positives = 121/237 (51%), Gaps = 25/237 (10%)
Query: 162 EITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212
++ +G F +G +VAVK L E + ++ F +E ++++K+ HPN+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG--ASEEEREEFLEEASIMKKLSHPNI 63
Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKP 271
V+ LG TQ P+ IVTEY+P GDL FL++ G L ++ AL IA+GM YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN- 122
Query: 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC----RYVAPEVFK 327
+HRDL N L ++ +K++DFG+S+ + + + +++APE K
Sbjct: 123 --FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY---YRKRGGGKLPIKWMAPESLK 177
Query: 328 NEEYDTKVDVFSFALILQEMIEGC-PPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
+ ++ +K DV+SF ++L E+ P+ + EV + R P P +LY
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELY 234
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 2e-54
Identities = 80/227 (35%), Positives = 118/227 (51%), Gaps = 11/227 (4%)
Query: 157 FTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
+ ++ G+F A + G VAVK L + A R E+ +L+++ HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPN 59
Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKP 271
+V+ + A + +V EY GDL +L R G L A + AL I RG+ YLH N
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG- 118
Query: 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEE 330
IIHRDL+P NIL D++G +K+ADFG++K L K LT + Y+APEV
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNG 175
Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
Y KVDV+S +IL E++ G PPF+ ++ + + PP +
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFD 222
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 3e-53
Identities = 70/224 (31%), Positives = 114/224 (50%), Gaps = 20/224 (8%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
++ +G+F LA + G VA+K + ++ I D E+ +L+K++HPN+V+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPNIVRLY 63
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ +V EY GDL LK++G L A + I + YLH I+H
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IVH 120
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDT 333
RDL+P NIL D+ G++K+ADFG+++ L E T Y+APEV + Y
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKL-----TTFVGTPEYMAPEVLLGKGYGK 175
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
VD++S +IL E++ G PPF D+++ + + +P P
Sbjct: 176 AVDIWSLGVILYELLTGKPPF--PGDDQLLELFKKIGKPKPPFP 217
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 4e-53
Identities = 72/225 (32%), Positives = 113/225 (50%), Gaps = 31/225 (13%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
+ ++VAVK L E+ + + ++ F E +++K+ HPNVV+ LG T+ P+ IV EY+
Sbjct: 26 KKKVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYM 83
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
GDL ++L K + L S + FAL IARGM YL IHRDL N L ++
Sbjct: 84 EGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLV 140
Query: 292 LKVADFGVSKLLTVKE-------DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+K++DFG+S+ L + P+ R++APE K ++ +K DV+SF ++L
Sbjct: 141 VKISDFGLSRDLYDDDYYRKRGGKLPI-------RWMAPESLKEGKFTSKSDVWSFGVLL 193
Query: 345 QEMI-------EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382
E+ G + + Y R P P +LY
Sbjct: 194 WEIFTLGEQPYPGMSNEEVLEY--LKNGY--RLPQPPNCPPELYD 234
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 4e-52
Identities = 76/239 (31%), Positives = 117/239 (48%), Gaps = 38/239 (15%)
Query: 166 GTFILAFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
G +G ++VAVK L E+ + + ++ F E +++K+ HPN+V+ LG
Sbjct: 13 GEVYKGTLKGKGDGKEVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNIVKLLGVC 70
Query: 220 TQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
T+ P+MIV EY+P GDL +L+ R L S + FAL IARGM YL IHR
Sbjct: 71 TEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHR 127
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKE-------DRPLTCQDTSCRYVAPEVFKNEE 330
DL N L ++ +K++DFG+S+ L + P+ R++APE K +
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI-------RWMAPESLKEGK 180
Query: 331 YDTKVDVFSFALILQEMI-------EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382
+ +K DV+SF ++L E+ G + + K Y R P P +LY
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEY--LKKGY--RLPKPPNCPPELYK 235
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 7e-51
Identities = 72/236 (30%), Positives = 118/236 (50%), Gaps = 24/236 (10%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ KG + +VAVK L E+ + ++ + F E +++K+ HPNVV+ LG T+
Sbjct: 10 EVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE 67
Query: 222 SSPMMIVTEYLPKGDLRAFLKR---------KGALKPSTAVRFALDIARGMNYLHENKPV 272
P+ +V EY+ GDL +L++ K L + FA+ IA+GM YL K
Sbjct: 68 EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-- 125
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC----RYVAPEVFKN 328
+HRDL N L + +K++DFG+S+ + + + T R++APE K+
Sbjct: 126 -FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY---YRKKTGGKLPIRWMAPESLKD 181
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF--KAPAKLY 381
+ +K DV+SF ++L E+ G P+ + EV + R P P +LY
Sbjct: 182 GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 6e-50
Identities = 68/193 (35%), Positives = 100/193 (51%), Gaps = 14/193 (7%)
Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
+ +G F LA + G +VA+K + + + E+ +L+K+ HPN+V+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ + +V EY G L+ LK L +R L I G+ YLH N IIH
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIH 115
Query: 277 RDLEPSNIL-RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTK 334
RDL+P NIL D+G +K+ADFG+SKLLT + T T Y+APEV + Y K
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP-AYMAPEVLLGKGYYSEK 174
Query: 335 VDVFSFALILQEM 347
D++S +IL E+
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-46
Identities = 58/186 (31%), Positives = 96/186 (51%), Gaps = 9/186 (4%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM--IVTEYLPKG 235
+AVK + E ++ + A E+ +L ++HPN+V++ G+ I EY+ G
Sbjct: 28 MAVKSV-ELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGG 86
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
L + LK+ G L ++ I G+ YLH N I+HRD++ +NIL D G +K+A
Sbjct: 87 SLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLA 143
Query: 296 DFGVSKLL--TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
DFG +K L + + + T ++APEV + EEY D++S + EM G PP
Sbjct: 144 DFGCAKRLGDIETGEGTGSVRGTP-YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
Query: 354 FTMKHD 359
++ +
Sbjct: 203 WSELGN 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 3e-39
Identities = 69/229 (30%), Positives = 111/229 (48%), Gaps = 25/229 (10%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
F +I KG F A + G +VA+K + E +++ E+ +L+K +HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHP 57
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHEN 269
N+V++ G+ + + IV E+ G L+ LK L S ++ +G+ YLH N
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVF 326
IIHRD++ +NIL G +K+ DFG+S L+ + R +T ++APEV
Sbjct: 118 G---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR-----NTMVGTPYWMAPEVI 169
Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA--YAARQRPP 373
+ YD K D++S + E+ EG PP+ + KA A PP
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPP 215
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 84/264 (31%), Positives = 130/264 (49%), Gaps = 53/264 (20%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
+ I+ EL + I KG F +L +RG +VAVK L ++ + +AF E +++
Sbjct: 1 WAINSKELKLGAT--IGKGEFGDVMLGDYRGQKVAVKCLKDDSTA----AQAFLAEASVM 54
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARG 262
+RHPN+VQ LG V Q +P+ IVTEY+ KG L +L+ +G + + + FALD+ G
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CR 319
M YL E +HRDL N+L + KV+DFG++K + QD+ +
Sbjct: 115 MEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-------QDSGKLPVK 164
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMI----------------------------EGC 351
+ APE + +++ TK DV+SF ++L E+ EGC
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGC 224
Query: 352 PPFTMKHDNEVPKAYAARQRPPFK 375
PP K + + A+ RP FK
Sbjct: 225 PPEVYKVMKDCWELDPAK-RPTFK 247
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 6e-37
Identities = 86/243 (35%), Positives = 129/243 (53%), Gaps = 21/243 (8%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
IDP EL F E+ G F L WRG I VA+K + E +S+DD F +E ++
Sbjct: 1 IDPSELTFLK--ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
K+ HPN+VQ G T+ P+ IVTEY+ G L +L+ RKG L + D+ M
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME 114
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS--CRYVA 322
YL N IHRDL N L + +KV+DFG+++ V +D+ + Q T ++
Sbjct: 115 YLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAP 169
Query: 323 PEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAA--RQRPPFKAPAK 379
PEVF + +K DV+SF +++ E+ EG P+ ++EV ++ +A R P AP +
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTE 229
Query: 380 LYA 382
+Y
Sbjct: 230 VYT 232
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-35
Identities = 81/240 (33%), Positives = 123/240 (51%), Gaps = 17/240 (7%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
I+P EL F E+ G F L WR I+VA+K + E +S++D F +E ++
Sbjct: 1 INPSELTFMK--ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
K+ HP +VQ G TQ P+ IVTE++ G L +L+ R+G L + D+ GM
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGME 114
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YL N IHRDL N L +G +KV+DFG+++ + E + ++ PE
Sbjct: 115 YLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPE 171
Query: 325 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
VF +Y +K DV+SF +++ E+ EG PF K + EV + + R P A +Y
Sbjct: 172 VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVY 231
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 62/180 (34%), Positives = 94/180 (52%), Gaps = 10/180 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ I V E +L +I HP +V+ A + +V EY P G+L
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+ L ++G A +A +I + YLH II+RDL+P NIL D G++K+ DFG
Sbjct: 82 SHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFG 138
Query: 299 VSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
++K L+ + R +T C Y+APEV + Y VD +S ++L EM+ G PPF
Sbjct: 139 LAKELSSEGSRT----NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFY 194
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 67/186 (36%), Positives = 102/186 (54%), Gaps = 16/186 (8%)
Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
G VA+KK+ EE I A R E++LL++++HPN+V+ L + + +V E
Sbjct: 24 GEIVALKKIRLDNEEEGIP----STALR-EISLLKELKHPNIVKLLDVIHTERKLYLVFE 78
Query: 231 YLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
Y DL+ +L KR G L P+ + RG+ Y H ++ I+HRDL+P NIL +
Sbjct: 79 YCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRD 134
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMI 348
G LK+ADFG+++ + R T + + Y APE+ ++ Y T VD++S I EMI
Sbjct: 135 GVLKLADFGLARAFGIP-LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMI 193
Query: 349 EGCPPF 354
G P F
Sbjct: 194 TGKPLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 5e-34
Identities = 62/189 (32%), Positives = 101/189 (53%), Gaps = 17/189 (8%)
Query: 175 GIQVAVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
G ++AVK++ + S + + V A E+ LL+ ++H +VQ+ G + + I EY+
Sbjct: 27 GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
P G ++ LK GAL + ++ I G+ YLH N I+HRD++ +NILRD +GN+
Sbjct: 87 PGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNV 143
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQ 345
K+ DFG SK L + + T + +++PEV E Y K DV+S +
Sbjct: 144 KLGDFGASKRL-----QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVV 198
Query: 346 EMIEGCPPF 354
EM+ PP+
Sbjct: 199 EMLTEKPPW 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 75/241 (31%), Positives = 124/241 (51%), Gaps = 19/241 (7%)
Query: 150 IDPHELDFTNSVEITKGTFILAFWRGI-----QVAVKKLGEEVISDDDRVRAFRDELALL 204
I P EL EI G F L W G +VA+K + E +S++D F +E ++
Sbjct: 1 IHPSELTL--VQEIGSGQFGLV-WLGYWLEKRKVAIKTIREGAMSEED----FIEEAQVM 53
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGM 263
K+ HP +VQ G T+ SP+ +V E++ G L +L+ ++G T + LD+ GM
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113
Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 323
YL + +IHRDL N L ++ +KV+DFG+++ + + T ++ +P
Sbjct: 114 AYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSP 170
Query: 324 EVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKL 380
EVF +Y +K DV+SF +++ E+ EG P+ + ++EV + A R P A +
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSV 230
Query: 381 Y 381
Y
Sbjct: 231 Y 231
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 55/185 (29%), Positives = 96/185 (51%), Gaps = 9/185 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +K++ +S+ +R A E+ +L+K+ HPN++++ + + + IV EY
Sbjct: 25 GKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83
Query: 235 GDLRAFLKRKGALKPSTAVRFALD----IARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
GDL +K++ LD + + YLH K I+HRD++P NI +G
Sbjct: 84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNG 140
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
+K+ DFG+SK+L+ D T T Y++PE+ +N+ Y+ K D++S +L E+
Sbjct: 141 LVKLGDFGISKVLSSTVDLAKTVVGTPY-YLSPELCQNKPYNYKSDIWSLGCVLYELCTL 199
Query: 351 CPPFT 355
PF
Sbjct: 200 KHPFE 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 62/192 (32%), Positives = 95/192 (49%), Gaps = 13/192 (6%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + + + ++V E +L + + P VV+ + + +V EYLP GDL
Sbjct: 21 YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+ L+ G+L A + +I + YLH N IIHRDL+P NIL D +G+LK+ DF
Sbjct: 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDF 137
Query: 298 GVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
G+SK+ V+ L + + Y+APEV + + VD +S IL E + G
Sbjct: 138 GLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
Query: 351 CPPFTMKHDNEV 362
PPF H
Sbjct: 198 IPPF---HGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 71/193 (36%), Positives = 106/193 (54%), Gaps = 18/193 (9%)
Query: 175 GIQVAVKK--LGEEVISDDDRVRAFRD----ELALLQKIRHPNVVQFLGAVTQSSPMMIV 228
G +AVK+ L S DR R+ D E+ALL++++H N+VQ+LG+ + + I
Sbjct: 25 GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
EY+P G + A L GA + + F I +G+NYLH IIHRD++ +NIL D+
Sbjct: 85 LEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDN 141
Query: 289 SGNLKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
G +K++DFG+SK L RP + Q S ++APEV K Y K D++S
Sbjct: 142 KGGIKISDFGISKKLEANSLSTKTNGARP-SLQG-SVFWMAPEVVKQTSYTRKADIWSLG 199
Query: 342 LILQEMIEGCPPF 354
++ EM+ G PF
Sbjct: 200 CLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-31
Identities = 59/205 (28%), Positives = 108/205 (52%), Gaps = 12/205 (5%)
Query: 156 DFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALLQKIRH 209
++ I +G F ++G+ VA+K++ E I ++ +++ E+ LL+ ++H
Sbjct: 1 NYQLGDLIGRGAFG-VVYKGLNLETGDFVAIKQISLEKIKEEA-LKSIMQEIDLLKNLKH 58
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
PN+V+++G++ S + I+ EY G LR +K+ G S + + +G+ YLHE
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
+IHRD++ +NIL G +K+ADFGV+ L + T ++APEV +
Sbjct: 119 G---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTP-YWMAPEVIEMS 174
Query: 330 EYDTKVDVFSFALILQEMIEGCPPF 354
T D++S + E++ G PP+
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPY 199
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-31
Identities = 63/182 (34%), Positives = 93/182 (51%), Gaps = 5/182 (2%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
G A+KK+ V D++ + EL L+ P VV+ GA + + IV EY+
Sbjct: 24 PTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
G L LK+ G + A I +G++YLH + IIHRD++PSN+L + G +
Sbjct: 82 DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEV 139
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
K+ADFG+SK+L D+ T T Y++PE + E Y D++S L L E G
Sbjct: 140 KIADFGISKVLENTLDQCNTFVGT-VTYMSPERIQGESYSYAADIWSLGLTLLECALGKF 198
Query: 353 PF 354
PF
Sbjct: 199 PF 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 120 bits (300), Expect = 2e-30
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 156 DFTNSVEITKGTFILAF--WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NV 212
+ ++ +G+F + VA+K L +++ S V F E+ +L + HP N+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAVRFALDIARGMNYLHEN 269
V+ + +V EY+ G L LK RKG L S A+ I + YLH
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 270 KPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLT-----VKEDRPLTCQDTSCRYVAP 323
IIHRD++P NIL D G +K+ DFG++KLL + + Y+AP
Sbjct: 121 G---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 324 EVFK---NEEYDTKVDVFSFALILQEMIEGCPPF 354
EV + D++S + L E++ G PPF
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPF 211
|
Length = 384 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 59/179 (32%), Positives = 93/179 (51%), Gaps = 8/179 (4%)
Query: 179 AVK--KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
AVK L ++ + + V+ E+ALL K++HPN+VQ+LG + + I E +P G
Sbjct: 29 AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGS 88
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L LK+ G+ + I G+ YLH+ +HRD++ +NIL D +G +K+AD
Sbjct: 89 LAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLAD 145
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPF 354
FG++K V E S ++APEV + Y D++S + EM G PP+
Sbjct: 146 FGMAK--QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW 202
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-30
Identities = 57/175 (32%), Positives = 97/175 (55%), Gaps = 8/175 (4%)
Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS 250
++ V A R E+ L+ ++ HP++++ LGA + S + E++ G + L + GA K +
Sbjct: 44 EEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA 103
Query: 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKEDR 309
+ + + RG++YLHEN+ IIHRD++ +N+L D +G L++ADFG + L K
Sbjct: 104 VIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160
Query: 310 PLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM-KHDN 360
Q + ++APEV + E+Y DV+S ++ EM PP+ KH N
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-29
Identities = 69/215 (32%), Positives = 113/215 (52%), Gaps = 18/215 (8%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
+ G +VAVK I D +AF +E A++ K+ H N+V+ LG + + + IV E +
Sbjct: 27 YTGQKVAVK-----NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM 80
Query: 233 PKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
KG+L FL+ +G S ++F+LD+A GM YL K ++HRDL NIL + G
Sbjct: 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDG 137
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 349
KV+DFG++++ + ++ APE K++++ +K DV+S+ ++L E+
Sbjct: 138 VAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSY 193
Query: 350 GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYA 382
G P+ EV + R PP PA +Y
Sbjct: 194 GRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYV 228
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 77/243 (31%), Positives = 125/243 (51%), Gaps = 25/243 (10%)
Query: 152 PHELDFTNSVEITKGTFILAF---WRG-IQVAVKKLGEEVISDDDRVRA--FRDELALLQ 205
P E +FT ++ G F + W+ ++VA+K ++ DD ++ F+ E+ L+
Sbjct: 4 PRE-EFTLERKLGSGYFGEVWEGLWKNRVRVAIK-----ILKSDDLLKQQDFQKEVQALK 57
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGM 263
++RH +++ + P+ I+TE + KG L AFL+ L ++ + A +A GM
Sbjct: 58 RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117
Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--RYV 321
YL E IHRDL NIL + KVADFG+++L+ KED L+ D ++
Sbjct: 118 AYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLS-SDKKIPYKWT 171
Query: 322 APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA--RQRPPFKAPA 378
APE + + TK DV+SF ++L EM G P+ +++EV A R P K P
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQ 231
Query: 379 KLY 381
++Y
Sbjct: 232 EIY 234
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 58/183 (31%), Positives = 95/183 (51%), Gaps = 11/183 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K++ +S +R A +E+ +L + HPN++ + A + + IV EY P GDL
Sbjct: 29 ALKEVDLGSMSQKEREDAV-NEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLS 87
Query: 239 AFLKRKGALK---PSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
+ ++ + P + R + + RG+ LHE K I+HRDL+ +NIL + +K+
Sbjct: 88 KAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKI 144
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
D G+SK+L Q + Y+APEV+K Y K D++S +L EM PPF
Sbjct: 145 GDLGISKVLK---KNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF 201
Query: 355 TMK 357
+
Sbjct: 202 EAR 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 59/194 (30%), Positives = 97/194 (50%), Gaps = 28/194 (14%)
Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--MMIV 228
G QVAVK L E+ SD F E+ +L+ + H N+V++ G + + ++
Sbjct: 33 GEQVAVKSLNHSGEEQHRSD------FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86
Query: 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
EYLP G LR +L+R + + + F+ I +GM+YL + IHRDL NIL +
Sbjct: 87 MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVE 143
Query: 288 DSGNLKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
+K++DFG++K+L VKE ++ + APE + ++ + DV+SF
Sbjct: 144 SEDLVKISDFGLAKVLPEDKDYYYVKEPG-----ESPIFWYAPECLRTSKFSSASDVWSF 198
Query: 341 ALILQEMIEGCPPF 354
+ L E+ P
Sbjct: 199 GVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 17/216 (7%)
Query: 179 AVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
AVK E I D+D ++ DE+ +L+ ++HPN+V++ G + I EY G
Sbjct: 29 AVK---EIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT 85
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L L+ L + L + G+ YLH + I+HRD++P+NI D +G +K+ D
Sbjct: 86 LEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGD 142
Query: 297 FGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTK---VDVFSFALILQEMIEG 350
FG + L + + Y+APEV + D++S ++ EM G
Sbjct: 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202
Query: 351 CPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARG 384
P++ + DNE + A +PP +L G
Sbjct: 203 KRPWS-ELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-29
Identities = 69/205 (33%), Positives = 99/205 (48%), Gaps = 16/205 (7%)
Query: 162 EITKGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220
E+ GT W G +VAVK L +S AF E +++K+RH +VQ +
Sbjct: 21 EVWMGT-----WNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 221 QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
+ P+ IVTEY+ KG L FLK L+ V A IA GM YL IHRD
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRD 128
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
L NIL ++ K+ADFG+++L+ E ++ APE + K DV+
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188
Query: 339 SFALILQEMI-EGCPPFTMKHDNEV 362
SF ++L E++ G P+ + EV
Sbjct: 189 SFGILLTEIVTYGRVPYPGMTNREV 213
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 9e-29
Identities = 77/241 (31%), Positives = 120/241 (49%), Gaps = 17/241 (7%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
IDP +L F E+ G F WRG VA+K + E +S+D+ F +E ++
Sbjct: 1 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMN 264
K+ H +VQ G T+ P+ IVTEY+ G L +L+ G +PS + D+ GM
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMA 114
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YL + IHRDL N L DD G +KV+DFG+S+ + E R+ PE
Sbjct: 115 YLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171
Query: 325 VFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
V ++ +K DV++F +++ E+ G P+ +++E + + R P A K+Y
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVY 231
Query: 382 A 382
A
Sbjct: 232 A 232
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 60/192 (31%), Positives = 99/192 (51%), Gaps = 18/192 (9%)
Query: 171 AFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228
W+ + VAVK L E+ + V F E A++++I+HPN+VQ LG T+ P I+
Sbjct: 25 GVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80
Query: 229 TEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
TE++ G+L +L+ + + + A I+ M YL + IHRDL N L
Sbjct: 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLV 137
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALI 343
++ +KVADFG+S+L+T T + ++ APE ++ K DV++F ++
Sbjct: 138 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 194
Query: 344 LQEMIE-GCPPF 354
L E+ G P+
Sbjct: 195 LWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 78/227 (34%), Positives = 112/227 (49%), Gaps = 14/227 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ +G L + I VA+K L + SD R F E +++ + HPN+++ G VT+
Sbjct: 19 EVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQR-LDFLTEASIMGQFDHPNIIRLEGVVTK 76
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
S P+MI+TEY+ G L FL+ G V IA GM YL E V HRDL
Sbjct: 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV---HRDLA 133
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFS 339
NIL + + KV+DFG+S+ L E T R+ APE ++ + DV+S
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWS 193
Query: 340 FALILQE-MIEGCPPFTMKHDNEVPKA----YAARQRPPFKAPAKLY 381
F +++ E M G P+ + +V KA Y R PP P+ LY
Sbjct: 194 FGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY--RLPPPMDCPSALY 238
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 6/192 (3%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + ++ + VR +E +LQ++ HP +V + M +V + L GDLR
Sbjct: 29 AMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLR 88
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L +K + +I + YLH IIHRD++P NIL D+ G++ + DF
Sbjct: 89 YHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFN 145
Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358
++ +T D T + Y+APEV + Y VD +S + E + G P+ H
Sbjct: 146 IATKVT--PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR-GH 202
Query: 359 DNEVPKAYAARQ 370
+ A+Q
Sbjct: 203 SRTIRDQIRAKQ 214
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 62/190 (32%), Positives = 102/190 (53%), Gaps = 7/190 (3%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
G VA+KK+ + +A R E+ LQ +HP VV+ L S ++V EY+P
Sbjct: 24 TGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP 82
Query: 234 KGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL L+ + L + + + +G+ Y+H N I+HRDL+P+N+L G L
Sbjct: 83 -SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVL 138
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGC 351
K+ADFG+++L + +E R + Q + Y APE+ + +YD VD+++ I E++ G
Sbjct: 139 KIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
Query: 352 PPFTMKHDNE 361
P F ++D E
Sbjct: 199 PLFPGENDIE 208
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-28
Identities = 60/177 (33%), Positives = 91/177 (51%), Gaps = 13/177 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+VAVK + D R F E +L++ HPN+V+ +G Q P+ IV E +P
Sbjct: 19 NTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76
Query: 235 GDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G L FL++K L ++ +LD A GM YL E+K IHRDL N L ++ LK
Sbjct: 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL-ESKNC--IHRDLAARNCLVGENNVLK 133
Query: 294 VADFGVSKLLTVKEDRPLTCQD----TSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
++DFG+S+ +E T D ++ APE Y ++ DV+S+ ++L E
Sbjct: 134 ISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 7e-28
Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 24/194 (12%)
Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA- 218
I KG F +L +RG +VAVK I +D +AF E +++ ++RH N+VQ LG
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
V + + IVTEY+ KG L +L+ +G L ++F+LD+ M YL N +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDT 333
RDL N+L + KV+DFG++K + + QDT ++ APE + +++ T
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREKKFST 178
Query: 334 KVDVFSFALILQEM 347
K DV+SF ++L E+
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 68/235 (28%), Positives = 115/235 (48%), Gaps = 11/235 (4%)
Query: 153 HELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212
EL N + KG +++ + ++VAVK L +E I+ + F E +++ ++ HP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCI 58
Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
V+ +G V + P+M+V E P G L +LK++ + S A +A GM YL V
Sbjct: 59 VRLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEE 330
HRDL N+L + K++DFG+S+ L D R T ++ APE +
Sbjct: 118 ---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 331 YDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYA 382
+ +K DV+S+ + L E G P+ EV + +R P + P ++Y+
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYS 229
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-27
Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+KK + +E+ +++ +HPN+V + + + +V EY+
Sbjct: 44 GKEVAIKK----MRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99
Query: 235 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G L + + + ++ +G+ YLH +IHRD++ NIL G++K
Sbjct: 100 GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVK 156
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
+ADFG + LT ++ + + T ++APEV K ++Y KVD++S ++ EM EG PP
Sbjct: 157 LADFGFAAQLTKEKSKRNSVVGTP-YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
Query: 354 FTMKHDNEVP-KA-YAARQR--PPFKAPAKL 380
+ E P +A + + PP K P K
Sbjct: 216 ----YLREPPLRALFLITTKGIPPLKNPEKW 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 57/185 (30%), Positives = 97/185 (52%), Gaps = 16/185 (8%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+VA+K + E S +R F +E +++++ +VV+ LG V+ P ++V E +
Sbjct: 35 PETRVAIKTVNENA-SMRER-IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMA 92
Query: 234 KGDLRAFLKRK-------GALKPSTAVRF---ALDIARGMNYLHENKPVPIIHRDLEPSN 283
KGDL+++L+ + L P T +F A +IA GM YL K +HRDL N
Sbjct: 93 KGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARN 149
Query: 284 ILRDDSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
+ + +K+ DFG+++ + + R R++APE K+ + TK DV+SF +
Sbjct: 150 CMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGV 209
Query: 343 ILQEM 347
+L EM
Sbjct: 210 VLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 54/184 (29%), Positives = 96/184 (52%), Gaps = 8/184 (4%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK+ S+ A R E+ LL+++ HPN+++ L + +V E++ DL
Sbjct: 27 VAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDL 84
Query: 238 RAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
+K + P + ++ + + +G+ + H + I+HRDL+P N+L + G LK+AD
Sbjct: 85 YKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLAD 141
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
FG+++ RP T + Y APE+ ++ Y T VD++S I E++ P F
Sbjct: 142 FGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200
Query: 356 MKHD 359
K +
Sbjct: 201 GKSE 204
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-27
Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 7/177 (3%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K L + I +V +E +LQ IRHP +V G+ S + +V EY+P G+L
Sbjct: 29 YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL 88
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+ L++ G A +A + + YLH I++RDL+P N+L D G +K+ DF
Sbjct: 89 FSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDF 145
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G +K + + R T T Y+APE+ ++ Y VD ++ +++ EM+ G PPF
Sbjct: 146 GFAKRV---KGRTYTLCGT-PEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 75/229 (32%), Positives = 115/229 (50%), Gaps = 17/229 (7%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ G L R I VA+K L + + + R F E +++ + HPN++ G VT+
Sbjct: 19 EVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
S P+MIVTEY+ G L AFL++ G V IA GM YL + + +HRDL
Sbjct: 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 133
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
NIL + + KV+DFG+S++L ED P T R+ APE ++ +
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 190
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
DV+S+ +++ E++ G P+ + +V KA R P PA L+
Sbjct: 191 DVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 68/250 (27%), Positives = 111/250 (44%), Gaps = 42/250 (16%)
Query: 157 FTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
FT I KG+F + + I VA+K + E +D + + E+ L + R P
Sbjct: 3 FTLLECIGKGSFGEVY-KAIDKRTNQVVAIKVIDLE--EAEDEIEDIQQEIQFLSQCRSP 59
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
+ ++ G+ + S + I+ EY G LK G L + ++ G+ YLHE
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEG 118
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---------YV 321
IHRD++ +NIL + G++K+ADFGVS LT T + ++
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLT----------STMSKRNTFVGTPFWM 165
Query: 322 APEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT----MKHDNEVPKAYAARQRPPFKAP 377
APEV K YD K D++S + E+ +G PP + M+ +PK P
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK------NNPPSLE 219
Query: 378 AKLYARGLKE 387
+++ K+
Sbjct: 220 GNKFSKPFKD 229
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 78/233 (33%), Positives = 116/233 (49%), Gaps = 25/233 (10%)
Query: 159 NSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
N E+ KGT VAVK E+ + + +++ F E +L++ HPN+V+ +G
Sbjct: 7 NFGEVFKGTL----KDKTPVAVKTCKED-LPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 219 VTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
TQ P+ IV E +P GD +FL K+K LK V+FALD A GM YL IHR
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC----QDTSCRYVAPEVFKNEEYDT 333
DL N L ++ LK++DFG+S+ +ED + + ++ APE Y +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 334 KVDVFSFALILQEMIE--GCPPFTMKHDN---EVPKAYAARQRPPFKAPAKLY 381
+ DV+S+ ++L E CP M + +V K Y R P K P +Y
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--RMSCPQKCPDDVY 224
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 60/185 (32%), Positives = 94/185 (50%), Gaps = 17/185 (9%)
Query: 178 VAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEY 231
VA+KK + ++++ + A R E+ LLQK+RHPN+V+ VT + +V EY
Sbjct: 27 VALKK----IRMENEKEGFPITAIR-EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81
Query: 232 LPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
+ DL L S + + G+ YLH N I+HRD++ SNIL ++ G
Sbjct: 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDG 137
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIE 349
LK+ADFG+++ T + T + + Y PE+ Y +VD++S IL E+
Sbjct: 138 VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL 197
Query: 350 GCPPF 354
G P F
Sbjct: 198 GKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 57/178 (32%), Positives = 92/178 (51%), Gaps = 5/178 (2%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK E +D + A R E+ +L+++RH N+V A + + +V EY+ + L
Sbjct: 29 VAIKKFKESEDDEDVKKTALR-EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLL 87
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
G L P + + + + Y H + IIHRD++P NIL +SG LK+ DF
Sbjct: 88 ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDF 144
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
G ++ L + PLT + Y APE+ + Y VDV++ I+ E+++G P F
Sbjct: 145 GFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 67/233 (28%), Positives = 119/233 (51%), Gaps = 16/233 (6%)
Query: 163 ITKGTFILAFWRGIQVAVKK-LGEEVI---SDDDRVRAFRDELALLQKIRH---PNVVQF 215
I +G + A +RG V + + ++I + DD V + E+ALL ++R PN+ ++
Sbjct: 9 IGRGAY-GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
G+ + + I+ EY G +R L + G + ++ + Y+H+ V +I
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHK---VGVI 123
Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTK 334
HRD++ +NIL ++GN+K+ DFGV+ LL + T T ++APEV + YDTK
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTP-YWMAPEVITEGKYYDTK 182
Query: 335 VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387
D++S + + EM G PP++ D + +PP + Y++ L+E
Sbjct: 183 ADIWSLGITIYEMATGNPPYS-DVDAFRAMMLIPKSKPP-RLEDNGYSKLLRE 233
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 60/170 (35%), Positives = 91/170 (53%), Gaps = 17/170 (10%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALKPST 251
V A E+ LL+ ++H +VQ+ G + + + I EY+P G ++ LK GAL S
Sbjct: 48 VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV 107
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
++ I GM+YLH N I+HRD++ +NILRD +GN+K+ DFG SK L + +
Sbjct: 108 TRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL-----QTI 159
Query: 312 TCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
T R +++PEV E Y K DV+S + EM+ PP+
Sbjct: 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 60/189 (31%), Positives = 93/189 (49%), Gaps = 13/189 (6%)
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
D V+A R E+ L+ + H N+VQ+LG T + I EY+P G + + L+ G +
Sbjct: 50 DMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL 109
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
F + G+ YLH I+HRDL+ N+L D G K++DFG+SK +D
Sbjct: 110 VRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK---SDDIYD 163
Query: 312 TCQDTSCR----YVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPK 364
Q+ S + ++APEV + Y KVD++S ++ EM G P+ + + K
Sbjct: 164 NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223
Query: 365 AYAARQRPP 373
R PP
Sbjct: 224 LGNKRSAPP 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 21/221 (9%)
Query: 173 WRGI-----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
W G+ VAVK L + D F E +++K+RHP ++Q T P+ I
Sbjct: 23 WEGLWNNTTPVAVKTLKPGTMDPKD----FLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78
Query: 228 VTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
VTE + G L +L+ ALK + A +A GM YL IHRDL N+L
Sbjct: 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVL 135
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
++ KVADFG+++++ ++ APE + K DV+SF ++L
Sbjct: 136 VGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLT 195
Query: 346 EMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLY 381
E++ G P+ + EV + Y R P P +LY
Sbjct: 196 EIVTYGRMPYPGMTNAEVLQQVDQGY--RMPCPPGCPKELY 234
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 55/161 (34%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
EL + + + P +V++ GA SS + I EY G L + K+ +
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108
Query: 258 DIA----RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
IA +G++YLH K IIHRD++PSNIL G +K+ DFGVS L T
Sbjct: 109 KIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT- 164
Query: 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
TS Y+APE + + Y DV+S L L E+ + PF
Sbjct: 165 -GTS-FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-25
Identities = 58/166 (34%), Positives = 91/166 (54%), Gaps = 7/166 (4%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
V A E+ LL+ +RH +VQ+ G + + + I EY+P G ++ LK GAL +
Sbjct: 48 VNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV 107
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV--KEDR 309
R+ I +G++YLH N I+HRD++ +NILRD +GN+K+ DFG SK +
Sbjct: 108 TRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT 164
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
+ + +++PEV E Y K DV+S A + EM+ PP+
Sbjct: 165 GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VA+K + V D + E+++L++ P +V++ G+ +++ + IV EY
Sbjct: 28 GQVVAIKVV--PVEEDLQEII---KEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82
Query: 235 GDLRAFLKRKGALKPSTAVRFAL---DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
G + +K K T A +G+ YLH NK IHRD++ NIL ++ G
Sbjct: 83 GSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQ 137
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
K+ADFGVS LT + T T ++APEV + Y+ K D++S + EM EG
Sbjct: 138 AKLADFGVSGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAK 379
PP++ H + P P K
Sbjct: 197 PPYSDIHPMRAIFMIPNKPPPTLSDPEK 224
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 59/185 (31%), Positives = 94/185 (50%), Gaps = 7/185 (3%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+K++ + ++ + VR E +L + +V+ L A + + EY+P GD
Sbjct: 29 VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF 88
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
R L G L A + ++ ++ LHE + IHRDL+P N L D SG++K+ DF
Sbjct: 89 RTLLNNLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDF 145
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
G+SK + + + D Y+APEV + + YD VD +S +L E + G PPF+
Sbjct: 146 GLSKGIVTYANSVVGSPD----YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201
Query: 358 HDNEV 362
NE
Sbjct: 202 TPNET 206
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 45/166 (27%), Positives = 83/166 (50%), Gaps = 11/166 (6%)
Query: 199 DELALLQKIRHPNVVQFLG--AVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTA 252
E+ +L++++HPN+V++ + + IV EY GDL +++ + ++
Sbjct: 48 SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107
Query: 253 VRFALDIARGMNYLH---ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
R + + H + ++HRDL+P+NI D + N+K+ DFG++K+L
Sbjct: 108 WRILTQLLLALYECHNRSDPGNT-VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
T T Y++PE + YD K D++S ++ E+ PPFT
Sbjct: 167 AKTYVGTP-YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 55/157 (35%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
EL +L K P +V F GA + + I EY+ G L LK +G + + A+
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
+ +G+ YLHE IIHRD++PSNIL + G +K+ DFGVS L T
Sbjct: 109 VLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV--NSLAKT--FVGT 162
Query: 319 R-YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y+APE + +Y K D++S L L E+ G P+
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 69/217 (31%), Positives = 115/217 (52%), Gaps = 23/217 (10%)
Query: 153 HELDFTNS---VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
+E ++ + V + KGT+ + + +++A+K++ E D V+ +E+AL
Sbjct: 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALH 59
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKP--STAVRFALDIAR 261
++H N+VQ+LG+ +++ I E +P G L A L+ K G LK T + + I
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQDT-SCR 319
G+ YLH+N+ I+HRD++ N+L + SG +K++DFG SK L P T T + +
Sbjct: 120 GLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTETFTGTLQ 174
Query: 320 YVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPF 354
Y+APEV Y D++S + EM G PPF
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 73/231 (31%), Positives = 113/231 (48%), Gaps = 19/231 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ +G L R I VA+K L + + + R F E +++ + HPN++ G VT+
Sbjct: 19 EVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
S P+MI+TE++ G L +FL++ G V IA GM YL E + +HRDL
Sbjct: 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLA 133
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC-------RYVAPEVFKNEEYDT 333
NIL + + KV+DFG+S+ L ED TS R+ APE ++ +
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTS 190
Query: 334 KVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
DV+S+ +++ E M G P+ + +V A R PP P L+
Sbjct: 191 ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALH 241
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 70/234 (29%), Positives = 108/234 (46%), Gaps = 39/234 (16%)
Query: 176 IQVAVKKLGE--EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VA+K L E E + FR E L+ ++HPN+V LG T+ P ++ EYL
Sbjct: 36 TSVAIKTLKENAEPKVQQE----FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLA 91
Query: 234 KGDLRAFLKR----------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
GDL FL R K +L S + A+ IA GM YL + +HR
Sbjct: 92 HGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHR 148
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEY 331
DL N L + +K++DFG+S+ + V+ L R++ PE ++
Sbjct: 149 DLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL-----PVRWMPPEAILYGKF 203
Query: 332 DTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYA 382
T+ D++SF ++L E+ G P+ + EV + +RQ P PA++YA
Sbjct: 204 TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYA 257
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 65/184 (35%), Positives = 98/184 (53%), Gaps = 13/184 (7%)
Query: 175 GIQVAVKK--LGEEVISDD--DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
G VA+KK LGE + D + A R E+ LLQ+++HPN++ L S + +V E
Sbjct: 25 GRIVAIKKIKLGERKEAKDGINFT-ALR-EIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82
Query: 231 YLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
++ DL +K K L P+ + L RG+ YLH N I+HRDL+P+N+L
Sbjct: 83 FME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASD 138
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMI 348
G LK+ADFG+++ +R +T Q + Y APE+ F Y VD++S I E++
Sbjct: 139 GVLKLADFGLAR-SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELL 197
Query: 349 EGCP 352
P
Sbjct: 198 LRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 5e-24
Identities = 58/182 (31%), Positives = 92/182 (50%), Gaps = 15/182 (8%)
Query: 178 VAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K VI D + E+++L++ RHPN+V + G+ + + IV EY G
Sbjct: 31 VAIK-----VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L+ + +G L + +G+ YLHE IHRD++ +NIL + G++K+
Sbjct: 86 SLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKL 142
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGC 351
ADFGVS LT + + T ++APEV E YD K D+++ + E+ E
Sbjct: 143 ADFGVSAQLTATIAKRKSFIGTP-YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201
Query: 352 PP 353
PP
Sbjct: 202 PP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 5e-24
Identities = 57/191 (29%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VA+K L EE + + DE ++ + HP+VV+ LG + SS + ++T+ +P G
Sbjct: 37 IPVAIKVLREE--TSPKANKEILDEAYVMASVDHPHVVRLLG-ICLSSQVQLITQLMPLG 93
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L +++ K + + + + IA+GM+YL E + ++HRDL N+L ++K+
Sbjct: 94 CLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKI 150
Query: 295 ADFGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCP 352
DFG++KLL V E +++A E + Y K DV+S+ + + E M G
Sbjct: 151 TDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
Query: 353 PFTMKHDNEVP 363
P+ E+P
Sbjct: 211 PYEGIPAVEIP 221
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 7e-24
Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 162 EITKGT-FILAFWRGIQ-VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
++ K T F L G VAVK L E + +R E LL+++ HP+V++ GA
Sbjct: 15 KVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLKQVNHPHVIKLYGAC 72
Query: 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPS------------------------TAVRF 255
+Q P++++ EY G LR+FL+ + PS + F
Sbjct: 73 SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISF 132
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
A I+RGM YL E K ++HRDL N+L + +K++DFG+S+ + ++ +
Sbjct: 133 AWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKG 189
Query: 316 -TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF 354
+++A E + Y T+ DV+SF ++L E++ G P+
Sbjct: 190 RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 8e-24
Identities = 61/185 (32%), Positives = 84/185 (45%), Gaps = 28/185 (15%)
Query: 176 IQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
I VAVK L + +SD DD F E A++ + H N+++ G V P+M+VTE P
Sbjct: 24 IPVAVKCLKSDKLSDIMDD----FLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78
Query: 234 KGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
G L L+ G ST +A+ IA GM YL + IHRDL NIL
Sbjct: 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDK 135
Query: 292 LKVADFGVSKLLTVKEDR---------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
+K+ DFG+ + L ED P + APE + + DV+ F +
Sbjct: 136 VKIGDFGLMRALPQNEDHYVMEEHLKVPFA-------WCAPESLRTRTFSHASDVWMFGV 188
Query: 343 ILQEM 347
L EM
Sbjct: 189 TLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 9e-24
Identities = 59/186 (31%), Positives = 95/186 (51%), Gaps = 9/186 (4%)
Query: 175 GIQVAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSSPMMIVTE 230
G ++AVK++ E V A E+ LL+ + H +VQ+ G + + I E
Sbjct: 27 GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
++P G ++ LK GAL + ++ I G++YLH N I+HRD++ +NILRD G
Sbjct: 87 HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVG 143
Query: 291 NLKVADFGVSKLLTV--KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
N+K+ DFG SK L + + +++PEV E Y K D++S + EM+
Sbjct: 144 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML 203
Query: 349 EGCPPF 354
PP+
Sbjct: 204 TEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 1e-23
Identities = 70/217 (32%), Positives = 107/217 (49%), Gaps = 18/217 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
V VK L + D++ FR EL + +K+ H NVV+ LG ++ P ++ EY GDL
Sbjct: 38 VLVKALQK--TKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95
Query: 238 RAFL----KRKGALKP---STAVRFAL--DIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
+ FL + LKP ST + AL IA GM++L + +HRDL N L
Sbjct: 96 KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSS 152
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
+KV+ +SK + E L R++APE + +++ TK DV+SF +++ E+
Sbjct: 153 QREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212
Query: 349 -EGCPPFTMKHDNEV---PKAYAARQRPPFKAPAKLY 381
+G PF D EV +A P P++LY
Sbjct: 213 TQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY 249
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-23
Identities = 68/213 (31%), Positives = 111/213 (52%), Gaps = 18/213 (8%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VAVK L +S V+AF +E L++ ++H +V+ VT+ P+ I+TEY+ KG
Sbjct: 32 KVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87
Query: 237 LRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L FLK G + + F+ IA GM Y+ IHRDL +N+L +S K+
Sbjct: 88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKI 144
Query: 295 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
ADFG+++++ ED T ++ + ++ APE + K DV+SF ++L E++ G
Sbjct: 145 ADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYG 201
Query: 351 CPPFTMKHDNEVPKAYAARQRPPF--KAPAKLY 381
P+ +++V A R P P +LY
Sbjct: 202 KIPYPGMSNSDVMSALQRGYRMPRMENCPDELY 234
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-23
Identities = 51/156 (32%), Positives = 91/156 (58%), Gaps = 7/156 (4%)
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
+E +L+++ HP +++ + ++ EY+P G+L ++L+ G ST + +A +
Sbjct: 50 NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
I + YLH + I++RDL+P NIL D G++K+ DFG +K L DR T T
Sbjct: 110 IVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR---DRTWTLCGTP- 162
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y+APEV +++ ++ VD ++ +++ EM+ G PPF
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-23
Identities = 55/224 (24%), Positives = 107/224 (47%), Gaps = 10/224 (4%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
++ +G ++ I VAVK + F E ++++ HP++V+ +G +T+
Sbjct: 21 DVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78
Query: 222 SSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
+ P+ IV E P G+LR++L K +L ++ + ++ ++ + YL + V HRD+
Sbjct: 79 N-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFV---HRDIA 134
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
N+L +K+ DFG+S+ L + + +++APE + + DV+ F
Sbjct: 135 ARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 194
Query: 341 ALILQE-MIEGCPPFTMKHDNEVPKAYAARQRPPF--KAPAKLY 381
+ + E ++ G PF +N+V +R P P LY
Sbjct: 195 GVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 238
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 60/185 (32%), Positives = 92/185 (49%), Gaps = 5/185 (2%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++VI DD V E +L +HP + Q + V EY+ GDL
Sbjct: 24 AVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R G A +A +I G+ +LHE II+RDL+ N+L D G++K+ADF
Sbjct: 84 MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADF 140
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
G+ K + T T Y+APE+ + Y VD ++ ++L EM+ G PF
Sbjct: 141 GMCKEGILGGVTTSTFCGTP-DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
Query: 358 HDNEV 362
++E+
Sbjct: 200 DEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-23
Identities = 70/229 (30%), Positives = 113/229 (49%), Gaps = 17/229 (7%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ +G + + + VA+K L + ++ R F E +++ + H N+++ G VT+
Sbjct: 20 EVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQD-FLSEASIMGQFSHHNIIRLEGVVTK 77
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
P MI+TEY+ G L +L+ G V IA GM YL + + +HRDL
Sbjct: 78 FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLA 134
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
NIL + + KV+DFG+S++L ED P TS R+ APE ++ +
Sbjct: 135 ARNILVNSNLECKVSDFGLSRVL---EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSAS 191
Query: 336 DVFSFALILQE-MIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLY 381
DV+SF +++ E M G P+ ++EV KA R P P+ +Y
Sbjct: 192 DVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 177 QVAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VAVK L + D R F E+ +L ++ PN+ + LG T P+ ++ EY+ G
Sbjct: 48 LVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104
Query: 236 DLRAFLKR-----------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
DL FL++ +L ST + A IA GM YL V HRDL N
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV---HRDLATRNC 161
Query: 285 LRDDSGNLKVADFGVSKLLTVK-----EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
L + +K+ADFG+S+ L + R R++A E ++ TK DV++
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAP----LPIRWMAWESVLLGKFTTKSDVWA 217
Query: 340 FALILQEMIEGC--PPFTMKHDNEV 362
F + L E++ C P+ D +V
Sbjct: 218 FGVTLWEILTLCREQPYEHLTDQQV 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-23
Identities = 71/237 (29%), Positives = 117/237 (49%), Gaps = 19/237 (8%)
Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQK 206
DP EL FT I KG+F ++GI K++ I D +D + + E+ +L +
Sbjct: 1 DPEEL-FTKLERIGKGSF-GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
P + ++ G+ + + + I+ EYL G LK G L+ + +I +G++YL
Sbjct: 59 CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYL 117
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
H + IHRD++ +N+L + G++K+ADFGV+ LT + + T T ++APEV
Sbjct: 118 HSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVI 173
Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV--------PKAYAARQRPPFK 375
K YD K D++S + E+ +G PP + H V P + PFK
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFK 230
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-23
Identities = 48/104 (46%), Positives = 64/104 (61%), Gaps = 5/104 (4%)
Query: 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
N D+DG L A+ +E +K LL++G DVN +D D RT LH+AA G E+
Sbjct: 1 NARDEDGRTP-----LHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEI 55
Query: 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V LLLE+GADV+ +D+ G+TPL A N +V+KLL KHGA
Sbjct: 56 VKLLLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGADV 99
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 6e-23
Identities = 68/215 (31%), Positives = 110/215 (51%), Gaps = 23/215 (10%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VA+K L + +S + AF E L+++++HP +V+ VTQ P+ I+TEY+ G
Sbjct: 32 KVAIKSLKQGSMSPE----AFLAEANLMKQLQHPRLVRLYAVVTQE-PIYIITEYMENGS 86
Query: 237 LRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L FLK L + + A IA GM ++ IHRDL +NIL ++ K+
Sbjct: 87 LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKI 143
Query: 295 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
ADFG+++L+ ED T ++ + ++ APE + K DV+SF ++L E++ G
Sbjct: 144 ADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYG 200
Query: 351 CPPFTMKHDNEV----PKAYAARQRPPFKAPAKLY 381
P+ + EV + Y R P P +LY
Sbjct: 201 RIPYPGMTNPEVIQNLERGY--RMPRPDNCPEELY 233
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 8e-23
Identities = 51/166 (30%), Positives = 98/166 (59%), Gaps = 9/166 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAVRFA 256
E++L+++++H N+V+ + + +M+V EY+ K DL+ ++ +GAL P+T F
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
+ +G+ + HEN+ ++HRDL+P N+L + G LK+ADFG+++ + + + +
Sbjct: 107 YQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV 162
Query: 317 SCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361
+ Y AP+V + Y T +D++S I+ EMI G P F ++ +
Sbjct: 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 1e-22
Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 23/200 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+ A+K L + + + +V+ ++ L + HP +++ + V EY P
Sbjct: 26 NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G+L ++++ G+L +A +I + YLH IIHRDL+P NIL D ++K
Sbjct: 86 NGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIK 142
Query: 294 VADFGVSKLL---------------TVKEDRPLTCQDTS----CRYVAPEVFKNEEYDTK 334
+ DFG +K+L + + S YV+PE+ +
Sbjct: 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS 202
Query: 335 VDVFSFALILQEMIEGCPPF 354
D+++ I+ +M+ G PPF
Sbjct: 203 SDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-22
Identities = 42/89 (47%), Positives = 54/89 (60%), Gaps = 2/89 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A ++E +K LL+ G DVN D TALH+AA G E+V LLLE GADV+ KD
Sbjct: 1 LHLAAKNGNLELVKLLLEKGADVNLGD--TDTALHLAARNGNLEIVKLLLEHGADVNAKD 58
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ G+T L A N E++KLL +HGA
Sbjct: 59 KDGNTALHLAARNGNLEIVKLLLEHGADI 87
|
Length = 91 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-22
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF +I KG+F + F A+K++ ++ +R A DE +L K+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSS 59
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
++++ + + IV EY GDL LK R L RF + I G+ +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
K I+HRD++ N+ D N+K+ D GV+KLL+ + T T Y++PE+ ++
Sbjct: 120 KK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTP-YYLSPELCED 175
Query: 329 EEYDTKVDVFSFALILQEMIEGCPPF 354
+ Y+ K DV++ ++L E G PF
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 3e-22
Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 19/220 (8%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
+QVAVK L E S+ D F E ++ K H N+V+ +G + P I+ E + G
Sbjct: 37 LQVAVKTL-PESCSEQDESD-FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGG 94
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
DL++FL+ R +PS+ + A D+A+G YL EN IHRD+ N L
Sbjct: 95 DLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTC 151
Query: 289 SGN---LKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
G K+ADFG+++ + R +++ PE F + + +K DV+SF ++L
Sbjct: 152 KGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLL 211
Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLY 381
E+ G P+ + + EV + R PP P +Y
Sbjct: 212 WEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVY 251
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-22
Identities = 72/204 (35%), Positives = 108/204 (52%), Gaps = 18/204 (8%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
G + W G +VAVK L +S + +F +E +++K+RH +VQ L AV P
Sbjct: 20 GEVWMGTWNGNTKVAVKTLKPGTMSPE----SFLEEAQIMKKLRHDKLVQ-LYAVVSEEP 74
Query: 225 MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ IVTEY+ KG L FLK ALK V A +A GM Y+ + IHRDL +
Sbjct: 75 IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSA 131
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
NIL D K+ADFG+++L+ ED T + + ++ APE + K DV+S
Sbjct: 132 NILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 340 FALILQEMI-EGCPPFTMKHDNEV 362
F ++L E++ +G P+ ++ EV
Sbjct: 189 FGILLTELVTKGRVPYPGMNNREV 212
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-22
Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 14/189 (7%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+VA+K++ E V R E+ + + HPNVV++ + + +V YL
Sbjct: 25 NNEKVAIKRIDLEKCQTS--VDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82
Query: 234 KGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
G L +K G L + ++ +G+ YLH N IHRD++ NIL + G
Sbjct: 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDG 139
Query: 291 NLKVADFGVSKLLTVKEDRPL----TCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQ 345
++K+ADFGVS L DR T T C ++APEV + YD K D++SF +
Sbjct: 140 SVKIADFGVSASLADGGDRTRKVRKTFVGTPC-WMAPEVMEQVHGYDFKADIWSFGITAI 198
Query: 346 EMIEGCPPF 354
E+ G P+
Sbjct: 199 ELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 60/182 (32%), Positives = 95/182 (52%), Gaps = 10/182 (5%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPK 234
VA+KK+ + D + + R E+ LL +RHPN+V+ V + +V EY +
Sbjct: 34 IVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ 92
Query: 235 GDLRAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
DL + L + V+ L + RG+ YLHEN IIHRDL+ SN+L D G LK
Sbjct: 93 -DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLK 148
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 352
+ADFG+++ + +P+T + + Y APE+ Y T +D+++ IL E++ P
Sbjct: 149 IADFGLARTYGLP-AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP 207
Query: 353 PF 354
Sbjct: 208 LL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-22
Identities = 68/197 (34%), Positives = 105/197 (53%), Gaps = 15/197 (7%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSS 223
GT I + + I AVK L I+D + V F E +++ HPNV+ LG ++ S
Sbjct: 14 GTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGS 71
Query: 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEP 281
P+ +V Y+ GDLR F+ R P+ + F L +A+GM YL K +HRDL
Sbjct: 72 PL-VVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAA 126
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKE---DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
N + D+S +KVADFG+++ + KE T +++A E + +++ TK DV+
Sbjct: 127 RNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVW 186
Query: 339 SFALILQE-MIEGCPPF 354
SF ++L E M G PP+
Sbjct: 187 SFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-22
Identities = 54/186 (29%), Positives = 101/186 (54%), Gaps = 13/186 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G Q +K++ +S +R + R E+A+L ++HPN+VQ+ + ++ + IV +Y
Sbjct: 25 GKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83
Query: 235 GDLRAFL-KRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL + ++G L P + + + I + ++H+ K I+HRD++ NI G +
Sbjct: 84 GDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTI 140
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
K+ DFG++++L + TC T Y++PE+ +N Y+ K D+++ +L EM
Sbjct: 141 KLGDFGIARVLNSTVELARTCIGTP-YYLSPEICENRPYNNKSDIWALGCVLYEMC---- 195
Query: 353 PFTMKH 358
T+KH
Sbjct: 196 --TLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 4e-22
Identities = 54/177 (30%), Positives = 88/177 (49%), Gaps = 5/177 (2%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + + I + + E +L++ HP +V+ + ++ EY G+L
Sbjct: 22 ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELW 81
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L+ +G TA + + YLH II+RDL+P N+L D +G +K+ DFG
Sbjct: 82 TILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFG 138
Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
+K L + + T T YVAPE+ N+ YD VD +S ++L E++ G PPF
Sbjct: 139 FAKKLKSGQ-KTWTFCGTP-EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 4e-22
Identities = 60/183 (32%), Positives = 98/183 (53%), Gaps = 12/183 (6%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA-VTQSSPMMIVTEYL 232
G VA+KK+ + + R +R EL LL+ +RH N++ ++ + VTE L
Sbjct: 34 TGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL 92
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL L L+ F I RG+ Y+H ++HRDL+PSNIL +++ +L
Sbjct: 93 GT-DLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDL 147
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGC 351
K+ DFG++++ +D +T ++ Y APE+ ++YD +VD++S I EM+EG
Sbjct: 148 KICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
Query: 352 PPF 354
P F
Sbjct: 204 PLF 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 5e-22
Identities = 57/182 (31%), Positives = 96/182 (52%), Gaps = 21/182 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAF--RDELALLQKIR---HPNVVQFLG-----AVTQSSPMMI 227
VA+KK+ V ++ + R E+ALL+++ HPN+V+ L + + +
Sbjct: 27 VALKKV--RVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83
Query: 228 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
V E++ + DL +L + K L P T + RG+++LH ++ I+HRDL+P NIL
Sbjct: 84 VFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNIL 139
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
G +K+ADFG++++ + + LT + Y APEV Y T VD++S I
Sbjct: 140 VTSDGQVKIADFGLARIYS--FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFA 197
Query: 346 EM 347
E+
Sbjct: 198 EL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 5e-22
Identities = 60/182 (32%), Positives = 101/182 (55%), Gaps = 13/182 (7%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+KK+ E ++D+ V A R E++LL+++ HPN+V+ L V + + +V E+L
Sbjct: 27 VALKKIRLE--TEDEGVPSTAIR-EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL- 82
Query: 236 DLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
DL+ ++ L P + + +G+ Y H ++ ++HRDL+P N+L D G LK
Sbjct: 83 DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALK 139
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 352
+ADFG+++ V R T + + Y APE+ + +Y T VD++S I EM+ P
Sbjct: 140 LADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP 198
Query: 353 PF 354
F
Sbjct: 199 LF 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 71/215 (33%), Positives = 109/215 (50%), Gaps = 14/215 (6%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
DF + + KG+F +LA +G A+K L ++VI DD V E LAL K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK- 59
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
P + Q + V EY+ GDL +++ G K AV +A +IA G+ +LH
Sbjct: 60 -PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
II+RDL+ N++ D G++K+ADFG+ K T T Y+APE+
Sbjct: 119 SKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP-DYIAPEIIA 174
Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
+ Y VD ++F ++L EM+ G PPF + ++E+
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 20/209 (9%)
Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAF---RDELALLQKIRHPNVVQFL 216
KG+F +LA +G A+K L ++V+ +DD V R LAL + HP +
Sbjct: 5 KGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWE--HPFLTHLF 62
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ V EYL GDL ++ G + A +A +I G+ +LH+ II+
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIY 119
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDT 333
RDL+ N+L D G++K+ADFG+ K E + T C Y+APE+ K ++Y+
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK----ASTFCGTPDYIAPEILKGQKYNE 175
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEV 362
VD +SF ++L EM+ G PF + ++E+
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 6e-22
Identities = 65/195 (33%), Positives = 94/195 (48%), Gaps = 27/195 (13%)
Query: 175 GIQVAVKKLGEEVISDD-DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIV 228
G +VA+KK+ V D D R R E+ LL+ +RH N++ L + SP IV
Sbjct: 25 GRKVAIKKI-SNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
TE + DL +K L F I RG+ YLH +IHRDL+PSNIL +
Sbjct: 83 TELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNS 138
Query: 289 SGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYV------APEVFKN-EEYDTKVDVFS 339
+ +LK+ DFG+++ + ED LT YV APE+ + Y +D++S
Sbjct: 139 NCDLKICDFGLARGVDPDEDEKGFLT------EYVVTRWYRAPELLLSSSRYTKAIDIWS 192
Query: 340 FALILQEMIEGCPPF 354
I E++ P F
Sbjct: 193 VGCIFAELLTRKPLF 207
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 6e-22
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 39/199 (19%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VAVK L ++ D + E+ +++ I +H N++ LG TQ P+ +V EY
Sbjct: 43 STVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAH 100
Query: 235 GDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
G+LR FL+ + L V FA +ARGM +L K IHRD
Sbjct: 101 GNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRD 157
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----TSCR----YVAPEVFKNE 329
L N+L + +K+ADFG++ R + D T+ R ++APE +
Sbjct: 158 LAARNVLVTEDHVMKIADFGLA--------RDIHHIDYYRKTTNGRLPVKWMAPEALFDR 209
Query: 330 EYDTKVDVFSFALILQEMI 348
Y + DV+SF ++L E+
Sbjct: 210 VYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 9e-22
Identities = 69/218 (31%), Positives = 111/218 (50%), Gaps = 15/218 (6%)
Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALL 204
DP EL FT I KG+F F +GI VA+K + E +D + + E+ +L
Sbjct: 1 DPEEL-FTKLERIGKGSFGEVF-KGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEITVL 56
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN 264
+ P V ++ G+ + + + I+ EYL G L R G +I +G++
Sbjct: 57 SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLD 115
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YLH K IHRD++ +N+L + G++K+ADFGV+ LT + + T T ++APE
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPE 171
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
V + YD+K D++S + E+ +G PP + H V
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV 209
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 9e-22
Identities = 74/241 (30%), Positives = 121/241 (50%), Gaps = 14/241 (5%)
Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQK 206
DP EL FT +I KG+F F +GI +K+ I D +D + + E+ +L +
Sbjct: 1 DPEEL-FTKLEKIGKGSFGEVF-KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
P V ++ G+ + + + I+ EYL G L+ G L + +I +G++YL
Sbjct: 59 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYL 117
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
H K IHRD++ +N+L + G +K+ADFGV+ LT + + T T ++APEV
Sbjct: 118 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVI 173
Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386
K YD+K D++S + E+ +G PP + H +V P + Y++ LK
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGN---YSKPLK 230
Query: 387 E 387
E
Sbjct: 231 E 231
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 9e-22
Identities = 52/190 (27%), Positives = 94/190 (49%), Gaps = 11/190 (5%)
Query: 174 RGIQVAVKKLG---EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
+G +AVK++ V++ + ++E+ LL+ ++H N+VQ+LG + + I E
Sbjct: 23 QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
++P G + + L R G L ++ I G+ YLH N ++HRD++ +N++ +G
Sbjct: 83 FVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNG 139
Query: 291 NLKVADFGVSKLL-----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
+K+ DFG ++ L L + ++APEV Y K D++S +
Sbjct: 140 IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVF 199
Query: 346 EMIEGCPPFT 355
EM G PP
Sbjct: 200 EMATGKPPLA 209
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 45/211 (21%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + +++ R E +L P +V+ + + +V EY+P GDL
Sbjct: 30 AMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLM 89
Query: 239 AFLKRKGALKPSTAVRF-------ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L RK TA RF ALD + + IHRD++P NIL D G+
Sbjct: 90 NLLIRKDVFPEETA-RFYIAELVLALDSVHKLGF---------IHRDIKPDNILIDADGH 139
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDT----------------------------SCRYVAP 323
+K+ADFG+ K + +DR D+ + Y+AP
Sbjct: 140 IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP 199
Query: 324 EVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
EV + Y + D +S +IL EM+ G PPF
Sbjct: 200 EVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 58/185 (31%), Positives = 91/185 (49%), Gaps = 5/185 (2%)
Query: 179 AVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++ I + E LL+ ++HP +V + + + V +Y+ G+L
Sbjct: 24 AVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGEL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L+R+ + A +A +IA + YLH II+RDL+P NIL D G++ + DF
Sbjct: 84 FFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDF 140
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
G+ K T T Y+APEV + + YD VD + +L EM+ G PPF +
Sbjct: 141 GLCKEGIEHSKTTSTFCGTP-EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199
Query: 358 HDNEV 362
E+
Sbjct: 200 DTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-21
Identities = 77/231 (33%), Positives = 116/231 (50%), Gaps = 29/231 (12%)
Query: 162 EITKGTFILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220
E+ GT W G +VA+K L +S + AF E +++K+RH +VQ L AV
Sbjct: 21 EVWMGT-----WNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-LYAVV 70
Query: 221 QSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
P+ IVTEY+ KG L FLK + L+ V A IA GM Y+ + +HRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 127
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKV 335
L +NIL ++ KVADFG+++L+ ED T + + ++ APE + K
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 336 DVFSFALILQEM-IEGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLY 381
DV+SF ++L E+ +G P+ + E V + Y R P + P L+
Sbjct: 185 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCPPECPESLH 233
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 52/173 (30%), Positives = 100/173 (57%), Gaps = 9/173 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
V +K++ E ++ D+R+ A ++E +L+ + HPN++++ + +MIV EY P G L
Sbjct: 28 VIIKQIPVEQMTKDERLAA-QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTL 86
Query: 238 RAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKV 294
+++++ L T + F + I ++++H I+HRDL+ NIL D +K+
Sbjct: 87 AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKI 143
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
DFG+SK+L+ K + T T C Y++PE+ + + Y+ K D+++ +L E+
Sbjct: 144 GDFGISKILSSKS-KAYTVVGTPC-YISPELCEGKPYNQKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-21
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIV 228
+VAVK L ++ S D + F E A +++ HPNV++ +G +S M++
Sbjct: 27 FQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85
Query: 229 TEYLPKGDLRAFL--KRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
++ GDL FL R G L T VRF +DIA GM YL IHRDL
Sbjct: 86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAAR 142
Query: 283 NILRDDSGNLKVADFGVS-KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
N + +++ + VADFG+S K+ + R +++A E + Y T DV++F
Sbjct: 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFG 202
Query: 342 LILQE-MIEGCPPFTMKHDNEVPKAYAA--RQRPPFKAPAKLY 381
+ + E M G P+ ++E+ R + P +Y
Sbjct: 203 VTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVY 245
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 4e-21
Identities = 69/218 (31%), Positives = 110/218 (50%), Gaps = 20/218 (9%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
DF + + KG+F +LA +G A+K L ++V+ DD V E LAL K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK- 59
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
P + Q + V EY+ GDL +++ G K AV +A +I+ G+ +LH
Sbjct: 60 -PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPE 324
II+RDL+ N++ D G++K+ADFG+ K V T C Y+APE
Sbjct: 119 RRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFCGTPDYIAPE 171
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
+ + Y VD +++ ++L EM+ G PPF + ++E+
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-21
Identities = 54/181 (29%), Positives = 93/181 (51%), Gaps = 7/181 (3%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
G A+K L + I +V+ E ++L ++ HP +V + + + + + E++
Sbjct: 42 TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVV 101
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G+L L++ G A + ++ YLH II+RDL+P N+L D+ G++K
Sbjct: 102 GGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVK 158
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
V DFG +K + DR T T Y+APEV +++ + VD ++ ++L E I G PP
Sbjct: 159 VTDFGFAKKVP---DRTFTLCGTP-EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
Query: 354 F 354
F
Sbjct: 215 F 215
|
Length = 329 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 7e-21
Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 178 VAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VAVK E + D ++A F E +L++ HPN+V+ +G TQ P+ IV E + GD
Sbjct: 23 VAVKSCRETLPPD---LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79
Query: 237 LRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
FL+ +G LK ++ + A GM YL E+K IHRDL N L + LK++
Sbjct: 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYL-ESKHC--IHRDLAARNCLVTEKNVLKIS 136
Query: 296 DFGVSKLLTVKEDRPLTC----QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
DFG+S+ +ED + ++ APE Y ++ DV+SF ++L E G
Sbjct: 137 DFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLG 193
Query: 351 CPPFTMKHDNEVPKAY--AARQRPPFKAPAKLY 381
P+ + + +A R P P +Y
Sbjct: 194 AVPYANLSNQQTREAIEQGVRLPCPELCPDAVY 226
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 7e-21
Identities = 65/194 (33%), Positives = 97/194 (50%), Gaps = 24/194 (12%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A K+ +E S++D R F EL +L K+ HPN++ LGA + I EY P G+L
Sbjct: 32 AAIKMLKEFASENDH-RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNL 90
Query: 238 RAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIHRDLEP 281
FL++ L+ A ++FA D+A GM YL E + IHRDL
Sbjct: 91 LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAA 147
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
N+L ++ K+ADFG+S+ V + T R++A E Y TK DV+SF
Sbjct: 148 RNVLVGENLASKIADFGLSRGEEVYVKK--TMGRLPVRWMAIESLNYSVYTTKSDVWSFG 205
Query: 342 LILQEMIE-GCPPF 354
++L E++ G P+
Sbjct: 206 VLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 8e-21
Identities = 62/197 (31%), Positives = 92/197 (46%), Gaps = 24/197 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP------MMIVTE 230
VA+K + +D ++E +L+K HPN+ F GA + +P + +V E
Sbjct: 34 VAIKIMD----IIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89
Query: 231 YLPKG---DL-RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
G DL + K+ LK + RG+ YLHENK +IHRD++ NIL
Sbjct: 90 LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILL 146
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTKVDVFSFA 341
+ +K+ DFGVS L R T T ++APEV +E YD + DV+S
Sbjct: 147 TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY-WMAPEVIACDEQPDASYDARSDVWSLG 205
Query: 342 LILQEMIEGCPPFTMKH 358
+ E+ +G PP H
Sbjct: 206 ITAIELADGKPPLCDMH 222
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 8e-21
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 179 AVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
AVK L ++ I + + + A R+ LL+ ++HP +V + + + V +Y+ G
Sbjct: 24 AVKVLQKKTILKKKEQNHIMAERN--VLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
+L L+R+ A +A ++A + YLH + II+RDL+P NIL D G++ +
Sbjct: 82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLT 138
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
DFG+ K E+ T T Y+APEV + E YD VD + +L EM+ G PPF
Sbjct: 139 DFGLCKEGVEPEETTSTFCGTP-EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF- 196
Query: 356 MKHDNEVPKAYAARQRPPFKAP 377
+ +V + Y P + P
Sbjct: 197 --YSRDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-20
Identities = 56/163 (34%), Positives = 90/163 (55%), Gaps = 12/163 (7%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPS-TAVRF 255
R E LL K++HPN+V F + + IV EY GDL +K ++G L P T +++
Sbjct: 46 RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
+ + G+ ++HE + ++HRD++ NI +G +K+ DFG ++LLT T
Sbjct: 106 FVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVG 162
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358
T YV PE+++N Y+ K D++S IL E+ C T+KH
Sbjct: 163 TP-YYVPPEIWENMPYNNKSDIWSLGCILYEL---C---TLKH 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-20
Identities = 56/187 (29%), Positives = 99/187 (52%), Gaps = 20/187 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYL 232
G QVAVK L E S + + + E+ +L+ + H N+V++ G T+ + + ++ E+L
Sbjct: 33 GEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90
Query: 233 PKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
P G L+ +L R K + +++A+ I +GM+YL + +HRDL N+L +
Sbjct: 91 PSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 147
Query: 292 LKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+K+ DFG++K + TVK+D D+ + APE ++ DV+SF + L
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDL-----DSPVFWYAPECLIQSKFYIASDVWSFGVTL 202
Query: 345 QEMIEGC 351
E++ C
Sbjct: 203 YELLTYC 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-20
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQF 215
I+KG F LA R G A+K L + + ++V + E A++ P V +
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
+ + +V EYL GD + +K G L A ++ ++ G+ LH+ II
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---II 119
Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
HRD++P N+L D +G+LK+ DFG+S+ + T Y+APE D
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD-----YLAPETILGVGDDKMS 174
Query: 336 DVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
D +S ++ E + G PPF E P A
Sbjct: 175 DWWSLGCVIFEFLFGYPPF----HAETPDAVFDN 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 67/230 (29%), Positives = 102/230 (44%), Gaps = 33/230 (14%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VAVK L E + +D + F E LL +H N+V+F G T+ P ++V EY+ G
Sbjct: 36 ELVAVKTLKE--TASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHG 93
Query: 236 DLRAFLKR--------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
DL FL+ G L S ++ A+ IA GM YL V HRDL
Sbjct: 94 DLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFV---HRDLAT 150
Query: 282 SNILRDDSGNLKVADFGVSK------LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
N L +K+ DFG+S+ V L R++ PE ++ T+
Sbjct: 151 RNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML-----PIRWMPPESIMYRKFTTES 205
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYA 382
DV+SF ++L E+ G P+ + EV + + + P P+++Y
Sbjct: 206 DVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYD 255
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 54/175 (30%), Positives = 88/175 (50%), Gaps = 16/175 (9%)
Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KG 245
I ++ + F E+ +L + +HPN+V A + + I+ E+ G L + + +G
Sbjct: 40 IESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG 99
Query: 246 ALKPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
+P R L+ +N+LH +K +IHRDL+ NIL G++K+ADFGVS
Sbjct: 100 LTEPQIRYVCRQMLE---ALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKN 153
Query: 304 TVKEDRPLTCQDTSCRYVAPEV-----FKNEEYDTKVDVFSFALILQEMIEGCPP 353
+ T T ++APEV FK+ YD K D++S + L E+ + PP
Sbjct: 154 KSTLQKRDTFIGTP-YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-20
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 33/206 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS---PMMIVTEYLPK 234
VAVKKL S + +R F E+ +L+ ++H N+V++ G V S+ + +V EYLP
Sbjct: 36 VAVKKLQH---STAEHLRDFEREIEILKSLQHDNIVKYKG-VCYSAGRRNLRLVMEYLPY 91
Query: 235 GDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G LR +L K + L + +A I +GM YL + +HRDL NIL + +K
Sbjct: 92 GSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVK 148
Query: 294 VADFGVSKLL-------TVKE--DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+ DFG++K+L V+E + P+ + APE ++ DV+SF ++L
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIF-------WYAPESLTESKFSVASDVWSFGVVL 201
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQ 370
E+ FT + P A R
Sbjct: 202 YEL------FTYSDKSCSPPAEFMRM 221
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-20
Identities = 39/82 (47%), Positives = 50/82 (60%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A +E +K LL+ G DVN RD D T LH+AA G +VV LLL+ GADV+ +D
Sbjct: 44 LHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGADVNARD 103
Query: 104 RWGSTPLGDAIYYKNHEVIKLL 125
+ G TPL A + EV+KLL
Sbjct: 104 KDGRTPLHLAAKNGHLEVVKLL 125
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 3e-20
Identities = 56/188 (29%), Positives = 83/188 (44%), Gaps = 13/188 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL-GAVTQSSPMMIVTEYLP 233
G +VA+K L + ++ + FR E AL ++ HPN+V L + V EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 290
LR L GAL R L + + H I+HRDL+P NI+
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRP 119
Query: 291 NLKVADFGVSKLLT-VKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+ KV DFG+ LL V++ T T + Y APE + E D++++ LI
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 345 QEMIEGCP 352
E + G
Sbjct: 180 LECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 3e-20
Identities = 67/210 (31%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIR 208
D+T +I +GT+ + + G VA+KK+ E S+++ V A R E++LL++++
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIR-EISLLKELQ 57
Query: 209 HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFAL-DIARGMNY 265
HPN+V + Q S + ++ E+L DL+ +L KG + V+ L I +G+ +
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
H + ++HRDL+P N+L D+ G +K+ADFG+++ + R T + + Y APEV
Sbjct: 117 CHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEV 172
Query: 326 F-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
+ Y T VD++S I EM P F
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 5e-20
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVK L EE + D F+ E AL+ + HPN+V+ LG PM ++ EY+ GDL
Sbjct: 38 VAVKMLKEE--ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDL 95
Query: 238 RAFLKRKGALKPSTAVR----------------------FALDIARGMNYLHENKPVPII 275
FL+ + + A +A GM YL E K +
Sbjct: 96 NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FV 152
Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTK 334
HRDL N L ++ +K+ADFG+S+ + + + D R++ PE Y T+
Sbjct: 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE 212
Query: 335 VDVFSFALILQEMIE-GCPP-FTMKHD 359
DV+++ ++L E+ G P + M H+
Sbjct: 213 SDVWAYGVVLWEIFSYGMQPYYGMAHE 239
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 5e-20
Identities = 64/194 (32%), Positives = 95/194 (48%), Gaps = 24/194 (12%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A K +E S DD R F EL +L K+ HPN++ LGA + + EY P G+L
Sbjct: 25 AAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 83
Query: 238 RAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIHRDLEP 281
FL++ L+ A + FA D+ARGM+YL + + IHRDL
Sbjct: 84 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAA 140
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
NIL ++ K+ADFG+S+ V + T R++A E Y T DV+S+
Sbjct: 141 RNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYG 198
Query: 342 LILQEMIE-GCPPF 354
++L E++ G P+
Sbjct: 199 VLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 5e-20
Identities = 55/215 (25%), Positives = 106/215 (49%), Gaps = 15/215 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGE-EVISDDDRVRAFRDELALLQKIRH 209
+F +I KG F + + G VA+KK+ E++ R + E+ LL+++ H
Sbjct: 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDH 61
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAV-RFALDIARGMNY 265
PNV+++L + +++ + IV E GDL +K ++ L P + ++ + + + +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
+H + I+HRD++P+N+ +G +K+ D G+ + + K + T Y++PE
Sbjct: 122 MHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP-YYMSPER 177
Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360
Y+ K D++S +L EM PF N
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 6e-20
Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 16/198 (8%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL ++ + R P +V F GA + + + E++ G L K+ G + + A+ +
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS-KLLTVKEDRPLTCQDTSC 318
G+ YL+ I+HRD++PSNIL + G +K+ DFGVS +L+ D T TS
Sbjct: 113 VEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD---TFVGTST 167
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--------- 369
Y++PE + +Y K DV+S + + E+ G PF + ++ +
Sbjct: 168 -YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226
Query: 370 QRPPFKAPAKLYARGLKE 387
Q PP + P+ + L++
Sbjct: 227 QEPPPRLPSSDFPEDLRD 244
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 6e-20
Identities = 63/226 (27%), Positives = 109/226 (48%), Gaps = 26/226 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+K L + I++ + F+ E +L+ ++ HPN+V LG VTQ P+ ++ EYL +GDL
Sbjct: 37 VAIKTLKD--INNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94
Query: 238 RAFL-----------------KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
FL K +L + A+ IA GM YL + +H+DL
Sbjct: 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLA 151
Query: 281 PSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
NIL + ++K++D G+S+ + + R R++ PE ++ + D++S
Sbjct: 152 ARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211
Query: 340 FALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK--APAKLYA 382
F ++L E+ G P+ + EV + RQ P P ++Y+
Sbjct: 212 FGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYS 257
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-19
Identities = 54/169 (31%), Positives = 93/169 (55%), Gaps = 13/169 (7%)
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGAL-KPSTAV 253
A + E+ LL K++HPN+V F + ++ + IV EY GDL + R +G L +
Sbjct: 45 ASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL 104
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL-KVADFGVSKLLTVKEDRPLT 312
+ + I+ G+ ++H+ K I+HRD++ NI +G + K+ DFG+++ L + T
Sbjct: 105 SWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161
Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361
C T Y++PE+ +N Y+ K D++S +L E+ C T+KH E
Sbjct: 162 CVGTP-YYLSPEICQNRPYNNKTDIWSLGCVLYEL---C---TLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 56/208 (26%), Positives = 105/208 (50%), Gaps = 12/208 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+K++ + + +E+ ++++ +HPN+V +L + + +V EYL
Sbjct: 44 GQEVAIKQMN---LQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + + + + + +LH N+ +IHRD++ NIL G++K+
Sbjct: 101 GSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
DFG +T ++ + T T ++APEV + Y KVD++S ++ EM+EG PP+
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
Query: 355 TMKHDNEVPKAY--AARQRPPFKAPAKL 380
++N + Y A P + P KL
Sbjct: 216 L--NENPLRALYLIATNGTPELQNPEKL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 68/213 (31%), Positives = 112/213 (52%), Gaps = 19/213 (8%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VAVK + +S V AF E +++ ++H +V+ L AV P+ I+TE++ KG
Sbjct: 32 KVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGS 86
Query: 237 LRAFLKR-KGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L FLK +G+ +P + F+ IA GM ++ + IHRDL +NIL S K+
Sbjct: 87 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKI 143
Query: 295 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
ADFG+++++ ED T ++ + ++ APE + K DV+SF ++L E++ G
Sbjct: 144 ADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 200
Query: 351 CPPFTMKHDNEVPKAYAARQRPPF--KAPAKLY 381
P+ + EV +A R P P +LY
Sbjct: 201 RIPYPGMSNPEVIRALERGYRMPRPENCPEELY 233
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 57/186 (30%), Positives = 98/186 (52%), Gaps = 11/186 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + +E++ DD+ + + E + Q +P +V +S + +V EY+ GDL
Sbjct: 24 AMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R+ L A +A +I +N+LHE II+RDL+ N+L D G++K+ D+
Sbjct: 84 MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDY 140
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K + P T C Y+APE+ + EEY VD ++ +++ EM+ G PF
Sbjct: 141 GMCK----EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196
Query: 355 TMKHDN 360
+ DN
Sbjct: 197 DIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 57/189 (30%), Positives = 100/189 (52%), Gaps = 11/189 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + +E+++DD+ + + E + Q HP +V S + V EY+ GDL
Sbjct: 24 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R+ L A ++ +I+ +NYLHE II+RDL+ N+L D G++K+ D+
Sbjct: 84 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 140
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K + RP T C Y+APE+ + E+Y VD ++ +++ EM+ G PF
Sbjct: 141 GMCK----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
Query: 355 TMKHDNEVP 363
+ ++ P
Sbjct: 197 DIVGSSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 54/189 (28%), Positives = 99/189 (52%), Gaps = 11/189 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + +E+++DD+ + + E + HP +V S + V E++ GDL
Sbjct: 24 AMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R+ L A ++ +I+ +N+LHE II+RDL+ N+L D G++K+ D+
Sbjct: 84 MFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDY 140
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K + RP T C Y+APE+ + E+Y VD ++ +++ EM+ G PF
Sbjct: 141 GMCK----EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
Query: 355 TMKHDNEVP 363
+ ++ P
Sbjct: 197 DIVGMSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 163 ITKGTF---ILAFWRGIQV--AVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFL 216
I KG+F +LA + + AVK L ++ I + E LL+ ++HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ + + V +Y+ G+L L+R+ A +A +IA + YLH + I++
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVY 119
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDT 333
RDL+P NIL D G++ + DFG+ K + T C Y+APEV + YD
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEV 362
VD + +L EM+ G PPF ++ E+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 64/197 (32%), Positives = 99/197 (50%), Gaps = 25/197 (12%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+ A+K++ E DD R F EL +L K+ HPN++ LGA + + EY P
Sbjct: 35 MDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 92
Query: 235 GDLRAFLKRKGALK--PSTAV--------------RFALDIARGMNYLHENKPVPIIHRD 278
G+L FL++ L+ P+ A+ FA D+ARGM+YL + + IHRD
Sbjct: 93 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRD 149
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
L NIL ++ K+ADFG+S+ V + T R++A E Y T DV+
Sbjct: 150 LAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVW 207
Query: 339 SFALILQEMIE-GCPPF 354
S+ ++L E++ G P+
Sbjct: 208 SYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 62/188 (32%), Positives = 94/188 (50%), Gaps = 19/188 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
G +VA+KKL S R +R EL LL+ + H NV+ L T +S + +V
Sbjct: 40 GRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRD 287
T L DL +K + L ++F + I RG+ Y+H IIHRDL+PSNI +
Sbjct: 99 TH-LMGADLNNIVKCQ-KLSDDH-IQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVN 152
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQE 346
+ LK+ DFG+++ D +T + Y APE+ N Y+ VD++S I+ E
Sbjct: 153 EDCELKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
Query: 347 MIEGCPPF 354
++ G F
Sbjct: 209 LLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 4e-19
Identities = 69/204 (33%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 166 GTFILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
G + W G +VA+K L + + AF E +++K+RH +V L AV P
Sbjct: 20 GEVWMGTWNGTTKVAIKTLKPGTMMPE----AFLQEAQIMKKLRHDKLVP-LYAVVSEEP 74
Query: 225 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ IVTE++ KG L FLK LK V A IA GM Y+ + IHRDL +
Sbjct: 75 IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAA 131
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
NIL D+ K+ADFG+++L+ ED T + + ++ APE + K DV+S
Sbjct: 132 NILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 340 FALILQEMI-EGCPPFTMKHDNEV 362
F ++L E++ +G P+ + EV
Sbjct: 189 FGILLTELVTKGRVPYPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 5e-19
Identities = 59/190 (31%), Positives = 95/190 (50%), Gaps = 5/190 (2%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVTEYL 232
+G AVK L ++V+ DD V E +L +P + + V E+L
Sbjct: 19 KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL ++ KG A +A +I G+ +LH II+RDL+ N++ D G++
Sbjct: 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHI 135
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
K+ADFG+ K ++R T T Y+APE+ + +Y VD +SF ++L EM+ G
Sbjct: 136 KIADFGMCKENVFGDNRASTFCGTP-DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQS 194
Query: 353 PFTMKHDNEV 362
PF ++E+
Sbjct: 195 PFHGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+ + VAVK L +V F E+ ++ ++++PN+++ LG P+ ++TEY+
Sbjct: 43 QPVLVAVKMLRADVTKTARN--DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYME 100
Query: 234 KGDLRAFLKRKG------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
GDL FL ++ ++ + + A+ IA GM YL + +HRDL
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLAT 157
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSF 340
N L + +K+ADFG+S+ L + + + R++A E ++ T DV++F
Sbjct: 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAF 217
Query: 341 ALILQEMIEGCP--PFTMKHDNEV 362
+ L EM C P+++ D +V
Sbjct: 218 GVTLWEMFTLCKEQPYSLLSDEQV 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 7e-19
Identities = 57/187 (30%), Positives = 98/187 (52%), Gaps = 9/187 (4%)
Query: 179 AVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
AVK L ++++ + + A R+ LL+ ++HP +V + + + V +++ G
Sbjct: 24 AVKVLQKKIVLNRKEQKHIMAERN--VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
+L L+R+ + A +A +IA + YLH + I++RDL+P NIL D G++ +
Sbjct: 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLT 138
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
DFG+ K + D T T Y+APEV + + YD VD + +L EM+ G PPF
Sbjct: 139 DFGLCKEGIAQSDTTTTFCGTP-EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY 197
Query: 356 MKHDNEV 362
+ E+
Sbjct: 198 CRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 7e-19
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 21/218 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++VAVK L + A EL ++ + H N+V LGA T P++++TEY
Sbjct: 66 MKVAVKMLKPT--AHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCY 123
Query: 235 GDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL FL+RK L + F+ +A+GM +L IHRDL N+L +
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIV 180
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
K+ DFG+++ + D + + +++APE N Y + DV+S+ ++L E+
Sbjct: 181 KICDFGLAR--DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
Query: 350 --GCP----PFTMKHDNEVPKAYAARQRPPFKAPAKLY 381
P P K + + Y R P APA++Y
Sbjct: 239 LGSNPYPGMPVDSKFYKLIKEGY--RMAQPEHAPAEIY 274
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 7e-19
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 16/205 (7%)
Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKIRHPNVVQFL 216
KG+F +LA +G A+K L ++VI DD V E LAL K HP +
Sbjct: 5 KGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTALH 62
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ V EY+ GDL ++R + +A ++ + +LH + +I+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIY 119
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
RDL+ NIL D G+ K+ADFG+ K + T T Y+APE+ + EY VD
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP-DYIAPEILQELEYGPSVD 178
Query: 337 VFSFALILQEMIEGCPPFTMKHDNE 361
++ +++ EM+ G PPF + DNE
Sbjct: 179 WWALGVLMYEMMAGQPPF--EADNE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 8e-19
Identities = 61/187 (32%), Positives = 97/187 (51%), Gaps = 14/187 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-IVTEYLP 233
G Q +KKL S +R +A E LL +++HPN+V + + ++ IV +
Sbjct: 25 GKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 234 KGDLRAFLK-RKGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
GDL LK +KG L P + V + + IA + YLHE I+HRDL+ N+ +
Sbjct: 84 GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNI 140
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
+KV D G++++L + D T T Y++PE+F N+ Y+ K DV++ + EM
Sbjct: 141 IKVGDLGIARVLENQCDMASTLIGTP-YYMSPELFSNKPYNYKSDVWALGCCVYEMA--- 196
Query: 352 PPFTMKH 358
T+KH
Sbjct: 197 ---TLKH 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 8e-19
Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MM 226
G VA+KK+ D + A R E+ +L+K++HPNVV + + +
Sbjct: 33 GRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91
Query: 227 IVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
+VT Y+ DL L+ L S + L + G+NYLHEN I+HRD++ +NIL
Sbjct: 92 MVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANIL 147
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRP------LTCQDTSC---R-YVAPEVFKNE-EYDTK 334
D+ G LK+ADFG+++ P T + T+ R Y PE+ E Y T
Sbjct: 148 IDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA 207
Query: 335 VDVFSFALILQEMIEGCPPFTMKHD 359
VD++ + EM P K D
Sbjct: 208 VDIWGIGCVFAEMFTRRPILQGKSD 232
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 10/192 (5%)
Query: 166 GTFILAFWRGIQ---VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
G ILA ++ VA+K+ + I +V E +L I HP V G+
Sbjct: 44 GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
S + +V E++ G+ FL+R +A I YL + + I++RDL+P
Sbjct: 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPE 160
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
N+L D G +K+ DFG +K++ + R T T Y+APE+ N + D ++ +
Sbjct: 161 NLLLDKDGFIKMTDFGFAKVV---DTRTYTLCGTP-EYIAPEILLNVGHGKAADWWTLGI 216
Query: 343 ILQEMIEGCPPF 354
+ E++ GCPPF
Sbjct: 217 FIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 9e-19
Identities = 51/183 (27%), Positives = 95/183 (51%), Gaps = 18/183 (9%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K++ + DD+ V A R E+ LL++++H N+V+ + + +V EY +
Sbjct: 28 VALKRVRLD--DDDEGVPSSALR-EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ- 83
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
DL+ + G + P F + +G+ + H + ++HRDL+P N+L + +G LK+
Sbjct: 84 DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKL 140
Query: 295 ADFGVSKLLTVKEDRPLTC---QDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEG 350
ADFG+++ + P+ C + + Y P+V F + Y T +D++S I E+
Sbjct: 141 ADFGLARAFGI----PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196
Query: 351 CPP 353
P
Sbjct: 197 GRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-18
Identities = 51/153 (33%), Positives = 80/153 (52%), Gaps = 11/153 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRF 255
E LL K+ HP +V+F + + I+TEY DL L + +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
+ + G++Y+H+ + I+HRDL+ NI L+++ LK+ DFGVS+LL D T
Sbjct: 112 FIQLLLGVHYMHQRR---ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFT 166
Query: 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
T Y++PE K++ YD+K D++S IL EM
Sbjct: 167 GTP-YYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 52/157 (33%), Positives = 87/157 (55%), Gaps = 7/157 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
E++LL+ ++H N+V + + +V EYL DL+ +L G L V+ F
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
+ RG++Y H+ K I+HRDL+P N+L ++ G LK+ADFG+++ +V + + + +
Sbjct: 112 LLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYSNEVVTL 167
Query: 319 RYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y P+V + EY T +D++ IL EM G P F
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 60/228 (26%), Positives = 107/228 (46%), Gaps = 23/228 (10%)
Query: 151 DPHELDFTNSVEI---TKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP N V+I + G +A + G QVAVKK+ + R +E+ +++
Sbjct: 16 DPRS-YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMR 71
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
+HPN+V+ + + +V E+L G L + + A L + + +++
Sbjct: 72 DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLAVLKALSF 130
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
LH +IHRD++ +IL G +K++DFG ++ + R + T ++APEV
Sbjct: 131 LHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTP-YWMAPEV 186
Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPF---------TMKHDNEVPK 364
Y T+VD++S +++ EM++G PP+ DN PK
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPK 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 60/187 (32%), Positives = 87/187 (46%), Gaps = 8/187 (4%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQ---KIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
A+K L + I D V + E + + RHP +V + V EY G
Sbjct: 28 AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
DL + +P AV +A + G+ YLHENK I++RDL+ N+L D G +K+A
Sbjct: 88 DLMMHIHTDVFSEPR-AVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIA 143
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
DFG+ K DR T T ++APEV Y VD + +++ EM+ G PF
Sbjct: 144 DFGLCKEGMGFGDRTSTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202
Query: 356 MKHDNEV 362
+ EV
Sbjct: 203 GDDEEEV 209
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 66/203 (32%), Positives = 100/203 (49%), Gaps = 11/203 (5%)
Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGA 218
KG+F LA +G A+K L ++V+ DD V E +L HP +
Sbjct: 5 KGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCT 64
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
+ V EYL GDL ++ A +A +I G+ +LH I++RD
Sbjct: 65 FQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRD 121
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
L+ NIL D G++K+ADFG+ K + + + T T Y+APE+ ++Y+T VD +
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP-DYIAPEILLGQKYNTSVDWW 180
Query: 339 SFALILQEMIEGCPPFTMKHDNE 361
SF ++L EM+ G PF HD E
Sbjct: 181 SFGVLLYEMLIGQSPF-HGHDEE 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 50/177 (28%), Positives = 88/177 (49%), Gaps = 9/177 (5%)
Query: 183 LGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYL---PKGDLR 238
G++ D + E+ ++ +++RHPN+V++ ++ + IV + + P G+
Sbjct: 41 FGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF 100
Query: 239 AFLKRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
LK K + + + + YLH+ K I+HRDL P+NI+ + + + DF
Sbjct: 101 NSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G++K + + LT + Y PE+ KNE Y K DV++F IL +M PPF
Sbjct: 159 GLAK--QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 52/178 (29%), Positives = 92/178 (51%), Gaps = 7/178 (3%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A KKL ++ + + +E +L+K+ +V A + +V + GDL+
Sbjct: 22 ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK 81
Query: 239 AFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
+ G + A+ +A I G+ +LH+ + I++RDL+P N+L DD GN++++D
Sbjct: 82 YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISD 138
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G++ + +K + + + + Y+APEV + E YD VD F+ L EMI G PF
Sbjct: 139 LGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 18/219 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A KKL ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84
Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL+ + G + AV +A +I G+ LH+ + I++RDL+P NIL DD G++
Sbjct: 85 GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHI 141
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
+++D G++ + V E + + + + Y+APEV KNE Y D ++ +L EMI G
Sbjct: 142 RISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199
Query: 353 PFTMKHD-----------NEVPKAYAARQRPPFKAPAKL 380
PF + EV + Y+ + P ++ K+
Sbjct: 200 PFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 59/184 (32%), Positives = 97/184 (52%), Gaps = 7/184 (3%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + DRVR + E +L ++ HP +V+ A + ++ ++L GDL
Sbjct: 28 AMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 86
Query: 239 AFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L K + V+F L ++A +++LH + II+RDL+P NIL D+ G++K+ DF
Sbjct: 87 TRLS-KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDF 142
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
G+SK E + + T Y+APEV + D +SF +++ EM+ G PF K
Sbjct: 143 GLSKESIDHEKKAYSFCGT-VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201
Query: 358 HDNE 361
E
Sbjct: 202 DRKE 205
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 69/221 (31%), Positives = 112/221 (50%), Gaps = 26/221 (11%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF + + KG+F +LA +G A+K L ++V+ DD V E +L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 211 NVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
+ L + Q+ + V EY+ GDL +++ G K AV +A +IA G+ +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL-----LTVKEDRPLTCQDTSC---RYV 321
II+RDL+ N++ D G++K+ADFG+ K +T K T C Y+
Sbjct: 121 G---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK---------TFCGTPDYI 168
Query: 322 APEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
APE+ + Y VD ++F ++L EM+ G PF + ++E+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 3e-18
Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVT 229
++VAVK + ++ + + + F E A ++ HPNV++ +G ++S + M++
Sbjct: 28 LKVAVKTMKLDIHTYSE-IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVIL 86
Query: 230 EYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
++ GDL +FL R G L T ++F +DIA GM YL IHRDL N
Sbjct: 87 PFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARN 143
Query: 284 ILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
+ + + VADFG+SK + D R +++A E + Y +K DV++F
Sbjct: 144 CMLREDMTVCVADFGLSKKI-YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 202
Query: 342 LILQE-MIEGCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYA 382
+ + E G P+ ++E+ + R + P +LY
Sbjct: 203 VTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYD 246
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 3e-18
Identities = 53/206 (25%), Positives = 103/206 (50%), Gaps = 8/206 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+K++ + + +E+ +++++++PN+V FL + + +V EYL
Sbjct: 44 GQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + + + + + +LH N+ +IHRD++ N+L G++K+
Sbjct: 101 GSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKL 156
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
DFG +T ++ + T T ++APEV + Y KVD++S ++ EM+EG PP+
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKL 380
++ A P + P KL
Sbjct: 216 LNENPLRALYLIATNGTPELQNPEKL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-18
Identities = 47/173 (27%), Positives = 91/173 (52%), Gaps = 7/173 (4%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
V K++ +S+ +R R +E+ +L ++HPN++ + + ++I EY G
Sbjct: 27 LVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85
Query: 237 L-RAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L +++KG L V + L I ++Y+H+ I+HRD++ NI +G +K+
Sbjct: 86 LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKL 142
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
DFG+SK+L + T T Y++PE+ + +Y+ K D+++ +L E+
Sbjct: 143 GDFGISKILGSEYSMAETVVGTP-YYMSPELCQGVKYNFKSDIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 6e-18
Identities = 54/194 (27%), Positives = 97/194 (50%), Gaps = 15/194 (7%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFR---DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
I VA+K I D + F+ D + + + H +V+ LG +S + +VT+
Sbjct: 37 IPVAIK-----TIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLS 90
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
P G L + + + +L P + + + IA+GM YL E++ ++HR+L NIL
Sbjct: 91 PLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSI 147
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 349
+++ADFGV+ LL + + + T +++A E Y + DV+S+ + + EM+
Sbjct: 148 VQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSY 207
Query: 350 GCPPFTMKHDNEVP 363
G P+ +EVP
Sbjct: 208 GAEPYAGMRPHEVP 221
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 7e-18
Identities = 52/161 (32%), Positives = 87/161 (54%), Gaps = 10/161 (6%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
+ E +L+ ++HP +V + A + ++ EYL G+L L+R+G TA +
Sbjct: 48 KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
+I+ + +LH+ II+RDL+P NIL D G++K+ DFG+ K ++ E T T
Sbjct: 108 EISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEG---TVTHTF 160
Query: 318 C---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
C Y+APE+ + VD +S ++ +M+ G PPFT
Sbjct: 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 7e-18
Identities = 50/154 (32%), Positives = 77/154 (50%), Gaps = 5/154 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL +L + P +V F GA + I E++ G L LK+ G + + + ++ +
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
RG+ YL E I+HRD++PSNIL + G +K+ DFGVS L D +
Sbjct: 109 LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 163
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
Y++PE + Y + D++S L L EM G P
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 8e-18
Identities = 51/181 (28%), Positives = 89/181 (49%), Gaps = 13/181 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
E +L ++ P +V + + +V ++ G+L L+R+G S A + ++
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 318
+ LH+ +I+RDL+P NIL D G++ + DFG+ KL +D+ +T C
Sbjct: 103 LCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK----TNTFCG 155
Query: 319 --RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376
Y+APE+ Y VD ++ ++L EM+ G PPF +D V + Y + P +
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPF---YDENVNEMYRKILQEPLRF 212
Query: 377 P 377
P
Sbjct: 213 P 213
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 56/192 (29%), Positives = 95/192 (49%), Gaps = 23/192 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
+ + VAVK L ++ D + E+ +++ I +H N++ LGA TQ P+ ++ EY
Sbjct: 43 KPVTVAVKMLKDDATDKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYA 100
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
KG+LR +L+ + L V A +ARGM YL K IH
Sbjct: 101 SKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH 157
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
RDL N+L + +K+ADFG+++ + + + T +++APE + Y +
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 217
Query: 336 DVFSFALILQEM 347
DV+SF ++L E+
Sbjct: 218 DVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 70/240 (29%), Positives = 114/240 (47%), Gaps = 26/240 (10%)
Query: 162 EITKGTF--ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
E+ +GT IL G I+VAVK L + D + F E L+ HPN+V+ LG
Sbjct: 10 EVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGV 67
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA-------VRFALDIARGMNYLHENKP 271
+ P I+ E + GDL ++L+ + + LD+A+G YL +
Sbjct: 68 CLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH- 126
Query: 272 VPIIHRDLEPSNILRDDSGN-----LKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPE 324
IHRDL N L + G +K+ DFG+++ + K D R R++APE
Sbjct: 127 --FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-YKSDYYRKEGEGLLPVRWMAPE 183
Query: 325 VFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA--RQRPPFKAPAKLY 381
+ ++ T+ DV+SF +++ E++ G P+ ++ EV + A R + P P K+Y
Sbjct: 184 SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIY 243
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 55/188 (29%), Positives = 88/188 (46%), Gaps = 18/188 (9%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + + V+ + V F +E +L P + Q A + +V EY P GDL
Sbjct: 30 AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL 89
Query: 239 AFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+ L R +F L ++ ++ +H+ + +HRD++P N+L D +G++K+ADF
Sbjct: 90 SLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADF 146
Query: 298 GVSKLLT----VKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEM 347
G + LT V P+ D Y+APEV Y + D +S +I EM
Sbjct: 147 GSAARLTANKMVNSKLPVGTPD----YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202
Query: 348 IEGCPPFT 355
I G PF
Sbjct: 203 IYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 45/157 (28%), Positives = 84/157 (53%), Gaps = 7/157 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFAL 257
E +L+K+ P +V A + + +V + GDL+ + G L+ + ++
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
I G+ +LH + I++RD++P N+L DD GN +++D G++ + +K+ + +T + +
Sbjct: 103 QITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGT 157
Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y+APE+ K E Y VD F+ + EM+ G PF
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 1e-17
Identities = 53/208 (25%), Positives = 103/208 (49%), Gaps = 8/208 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+K++ + + +E+ ++++ ++PN+V +L + + +V EYL
Sbjct: 44 GQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + + + +++LH N+ +IHRD++ NIL G++K+
Sbjct: 101 GSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
DFG +T ++ + T T ++APEV + Y KVD++S ++ EM+EG PP+
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYA 382
++ A P + P +L A
Sbjct: 216 LNENPLRALYLIATNGTPELQNPERLSA 243
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 23/190 (12%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+ VAVK L ++ D + E+ +++ I +H N++ LGA TQ P+ ++ EY K
Sbjct: 48 VTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105
Query: 235 GDLRAFLKRKGALK----------PSTAVRF------ALDIARGMNYLHENKPVPIIHRD 278
G+LR +L+ + P + F +ARGM YL K IHRD
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRD 162
Query: 279 LEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 337
L N+L ++ +K+ADFG+++ + + + T +++APE + Y + DV
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222
Query: 338 FSFALILQEM 347
+SF +++ E+
Sbjct: 223 WSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 7/182 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A KKL ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84
Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL+ + G AV +A +I G+ LH + I++RDL+P NIL DD G++
Sbjct: 85 GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHI 141
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
+++D G++ + + E + + + Y+APEV KNE Y D + ++ EMIEG
Sbjct: 142 RISDLGLA--VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199
Query: 353 PF 354
PF
Sbjct: 200 PF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 51/177 (28%), Positives = 96/177 (54%), Gaps = 9/177 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VA+KK+ + ++ A R E++LL+++ HPN+V+ L + + + +V E+L +
Sbjct: 25 GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 83
Query: 235 GDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL+ F+ + + + +G+ + H ++ ++HRDL+P N+L + G +
Sbjct: 84 -DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAI 139
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMI 348
K+ADFG+++ V R T + + Y APE+ + Y T VD++S I EM+
Sbjct: 140 KLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 2e-17
Identities = 59/201 (29%), Positives = 107/201 (53%), Gaps = 22/201 (10%)
Query: 164 TKGTFILAFWR--GIQVAVKKLGEEVISDDD--RVRAFRDELALLQKI-RHPNVVQFLGA 218
T G+ LA + G VA+KK+ ++ S ++ +R E+ L+K+ HPN+V+
Sbjct: 11 TFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR----EVKSLRKLNEHPNIVKLKEV 66
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIH 276
++ + V EY+ +G+L +K RKG + +R + I +G+ ++H++ H
Sbjct: 67 FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFH 122
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-TSCR-YVAPEVF-KNEEYDT 333
RDL+P N+L +K+ADFG+++ ++ P T D S R Y APE+ ++ Y +
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYT--DYVSTRWYRAPEILLRSTSYSS 178
Query: 334 KVDVFSFALILQEMIEGCPPF 354
VD+++ I+ E+ P F
Sbjct: 179 PVDIWALGCIMAELYTLRPLF 199
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 51/157 (32%), Positives = 86/157 (54%), Gaps = 7/157 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
E++LL+ ++H N+V V + +V EYL K DL+ ++ G + V+ F
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQ 112
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
I RG+ Y H K ++HRDL+P N+L ++ G LK+ADFG+++ +V + + + +
Sbjct: 113 ILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSNEVVTL 168
Query: 319 RYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y P+V + EY T++D++ I EM G P F
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 16/189 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEY-- 231
G +AVK++ D+ + +L ++ + P +V+F GA+ + I E
Sbjct: 29 GTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86
Query: 232 --LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
L K + K + + A+ + +NYL E + IIHRD++PSNIL D +
Sbjct: 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRN 144
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPE---VFKNEEYDTKVDVFSFALILQ 345
GN+K+ DFG+S L D +D CR Y+APE + YD + DV+S + L
Sbjct: 145 GNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLY 201
Query: 346 EMIEGCPPF 354
E+ G P+
Sbjct: 202 EVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 23/192 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
R +VAVK L + D + E+ +++ I +H N++ LGA TQ P+ ++ EY
Sbjct: 49 RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 106
Query: 233 PKGDLRAFL--KRKGALK----PSTA----------VRFALDIARGMNYLHENKPVPIIH 276
KG+LR +L +R ++ P+ V A +ARGM YL K IH
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIH 163
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
RDL N+L + +K+ADFG+++ + + + T +++APE + Y +
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 223
Query: 336 DVFSFALILQEM 347
DV+SF ++L E+
Sbjct: 224 DVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 58/190 (30%), Positives = 92/190 (48%), Gaps = 16/190 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +AVK++ V S + + R D ++ + P V F GA+ + + I E +
Sbjct: 26 GTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME-VMD 83
Query: 235 GDLRAFLKR---KGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
L F K+ KG P + + A+ I + + YLH V IHRD++PSN+L + +G
Sbjct: 84 TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNG 141
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVF----KNEEYDTKVDVFSFALILQ 345
+K+ DFG+S L D D C+ Y+APE + YD K DV+S + +
Sbjct: 142 QVKLCDFGISGYLV---DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMI 198
Query: 346 EMIEGCPPFT 355
E+ G P+
Sbjct: 199 ELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 4e-17
Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
+V VK+L + D F E+ +++ HPNV+Q LG +S P ++V E+ P
Sbjct: 21 SKARVVVKEL--RASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78
Query: 234 KGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
GDL+ +L+ + R A ++A G+ +LH+ IH DL N
Sbjct: 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTA 135
Query: 289 SGNLKVADFGVSKLLTVKEDRPLT--CQDTSCRYVAPEVFKNEEYDTKV-------DVFS 339
++K+ D+G++ L ED +T C R++APE+ + D +++S
Sbjct: 136 DLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS 194
Query: 340 FALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371
+ + E+ P+ +E R++
Sbjct: 195 LGVTMWELFTAADQPYP-DLSDEQVLKQVVREQ 226
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 4e-17
Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 19/229 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
E+ +G L R + VA+ L SD R R F E L + H N+V+ G +T+
Sbjct: 20 ELCRGCLKLPSKRELPVAIHTL-RAGCSDKQR-RGFLAEALTLGQFDHSNIVRLEGVITR 77
Query: 222 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
+ MMIVTEY+ G L +FL++ +G L + +A GM YL E + +H+ L
Sbjct: 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLA 134
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKV 335
+L + K++ F ++ED+ T + APE + + +
Sbjct: 135 AHKVLVNSDLVCKISGFR-----RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSAS 189
Query: 336 DVFSFALILQE-MIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLY 381
DV+SF +++ E M G P+ +V KA R P P L+
Sbjct: 190 DVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH 238
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 11/181 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI---VTEY 231
G +VA+KK+ R R EL +L+ +H N++ + V
Sbjct: 30 GKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L + DL + L F + RG+ Y+H +IHRDL+PSN+L ++
Sbjct: 89 LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCE 145
Query: 292 LKVADFGVSKLLT---VKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEM 347
L++ DFG+++ L+ + +T + Y APE+ EY T +D++S I EM
Sbjct: 146 LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
Query: 348 I 348
+
Sbjct: 206 L 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 4e-17
Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 5/156 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
E +LL+ ++H N+V + + +V EY+ + K G L P F +
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQL 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
RG++Y+H+ I+HRDL+P N+L D+G LK+ADFG+++ +V + + +
Sbjct: 113 LRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVVTLW 168
Query: 320 YVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y P+V + EY T +D++ I EMI+G F
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 7/157 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
E++LL+ ++H N+V + + +V EYL K DL+ +L G V+ F
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
+ RG+NY H K ++HRDL+P N+L ++ G LK+ADFG+++ ++ + + + +
Sbjct: 113 LLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVVTL 168
Query: 319 RYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y P++ + +Y T++D++ I EM G P F
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-17
Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKP 249
++ + + E+ +L HPN+V+ L A + + I+ E+ G + A L+ + L
Sbjct: 43 EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE 102
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
+NYLHENK IIHRDL+ NIL G++K+ADFGVS K R
Sbjct: 103 PQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVS----AKNTR 155
Query: 310 PLTCQDT---SCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361
+ +D+ + ++APEV K+ YD K DV+S + L EM + PP +
Sbjct: 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215
Query: 362 VPKAYAARQRPPFKAPAK 379
V A + P P++
Sbjct: 216 VLLKIAKSEPPTLAQPSR 233
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 5e-17
Identities = 56/189 (29%), Positives = 91/189 (48%), Gaps = 20/189 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--MMIVTEYL 232
G VAVK L E ++ E+ +L+ + H N+V++ G ++ + ++ EY+
Sbjct: 33 GEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
P G LR +L + L + + FA I GM YLH IHRDL N+L D+ +
Sbjct: 91 PLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLV 146
Query: 293 KVADFGVSKLLT-------VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
K+ DFG++K + V+ED D+ + A E K ++ DV+SF + L
Sbjct: 147 KIGDFGLAKAVPEGHEYYRVRED-----GDSPVFWYAVECLKENKFSYASDVWSFGVTLY 201
Query: 346 EMIEGCPPF 354
E++ C
Sbjct: 202 ELLTHCDSK 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 5e-17
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-------SPMMIV 228
++VAVK + + I + F E +++ HPNV++ +G Q+ SP++I+
Sbjct: 27 LKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVIL 85
Query: 229 TEYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
++ GDL +FL R G L V+F DIA GM YL IHRDL
Sbjct: 86 P-FMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAAR 141
Query: 283 NILRDDSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
N + +++ N+ VADFG+SK + + R +++A E + Y TK DV+SF
Sbjct: 142 NCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFG 201
Query: 342 LILQEM-IEGCPPFTMKHDNEV 362
+ + E+ G P+ ++E+
Sbjct: 202 VTMWEIATRGQTPYPGVENSEI 223
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 8e-17
Identities = 56/182 (30%), Positives = 92/182 (50%), Gaps = 14/182 (7%)
Query: 178 VAVKKLGEEVISDDDRVR--AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+KK E DD V+ A R E+ +L+++RH N+V + + + +V E++
Sbjct: 29 VAIKKFLES--EDDKMVKKIAMR-EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
L K L S ++ I RG+ + H + IIHRD++P NIL SG +K+
Sbjct: 86 VLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLC 142
Query: 296 DFGVSKLLTVKEDRPLTCQD-TSCR-YVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCP 352
DFG ++ L + D + R Y APE + + +Y VD+++ ++ EM+ G P
Sbjct: 143 DFGFARTLAAPGE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199
Query: 353 PF 354
F
Sbjct: 200 LF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 8e-17
Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 8/208 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA++++ + + +E+ ++++ ++PN+V +L + + +V EYL
Sbjct: 45 GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + + + + +LH N+ +IHRD++ NIL G++K+
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
DFG +T ++ + T T ++APEV + Y KVD++S ++ EMIEG PP+
Sbjct: 158 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYA 382
++ A P + P KL A
Sbjct: 217 LNENPLRALYLIATNGTPELQNPEKLSA 244
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 8e-17
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VAVK L + + D+ + F E LL ++H ++V+F G + P+++V EY+ G
Sbjct: 36 ILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 92
Query: 236 DLRAFLKRKGA-------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
DL FL+ G L S + A IA GM YL +HRDL
Sbjct: 93 DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATR 149
Query: 283 NILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
N L ++ +K+ DFG+S+ + + R R++ PE ++ T+ DV+S
Sbjct: 150 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 209
Query: 342 LILQEMIE-GCPPFTMKHDNEV 362
++L E+ G P+ +NEV
Sbjct: 210 VVLWEIFTYGKQPWYQLSNNEV 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 9e-17
Identities = 56/191 (29%), Positives = 94/191 (49%), Gaps = 11/191 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++VI DD V E +L R HP + Q + V E++ GDL
Sbjct: 24 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL 83
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+++ + A +A +I + +LH+ II+RDL+ N+L D G+ K+ADF
Sbjct: 84 MFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 140
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K + T C Y+APE+ + Y VD ++ ++L EM+ G PF
Sbjct: 141 GMCK----EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196
Query: 355 TMKHDNEVPKA 365
++++++ +A
Sbjct: 197 EAENEDDLFEA 207
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 57/181 (31%), Positives = 96/181 (53%), Gaps = 10/181 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKG 235
VA+KKL E + + + R E+ +L K++HPN+V V S+ + +V EY+ +
Sbjct: 33 VALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-EH 90
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
DL++ ++ K S L + G+ +LH+N I+HRDL+ SN+L ++ G LK+
Sbjct: 91 DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKI 147
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPP 353
DFG+++ +P T + Y APE+ EY T +D++S I E++ P
Sbjct: 148 CDFGLAREYGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPL 206
Query: 354 F 354
F
Sbjct: 207 F 207
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 38/207 (18%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVR-- 254
E LL + H N++ L + P ++ Y+ G+L+ FL+ R G A+
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117
Query: 255 ----FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK--------L 302
A+ IA GM+YLH+ +IH+D+ N + D+ +K+ D +S+
Sbjct: 118 QLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCP-----PFT 355
L E+RP+ +++A E N+EY + DV+SF ++L E++ P PF
Sbjct: 175 LGDNENRPV-------KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227
Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYA 382
M + Y Q P P +L+A
Sbjct: 228 MAA--YLKDGYRLAQ--PINCPDELFA 250
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 20/177 (11%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL ++ +I+H N++ + + + +V + + DL+ + RK L S L I
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV-------------SKLLTVK 306
G+N LH+ +HRDL P+NI + G K+ADFG+ SK T++
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 307 EDRPLTCQDTSCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
+T + + Y APE + E+Y VD++S I E++ G P F +NE+
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP--GENEI 240
|
Length = 335 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 56/225 (24%), Positives = 101/225 (44%), Gaps = 25/225 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+K L ++ + F+ E + +++HPN+V LG VT+ P+ ++ Y DL
Sbjct: 38 VAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 238 RAFL----------------KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
FL K L+P+ V IA GM +L + ++H+DL
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLAT 152
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSF 340
N+L D N+K++D G+ + + + L R+++PE ++ D++S+
Sbjct: 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212
Query: 341 ALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYA 382
++L E+ G P+ + +V + RQ P PA +Y
Sbjct: 213 GVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYT 257
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVK ++ +D+ A +DEL ++Q++ +P +V+ +G + ++ M+V E
Sbjct: 25 VAVK-----ILKNDNNDPALKDELLREANVMQQLDNPYIVRMIG-ICEAESWMLVMELAE 78
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G L FL++ + ++ GM YL E +HRDL N+L K
Sbjct: 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAK 135
Query: 294 VADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
++DFG+SK L E+ + T ++ APE ++ +K DV+SF +++ E G
Sbjct: 136 ISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYG 195
Query: 351 CPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
P+ NEV + + +R P + P ++Y
Sbjct: 196 QKPYKGMKGNEVTQMIESGERMECPQRCPPEMY 228
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 52/185 (28%), Positives = 99/185 (53%), Gaps = 22/185 (11%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VA+K + E S +R+ F +E +++++ +VV+ LG V+Q P +++ E + +GD
Sbjct: 38 RVAIKTVNEAA-SMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 95
Query: 237 LRAFLKRKGALKPSTA-------------VRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
L+++L+ +L+P ++ A +IA GM YL+ NK +HRDL N
Sbjct: 96 LKSYLR---SLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARN 149
Query: 284 ILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
+ + +K+ DFG+++ + R R+++PE K+ + T DV+SF +
Sbjct: 150 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 209
Query: 343 ILQEM 347
+L E+
Sbjct: 210 VLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 17/190 (8%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+KK+ ++ + ++++ E +L +P VV + + +V EY+ GD
Sbjct: 30 AMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCA 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
LK GAL A + + + YLH I+HRDL+P N+L G++K+ DFG
Sbjct: 90 TLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFG 146
Query: 299 VSKL----LTV--------KEDRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+SK+ LT K+ R + + Y+APEV + Y VD ++ +IL
Sbjct: 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIIL 206
Query: 345 QEMIEGCPPF 354
E + GC PF
Sbjct: 207 YEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 54/192 (28%), Positives = 94/192 (48%), Gaps = 23/192 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
+ + VAVK L + + D + E+ L++ I +H N++ LG TQ P+ ++ EY
Sbjct: 43 QTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYA 100
Query: 233 PKGDLRAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIH 276
KG+LR FL+ + P V A +ARGM YL + IH
Sbjct: 101 AKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIH 157
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
RDL N+L + +K+ADFG+++ + + + + +++APE + Y +
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS 217
Query: 336 DVFSFALILQEM 347
DV+SF +++ E+
Sbjct: 218 DVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-16
Identities = 56/190 (29%), Positives = 90/190 (47%), Gaps = 18/190 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G+ +A+K++ E+ D+ + EL +L K P +V F GA + + EY+
Sbjct: 26 GVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83
Query: 235 GDLRAFLKRKGAL--KPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
G L A P +R + +G+ +L E IIHRD++P+N+L + +G
Sbjct: 84 GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQ 141
Query: 292 LKVADFGVS-KLLTVKEDRPLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALIL 344
+K+ DFGVS L+ + CQ Y+APE K+ Y + DV+S L +
Sbjct: 142 VKLCDFGVSGNLVASLAKTNIGCQS----YMAPERIKSGGPNQNPTYTVQSDVWSLGLSI 197
Query: 345 QEMIEGCPPF 354
EM G P+
Sbjct: 198 LEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-16
Identities = 50/180 (27%), Positives = 85/180 (47%), Gaps = 8/180 (4%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A KKL ++ + E +L K+ +V A + + +V + GDLR
Sbjct: 22 ACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLR 81
Query: 239 AFL----KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
+ + A + I G+ +LH+ + II+RDL+P N+L D+ GN+++
Sbjct: 82 YHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRI 138
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
+D G++ L + + T ++APE+ + EEYD VD F+ + L EMI PF
Sbjct: 139 SDLGLAVELKDGQSKTKGYAGTP-GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 9/195 (4%)
Query: 165 KGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
KGTF IL + G A+K L +EVI D V E +LQ RHP + A
Sbjct: 5 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 64
Query: 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
+ V EY G+L L R+ A + +I + YLH +++RD+
Sbjct: 65 QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDI 121
Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
+ N++ D G++K+ DFG+ K T T Y+APEV ++ +Y VD +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP-EYLAPEVLEDNDYGRAVDWWG 180
Query: 340 FALILQEMIEGCPPF 354
+++ EM+ G PF
Sbjct: 181 LGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 7/157 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
E +LL+ ++H N+V + + +V EYL DL+ ++ G L F
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
+ RG+ Y H+ + ++HRDL+P N+L + G LK+ADFG+++ +V + + + +
Sbjct: 112 LLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSNEVVTL 167
Query: 319 RYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y P+V + EY T +D++ I EM G P F
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 23/197 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVTQSS-----P 224
G++VA+KK IS + R R E+ +L++ +H N++ L + S
Sbjct: 29 TGVKVAIKK-----ISPFEHQTFCQRTLR-EIKILRRFKHENIIGILDIIRPPSFESFND 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+ IV E + DL +K + L F I RG+ Y+H ++HRDL+PSN+
Sbjct: 83 VYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNL 137
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFA 341
L + + +LK+ DFG++++ + D LT + Y APE+ N + Y +D++S
Sbjct: 138 LLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVG 197
Query: 342 LILQEMIEGCPPFTMKH 358
IL EM+ P F K
Sbjct: 198 CILAEMLSNRPLFPGKD 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 7e-16
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 33/206 (16%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ + ++V+ E +L + HP + + + + +V +Y P G+L
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89
Query: 239 AFL-KRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L ++ G RF A ++ + YLH I++RDL+P NIL +SG++ ++D
Sbjct: 90 RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSD 146
Query: 297 FGVSKLLTVK--------------------EDRPLTCQDT----SC----RYVAPEVFKN 328
F +SK V+ + + + S Y+APEV
Sbjct: 147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG 206
Query: 329 EEYDTKVDVFSFALILQEMIEGCPPF 354
+ + + VD ++ ++L EM+ G PF
Sbjct: 207 DGHGSAVDWWTLGILLYEMLYGTTPF 232
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 53/176 (30%), Positives = 87/176 (49%), Gaps = 3/176 (1%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +EVI D V E +LQ RHP + + + V EY G+L
Sbjct: 24 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L R+ A + +I ++YLH K V ++RDL+ N++ D G++K+ DFG
Sbjct: 84 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFG 141
Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
+ K +K+ + + Y+APEV ++ +Y VD + +++ EM+ G PF
Sbjct: 142 LCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 7e-16
Identities = 50/182 (27%), Positives = 87/182 (47%), Gaps = 7/182 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A K+L ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84
Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL+ + G + A+ +A +I G+ LH ++RDL+P NIL DD G++
Sbjct: 85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHI 141
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
+++D G++ + + E + + + Y+APEV N+ Y D + ++ EMIEG
Sbjct: 142 RISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199
Query: 353 PF 354
PF
Sbjct: 200 PF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 8e-16
Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 29/195 (14%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRH-PNVVQFLGA--VTQSSP---MMIVT 229
VA+KK E D++ + A R E++LLQ + +V+ L V + + + +V
Sbjct: 29 VALKKTRLE--MDEEGIPPTALR-EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85
Query: 230 EYLPKGDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
EYL DL+ F+ G L T F + +G+ + H++ ++HRDL+P N+
Sbjct: 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNL 141
Query: 285 LRDDSGN-LKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEV-FKNEEYDTKVDVFS 339
L D LK+AD G+ + ++ P+ T + + Y APEV + Y T VD++S
Sbjct: 142 LVDKQKGLLKIADLGLGRAFSI----PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWS 197
Query: 340 FALILQEMIEGCPPF 354
I EM P F
Sbjct: 198 VGCIFAEMSRKQPLF 212
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 8e-16
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 18/215 (8%)
Query: 151 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP +L F++ EI G+F + F R ++ VA+KK+ +++ + E+ LQ
Sbjct: 12 DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
K+RHPN +Q+ G + +V EY K L+ +G+ Y
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
LH + +IHRD++ NIL + G +K+ DFG + ++ P + ++APEV
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAPEV 182
Query: 326 ---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTM 356
+YD KVDV+S + E+ E PP F M
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 204 LQKIRHPNVVQFLGAVTQS-----SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFA 256
L+ HPNVV+ T S + + +V E++ + DL +L + + + T
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 116
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
+ RG+++LH ++ ++HRDL+P NIL SG +K+ADFG++++ + + LT
Sbjct: 117 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVV 171
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359
+ Y APEV Y T VD++S I EM P F D
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 1e-15
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 17/215 (7%)
Query: 148 YEIDPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELA 202
++ DP +L FT+ EI G+F + F R ++ VA+KK+ +++ + E+
Sbjct: 19 FKEDPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
LQ+I+HPN +++ G + +V EY K L+ +G
Sbjct: 78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 137
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
+ YLH + +IHRD++ NIL + G +K+ADFG + + + P + ++A
Sbjct: 138 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS-----PANSFVGTPYWMA 189
Query: 323 PEV---FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
PEV +YD KVDV+S + E+ E PP
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 53/200 (26%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGA 218
E+ + T +L G+ VA+KK+ I D +A D E+ LL+++ HPNV+++ +
Sbjct: 17 EVYRATCLL---DGVPVALKKVQ---IFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS 70
Query: 219 VTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPI 274
+ + + IV E GDL + F K+K + T ++ + + + ++H + +
Sbjct: 71 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---V 127
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK 334
+HRD++P+N+ +G +K+ D G+ + + K + T Y++PE Y+ K
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP-YYMSPERIHENGYNFK 186
Query: 335 VDVFSFALILQEMIEGCPPF 354
D++S +L EM PF
Sbjct: 187 SDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 49/154 (31%), Positives = 76/154 (49%), Gaps = 5/154 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL +L + P +V F GA + I E++ G L LK+ G + + ++ +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
+G+ YL E I+HRD++PSNIL + G +K+ DFGVS L D +
Sbjct: 113 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 167
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
Y++PE + Y + D++S L L EM G P
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 5/184 (2%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +EVI D V E +LQ RHP + + + V EY G+L
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L R+ A + +I + YLH +++RDL+ N++ D G++K+ DFG
Sbjct: 84 FHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFG 140
Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358
+ K T T Y+APEV ++ +Y VD + +++ EM+ G PF +
Sbjct: 141 LCKEGISDGATMKTFCGTP-EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ- 198
Query: 359 DNEV 362
D+E
Sbjct: 199 DHEK 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KGAL 247
++ + + E+ +L HP +V+ LGA + I+ E+ P G + A + +G
Sbjct: 49 SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT 108
Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
+P V + + YLH K IIHRDL+ N+L G++K+ADFGVS K
Sbjct: 109 EPQIQV-ICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVS----AKN 160
Query: 308 DRPLTCQDT---SCRYVAPEV-----FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359
+ L +D+ + ++APEV K+ YD K D++S + L EM + PP +
Sbjct: 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220
Query: 360 NEVPKAYAARQRPPFKAPAK 379
V A + P P+K
Sbjct: 221 MRVLLKIAKSEPPTLSQPSK 240
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 4/180 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A+K L +EVI D V E +L+ RHP + + + V EY+
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G+L L R+ + +I ++YLH K I++RDL+ N++ D G++K+
Sbjct: 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKI 136
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
DFG+ K + + + + Y+APEV ++ +Y VD + +++ EM+ G PF
Sbjct: 137 TDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 39/203 (19%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VA+KK+ + + + A R E+ +L+++ H N+V IVT+ K
Sbjct: 32 GELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRNIVNL---------KEIVTD---K 78
Query: 235 GDLRAFLKRKGA--------------LKPSTAVRFALD--------IARGMNYLHENKPV 272
D F K KGA L S V F+ D + G+NY H+
Sbjct: 79 QDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN-- 136
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-Y 331
+HRD++ SNIL ++ G +K+ADFG+++L +E RP T + + Y PE+ EE Y
Sbjct: 137 -FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERY 195
Query: 332 DTKVDVFSFALILQEMIEGCPPF 354
+DV+S IL E+ P F
Sbjct: 196 GPAIDVWSCGCILGELFTKKPIF 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
E +LL+ ++H N+V + + V EY+ DL ++ + G L P F
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ 111
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
+ RG+ Y+H I+HRDL+P N+L G LK+ADFG+++ + + Q S
Sbjct: 112 LLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSS 162
Query: 319 R-----YVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y P+V +Y + +D++ I EM++G P F
Sbjct: 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 55/205 (26%), Positives = 84/205 (40%), Gaps = 57/205 (27%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
VRA RD LA + +P VV+ + + + ++ EYLP GD+ L +K
Sbjct: 48 VRAERDILA---EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET- 103
Query: 254 RF-------ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL--- 303
RF A+D + Y IHRD++P N+L D G++K++DFG+ L
Sbjct: 104 RFYIAETILAIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154
Query: 304 -------TVKEDRPLTCQDTSCR---------------------------YVAPEVFKNE 329
+ P D + Y+APEVF
Sbjct: 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT 214
Query: 330 EYDTKVDVFSFALILQEMIEGCPPF 354
Y+ + D +S +I+ EM+ G PPF
Sbjct: 215 GYNKECDWWSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 26/205 (12%)
Query: 173 WRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP----- 224
++G V +L + D D + E+ +L+K H N+ + GA + +P
Sbjct: 23 YKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82
Query: 225 -MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
+ +V E+ G + +K + LK +I RG+++LH++K +IHRD++
Sbjct: 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKG 139
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEE-----YDT 333
N+L ++ +K+ DFGVS L DR + ++T + ++APEV +E YD
Sbjct: 140 QNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDF 195
Query: 334 KVDVFSFALILQEMIEGCPPFTMKH 358
K D++S + EM EG PP H
Sbjct: 196 KSDLWSLGITAIEMAEGAPPLCDMH 220
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 67/245 (27%), Positives = 112/245 (45%), Gaps = 40/245 (16%)
Query: 144 EVPEYEID-PHEL---DFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
EV E+ P +L F +V KG R + VAVK L + ++ + F
Sbjct: 20 EVHLCEVVNPQDLPTLQFPFNVR--KG-------RPLLVAVKILRPD--ANKNARNDFLK 68
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------- 245
E+ +L +++ PN+++ LG P+ ++TEY+ GDL FL
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 246 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
A+ S+ + AL IA GM YL + +HRDL N L ++ +K+ADFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 301 KLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC--PPFTMK 357
+ L + + + R++A E ++ T DV++F + L E++ C P+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245
Query: 358 HDNEV 362
D +V
Sbjct: 246 TDEQV 250
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 50/194 (25%), Positives = 94/194 (48%), Gaps = 12/194 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRF 255
E+ LL+++ HPNV+++L + + + + IV E GDL + F K+K + T ++
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
+ + + ++H + ++HRD++P+N+ +G +K+ D G+ + + K +
Sbjct: 112 FVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPP 373
T Y++PE Y+ K D++S +L EM PF N Q PP
Sbjct: 169 TP-YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227
Query: 374 FKAPAKLYARGLKE 387
P + Y+ L+E
Sbjct: 228 L--PTEHYSEKLRE 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 3e-15
Identities = 30/60 (50%), Positives = 39/60 (65%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A ++E +K LL+ G DVN +D D TALH+AA G E+V LLLE GAD++ KD
Sbjct: 32 LHLAARNGNLEIVKLLLEHGADVNAKDKDGNTALHLAARNGNLEIVKLLLEHGADINLKD 91
|
Length = 91 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 56/187 (29%), Positives = 88/187 (47%), Gaps = 23/187 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVK L + ++ + F+ E LL ++H ++V+F G P+++V EY+ GDL
Sbjct: 38 VAVKALKDPTLAAR---KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL 94
Query: 238 RAFLK----------------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
FL+ KG L S + A IA GM YL +HRDL
Sbjct: 95 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLAT 151
Query: 282 SNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
N L + +K+ DFG+S+ + + R R++ PE ++ T+ DV+SF
Sbjct: 152 RNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211
Query: 341 ALILQEM 347
+IL E+
Sbjct: 212 GVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 65/230 (28%), Positives = 112/230 (48%), Gaps = 28/230 (12%)
Query: 173 WRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP----- 224
++G V +L + D +D + E+ +L+K H N+ + GA + SP
Sbjct: 33 YKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92
Query: 225 -MMIVTEYLPKGDLRAFLKR-KG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
+ +V E+ G + +K KG ALK +I RG+ +LH +K +IHRD++
Sbjct: 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKG 149
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEE-----YDT 333
N+L ++ +K+ DFGVS L DR + ++T + ++APEV +E YD
Sbjct: 150 QNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDY 205
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
+ D++S + EM EG PP H + + + PP K +K +++
Sbjct: 206 RSDIWSLGITAIEMAEGAPPLCDMH--PMRALFLIPRNPPPKLKSKKWSK 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 17/185 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MM 226
G +VA+KK+ + R FR EL +L +H NV L A+ P +
Sbjct: 25 GKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNV---LSALDILQPPHIDPFEEIY 80
Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
+VTE L + DL + L F I RG+ YLH I+HRD++P N+L
Sbjct: 81 VVTE-LMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLV 136
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQ 345
+ + LK+ DFG++++ E + +T + + Y APE+ + Y + VD++S I
Sbjct: 137 NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA 196
Query: 346 EMIEG 350
E++
Sbjct: 197 ELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 8/180 (4%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
A+K L ++ I V E +L + P +V + S + +VT+Y+ G
Sbjct: 22 AMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGG 81
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
+L L+++G A + ++ + +LH+ I++RDL+P NIL D +G++ +
Sbjct: 82 ELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALC 138
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPF 354
DFG+SK T T+ Y+APEV +E+ Y VD +S +++ EM G PF
Sbjct: 139 DFGLSKANLTDNKTTNTFCGTT-EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 5e-15
Identities = 53/165 (32%), Positives = 85/165 (51%), Gaps = 16/165 (9%)
Query: 200 ELALLQKIR---HPNVVQFLGAVT-----QSSPMMIVTEYLPKGDLRAFLKRKGA--LKP 249
E+ALL+++ HPN+V+ + + + + +V E++ + DLR +L + L
Sbjct: 49 EVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA 107
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
T RG+++LH N I+HRDL+P NIL G +K+ADFG++++ + +
Sbjct: 108 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--M 162
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
LT + Y APEV Y T VD++S I EM P F
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 6e-15
Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 28/222 (12%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
QV VK+L + F +E + ++H N++Q LG T+ +P ++V E+ P GD
Sbjct: 24 QVVVKELRVSASVQEQM--KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81
Query: 237 LRAFLK--RKGAL---KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L+ +L+ RK L P+T R A +IA G+ +LH+N IH DL N L
Sbjct: 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLT 138
Query: 292 LKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKV-------DVFSFAL 342
+K+ D+G+S KED +T R++APE+ + V +V+S +
Sbjct: 139 VKIGDYGLSH-NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGV 197
Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAYAARQ------RPPFKAP 377
+ E+ E G P+ D +V Y R+ +P K P
Sbjct: 198 TIWELFELGSQPYRHLSDEQV-LTYTVREQQLKLPKPRLKLP 238
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 7e-15
Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVK L E+ ++ + F E+ ++ +++ PN+++ L S P+ ++TEY+ GDL
Sbjct: 49 VAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 238 RAFLKRKGALKP-----------STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
FL R + ST + A IA GM YL + +HRDL N L
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
+ +K+ADFG+S+ L + + + R+++ E ++ T DV++F + L
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223
Query: 346 EMIEGCP--PFTMKHDNEV 362
E++ C P++ D +V
Sbjct: 224 EILTLCKEQPYSQLSDEQV 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G QVAVKK+ + R +E+ +++ H NVV + + +V E+L
Sbjct: 47 GKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + A L + R ++YLH +IHRD++ +IL G +K+
Sbjct: 104 GALTDIVTHTRMNEEQIAT-VCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKL 159
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
+DFG ++ + + + T ++APEV Y T+VD++S +++ EMI+G PP+
Sbjct: 160 SDFGFCAQVSKEVPKRKSLVGTP-YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
Query: 355 TMKHDNEVPKAYAARQR---PP 373
NE P R R PP
Sbjct: 219 F----NEPPLQAMRRIRDNLPP 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 64/200 (32%), Positives = 93/200 (46%), Gaps = 25/200 (12%)
Query: 175 GIQVAVKKLGEEVISD-DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS-----PMMI 227
G AVK L + ISD D+ + A E +LQ + HPNVV+F G ++ + +
Sbjct: 47 GSLAAVKIL--DPISDVDEEIEA---EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101
Query: 228 VTEYLPKGD----LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
V E G ++ L L + G+ +LH N+ IIHRD++ +N
Sbjct: 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNN 158
Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTKVDVF 338
IL G +K+ DFGVS LT R T T ++APEV E+ YD + DV+
Sbjct: 159 ILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF-WMAPEVIACEQQYDYSYDARCDVW 217
Query: 339 SFALILQEMIEGCPPFTMKH 358
S + E+ +G PP H
Sbjct: 218 SLGITAIELGDGDPPLFDMH 237
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 8e-15
Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 10/167 (5%)
Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR 254
+ EL +L K P ++ F GA + + I TE++ G L + + R
Sbjct: 44 KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGR 99
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
A+ + +G+ YL K I+HRD++PSN+L + G +K+ DFGVS L +
Sbjct: 100 IAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGT 156
Query: 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361
+ Y+APE E+Y DV+S + E+ G P+ N+
Sbjct: 157 NA---YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQ 200
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 8e-15
Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 151 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP +L FT+ EI G+F + F R ++ VA+KK+ +++ + E+ LQ
Sbjct: 12 DPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYL--PKGDLRAFLKRKGALKPSTAVRFA---LDIA 260
++RHPN +++ G + +V EY D+ K KP V A
Sbjct: 71 QLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK-----KPLQEVEIAAICHGAL 125
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
+G+ YLH ++ IHRD++ NIL + G +K+ADFG + L++ P + +
Sbjct: 126 QGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS-----PANSFVGTPYW 177
Query: 321 VAPEV---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTM 356
+APEV +YD KVDV+S + E+ E PP F M
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 51/174 (29%), Positives = 84/174 (48%), Gaps = 21/174 (12%)
Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
+D R E+ +L+ + HPNVV+ + + ++ E++ G L A +
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG---THIADEQ 168
Query: 250 STAVRFALDIAR----GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
A D+AR G+ YLH I+HRD++PSN+L + + N+K+ADFGVS++L
Sbjct: 169 FLA-----DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220
Query: 306 KEDRPLTCQDTSCRYVAPEVFKNE----EYDTKV-DVFSFALILQEMIEGCPPF 354
D P + Y++PE + YD D++S + + E G PF
Sbjct: 221 TMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 51/184 (27%), Positives = 92/184 (50%), Gaps = 11/184 (5%)
Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
R E +L+ +R P +V A + + ++ +Y+ G+L L ++ S +
Sbjct: 52 RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI 111
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQD 315
+I +++LH+ II+RD++ NIL D G++ + DFG+SK L +E+R +
Sbjct: 112 AEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCG 168
Query: 316 TSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---Q 370
T Y+APEV + +D VD +S ++ E++ G PFT+ + + R
Sbjct: 169 T-IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS 227
Query: 371 RPPF 374
+PPF
Sbjct: 228 KPPF 231
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 59/183 (32%), Positives = 96/183 (52%), Gaps = 14/183 (7%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
+A+KK+ E +D+ V A R E++LL++++H N+V+ V + +V EYL
Sbjct: 30 IALKKIRLE--QEDEGVPSTAIR-EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL- 85
Query: 236 DLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-L 292
DL+ + A P + I RG+ Y H ++ ++HRDL+P N+L D N L
Sbjct: 86 DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNAL 142
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGC 351
K+ADFG+++ + R T + + Y APE+ + Y T VD++S I EM+
Sbjct: 143 KLADFGLARAFGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
Query: 352 PPF 354
P F
Sbjct: 202 PLF 204
|
Length = 294 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 55/189 (29%), Positives = 84/189 (44%), Gaps = 20/189 (10%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
EL +L + P +V F GA + I E++ G L LK + + ++ +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
RG+ YL E I+HRD++PSNIL + G +K+ DFGVS L D +
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 167
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPPFTMKHDNEV------------PK 364
Y++PE + Y + D++S L L E+ G PP K + P
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227
Query: 365 AYAARQRPP 373
+ + R RPP
Sbjct: 228 SISPRPRPP 236
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 50/182 (27%), Positives = 88/182 (48%), Gaps = 7/182 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A KKL ++ I +E +L+K+ VV A + +V +
Sbjct: 25 GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84
Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL+ + G A+ +A ++ G+ L + I++RDL+P NIL DD G++
Sbjct: 85 GDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHI 141
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
+++D G++ + + E + + + Y+APEV NE+Y D + ++ EMI+G
Sbjct: 142 RISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199
Query: 353 PF 354
PF
Sbjct: 200 PF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 56/186 (30%), Positives = 89/186 (47%), Gaps = 22/186 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVK L E S+ R + F+ E LL ++H ++V+F G T+ P+++V EY+ GDL
Sbjct: 38 VAVKALKE--ASESAR-QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL 94
Query: 238 RAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
FL+ G L + A IA GM YL + +HRDL
Sbjct: 95 NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATR 151
Query: 283 NILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
N L +K+ DFG+S+ + + R R++ PE ++ T+ D++SF
Sbjct: 152 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFG 211
Query: 342 LILQEM 347
++L E+
Sbjct: 212 VVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 64/194 (32%), Positives = 101/194 (52%), Gaps = 30/194 (15%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM---IVTEYLP 233
VA+KK+ + + D R FR E+ LQ++ HPN+V+ L V ++ +V EY+
Sbjct: 35 VALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL-NVIKAENDKDIYLVFEYM- 91
Query: 234 KGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
+ DL A + R L+ R+ + + + + Y+H +IHRDL+PSNIL + +
Sbjct: 92 ETDLHAVI-RANILED-VHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRV 146
Query: 293 KVADFGVSKLLTVKEDRP----LTCQDTSCRYVA------PEV-FKNEEYDTKVDVFSFA 341
K+ADFG+++ L+ E+ P LT YVA PE+ + Y VD++S
Sbjct: 147 KLADFGLARSLSELEENPENPVLT------DYVATRWYRAPEILLGSTRYTKGVDMWSVG 200
Query: 342 LILQEMIEGCPPFT 355
IL EM+ G P F
Sbjct: 201 CILGEMLLGKPLFP 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 68/215 (31%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 163 ITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
I KGT+ +L G + AVK L + + D+ + A + L L HPNVV+F G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSD--HPNVVKFYG 82
Query: 218 A-----VTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
V + +V E G + + FLKR ++ + G+ +LH
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
NK IHRD++ +NIL G +K+ DFGVS LT R T T ++APEV
Sbjct: 143 NK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF-WMAPEVIAC 198
Query: 329 EE-----YDTKVDVFSFALILQEMIEGCPPFTMKH 358
E+ YD + DV+S + E+ +G PP H
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 58/186 (31%), Positives = 91/186 (48%), Gaps = 15/186 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY--- 231
G +VA+KKL S+ RA+R EL LL+ ++H NV+ L T + ++
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98
Query: 232 LP--KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
+P DL +K + L + +G+ Y+H IIHRDL+P N+ ++
Sbjct: 99 MPFMGTDLGKLMKHE-KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNED 154
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
LK+ DFG+++ + D +T + Y APEV N Y VD++S I+ EM+
Sbjct: 155 CELKILDFGLAR----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210
Query: 349 EGCPPF 354
G P F
Sbjct: 211 TGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 58/183 (31%), Positives = 93/183 (50%), Gaps = 17/183 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
G++VAVKKL S R +R EL LL+ ++H NV+ L T + + + +
Sbjct: 42 GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
+L DL +K + V+F + I RG+ Y+H IIHRDL+PSN+ ++
Sbjct: 101 THLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 155
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEM 347
LK+ DFG+++ D +T + Y APE+ N Y+ VD++S I+ E+
Sbjct: 156 DCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211
Query: 348 IEG 350
+ G
Sbjct: 212 LTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 43/123 (34%), Positives = 71/123 (57%), Gaps = 9/123 (7%)
Query: 193 RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA 252
+V+A RD LAL + P +V ++ ++ + +V EYL GD+++ L G A
Sbjct: 50 QVQAERDALAL---SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA 106
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
V++ ++A ++YLH + IIHRDL+P N+L + G++K+ DFG+SK V +R L
Sbjct: 107 VKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK---VTLNRELN 160
Query: 313 CQD 315
D
Sbjct: 161 MMD 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVRAFRDELA 202
Y+ DP E+ F EI G+F ++ VAVKK+ +++ + E+
Sbjct: 15 YKDDPEEI-FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
LQ+++HPN +++ G + +V EY K L+ +G
Sbjct: 74 FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 133
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
+ YLH + +IHRD++ NIL + G +K+ADFG + + P + ++A
Sbjct: 134 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVGTPYWMA 185
Query: 323 PEV---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTM 356
PEV +YD KVDV+S + E+ E PP F M
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-14
Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 17/237 (7%)
Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVK--KLGEEVISDDDRVRAFRDELALLQKIRHPN 211
EL N + KG + + + I VA+K K E D+ +R E ++ ++ +P
Sbjct: 2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNENEKSVRDEMMR----EAEIMHQLDNPY 56
Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENK 270
+V+ +G V ++ +M+V E G L FL +K + S V ++ GM YL
Sbjct: 57 IVRMIG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN 328
+HRDL N+L + K++DFG+SK L + + + ++ APE
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYA 382
++ ++ DV+S+ + + E G P+ EV R P + P ++YA
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYA 229
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 46/177 (25%), Positives = 88/177 (49%), Gaps = 4/177 (2%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK + +++ + R EL +L+ ++ N+V+ A + + +V EY+ K L
Sbjct: 29 VAIKKFKDSEENEEVKETTLR-ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNML 87
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+ + P + + + +++ H+N I+HRD++P N+L + LK+ DF
Sbjct: 88 ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDF 144
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G ++ L+ + T + Y +PE+ Y VD++S IL E+ +G P F
Sbjct: 145 GFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 56/184 (30%), Positives = 91/184 (49%), Gaps = 12/184 (6%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-----QSSPMMIVTEY 231
+VA+KK+ + D R R E+ LL+ + H NV+ + + + IV E
Sbjct: 32 KVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE- 89
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L DL ++ L F + RG+ Y+H ++HRDL+PSN+L + + +
Sbjct: 90 LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCD 146
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG 350
LK+ DFG+++ + K D +T + Y APE+ N EY T +DV+S I E++
Sbjct: 147 LKICDFGLARTTSEKGDF-MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGR 205
Query: 351 CPPF 354
P F
Sbjct: 206 KPLF 209
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 11/152 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP--KGDLRAFL-KRKGALKPSTAVRFA 256
E LLQ + HP+V++ + + +V LP DL +L KR L A+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
I G+ YLH + IIHRD++ NI +D + + D G ++ V L T
Sbjct: 164 KQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLAGT 219
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
APEV ++Y++K D++S ++L EM+
Sbjct: 220 -VETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-14
Identities = 52/183 (28%), Positives = 94/183 (51%), Gaps = 16/183 (8%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
+VAVK + E S +R+ F +E ++++ +VV+ LG V++ P ++V E + G
Sbjct: 37 TRVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 94
Query: 236 DLRAFLK--------RKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
DL+++L+ G P+ ++ A +IA GM YL+ K +HRDL N +
Sbjct: 95 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 151
Query: 286 RDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+K+ DFG+++ + R R++APE K+ + T D++SF ++L
Sbjct: 152 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211
Query: 345 QEM 347
E+
Sbjct: 212 WEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 9e-14
Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 12/179 (6%)
Query: 178 VAVKKLGEEVISDDD---RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VA+KK E S+DD + A R E+ +L++++HPN+V + + + +V EY
Sbjct: 29 VAIKKFVE---SEDDPVIKKIALR-EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L K + + + +N+ H++ IHRD++P NIL G +K+
Sbjct: 85 TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKL 141
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCP 352
DFG +++LT D T Y APE+ + +Y VDV++ + E++ G P
Sbjct: 142 CDFGFARILTGPGDDYTDYVATRW-YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 9/201 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VA+K L E + F DE ++ + HP++V+ LG V S + +VT+ +P G
Sbjct: 37 IPVAIKILNETTGPKANV--EFMDEALIMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHG 93
Query: 236 DLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L ++ + K + + + + IA+GM YL E + ++HRDL N+L ++K+
Sbjct: 94 CLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKI 150
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
DFG+++LL E + +++A E ++ + DV+S+ + + E++ G
Sbjct: 151 TDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGK 210
Query: 353 PFTMKHDNEVPKAYAARQRPP 373
P+ E+P +R P
Sbjct: 211 PYDGIPTREIPDLLEKGERLP 231
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 40/107 (37%), Positives = 58/107 (54%), Gaps = 7/107 (6%)
Query: 31 LDDDGEEIKPE---FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHV---AACQG 84
+D+ +I E + + A+ VE ++ LL +G DVNFR +T LH+ + +
Sbjct: 2 EEDESVDIIMEAALYDYLLNASNVTVEEVRRLLAAGADVNFRGEYGKTPLHLYLHYSSEK 61
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE-VIKLLEKHGA 130
++V LLLE GADV+ +R G TPL +Y VIKLL K GA
Sbjct: 62 VKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGA 108
|
Length = 471 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 44/159 (27%), Positives = 80/159 (50%), Gaps = 7/159 (4%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
+ E+ +++ +H N+V + G+ + + I E+ G L+ G L S +
Sbjct: 54 QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR 113
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
+ +G+ YLH +HRD++ +NIL D+G++K+ADFGVS +T + + T
Sbjct: 114 ETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTP 170
Query: 318 CRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPP 353
++APEV E Y+ D+++ + E+ E PP
Sbjct: 171 -YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 58/186 (31%), Positives = 87/186 (46%), Gaps = 23/186 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
GI VAVKKL + RA+R EL LL+ + H N++ L T P + E+
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFT---PQKSLEEF--- 98
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNI 284
D+ ++ A + LD R G+ +LH IIHRDL+PSNI
Sbjct: 99 QDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNI 154
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+ LK+ DFG+++ T + +T + Y APEV Y VD++S I+
Sbjct: 155 VVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 212
Query: 345 QEMIEG 350
E+++G
Sbjct: 213 GELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 50/182 (27%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VA+K+L E ++ DE ++ + +P+V + LG + +S + ++T+ +P G
Sbjct: 37 IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 93
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L +++ K + + + + IA+GMNYL E + ++HRDL N+L ++K+
Sbjct: 94 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKI 150
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCP 352
DFG++KLL E + +++A E + Y + DV+S+ + + E M G
Sbjct: 151 TDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 210
Query: 353 PF 354
P+
Sbjct: 211 PY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 51/150 (34%), Positives = 75/150 (50%), Gaps = 10/150 (6%)
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE 268
P +V+ G S + I E L L LKR +G + + + I + ++YL E
Sbjct: 74 PYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF-- 326
V IHRD++PSNIL D SGN+K+ DFG+S L + + T Y+APE
Sbjct: 133 KHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAKTRSAGCAAYMAPERIDP 188
Query: 327 --KNEEYDTKVDVFSFALILQEMIEGCPPF 354
N +YD + DV+S + L E+ G P+
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPY 218
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 52/201 (25%), Positives = 100/201 (49%), Gaps = 9/201 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
I VA+K L E ++ DE ++ + P V + LG + +S + +VT+ +P G
Sbjct: 37 IPVAIKVLRENTSPKANK--EILDEAYVMAGVGSPYVCRLLG-ICLTSTVQLVTQLMPYG 93
Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L +++ K + + + + IA+GM+YL E V ++HRDL N+L ++K+
Sbjct: 94 CLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKI 150
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
DFG+++LL + E + +++A E + + + DV+S+ + + E++ G
Sbjct: 151 TDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAK 210
Query: 353 PFTMKHDNEVPKAYAARQRPP 373
P+ E+P +R P
Sbjct: 211 PYDGIPAREIPDLLEKGERLP 231
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 151 DPHELDFTNSVEITKG-TFILAFWR----GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP L N ++I +G T I+ R G QVAVK + + R +E+ +++
Sbjct: 18 DPRSL-LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 73
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
+H NVV+ + + ++ E+L G L + + L + + + Y
Sbjct: 74 DYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCY 132
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY-VAPE 324
LH +IHRD++ +IL G +K++DFG + +D P Y +APE
Sbjct: 133 LHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPE 187
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376
V Y T+VD++S +++ EM++G PP+ D+ V R PP K
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDGEPPYF--SDSPVQAMKRLRDSPPPKL 237
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 5e-13
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 22/196 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-----MMIVT 229
G +VA+KK+ + D R R E+ LL+ +RHP++V+ + S + +V
Sbjct: 25 GEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
E L + DL +K L P F + R + Y+H + HRDL+P NIL +
Sbjct: 84 E-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANAD 139
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE--------YDTKVDVFSFA 341
LK+ DFG++++ D P T YVA ++ E Y +D++S
Sbjct: 140 CKLKICDFGLARVAF--NDTPTAIFWTD--YVATRWYRAPELCGSFFSKYTPAIDIWSIG 195
Query: 342 LILQEMIEGCPPFTMK 357
I E++ G P F K
Sbjct: 196 CIFAEVLTGKPLFPGK 211
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 15/180 (8%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY----- 231
+VAVKKL S R +R EL LL+ ++H NV+ L T ++ + E
Sbjct: 42 KVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L DL +K + L + RG+ Y+H IIHRDL+PSN+ ++
Sbjct: 101 LMGADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCE 156
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG 350
L++ DFG+++ + D +T + Y APE+ N Y+ VD++S I+ E+++G
Sbjct: 157 LRILDFGLAR----QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 34/199 (17%)
Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229
VA+KK+ +++++ RA R EL LL+ R H N+ M IV
Sbjct: 27 EETVAIKKITNVFSKKILAK----RALR-ELKLLRHFRGHKNITCLYD-------MDIVF 74
Query: 230 ----------EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
E L + DL ++ L + F I G+ Y+H ++HRDL
Sbjct: 75 PGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDL 131
Query: 280 EPSNILRDDSGNLKVADFGVSKLLT---VKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKV 335
+P N+L + LK+ DFG+++ + + +T + Y APE+ + Y +
Sbjct: 132 KPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAI 191
Query: 336 DVFSFALILQEMIEGCPPF 354
DV+S IL E++ P F
Sbjct: 192 DVWSVGCILAELLGRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 8e-13
Identities = 53/203 (26%), Positives = 101/203 (49%), Gaps = 26/203 (12%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF--------------LGAVTQS 222
+VAVKK+ V++D V+ E+ +++++ H N+V+ +G++T+
Sbjct: 32 RVAVKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ + IV EY+ + DL L+ +G L A F + RG+ Y+H ++HRDL+P+
Sbjct: 89 NSVYIVQEYM-ETDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 143
Query: 283 NIL-RDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE-VFKNEEYDTKVDVF 338
N+ + LK+ DFG+++++ L+ + Y +P + Y +D++
Sbjct: 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMW 203
Query: 339 SFALILQEMIEGCPPFTMKHDNE 361
+ I EM+ G P F H+ E
Sbjct: 204 AAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 67/270 (24%), Positives = 113/270 (41%), Gaps = 22/270 (8%)
Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELD-------FTNSVEITKGTFILAFWRG 175
+ EK+ A + P K ++PE E P + T V T RG
Sbjct: 32 EAFEKYCAD--LDPEAYKKCVDLPEGEEVPESNNPREHMYVLTTLVGRNPTTAAFVATRG 89
Query: 176 IQVAVKKLGEEVISDDDRVRAF-RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
K + + V+ +D+R A+ R EL L H +V+ ++++ EY
Sbjct: 90 SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149
Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
GDL + LK + I ++ +H K ++HRDL+ +NI +G
Sbjct: 150 GDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTG 206
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEM 347
+K+ DFG SK + + L + C Y+APE+++ + Y K D++S +IL E+
Sbjct: 207 IIKLGDFGFSKQYS--DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYEL 264
Query: 348 IEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
+ PF E+ + + PF P
Sbjct: 265 LTLHRPFKGPSQREIMQQVLYGKYDPFPCP 294
|
Length = 478 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 59/188 (31%), Positives = 83/188 (44%), Gaps = 25/188 (13%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYL 232
G VA+KKL + RA+R EL L++ + H N++ L T Q S YL
Sbjct: 40 TGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPS 282
+ A L ++ LD R G+ +LH IIHRDL+PS
Sbjct: 99 VMELMDANL--------CQVIQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPS 147
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
NI+ LK+ DFG+++ T +T + Y APEV Y VD++S
Sbjct: 148 NIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 205
Query: 343 ILQEMIEG 350
I+ EMI G
Sbjct: 206 IMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 24/170 (14%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPST 251
F +E ++ P VVQ A + +V EY+P GDL + K A +
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 149
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
V ALD M + IHRD++P N+L D SG+LK+ADFG + + ++ +
Sbjct: 150 EVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMV 198
Query: 312 TCQDTSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 354
C DT+ Y++PEV K++ Y + D +S + L EM+ G PF
Sbjct: 199 RC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 34/191 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM---------IV 228
VA+KK+ E + + A R E+ +LQ ++H NVV L + ++ +V
Sbjct: 40 VALKKVLMENEKEGFPITALR-EIKILQLLKHENVVN-LIEICRTKATPYNRYKGSFYLV 97
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIAR-------GMNYLHENKPVPIIHRDLE 280
E+ DL L K V+F L +I + G+ Y+H NK I+HRD++
Sbjct: 98 FEFCEH-DLAGLLSNK-------NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMK 146
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNE-EYDTKVD 336
+NIL G LK+ADFG+++ ++ ++ + Y PE+ E +Y +D
Sbjct: 147 AANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPID 206
Query: 337 VFSFALILQEM 347
++ I+ EM
Sbjct: 207 MWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 57/180 (31%), Positives = 90/180 (50%), Gaps = 12/180 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYLP 233
G +VA+KKL S+ RA+R EL LL+ ++H NV+ L T S YL
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98
Query: 234 KGDLRAFLKRKGALKPST-AVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
++ L++ S V++ + + G+ Y+H IIHRDL+P N+ ++
Sbjct: 99 MPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCE 155
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG 350
LK+ DFG+++ D +T + Y APEV N Y+ VD++S I+ EM+ G
Sbjct: 156 LKILDFGLAR----HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 46/183 (25%), Positives = 90/183 (49%), Gaps = 9/183 (4%)
Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
R E +L+ IR P +V A + + ++ +Y+ G+L L ++ K ++
Sbjct: 52 RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
+I + +LH+ + II+RD++ NIL D +G++ + DFG+SK E
Sbjct: 112 GEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG 168
Query: 317 SCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---QR 371
+ Y+AP++ + + +D VD +S +++ E++ G PFT+ + + R
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 228
Query: 372 PPF 374
PP+
Sbjct: 229 PPY 231
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 7/165 (4%)
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
D + E+ ++++ +H N+V + G+ + I EY G L+ G L
Sbjct: 48 DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ 107
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
+ +G+ YLH +HRD++ +NIL D+G++K+ADFGV+ +T +
Sbjct: 108 IAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164
Query: 312 TCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPP 353
+ T ++APEV KN Y+ D+++ + E+ E PP
Sbjct: 165 SFIGTP-YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF- 255
F +E ++ P VVQ A + +V EY+P GDL + P +F
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV--PEKWAKFY 147
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
++ ++ +H + +IHRD++P N+L D G+LK+ADFG + + E + C D
Sbjct: 148 TAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRC-D 201
Query: 316 TSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 354
T+ Y++PEV K++ Y + D +S + L EM+ G PF
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 50/157 (31%), Positives = 75/157 (47%), Gaps = 24/157 (15%)
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMN 264
+VQ A + +V EY+P GDL + K A + V ALD M
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG 162
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYV 321
+ IHRD++P N+L D SG+LK+ADFG + + + + C DT+ Y+
Sbjct: 163 F---------IHRDVKPDNMLLDKSGHLKLADFGTC--MKMDANGMVRC-DTAVGTPDYI 210
Query: 322 APEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 354
+PEV K++ Y + D +S + L EM+ G PF
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|140343 PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 37/82 (45%), Positives = 45/82 (54%)
Query: 47 LANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
LA D G + LL G D N RD D RT LH+A G +VV +LLE GAD D+ G
Sbjct: 89 LAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDG 148
Query: 107 STPLGDAIYYKNHEVIKLLEKH 128
TPL A EV++LL +H
Sbjct: 149 KTPLELAEENGFREVVQLLSRH 170
|
Length = 664 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VAVKK+ + R +E+ +++ +H NVV+ + + +V E+L
Sbjct: 45 GKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L + + A L + + ++ LH +IHRD++ +IL G +K+
Sbjct: 102 GALTDIVTHTRMNEEQIAA-VCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKL 157
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
+DFG ++ + R + T ++APE+ Y +VD++S +++ EM++G PP+
Sbjct: 158 SDFGFCAQVSKEVPRRKSLVGTP-YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
Query: 355 ---------TMKHDNEVPKAYAARQRPP 373
M DN PK + P
Sbjct: 217 FNEPPLKAMKMIRDNLPPKLKNLHKVSP 244
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 37/210 (17%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + + ++V R E +L + VV+ + + ++ E+LP GD+
Sbjct: 30 AMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMM 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L +K L + + ++ +H+ + IHRD++P N+L D G++K++DFG
Sbjct: 90 TLLMKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFG 146
Query: 299 V--------------------------------SKLLTVKEDRPLTCQDT--SCRYVAPE 324
+ K T K++R T + Y+APE
Sbjct: 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE 206
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
VF Y+ D +S +I+ EM+ G PPF
Sbjct: 207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYLPKGDLRAFLK-----RKGALKPSTA 252
E+ALL++++H NVV + + + + + +Y + DL +K ++ ++ PS
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKLLTVKED 308
I G++YLH N ++HRDL+P+NIL + G +K+ D G+++L
Sbjct: 111 KSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPL 166
Query: 309 RPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPF 354
+PL D + Y APE+ + TK +D+++ I E++ P F
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 33/77 (42%), Positives = 48/77 (62%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
+ IK +LD GIDVN +D + +T LH A +G E + +L E GADV+ +D G P+ A
Sbjct: 105 DMIKTILDCGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIA 164
Query: 114 IYYKNHEVIKLLEKHGA 130
I + ++IKLL + GA
Sbjct: 165 IKHNFFDIIKLLLEKGA 181
|
Length = 434 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + + ++V R E +L + VV+ + + ++ E+LP GD+
Sbjct: 30 AMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMM 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L +K L + + ++ +H+ + IHRD++P N+L D G++K++DFG
Sbjct: 90 TLLMKKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFG 146
Query: 299 V--------------------------------SKLLTVKEDRPLTCQDT--SCRYVAPE 324
+ K T K +R T + Y+APE
Sbjct: 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPE 206
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 364
VF Y+ D +S +I+ EM+ G PPF + E K
Sbjct: 207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYK 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 52/203 (25%), Positives = 83/203 (40%), Gaps = 48/203 (23%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
V+A RD LA + + VV+ + + V +Y+P GD+ + L R G + A
Sbjct: 48 VKAERDILA---EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLAR 104
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV-------------- 299
+ ++ + +H+ + IHRD++P NIL D G++K+ DFG+
Sbjct: 105 FYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161
Query: 300 ------------SKLLTVKEDRPLTC-------QDTSCR---------YVAPEVFKNEEY 331
S+ + + L Q C Y+APEV Y
Sbjct: 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY 221
Query: 332 DTKVDVFSFALILQEMIEGCPPF 354
D +S +IL EM+ G PPF
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 8/138 (5%)
Query: 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89
G+D + ++ + + L + + D+E IK L + G DVN D + +H+A F +++
Sbjct: 114 GIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDII 173
Query: 90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA------KPLMAPMH--VKH 141
LLLE+GA + KD G +PL +A Y ++ IKLL HG K P+H + H
Sbjct: 174 KLLLEKGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHGNHIMNKCKNGFTPLHNAIIH 233
Query: 142 AREVPEYEIDPHELDFTN 159
R E I+ ++ +
Sbjct: 234 NRSAIELLINNASINDQD 251
|
Length = 434 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 40/121 (33%), Positives = 68/121 (56%), Gaps = 7/121 (5%)
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
GDL L + G + +A +I G+ ++H N+ V ++RDL+P+NIL D+ G++++
Sbjct: 82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH-NRFV--VYRDLKPANILLDEHGHVRI 138
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPP 353
+D G++ + K +P T Y+APEV K YD+ D FS +L +++ G P
Sbjct: 139 SDLGLACDFSKK--KPHASVGTH-GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
Query: 354 F 354
F
Sbjct: 196 F 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 7/158 (4%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
R L+L+ P +V A + + + + GDL L + G +A
Sbjct: 45 RIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYAT 104
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
+I G+ ++H +++RDL+P+NIL D+ G+++++D G++ + K +P T
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTH 159
Query: 318 CRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y+APEV K YD+ D FS +L +++ G PF
Sbjct: 160 -GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 10/154 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP--KGDLRAFLKRKGALKPSTAVRFAL 257
E +L+ I HP+++Q G T + ++ LP K DL +L K + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL-LTVKEDRPLTCQDT 316
+ R + YLHEN+ IIHRD++ NI + G++ + DFG + + + ++ T
Sbjct: 190 SVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
APE+ + Y VD++S ++L EM
Sbjct: 247 IATN-APELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 48/194 (24%), Positives = 98/194 (50%), Gaps = 10/194 (5%)
Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
R E +L+ +R P +V A + + ++ +Y+ G++ L ++ ++
Sbjct: 52 RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS 111
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQD 315
+I + +LH+ + I++RD++ NIL D G++ + DFG+SK L+ +++R +
Sbjct: 112 GEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCG 168
Query: 316 TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---QR 371
T Y+APE+ + + K VD +S +++ E++ G PFT++ + + R
Sbjct: 169 TI-EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD 227
Query: 372 PPFKAPAKLYARGL 385
PPF + A+ L
Sbjct: 228 PPFPSFIGPEAQDL 241
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 42/190 (22%), Positives = 86/190 (45%), Gaps = 18/190 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VAVKK+ + + ++ + E+ ++++HPN++ ++ + S + +V+ + G
Sbjct: 28 VAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86
Query: 238 RAFLKR--KGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
LK L P A+ F L D+ ++Y+H IHR ++ S+IL G + +
Sbjct: 87 EDLLKTHFPEGL-PELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVL 142
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRY-------VAPEVFKN--EEYDTKVDVFSFALILQ 345
+ S + +K + + ++PEV + + Y+ K D++S +
Sbjct: 143 SGLRYSVSM-IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITAC 201
Query: 346 EMIEGCPPFT 355
E+ G PF
Sbjct: 202 ELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 48/155 (30%), Positives = 80/155 (51%), Gaps = 11/155 (7%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
+ +V +Y GDLR +K + + A + + ++++H +IHRD++
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIK 170
Query: 281 PSNILRDDSGNLKVADFGVSKLL--TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
+NIL +G +K+ DFG SK+ TV +D T T YVAPE+++ + Y K D+F
Sbjct: 171 SANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP-YYVAPEIWRRKPYSKKADMF 229
Query: 339 SFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRP 372
S ++L E++ PF ++ EV K A R P
Sbjct: 230 SLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264
|
Length = 496 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 46/214 (21%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPM-MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
E+ +L+ I H ++ + A S + M++ +Y K DL ++ R G L A+
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKY--KCDLFTYVDRSGPLPLEQAITIQRR 193
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL------T 312
+ + YLH IIHRD++ NI D+ N + DFG + L D P T
Sbjct: 194 LLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250
Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM-IEGCPPFTMK-------------- 357
+ S PE+ + Y K D++S L+L EM ++ F +
Sbjct: 251 LETNS-----PELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305
Query: 358 ---HDNEVP-----------KAYAARQRPPFKAP 377
H E P K YA RPP+ P
Sbjct: 306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIP 339
|
Length = 392 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 8e-11
Identities = 56/184 (30%), Positives = 85/184 (46%), Gaps = 23/184 (12%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VA+KKL + RA+R EL L++ + H N++ L T P + E+ D
Sbjct: 51 NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFT---PQKSLEEF---QD 103
Query: 237 LRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILR 286
+ ++ A ++ LD R G+ +LH IIHRDL+PSNI+
Sbjct: 104 VYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVV 159
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
LK+ DFG+++ T +T + Y APEV Y VD++S I+ E
Sbjct: 160 KSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 347 MIEG 350
MI+G
Sbjct: 218 MIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 49/219 (22%), Positives = 99/219 (45%), Gaps = 25/219 (11%)
Query: 150 IDPHELDFTNSVEITKGT--FILAFWRGI----QVAVKKLGEEVISDDDRVRAFRDELAL 203
I+ ++D SV I + I ++GI +V ++ + + +E+
Sbjct: 15 IESDDIDKYTSVLIKENDQNSI---YKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKN 71
Query: 204 LQKIRHPNVVQFLG---AVTQSSP-MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
L++I N+++ G + P + ++ EY +G LR L ++ L T + A+D
Sbjct: 72 LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDC 131
Query: 260 ARGMNYLHE--NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
+G+ L++ NKP +++L + L ++ LK+ G+ K+L+ P
Sbjct: 132 CKGLYNLYKYTNKP----YKNLTSVSFLVTENYKLKIICHGLEKILSS----PPFKNVNF 183
Query: 318 CRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPF 354
Y + ++ + EY K D++S ++L E+ G PF
Sbjct: 184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF 222
|
Length = 283 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 3e-10
Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KKL + RA+R EL L++ + H N++ L T P + E+ D+
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKSLEEF---QDV 97
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
++ A ++ LD R G+ +LH IIHRDL+PSNI+
Sbjct: 98 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 153
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
LK+ DFG+++ T +T + Y APEV Y VD++S I+ EM
Sbjct: 154 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
Query: 348 I 348
+
Sbjct: 212 V 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 52/207 (25%)
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
V+A RD LA + P VV + + + ++ E+LP GDL L +
Sbjct: 48 VKAERDVLA---ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR 104
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS------------- 300
+ + + +H+ + IHRD++P NIL D G++K++DFG+S
Sbjct: 105 FYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161
Query: 301 KLLTVKEDRP----------------LTCQDT-----------------SCRYVAPEVFK 327
KLL K ++ ++ +D + Y+APE+F
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221
Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPF 354
+ Y + D +S I+ E + G PPF
Sbjct: 222 QQGYGQECDWWSLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 45/190 (23%), Positives = 84/190 (44%), Gaps = 22/190 (11%)
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
AF + +L+ ++ H ++V+ G V ++V EY+ G L FL R+ S +
Sbjct: 47 AFFETASLMSQLSHKHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKN-NVSLHWKL 104
Query: 256 --ALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGN---LKVADFGVSKLLTVK 306
A +A ++YL + K ++H ++ NIL + G +K++D G+ + +
Sbjct: 105 DVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161
Query: 307 EDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCP-PFTMKHDNEVP 363
E+R ++APE +N + D +SF L E+ P + +E
Sbjct: 162 EERVERIP-----WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE 216
Query: 364 KAYAARQRPP 373
+ Y + R P
Sbjct: 217 RFYQDQHRLP 226
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 49/222 (22%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ + + ++V + E +L + + VV+ + + V +Y+P GD+
Sbjct: 30 AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+ L R A + ++ + +H+ + IHRD++P NIL D G++K+ DFG
Sbjct: 90 SLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFG 146
Query: 299 V-------------SKLLTVKED--RPLTCQD--TSCR---------------------- 319
+ K +++D P D ++CR
Sbjct: 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206
Query: 320 -------YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y+APEV + Y D +S +IL EM+ G PPF
Sbjct: 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-10
Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 20/171 (11%)
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV----RFALDIARG 262
++HPN++Q LG ++ P ++V EY GDL+++L ++ + ++ + R A +IA G
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---R 319
+ ++H++ +H DL N +KV D+G+ KED + +D C R
Sbjct: 112 VTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDY-IETEDDKCVPLR 166
Query: 320 YVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV 362
++APE+ E +V++ + L E+ E P++ D EV
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 49/222 (22%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ + ++V + E +L + + VV+ + + V +Y+P GD+
Sbjct: 30 AMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+ L R G A + ++ + +H+ + IHRD++P NIL D G++K+ DFG
Sbjct: 90 SLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFG 146
Query: 299 V---------SKLLT----VKEDR---------PLTC---------------QDTSC--- 318
+ SK V++D P C Q C
Sbjct: 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAH 206
Query: 319 ------RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
Y+APEV Y D +S +IL EM+ G PPF
Sbjct: 207 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE-VVSLLLERGADVDPK 102
+ ++E+ + ++ LL++G DVN + T LH+ T V+ LL++ GADV+ K
Sbjct: 54 YLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAK 113
Query: 103 DRWGSTPL-----GDAIYYKNHEVIKLLEKHGAKP------LMAPMHV 139
D+ G TPL G I K VI+LL + GA M P+ V
Sbjct: 114 DKVGRTPLHVYLSGFNINPK---VIRLLLRKGADVNALDLYGMTPLAV 158
|
Length = 471 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 18/95 (18%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAA--CQGFTEVVSLLLERGADVDPKDR--------- 104
++ LLD+G +VN ++ D LH+ + +++ LL+++G D++ K+R
Sbjct: 124 VEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRVNYLLSYGV 183
Query: 105 -------WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+G TPL A+Y N E +K L GA P
Sbjct: 184 PINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANP 218
|
Length = 422 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 42/174 (24%), Positives = 83/174 (47%), Gaps = 10/174 (5%)
Query: 209 HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
+PN ++ +VT +++ +Y+ GDL LK++G L + + + +N LH+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 269 NKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
+ IIH D++ N+L D + + + D+G+ K++ +C D + Y +PE K
Sbjct: 128 HN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIK 179
Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKL 380
YD D ++ ++ E++ G PF D E+ ++ RQ+ +
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNV 233
|
Length = 267 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 13/134 (9%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + +D + LL G +VN D N + LH A +V +LLE GA D +D
Sbjct: 172 LHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARD 231
Query: 104 RWGSTPLGDAI-YYKNHEVIKLLEKHG----AKPL---MAPMHVKHARE-----VPEYEI 150
+ G+TPL ++ Y K+++++KLL +HG AK + +H E + EY
Sbjct: 232 KCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILGLTALHSSIKSERKLKLLLEYGA 291
Query: 151 DPHELDFTNSVEIT 164
D + L+ ++
Sbjct: 292 DINSLNSYKLTPLS 305
|
Length = 477 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 56.0 bits (134), Expect = 6e-09
Identities = 32/77 (41%), Positives = 42/77 (54%), Gaps = 3/77 (3%)
Query: 56 IKELLDSGI--DVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112
K LL++G DVN D D T LH AA G ++V LLLE GAD + ++ +G T L
Sbjct: 127 AKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADPNSRNSYGVTALDP 186
Query: 113 AIYYKNHEVIKLLEKHG 129
A E++KLL G
Sbjct: 187 AAKNGRIELVKLLLDKG 203
|
Length = 235 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 46/168 (27%), Positives = 82/168 (48%), Gaps = 17/168 (10%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
FR+E +L + + A + + +V +Y GDL L + P RF
Sbjct: 48 FREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107
Query: 257 L-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
L ++ ++ +H+ + +HRD++P NIL D +G++++ADFG L + ED T Q
Sbjct: 108 LAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDG--TVQS 160
Query: 316 T----SCRYVAPEVFKNEE-----YDTKVDVFSFALILQEMIEGCPPF 354
+ + Y++PE+ + E Y + D +S + + EM+ G PF
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 24/180 (13%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALK--------P 249
E+ALL++++HPNV+ S + ++ +Y + DL +K A K P
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLP 106
Query: 250 STAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKLLT 304
+ V+ L I G++YLH N ++HRDL+P+NIL + G +K+AD G ++L
Sbjct: 107 RSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163
Query: 305 VKEDRPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDN 360
+PL D + Y APE+ + TK +D+++ I E++ P F + ++
Sbjct: 164 -SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 29/194 (14%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV-----QFLGAVTQSSP---MMIV 228
+VA+KK V+ D + EL +++ + H N++ + ++ + +V
Sbjct: 93 KVAIKK----VLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145
Query: 229 TEYLPKGDLRAFLK---RKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNI 284
E++P+ + ++K R P V+ ++ + R + Y+H I HRDL+P N+
Sbjct: 146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNL 201
Query: 285 LRD-DSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFA 341
L D ++ LK+ DFG +K LL + C S Y APE+ Y T +D++S
Sbjct: 202 LIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC---SRFYRAPELMLGATNYTTHIDLWSLG 258
Query: 342 LILQEMIEGCPPFT 355
I+ EMI G P F+
Sbjct: 259 CIIAEMILGYPIFS 272
|
Length = 440 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 27/75 (36%), Positives = 40/75 (53%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ LL G+ +N +D+ T LH A E V LL+ GA+ + +++G TPL AI
Sbjct: 175 VNYLLSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIAIL 234
Query: 116 YKNHEVIKLLEKHGA 130
N E+ KLL +G
Sbjct: 235 NNNKEIFKLLLNNGP 249
|
Length = 422 |
| >gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 2/96 (2%)
Query: 32 DDDGEEIKP--EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89
D+ GE P L+ +A+ + ++ELL + +D + D RT LH+AA +G+ + V
Sbjct: 515 DNGGEHDDPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCV 574
Query: 90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
+LL+ +V +D G+T L +AI K+H++ ++L
Sbjct: 575 LVLLKHACNVHIRDANGNTALWNAISAKHHKIFRIL 610
|
Length = 823 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 31/83 (37%), Positives = 46/83 (55%), Gaps = 7/83 (8%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFT-----EVVSLLLERGADVDPKDRWGSTPL 110
+K LLD+G D+N +N T LH + + E+V LLLE GA+V+ D G TPL
Sbjct: 51 VKILLDNGADINSSTKNNSTPLHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPL 110
Query: 111 GDAIYYK--NHEVIKLLEKHGAK 131
AI K ++ +++ L +GA
Sbjct: 111 LYAISKKSNSYSIVEYLLDNGAN 133
|
Length = 422 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 27/70 (38%), Positives = 41/70 (58%), Gaps = 3/70 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++VAVK L + + D A EL +L + +H N+V LGA T P++++TEY
Sbjct: 69 LRVAVKML--KASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCY 126
Query: 235 GDLRAFLKRK 244
GDL FL++K
Sbjct: 127 GDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 41/135 (30%), Positives = 71/135 (52%), Gaps = 14/135 (10%)
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
++ +ARGM +L K IHRDL NIL ++ +K+ DFG+++ + +D P +
Sbjct: 179 YSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLAR--DIYKD-PDYVR 232
Query: 315 DTSCR----YVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT-MKHDNEVPKAY-- 366
S R ++APE ++ Y T+ DV+SF ++L E+ G P+ ++ + E +
Sbjct: 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD 292
Query: 367 AARQRPPFKAPAKLY 381
R R P A ++Y
Sbjct: 293 GTRMRAPENATPEIY 307
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 51/180 (28%), Positives = 89/180 (49%), Gaps = 24/180 (13%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALK--------P 249
E+ALL++++HPNV+ + + ++ +Y + DL +K A K P
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 106
Query: 250 STAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKLLT 304
V+ L I G++YLH N ++HRDL+P+NIL + G +K+AD G ++L
Sbjct: 107 RGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163
Query: 305 VKEDRPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDN 360
+PL D + Y APE+ + TK +D+++ I E++ P F + ++
Sbjct: 164 -SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 3e-08
Identities = 25/50 (50%), Positives = 30/50 (60%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93
L A +++ +K LL G DVN RD D RT LH+AA G EVV LLL
Sbjct: 77 LHLAARNGNLDVVKLLLKHGADVNARDKDGRTPLHLAAKNGHLEVVKLLL 126
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 3e-08
Identities = 19/33 (57%), Positives = 23/33 (69%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104
D T LH+AA G EVV LLLE GADV+ +D+
Sbjct: 1 DGNTPLHLAARNGHLEVVKLLLEAGADVNARDK 33
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 50/191 (26%), Positives = 92/191 (48%), Gaps = 18/191 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP--MMIVTEYLPK 234
A+K + ++ ++V R E+ L+++ HPN+++ + + + +V E L
Sbjct: 27 YAIKCM-KKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE-LMD 83
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
+L +K RK L + + + ++++H N I HRD++P NIL D LK
Sbjct: 84 MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILK 139
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCR-YVAPE-VFKNEEYDTKVDVFSFALILQEMIEGC 351
+ADFG + + P T + S R Y APE + + Y K+D+++ + E++
Sbjct: 140 LADFGSCR--GIYSKPPYT-EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLF 196
Query: 352 PPFTMKHDNEV 362
P F NE+
Sbjct: 197 PLFPGT--NEL 205
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 6e-08
Identities = 41/139 (29%), Positives = 69/139 (49%), Gaps = 22/139 (15%)
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR----- 309
++ +ARGM +L K IHRDL NIL ++ +K+ DFG+++ + D
Sbjct: 178 YSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 310 ---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT-MKHDNEVPK 364
PL +++APE ++ Y T+ DV+SF ++L E+ G P+ ++ D E +
Sbjct: 235 ARLPL-------KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR 287
Query: 365 AY--AARQRPPFKAPAKLY 381
R R P A ++Y
Sbjct: 288 RLKEGTRMRAPEYATPEIY 306
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 49/192 (25%), Positives = 90/192 (46%), Gaps = 18/192 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G V V+ E +++ ++A ++E+ L RHPN++ T S + +++ ++
Sbjct: 25 GTLVTVRITDLENCTEE-HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83
Query: 235 GDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
G + LK S A+ RG+NYLH+N IHR+++ S+IL G +
Sbjct: 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLV 140
Query: 293 KVADFGVSKL--LTVKEDRPLTCQD-----TSCR-YVAPEVFKNE--EYDTKVDVFSFAL 342
++ G+S L L + D TS +++PE+ + + Y+ K D++S +
Sbjct: 141 SLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198
Query: 343 ILQEMIEGCPPF 354
E+ G PF
Sbjct: 199 TACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 8e-08
Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 35/186 (18%)
Query: 200 ELALLQKIRHPNVVQ----FLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPST 251
E+ ++++++H N+V+ FL Q + I+ E+ GDL + K G ++
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQK--LYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119
Query: 252 AVRFALDIARGMNYLHENKPVP----IIHRDLEPSNI-----------LRDDSGNL---- 292
V + + Y H K P ++HRDL+P NI + + NL
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179
Query: 293 --KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMI 348
K+ DFG+SK + + E +C T Y +PE+ +E YD K D+++ I+ E+
Sbjct: 180 IAKIGDFGLSKNIGI-ESMAHSCVGTP-YYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 349 EGCPPF 354
G PF
Sbjct: 238 SGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 38/140 (27%), Positives = 71/140 (50%), Gaps = 17/140 (12%)
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSN 283
+ +V +Y GDL L + P RF + ++ ++ +H+ V HRD++P N
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYV---HRDIKPDN 132
Query: 284 ILRDDSGNLKVADFG----VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTK 334
+L D +G++++ADFG +++ TV+ + D Y++PE+ + E Y +
Sbjct: 133 VLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD----YISPEILQAMEDGMGKYGPE 188
Query: 335 VDVFSFALILQEMIEGCPPF 354
D +S + + EM+ G PF
Sbjct: 189 CDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 33/116 (28%), Positives = 57/116 (49%), Gaps = 19/116 (16%)
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR----- 309
++ +A+GM +L K IHRDL NIL ++ +K+ DFG+++ + D
Sbjct: 184 YSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 310 ---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNE 361
PL +++APE + Y + DV+SF ++L E+ G P+ +E
Sbjct: 241 ARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 289
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 40/138 (28%), Positives = 72/138 (52%), Gaps = 17/138 (12%)
Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL 285
+V +Y GDL L + P RF L ++ ++ +H+ + +HRD++P N+L
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVL 134
Query: 286 RDDSGNLKVADFGVS-KLL---TVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTKVD 336
D +G++++ADFG +LL TV+ + + D Y++PE+ + E Y + D
Sbjct: 135 LDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD----YISPEILQAMEDGKGRYGPECD 190
Query: 337 VFSFALILQEMIEGCPPF 354
+S + + EM+ G PF
Sbjct: 191 WWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 44/128 (34%), Positives = 61/128 (47%), Gaps = 4/128 (3%)
Query: 8 RTTLLKQSSLAPDRERKEAEL--NGLDDDGEEIKPEFRLMFLA-NERDVEGIKELLDSGI 64
+ T L +S AP R +L G D + + IK E L +A N D E I+ L+ G
Sbjct: 273 KNTPLHHASQAPSLSRLVPKLLERGADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGA 332
Query: 65 DVNFRDIDNRTALHVAAC-QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
DVN D T LH A+ ++V LLE GA+V+ +D TP+ A N +I
Sbjct: 333 DVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIIN 392
Query: 124 LLEKHGAK 131
L +GA
Sbjct: 393 TLLDYGAD 400
|
Length = 682 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 2e-07
Identities = 26/53 (49%), Positives = 32/53 (60%)
Query: 73 NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
RTALH AA G E+V LLE+G D++ D G+T L A N EV+KLL
Sbjct: 1 GRTALHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLL 53
|
Length = 54 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-07
Identities = 23/50 (46%), Positives = 30/50 (60%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93
L A +E +K LL+ G+D+N D D TALH+AA G EV+ LLL
Sbjct: 5 LHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLLL 54
|
Length = 54 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 28/185 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G+Q VK+ I+D + + + E+A + K++HPN+V+ +G ++ EY+
Sbjct: 715 GMQFVVKE-----INDVNSIPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNL 292
+L L+ L + A+ IA+ + +LH ++ +L P I+ D D +L
Sbjct: 768 KNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCR----YVAPEVFKNEEYDTKVDVFSFALILQEMI 348
+++ G L C DT C YVAPE + ++ K D++ F LIL E++
Sbjct: 825 RLSLPG------------LLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELL 872
Query: 349 EGCPP 353
G P
Sbjct: 873 TGKSP 877
|
Length = 968 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 51.0 bits (121), Expect = 3e-07
Identities = 39/97 (40%), Positives = 55/97 (56%), Gaps = 8/97 (8%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA-----CQGFTEVVSLLLERGAD 98
L A++ D + +K LL SG DVN +D D T LH+AA +G EV LLLE GAD
Sbjct: 77 LHSAASKGDDKIVKLLLASGADVNAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGAD 136
Query: 99 VDPKDRW---GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+D + G+TPL A + ++++LL + GA P
Sbjct: 137 LDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADP 173
|
Length = 235 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 35/142 (24%), Positives = 60/142 (42%), Gaps = 9/142 (6%)
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
PN+V + + +V ++ G L + + + + R+A ++ ++ LH
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVFKN 328
I+ RDL P+NIL DD G++++ F E + Y APEV
Sbjct: 105 G---IVCRDLNPNNILLDDRGHIQLTYFS-----RWSEVEDSCDGEAVENMYCAPEVGGI 156
Query: 329 EEYDTKVDVFSFALILQEMIEG 350
E D +S IL E++ G
Sbjct: 157 SEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-07
Identities = 20/47 (42%), Positives = 28/47 (59%)
Query: 64 IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
ID+N D + T LH+AA G E+V LL+ G D++ +D G T L
Sbjct: 7 IDLNATDGNGNTPLHLAAKYGALELVQWLLKPGVDLNLRDSDGLTAL 53
|
Length = 56 |
| >gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 23/57 (40%), Positives = 32/57 (56%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
L A D+ +KELL G++V+ D TAL VA + ++V LL+ GADVD
Sbjct: 626 LCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVD 682
|
Length = 823 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 1/80 (1%)
Query: 52 DVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+ E K LL G D+N +D TALH A + LLL GA+V+ D+ ++PL
Sbjct: 146 EAEITKLLLSYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPL 205
Query: 111 GDAIYYKNHEVIKLLEKHGA 130
A+ + N ++ +L ++GA
Sbjct: 206 HHAVKHYNKPIVHILLENGA 225
|
Length = 477 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 48.7 bits (115), Expect = 2e-06
Identities = 34/98 (34%), Positives = 45/98 (45%), Gaps = 5/98 (5%)
Query: 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99
+ + L + + L + RD+D R LH AA +G ++V LLL GADV
Sbjct: 40 NLYLELALLPAASLSELLLKLIVDRHLAARDLDGRLPLHSAASKGDDKIVKLLLASGADV 99
Query: 100 DPKDRWGSTPLGDAIYYKN-----HEVIKLLEKHGAKP 132
+ KD G TPL A N EV KLL + GA
Sbjct: 100 NAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGADL 137
|
Length = 235 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 23/82 (28%), Positives = 42/82 (51%)
Query: 51 RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+ ++ +K L+ G D + + D + LH+A G + + LL++ A +D +D G TPL
Sbjct: 113 KKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPL 172
Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
A+ + + K+L GA
Sbjct: 173 IIAMAKGDIAICKMLLDSGANI 194
|
Length = 413 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 40/104 (38%), Positives = 55/104 (52%), Gaps = 5/104 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANER---DVEGIKE-LLDSGIDVNFRDIDNRTALHV 79
KEA ++G D ++I M L ER D I E LL+ G DVN +DI T +H
Sbjct: 126 KEA-ISGNDIHYDKINESIEYMKLIKERIQQDELLIAEMLLEGGADVNAKDIYCITPIHY 184
Query: 80 AACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
AA +G ++V+LLL GADV+ + L A+ KN + IK
Sbjct: 185 AAERGNAKMVNLLLSYGADVNIIALDDLSVLECAVDSKNIDTIK 228
|
Length = 682 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 18/161 (11%)
Query: 232 LPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
+++ L G+ L + F +ARGM +L V HRDL N+L
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV---HRDLAARNVLLAQG 273
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQE 346
+K+ DFG+++ + D + ++ +++APE + Y T DV+S+ ++L E
Sbjct: 274 KIVKICDFGLAR--DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE 331
Query: 347 MIE--GCPPFTMKHD----NEVPKAYAARQRPPFKAPAKLY 381
+ G P M D N++ Y R P A ++Y
Sbjct: 332 IFSLGGTPYPGMIVDSTFYNKIKSGY--RMAKPDHATQEVY 370
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 21/178 (11%)
Query: 218 AVTQSSPMMI-VTEYLP----KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
A +SS +YLP + + AL V F+ +A GM +L V
Sbjct: 202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV 261
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNE 329
HRDL N+L + +K+ DFG+++ + D + ++ +++APE N
Sbjct: 262 ---HRDLAARNVLICEGKLVKICDFGLAR--DIMRDSNYISKGSTFLPLKWMAPESIFNN 316
Query: 330 EYDTKVDVFSFALILQEM--IEGCP----PFTMKHDNEVPKAYAARQRPPFKAPAKLY 381
Y T DV+SF ++L E+ + G P P + N + + Y R P A ++Y
Sbjct: 317 LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY--RMAKPAHASDEIY 372
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 23/79 (29%), Positives = 37/79 (46%), Gaps = 2/79 (2%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTE--VVSLLLERGADVDPKDRWGSTPLGDA 113
++EL+ +G D D+ T LH A + +V LL G ++ ++R+G TPL A
Sbjct: 205 VRELIRAGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYA 264
Query: 114 IYYKNHEVIKLLEKHGAKP 132
+ N + L GA
Sbjct: 265 AVFNNPRACRRLIALGADI 283
|
Length = 471 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 28/99 (28%), Positives = 45/99 (45%), Gaps = 13/99 (13%)
Query: 44 LMFLANE-----RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ--GFTEVVSLLLERG 96
L +L+N E +K LL+ G +VN D + T L A + +V LL+ G
Sbjct: 72 LHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAISKKSNSYSIVEYLLDNG 131
Query: 97 ADVDPKDRWGSTPLGDAIY----YKNHEVIKLLEKHGAK 131
A+V+ K+ G L +Y + +++KLL G
Sbjct: 132 ANVNIKNSDGENLL--HLYLESNKIDLKILKLLIDKGVD 168
|
Length = 422 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 44/163 (26%), Positives = 68/163 (41%), Gaps = 28/163 (17%)
Query: 150 IDPHELDFTNSVEITKGTFIL-------AFWR--------------GIQVAVKKLGEEVI 188
+DP +L + ++ E+ + +L AF R ++VAVK L
Sbjct: 21 VDPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR 80
Query: 189 SDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
S + + A EL ++ + H N+V LGA T+ P+ I+TEY GDL +L R
Sbjct: 81 SSEKQ--ALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR---- 134
Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
T +++ LD R L P+ R S D G
Sbjct: 135 NKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGG 177
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 12/143 (8%)
Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
AL + F+ +A+GM++L IHRDL NIL K+ DFG+++ +
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR--DI 264
Query: 306 KEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT-MKHDN 360
+ D + + +++APE N Y + DV+S+ ++L E+ G P+ M D+
Sbjct: 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324
Query: 361 EVPKAYAA--RQRPPFKAPAKLY 381
+ K R P AP+++Y
Sbjct: 325 KFYKMIKEGYRMLSPECAPSEMY 347
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|205784 pfam13606, Ank_3, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 3e-05
Identities = 16/29 (55%), Positives = 20/29 (68%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVD 100
D T LH+AA G E+V LLLE GAD++
Sbjct: 1 DGNTPLHLAARNGNLELVKLLLEHGADIN 29
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Length = 30 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 27/69 (39%), Positives = 38/69 (55%), Gaps = 4/69 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS-PMMIVTEYLPKG 235
VAVK L E + + + A EL +L I H NVV LGA T+ P+M++ EY G
Sbjct: 40 VAVKMLKEGATASEYK--ALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFG 97
Query: 236 DLRAFLKRK 244
+L +L+ K
Sbjct: 98 NLSNYLRSK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 20/61 (32%), Positives = 29/61 (47%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
LL +GI +N R+ +T LH AA L+ GAD++ G+TPL + N
Sbjct: 243 LLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDGNTPLSLMVRNNN 302
Query: 119 H 119
Sbjct: 303 G 303
|
Length = 471 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 46/209 (22%), Positives = 83/209 (39%), Gaps = 31/209 (14%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VA+KK+ E++ + + F E + + HP +V + P+ Y+
Sbjct: 29 RVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYT 88
Query: 237 LRAFLKR-------KGALKPSTAVRFALDI----ARGMNYLHENKPVPIIHRDLEPSNIL 285
L++ LK L T+V L I + Y+H ++HRDL+P NIL
Sbjct: 89 LKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNIL 145
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTC---QDTSC--------------RYVAPEVFKN 328
G + + D+G + ++E+ L + C Y+APE
Sbjct: 146 LGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205
Query: 329 EEYDTKVDVFSFALILQEMIEGCPPFTMK 357
D+++ +IL +M+ P+ K
Sbjct: 206 VPASESTDIYALGVILYQMLTLSFPYRRK 234
|
Length = 932 |
| >gnl|CDD|197603 smart00248, ANK, ankyrin repeats | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 5e-05
Identities = 17/29 (58%), Positives = 22/29 (75%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVD 100
D RT LH+AA G EVV LLL++GAD++
Sbjct: 1 DGRTPLHLAAENGNLEVVKLLLDKGADIN 29
|
Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure. Length = 30 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 32/85 (37%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 51 RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA---DVDPKDRWGS 107
RD E IK L+ G + + D + LH A +G + V LL+ G DV KD G
Sbjct: 46 RDSEAIKLLMKHGAIPDVKYPDIESELHDAVEEGDVKAVEELLDLGKFADDVFYKD--GM 103
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132
TPL A K +++KLL GA P
Sbjct: 104 TPLHLATILKKLDIMKLLIARGADP 128
|
Length = 413 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 11/106 (10%)
Query: 49 NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-TEVVSLLLERGADVDPKDR-WG 106
N R+VE K +L + N + ID + E+ LLL GAD++ KDR G
Sbjct: 110 NNRNVEIFKIILTNRYK-NIQTIDLVYIDKKSKDDIIEAEITKLLLSYGADINMKDRHKG 168
Query: 107 STPLGDAIYYKNHEVIKLLEKHGAKPLM------APMH--VKHARE 144
+T L A K+ + +LL +GA + +P+H VKH +
Sbjct: 169 NTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNK 214
|
Length = 477 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 29/101 (28%), Positives = 53/101 (52%), Gaps = 14/101 (13%)
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL------TVK 306
+RF+ +A+GM++L IHRD+ N+L D K+ DFG+++ + VK
Sbjct: 215 LRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271
Query: 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
+ L +++APE + Y + DV+S+ ++L E+
Sbjct: 272 GNARL-----PVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 27/69 (39%), Positives = 39/69 (56%), Gaps = 4/69 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
VAVK L E + + + A EL +L I H NVV LGA T+ + P+M++ E+ G
Sbjct: 40 VAVKMLKEGATASEHK--ALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYG 97
Query: 236 DLRAFLKRK 244
+L FL+ K
Sbjct: 98 NLSNFLRAK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 30/84 (35%), Positives = 46/84 (54%), Gaps = 5/84 (5%)
Query: 50 ERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
E DV+ ++ELLD G DV ++D T LH+A +++ LL+ RGAD D +
Sbjct: 78 EGDVKAVEELLDLGKFADDVFYKD--GMTPLHLATILKKLDIMKLLIARGADPDIPNTDK 135
Query: 107 STPLGDAIYYKNHEVIKLLEKHGA 130
+PL A+ + + I+LL H A
Sbjct: 136 FSPLHLAVMMGDIKGIELLIDHKA 159
|
Length = 413 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 27/68 (39%), Positives = 35/68 (51%), Gaps = 3/68 (4%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VAVK L + A EL +L + H N+V LGA T P +++TEY GD
Sbjct: 68 VAVKMLKPSAHLTERE--ALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGD 125
Query: 237 LRAFLKRK 244
L FL+RK
Sbjct: 126 LLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 27/69 (39%), Positives = 37/69 (53%), Gaps = 4/69 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
VAVK L E + R A EL +L I H NVV LGA T+ P+M++ E+ G
Sbjct: 40 VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 97
Query: 236 DLRAFLKRK 244
+L +L+ K
Sbjct: 98 NLSNYLRSK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 28/73 (38%), Positives = 37/73 (50%), Gaps = 1/73 (1%)
Query: 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA-CQGFTEVVSLLLERGA 97
K + L+ D+E L D+G VN D T LH A+ + +V LLERGA
Sbjct: 239 KNDLSLLKAIRNEDLETSLLLYDAGFSVNSIDDCKNTPLHHASQAPSLSRLVPKLLERGA 298
Query: 98 DVDPKDRWGSTPL 110
DV+ K+ G TPL
Sbjct: 299 DVNAKNIKGETPL 311
|
Length = 682 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 26/69 (37%), Positives = 39/69 (56%), Gaps = 3/69 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++VAVK L S + + A EL ++ + H N+V LGA T+S P+ I+TEY
Sbjct: 68 MKVAVKMLKPTARSSEKQ--ALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFY 125
Query: 235 GDLRAFLKR 243
GDL +L +
Sbjct: 126 GDLVNYLHK 134
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 42/155 (27%), Positives = 67/155 (43%), Gaps = 18/155 (11%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK--GDLRAFL-KRKGALKPSTAVRFA 256
E LL+++ HP V+ L +V LPK DL +L R L + A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT---- 312
+ ++Y+H IIHRD++ N+L + ++ + DFG + P
Sbjct: 267 RQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 313 -CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
DT+ APEV + Y VD++S L++ E
Sbjct: 324 GTVDTN----APEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 7/79 (8%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAA---CQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112
+K L+D G +VN ++ D T LH A C+ +V+ +LL+ GADV+ + PL
Sbjct: 425 VKTLIDRGANVNSKNKDLSTPLHYACKKNCK--LDVIEMLLDNGADVNAINIQNQYPLLI 482
Query: 113 AIYYKNHEVIKLLEKHGAK 131
A+ Y H ++ +L +GA+
Sbjct: 483 ALEY--HGIVNILLHYGAE 499
|
Length = 682 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 26/79 (32%), Positives = 42/79 (53%), Gaps = 4/79 (5%)
Query: 52 DVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
D + +K LL+ G+DVN + I TALH + + LLLE GAD++ + + TPL
Sbjct: 247 DYDILKLLLEHGVDVNAKSYILGLTALHSSIKS--ERKLKLLLEYGADINSLNSYKLTPL 304
Query: 111 GDAIY-YKNHEVIKLLEKH 128
A+ Y + ++L +
Sbjct: 305 SSAVKQYLCINIGRILISN 323
|
Length = 477 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 29/96 (30%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 50 ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
+R+ + + LL+ G +VN RD ++T +H AA + +++ LL+ GAD++ + T
Sbjct: 352 DRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTA 411
Query: 110 LGDAIYYKN-HEVIKLLEKHGA------KPLMAPMH 138
L A+ N + +K L GA K L P+H
Sbjct: 412 LHFALCGTNPYMSVKTLIDRGANVNSKNKDLSTPLH 447
|
Length = 682 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 48/195 (24%), Positives = 87/195 (44%), Gaps = 18/195 (9%)
Query: 189 SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGAL 247
S D AF + +L+ ++ H ++ G + S ++V E++ G L L++ KG +
Sbjct: 55 SHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV 114
Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-------NLKVADFGVS 300
+ + A +A ++YL E+K ++H ++ NIL G +K++D GVS
Sbjct: 115 PVAWKITVAQQLASALSYL-EDK--NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171
Query: 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEM-IEGCPPFTMKH 358
+E+R ++APE T D +SF L E+ +G P +
Sbjct: 172 FTALSREERV-----ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226
Query: 359 DNEVPKAYAARQRPP 373
+E + Y + R P
Sbjct: 227 PSEKERFYEKKHRLP 241
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165256 PHA02946, PHA02946, ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 34/89 (38%), Positives = 46/89 (51%), Gaps = 13/89 (14%)
Query: 49 NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108
+ER VE ELL G N D D LH+A+ +V++LL GAD + D+ T
Sbjct: 51 DERFVE---ELLHRGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKT 107
Query: 109 PLGDAIYY---KNHEVIK---LLEKHGAK 131
PL YY + EVI+ LL ++GAK
Sbjct: 108 PL----YYLSGTDDEVIERINLLVQYGAK 132
|
Length = 446 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 29/206 (14%)
Query: 165 KGTFILAFWRGIQVAVKKLGE----EVI------SDDDRVRAFRDELALLQKIRHPNVVQ 214
+GTF F +GI+ V GE EV+ S + +F + +++ ++ H ++V
Sbjct: 5 QGTFTKIF-KGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVL 63
Query: 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST-AVRFALDIARGMNYLHENKPVP 273
G ++V EY+ G L +LK+ L + + A +A +++L +
Sbjct: 64 NYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--- 120
Query: 274 IIHRDLEPSNIL-----RDDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
+ H ++ N+L +GN +K++D G+S +TV L +V PE
Sbjct: 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILL---ERIPWVPPEC 175
Query: 326 FKN-EEYDTKVDVFSFALILQEMIEG 350
+N + D +SF L E+ G
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|233161 TIGR00870, trp, transient-receptor-potential calcium channel protein | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 26/83 (31%), Positives = 38/83 (45%), Gaps = 19/83 (22%)
Query: 68 FRDIDNRTALHVAA-CQGFTEVVSLLLERGADVDPK---DRWGSTPLGDAIYY------- 116
I TALH+AA Q + E+V LLLERGA V + D + + D+ Y+
Sbjct: 126 TPGI---TALHLAAHRQNY-EIVKLLLERGASVPARACGDFFVKSQGVDSFYHGESPLNA 181
Query: 117 ----KNHEVIKLLEKHGAKPLMA 135
+ ++ LL + A L A
Sbjct: 182 AACLGSPSIVALLSEDPADILTA 204
|
The Transient Receptor Potential Ca2+ Channel (TRP-CC) Family (TC. 1.A.4)The TRP-CC family has also been called the store-operated calcium channel (SOC) family. The prototypical members include the Drosophila retinal proteinsTRP and TRPL (Montell and Rubin, 1989; Hardie and Minke, 1993). SOC members of the family mediate the entry of extracellular Ca2+ into cells in responseto depletion of intracellular Ca2+ stores (Clapham, 1996) and agonist stimulated production of inositol-1,4,5 trisphosphate (IP3). One member of the TRP-CCfamily, mammalian Htrp3, has been shown to form a tight complex with the IP3 receptor (TC #1.A.3.2.1). This interaction is apparently required for IP3 tostimulate Ca2+ release via Htrp3. The vanilloid receptor subtype 1 (VR1), which is the receptor for capsaicin (the ?hot? ingredient in chili peppers) and servesas a heat-activated ion channel in the pain pathway (Caterina et al., 1997), is also a member of this family. The stretch-inhibitable non-selective cation channel(SIC) is identical to the vanilloid receptor throughout all of its first 700 residues, but it exhibits a different sequence in its last 100 residues. VR1 and SICtransport monovalent cations as well as Ca2+. VR1 is about 10x more permeable to Ca2+ than to monovalent ions. Ca2+ overload probably causes cell deathafter chronic exposure to capsaicin. (McCleskey and Gold, 1999) [Transport and binding proteins, Cations and iron carrying compounds]. Length = 743 |
| >gnl|CDD|165089 PHA02716, PHA02716, CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 24/95 (25%), Positives = 43/95 (45%), Gaps = 4/95 (4%)
Query: 20 DRERKEAELNGLDDDGEEIKPEFRLMF--LANERDVEGIKELLDSGIDVNFRDIDNRTAL 77
+ E + LD + + P + LA D+ + L G+ ++++D RT L
Sbjct: 262 NPEITNIYIESLDGNKVKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCL 321
Query: 78 HVAACQGF--TEVVSLLLERGADVDPKDRWGSTPL 110
H + T+++ LL E G D++ D G+T L
Sbjct: 322 HQYILRHNISTDIIKLLHEYGNDLNEPDNIGNTVL 356
|
Length = 764 |
| >gnl|CDD|222931 PHA02798, PHA02798, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 23/84 (27%), Positives = 44/84 (52%), Gaps = 8/84 (9%)
Query: 56 IKELLDSGIDVNFRDIDNRTAL-----HVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+K ++ G +VN D + T L ++ + ++V +L+E GAD++ K+ G TPL
Sbjct: 54 VKLFINLGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPL 113
Query: 111 GDAI---YYKNHEVIKLLEKHGAK 131
+ Y N E++ + ++GA
Sbjct: 114 YCLLSNGYINNLEILLFMIENGAD 137
|
Length = 489 |
| >gnl|CDD|165103 PHA02736, PHA02736, Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 19/58 (32%), Positives = 34/58 (58%), Gaps = 4/58 (6%)
Query: 72 DNRTALHVAACQGFT---EVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLL 125
+ +H+ + E + LL+E GAD++ K+R +G+TPL A+Y +N+E+ L
Sbjct: 54 HGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWL 111
|
Length = 154 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.004
Identities = 17/61 (27%), Positives = 25/61 (40%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + + E +K LLD G + N + T LH+A E+ LLL G +
Sbjct: 196 LHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIAILNNNKEIFKLLLNNGPSIKTII 255
Query: 104 R 104
Sbjct: 256 E 256
|
Length = 422 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 387 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.82 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.81 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.79 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| PF12796 | 89 | Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02 | 99.78 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.78 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 99.77 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| KOG0502 | 296 | consensus Integral membrane ankyrin-repeat protein | 99.77 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.77 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.77 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 99.75 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 99.75 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 99.75 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 99.74 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 99.74 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.74 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.73 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.73 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 99.72 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 99.72 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.72 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.72 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.72 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 99.72 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 99.72 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 99.71 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 99.69 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 99.69 | |
| KOG4214 | 117 | consensus Myotrophin and similar proteins [Transcr | 99.68 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 99.68 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 99.68 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.67 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 99.66 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 99.66 | |
| KOG0510 | 929 | consensus Ankyrin repeat protein [General function | 99.65 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 99.65 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 99.64 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 99.64 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 99.64 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.64 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.63 | |
| PF12796 | 89 | Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02 | 99.63 | |
| PF13637 | 54 | Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A | 99.63 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 99.62 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 99.62 | |
| PF13857 | 56 | Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A | 99.62 | |
| KOG4214 | 117 | consensus Myotrophin and similar proteins [Transcr | 99.61 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 99.61 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.6 | |
| KOG0510 | 929 | consensus Ankyrin repeat protein [General function | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| KOG0502 | 296 | consensus Integral membrane ankyrin-repeat protein | 99.59 | |
| KOG0505 | 527 | consensus Myosin phosphatase, regulatory subunit [ | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 99.57 | |
| cd00204 | 126 | ANK ankyrin repeats; ankyrin repeats mediate prote | 99.57 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.57 | |
| PHA02792 | 631 | ankyrin-like protein; Provisional | 99.56 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=342.06 Aligned_cols=209 Identities=33% Similarity=0.599 Sum_probs=190.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...++||+|+|++||. ++..||||.+.+... ..+.++.+..|+.+|+.++|||||++++++..++.+|+|||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 566677899999999974 678999999987654 56778889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC------CCEEEEeecCccccc
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS------GNLKVADFGVSKLLT 304 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~------~~~kl~Dfg~~~~~~ 304 (387)
||.||+|.+|+++.+.+++..+..++.||+.||++||+++ ||||||||.|||++.. -.+||+|||+|+...
T Consensus 90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999999999999999999999999999999999999999 9999999999999865 458999999999876
Q ss_pred cCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
. ........|++.|||||++...+|+.|+|+||+|+++|++++|+.||...+..++...|..+.
T Consensus 167 ~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~ 230 (429)
T KOG0595|consen 167 P--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN 230 (429)
T ss_pred c--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc
Confidence 3 344455679999999999999999999999999999999999999999999999999887776
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=339.35 Aligned_cols=216 Identities=31% Similarity=0.482 Sum_probs=198.2
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +++.+|+|++++..+......+....|.++|..++||+||.++..|++...+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 3677888999999998873 68899999999988877777888999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+.||.|..++++++.+++..+..++.+|+.||.|||++| ||||||||+|||++.+|+++|+|||+++..... ..
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~~ 180 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-GD 180 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC-CC
Confidence 99999999999999999999999999999999999999999 999999999999999999999999999864433 33
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......||+.|||||++.+.+++..+|+||||+++|||++|.+||.+.+...+.++|..++.+.+
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~ 245 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLP 245 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCC
Confidence 44457899999999999999999999999999999999999999999999999999998883433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=349.14 Aligned_cols=223 Identities=29% Similarity=0.477 Sum_probs=204.0
Q ss_pred CCCccccCccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeE
Q 016544 144 EVPEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218 (387)
Q Consensus 144 ~~~~~ei~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~ 218 (387)
.++..-.++....|...+.||+|+|..+|. +|..||+|++.+.........+.+.+|+++.++++|||||+++++
T Consensus 7 ~ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~ 86 (592)
T KOG0575|consen 7 EIPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF 86 (592)
T ss_pred CCCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE
Confidence 344444455557799999999999988873 689999999999888888888999999999999999999999999
Q ss_pred EeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeec
Q 016544 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (387)
Q Consensus 219 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 298 (387)
|++...+|+|.|+|..++|..++++.+++++.++..+++||+.||.|||+++ |+|||||..|+|++++.++||+|||
T Consensus 87 FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 87 FEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred eecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccc
Confidence 9999999999999999999999999899999999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
+|....... .......|||.|+|||++....++..+||||+||+||.||.|++||...+-.+++.+|+...
T Consensus 164 LAt~le~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~ 234 (592)
T KOG0575|consen 164 LATQLEYDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE 234 (592)
T ss_pred eeeeecCcc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC
Confidence 998877543 33445679999999999999999999999999999999999999999999999999998888
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=317.36 Aligned_cols=208 Identities=28% Similarity=0.526 Sum_probs=194.3
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.|- -+|.-+|+|++.+...-..++.+...+|..+|+.+.||+++++++.|.+...+|+|||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 67777899999999875 3688999999998877777788889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|++||.|.+++++.+++++..++.++.||+.||+|||+++ |++|||||+|||+|.+|.+||+|||+|+.... .
T Consensus 125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---r- 197 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---R- 197 (355)
T ss_pred ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC---c-
Confidence 9999999999999999999999999999999999999999 99999999999999999999999999987642 2
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....|||.|+|||++++.++..++|+|||||++|||+.|.+||.+.++..++++|..++
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~ 257 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK 257 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc
Confidence 334679999999999999999999999999999999999999999999999999999998
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=338.53 Aligned_cols=227 Identities=43% Similarity=0.745 Sum_probs=195.8
Q ss_pred CCccccCccccCcccceeecccEEEEEE---EcCeE-EEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEe
Q 016544 145 VPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQ-VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (387)
Q Consensus 145 ~~~~ei~~~~~~~~~~~~lg~G~~~~v~---~~g~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~ 220 (387)
...++++...+.+.. .+|.|+||.|| |.|+. ||+|.+......... .+.|.+|+.+|.+++|||||+++|++.
T Consensus 33 ~~~~~i~~~~l~~~~--~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~ 109 (362)
T KOG0192|consen 33 LPEEEIDPDELPIEE--VLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACT 109 (362)
T ss_pred ccceecChHHhhhhh--hcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 345666666554443 49999998776 88998 999999877655544 789999999999999999999999999
Q ss_pred eCC-ceEEEEEccCCCCHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEe
Q 016544 221 QSS-PMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVAD 296 (387)
Q Consensus 221 ~~~-~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~D 296 (387)
... ..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++| ||||||||+|||++.++ ++||+|
T Consensus 110 ~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 110 SPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred CCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECC
Confidence 887 79999999999999999988 5679999999999999999999999985 99999999999999997 999999
Q ss_pred ecCccccccCCCCCcccCCCCCccccccccc--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC-CCC
Q 016544 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP 373 (387)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~ 373 (387)
||+++...... ...+...||+.|||||++. ...++.++||||||+++|||+||+.||.+..+..+...+...+ ||+
T Consensus 188 FGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~ 266 (362)
T KOG0192|consen 188 FGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP 266 (362)
T ss_pred Cccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 99998765332 3333467899999999999 5699999999999999999999999999999988888876555 888
Q ss_pred CCCC
Q 016544 374 FKAP 377 (387)
Q Consensus 374 ~~~~ 377 (387)
++..
T Consensus 267 ~p~~ 270 (362)
T KOG0192|consen 267 IPKE 270 (362)
T ss_pred CCcc
Confidence 7653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=322.43 Aligned_cols=227 Identities=26% Similarity=0.458 Sum_probs=196.0
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeee-EEeeCCc-eEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG-AVTQSSP-MMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~-~~~~~~~-~~lv 228 (387)
+|.+.+.||+|+||.|| ++|..+|.|.+.=.. -+....+....|+.+|++++|||||++++ .|..+.. ++|+
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 57788899999999887 589999999998433 35666788899999999999999999999 5555555 8999
Q ss_pred EEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCC-CeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPV-PIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~-~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
||+|.+|+|.+.++. ...+++..+++++.|++.||..+|+..|. .|+||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999863 34499999999999999999999995432 3899999999999999999999999999988
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhh
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 383 (387)
+.. .....+.+|||.||+||.+.+.+|+.+|||||+||++|||++-++||.+.+-.+++++|..+..||++ ..-|+.
T Consensus 179 ~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p--~~~YS~ 255 (375)
T KOG0591|consen 179 SSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP--DEHYST 255 (375)
T ss_pred cch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc--HHHhhh
Confidence 754 33345678999999999999999999999999999999999999999999999999999999877764 255665
Q ss_pred ccc
Q 016544 384 GLK 386 (387)
Q Consensus 384 ~l~ 386 (387)
+|+
T Consensus 256 ~l~ 258 (375)
T KOG0591|consen 256 DLR 258 (375)
T ss_pred HHH
Confidence 554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=323.97 Aligned_cols=221 Identities=29% Similarity=0.441 Sum_probs=191.7
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc-eEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~lv~ 229 (387)
++.....||+|..|+|+ ++++.+|+|.+... .++...+++.+|+++++..+||+||.+||.|..++. +.|+|
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 34455689999999886 47899999999543 356778889999999999999999999999999995 99999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|||++|||..++...+.+++.....++.+|++||.|||+ ++ ||||||||+|||++..|.+||+|||.+......
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999999998899999999999999999999996 77 999999999999999999999999999876543
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC-----CCCcHHHHHHccCCCCCCCChhhhhh
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK-----HDNEVPKAYAARQRPPFKAPAKLYAR 383 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~ 383 (387)
....+.||..|||||.+.+..|+.++||||||+.++|+.+|+.||... +..+++..|..+..|.++. ..|++
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~--~~fS~ 309 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE--GEFSP 309 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc--ccCCH
Confidence 445678999999999999999999999999999999999999999874 4556677777666555533 24666
Q ss_pred ccc
Q 016544 384 GLK 386 (387)
Q Consensus 384 ~l~ 386 (387)
+++
T Consensus 310 ef~ 312 (364)
T KOG0581|consen 310 EFR 312 (364)
T ss_pred HHH
Confidence 654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=329.42 Aligned_cols=213 Identities=27% Similarity=0.430 Sum_probs=185.8
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHH----HHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDD----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
.|...+.||+|+||.|. .+|+.||||++++....... .....++|+++|++++|||||+++++|......|
T Consensus 173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y 252 (475)
T KOG0615|consen 173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY 252 (475)
T ss_pred eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence 56778899999999885 47999999999876554322 2334679999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC---CCEEEEeecCcccc
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLL 303 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfg~~~~~ 303 (387)
+||||++||+|.+.+-.++.+.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||+|+..
T Consensus 253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 99999999999999999988999999999999999999999999 9999999999999976 67999999999987
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCC---CchhHHHHHHHHHHHHcCCCCCCCCCCCc-HHHHHHccCCCC
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYD---TKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPP 373 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Dv~slG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~ 373 (387)
+ +........|||.|.|||++.+...+ .++|+||+||++|-+++|.+||.+..... +.++|..+..+-
T Consensus 330 g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f 401 (475)
T KOG0615|consen 330 G--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAF 401 (475)
T ss_pred c--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccc
Confidence 5 34445567899999999999876433 37899999999999999999999877766 899998888433
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=310.34 Aligned_cols=335 Identities=27% Similarity=0.405 Sum_probs=267.1
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
+-|.|..|-.|.+||||||+.|+..+++.|+..|+.+|+.+.-..||||+|+.+|+.++|+.|++..+|+|..|..|.||
T Consensus 24 ehdln~gddhgfsplhwaakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgntp 103 (448)
T KOG0195|consen 24 EHDLNVGDDHGFSPLHWAAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTP 103 (448)
T ss_pred ccccccccccCcchhhhhhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCc
Confidence 44556666678899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhCCCCCCCCc-----------------------cccccCCCCccccCcc-------------
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPM-----------------------HVKHAREVPEYEIDPH------------- 153 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~~~~~~-----------------------~~~~~~~~~~~ei~~~------------- 153 (387)
|||||..|...+++-|++.|+.+..-+. +...+..++..+....
T Consensus 104 lhyacfwgydqiaedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdatlsr 183 (448)
T KOG0195|consen 104 LHYACFWGYDQIAEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDATLSR 183 (448)
T ss_pred hhhhhhhcHHHHHHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCccccccccccccccccccccccc
Confidence 9999999999999999999987643221 1222223332221111
Q ss_pred -------ccCcc-cceeecccEEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 154 -------ELDFT-NSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 154 -------~~~~~-~~~~lg~G~~~~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
.+++. ...+-.+|..+.+.|.|..+++|++..... .....+.|..|.-.++.+.||||+.+++.|.....+
T Consensus 184 ~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 184 YTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL 262 (448)
T ss_pred ccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence 11110 011123466677889999999999875433 233346789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEE--eecCcc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA--DFGVSK 301 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~--Dfg~~~ 301 (387)
.++..||+.|||..++++... ++..++.+++.+++.|++|||+..|. |.---|.+..++++++.+++|. |--++.
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsf 341 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSF 341 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeee
Confidence 999999999999999997654 67789999999999999999999852 3344689999999999887765 322221
Q ss_pred ccccCCCCCcccCCCCCcccccccccCCCCC---CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC-CCCC
Q 016544 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD---TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPF 374 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~ 374 (387)
.. .....+|.|++||.++..+-. .++|+|||++++|||.|++.||.+.++.++-.+|...+ |+-+
T Consensus 342 qe--------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i 410 (448)
T KOG0195|consen 342 QE--------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI 410 (448)
T ss_pred ec--------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC
Confidence 10 112347889999999886543 57999999999999999999999999999999998877 4443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=328.39 Aligned_cols=214 Identities=29% Similarity=0.522 Sum_probs=195.8
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l 227 (387)
..+|..++.||.|+|..|+. .++.||||++.+..+-.+..++....|..+|.++ +||+|++|+..|+++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 34788888999999988863 6889999999888777777778889999999999 89999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|+||+++|+|.++|++-+.+++..+..++.||+.||+|||++| ||||||||+|||++.+++++|+|||.|..+....
T Consensus 152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999999999999999999999999999999999999999 9999999999999999999999999998775432
Q ss_pred CC------------CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 308 DR------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 308 ~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.. ....++||..|.+||++.....++.+|+|+|||++|+|++|.+||.+.++.-+.++|+.-.
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 21 1145789999999999999999999999999999999999999999999999999998877
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=328.62 Aligned_cols=229 Identities=33% Similarity=0.552 Sum_probs=195.0
Q ss_pred CCccccCccccCcccceeecccEEEEEE---EcCe-EEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEe
Q 016544 145 VPEYEIDPHELDFTNSVEITKGTFILAF---WRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (387)
Q Consensus 145 ~~~~ei~~~~~~~~~~~~lg~G~~~~v~---~~g~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~ 220 (387)
...|++++..+. ..++||+|.||.|. |+|. +||+|.++..... .+.|.+|+++|++++|++||+++++|.
T Consensus 198 ~d~wei~r~~l~--l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 198 RDPWEIPREELK--LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred cCCeeecHHHHH--HHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 345566555444 35689999999774 7776 9999999875433 356889999999999999999999999
Q ss_pred eCCceEEEEEccCCCCHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeec
Q 016544 221 QSSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (387)
Q Consensus 221 ~~~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 298 (387)
.++.++||||||+.|+|.++++. ...+...+.+.++.|||+||+||++++ +|||||-.+|||++++..+||+|||
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFG 348 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFG 348 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccc
Confidence 98999999999999999999987 345899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCCCCC
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP 377 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 377 (387)
+|+......-.......-+..|.|||.+....++.+||||||||+|||++| |+.||.+++..++++.+..|.|-|-
T Consensus 349 LAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~--- 425 (468)
T KOG0197|consen 349 LARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR--- 425 (468)
T ss_pred cccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---
Confidence 999544333333344445788999999999999999999999999999998 9999999999999999999986554
Q ss_pred hhhhhhcc
Q 016544 378 AKLYARGL 385 (387)
Q Consensus 378 ~~~~~~~l 385 (387)
|..||+.+
T Consensus 426 P~~CP~~v 433 (468)
T KOG0197|consen 426 PEGCPDEV 433 (468)
T ss_pred CCCCCHHH
Confidence 24455543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=311.15 Aligned_cols=210 Identities=27% Similarity=0.516 Sum_probs=196.2
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|+||.|. ..|+.||||.+++..+.++...-.+++|+++|..++||||+.+|.+|+..+.+.||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 45666789999999886 3689999999999999998888899999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|..+|.|++|+.+.+.+++.++..+++||++|+.|+|.++ ++|||||.+|||+|.++++||+|||++..+.. ...
T Consensus 134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~--~kf 208 (668)
T KOG0611|consen 134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD--KKF 208 (668)
T ss_pred ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc--ccH
Confidence 9999999999999999999999999999999999999999 99999999999999999999999999988764 345
Q ss_pred cccCCCCCcccccccccCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.+.+.|+|.|.+||++.|.+|. +.+|-|||||++|.|+.|..||+|.+...++.+|..+.
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga 269 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA 269 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc
Confidence 5667899999999999999885 88999999999999999999999999999999998887
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=316.94 Aligned_cols=213 Identities=29% Similarity=0.446 Sum_probs=192.4
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +|.-+|+|++++........++..+.|.++|....+|+||+||-.|++...+||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 3677788999999999874 78999999999887777888899999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc----
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV---- 305 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~---- 305 (387)
||++||++..+|.+.+.+++..+..++.+++-|++.+|++| ||||||||+|+|||..|++||+|||++.-+..
T Consensus 221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 99999999999999999999999999999999999999999 99999999999999999999999999742211
Q ss_pred -----------------CCCCC-----c--------------------ccCCCCCcccccccccCCCCCCchhHHHHHHH
Q 016544 306 -----------------KEDRP-----L--------------------TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 343 (387)
Q Consensus 306 -----------------~~~~~-----~--------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 343 (387)
..+.. . ...+|||-|+|||++.+..|+..+|+||||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 00000 0 12569999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 344 LQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 344 l~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
+||||.|.+||...++.+++.+|..-.
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr 404 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWR 404 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999999999999999999999998766
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=316.96 Aligned_cols=212 Identities=30% Similarity=0.508 Sum_probs=187.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH--HHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD--DRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~ 226 (387)
-.|...+.||.|+||.|+. +|..||+|++........ ...+.+.+|+.+++++. ||||+++++++.....+|
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 3677788999999999873 679999998776432211 34456778999999998 999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC-CCEEEEeecCcccccc
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLTV 305 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~~~ 305 (387)
+||||+.||+|.+++.+.+++.+.++..+++|+++|++|||++| |+||||||+|||++.+ +++||+|||++....
T Consensus 97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 99999999999999999889999999999999999999999999 9999999999999999 999999999998764
Q ss_pred CCCCCcccCCCCCcccccccccCCC-CC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNEE-YD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
..+.......||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||.+.+...+..+|..+.
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~ 239 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE 239 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC
Confidence 2344555678999999999999987 76 78999999999999999999999998888999987776
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=318.19 Aligned_cols=220 Identities=29% Similarity=0.520 Sum_probs=196.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|.+.+.||+|+||+||. +.+.||+|.+.+... .++..+.+++|+++++.++||||+.++++|+....+++|+|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 466678899999999984 567899999987643 45667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+.| +|..++...+.++++.+..++.++++||.|||+++ |+|||+||.|||++.++.+|++|||+++..+.. ...
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~v 156 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSV 156 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-cee
Confidence 9976 99999999999999999999999999999999999 999999999999999999999999999987653 344
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhh
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 381 (387)
.+...|||.|||||.+.+.+|+..+|+|||||++||+++|++||...+-.++.+.|.....++++.....|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f 227 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSF 227 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHH
Confidence 45678999999999999999999999999999999999999999999988999999888855544443333
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=312.02 Aligned_cols=211 Identities=27% Similarity=0.451 Sum_probs=187.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI 227 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~l 227 (387)
..|...+.||+|+||.||. +|+.||+|+++......+ ...-..+|+.+|+++.||||++|.+...+. +.+|+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3566778899999999984 689999999987654443 334457799999999999999999988876 68999
Q ss_pred EEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|+|||+. +|.-++...+ .+++.++..++.||+.||+|||++| |+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999976 9998888754 4999999999999999999999999 999999999999999999999999999998877
Q ss_pred CCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....+..+.|..|.|||.+.|. .|++++|+||.||||.||++|++.|.+.++.+-+.+|-.-.
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklc 336 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLC 336 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHh
Confidence 77777888889999999999986 78999999999999999999999999999988888885544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=318.57 Aligned_cols=219 Identities=27% Similarity=0.393 Sum_probs=194.2
Q ss_pred cceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccC
Q 016544 159 NSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 159 ~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
.++.||.|+-|.|. .+|+.+|||++.+...-.......+.+|+-+|+.+.||||+++|+++.....+|+|.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 35679999998875 4899999999987644455556778999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCccc
Q 016544 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (387)
Q Consensus 234 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 313 (387)
+|-|.+++-+++++++.++.++++||+.|+.|+|..+ |+||||||+|+|++..+++||+|||||..-. .+.....
T Consensus 96 gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gklLeT 170 (786)
T KOG0588|consen 96 GGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGKLLET 170 (786)
T ss_pred CchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--CCccccc
Confidence 9999999999999999999999999999999999999 9999999999999999999999999997643 3455566
Q ss_pred CCCCCcccccccccCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhh
Q 016544 314 QDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (387)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 382 (387)
..|+|.|.|||++.|.+|. .++||||+|||||.||||++||.+.+-..++.+++.|.-..++..+...-
T Consensus 171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQ 240 (786)
T KOG0588|consen 171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQ 240 (786)
T ss_pred cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHH
Confidence 7899999999999999885 78999999999999999999999999999999999988544444444433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=318.83 Aligned_cols=212 Identities=27% Similarity=0.416 Sum_probs=192.2
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~l 227 (387)
..+|...+.||+|+||+|.. +++.+|||++++..+-..+.++....|..++.... ||.++.++.+|+.+.++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 34688888999999999863 67899999999988888888999999999999885 9999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||||+.||++..+ +..+.+++..+..++..|+.||.|||++| ||+||||.+|||+|..|.+||+|||+++......
T Consensus 447 vmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 447 VMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 9999999995443 33456999999999999999999999999 9999999999999999999999999998755443
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
...+.+.|||.|||||++.+..|+.++|+|||||+||||+.|+.||.+.+.+++...|+...
T Consensus 523 -~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~ 584 (694)
T KOG0694|consen 523 -DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE 584 (694)
T ss_pred -CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC
Confidence 35556789999999999999999999999999999999999999999999999999998877
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=291.62 Aligned_cols=207 Identities=22% Similarity=0.410 Sum_probs=178.3
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|.....+|+|+||+|+. +|+.||||++.+.. +++...+-..+|+++|++++|||+|.++++|...+.+++|+||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 45566799999999984 68999999998643 3455566678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
|+..-|.++-.-...++...+..++.|++.|+.|+|+++ +|||||||+|||++.+|.+||||||+|+..... ....
T Consensus 83 ~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd~Y 158 (396)
T KOG0593|consen 83 CDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GDNY 158 (396)
T ss_pred cchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-cchh
Confidence 977444443333445899999999999999999999999 999999999999999999999999999988753 3444
Q ss_pred ccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 312 TCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
+.++.|..|.|||.+.| .+|++++||||+||++.||++|.+.|.+.++-+.+-.|..
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k 216 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK 216 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH
Confidence 55677999999999998 6899999999999999999999999999998777666643
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=312.52 Aligned_cols=211 Identities=36% Similarity=0.566 Sum_probs=182.6
Q ss_pred CCCCccccCccccCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeE
Q 016544 143 REVPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218 (387)
Q Consensus 143 ~~~~~~ei~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~ 218 (387)
..+...++..++.+|.....||+|+||.||. +|..||||.+....... ..+|.+|+.++.+++|||+|+++||
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 3455667778888999999999999999984 45899999887553321 3559999999999999999999999
Q ss_pred EeeCC-ceEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEE
Q 016544 219 VTQSS-PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (387)
Q Consensus 219 ~~~~~-~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 295 (387)
|.+.+ ..+||+||+++|+|.+++.... +++|..+.+|+.++++||+|||+..+.+||||||||+|||+|++.++||+
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99988 4999999999999999998654 79999999999999999999999887789999999999999999999999
Q ss_pred eecCccccccCCCCCcccC-CCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 296 DFGVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
|||+|+..... ....... .||.+|+|||+...+..+.++|||||||++.|++||+.|....
T Consensus 220 DFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 220 DFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 99999655431 2222222 7899999999999999999999999999999999999988754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=277.51 Aligned_cols=206 Identities=28% Similarity=0.500 Sum_probs=179.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.+|+|+||+||. +|+.||||+++.....++-... ..+|++.|+.++|+||+.++++|...+.+.||+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~t-alREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRT-ALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHH-HHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 455667899999999984 7899999999877655444444 4569999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|++. +|+..++.+. .++..++..++.++++|++|||+++ |+||||||.|+|++.+|.+||+|||+++.+......
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9965 9999998654 4999999999999999999999999 999999999999999999999999999988765433
Q ss_pred CcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
.. ..+.|..|.|||.+.|. .|+..+|+||.|||+.||+-|.+-|.|.++-+-+..|-
T Consensus 158 ~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If 215 (318)
T KOG0659|consen 158 QT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIF 215 (318)
T ss_pred cc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHH
Confidence 33 23568899999999875 78999999999999999999999999999877766663
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=306.49 Aligned_cols=223 Identities=25% Similarity=0.471 Sum_probs=196.9
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|..-..||.|.-|.|| .+++.||||.+...... ..+-+.+|+.+|+..+|+|||.+++.|...+.+++|||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP---KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC---chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 46666788988877665 36789999999765433 34567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|++||+|.+.+.... +++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 351 ym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred ecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 999999999988754 899999999999999999999999 99999999999999999999999999987765543 3
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhcccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~ 387 (387)
....+|||.|||||++....|++++||||||++++||+.|++||-..++-..+..|...+.|.+..+ +.++++|||
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~-~klS~~~kd 501 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNP-EKLSPELKD 501 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCc-cccCHHHHH
Confidence 4457899999999999999999999999999999999999999999999999999999999999876 666666653
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=285.90 Aligned_cols=207 Identities=30% Similarity=0.486 Sum_probs=180.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv 228 (387)
+|.....|+.|+||.||. ++..||+|+++.+....+-....+ +|++++.+++|||||.+-.+.... +.+|+|
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsL-REIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSL-REINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhH-HHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 466677899999999984 578999999987765554444544 599999999999999999888754 569999
Q ss_pred EEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||||+. +|..++..-+ ++...++..++.|+++|+.|||.++ |+||||||+|+|++..|.+||+|||+|+.++..
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp- 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP- 230 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence 999965 9999998754 6999999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
....+..+-|..|.|||.+.+. .|+++.|+||+|||+.||+++++.|.|.+..+-+.+|-.
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ 292 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK 292 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH
Confidence 3444556679999999999886 689999999999999999999999999999888888743
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=307.77 Aligned_cols=212 Identities=26% Similarity=0.432 Sum_probs=184.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +++.||+|++.+...........+..|+.++.+++||+|+++++.+.+...+|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 467778999999998873 578999999976544344555678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC--
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 308 (387)
|+++|+|.+++.+.+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999865432110
Q ss_pred --------------------------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 309 --------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 309 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 001234689999999999999999999999999999999999999999
Q ss_pred CCCCcHHHHHHccC
Q 016544 357 KHDNEVPKAYAARQ 370 (387)
Q Consensus 357 ~~~~~~~~~i~~~~ 370 (387)
.+..+...++....
T Consensus 239 ~~~~~~~~~i~~~~ 252 (363)
T cd05628 239 ETPQETYKKVMNWK 252 (363)
T ss_pred CCHHHHHHHHHcCc
Confidence 88888888887643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=295.81 Aligned_cols=211 Identities=29% Similarity=0.519 Sum_probs=174.9
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC--ceE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMM 226 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--~~~ 226 (387)
..++...+.||+|+||.|+. +|...|||.+.... . ...+.+.+|+.+|.+++|||||+++|...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~-~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--S-PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--c-hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 34577788999999999873 36899999887552 1 22677999999999999999999999755444 699
Q ss_pred EEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-CCCEEEEeecCccccc
Q 016544 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLT 304 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~ 304 (387)
+.|||+++|+|.+++.+.+ .+++..+..+.+||++||.|||++| |+||||||+|||++. ++.+||+|||++....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999999877 7999999999999999999999999 999999999999999 7999999999988765
Q ss_pred c--CCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCC-CCCCcHHHHHHccC
Q 016544 305 V--KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTM-KHDNEVPKAYAARQ 370 (387)
Q Consensus 305 ~--~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~-~~~~~~~~~i~~~~ 370 (387)
. ..........||+.|||||++..+ ...+++|||||||++.||+||.+||.+ ....+.+-.|....
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~ 239 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED 239 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC
Confidence 3 112223456799999999999953 344699999999999999999999998 44444444444443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=292.60 Aligned_cols=212 Identities=27% Similarity=0.437 Sum_probs=176.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCC-----------HHHHHHHHHHHHHHHcCCCCcceeeeeEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD-----------DDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~ 219 (387)
+|+..++||+|.||.|.. +++.||||++.+..... -...+..++|+.+|+++.|||||+|+++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 688889999999998863 68999999997633211 11235788999999999999999999998
Q ss_pred eeC--CceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 220 TQS--SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 220 ~~~--~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
.+. ..+|+|+|||..|.+...-.....+++.+++.++++++.||+|||.+| ||||||||+|+|++.+|++||+||
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeecc
Confidence 764 579999999998877643333323899999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCCCC----cccCCCCCcccccccccCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 298 GVSKLLTVKEDRP----LTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 298 g~~~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
|.+.......... .....|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.+....++..+|++.
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND 334 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence 9998763322211 12357999999999998742 346899999999999999999999999999999999877
Q ss_pred C
Q 016544 370 Q 370 (387)
Q Consensus 370 ~ 370 (387)
.
T Consensus 335 p 335 (576)
T KOG0585|consen 335 P 335 (576)
T ss_pred c
Confidence 6
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=302.21 Aligned_cols=250 Identities=27% Similarity=0.487 Sum_probs=209.9
Q ss_pred HHHHHHHHhhCCCCCCCCccccccCCCCccccCccccCcccceeecccEEEEEEE------cC---eEEEEEEcCcccCC
Q 016544 119 HEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW------RG---IQVAVKKLGEEVIS 189 (387)
Q Consensus 119 ~~~~~~L~~~g~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~~~lg~G~~~~v~~------~g---~~vavK~~~~~~~~ 189 (387)
.+++.+....-..+........++.....|++...++.+. +.||+|.||.|+. ++ ..||+|........
T Consensus 123 ~~li~~~~~~~~~~~~~~~~L~~PI~r~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~ 200 (474)
T KOG0194|consen 123 SELVNYYKFSKLEITGKNFFLKRPIPRQKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL 200 (474)
T ss_pred HHHHHHHHhcccceeccceeecccccccccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccc
Confidence 3555555555555544445567788888999988888877 7899999998863 12 23899998865556
Q ss_pred CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCHHHHHHHcCC-CChHHHHHHHHHHHHHHHHHHh
Q 016544 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHE 268 (387)
Q Consensus 190 ~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~ 268 (387)
..+...++.+|++++++++|||||++||++..+.++++|||+|.||+|.+++++.+. ++..+...++.+++.||+|||+
T Consensus 201 ~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~ 280 (474)
T KOG0194|consen 201 TKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS 280 (474)
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH
Confidence 678889999999999999999999999999999999999999999999999998775 9999999999999999999999
Q ss_pred CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHH
Q 016544 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348 (387)
Q Consensus 269 ~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 348 (387)
++ +|||||-.+|+|++.++.+||+|||+++......... ....-+.+|+|||.+....++.++|||||||++||++
T Consensus 281 k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif 356 (474)
T KOG0194|consen 281 KN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIF 356 (474)
T ss_pred CC---CcchhHhHHHheecCCCeEEeCccccccCCcceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeee
Confidence 99 9999999999999999999999999987654211111 1123468999999999999999999999999999999
Q ss_pred c-CCCCCCCCCCCcHHHHHHccC-CCCC
Q 016544 349 E-GCPPFTMKHDNEVPKAYAARQ-RPPF 374 (387)
Q Consensus 349 t-g~~pf~~~~~~~~~~~i~~~~-~~~~ 374 (387)
+ |..||.+....++..+|...+ |.++
T Consensus 357 ~~g~~Py~g~~~~~v~~kI~~~~~r~~~ 384 (474)
T KOG0194|consen 357 ENGAEPYPGMKNYEVKAKIVKNGYRMPI 384 (474)
T ss_pred ccCCCCCCCCCHHHHHHHHHhcCccCCC
Confidence 8 899999999999999995544 4444
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=304.94 Aligned_cols=210 Identities=24% Similarity=0.377 Sum_probs=180.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|+||.|+. ++..||+|++...........+.+.+|+.+++.++||||+++++++.+...+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 366778899999999874 578999999976544445556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC--
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 308 (387)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999999999998888999999999999999999999999 99999999999999999999999998753311000
Q ss_pred --------------------------------------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHH
Q 016544 309 --------------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344 (387)
Q Consensus 309 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 344 (387)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 001124689999999999998999999999999999
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 345 QEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 345 ~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
|||++|+.||...+..+...++..
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~ 262 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVIN 262 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHc
Confidence 999999999998877776666654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=315.62 Aligned_cols=220 Identities=30% Similarity=0.500 Sum_probs=187.5
Q ss_pred ccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 158 TNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 158 ~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
...++||+|.||+|+. ....||||.+++. .+....++|++|+.++..++|||||+++|+|..++.+++
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 3356899999999973 3468999999865 345578899999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc--------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEE
Q 016544 228 VTEYLPKGDLRAFLKRK--------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 293 (387)
|+|||..|||.+|+... .+++..+.+.|+.||+.||.||-++. +|||||-.+|+||.++..+|
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEE
Confidence 99999999999999632 12778899999999999999999999 99999999999999999999
Q ss_pred EEeecCccccccCCCCCcc-cCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 294 VADFGVSKLLTVKEDRPLT-CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 294 l~Dfg~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
|+|||+++..-..+-.... ...-+++|||||.+..++||++||||||||+|||+++ |+.||.+.+++++++.|+.++-
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l 723 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL 723 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence 9999999754332221111 1223689999999999999999999999999999997 9999999999999999998885
Q ss_pred CCCCCChhhhhhcc
Q 016544 372 PPFKAPAKLYARGL 385 (387)
Q Consensus 372 ~~~~~~~~~~~~~l 385 (387)
++. ++.||.++
T Consensus 724 --L~~-Pe~CP~~v 734 (774)
T KOG1026|consen 724 --LSC-PENCPTEV 734 (774)
T ss_pred --ccC-CCCCCHHH
Confidence 322 35666654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=293.32 Aligned_cols=208 Identities=26% Similarity=0.456 Sum_probs=182.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||+|.+...........+.+.+|+.++++++||||+++++++.+...+++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 466778999999998873 478999999875433333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++...+.+++..+..++.|++.||+|||+++ ++||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999999999998888999999999999999999999999 999999999999999999999999998765322
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++.+++..+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 214 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK 214 (291)
T ss_pred cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 122457899999999999889999999999999999999999999988888888886665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=277.96 Aligned_cols=210 Identities=24% Similarity=0.435 Sum_probs=186.3
Q ss_pred cCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|.|.+|+ -+|+.+|+|++....+... ..+.+.+|+.+.+.++||||+++.+.+.+.+..|+|+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 357777889999998775 4788999998876555433 5678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC---CCEEEEeecCccccccC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVK 306 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~ 306 (387)
|+|+|++|-.-+-..-.+++..+..+++||+++|.|+|.++ |||||+||+|+++-.. .-+||+|||++...+
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999999665544445789999999999999999999999 9999999999999643 348999999998776
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
....+....|||+|||||++...+++..+|||+.||++|-|+.|.+||.+.+...++++|..+.
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~ 228 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA 228 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc
Confidence 5667778899999999999999999999999999999999999999999999999999999888
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=297.83 Aligned_cols=209 Identities=25% Similarity=0.430 Sum_probs=183.3
Q ss_pred cCcccceeecccEEEEEEE---c---CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 155 LDFTNSVEITKGTFILAFW---R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~---~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
.+|...+.||+|+||.|+. . +..||+|.+...........+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 3677788999999998863 1 257999998755443444566788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|||+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 999999999999998888999999999999999999999999 999999999999999999999999998765321
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.++..+.+++..+.
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 244 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI 244 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC
Confidence 223468999999999999889999999999999999999999999988877788887655
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=303.95 Aligned_cols=212 Identities=27% Similarity=0.461 Sum_probs=182.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.|+. +|+.||||++.............+.+|+.+++.++||||+++++++..+..+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 567788999999998873 578999999976543344455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC-
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 309 (387)
|+++|+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.........
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999999999998888999999999999999999999999 999999999999999999999999998654221100
Q ss_pred ------------------------------------CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCC
Q 016544 310 ------------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353 (387)
Q Consensus 310 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p 353 (387)
......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 00123589999999999999999999999999999999999999
Q ss_pred CCCCCCCcHHHHHHccC
Q 016544 354 FTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 354 f~~~~~~~~~~~i~~~~ 370 (387)
|.+.+..+...++....
T Consensus 239 f~~~~~~~~~~~i~~~~ 255 (364)
T cd05599 239 FCSDNPQETYRKIINWK 255 (364)
T ss_pred CCCCCHHHHHHHHHcCC
Confidence 99888777777775543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=283.18 Aligned_cols=212 Identities=24% Similarity=0.412 Sum_probs=186.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|..|.||. .+..+|+|++.+......+...+.+.|.+||..+.||.++.||+.|+.+...|++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 455667899999999884 347899999998877777778888999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC--
Q 016544 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK-- 306 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-- 306 (387)
||+||+|..+++++. .+++..+..++.+++-||+|||-.| ||.|||||+|||+.++|++-|+||.++......
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999998754 3999999999999999999999999 999999999999999999999999986432110
Q ss_pred ------------------------------C-C----------------------CCcccCCCCCcccccccccCCCCCC
Q 016544 307 ------------------------------E-D----------------------RPLTCQDTSCRYVAPEVFKNEEYDT 333 (387)
Q Consensus 307 ------------------------------~-~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~ 333 (387)
. . .....++||-.|+|||++.|..++.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 0012356888999999999999999
Q ss_pred chhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 334 ~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
++|||+|||++|||+.|.-||.|.+..+.+.+|+...
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~ 351 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP 351 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC
Confidence 9999999999999999999999999999999997665
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=304.46 Aligned_cols=212 Identities=25% Similarity=0.385 Sum_probs=180.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|+||.|+. ++..||+|.+.+...........+.+|+.++++++||||+++++.+.+...+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 366778999999998874 578899999876544344556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC--
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 308 (387)
|+++|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999999999988878999999999999999999999999 99999999999999999999999999753210000
Q ss_pred --------------------------------------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHH
Q 016544 309 --------------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344 (387)
Q Consensus 309 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 344 (387)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 001123589999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 345 QEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 345 ~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|||++|++||.+.++.+...++....
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~ 264 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQ 264 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccC
Confidence 99999999999888777777765533
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=298.93 Aligned_cols=206 Identities=31% Similarity=0.491 Sum_probs=181.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. ++..||+|++.............+..|+.++..++||||+++++++......|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 467788999999998873 478999999976544344455678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..... .
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999875432 2
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 212 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY 212 (333)
T ss_pred cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh
Confidence 2334678999999999999999999999999999999999999998887777776654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=296.32 Aligned_cols=205 Identities=27% Similarity=0.420 Sum_probs=178.5
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 236 (387)
.||+|+||.|+. +|+.||+|++.............+..|+.++++++||||+++++++...+.+++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 589999998873 578999999976544444555677889999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCC
Q 016544 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (387)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 316 (387)
|.+++...+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ........|
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~g 157 (323)
T cd05571 82 LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccceec
Confidence 9999998888999999999999999999999999 999999999999999999999999998753221 122233468
Q ss_pred CCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 317 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+....
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~ 211 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211 (323)
T ss_pred CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 999999999999999999999999999999999999999887777777775544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=304.38 Aligned_cols=210 Identities=26% Similarity=0.428 Sum_probs=180.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.|+. +|..||+|.+.+.........+.+.+|+.++++++||||+++++++.+...+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 567778999999999873 678999999875433334456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC-
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR- 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 309 (387)
|+++|+|.+++...+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++..+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999999988888999999999999999999999999 999999999999999999999999998633210000
Q ss_pred ---------------------------------------------CcccCCCCCcccccccccCCCCCCchhHHHHHHHH
Q 016544 310 ---------------------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344 (387)
Q Consensus 310 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 344 (387)
......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 00123589999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 345 QEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 345 ~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
|||++|.+||.+.+..+...++..
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~ 262 (377)
T cd05629 239 FECLIGWPPFCSENSHETYRKIIN 262 (377)
T ss_pred hhhhcCCCCCCCCCHHHHHHHHHc
Confidence 999999999998877777777754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=297.57 Aligned_cols=208 Identities=26% Similarity=0.444 Sum_probs=183.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||+|.+...........+.+.+|+.++++++||||+++++++..++.++++||
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 577788999999998873 578999999876543334455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+.+++|.+++.+.+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---- 171 (329)
T PTZ00263 99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---- 171 (329)
T ss_pred CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC----
Confidence 9999999999998888999999999999999999999999 999999999999999999999999998765322
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.++.++.+++..+.
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 231 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR 231 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC
Confidence 122457899999999999999999999999999999999999999888877888876654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=293.83 Aligned_cols=205 Identities=27% Similarity=0.423 Sum_probs=178.6
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 236 (387)
.||+|+||.|+. +|..||+|.+.............+.+|+.+++.++||||+++++++.....+++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 589999998873 578999999976544444556677889999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCC
Q 016544 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (387)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 316 (387)
|..++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... ........|
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~g 157 (323)
T cd05595 82 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccccccC
Confidence 9999988888999999999999999999999999 999999999999999999999999988653221 122233468
Q ss_pred CCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 317 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+....
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~ 211 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211 (323)
T ss_pred CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 999999999999899999999999999999999999999888777777776554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=304.39 Aligned_cols=211 Identities=25% Similarity=0.386 Sum_probs=179.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+..+.||+|+||.|+. +++.||+|.+.+...........+.+|+.++++++||||+++++.+.+++.+++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 467788999999998873 578999999875433333445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC--
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 308 (387)
|+++|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++..+.....
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999999998888899999999999999999999999 99999999999999999999999999743210000
Q ss_pred ----------------------------------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHH
Q 016544 309 ----------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348 (387)
Q Consensus 309 ----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 348 (387)
.......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 0011246899999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCcHHHHHHcc
Q 016544 349 EGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 349 tg~~pf~~~~~~~~~~~i~~~ 369 (387)
+|+.||.+.+..+...++...
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~ 259 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINW 259 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhcc
Confidence 999999988877776666543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=301.11 Aligned_cols=234 Identities=29% Similarity=0.526 Sum_probs=196.4
Q ss_pred CccccCccccCcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC
Q 016544 146 PEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (387)
Q Consensus 146 ~~~ei~~~~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~ 222 (387)
.+|+|...+ +.....||+|.||+|| |.| .||||++..... .++..+.|++|+.++++-+|.||+-+.|+|...
T Consensus 385 ~~WeIp~~e--v~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEE--VLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHH--hhccceeccccccceeeccccc-ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 355555443 3445689999999987 444 799999987655 456889999999999999999999999999877
Q ss_pred CceEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
.. .||+.||+|-+|+.+++.. ..+...+...|++|+++|+.|||.++ |||+|||..||++.+++.|||+|||++.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 66 9999999999999999753 44888999999999999999999999 9999999999999999999999999986
Q ss_pred ccccC-CCCCcccCCCCCcccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC-CCCCCC
Q 016544 302 LLTVK-EDRPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKA 376 (387)
Q Consensus 302 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~~~ 376 (387)
.-... .........+...|||||+++.. +|+..+||||||+++|||+||..||.....+.++-++-.|- +|....
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~ 616 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK 616 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh
Confidence 54332 22333445678899999999754 78999999999999999999999999888888888876664 788888
Q ss_pred ChhhhhhcccC
Q 016544 377 PAKLYARGLKE 387 (387)
Q Consensus 377 ~~~~~~~~l~~ 387 (387)
+...+|.+|++
T Consensus 617 ~~s~~pk~mk~ 627 (678)
T KOG0193|consen 617 IRSNCPKAMKR 627 (678)
T ss_pred hhccCHHHHHH
Confidence 77788877653
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=296.93 Aligned_cols=212 Identities=22% Similarity=0.333 Sum_probs=180.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. ++..||+|.+.+...........+.+|..++..++|++|+++++++...+..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 567788999999998762 567899999875433334445668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++|+|.+++.+ ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999987 456899999999999999999999999 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+...++....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~ 224 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 224 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC
Confidence 2233468999999999876 467889999999999999999999999888777777776654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=292.01 Aligned_cols=204 Identities=26% Similarity=0.411 Sum_probs=177.5
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
||+|+||.|+. ++..||+|.+.............+..|+.++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 68999998873 4778999998765444445566788899999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCC
Q 016544 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317 (387)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 317 (387)
.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... .......||
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt 156 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGT 156 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCC
Confidence 999998888999999999999999999999999 9999999999999999999999999987543221 222334689
Q ss_pred CcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 318 ~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++.+++....
T Consensus 157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~ 209 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP 209 (312)
T ss_pred cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC
Confidence 99999999999999999999999999999999999999888777777776544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=293.30 Aligned_cols=205 Identities=27% Similarity=0.433 Sum_probs=178.4
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 236 (387)
.||+|+||.|+. +|..||+|++.+...........+.+|+.+++.++||||+++++++.....+++||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 589999998873 578999999986544445556778889999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCC
Q 016544 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (387)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 316 (387)
|..++.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ........|
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~g 157 (328)
T cd05593 82 LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCG 157 (328)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccC
Confidence 9999988888999999999999999999999999 999999999999999999999999998753221 122233468
Q ss_pred CCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 317 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++.+.+....
T Consensus 158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 211 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211 (328)
T ss_pred CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC
Confidence 999999999999899999999999999999999999999887777777765444
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.85 Aligned_cols=215 Identities=24% Similarity=0.391 Sum_probs=182.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCC-ceEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS-PMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~-~~~lv 228 (387)
.|...++||.|+||.|+. .|..||||.+++....-++ .-. .+|++.|++++ ||||+++.+++.+.. .+|+|
T Consensus 11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~n-LREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHH-HHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 577788999999999874 6788999999876554333 333 45999999998 999999999998887 89999
Q ss_pred EEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||||+. .|.++++.. ..+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+....
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S-- 162 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS-- 162 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc--
Confidence 999965 999999865 45999999999999999999999999 99999999999999888999999999987653
Q ss_pred CCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc-CCCCCCCCh
Q 016544 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPPFKAPA 378 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~~~~~~~ 378 (387)
..+.+.++.|..|.|||++.. +-|+.+.|+||+|||++|+.+-++.|.|.++.+-+.+|..- +.|.....+
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 355667788999999999865 57899999999999999999999999999988777777433 255444433
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=294.43 Aligned_cols=212 Identities=23% Similarity=0.352 Sum_probs=179.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +++.||+|++.+.........+.+.+|..++..++||||+++++++..++.+|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 567788999999998863 578999999875433334445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++++|.+++.+ ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++.........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999976 446899999999999999999999999 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...++....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~ 224 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 224 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 2233458999999999873 357789999999999999999999999887777777775543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=299.77 Aligned_cols=212 Identities=25% Similarity=0.353 Sum_probs=180.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|+..+.||+|+||.|+. ++..||+|.+.+...........+.+|+.+++.++||||+++++++..+..+++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4677888999999998873 57899999987543333344566888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 999999999999764 5889999999999999999999999 999999999999999999999999999765433222
Q ss_pred CcccCCCCCcccccccccCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+......+|....
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~ 263 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 22345689999999999764 37789999999999999999999999888777788876544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=285.94 Aligned_cols=201 Identities=26% Similarity=0.417 Sum_probs=172.0
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||+|+||.|+. +|..||+|.+.............+.+|+.++++++|++|+++++++...+..+++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 55677899999998863 5789999998765443333445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++...... .
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--E 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--C
Confidence 9999999888643 35889999999999999999999999 999999999999999999999999998765322 2
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 209 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK 209 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh
Confidence 22334689999999999999999999999999999999999999987665433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=294.77 Aligned_cols=212 Identities=23% Similarity=0.345 Sum_probs=179.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. .+..+|+|.+.+...........+..|..++..++|++|+++++++.....+++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 567778999999998863 467899999865333333445568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++|+|.+++.+ ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.........
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999987 456899999999999999999999999 999999999999999999999999998754332222
Q ss_pred CcccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|+|||++. ...++.++|||||||++|+|++|+.||...+..+...++....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~ 224 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 224 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Confidence 223356899999999986 3467889999999999999999999999988888888886655
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=284.96 Aligned_cols=218 Identities=19% Similarity=0.312 Sum_probs=182.3
Q ss_pred cCccccCcccceeecccEEEEE---EEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee----C
Q 016544 150 IDPHELDFTNSVEITKGTFILA---FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----S 222 (387)
Q Consensus 150 i~~~~~~~~~~~~lg~G~~~~v---~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~ 222 (387)
++..+++......++.|+++.+ .++|+.||||.+...........+.+.+|+.++++++||||+++++++.+ .
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 3444444454457888887765 47899999999987655555556788999999999999999999999876 3
Q ss_pred CceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
..++++|||+++|+|.+++.+...+++.....++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++.
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHh
Confidence 46899999999999999999887899999999999999999999985 6 8899999999999999999999999987
Q ss_pred ccccCCCCCcccCCCCCcccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC-CCCC
Q 016544 302 LLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPF 374 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~ 374 (387)
...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..++...+.... ++++
T Consensus 172 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 243 (283)
T PHA02988 172 ILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL 243 (283)
T ss_pred hhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 654221 22356889999999976 688999999999999999999999999988878877775544 4444
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=299.97 Aligned_cols=211 Identities=26% Similarity=0.436 Sum_probs=182.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. ++..||+|++.............++.|..++..++||+|+++++.+.....+++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 466778899999998873 578999999975443344556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC--
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 308 (387)
|+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999999999998888999999999999999999999999 99999999999999999999999999864321100
Q ss_pred --------------------------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 309 --------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 309 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001134689999999999999999999999999999999999999999
Q ss_pred CCCCcHHHHHHcc
Q 016544 357 KHDNEVPKAYAAR 369 (387)
Q Consensus 357 ~~~~~~~~~i~~~ 369 (387)
.++.....++...
T Consensus 239 ~~~~~~~~~i~~~ 251 (360)
T cd05627 239 ETPQETYRKVMNW 251 (360)
T ss_pred CCHHHHHHHHHcC
Confidence 8888888877653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=297.89 Aligned_cols=213 Identities=25% Similarity=0.355 Sum_probs=180.9
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
..+|...+.||+|+||.|+. ++..||+|.+...........+.+.+|..+++.++||||+++++.+.....+++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 34788889999999998873 5789999998654333334455678899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|||+++|+|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 122 ~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 122 MEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 9999999999998764 4888999999999999999999999 99999999999999999999999999876543322
Q ss_pred CCcccCCCCCcccccccccCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+......+|....
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 263 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 263 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 2233456899999999997643 7889999999999999999999999888777788886654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=268.36 Aligned_cols=209 Identities=28% Similarity=0.469 Sum_probs=188.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|..++.||+|-||.||. ++..||+|++.+..+.......++++|+++...++||||+++|++|.++..+|+++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 677788999999998874 567899999987766666666789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHH--HcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|...|+|...++ ....+++..+..++.|++.|+.|+|..+ +|||||||+|+|++..+.+||+|||-+-.-. .
T Consensus 103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~ 176 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP---S 176 (281)
T ss_pred ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC---C
Confidence 999999999998 5566999999999999999999999999 9999999999999999999999999886543 2
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......||.-|++||...+..++..+|+|++|++.||++.|.+||...+..+.+++|..-.
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~ 238 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD 238 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc
Confidence 23344578999999999999999999999999999999999999999999999999997766
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=293.15 Aligned_cols=214 Identities=26% Similarity=0.462 Sum_probs=190.6
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc-eEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~-~~lv~ 229 (387)
+|...+.+|+|+||.++ .++..+++|.+......... .+...+|+.++.++.|||||.+.+.|..++. .+|||
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56667889999999775 36789999999876654443 3467889999999999999999999999888 99999
Q ss_pred EccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 230 EYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
+|++||+|.+.+.+.. .++++.++.|+.|++.|+.|||++. |+|||||+.||+++.++.|+|.|||+|+......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998654 3899999999999999999999988 9999999999999999999999999999887543
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.......||+.|++||++.+.+|..++|||||||++|||++-+++|...+...++.+|..+.-.|+
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl 226 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL 226 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC
Confidence 344567899999999999999999999999999999999999999999999999999988885555
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=277.85 Aligned_cols=205 Identities=30% Similarity=0.513 Sum_probs=175.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCc-ceeeeeEEeeCC------
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSS------ 223 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~------ 223 (387)
.|...+.+|+|+||+||. +|+.||+|+++.+....+ .-....+|+.+++.++|+| |+++++++....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG-~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG-VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC-CCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 355666799999999874 689999999986543211 2234577999999999999 999999999877
Q ss_pred ceEEEEEccCCCCHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecC
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 299 (387)
.+++|+||++ -+|..++.... .++...++.+++||+.||+|||+++ |+||||||.|||+++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7999999995 59999998755 4777889999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
|+.+..+. ...+...+|..|.|||++.+. .|++..||||+|||++||+++++.|.+.++.+.+.+|
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~I 233 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRI 233 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence 99766442 334445678899999999987 7899999999999999999999999999987777666
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=278.60 Aligned_cols=217 Identities=28% Similarity=0.432 Sum_probs=183.8
Q ss_pred CccccCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 151 ~~~~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
......|.....||.|.-+.|+ -.+..||||++..+.-.. ....+++|+..+..++||||++++..|..+..+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 3444467777899999776665 367999999998765433 378899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 226 MIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
|+||.||.+||+.+++... ..+++..+..|++++++||.|||.+| .||||||+.|||++.+|.+||+|||.+..+
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999999864 33899999999999999999999999 999999999999999999999999987544
Q ss_pred ccCCCCC--c-ccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 304 TVKEDRP--L-TCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 304 ~~~~~~~--~-~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
.....+. . ....|++.|||||++... .|+.|+||||||++..||.+|+.||....+..++..-..+..|
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp 250 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP 250 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC
Confidence 3322211 1 456899999999997553 7889999999999999999999999999998887776555544
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=297.21 Aligned_cols=212 Identities=25% Similarity=0.346 Sum_probs=180.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. ++..||+|.+.+...........+.+|+.+++.++||||+++++++..+..+++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 3677788999999998873 57899999987543333334456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++|+|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 123 EYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 999999999988764 5888899999999999999999999 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccccccccCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~----~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+......+|....
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 263 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK 263 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC
Confidence 23345689999999998753 47889999999999999999999999988877888886654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=288.52 Aligned_cols=204 Identities=30% Similarity=0.485 Sum_probs=173.9
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. ++..||+|.++..........+.+..|..++... +||||+++++++.....+++||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 589999998873 4678999999765433334445556677777654 8999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... .......
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~ 157 (316)
T cd05592 82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC 157 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence 99999988888999999999999999999999998 9999999999999999999999999987543222 2233456
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+...
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 211 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND 211 (316)
T ss_pred CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 899999999999989999999999999999999999999998887777777543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=285.33 Aligned_cols=219 Identities=25% Similarity=0.446 Sum_probs=189.1
Q ss_pred cccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||+|-|.+|. ++|..||||++.+...+. .....+.+|+.+|+.++|||||++|++......+|||+|+
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3445679999999875 689999999999887654 4456678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe-CCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR-DDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
-.+|+|.+|+.+.. .+.+..+.+++.||+.|+.|+|+.. +|||||||+|+.+ .+-|-+||.|||++..+..+.
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-- 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-- 173 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc--
Confidence 99999999997653 4999999999999999999999998 9999999999865 577899999999998776543
Q ss_pred CcccCCCCCcccccccccCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhh
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 381 (387)
......|+..|-|||++.|..|. +++||||||||+|.|++|++||+..++.+.+-+|...+...++.....|
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eC 246 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKEC 246 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHH
Confidence 33445789999999999999887 6899999999999999999999999999999999877755544444333
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=288.52 Aligned_cols=211 Identities=29% Similarity=0.447 Sum_probs=180.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|...+.||+|+||.|+. ++..||+|.+.+.........+.+..|..++..+ +||+|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 366678899999998873 4679999998865443444455667788888777 5899999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++|+|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-GV 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC-CC
Confidence 99999999999988888999999999999999999999999 999999999999999999999999998753322 22
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|+|||++.+..++.++|+|||||++|+|+||+.||.+.+...+.+.+....
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~ 217 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 217 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 2234568999999999999999999999999999999999999999988888888876654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=288.99 Aligned_cols=206 Identities=27% Similarity=0.455 Sum_probs=176.5
Q ss_pred eeecccEEEEEEE--------cCeEEEEEEcCcccC-CCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 161 VEITKGTFILAFW--------RGIQVAVKKLGEEVI-SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 161 ~~lg~G~~~~v~~--------~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+.||+|+||.|+. .++.||+|.+..... ........+..|+.+++.++||||+++++++..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4689999998873 467899999875432 1223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
+.+++|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC-CCcc
Confidence 999999999998888899999999999999999999999 999999999999999999999999998643222 1222
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......++..+.
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~ 216 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK 216 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 33468999999999999889999999999999999999999999888777777776554
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=288.95 Aligned_cols=211 Identities=29% Similarity=0.490 Sum_probs=190.9
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~l 227 (387)
...|...+.||+|.||.++. +|..+|+|.+.+...........+.+|+.+|+++. ||||+.++++|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 34577778999999998873 58999999998877666556678999999999998 9999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC----CCEEEEeecCcccc
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVADFGVSKLL 303 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~----~~~kl~Dfg~~~~~ 303 (387)
|||++.||.|.+.+... .+++.++..+++|++.++.|||+.| |+||||||+|+|+... +.++++|||++...
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999876 4999999999999999999999999 9999999999999743 47999999999887
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.. ........||+.|+|||++....++..+|+||+||++|.|++|.+||.+.+......+|..+.
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~ 254 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD 254 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC
Confidence 65 445566789999999999999999999999999999999999999999999999999998886
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=287.39 Aligned_cols=211 Identities=30% Similarity=0.468 Sum_probs=180.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCC-CcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|...+.||+|+||.|+. ++..||+|++...........+.+..|..++..+.| ++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 366778999999998873 457899999976544344455677889999999975 56888999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GK 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CC
Confidence 99999999999988888999999999999999999999998 999999999999999999999999998643221 12
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|+|||++.+..++.++|+|||||++|+|+||+.||.+.+..++...+....
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~ 217 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 217 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 2233468999999999999999999999999999999999999999888888888876554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=290.99 Aligned_cols=205 Identities=27% Similarity=0.424 Sum_probs=177.6
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 236 (387)
.||+|+||.|+. +|..||+|.+.............+..|+.+++.++||||+++++++.....+++||||+++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 589999998873 678999999986554444556677889999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
|..++.....+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++...... ........
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (325)
T cd05594 82 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFC 157 (325)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccccccc
Confidence 99999888889999999999999999999997 67 999999999999999999999999998653221 12223346
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~ 212 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 212 (325)
T ss_pred CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC
Confidence 8999999999999899999999999999999999999999887777777765544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=296.59 Aligned_cols=210 Identities=29% Similarity=0.467 Sum_probs=183.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|..||+|++.............+..|+.++..++||||+++++++.++..+++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 467788999999998873 478999999976544333455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC---
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE--- 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 307 (387)
|+++++|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999999998878999999999999999999999998 9999999999999999999999999987654332
Q ss_pred -------------------------CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 308 -------------------------DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 308 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 0122334689999999999999999999999999999999999999998887777
Q ss_pred HHHHHc
Q 016544 363 PKAYAA 368 (387)
Q Consensus 363 ~~~i~~ 368 (387)
..++..
T Consensus 239 ~~~i~~ 244 (350)
T cd05573 239 YNKIIN 244 (350)
T ss_pred HHHHhc
Confidence 777765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=288.39 Aligned_cols=205 Identities=28% Similarity=0.454 Sum_probs=176.8
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. +++.||+|.+.+.........+.+..|..++..+ +||||+++++++...+.+|+||||++++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 589999998873 5789999998765433334456677788888776 6999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|.+++.+...+++..+..++.|++.||.|||+++ ++||||||+|||++.++.++|+|||++...... ........
T Consensus 82 ~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (320)
T cd05590 82 DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFC 157 (320)
T ss_pred hHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998653221 12223356
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..++.+.+....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~ 212 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 212 (320)
T ss_pred cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC
Confidence 8999999999999899999999999999999999999999988888888886654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=291.22 Aligned_cols=201 Identities=23% Similarity=0.413 Sum_probs=171.5
Q ss_pred CcccceeecccEEEEEEE--------cCeEEEEEEcCcccC-CCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVI-SDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 225 (387)
+|...+.||+|+||.||. ++..||+|++.+... ......+.+..|+.+++.+ +||+|+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 366778999999998873 578899999875332 2233456678899999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
++||||+++|+|.+++.+...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999999999988888999999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
..........||+.|+|||++.+. .++.++|||||||++|+|+||+.||.....
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 212 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE 212 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC
Confidence 333333345689999999999875 478899999999999999999999975433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=288.58 Aligned_cols=205 Identities=27% Similarity=0.442 Sum_probs=177.9
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. ++..||+|.+...........+.+..|..++..+ +||||+++++++...+.+|+||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 589999998873 4679999999765444445556677888888866 7999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|..++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...... ........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (321)
T cd05591 82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFC 157 (321)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC-Cccccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998753322 22223345
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.....+++....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD 212 (321)
T ss_pred cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 7899999999999899999999999999999999999999988888888887655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=293.75 Aligned_cols=212 Identities=27% Similarity=0.404 Sum_probs=183.0
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|..||+|.+...........+.+..|+.+++.++||||+++++++.....+++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 467788999999998873 678999999986544444556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999999999876 66999999999999999999999999 999999999999999999999999999765433322
Q ss_pred CcccCCCCCccccccccc------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......+|+.|+|||++. +..++.++|||||||++|+|++|+.||...+......++....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~ 225 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ 225 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC
Confidence 223346889999999987 4567889999999999999999999999888777777776554
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=286.36 Aligned_cols=210 Identities=29% Similarity=0.459 Sum_probs=179.6
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e 230 (387)
|...+.||+|+||.|+. +|..||+|++.+.........+.+..|..++..+. |++|+++++++.....+|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 55667899999998873 57899999987654333444566778888888885 6788899999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++.+.+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++....... ..
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 9999999999998888999999999999999999999999 9999999999999999999999999987543221 12
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+...+.+.+....
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~ 217 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 217 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 233457899999999999899999999999999999999999999988877788776654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=287.07 Aligned_cols=205 Identities=30% Similarity=0.474 Sum_probs=173.2
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHHcCCCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. +|+.||+|++.............+..|.. +++.++||||+++++.+.....+++||||++++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 589999998862 57899999987543333333344455544 567889999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|..++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (323)
T cd05575 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFC 157 (323)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccccc
Confidence 99999998888999999999999999999999999 999999999999999999999999998653222 22223346
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++.+++....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 212 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP 212 (323)
T ss_pred CChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 8999999999999999999999999999999999999999888777777776554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=287.82 Aligned_cols=225 Identities=29% Similarity=0.470 Sum_probs=196.6
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
....|+....||+|.||.||. .++.||+|++..+.. +...+.+++|+.++.+++++||.++|+.+..+..+++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence 344677778999999999984 578999999986543 4567889999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
+||||.||++.+.++....+.+....-++++++.|+.|||+++ .+|||||+.|||+..+|.+||+|||.+-......
T Consensus 89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 9999999999999998877788888999999999999999999 9999999999999999999999999998776554
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhccc
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~ 386 (387)
... ..+.|||.|||||++.+..|+.++||||||++.+||.+|.+||.+..++.++-.|-+...|.+.. .+++.++
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~---~~S~~~k 240 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG---DFSPPFK 240 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc---ccCHHHH
Confidence 444 56789999999999999999999999999999999999999999999988887775555555533 5555444
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=292.70 Aligned_cols=207 Identities=35% Similarity=0.511 Sum_probs=178.8
Q ss_pred ccccCccccCcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC
Q 016544 147 EYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (387)
Q Consensus 147 ~~ei~~~~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 223 (387)
.||+.... +...+.||.|+-|.|+ ..+..||||+++.- -..+++-|++++||||+.+.|+|....
T Consensus 118 ~WeiPFe~--IsELeWlGSGaQGAVF~Grl~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 118 LWEIPFEE--ISELEWLGSGAQGAVFLGRLHNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hccCCHHH--hhhhhhhccCcccceeeeeccCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCc
Confidence 45554332 2344568999888776 57899999988632 134788999999999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
-+|||||||..|-|..+++...+++......|..+|+.|+.|||.+. |||||||.-||||+.+..+||+|||.++..
T Consensus 186 cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhh
Confidence 99999999999999999999989999999999999999999999999 999999999999999999999999998876
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
... ...-.+.||..|||||++...+.+.|+|||||||+|||||||..||.+.+...|+.-+-.+-
T Consensus 263 ~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNs 327 (904)
T KOG4721|consen 263 SDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNS 327 (904)
T ss_pred hhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCc
Confidence 543 33334679999999999999999999999999999999999999999988887777664443
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=266.02 Aligned_cols=210 Identities=26% Similarity=0.477 Sum_probs=181.4
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccC-----CCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVI-----SDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 224 (387)
.|...+.+|.|.-.++. .+|...|+|++..... ......+.-++|+.+|+++ .||+|+++.++|+++..
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 35556678888876553 5788999998753211 1234456678899999998 79999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
+|+|+|.|+.|.|.+++.+.-.+++++..+|++|+.+|++|||.++ ||||||||+|||++++.+++|+|||++..+.
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999999999888999999999999999999999999 9999999999999999999999999998876
Q ss_pred cCCCCCcccCCCCCccccccccc------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.+ .......|||+|+|||.+. ...|+..+|+||+|||||.|+.|.+||-.....-++..|..++
T Consensus 175 ~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk 244 (411)
T KOG0599|consen 175 PG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK 244 (411)
T ss_pred Cc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence 54 3444567999999999884 3478889999999999999999999999887777888888887
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=277.02 Aligned_cols=203 Identities=29% Similarity=0.480 Sum_probs=171.0
Q ss_pred ccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC---
Q 016544 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--- 223 (387)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--- 223 (387)
...+.|...+.+|+|+||.|+. .+..||||+...+.. .-.+|+.+|+.+.|||||++..+|....
T Consensus 21 ~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d 93 (364)
T KOG0658|consen 21 KVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESD 93 (364)
T ss_pred ceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCc
Confidence 3456788889999999999984 578999998764421 1246999999999999999999887432
Q ss_pred --ceEEEEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC-CCEEEEe
Q 016544 224 --PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVAD 296 (387)
Q Consensus 224 --~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~D 296 (387)
...+|||||+. +|.++++. +..++.-.++-+..||++||.|||+.+ |+||||||.|+|+|.+ |.+||||
T Consensus 94 ~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicD 169 (364)
T KOG0658|consen 94 EVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICD 169 (364)
T ss_pred hhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEecc
Confidence 35689999976 99998874 456888889999999999999999998 9999999999999965 8999999
Q ss_pred ecCccccccCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
||+|+..... .+..++.+|..|.|||.+.|. .|+.+.||||.||++.||+-|++-|.|.+....+..|.
T Consensus 170 FGSAK~L~~~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIi 239 (364)
T KOG0658|consen 170 FGSAKVLVKG--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEII 239 (364)
T ss_pred CCcceeeccC--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHH
Confidence 9999987644 334556789999999999885 78999999999999999999999999988766665553
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=284.89 Aligned_cols=209 Identities=28% Similarity=0.430 Sum_probs=175.9
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHH---HcCCCCcceeeeeEEeeCCceEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL---QKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
|...+.||+|+||.|+. +|+.||+|.+.+.........+.+..|..++ +.++||||+++++++.....+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 45567899999998873 5789999999765433334455677776665 456799999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|||+++++|..++.. +.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-G 155 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC-C
Confidence 999999999988865 45899999999999999999999999 999999999999999999999999998643222 1
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..++...+....
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~ 217 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE 217 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 22234568999999999999999999999999999999999999999888777888776655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=285.44 Aligned_cols=205 Identities=29% Similarity=0.458 Sum_probs=171.6
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHH-HHHHcCCCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. ++..||+|++.............+..|. .+++.++||||+++++++...+.+++||||++++
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 589999998873 4678999998754332222233344444 4567889999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++...... ........
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~~~ 157 (325)
T cd05602 82 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTFC 157 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccccc
Confidence 99999988888899999999999999999999999 999999999999999999999999998653222 12223456
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+..+++....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 212 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP 212 (325)
T ss_pred CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC
Confidence 8999999999999999999999999999999999999999888777777776554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=283.65 Aligned_cols=191 Identities=27% Similarity=0.492 Sum_probs=168.0
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. ++..||+|++++...........+..|..+++.+ +||||+++++++.....+|+||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 589999998873 5789999999876555555567788999999988 6999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|.+++.+.+.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++...... ........
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (329)
T cd05588 82 DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFC 157 (329)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998642211 12223356
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 89999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=285.81 Aligned_cols=205 Identities=29% Similarity=0.470 Sum_probs=173.9
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHHcCCCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. +|+.||+|++.+...........+..|.. +++.++||||+++++.+...+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 589999998873 57899999987653333334445555555 467789999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|..++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++...... ........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (325)
T cd05604 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFC 157 (325)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998653222 12223346
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|++.|+|||++.+..++.++|||||||++|+|++|..||...+..++..++....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~ 212 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 8999999999999999999999999999999999999999888777777776554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=284.79 Aligned_cols=205 Identities=29% Similarity=0.459 Sum_probs=172.4
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHHcCCCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||.|+||.|+. +|..||+|++.+...........+..|.. +++.++||||+++++.+...+..++||||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 589999998873 57899999987543333333444555554 678889999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|..++.....+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...... ........
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (321)
T cd05603 82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTSTFC 157 (321)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccccc
Confidence 99999988778999999999999999999999998 999999999999999999999999998653222 12223346
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+...+...+....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP 212 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC
Confidence 7899999999999899999999999999999999999999887777777776543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=282.75 Aligned_cols=205 Identities=29% Similarity=0.463 Sum_probs=173.7
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. +|..||+|.+...........+.+..|..++... .||+|+++++++...+.+|+||||+.++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 589999998873 5789999999764332223345566777777754 8999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|..++...+.+++.++..++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++...... ........
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (316)
T cd05620 82 DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTFC 157 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceeccC
Confidence 99999988888999999999999999999999999 999999999999999999999999998643211 22223456
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++.+.+....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~ 212 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT 212 (316)
T ss_pred CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 8999999999999999999999999999999999999999888777777775443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=274.29 Aligned_cols=214 Identities=26% Similarity=0.407 Sum_probs=179.5
Q ss_pred CcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|...+.||+|+||.|+. .+..||+|.+.... .......+.+|+.++++++||||+++++++..+...++
T Consensus 6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 566778899999998852 35689999997642 33445678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
||||+++++|.+++... ..+++.+++.++.|++.||+|||+++ ++||||||+||+++.++.++++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999874 46899999999999999999999999 999999999999999999999999987553222
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.........++..|+|||.+.+..++.++|||||||++|++++ |..||.+.+..++.+.+..+.+++.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPA 229 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC
Confidence 1111112334678999999999999999999999999999875 9999999888888888866654443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=277.58 Aligned_cols=193 Identities=27% Similarity=0.429 Sum_probs=165.8
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
||+|+||.||. +|+.||+|.+...........+.+..|+.+++.++||||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 68999998873 5789999998765444444456678899999999999999999999999999999999999999
Q ss_pred HHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCccc
Q 016544 238 RAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (387)
Q Consensus 238 ~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 313 (387)
..++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988753 345899999999999999999999999 99999999999999999999999999876543322 2233
Q ss_pred CCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
..+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.....
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 202 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 202 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCc
Confidence 4678999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=290.62 Aligned_cols=203 Identities=30% Similarity=0.397 Sum_probs=176.4
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-C-----CcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-H-----PNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~iv~l~~~~~~~~~ 224 (387)
+|.+.+.||+|+||.|. .+++.||||+++.. .....+-..|+.+|..++ | -|+|+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 57778899999999775 36899999999854 445566677999999996 3 289999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC--CEEEEeecCc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG--NLKVADFGVS 300 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~--~~kl~Dfg~~ 300 (387)
+|||+|.++ -+|.++++.+. .++...+..++.||+.||.+||+.+ |||+||||+|||+.... .+||+|||+|
T Consensus 263 lciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 999999994 59999999764 4889999999999999999999999 99999999999998544 6999999999
Q ss_pred cccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
+..... ...+.-+..|.|||++.|.+|+.+.||||||||+.||++|.+.|.|.++.+.+..|..-.
T Consensus 339 c~~~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l 404 (586)
T KOG0667|consen 339 CFESQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL 404 (586)
T ss_pred cccCCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence 875432 224556788999999999999999999999999999999999999999999988886655
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=281.83 Aligned_cols=205 Identities=30% Similarity=0.476 Sum_probs=176.4
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. ++..||+|.+.+...........+..|..+++.+ +||||+++++++...+.+++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 589999998873 4679999999865443444556677888998888 6999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|..++.+.+.+++.++..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... .......
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (318)
T cd05570 82 DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFC 157 (318)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccccee
Confidence 99999988888999999999999999999999999 9999999999999999999999999986432221 1222345
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
+++.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+...+...+....
T Consensus 158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~ 212 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE 212 (318)
T ss_pred cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 7899999999999999999999999999999999999999888777777775544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=283.11 Aligned_cols=210 Identities=30% Similarity=0.486 Sum_probs=169.1
Q ss_pred CcccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC-C
Q 016544 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-S 223 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~-~ 223 (387)
+|...+.||.|+||.||.. +..||+|.+.... .....+.+.+|+.+++.+ +||||+++++++... .
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 5677789999999988642 3579999987532 234456788999999999 899999999988764 4
Q ss_pred ceEEEEEccCCCCHHHHHHHc-----------------------------------------------------------
Q 016544 224 PMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------- 244 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~----------------------------------------------------------- 244 (387)
.++++|||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 689999999999999998752
Q ss_pred ---CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC-CcccCCCCCcc
Q 016544 245 ---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRY 320 (387)
Q Consensus 245 ---~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y 320 (387)
.++++.++..++.|+++||.|||+.+ |+||||||+|||++.++.++|+|||+++........ ......+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 23677788999999999999999998 999999999999999999999999998764322111 11223456789
Q ss_pred cccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcH-HHHHHccC
Q 016544 321 VAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV-PKAYAARQ 370 (387)
Q Consensus 321 ~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~-~~~i~~~~ 370 (387)
+|||++.+..++.++|||||||++|||++ |..||.+....+. ...+..+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 294 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT 294 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC
Confidence 99999999899999999999999999997 9999988665443 34443333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=280.71 Aligned_cols=205 Identities=29% Similarity=0.458 Sum_probs=173.1
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. ++..||+|.+...........+.+..|..++... +||||+++++++...+.+++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 589999998873 4678999998765332233345566677777764 8999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|.+++.....+++.++..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++....... .......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05619 82 DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFC 157 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeeec
Confidence 99999988778999999999999999999999999 9999999999999999999999999986532221 1223345
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..++.+.+....
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~ 212 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN 212 (316)
T ss_pred CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 7899999999999899999999999999999999999999888777777765443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=293.60 Aligned_cols=215 Identities=23% Similarity=0.352 Sum_probs=182.4
Q ss_pred ccCcccceeecccEEEEEEE-----c-CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----R-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
...|...+.||+|++|.|+. + +..||+|.+... .......+++|+.+++.++||||+++++++...+.+|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 33478888999999998863 2 567899976432 34455678889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 228 VTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
||||+++|+|.+++.. ..++++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 9999999999988753 345889999999999999999999998 999999999999999999999999999865
Q ss_pred ccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 304 TVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 304 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++..++..+..+++
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~ 291 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF 291 (478)
T ss_pred CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 43221 122334689999999999999999999999999999999999999998888888888877665443
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=276.70 Aligned_cols=204 Identities=28% Similarity=0.425 Sum_probs=172.8
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||+|+||.|+. ++..||+|.+.............+.+|+.+++.++||||+++++.+.....++++|||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 56678899999998863 5789999998764443333345577899999999999999999999998999999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~ 156 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--E 156 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC--C
Confidence 9999999888654 34899999999999999999999998 999999999999999999999999998765322 1
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~ 365 (387)
......+++.|+|||++.+..++.++|+|||||++|+|++|+.||.+.......+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE 212 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH
Confidence 22234578999999999988899999999999999999999999998765444333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=270.35 Aligned_cols=208 Identities=30% Similarity=0.479 Sum_probs=177.1
Q ss_pred cccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee-----CCceE
Q 016544 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-----SSPMM 226 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-----~~~~~ 226 (387)
|...+.||.|.||.|. .+|..||||++... +...-..++..+|+++++.++|+||+.+++.+.. -..+|
T Consensus 24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred ecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 3335679999999774 47899999999754 3455556777889999999999999999998865 24689
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+|+|+| +.+|.+.++.+..++...+..++.|++.||.|+|+.+ |+||||||+|++++.+..+||+|||+|+.....
T Consensus 103 iV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 103 LVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred EehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecccc
Confidence 999999 5699999999888999999999999999999999999 999999999999999999999999999877543
Q ss_pred -CCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 307 -EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 307 -~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
.....+.++.|..|.|||++.. ..|+.+.||||.|||+.||++|++-|.|.+...-++.|..-
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~ 243 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL 243 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence 1233366778999999998755 58999999999999999999999999998876666666443
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=281.37 Aligned_cols=190 Identities=28% Similarity=0.498 Sum_probs=166.8
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. +++.||+|.+.+...........+..|..++.++ +||||+++++++.....+++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 589999998863 5789999999876555555566788899988877 7999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|..++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...... ........
T Consensus 82 ~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (329)
T cd05618 82 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFC 157 (329)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCcccccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998653222 12223356
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
||+.|+|||++.+..++.++|+|||||++|+|++|+.||.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 8999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=276.12 Aligned_cols=207 Identities=23% Similarity=0.396 Sum_probs=174.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+|+.|+. ++..||+|++..... .....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 467788999999998863 578899999875432 23345667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|++++++..+......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9998777666555556899999999999999999999999 9999999999999999999999999997764333333
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.....+++.|+|||++.+..++.++|+|||||++|+|++|++||.+.+.......+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 33456789999999999988999999999999999999999999987655444433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=284.20 Aligned_cols=205 Identities=26% Similarity=0.398 Sum_probs=176.5
Q ss_pred eeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEcc
Q 016544 161 VEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (387)
Q Consensus 161 ~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 232 (387)
+.||+|+||.|+. +|..||+|++...... ......+..|+.++++++||||+++++++..++.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 4689999998862 5789999999754332 223345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcc
Q 016544 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312 (387)
Q Consensus 233 ~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 312 (387)
++++|.+++.+...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~ 156 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAY 156 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Ccee
Confidence 99999999988878999999999999999999999999 9999999999999999999999999987643321 2223
Q ss_pred cCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 313 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~ 214 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC
Confidence 3467899999999999889999999999999999999999999888777777776554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=280.44 Aligned_cols=191 Identities=28% Similarity=0.492 Sum_probs=167.9
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
.||+|+||.|+. ++..||+|++.+.........+.+..|..++.++ +||+|+++++++.....+|+||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 589999998863 5689999999876554555667788999999888 6999999999999999999999999999
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
+|..++...+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++...... ........
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (327)
T cd05617 82 DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFC 157 (327)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceeccc
Confidence 99999988888999999999999999999999999 999999999999999999999999998643221 12223356
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
||+.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 89999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=304.06 Aligned_cols=212 Identities=34% Similarity=0.540 Sum_probs=182.8
Q ss_pred ccceeecccEEEEEEE------cC----eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 158 TNSVEITKGTFILAFW------RG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 158 ~~~~~lg~G~~~~v~~------~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+....||+|.||.||. .| ..||+|.+.+. .+.....+|.+|..+|..+.|||||+++|++.+....+|
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 3345799999999984 23 35999988754 456778899999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc-------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 228 VTEYLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
++|||++|+|..|+++. ..++..+.+.++.||++|+.||++++ +|||||..+|+|++....+||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999875 33889999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCcccC-CCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 301 KLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 301 ~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
+.+...+-...... .-+..|||||.+..+.|+.++|||||||++||++| |..||.+.++.++..-++.++|-+.
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~ 925 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP 925 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC
Confidence 84432222222111 33578999999999999999999999999999998 9999999999999998888884443
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=267.29 Aligned_cols=211 Identities=28% Similarity=0.408 Sum_probs=192.9
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|. .+|+-+|+|+++++.+-..+.+..-..|-.+|+..+||.+..+.-.|+..+++|+|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 46667789999999885 3688999999999988888888888889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|..||.|.-++.+...+++..+..+...|+.||.|||+++ ||.||||.+|.|++++|++||+|||+++..-.. ...
T Consensus 249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~t 324 (516)
T KOG0690|consen 249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-GDT 324 (516)
T ss_pred EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc-cce
Confidence 9999999999999888999999999999999999999999 999999999999999999999999998754332 334
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
...+.|||.|+|||++....|+..+|+|.+||++|||++|+.||...+.+.+.+-|....
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed 384 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED 384 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh
Confidence 456789999999999999999999999999999999999999999999999999997776
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=274.54 Aligned_cols=206 Identities=28% Similarity=0.482 Sum_probs=171.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.|+. ++..||+|.+...... .....+.+|+.++++++||||+++++++..+...++|||
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 477788999999998874 5789999998754221 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCC-CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+.+ +|.+++...+. +++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~ 158 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-K 158 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-c
Confidence 9975 99998876543 788999999999999999999999 9999999999999999999999999987543221 2
Q ss_pred CcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
......+++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+..+.+..+..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 218 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2233456889999999876 4688999999999999999999999998776666655543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=283.03 Aligned_cols=214 Identities=29% Similarity=0.511 Sum_probs=190.4
Q ss_pred cCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
-.|.....||+|.|+.|. .++..||+|.+.+....... .+.+.+|+++|+.++|||||+++.+...+..+|+||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 356667789999999886 36899999999987665444 445889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+.+|.+.+++...+...+.++..++.|+++|++|||+++ |+|||||.+|+|++.+.++||+|||++.++... .
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~ 209 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG--L 209 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc--c
Confidence 99999999999999999888999999999999999999999 999999999999999999999999999887633 3
Q ss_pred CcccCCCCCcccccccccCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC-CCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~ 374 (387)
......|++.|.|||++.+.++. +.+|+||+|+++|.|+.|.+||.+.+-.++-.++..++ |.++
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~ 276 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF 276 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc
Confidence 34456789999999999998764 88999999999999999999999988888888887777 5555
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=269.23 Aligned_cols=191 Identities=28% Similarity=0.455 Sum_probs=162.8
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
||+|+||.|+. +|+.||+|.+.............+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 68999998863 5889999998754433333334556799999999999999999999999999999999999999
Q ss_pred HHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 238 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 238 ~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
.+++...+ .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccC
Confidence 98886543 4788889999999999999999999 999999999999999999999999998765432 1223345
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
++..|+|||++.+..++.++|+|||||++|+|++|+.||.+..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 7889999999999889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=306.60 Aligned_cols=219 Identities=25% Similarity=0.355 Sum_probs=192.8
Q ss_pred ccCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
..+|.+.+.||+|+||.|. .+++.||+|++++-..-.......|..|..+|..-..+.|+.+.-.|+++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 3468888999999999764 36889999999864333334457799999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||||+||+|-.++.+.+++++..+..++..|+-||..||+.| +|||||||+|||++..|++||+|||.+-.+...+.
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 999999999999999888999999999999999999999999 99999999999999999999999998876665555
Q ss_pred CCcccCCCCCcccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC-CCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFK 375 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~~ 375 (387)
......+|||-|++||++.. +.|++.+|+||+||++|||+.|.-||.-.+-.+.+.+|...+ ...||
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP 303 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence 55566789999999999953 468999999999999999999999999999999999998886 44443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=275.08 Aligned_cols=203 Identities=28% Similarity=0.421 Sum_probs=175.9
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +|..+|+|.+.... .....+.+.+|+.++++++||||+++++++..++.+++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 4677888999999998863 57889999987542 3455677999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++.....+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.++|+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 99999999999998878999999999999999999999863 2999999999999999999999999998755322
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 364 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~ 364 (387)
......+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..++..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~ 212 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA 212 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2233467899999999999899999999999999999999999998766554433
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=289.52 Aligned_cols=219 Identities=24% Similarity=0.347 Sum_probs=183.4
Q ss_pred ccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC---
Q 016544 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--- 223 (387)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--- 223 (387)
....+|...+.||+|+||.||. +|..||||.+..... .......+.+|+.++..+.|+||++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 3445888899999999998863 578999999876544 3445567888999999999999999988775432
Q ss_pred -----ceEEEEEccCCCCHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEE
Q 016544 224 -----PMMIVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (387)
Q Consensus 224 -----~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 294 (387)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 368999999999999998652 35889999999999999999999998 999999999999999999999
Q ss_pred EeecCccccccCC-CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 295 ~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++..++..+..++
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~ 264 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 9999987654321 112233568999999999999999999999999999999999999999888778888887766544
Q ss_pred C
Q 016544 374 F 374 (387)
Q Consensus 374 ~ 374 (387)
+
T Consensus 265 ~ 265 (496)
T PTZ00283 265 L 265 (496)
T ss_pred C
Confidence 3
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=274.22 Aligned_cols=211 Identities=31% Similarity=0.480 Sum_probs=189.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|.....||+|+||.|.. +...+|||++++..+-..+.++--..|.++|... +-|.++++..+|+..+++|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 566677899999998864 3457999999998776666667677788888887 4678999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+.||+|-.++++-+.+.+..+..++.+|+-||-+||++| ||.||||.+|||++..|++||+|||+++.- .....
T Consensus 430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn-i~~~~ 505 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN-IFDGV 505 (683)
T ss_pred EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc-ccCCc
Confidence 99999999999999999999999999999999999999999 999999999999999999999999998753 23345
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......|||.|+|||++...+|+.++|+||+||++|||+.|++||.+.+.+++.+.|....
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn 566 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN 566 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc
Confidence 5566789999999999999999999999999999999999999999999999999997665
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=272.35 Aligned_cols=206 Identities=29% Similarity=0.468 Sum_probs=171.2
Q ss_pred CcccceeecccEEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCccee
Q 016544 156 DFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~---------------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 214 (387)
.|...+.||+|+||.|+. ++..||+|.+.... .......+.+|+.++.+++||||++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 466778899999998873 23479999987542 3455677899999999999999999
Q ss_pred eeeEEeeCCceEEEEEccCCCCHHHHHHHcC-------------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 016544 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------------ALKPSTAVRFALDIARGMNYLHENKPVPII 275 (387)
Q Consensus 215 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 275 (387)
+++++......+++|||+++++|.+++.... .+++.+...++.|++.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999986532 2567788999999999999999999 99
Q ss_pred eCCCCCCCEEeCCCCCEEEEeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc--CCC
Q 016544 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCP 352 (387)
Q Consensus 276 H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~ 352 (387)
||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999998755332211 1122334778999999998899999999999999999986 678
Q ss_pred CCCCCCCCcHHHHH
Q 016544 353 PFTMKHDNEVPKAY 366 (387)
Q Consensus 353 pf~~~~~~~~~~~i 366 (387)
||.+.+..++...+
T Consensus 241 p~~~~~~~~~~~~~ 254 (304)
T cd05096 241 PYGELTDEQVIENA 254 (304)
T ss_pred CCCcCCHHHHHHHH
Confidence 99887777666554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=269.95 Aligned_cols=205 Identities=25% Similarity=0.405 Sum_probs=173.6
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||.|+||.++. +++.||+|.+.............+.+|+.++++++|++|+++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 55667899999998864 5789999998765444444445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence 9999999888653 35899999999999999999999999 999999999999999999999999998654322 1
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
......++..|+|||++.+..++.++|+|||||++|+|++|..||.+.......+.+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~ 213 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 223346789999999999889999999999999999999999999876654443333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=281.10 Aligned_cols=204 Identities=27% Similarity=0.435 Sum_probs=171.2
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC---CCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
||+|+||.||. +|..||+|++.+..............|..++... .||+|+++++.+.....+++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 68999998873 5789999998754333333344455566776655 699999999999999999999999999
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccC
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 314 (387)
++|.+++...+.+++..+..++.||++||+|||+++ |+||||||+|||++.++.++|+|||++...... .......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~~ 156 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTTNTF 156 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCccCc
Confidence 999999998888999999999999999999999999 999999999999999999999999998653322 2222345
Q ss_pred CCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 315 DTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 315 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..++.+++..+.
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 213 (330)
T cd05586 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213 (330)
T ss_pred cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC
Confidence 689999999998764 47899999999999999999999999888777777776554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=296.37 Aligned_cols=205 Identities=21% Similarity=0.345 Sum_probs=173.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||+|++...........+++.+|+.++++++||||+++++++..++..+++||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME 82 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence 467778999999998873 478999999986655555666789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-----------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecC
Q 016544 231 YLPKGDLRAFLKRK-----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (387)
Q Consensus 231 ~~~~~sL~~~l~~~-----------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 299 (387)
|++|++|.+++... ...+...++.++.|+++||+|||+++ |+||||||+||+++.++.++|+|||+
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCc
Confidence 99999999998641 12456678899999999999999998 99999999999999999999999999
Q ss_pred ccccccCCC-----------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 300 SKLLTVKED-----------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 300 ~~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
+........ .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.......+
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 976521110 001124589999999999999999999999999999999999999987655444
Q ss_pred H
Q 016544 363 P 363 (387)
Q Consensus 363 ~ 363 (387)
.
T Consensus 240 ~ 240 (932)
T PRK13184 240 S 240 (932)
T ss_pred h
Confidence 3
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=282.91 Aligned_cols=212 Identities=27% Similarity=0.459 Sum_probs=189.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
-|...++||.|+||.||+ +...||||+++-..-...+..+++..|+.+|+++.|||++.+.|+|..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 366677899999999985 567899999986665667778889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||- ||-.+++.- ..++.+-++..|+.+.++||+|||+++ .||||||..|||+++.|.+||+|||.+....+
T Consensus 107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence 995 599988875 346889999999999999999999999 99999999999999999999999999877543
Q ss_pred CcccCCCCCcccccccccC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 376 (387)
...++|||.|||||++.. ++|+-++||||||++..||..+++|+..++....+-.|..+..|.+..
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs 247 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS 247 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC
Confidence 355789999999998854 589999999999999999999999999999999999998888887753
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=276.98 Aligned_cols=200 Identities=27% Similarity=0.457 Sum_probs=166.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC-----ce
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~ 225 (387)
+|+..+.||+|+||.|+. +|..||+|.+..... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 366778899999998863 578999999874322 2233456788999999999999999999886432 47
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
|+||||+. ++|.+++.....+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 99999995 699999988878999999999999999999999999 99999999999999999999999999875432
Q ss_pred CCC--CCcccCCCCCcccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 306 KED--RPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 306 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
... .......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~ 214 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 214 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH
Confidence 211 12233568899999999876 57889999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=279.55 Aligned_cols=189 Identities=24% Similarity=0.359 Sum_probs=165.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +++.||+|.... ..+.+|+.++++++||||++++++|......++++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 4688889999999998874 578999996532 34678999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|++. ++|.+++.....+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.........
T Consensus 163 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 163 PRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 9995 699999988778999999999999999999999999 999999999999999999999999998654322222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 23345689999999999998999999999999999999999988754
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=268.15 Aligned_cols=214 Identities=31% Similarity=0.519 Sum_probs=179.6
Q ss_pred CcccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|+..+.||.|+||.|+.. ...||+|.+.... .......+.+|+.++++++||||+++++++......
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 4666778999999887631 2579999987542 345567789999999999999999999999998999
Q ss_pred EEEEEccCCCCHHHHHHHc----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC
Q 016544 226 MIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~ 289 (387)
+++|||+++++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||||+||+++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence 9999999999999999764 34778889999999999999999999 9999999999999999
Q ss_pred CCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHH
Q 016544 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 290 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~ 367 (387)
+.++|+|||++........ .......+++.|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..++...+.
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999875432221 11223345788999999988889999999999999999998 999999988888888887
Q ss_pred ccCCCCC
Q 016544 368 ARQRPPF 374 (387)
Q Consensus 368 ~~~~~~~ 374 (387)
.+..++.
T Consensus 241 ~~~~~~~ 247 (283)
T cd05048 241 SRQLLPC 247 (283)
T ss_pred cCCcCCC
Confidence 6664443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=267.60 Aligned_cols=198 Identities=29% Similarity=0.460 Sum_probs=169.7
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||+|+||.|+. +++.||+|.+.............+..|+.++++++|++|+++++.+...+.++++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 45567899999998864 5789999998765444444445677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++...+ .+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999999886533 4889999999999999999999998 9999999999999999999999999986543221
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~ 206 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 206 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCc
Confidence 22234678999999999998999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=279.03 Aligned_cols=209 Identities=29% Similarity=0.472 Sum_probs=171.1
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 224 (387)
+|...+.||+|+||.|+. ++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 577788999999998863 12479999997543 234456788999999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHc------------------------------------------------------------
Q 016544 225 MMIVTEYLPKGDLRAFLKRK------------------------------------------------------------ 244 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~------------------------------------------------------------ 244 (387)
.++||||+++|+|.+++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999998642
Q ss_pred ----------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC-ccc
Q 016544 245 ----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTC 313 (387)
Q Consensus 245 ----------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~ 313 (387)
.++++.++..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.......... ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 13677888999999999999999998 9999999999999999999999999987653322111 112
Q ss_pred CCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHcc
Q 016544 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 369 (387)
..+++.|+|||++.+..++.++|||||||++|+|++ |+.||..........++...
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~ 330 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR 330 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc
Confidence 234567999999998899999999999999999997 99999877665544444333
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=275.49 Aligned_cols=196 Identities=31% Similarity=0.495 Sum_probs=174.8
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|+.-+.||+|+||.|+ .+|+.+|.|++.+..+....-.....+|..++.+++.+.||.+--.|+..+.+++|+.
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt 265 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT 265 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence 46667789999999775 4789999998876655443333445779999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
.|.||+|.-++...+ .+++..+..++.+|+.||++||+.+ ||.|||||+|||+|+.|+++|+|+|+|..+. ..
T Consensus 266 lMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~--~g 340 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP--EG 340 (591)
T ss_pred eecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC--CC
Confidence 999999999997765 5999999999999999999999999 9999999999999999999999999998765 34
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
.+....+||.+|||||++.+..|+.+.|+|||||++|||+.|+.||..
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 555666899999999999999999999999999999999999999975
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=262.41 Aligned_cols=212 Identities=32% Similarity=0.545 Sum_probs=178.3
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|+..+.||+|+|+.++. .+..+|+|.+..... ....+..|+.++++++||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 355667899999987763 346899998764422 235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++++|.+++... +.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999999753 45889999999999999999999999 9999999999999999999999999887653322222
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..++.+.+..+.++..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~ 222 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR 222 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC
Confidence 222345668999999998889999999999999999999 9999999888888888877665443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=278.53 Aligned_cols=207 Identities=26% Similarity=0.424 Sum_probs=174.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC-----ce
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~ 225 (387)
+|...+.||+|+||.|+. +|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 356678899999998873 57899999986542 23344567888999999999999999999998776 78
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
|+|+||+. ++|.+++.....+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99999995 589998887778999999999999999999999999 99999999999999999999999999976543
Q ss_pred CCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
..........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.++...+..|.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 218 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 333333344578899999999875 47889999999999999999999999887766665553
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=277.69 Aligned_cols=206 Identities=29% Similarity=0.445 Sum_probs=169.0
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 224 (387)
+|...+.||+|+||.|+. .+..||||+++.... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 567788999999998863 245899999875432 23446788899999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC-----------------------------------------------------------
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG----------------------------------------------------------- 245 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~----------------------------------------------------------- 245 (387)
.++||||+++|+|.+++.+..
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986432
Q ss_pred ----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 246 ----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 246 ----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 3677888999999999999999998 999999999999999999999999998765432211
Q ss_pred C-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHH
Q 016544 310 P-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 310 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i 366 (387)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+........++
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~ 329 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM 329 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH
Confidence 1 112234567999999999999999999999999999997 99999876554333333
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=279.40 Aligned_cols=210 Identities=25% Similarity=0.377 Sum_probs=191.0
Q ss_pred CcccceeecccEEEEEE---EcCeE--EEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF---WRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~---~~g~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
++.....||.|+||.|. .+++. +|+|++++..+-+....+.+..|.++|...+.|.||++|-.|.++..+|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 34445578999999764 45555 89999998888778888889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
-|-||.|+..+...+.+...++..++.-+++|++|||+++ ||.|||||+|++++.+|.+||.|||+|+.+..+ ...
T Consensus 501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-~KT 576 (732)
T KOG0614|consen 501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-RKT 576 (732)
T ss_pred hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC-Cce
Confidence 9999999999999999999999999999999999999999 999999999999999999999999999887643 333
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
-.+.|||.|.|||++....++.++|.||||+++|||++|.+||.+.++...+..|.++-
T Consensus 577 -wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi 635 (732)
T KOG0614|consen 577 -WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI 635 (732)
T ss_pred -eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh
Confidence 34678999999999999999999999999999999999999999999999999998876
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=261.83 Aligned_cols=211 Identities=30% Similarity=0.512 Sum_probs=177.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCC--HHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
+|...+.||.|+++.++. ++..||+|.+....... ....+.+.+|+.++++++||||+++++++..+..++++
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 467788999999987763 57899999987543222 22346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
+||+++++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 999999999999998888999999999999999999999999 99999999999999999999999999876543211
Q ss_pred CCc--ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 309 RPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 309 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..........++...
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 222 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 222 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc
Confidence 111 2234678899999999988999999999999999999999999877665555554433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=270.21 Aligned_cols=198 Identities=28% Similarity=0.528 Sum_probs=165.5
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||.|+||.|+. ++..||+|++..... ......+.+|+.+++.++||||+++++++..+...++||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 3677888999999998863 578999999875422 122345677999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+. ++|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 157 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP-S 157 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC-C
Confidence 9995 5888887654 45889999999999999999999999 999999999999999999999999998754322 1
Q ss_pred CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
.......+++.|+|||++.+. .++.++|+|||||++|+|++|..||.+..+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 209 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 222334578899999998764 578899999999999999999999987544
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=266.21 Aligned_cols=208 Identities=29% Similarity=0.504 Sum_probs=180.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+..+.||.|+|+.++. +++.||+|.+.............+.+|+++++++.||||+++++++.....++++||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 466778899999987762 578999999876544444556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++...+.++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999999999998888999999999999999999999998 999999999999999999999999998765433
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....+++.|+|||.+.+...+.++|+||||+++|+|++|..||...+.....+++..+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 214 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK 214 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 223357889999999988888999999999999999999999998877666667765443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=261.15 Aligned_cols=208 Identities=27% Similarity=0.427 Sum_probs=175.5
Q ss_pred eecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 162 ~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
+||+|+||.|+. ++..+|+|++.... ......+.+..|+.+++.+.||||+++++++.. ...+++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999988763 46889999987543 344556788999999999999999999998864 567899999999
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC--cc
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LT 312 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~ 312 (387)
++|.+++.....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999999988778999999999999999999999999 9999999999999999999999999987654332211 11
Q ss_pred cCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 313 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
...++..|+|||.+....++.++|+|||||++|||++ |..||...+..++.+.+..+.++++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~ 219 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC 219 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC
Confidence 2233578999999988888999999999999999998 9999998888888888877665554
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=270.41 Aligned_cols=200 Identities=30% Similarity=0.467 Sum_probs=173.8
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||.|+||.|+. ++..+|+|.+.... .......+.+|++++++++||||++++++|...+.+++||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4677888999999998874 57789999887542 3445567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+.+++|.+++...+.+++..+..++.|++.||.|||+. + ++|+||||+|||++.++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 9999999999999888899999999999999999999985 5 999999999999999999999999998654321
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
......++..|+|||++.+..++.++|+|||||++|+|++|+.||.......+
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 210 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 22234578899999999998899999999999999999999999987655443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=279.57 Aligned_cols=220 Identities=26% Similarity=0.520 Sum_probs=184.4
Q ss_pred cccCccccCcccceeecccEEEEEEE-----cCeEEEEEEcCc-ccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee
Q 016544 148 YEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGE-EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (387)
Q Consensus 148 ~ei~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~-~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~ 221 (387)
.+.++...-......||+|+|-+||. +|..||--.++. ...+.+...++|..|+.+|+.|+||||+++|.++.+
T Consensus 33 ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d 112 (632)
T KOG0584|consen 33 VEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD 112 (632)
T ss_pred cccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence 34444444455566899999998884 567777433221 233456778999999999999999999999999987
Q ss_pred CCc--eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC-CCCCEEEEeec
Q 016544 222 SSP--MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFG 298 (387)
Q Consensus 222 ~~~--~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg 298 (387)
... +-+|+|.+..|+|..|+++.+.++.+....|++||++||.|||++.| ||||||||.+||+|+ ..|.+||+|+|
T Consensus 113 ~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 113 TDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred CCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchh
Confidence 654 88999999999999999999999999999999999999999999985 799999999999998 55889999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC-CCCcHHHHHHccCCC
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK-HDNEVPKAYAARQRP 372 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~ 372 (387)
+|..... .......|||.|||||... ..|...+||||||++++||+|+.+||... ++.+|++++..|..|
T Consensus 192 LAtl~r~---s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP 262 (632)
T KOG0584|consen 192 LATLLRK---SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP 262 (632)
T ss_pred HHHHhhc---cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH
Confidence 9987643 2333468999999999988 58999999999999999999999999864 457889998888744
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=261.71 Aligned_cols=212 Identities=30% Similarity=0.515 Sum_probs=176.6
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|+..+.||.|+|+.|+. .+..+|+|.+...... ...+.+|+.++++++||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 466778899999998763 3458999998654322 24577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++++|.+++... +.+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||+++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999999764 45889999999999999999999999 9999999999999999999999999987553221111
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...++.++...+....++..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 222 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR 222 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 112223457999999998899999999999999999999 8999998888888888876654443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=274.45 Aligned_cols=196 Identities=26% Similarity=0.426 Sum_probs=162.0
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.||. +|+.||+|.+.... .......+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 455667899999998873 47899999986432 34456778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|... ...++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 224 (353)
T PLN00034 153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DP 224 (353)
T ss_pred cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-cc
Confidence 9999998653 23566778889999999999999999 9999999999999999999999999987654321 12
Q ss_pred cccCCCCCcccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 016544 311 LTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~ 361 (387)
.....|+..|+|||.+.. ...+.++|||||||++|+|++|+.||......+
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~ 280 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD 280 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 233468999999998753 234568999999999999999999998544333
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=262.16 Aligned_cols=211 Identities=30% Similarity=0.497 Sum_probs=176.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. .+..||+|.+... ......+.+|+.++++++||||+++++++..+..++++||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 456667899999987753 4789999998743 2234678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+++++|.+++.... .+++..+..++.|++++|+|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999997643 4888999999999999999999998 99999999999999999999999999876543322
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
........++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+..+.++.
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 225 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME 225 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC
Confidence 22122234567999999999899999999999999999998 999999877777777775544433
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=261.26 Aligned_cols=210 Identities=29% Similarity=0.457 Sum_probs=176.7
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|+..+.||.|+++.++. .+..||+|.+..... ..+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 466778999999987763 457899999875432 235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++.... .+++.....++.|++.|+.+||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999997654 5899999999999999999999998 999999999999999999999999998776522211
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
.......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+...+...+....++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 223 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM 223 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 1111223457999999999899999999999999999999 99999988877777777655433
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=264.02 Aligned_cols=213 Identities=29% Similarity=0.484 Sum_probs=176.4
Q ss_pred CcccceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
+|+..+.||+|+||.|+. .+..|++|.+... ........+.+|+.++++++||||+++++++......+
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 355567899999998864 3468999998743 23445567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHc-----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC
Q 016544 227 IVTEYLPKGDLRAFLKRK-----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~-----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~ 289 (387)
++|||+.+++|.+++... ..+++.+...++.|++.||.|||+++ ++|+||||+||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence 999999999999998632 23678888999999999999999998 9999999999999999
Q ss_pred CCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHH
Q 016544 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 290 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~ 367 (387)
+.++|+|||++........ .......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+...+.+.+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876532221 11122334677999999998889999999999999999998 999999887777777776
Q ss_pred ccCCCC
Q 016544 368 ARQRPP 373 (387)
Q Consensus 368 ~~~~~~ 373 (387)
....++
T Consensus 241 ~~~~~~ 246 (283)
T cd05090 241 KRQLLP 246 (283)
T ss_pred cCCcCC
Confidence 655443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=264.40 Aligned_cols=212 Identities=30% Similarity=0.507 Sum_probs=178.7
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|...+.||.|+|+.++. ++..+|+|.+... .....+.+.+|+.++++++||||+++++++.....+
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 567778899999998863 2356899988643 344566789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC-------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCE
Q 016544 226 MIVTEYLPKGDLRAFLKRKG-------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~-------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 292 (387)
+++|||+++++|.+++...+ .+++.++..++.|++.||+|||+++ ++||||||+||+++.++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 99999999999999997543 3889999999999999999999998 9999999999999999999
Q ss_pred EEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 293 KVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 293 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
+|+|||++........ .......+++.|+|||.+.+..++.++|+|||||++|+|++ |.+||......++...+..+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999875432211 11122334678999999998889999999999999999998 999999888888888887766
Q ss_pred CCC
Q 016544 371 RPP 373 (387)
Q Consensus 371 ~~~ 373 (387)
.+.
T Consensus 240 ~~~ 242 (288)
T cd05093 240 VLQ 242 (288)
T ss_pred cCC
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=266.50 Aligned_cols=212 Identities=27% Similarity=0.427 Sum_probs=179.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. .+..|++|.+.............+.+|+.+++.++||||+++++.+..+..++++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 466678899999988762 467899999876544334455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC--
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-- 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 308 (387)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999999999988888999999999999999999999998 99999999999999999999999998864211100
Q ss_pred ------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 309 ------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 309 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+....++..++..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~ 232 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 232 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 00112346778999999998889999999999999999999999999888888888776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=272.98 Aligned_cols=202 Identities=26% Similarity=0.463 Sum_probs=178.0
Q ss_pred ceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 160 ~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
.+.||+|.||+|| .+|+.||||++.+..+..... ..+++|+.+|+.+.||+||.+--.|+..+.+|+|||-+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~- 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH- 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-
Confidence 4679999999998 479999999999877765444 779999999999999999999999999999999999995
Q ss_pred CCHHHHHH--HcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC---CCEEEEeecCccccccCCCC
Q 016544 235 GDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 235 ~sL~~~l~--~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|++.+.+- +.+.+++.....++.||+.||.|||-++ |+|+||||+|||+... ..+||+|||+|++++.. .
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--s 721 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--S 721 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh--h
Confidence 57766663 4577999999999999999999999999 9999999999999754 46999999999998644 3
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....+|||.|+|||+++...|.++-|+||.|||+|--+.|..||.. ++++-.+|++..
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAa 780 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAA 780 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccc
Confidence 34457899999999999999999999999999999999999999974 477888888777
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=265.62 Aligned_cols=207 Identities=29% Similarity=0.484 Sum_probs=169.2
Q ss_pred CcccceeecccEEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC---CCCcceeeeeEEee-----
Q 016544 156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQ----- 221 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~----- 221 (387)
+|...+.||+|+||.||. .|..||+|.+........ ....+.+|+.+++.+ .||||+++++++..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 577788999999998873 357899998875433221 223445677776665 69999999998853
Q ss_pred CCceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecC
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 299 (387)
...++++|||+. ++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 356899999996 5999998763 34889999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
+...... .......+++.|+|||.+.+..++.++|||||||++|+|++|++||.+.+..+.+.++...
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~ 224 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 224 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHH
Confidence 8765432 2223345789999999999889999999999999999999999999998887777777544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=259.22 Aligned_cols=214 Identities=27% Similarity=0.430 Sum_probs=182.7
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||+|+++.++. ++..|++|.+...... ......+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 55667899999987763 5789999998754333 44566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~ 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-N 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc-c
Confidence 9999999999764 45889999999999999999999998 9999999999999999999999999987654322 1
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 375 (387)
......+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+......++..+..++++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS 222 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 223345788899999999988999999999999999999999999988877777887777666654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=266.47 Aligned_cols=210 Identities=38% Similarity=0.690 Sum_probs=175.5
Q ss_pred ceeecccEEEEEE---Ec------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 160 SVEITKGTFILAF---WR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 160 ~~~lg~G~~~~v~---~~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.+.||.|.||.|+ +. +..|+||.+... ......+.+.+|++.+++++||||+++++++...+..++|+|
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4679999999876 34 678999999643 345557889999999999999999999999998888999999
Q ss_pred ccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+++|+|.+++... ..+++.++..|+.|++.||.|||+++ ++|+||+++||+++.++.+||+|||++........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999999986 56999999999999999999999998 99999999999999999999999999876622211
Q ss_pred -CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 309 -RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 309 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
...........|+|||.+....++.++||||||+++||+++ |+.||.+.+..++..++..+.++++
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee
Confidence 11122335678999999998889999999999999999999 7899999988888889877766554
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=260.59 Aligned_cols=213 Identities=32% Similarity=0.509 Sum_probs=180.0
Q ss_pred CcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|+..+.||+|+||.||. +...||+|.+.... .......+..|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 567788999999998873 13579999987542 34456678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+|||+++++|.+++... +.+++.++..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999764 45899999999999999999999998 999999999999999999999999999876422
Q ss_pred CCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 307 EDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 307 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......++...+....+++
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 211 1122334678999999999899999999999999999998 999999888888888886655433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=263.15 Aligned_cols=214 Identities=25% Similarity=0.423 Sum_probs=176.0
Q ss_pred cCcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
.+|+....||+|+||.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3577788999999998863 24679999986432 23345668899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC----------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEE
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 294 (387)
.++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999997532 2466788899999999999999998 999999999999999999999
Q ss_pred EeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 295 ADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 295 ~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
+|||++.......... .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..+..+.+.....+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999987543222111 112234678999999998889999999999999999999 79999988887777777665543
Q ss_pred C
Q 016544 373 P 373 (387)
Q Consensus 373 ~ 373 (387)
+
T Consensus 241 ~ 241 (277)
T cd05062 241 D 241 (277)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=274.30 Aligned_cols=217 Identities=27% Similarity=0.485 Sum_probs=187.8
Q ss_pred ceeecccEEEEEEE-------cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 160 SVEITKGTFILAFW-------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 160 ~~~lg~G~~~~v~~-------~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.+.||.|.||.||. .| ..||||.-+.+ ...+..+.|..|+.+|+.+.||||++++|+|.+ ...+||||
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE 470 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME 470 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence 45789999998763 22 36888877654 344557889999999999999999999999975 57899999
Q ss_pred ccCCCCHHHHHHHcCC-CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
.++-|.|..|++.+.. ++......++.||+.||.|||+.. +|||||-.+|||+.....+||+|||+++......-.
T Consensus 471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 9999999999987654 888999999999999999999999 999999999999999999999999999987755444
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhcc
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
..+...-++.|||||.+.-+.++.++|||.|||++||++. |..||.+..+.+++-.|.+|.|+|. |+.||+.|
T Consensus 548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~---P~nCPp~L 621 (974)
T KOG4257|consen 548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC---PPNCPPAL 621 (974)
T ss_pred hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC---CCCCChHH
Confidence 4444445778999999999999999999999999999985 9999999999999999999998887 45666654
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=261.55 Aligned_cols=210 Identities=30% Similarity=0.504 Sum_probs=177.2
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|...+.||.|+||.++. ++..||+|.+.... ...+.+.+|+.++++++||||+++++.+...+..+++|||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 566678899999998863 46789999876432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++.+. ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999753 34788899999999999999999998 999999999999999999999999999765432222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
......++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.......+...+....++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~ 223 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM 223 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC
Confidence 2222345678999999998889999999999999999998 99999988877778777655443
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=260.78 Aligned_cols=211 Identities=30% Similarity=0.511 Sum_probs=176.7
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|+..+.||+|+|+.++. .+..+|+|.+..... ....+.+|+.++++++||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 456677899999988763 234699998875432 235688899999999999999999999988899999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+.+++|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+..........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999764 35899999999999999999999998 9999999999999999999999999987553322211
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
.....++..|++||.+.+..++.++|+|||||++|+|++ |..||......++..++..+.++.
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC
Confidence 122234677999999998889999999999999999998 999999888777888887766544
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=274.69 Aligned_cols=206 Identities=29% Similarity=0.470 Sum_probs=176.4
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
...+++.||+|.||.+.. .+..||||+++... ......+|..|+++|.+++||||++++|+|..++.+++|+||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 355677899999998753 34899999998763 345578899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++|+|.+|+.++.. +......+|+.||++||+||.+.+ +|||||.++|+|++.++++||+|||+++..-..+..
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999987632 355667789999999999999998 999999999999999999999999999854333222
Q ss_pred Ccc-cCCCCCcccccccccCCCCCCchhHHHHHHHHHHHH--cCCCCCCCCCCCcHHHHH
Q 016544 310 PLT-CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI--EGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 310 ~~~-~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell--tg~~pf~~~~~~~~~~~i 366 (387)
..+ ...-+++|||||.+.-++++.++|+|+||+++||++ +...||...+++++.++.
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~ 753 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENA 753 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhh
Confidence 222 223468999999999999999999999999999986 699999999999888775
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=263.67 Aligned_cols=211 Identities=31% Similarity=0.494 Sum_probs=178.2
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|...+.||.|+|+.|+. ++..||+|.+.... ..+..+.+.+|+++++.++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 466677899999998873 13689999987542 334567899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC--------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC
Q 016544 226 MIVTEYLPKGDLRAFLKRKG--------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~--------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 291 (387)
+++|||+++++|.+++...+ .+++.++..++.|++.|+.|||+++ ++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997643 3678889999999999999999999 999999999999999999
Q ss_pred EEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHcc
Q 016544 292 LKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 292 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 369 (387)
++|+|||++........ .......+++.|+|||.+.+..+++++|||||||++|+|++ |..||.+.+..+....+..+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999999875432211 11122334678999999999999999999999999999998 99999988888888888765
Q ss_pred CC
Q 016544 370 QR 371 (387)
Q Consensus 370 ~~ 371 (387)
..
T Consensus 241 ~~ 242 (280)
T cd05049 241 RL 242 (280)
T ss_pred Cc
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=258.48 Aligned_cols=207 Identities=25% Similarity=0.431 Sum_probs=172.0
Q ss_pred eecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 162 ~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
.||.|+||.|+. .+..||+|.+.... .....+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 479999988763 24579999987542 34455678999999999999999999998864 578999999999
Q ss_pred CCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC--c
Q 016544 235 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--L 311 (387)
Q Consensus 235 ~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~ 311 (387)
++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......... .
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999999975 446899999999999999999999998 9999999999999999999999999987554322211 1
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
....+++.|+|||.+.+..++.++|+|||||++|++++ |..||.+....++...+..+.++.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC
Confidence 12223568999999988889999999999999999996 9999999888888887777665544
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=285.00 Aligned_cols=219 Identities=32% Similarity=0.542 Sum_probs=190.5
Q ss_pred cccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
..+.+.||.|.||.|+. ....||||.++.. ..++...+|..|+.||-++.||||++|-|+......+.||
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 34456899999999874 3468999999854 3577788899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
+|||++|+|..||.++ +.++.-+...+++.|+.||.||-+.+ +|||||..+|||++.+-..|++|||+++.+....
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999999865 56999999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCCcccC--CCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC--CCCCCCChhh
Q 016544 308 DRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKL 380 (387)
Q Consensus 308 ~~~~~~~--~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~ 380 (387)
....+.. .-+.+|.|||.+..++++.++||||||++|||.++ |+.||=++++.++++.|..+= .||++.|...
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL 863 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAAL 863 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHH
Confidence 3333333 23679999999999999999999999999999885 999999999999999998777 4555555443
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=257.60 Aligned_cols=208 Identities=31% Similarity=0.510 Sum_probs=172.4
Q ss_pred eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCC
Q 016544 162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 236 (387)
.||.|+||.||. +++.||+|.+.... ..+....+.+|+.++++++||||+++++++......++||||+.+++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 589999988863 67889999886432 34555778999999999999999999999999999999999999999
Q ss_pred HHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc-ccC
Q 016544 237 LRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-TCQ 314 (387)
Q Consensus 237 L~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~ 314 (387)
|.+++...+ .+++.+++.++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++........... ...
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 999997654 4889999999999999999999998 99999999999999999999999999875432111111 111
Q ss_pred CCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
..+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.......+....+++.
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 217 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC 217 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC
Confidence 23456999999998889999999999999999997 9999988777666666655444443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=272.54 Aligned_cols=213 Identities=27% Similarity=0.435 Sum_probs=171.9
Q ss_pred CcccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~ 224 (387)
+|...+.||+|+||.|+.. +..||||++.... .....+.+.+|+.+++++. ||||+++++++.....
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 6777789999999988631 2469999997542 3344567899999999996 9999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHc------------------------------------------------------------
Q 016544 225 MMIVTEYLPKGDLRAFLKRK------------------------------------------------------------ 244 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~------------------------------------------------------------ 244 (387)
+|+||||+++|+|.+++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999988642
Q ss_pred ------------------------------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC
Q 016544 245 ------------------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288 (387)
Q Consensus 245 ------------------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~ 288 (387)
..+++.++..++.|++.||.|||+.+ ++|+||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 12667778899999999999999998 999999999999999
Q ss_pred CCCEEEEeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCc-HHHH
Q 016544 289 SGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNE-VPKA 365 (387)
Q Consensus 289 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~-~~~~ 365 (387)
++.++|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||....... +...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 999999999998765332211 1122345678999999999889999999999999999997 999998765443 3444
Q ss_pred HHccCCCC
Q 016544 366 YAARQRPP 373 (387)
Q Consensus 366 i~~~~~~~ 373 (387)
+..+.+++
T Consensus 353 ~~~~~~~~ 360 (400)
T cd05105 353 IKSGYRMA 360 (400)
T ss_pred HhcCCCCC
Confidence 44433433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=258.51 Aligned_cols=215 Identities=32% Similarity=0.537 Sum_probs=178.6
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCC------HHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
|.....||.|+|+.++. ++..+|+|.+....... ....+.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 56677899999988763 56899999886543322 12346788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
++++||+++++|.+++.+.+.++...+..++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 999999999999999998888999999999999999999999998 99999999999999999999999999876542
Q ss_pred CCC-----CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 306 KED-----RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 306 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+......++.....|.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI 232 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcC
Confidence 111 111123467889999999998899999999999999999999999998766555555544444443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=259.90 Aligned_cols=204 Identities=25% Similarity=0.385 Sum_probs=171.6
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.++. ++..||+|++.... ......+.+|+.++++++||||+++++.+......++||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 3678888999999998763 57889999986432 223456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++...+++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...... ..
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~-~~ 161 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITAT-IA 161 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccc-cc
Confidence 99999999999988788999999999999999999999998 999999999999999999999999998765322 11
Q ss_pred CcccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~ 365 (387)
......+++.|+|||.+. ...++.++|+|||||++|+|++|+.||....+......
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~ 220 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL 220 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee
Confidence 122345788999999885 34577899999999999999999999976655444333
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=271.69 Aligned_cols=199 Identities=27% Similarity=0.401 Sum_probs=166.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 223 (387)
.+|...+.||+|+||.|+. .|..||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 3678888999999998863 578999999875532 3344566788999999999999999999986543
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.+|+||||+.+ +|.+.+.. .++...+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999965 67666643 4788899999999999999999999 999999999999999999999999998754
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....
T Consensus 174 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~ 230 (359)
T cd07876 174 CTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ 230 (359)
T ss_pred ccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 321 222334678999999999999999999999999999999999999987765443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=258.11 Aligned_cols=214 Identities=24% Similarity=0.437 Sum_probs=177.4
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.|+ .++..||+|.+.............+.+|+.+++.++||||+++++++...+..++++|
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence 56777889999998776 2678999998875444455666778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 231 ~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 9999999988853 234788999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--CcHHHHHHccCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEVPKAYAARQRPP 373 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~ 373 (387)
. .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..+...+.....|+
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08228 160 T-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227 (267)
T ss_pred h-HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC
Confidence 1 112234578899999999988899999999999999999999999975432 34555554444444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=260.20 Aligned_cols=211 Identities=29% Similarity=0.479 Sum_probs=176.4
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
++.....||+|+||.|+. ++..+|+|.+... .......+.+|+.+++.++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 455677899999998874 3568999987643 344567899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC---------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC
Q 016544 226 MIVTEYLPKGDLRAFLKRKG---------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~---------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~ 290 (387)
+++|||+++++|.+++...+ .+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCC
Confidence 99999999999999997643 3788899999999999999999999 99999999999999999
Q ss_pred CEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHc
Q 016544 291 NLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 291 ~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~ 368 (387)
.++|+|||++.......... .....+++.|+|||.+.+..++.++|+|||||++|+|++ |.+||......+....+..
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 99999999987543221111 112234678999999999899999999999999999998 9999988877777777766
Q ss_pred cCCC
Q 016544 369 RQRP 372 (387)
Q Consensus 369 ~~~~ 372 (387)
+..+
T Consensus 240 ~~~~ 243 (280)
T cd05092 240 GREL 243 (280)
T ss_pred CccC
Confidence 5543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=272.26 Aligned_cols=206 Identities=26% Similarity=0.360 Sum_probs=171.6
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC------C
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~ 223 (387)
.+|...+.||+|+||.|+. .+..||||++..... .......+.+|+.+++.++||||+++++++... .
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4688888999999998863 578899999876432 234456678899999999999999999987643 3
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.+|+||||+.+ +|.+++.. .++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 57999999965 78777754 3788899999999999999999999 999999999999999999999999999764
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
... .......+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++...
T Consensus 177 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 240 (364)
T cd07875 177 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240 (364)
T ss_pred CCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 322 2223346789999999999999999999999999999999999999988776666666443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=264.09 Aligned_cols=213 Identities=25% Similarity=0.487 Sum_probs=174.4
Q ss_pred cCcccceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
.+|+..+.||+|+||.|+. ++. .||+|.+... ......+.+..|+.+++.++||||+++++++... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 4677888999999998863 233 4899998743 2344556788999999999999999999998764 57
Q ss_pred EEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
++++||+.+|+|.+++.... .+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 89999999999999998743 4888899999999999999999999 9999999999999999999999999998764
Q ss_pred cCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 305 VKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 305 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
...... ......+..|+|||.+.+..++.++|||||||++|||++ |..||.+....++...+..+.+++
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 231 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCC
Confidence 332211 112234668999999999999999999999999999998 999999877666655555444433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=253.27 Aligned_cols=194 Identities=26% Similarity=0.454 Sum_probs=164.0
Q ss_pred ceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccC
Q 016544 160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 160 ~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
.+.||.|.|+.|. ++|..+|||++.+. ......+..+|++++.+. .|+||++++++|+++..+|||||-|.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 3568999998764 68999999999765 344567778899999998 59999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC---EEEEeecCccccccCCC--
Q 016544 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTVKED-- 308 (387)
Q Consensus 234 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~~-- 308 (387)
||+|..++++...+++.++.++.++|+.||.+||.+| |.||||||+|||-..... +||+||.+..-+....+
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9999999999888999999999999999999999999 999999999999875544 89999988653321111
Q ss_pred ----CCcccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 309 ----RPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 309 ----~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
-......|+..|||||+.. ...|+.++|.||||||+|-|++|.+||.|.=.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 1123456888999999763 23688999999999999999999999987543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=259.52 Aligned_cols=218 Identities=28% Similarity=0.463 Sum_probs=190.2
Q ss_pred cccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|.+...||.|+||.|+ ..|+.+|+|.+..+ ...+++..|+.++++...|++|++||.|.....+++||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 5667789999999875 57999999988643 3468889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHH-HcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~-~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|..||..+.+. ++.++++.++..+++.-+.||+|||... -||||||..|||++.+|.+||+|||.+..+...- ..
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AK 185 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AK 185 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH-Hh
Confidence 99999999997 4567999999999999999999999988 8999999999999999999999999986654321 12
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhc
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 384 (387)
.....|||.|||||++..-.|..++||||||++..||..|++||.+..+...+-.|-....|.|..| +.++++
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KP-E~WS~~ 258 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKP-EEWSSE 258 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCCh-HhhhhH
Confidence 2446799999999999999999999999999999999999999999999988888877777777664 555544
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=257.45 Aligned_cols=214 Identities=32% Similarity=0.514 Sum_probs=178.3
Q ss_pred CcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|...+.||+|+||.++. .+..+|+|.+.... .....+.+..|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 456678899999987763 23379999987542 23455688999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+|||+++++|.+++.+. +.+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999865 45899999999999999999999999 999999999999999999999999998765433
Q ss_pred CCCCc--ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 307 EDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 307 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
..... ....++..|++||.+.+..++.++|+|||||++|++++ |..||.+.+..+....+....+++.
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~ 230 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA 230 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCC
Confidence 22111 11223567999999998889999999999999999886 9999998887778888776654443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=261.71 Aligned_cols=213 Identities=25% Similarity=0.461 Sum_probs=177.6
Q ss_pred cccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 157 FTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
|...+.||.|+||.|+.. +..||+|.+.... .....+.+..|+.++..++||||+++++++......+
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 555678999999887642 4789999997542 3344567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHc----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC
Q 016544 227 IVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~ 290 (387)
+++||+.+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999998532 23778888999999999999999999 99999999999999999
Q ss_pred CEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHc
Q 016544 291 NLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 291 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~ 368 (387)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....++.+.+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999875432221 11122345678999999988889999999999999999998 9999999888888888877
Q ss_pred cCCCCC
Q 016544 369 RQRPPF 374 (387)
Q Consensus 369 ~~~~~~ 374 (387)
...+++
T Consensus 242 ~~~~~~ 247 (283)
T cd05091 242 RQVLPC 247 (283)
T ss_pred CCcCCC
Confidence 775543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=253.62 Aligned_cols=206 Identities=32% Similarity=0.523 Sum_probs=172.5
Q ss_pred eecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 162 EITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 162 ~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
.||.|+|+.||. ++..+|+|.+.... .......+.+|+.+++.++||||+++++++......+++|||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 579999988863 56789999987543 344455788999999999999999999999999999999999999999
Q ss_pred HHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCC
Q 016544 238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316 (387)
Q Consensus 238 ~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 316 (387)
.+++... ..+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||++...............+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9998754 45789999999999999999999999 9999999999999999999999999986543222211122234
Q ss_pred CCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 317 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
++.|+|||++.+..++.++|+||||+++|++++ |..||.+.........+....++
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~ 213 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM 213 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 567999999998889999999999999999998 99999988777777777555443
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=254.89 Aligned_cols=204 Identities=29% Similarity=0.506 Sum_probs=171.6
Q ss_pred eecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccC
Q 016544 162 EITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 162 ~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
.||+|+||.|+. .+..+|+|.+...... ...+.+..|+.+++++.||||+++++++.. ...+++|||+.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 589999998752 2268999999865432 445678899999999999999999998764 56899999999
Q ss_pred CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc--
Q 016544 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-- 311 (387)
Q Consensus 234 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-- 311 (387)
+++|.+++.....+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||+++..........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999998778999999999999999999999998 99999999999999999999999999876543322111
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
....++..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+..++.+.+....+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~ 216 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER 216 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc
Confidence 11223467999999998899999999999999999998 9999998887777777766554
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=260.73 Aligned_cols=211 Identities=30% Similarity=0.483 Sum_probs=176.0
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|.....||.|+||.++. ++..+++|.+... .....+.+.+|+.++++++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 455667899999988763 2356899988643 234446788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC
Q 016544 226 MIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~ 289 (387)
++||||+++++|.+++...+ .+++..++.++.|++.||+|||+++ ++|+||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 99999999999999997542 3788899999999999999999999 9999999999999999
Q ss_pred CCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHH
Q 016544 290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 290 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~ 367 (387)
+.++|+|||++........ .......++..|+|||.+.+..++.++|+|||||++|+|+| |..||...+..+..+.+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 9999999999875433211 11222345778999999999899999999999999999999 999998888877777776
Q ss_pred ccCCC
Q 016544 368 ARQRP 372 (387)
Q Consensus 368 ~~~~~ 372 (387)
.+..+
T Consensus 240 ~~~~~ 244 (291)
T cd05094 240 QGRVL 244 (291)
T ss_pred CCCCC
Confidence 65543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=254.42 Aligned_cols=213 Identities=22% Similarity=0.379 Sum_probs=181.8
Q ss_pred cccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||.|+||.++ .++..+++|.+...... ......+.+|+.++++++|+||+++++++.+...++++|||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 6677889999998654 35789999998654433 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++.+. ..+++.++..++.|++.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999865 34889999999999999999999998 99999999999999999999999999876543321
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+....+..+..++.
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 22334578899999999988889999999999999999999999998888888888876654443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=254.49 Aligned_cols=209 Identities=29% Similarity=0.484 Sum_probs=173.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCccc--CCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~ 226 (387)
+|...+.||.|+||.++. +|..||+|.+.... .......+.+.+|+.+++++.||||+++++++.+. ..++
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence 567788999999998863 57899999875322 22334567889999999999999999999988764 4688
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
++|||+++++|.+++.+...+++.....++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 99999999999999988777899999999999999999999999 999999999999999999999999998754321
Q ss_pred CC--CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 307 ED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 307 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
.. .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.+........++.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 222 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA 222 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh
Confidence 11 11222357889999999998889999999999999999999999998765555444443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=256.13 Aligned_cols=210 Identities=26% Similarity=0.492 Sum_probs=175.9
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCC---CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
+|+..+.||.|+|+.++. +|..+|+|.+...... .......+.+|+.++++++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 466778899999998863 6788999988643221 233346688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC-
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE- 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 307 (387)
+||+++++|.+++.+.+.+++..+..++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999999988778899999999999999999999998 9999999999999999999999999987543211
Q ss_pred ----CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 308 ----DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 308 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
........++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 222 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA 222 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh
Confidence 1112234578899999999998899999999999999999999999987665544444433
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=276.21 Aligned_cols=200 Identities=26% Similarity=0.415 Sum_probs=163.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------- 222 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------- 222 (387)
.+|...+.||+|+||.|+. ++..||||++.... ....+|+.+++.++||||+++++++...
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3688889999999998873 57899999885431 2235699999999999999999887432
Q ss_pred -CceEEEEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEe
Q 016544 223 -SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVAD 296 (387)
Q Consensus 223 -~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~D 296 (387)
..+++||||+++ +|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence 246789999965 77777642 355899999999999999999999999 99999999999999665 699999
Q ss_pred ecCccccccCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++.
T Consensus 215 FGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 284 (440)
T PTZ00036 215 FGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284 (440)
T ss_pred cccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99998654322 22234678999999998764 68999999999999999999999999887766655554
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=263.47 Aligned_cols=205 Identities=28% Similarity=0.485 Sum_probs=170.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.|+. ++..||+|.+...... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 577788999999998874 5778999998754322 223456779999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+.+ +|.+++...+ .++...+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 159 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-K 159 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-c
Confidence 9975 8888887654 4788999999999999999999999 9999999999999999999999999987543322 1
Q ss_pred CcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
......+++.|+|||.+.+ ..++.++|+|||||++|+|+||++||.+.+..+....+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 218 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 2223456889999999865 467889999999999999999999999877666655553
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=280.65 Aligned_cols=202 Identities=22% Similarity=0.408 Sum_probs=167.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeE-Eee---C--
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGA-VTQ---S-- 222 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~-~~~---~-- 222 (387)
.+.++.+.|.+|||+.||. .|.+||+|++-. .++...+..++|+.+|++++ |+|||.+++. ... .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3566778899999998884 348999998853 36788899999999999996 9999999993 221 1
Q ss_pred -CceEEEEEccCCCCHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecC
Q 016544 223 -SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (387)
Q Consensus 223 -~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 299 (387)
-.++|.||||.||+|-+++.. ...|++.++++|+.|+++|+.+||... .||||||||.+||||+.+++.||||||.
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 247899999999999999974 345999999999999999999999997 5799999999999999999999999999
Q ss_pred ccccccCCCCCc--------ccCCCCCcccccccc---cCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 300 SKLLTVKEDRPL--------TCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 300 ~~~~~~~~~~~~--------~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
+........... -....|+.|.|||++ .+.+.++|+|||+|||+||.|+....||.+....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l 264 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL 264 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence 864332221111 112368999999986 5678999999999999999999999999976433
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=260.67 Aligned_cols=209 Identities=29% Similarity=0.455 Sum_probs=175.9
Q ss_pred cCcccceeecccEEEEEEE---------------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcce
Q 016544 155 LDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~---------------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 213 (387)
.+|...+.||+|+||.++. .+..||+|.+.... .....+.+.+|+.++++++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3567778999999998874 23568999987543 235567889999999999999999
Q ss_pred eeeeEEeeCCceEEEEEccCCCCHHHHHHHcC-----------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 016544 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (387)
Q Consensus 214 ~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~ 282 (387)
++++++..+...+++||++.+++|.+++.+.. .+++..++.++.|++.||.|||+++ ++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence 99999999999999999999999999998765 6889999999999999999999998 999999999
Q ss_pred CEEeCCCCCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCC
Q 016544 283 NILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHD 359 (387)
Q Consensus 283 Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~pf~~~~~ 359 (387)
||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999875432221 11223345678999999998889999999999999999998 7899988777
Q ss_pred CcHHHHHHc
Q 016544 360 NEVPKAYAA 368 (387)
Q Consensus 360 ~~~~~~i~~ 368 (387)
.+++..+..
T Consensus 240 ~~~~~~~~~ 248 (296)
T cd05051 240 QQVIENAGH 248 (296)
T ss_pred HHHHHHHHh
Confidence 776666644
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=257.69 Aligned_cols=204 Identities=25% Similarity=0.399 Sum_probs=172.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. ++..||+|.++... ......+.+|+.+++.++||||+++++.+...+..+++||
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 577778899999988763 57899999986442 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++...+.+++.++..++.|++.|+.|||+++ ++|+||||+||+++.++.++|+|||++...... ...
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~ 162 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAK 162 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccc
Confidence 9999999999988888999999999999999999999999 999999999999999999999999998655322 122
Q ss_pred cccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.....++..|+|||.+. ...++.++|+|||||++|+|++|..||....+......+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~ 221 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh
Confidence 23346789999999974 446788999999999999999999999876655444443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=272.09 Aligned_cols=194 Identities=25% Similarity=0.357 Sum_probs=167.5
Q ss_pred cCcccceeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 155 LDFTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
.+|...+.||.|+||.||. .+..||+|.+... ....+|+.++++++||||+++++++......++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 3688889999999998873 2467999987643 234579999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
+||++. ++|.+++.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++.......
T Consensus 164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999995 689999977778999999999999999999999999 9999999999999999999999999987654332
Q ss_pred CCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 308 DRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 308 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 293 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCC
Confidence 221 22346899999999999999999999999999999999999999876543
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=258.79 Aligned_cols=214 Identities=28% Similarity=0.456 Sum_probs=177.9
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|.....||.|+||.|+. .+..||+|.+.... .......+.+|+.+++.++||||+++++++......
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 566778999999998862 23679999986442 234456788899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC----------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEE
Q 016544 226 MIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 295 (387)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999997532 2577889999999999999999998 9999999999999999999999
Q ss_pred eecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 296 DFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 296 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
|||+++....... .......++..|+|||.+.+..++.++|+|||||++|++++ |..||.+.+..++.+.+..+..++
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 9999875543221 11222345778999999988889999999999999999998 999999888888888887555444
Q ss_pred C
Q 016544 374 F 374 (387)
Q Consensus 374 ~ 374 (387)
+
T Consensus 242 ~ 242 (277)
T cd05032 242 L 242 (277)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=262.97 Aligned_cols=213 Identities=29% Similarity=0.498 Sum_probs=175.9
Q ss_pred CcccceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC
Q 016544 156 DFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~ 222 (387)
+|...+.||+|+||.|+.. +..+|+|.+.... .......+..|+.+++.+ +||||+++++++...
T Consensus 19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 5788889999999988732 2469999997542 234456788899999999 799999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill 286 (387)
+..+++|||+.+++|.+++.... .+++.+++.++.|++.||+|||+++ ++|+||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 99999999999999999997642 3788899999999999999999998 9999999999999
Q ss_pred CCCCCEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHH
Q 016544 287 DDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK 364 (387)
Q Consensus 287 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~ 364 (387)
+.++.++|+|||++.......... .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..++.+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 999999999999987553221111 112234568999999998889999999999999999998 999998877777777
Q ss_pred HHHccCCCC
Q 016544 365 AYAARQRPP 373 (387)
Q Consensus 365 ~i~~~~~~~ 373 (387)
.+....++.
T Consensus 254 ~~~~~~~~~ 262 (307)
T cd05098 254 LLKEGHRMD 262 (307)
T ss_pred HHHcCCCCC
Confidence 765555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=261.97 Aligned_cols=210 Identities=26% Similarity=0.428 Sum_probs=178.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.+|. ++..||+|.+...........+.+..|+.+++.++||||+++++.+......+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 466778899999998763 478999999987655444566778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999999764 45899999999999999999999998 99999999999999999999999998865432211
Q ss_pred C----------------------------CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 309 R----------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 309 ~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 011235688899999999988999999999999999999999999988777
Q ss_pred cHHHHHHc
Q 016544 361 EVPKAYAA 368 (387)
Q Consensus 361 ~~~~~i~~ 368 (387)
....++..
T Consensus 239 ~~~~~~~~ 246 (316)
T cd05574 239 ETFSNILK 246 (316)
T ss_pred HHHHHHhc
Confidence 66666653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=255.24 Aligned_cols=213 Identities=26% Similarity=0.428 Sum_probs=179.8
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.++ .++..+|+|.+.... .....+.+..|+.+++.++||||+++++.+..++.++++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 35667889999998775 267899999986432 23455678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 99999999988653 34788999999999999999999999 9999999999999999999999999987654321
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.......+++.|+|||++.+..+++++|+||||+++|+|++|..||...+.......+..+..+++
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 220 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL 220 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC
Confidence 122234578889999999998899999999999999999999999998777777777766654443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=256.46 Aligned_cols=209 Identities=32% Similarity=0.486 Sum_probs=173.2
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|+..+.||.|+|+.|+. .+..||+|++..... ..+.+.+|+.++++++||||+++++.+. ....+++|||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 477778899999987763 335799999975432 1256888999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999863 34788999999999999999999998 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
......++..|+|||...+..++.++|+|||||++|+|+| |+.||.+....++..++....++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC
Confidence 2223345678999999988889999999999999999999 99999988777777777655433
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=255.22 Aligned_cols=210 Identities=30% Similarity=0.503 Sum_probs=175.1
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|...+.||.|+||.++. ++..||+|.+...... ...+.+|+.++++++||||+++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred HceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 466678899999998863 6789999998754332 356888999999999999999999874 4578999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+.+++|.+++... ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999998753 34888999999999999999999998 999999999999999999999999998765422222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
......++..|+|||.+.+..++.++|+||||+++|++++ |++||.+.+..++.+.+....+++
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP 223 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC
Confidence 2222345678999999998889999999999999999999 999999888777777776554443
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=256.10 Aligned_cols=205 Identities=27% Similarity=0.457 Sum_probs=165.2
Q ss_pred eecccEEEEEEE----c---CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 162 EITKGTFILAFW----R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 162 ~lg~G~~~~v~~----~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
+||+|+||.|+. . ...+++|.+.... .......+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 589999998863 2 3478888876432 344456788899999999999999999999999999999999999
Q ss_pred CCHHHHHHHcCC-----CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC-
Q 016544 235 GDLRAFLKRKGA-----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED- 308 (387)
Q Consensus 235 ~sL~~~l~~~~~-----l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 308 (387)
++|.+++..... .++.....++.|++.||+|||+++ |+||||||+||+++.++.++|+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999976432 456778899999999999999999 99999999999999999999999999865322111
Q ss_pred CCcccCCCCCcccccccccC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
.......+++.|+|||++.. ..++.++|||||||++|+|++ |..||....+.+...++.....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 227 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD 227 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC
Confidence 11122345678999998743 356789999999999999998 8999998877777766655553
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=254.96 Aligned_cols=210 Identities=31% Similarity=0.528 Sum_probs=174.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCccc--CCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~ 226 (387)
+|...+.||+|+||.++. ++..||+|.+.... .........+.+|+.++++++||||+++++++.+. ..++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence 577788999999987763 57899999875321 12334556789999999999999999999998764 4588
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+++||+++++|.+++.+.+.+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999999999988777899999999999999999999999 999999999999999999999999998754321
Q ss_pred C--CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 307 E--DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 307 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
. ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||.+........++..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 223 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT 223 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc
Confidence 1 1111234578899999999988889999999999999999999999987765555555443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=256.68 Aligned_cols=213 Identities=24% Similarity=0.446 Sum_probs=176.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.++. ++..+|||.+.............+.+|+.+++.++||||+++++++..++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 466677899999987762 688999998876544445556788899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 231 ~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999999864 344889999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--CcHHHHHHccCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEVPKAYAARQRP 372 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~ 372 (387)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+... ....+++.....|
T Consensus 160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 226 (267)
T cd08229 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 226 (267)
T ss_pred Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCC
Confidence 21 12234578899999999988899999999999999999999999976543 2444455444333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=261.19 Aligned_cols=215 Identities=28% Similarity=0.500 Sum_probs=178.4
Q ss_pred ccCcccceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEe
Q 016544 154 ELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT 220 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~ 220 (387)
..+|...+.||.|+||.|+.. +..||+|.+.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 345677789999999988622 3479999987542 234457788999999999 7999999999999
Q ss_pred eCCceEEEEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCE
Q 016544 221 QSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284 (387)
Q Consensus 221 ~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Ni 284 (387)
.....+++|||+.+++|.+++.+.. .+++.++..++.|+++||.|||+++ ++|+||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 9999999999999999999997632 3677888999999999999999999 99999999999
Q ss_pred EeCCCCCEEEEeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcH
Q 016544 285 LRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV 362 (387)
Q Consensus 285 ll~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~ 362 (387)
+++.++.++|+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..++
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 9999999999999998765432221 1222345678999999998889999999999999999998 8999998888888
Q ss_pred HHHHHccCCCC
Q 016544 363 PKAYAARQRPP 373 (387)
Q Consensus 363 ~~~i~~~~~~~ 373 (387)
.+.+....++.
T Consensus 249 ~~~~~~~~~~~ 259 (304)
T cd05101 249 FKLLKEGHRMD 259 (304)
T ss_pred HHHHHcCCcCC
Confidence 88876665443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=259.22 Aligned_cols=200 Identities=30% Similarity=0.459 Sum_probs=172.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.|+. ++..+|+|.+.... .......+.+|++++++++||||+++++++..++.++++||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 477788999999998863 57889999887532 34455678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++++|.+++.+.+.+++..+..++.|+++||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 99999999999988889999999999999999999998 46 999999999999999999999999998654322
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~ 363 (387)
......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 207 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE 207 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH
Confidence 122345788999999998888999999999999999999999999765544433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=257.85 Aligned_cols=192 Identities=29% Similarity=0.479 Sum_probs=164.9
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
||.|+||.||. +|..||+|.+.............+..|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 58889988763 5789999998764433333445667899999999999999999999999999999999999999
Q ss_pred HHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC
Q 016544 238 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 238 ~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
.+++.+.. .+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+..... ........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccccc
Confidence 99998765 5899999999999999999999999 99999999999999999999999999876543 22223345
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
++..|+|||.+.+..++.++|+|||||++|+|++|+.||.....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 67889999999888889999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=255.20 Aligned_cols=211 Identities=33% Similarity=0.511 Sum_probs=175.5
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|+..+.||+|+|+.++. .+..+|+|.+...... .+.+.+|+.++++++||+++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 466778899999988762 4568999998764332 246889999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999999763 34889999999999999999999998 999999999999999999999999998765432222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||.+.+..++...+....+++.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 224 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC 224 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 2222334667999999988889999999999999999999 9999998888888888866544443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=254.67 Aligned_cols=207 Identities=33% Similarity=0.577 Sum_probs=177.7
Q ss_pred eecccEEEEEEE---c-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccC
Q 016544 162 EITKGTFILAFW---R-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 162 ~lg~G~~~~v~~---~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
.||.|+||.++. . +..|++|.+...... ...+.+.+|+.+++.++|+||+++++++......+++|||++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 589999987752 2 778999999765332 256788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHc---------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 234 KGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 234 ~~sL~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
+++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999875 66999999999999999999999998 9999999999999999999999999997665
Q ss_pred cCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 305 VKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 305 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
.... .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..++.+.+..+.++.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP 227 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 4321 11223446788999999998889999999999999999999 699999988888888887655443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=256.27 Aligned_cols=211 Identities=29% Similarity=0.430 Sum_probs=175.1
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||.|+||.++. ++..+++|.+... .....+.+.+|+.+++.+.||||+++++.+......++++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 45567799999998863 4678899988643 344567788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++++|..++.+ ..++++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 999999998765 456899999999999999999999998 9999999999999999999999999986543221 12
Q ss_pred cccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.....+++.|+|||++. +..++.++|+|||||++|+|++|++||...+..+...++.....+.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 228 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC
Confidence 23345788999999984 34577899999999999999999999998777666666655544443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=261.23 Aligned_cols=213 Identities=29% Similarity=0.497 Sum_probs=176.2
Q ss_pred cCcccceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEee
Q 016544 155 LDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~ 221 (387)
.+|...+.||+|+||.|+.. ...+|+|.+.... .......+..|+.+++++ .||||+++++++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 35677889999999988642 3469999987542 234456788899999999 69999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHHc----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEE
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nil 285 (387)
.+.++++|||+.+++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 99999999999999999999753 23788889999999999999999998 999999999999
Q ss_pred eCCCCCEEEEeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHH
Q 016544 286 RDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 363 (387)
Q Consensus 286 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~ 363 (387)
++.++.++|+|||+++........ ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..++.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999998765422111 1112234567999999998889999999999999999999 99999988877778
Q ss_pred HHHHccCCC
Q 016544 364 KAYAARQRP 372 (387)
Q Consensus 364 ~~i~~~~~~ 372 (387)
..+..+..+
T Consensus 247 ~~~~~~~~~ 255 (314)
T cd05099 247 KLLREGHRM 255 (314)
T ss_pred HHHHcCCCC
Confidence 777665543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=256.72 Aligned_cols=213 Identities=31% Similarity=0.490 Sum_probs=180.2
Q ss_pred cCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.+|+..+.||.|+|+.++. .+..+++|.+.... ......+..|+.+++.++||||+++++++......+++||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 3577788999999988763 46889999987542 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+++++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999763 34889999999999999999999999 99999999999999999999999999876543211
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
. .....++..|++||.+.+..++.++|+||||+++|+|++ |+.||.+.+..++...+....+++.
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 225 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC 225 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC
Confidence 1 123345678999999998889999999999999999998 8999998888888888876554443
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=258.72 Aligned_cols=211 Identities=24% Similarity=0.451 Sum_probs=175.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|+..+.||.|+|+.++. ++..|++|.+..... ...+.+.+|+.+++.+.||||+++++.+......++||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 4677788999999988763 578999998875432 23466888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++.+. .+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....... .
T Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~ 171 (296)
T cd06654 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (296)
T ss_pred cccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc-c
Confidence 999999999998753 5789999999999999999999999 9999999999999999999999999887543221 1
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||....+......+.....++
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE 235 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCC
Confidence 1223457889999999999889999999999999999999999998776544433443333333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=256.59 Aligned_cols=213 Identities=29% Similarity=0.446 Sum_probs=174.0
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|...+.||+|+|+.+|. .+..|++|.+... ........+..|+.+++.++|+||+++++++......
T Consensus 7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 566778899999987762 3467999988643 2334456688899999999999999999999988999
Q ss_pred EEEEEccCCCCHHHHHHHcC-------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC---CEEEE
Q 016544 226 MIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVA 295 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~ 295 (387)
+++|||+++++|.+++.+.. .+++..+..++.||+.||+|||+++ ++|+||||+||+++.++ .++|+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 99999999999999997653 3788999999999999999999999 99999999999998654 58999
Q ss_pred eecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 296 DFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 296 Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
|||+++......... ......++.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+...+...+....++.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 999987653221111 111223567999999998899999999999999999997 999999888777777776555433
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=258.37 Aligned_cols=211 Identities=29% Similarity=0.506 Sum_probs=174.1
Q ss_pred cccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 157 FTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
|+..+.||+|+||.+|. ....+++|.+.... .......+.+|+.+++.++||||+++++.+...+..+
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 56677899999998864 12568999887543 2344567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHc------------------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 016544 227 IVTEYLPKGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~ 282 (387)
+++||+.+++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhh
Confidence 999999999999998642 23678889999999999999999998 999999999
Q ss_pred CEEeCCCCCEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 016544 283 NILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDN 360 (387)
Q Consensus 283 Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~ 360 (387)
||+++.++.++|+|||+++......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+..+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999987543222111 122234678999999988889999999999999999998 99999988877
Q ss_pred cHHHHHHccCCC
Q 016544 361 EVPKAYAARQRP 372 (387)
Q Consensus 361 ~~~~~i~~~~~~ 372 (387)
++.+.+....++
T Consensus 237 ~~~~~~~~~~~~ 248 (290)
T cd05045 237 RLFNLLKTGYRM 248 (290)
T ss_pred HHHHHHhCCCCC
Confidence 777776554433
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=259.26 Aligned_cols=211 Identities=33% Similarity=0.515 Sum_probs=172.4
Q ss_pred CcccceeecccEEEEEEE-----cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l 227 (387)
+|+..+.||.|+||.++. ++ ..+++|.++.. ......+.+.+|+.++.++ +||||+++++++...+.+++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 466777899999998763 23 35788887632 2334456788999999999 79999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC
Q 016544 228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 291 (387)
++||+++++|.+++.+.. .+++..+..++.|++.||+|||+++ ++||||||+||+++.++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence 999999999999997542 3778899999999999999999998 999999999999999999
Q ss_pred EEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 292 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
+||+|||++...... ........+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+...+..++..+.
T Consensus 158 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 158 SKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999998642211 11111223557999999998889999999999999999997 999999888777777776554
Q ss_pred CCC
Q 016544 371 RPP 373 (387)
Q Consensus 371 ~~~ 373 (387)
+++
T Consensus 236 ~~~ 238 (297)
T cd05089 236 RME 238 (297)
T ss_pred CCC
Confidence 433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=269.02 Aligned_cols=200 Identities=26% Similarity=0.353 Sum_probs=166.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 223 (387)
.+|...+.||+|+||.|+. .+..||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 3678888999999998863 578999999875432 3344566778999999999999999999886543
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
..+++|||+++ +|.+.+.. .++...+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 47999999965 77777654 3788899999999999999999999 999999999999999999999999998764
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHH
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~ 363 (387)
... .......+|+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+..
T Consensus 170 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 227 (355)
T cd07874 170 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227 (355)
T ss_pred CCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 322 2223346789999999999989999999999999999999999999876644333
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=256.99 Aligned_cols=199 Identities=28% Similarity=0.435 Sum_probs=175.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. ++..||+|.+.+.........+.+.+|+.++++++||||+++++++......++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 366778899999987652 478999999987655555567789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+.+++|.+++....++++.++..++.|++++|.|||+++ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~ 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence 9999999999988778999999999999999999999998 9999999999999999999999999987654332 2
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 2334577889999999988889999999999999999999999998774
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=253.88 Aligned_cols=197 Identities=27% Similarity=0.441 Sum_probs=166.0
Q ss_pred cCcccceeecccEEEEEEEc---------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee-CCc
Q 016544 155 LDFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~ 224 (387)
.+|.....||+|+||.||.. ...+|+|++..+.-.++-+ ....+|+.+++.++||||+.+..+|.. +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 46777888999999999853 3479999998664333333 345669999999999999999999987 788
Q ss_pred eEEEEEccCCCCHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC----CCEEEE
Q 016544 225 MMIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVA 295 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~----~~~kl~ 295 (387)
+++++||.+. +|+.+++- ...++...+..|++||+.|+.|||+++ |+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999975 99999862 234889999999999999999999999 9999999999999987 899999
Q ss_pred eecCccccccCCCC--CcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 296 DFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 296 Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
|||+++.+...-.. .....+.|+.|.|||.+.|. .|+++.|+||.|||+.||+|-++.|.+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 99999988754222 22344568999999999886 688999999999999999999999975
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=252.84 Aligned_cols=207 Identities=30% Similarity=0.453 Sum_probs=175.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.+|.|+|+.++. ++..+++|.+.... ....+.+.+|+.++++++||||+++++++.....++++||
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 567778899999987762 46789999987542 2345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+.+++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 156 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A 156 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence 99999999999876 67999999999999999999999998 9999999999999999999999999987654321 1
Q ss_pred CcccCCCCCcccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 310 PLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||.+.++......+...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~ 219 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS 219 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 12234567889999999876 7889999999999999999999999887766555555444
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=255.09 Aligned_cols=210 Identities=31% Similarity=0.492 Sum_probs=177.1
Q ss_pred cCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.+|...+.||.|+|+.++. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++......+++||
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3567778999999998863 456799999875432 23568889999999999999999999998899999999
Q ss_pred ccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+++++|.+++.... .+++..+..++.|++.|+.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999997643 5889999999999999999999999 99999999999999999999999999876543211
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
........+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.......+++....+
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~ 222 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR 222 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 11122234567999999998889999999999999999998 9999998887778888766543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=252.16 Aligned_cols=209 Identities=31% Similarity=0.528 Sum_probs=174.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--Cce
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~ 225 (387)
.+|...+.||+|+||.++. ++..|++|.+...... .......+.+|+.++++++||||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4678888999999998763 5789999988654322 233456788999999999999999999988753 568
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
++++||+++++|.+++...+.+++...+.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 899999999999999988777999999999999999999999998 99999999999999999999999999875432
Q ss_pred CC--CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 306 KE--DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 306 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.. ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||..........++
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~ 221 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH
Confidence 11 11112345788999999999988999999999999999999999999876655444444
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=254.31 Aligned_cols=203 Identities=29% Similarity=0.576 Sum_probs=171.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCC---CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|+..+.||.|+||.++. ++..||+|.+...... .....+.+..|+.++++++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 366678899999998873 6789999998743321 22345788999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 306 (387)
|+||+++++|.+++.+.+++++..+..++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999999988888999999999999999999999999 99999999999998776 5999999998765432
Q ss_pred CCC---CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 016544 307 EDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (387)
Q Consensus 307 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~ 361 (387)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 215 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 111 1122356889999999988888999999999999999999999997655433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=257.26 Aligned_cols=215 Identities=25% Similarity=0.400 Sum_probs=175.8
Q ss_pred cCcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
.+|+..+.||+|+||.||. .+..||+|.+.... .......+.+|+.++++++||||+++++++.....
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3577778999999998874 13479999886442 23334567889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC----------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEE
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 294 (387)
.+++|||+++|+|.+++.... ..+...+..++.|++.||.|||+++ ++||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997532 2455678889999999999999998 999999999999999999999
Q ss_pred EeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 295 ADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 295 ~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
+|||+++......... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+.+++.+.+..+..+
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999987543322111 112234677999999998889999999999999999998 89999988888887777666544
Q ss_pred CC
Q 016544 373 PF 374 (387)
Q Consensus 373 ~~ 374 (387)
..
T Consensus 241 ~~ 242 (288)
T cd05061 241 DQ 242 (288)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=258.11 Aligned_cols=206 Identities=28% Similarity=0.475 Sum_probs=171.0
Q ss_pred CcccceeecccEEEEEEEc-------------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeee
Q 016544 156 DFTNSVEITKGTFILAFWR-------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~~-------------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~ 216 (387)
+|...+.||+|+||.|+.. ...||+|.++... .......+.+|++++++++||||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 5667788999999988731 2358999987542 344566789999999999999999999
Q ss_pred eEEeeCCceEEEEEccCCCCHHHHHHHcC------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCE
Q 016544 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284 (387)
Q Consensus 217 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Ni 284 (387)
+++......++||||+.+++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999986532 3677888999999999999999999 99999999999
Q ss_pred EeCCCCCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCCCc
Q 016544 285 LRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHDNE 361 (387)
Q Consensus 285 ll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~pf~~~~~~~ 361 (387)
+++.++.+||+|||++........ .......++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999875432211 11122234678999999998889999999999999999987 788999877766
Q ss_pred HHHHH
Q 016544 362 VPKAY 366 (387)
Q Consensus 362 ~~~~i 366 (387)
+...+
T Consensus 241 ~~~~~ 245 (295)
T cd05097 241 VIENT 245 (295)
T ss_pred HHHHH
Confidence 66554
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=258.34 Aligned_cols=213 Identities=24% Similarity=0.469 Sum_probs=178.1
Q ss_pred cccCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
....|+..+.||.|+|+.++ .+|+.|++|.+..... ...+.+.+|+.+++.++||||+++++++.....+++
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 33467888899999998876 3678999998864422 234668889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|+||+.+++|.+++... .+++.++..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 94 VMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999999999988764 5899999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
. ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.++......+.....+.
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T cd06655 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE 234 (296)
T ss_pred c-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc
Confidence 2 1222357789999999998889999999999999999999999998877655555554444333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=252.49 Aligned_cols=205 Identities=35% Similarity=0.617 Sum_probs=176.3
Q ss_pred CcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEcc
Q 016544 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 232 (387)
+|...+.||.|+||.|+ ..|+.||+|.+..... ..+++.+|+.+++.++|+||+++++++......+++|||+
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hccceeeeecCCCceEEEEEecCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 55667789999998876 4789999999975422 4567889999999999999999999999889999999999
Q ss_pred CCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 233 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 233 ~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999998765 5899999999999999999999999 99999999999999999999999999876532211
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
....+..|+|||.+.+..++.++|+||||+++|++++ |..||...+..++...+..+.+
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 217 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR 217 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Confidence 2234567999999998889999999999999999997 9999998877777776655443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=256.05 Aligned_cols=213 Identities=24% Similarity=0.481 Sum_probs=175.0
Q ss_pred CcccceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
+|...+.||.|+||.+|. +|. .||+|.+.... .....+.+..|..+++.++||||+++++++.. ...+
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 566678899999998863 343 48999987542 34455678899999999999999999999875 4578
Q ss_pred EEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
+++||+++|+|.+++... +.+++.++..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999764 45899999999999999999999999 99999999999999999999999999876643
Q ss_pred CCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 306 KEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 306 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
..... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.......+...+..+..++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ 232 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC
Confidence 22111 112234678999999998889999999999999999998 9999988777767776666554443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=254.05 Aligned_cols=213 Identities=25% Similarity=0.475 Sum_probs=176.2
Q ss_pred CcccceeecccEEEEEEEc--------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|+..+.||.|+||.++.. ...|++|...... .....+.+.+|+.+++++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4667789999999988631 2368999886442 24456788999999999999999999998875 55789
Q ss_pred EEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+|||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999998754 4899999999999999999999998 999999999999999999999999998765433
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.........+++.|+|||.+.+..++.++|+||||+++|++++ |+.||.+.+..+....+..+.+++.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 229 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM 229 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 2222222234567999999988889999999999999999986 9999998888888888776665543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=255.93 Aligned_cols=212 Identities=27% Similarity=0.411 Sum_probs=176.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|+..+.||.|+||.++. ++..+++|.+... .....+.+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 477778899999998873 5789999998643 44556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++++|..++.+ ...+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||++...... ..
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~ 165 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQ 165 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-cc
Confidence 9999999988765 455899999999999999999999998 999999999999999999999999987653322 11
Q ss_pred CcccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......+++.|+|||.+. ...++.++|+|||||++|+|++|+.||...+..+...++.....|.+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 235 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccC
Confidence 122345678899999985 34567899999999999999999999988776666666654444433
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=241.46 Aligned_cols=201 Identities=24% Similarity=0.408 Sum_probs=168.7
Q ss_pred ccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC----
Q 016544 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS---- 222 (387)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~---- 222 (387)
..+..|++.+.+|.|||..|+. ++..+|+|++.-. ..+..+...+|++..++++||||++++++...+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 3455799999999999987763 6789999998744 345667788999999999999999999877544
Q ss_pred -CceEEEEEccCCCCHHHHHHHc---C-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 223 -SPMMIVTEYLPKGDLRAFLKRK---G-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 223 -~~~~lv~e~~~~~sL~~~l~~~---~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
...|++++|...|||.+.+.+. + .+++.+.+.|+.++++||.+||+..| ++.||||||.|||+.+.+.++|.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEec
Confidence 3499999999999999999752 3 49999999999999999999999985 6999999999999999999999999
Q ss_pred cCccccccCCC--------CCcccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 298 GVSKLLTVKED--------RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 298 g~~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
|++........ +.+....+|..|.|||.+. +...+.++|||||||++|+|+.|..||..
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 99865432211 1123456899999999985 44678899999999999999999999963
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=254.29 Aligned_cols=210 Identities=31% Similarity=0.527 Sum_probs=174.8
Q ss_pred cccceeecccEEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
|...+.||+|+||.++. ++ ..||+|.+.... .......+..|+.+++.++||||+++++++..+...+++
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 55677899999988763 22 369999987542 355567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|||+++++|.+++... +.+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999764 45899999999999999999999998 9999999999999999999999999987654322
Q ss_pred CCCc-cc-C--CCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 308 DRPL-TC-Q--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 308 ~~~~-~~-~--~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
.... .. . ..+..|+|||.+.+..++.++|+|||||++||+++ |..||.+.+..++...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~ 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 2111 11 1 12457999999999899999999999999999986 9999998887777777755443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=253.25 Aligned_cols=210 Identities=32% Similarity=0.497 Sum_probs=172.9
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|.....||.|+|+.++. .+..+|+|.+..... ..+.+.+|+.++++++|||++++++++. ....+++|||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 366677899999988763 335799998865432 2356788999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999997643 3788999999999999999999998 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
......++..|+|||...+..++.++|+||||+++|+|++ |+.||.+..+.+...++.....++
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP 223 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 2222345678999999998889999999999999999999 999999888777777776654443
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=262.27 Aligned_cols=203 Identities=31% Similarity=0.508 Sum_probs=166.8
Q ss_pred CcccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC-C
Q 016544 156 DFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-S 223 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~-~ 223 (387)
+|...+.||.|+||.||.. ++.||+|++.... .....+.+..|+.+++++ +||||+++++++... .
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 4677789999999998742 3689999987542 233456678899999999 799999999988654 5
Q ss_pred ceEEEEEccCCCCHHHHHHHc-----------------------------------------------------------
Q 016544 224 PMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------- 244 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~----------------------------------------------------------- 244 (387)
.++++|||+++++|.+++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999998642
Q ss_pred --CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC-CCcccCCCCCccc
Q 016544 245 --GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYV 321 (387)
Q Consensus 245 --~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~ 321 (387)
.++++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++........ .......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 25788889999999999999999998 99999999999999999999999999976532221 1112234567899
Q ss_pred ccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHH
Q 016544 322 APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 363 (387)
Q Consensus 322 aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~ 363 (387)
|||++.+..++.++|||||||++|+|++ |..||.+....+..
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~ 285 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF 285 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH
Confidence 9999999999999999999999999997 99999876554443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=255.09 Aligned_cols=212 Identities=30% Similarity=0.457 Sum_probs=179.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. ++..||+|.+.... .......+.+|+.+++.++||||+++++++..+..+++++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 456667899999988763 57899999987542 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++... ++++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 154 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-K 154 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-c
Confidence 99999999999875 6899999999999999999999998 99999999999999999999999999877654321 2
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.....+++.|+|||.+.+..++.++|+||||+++|+|+||+.||...++......+.....|.+
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 218 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSL 218 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCC
Confidence 2234567889999999998899999999999999999999999988776666666655544443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=260.61 Aligned_cols=207 Identities=32% Similarity=0.537 Sum_probs=170.4
Q ss_pred CcccceeecccEEEEEEE-----cCe--EEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l 227 (387)
+|...+.||+|+||.|+. ++. .+++|.+... ........+.+|+.++.++ +||||+++++++..++.+++
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 456677899999998763 333 4677776532 2344567788999999999 89999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC
Q 016544 228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 291 (387)
+|||+++++|.+++.+.+ .+++.+++.++.|++.||+|||+++ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999997542 3678899999999999999999998 999999999999999999
Q ss_pred EEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHcc
Q 016544 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 292 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 369 (387)
++|+|||++....... .......+..|+|||.+.+..++.++|||||||++|+|+| |..||.+.+..+..+.+...
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 9999999986432111 1111223567999999988888999999999999999998 99999988777777766444
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=254.09 Aligned_cols=213 Identities=25% Similarity=0.468 Sum_probs=173.3
Q ss_pred CcccceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
+|...+.||.|+|+.+|. ++. .+++|.+... .......++..|+..+.++.||||+++++++.. ...+
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~ 84 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ 84 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence 456667899999998863 343 5888887533 223445677888889999999999999998764 5578
Q ss_pred EEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
+++||+++|+|.+++... +.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 899999999999999764 45899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 306 KED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 306 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
... .......++..|+|||.+.+..++.++|+|||||++||+++ |..||.+.....+.+.+..+.+++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 232 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ 232 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC
Confidence 221 11223446678999999998889999999999999999998 9999998877766666665555443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=259.12 Aligned_cols=212 Identities=24% Similarity=0.454 Sum_probs=176.8
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|+..+.||.|+||.++. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++......++||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 4678888999999988762 688999999865432 23466788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++.+. .+++.++..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 96 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~ 170 (297)
T cd06656 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 170 (297)
T ss_pred cccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc-c
Confidence 999999999998754 4788999999999999999999998 9999999999999999999999999987643322 1
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......+++.|+|||.+.+..++.++|+|||||++|++++|..||.+.++......+...+.|+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~ 235 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCC
Confidence 12234578889999999998899999999999999999999999987665544444444444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=252.26 Aligned_cols=214 Identities=29% Similarity=0.476 Sum_probs=180.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+..+.||.|+||.++. ++..+++|.+...... ...+.+.+|+.+++.++|+||+++++.+......++++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 567788899999987762 5678999998754332 255778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
++++++|.+++... +.+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999999764 34899999999999999999999999 9999999999999999999999999987655432
Q ss_pred CC---CcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 308 DR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 308 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.. ......++..|+|||++... .++.++|+|||||++|+|++|+.||...+......++.....+.+
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSL 227 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCc
Confidence 22 12233578899999998876 788999999999999999999999998887777777665554444
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=252.43 Aligned_cols=202 Identities=28% Similarity=0.431 Sum_probs=168.7
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHH-HcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
+.||.|+||.++. +|+.||+|.+.............+..|..++ ....|||++++++++.....+++++||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 3588999988763 5789999998754332233333445555544 445899999999999999999999999999
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccC
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 314 (387)
++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~ 153 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF 153 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence 999999998888999999999999999999999998 99999999999999999999999998875432 1223
Q ss_pred CCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.+++.|++||.+.+..++.++|+||||+++|+|++|..||...+...+...+..+.
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 209 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR 209 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc
Confidence 46788999999988888999999999999999999999999888777777765544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=256.31 Aligned_cols=213 Identities=26% Similarity=0.392 Sum_probs=178.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. ++..||+|.+... .....+.+..|+.++++++||||+++++.+......++|||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 467778899999987753 4789999998633 44556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++++|.+++... ..+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 99999999998764 45899999999999999999999999 9999999999999999999999999876543221 1
Q ss_pred CcccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 375 (387)
......+++.|+|||.+. ...++.++|+||||+++|+|++|+.||...+..+...++.....|.+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 229 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLD 229 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcC
Confidence 222345788999999975 335677999999999999999999999988877777777666555443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=253.55 Aligned_cols=214 Identities=26% Similarity=0.430 Sum_probs=174.7
Q ss_pred cccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc----
Q 016544 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 224 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~---- 224 (387)
|...+.||+|+||.|+. .+..||+|.+..... .......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 34567899999998863 136799999875432 34456778999999999999999999998865543
Q ss_pred --eEEEEEccCCCCHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEe
Q 016544 225 --MMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (387)
Q Consensus 225 --~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 296 (387)
.++++||+++++|..++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECC
Confidence 79999999999999998542 24788899999999999999999998 99999999999999999999999
Q ss_pred ecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 297 FGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 297 fg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
||+++......... ......+..|+|||.+.+..++.++|||||||++|||++ |..||.+..+.++.+.+..+..+..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99987654332211 112234668999999988889999999999999999999 9999998888888887766654443
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=252.28 Aligned_cols=203 Identities=32% Similarity=0.573 Sum_probs=170.3
Q ss_pred CcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEe-eCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~~lv~e~ 231 (387)
+|...+.||+|+|+.++ ..|..||+|.+... ...+.+.+|+.++++++|++++++++++. .....++++||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 46667789999998765 57889999988643 22456889999999999999999999764 45678999999
Q ss_pred cCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++.+.. .+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999998644 3788999999999999999999998 9999999999999999999999999987543221
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....+..|+|||++.+..++.++|+|||||++|+|++ |+.||......++...+..+.
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~ 216 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 216 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC
Confidence 12234567999999998889999999999999999997 999999877777777765543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=252.02 Aligned_cols=207 Identities=29% Similarity=0.479 Sum_probs=173.8
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|...+.||+|+|+.++. .+..+++|.+... ....+.+.+|+.++++++|+||+++++.+.. ...+++|||
T Consensus 7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 567778999999998873 4567999988643 2345678899999999999999999999887 778999999
Q ss_pred cCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999763 34778889999999999999999998 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
......++..|+|||.+.+..++.++|+|||||++|++++ |+.||.+.+...+...+..+.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~ 220 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 220 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Confidence 2223345677999999998889999999999999999998 999999888777777765543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=273.81 Aligned_cols=202 Identities=20% Similarity=0.270 Sum_probs=164.7
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCC------CcceeeeeEEee
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH------PNVVQFLGAVTQ 221 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~l~~~~~~ 221 (387)
...+|...+.||+|+||.|+. .+..||||++... ......+..|+.+++.+.| ++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 345688889999999999874 4788999998642 1223445567777776654 458889998876
Q ss_pred C-CceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCC---------
Q 016544 222 S-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSG--------- 290 (387)
Q Consensus 222 ~-~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~--------- 290 (387)
+ ..+++|||++ +++|.+++.+.+.+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccc
Confidence 5 4688999988 77999999888889999999999999999999998 47 99999999999998765
Q ss_pred -------CEEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHH
Q 016544 291 -------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363 (387)
Q Consensus 291 -------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~ 363 (387)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred ccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 49999999875422 2223456899999999999999999999999999999999999999987766555
Q ss_pred HHH
Q 016544 364 KAY 366 (387)
Q Consensus 364 ~~i 366 (387)
..+
T Consensus 355 ~~i 357 (467)
T PTZ00284 355 HLM 357 (467)
T ss_pred HHH
Confidence 544
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=282.99 Aligned_cols=203 Identities=22% Similarity=0.397 Sum_probs=166.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI 227 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~l 227 (387)
.+|.+.+.||.|+||.|+. .+..||+|.+..... .......+..|+.++++++||||++++++|... ..+|+
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 3688889999999998873 567899999875543 334456788999999999999999999988653 56899
Q ss_pred EEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCC----CCeEeCCCCCCCEEeCC-----------
Q 016544 228 VTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP----VPIIHRDLEPSNILRDD----------- 288 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~----~~iiH~Dlkp~Nill~~----------- 288 (387)
||||+++++|.+++.. .+.+++..++.|+.||+.||.|||+.++ .+|+|+||||+|||++.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 9999999999999875 2468999999999999999999998541 23999999999999964
Q ss_pred ------CCCEEEEeecCccccccCCCCCcccCCCCCcccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 289 ------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 289 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
.+.+||+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|+||..||...+..
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 234899999998765422 12233468999999999865 35789999999999999999999999865543
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=252.57 Aligned_cols=213 Identities=31% Similarity=0.523 Sum_probs=177.6
Q ss_pred CcccceeecccEEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|+..+.||+|+||.+|. ++ ..+++|.+.... .....+.+..|+.++++++||||+++.+++...+..++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 566678899999988762 22 379999986542 23445678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+|||+++++|.+++... +.+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999764 56899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCcc--cCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 307 EDRPLT--CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 307 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
...... ....++.|+|||.+.+..++.++|+|||||++|+|++ |+.||...+..++...+....+++
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~ 230 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP 230 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC
Confidence 221111 1223457999999998889999999999999999997 999998888888888887655443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=272.04 Aligned_cols=206 Identities=28% Similarity=0.462 Sum_probs=170.9
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------ce
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------PM 225 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------~~ 225 (387)
|...+.||+|+||.|+. +|..||||.+++.. .....+..-+|++++++++|||||+++++-+... ..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 33456799999998873 68999999998754 3455677889999999999999999998765443 46
Q ss_pred EEEEEccCCCCHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC--CCCC--EEEEeec
Q 016544 226 MIVTEYLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGN--LKVADFG 298 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~--~~~~--~kl~Dfg 298 (387)
.++||||.||||...+.+. ..+++.+.+.++.+++.||.|||+++ |+||||||.||++- .+|. -||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 8999999999999999753 34999999999999999999999999 99999999999975 3333 6999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC----CCcHHHHHHcc
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKH----DNEVPKAYAAR 369 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~----~~~~~~~i~~~ 369 (387)
.|+.... .....+..||..|++||.+.. ..|+..+|.|||||++|++.||..||.... ..++...+...
T Consensus 170 ~Arel~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk 243 (732)
T KOG4250|consen 170 AARELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK 243 (732)
T ss_pred ccccCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence 9987653 346677889999999999984 788999999999999999999999996422 33355555433
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=252.07 Aligned_cols=201 Identities=27% Similarity=0.435 Sum_probs=172.5
Q ss_pred ecccEEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 163 ITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 163 lg~G~~~~v~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
||.|+|+.++ . ++..||+|.+...........+.+.+|+.++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 5777777654 3 3789999999766554455567899999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCC
Q 016544 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317 (387)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 317 (387)
.+++.+...++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~ 155 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT 155 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence 999988777899999999999999999999998 9999999999999999999999999987654332 12223568
Q ss_pred CcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC--CCcHHHHHHc
Q 016544 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH--DNEVPKAYAA 368 (387)
Q Consensus 318 ~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~--~~~~~~~i~~ 368 (387)
+.|++||.+.+..++.++|+||||+++|+|++|..||.... ...+..++..
T Consensus 156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 208 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK 208 (262)
T ss_pred cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc
Confidence 88999999988889999999999999999999999998766 4555666653
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=251.39 Aligned_cols=214 Identities=24% Similarity=0.439 Sum_probs=181.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+..+.||.|+||.++. +|..||+|.+...... .....++.+|+.++++++||||+++++++...+..++++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 366778999999987764 6789999998754332 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+.+++|.+++.... .+++.++..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~- 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV- 155 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch-
Confidence 999999999997643 4788999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.......+++.|+|||++.+..++.++|+|||||++|+|++|+.||......+...++..+..++.
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 221 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV 221 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC
Confidence 111223467889999999998899999999999999999999999988777777777777665544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=253.61 Aligned_cols=191 Identities=25% Similarity=0.417 Sum_probs=158.0
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHc---CCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK---IRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~---l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
||+|+||.||. ++..+|+|.+.+...........+.+|..+++. ..||+|+.+++.+...+..++||||+++
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence 78999998873 578999999876544333222333445444433 4799999999999999999999999999
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccC
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 314 (387)
++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ....
T Consensus 82 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 155 (279)
T cd05633 82 GDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (279)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCc
Confidence 999999988888999999999999999999999999 9999999999999999999999999986543221 1224
Q ss_pred CCCCccccccccc-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 315 DTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 315 ~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
.+++.|+|||.+. +..++.++|+|||||++|+|++|+.||.....
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 5789999999986 45688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=253.51 Aligned_cols=210 Identities=30% Similarity=0.485 Sum_probs=177.1
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|.....||.|+||.++. ....|++|.+... ......+.+.+|+.++++++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 566778899999998863 2457999988643 2334567789999999999999999999999998999
Q ss_pred EEEEEccCCCCHHHHHHHcC---------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEe
Q 016544 226 MIVTEYLPKGDLRAFLKRKG---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~---------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 296 (387)
+++|||+++++|.+++.... .+++..+..++.|++.+|.|||+.+ |+|+||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999998655 6899999999999999999999999 99999999999999999999999
Q ss_pred ecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
||++...............++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.....+...+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~ 235 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGK 235 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCC
Confidence 99986543222222233345677999999988888999999999999999998 899999887777777775444
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=255.73 Aligned_cols=200 Identities=25% Similarity=0.413 Sum_probs=168.2
Q ss_pred cccceeecccEEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceE
Q 016544 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~ 226 (387)
|+..+.||.|+||.++. +|..||+|.+...... .....+.+..|+.+++++ +|++|+++++++..+..++
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 56677899999997762 6789999998754321 223346678899999999 5999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+|+||+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 99999999999999988888999999999999999999999998 999999999999999999999999998765433
Q ss_pred CCCCcccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
.........++..|+|||.+.+. .++.++|+||||+++|+|++|..||.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 213 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc
Confidence 22222334578899999998753 467889999999999999999999975433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=250.25 Aligned_cols=215 Identities=26% Similarity=0.462 Sum_probs=177.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. +|..||+|.++..........+.+.+|+.++++++|++|+++++++...+..+++||
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 567778899999987762 588999999875444445556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 231 ~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|+++++|.+++.. ...+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 9999999999864 234788999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--CcHHHHHHccCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEVPKAYAARQRPPF 374 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~--~~~~~~i~~~~~~~~ 374 (387)
.. ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||..... .++.+.+..+..++.
T Consensus 160 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (267)
T cd08224 160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL 228 (267)
T ss_pred Cc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCC
Confidence 21 12223567889999999998899999999999999999999999965432 234444444444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=255.84 Aligned_cols=212 Identities=31% Similarity=0.490 Sum_probs=176.3
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|.....||.|+||.++. .+..||+|.+.... .......+.+|+.+++++.||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 566778899999988764 45789999987542 344456788999999999999999999999998999
Q ss_pred EEEEEccCCCCHHHHHHHcC----------------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 016544 226 MIVTEYLPKGDLRAFLKRKG----------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~----------------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~N 283 (387)
++++||+.+++|.+++.... .+++.+++.++.|++.||.|||+++ ++|+||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999997432 2677888999999999999999998 9999999999
Q ss_pred EEeCCCCCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 016544 284 ILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNE 361 (387)
Q Consensus 284 ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~ 361 (387)
|+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875432211 11112234667999999998899999999999999999997 999999888888
Q ss_pred HHHHHHccCCC
Q 016544 362 VPKAYAARQRP 372 (387)
Q Consensus 362 ~~~~i~~~~~~ 372 (387)
+...+..+..+
T Consensus 241 ~~~~~~~~~~~ 251 (288)
T cd05050 241 VIYYVRDGNVL 251 (288)
T ss_pred HHHHHhcCCCC
Confidence 88877665543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=256.06 Aligned_cols=203 Identities=27% Similarity=0.474 Sum_probs=169.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+..+.||.|+||.++. .|..||+|.+.... .......+.+|+.++++++||||+++++.+...+.+++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 456677899999988753 57899999886432 34445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 231 ~~~~~sL~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|+++++|.+++... ..+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999998763 3589999999999999999999974 6 999999999999999999999999998654322
Q ss_pred CCCCcccCCCCCcccccccccCCC------CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
......+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...........+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 219 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL 219 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH
Confidence 122234678899999986543 478999999999999999999999876655554443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=250.05 Aligned_cols=213 Identities=27% Similarity=0.404 Sum_probs=176.1
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee-CCceEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~~~lv~ 229 (387)
+|...+.||.|+++.++ .+++.||+|.+..... .....+.+.+|+.++++++|||++++++.+.. +..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 36677889999998776 2567899999865433 23445678889999999999999999998764 44689999
Q ss_pred EccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 230 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||+++++|.+++... ..+++.++..++.|++.++.+||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999999763 34899999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+..+..|+
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 221 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP 221 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 22233457889999999999889999999999999999999999998777666666665555444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=253.08 Aligned_cols=195 Identities=28% Similarity=0.507 Sum_probs=163.2
Q ss_pred cccceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--Cce
Q 016544 157 FTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM 225 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~ 225 (387)
|...+.||+|+||.|+. ++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 36677899999998842 46789999987542 233456788899999999999999999988653 358
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
+++|||+.+++|.+++... .+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999999999764 4899999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCC--CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 306 KEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 306 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
.... ......++..|+|||.+.+..++.++||||||+++|+|+||..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 2211 112233466799999999888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=253.17 Aligned_cols=212 Identities=27% Similarity=0.444 Sum_probs=171.8
Q ss_pred ccceeecccEEEEEEE-----cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC------Cc
Q 016544 158 TNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 224 (387)
Q Consensus 158 ~~~~~lg~G~~~~v~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~~ 224 (387)
...+.||+|+||.|+. .+ ..+|+|.+.... ......+.+..|+.+++.++||||+++++++... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3456899999998873 22 269999887543 2445567889999999999999999999977432 24
Q ss_pred eEEEEEccCCCCHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeec
Q 016544 225 MMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 298 (387)
.+++|||+++++|.+++... ..+++.....++.|++.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 78999999999999988421 23788999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 299 VSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 299 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
++......... .......++.|++||.+.+..+++++|+|||||++|+|++ |+.||.+....++...+..+.+++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK 234 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 98765432211 1122235678999999999899999999999999999999 899999888777888777665443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=257.87 Aligned_cols=205 Identities=18% Similarity=0.341 Sum_probs=165.2
Q ss_pred eeeccc--EEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccC
Q 016544 161 VEITKG--TFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 161 ~~lg~G--~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
..||+| +|+.|+ .+|..||+|.+..... .....+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 468888 555554 3678999999875533 23455678889999999999999999999999999999999999
Q ss_pred CCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC--
Q 016544 234 KGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-- 309 (387)
Q Consensus 234 ~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 309 (387)
+++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++++||+...........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 99999999753 34889999999999999999999999 999999999999999999999999865432211110
Q ss_pred ----CcccCCCCCcccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 310 ----PLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 310 ----~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||..............+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 225 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 225 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC
Confidence 0112245677999999976 46889999999999999999999999877665554444333
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=271.85 Aligned_cols=214 Identities=25% Similarity=0.394 Sum_probs=185.1
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|.+..+||.|.||.||. .+...|.|++. ..+++..+.|.-|+.||....||+||++++.|..++.++++.||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 45566899999999984 23456667764 35678889999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|.||....++-+- ..+++.++..+++|++.||.|||+++ |||||||..|||++-+|.++|+|||.+.... .....
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qk 186 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQK 186 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch-hHHhh
Confidence 9999999888764 45999999999999999999999999 9999999999999999999999999875422 22333
Q ss_pred cccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 377 (387)
...+.|||.|||||+.. ..+|+.++||||||+++.||..+.+|....++..++-+|..-..|.+--|
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqP 258 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQP 258 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCc
Confidence 45678999999999874 45889999999999999999999999999999999999988877777554
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=249.71 Aligned_cols=212 Identities=34% Similarity=0.589 Sum_probs=178.4
Q ss_pred ccceeecccEEEEEEE---c------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 158 TNSVEITKGTFILAFW---R------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 158 ~~~~~lg~G~~~~v~~---~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
+..+.||.|+||.++. . +..||+|.+.... .....+.+..|+.+++.++|+||+++++++...+..+++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3456799999987752 2 3789999997543 223567889999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 229 TEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|||+++++|.+++..... +++.++..++.|++.||++||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999986544 899999999999999999999998 999999999999999999999999998765543
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.........+++.|+|||.+.+..++.++|+||||+++|+|++ |++||...+...+.+.+.....++.
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 225 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK 225 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 2222212336788999999988889999999999999999998 8999998887778888776665443
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=266.17 Aligned_cols=210 Identities=25% Similarity=0.400 Sum_probs=181.4
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||-|.||.|.. +...+|+|.+.+...-....+...+.|..||.....+.||+||..|++.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 66677899999998753 3467999998876655566677788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc-------
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT------- 304 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~------- 304 (387)
++||++-.+|-+.+-+.+..+..++.++..|+++.|..| +|||||||+|||||.+|++||.|||++.-+.
T Consensus 711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 999999999999999999999999999999999999999 9999999999999999999999999874221
Q ss_pred --cCCC----CC----------------------------cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcC
Q 016544 305 --VKED----RP----------------------------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350 (387)
Q Consensus 305 --~~~~----~~----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg 350 (387)
.++. .. ....+||+.|+|||++....++..+|+||.|||||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 1100 00 0125699999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcHHHHHHcc
Q 016544 351 CPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~ 369 (387)
++||...++.+...+|.+=
T Consensus 868 ~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINW 886 (1034)
T ss_pred CCCccCCCCCcceeeeeeh
Confidence 9999998888877766443
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=252.87 Aligned_cols=210 Identities=29% Similarity=0.480 Sum_probs=176.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|+..+.||.|+||.++. ++..||+|.+.... .......+.+|+.+++++.||||+++++++.++...++|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 355667899999988763 57899999987542 23445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++.. +++++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence 9999999999875 46889999999999999999999998 99999999999999999999999999876543221 2
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
.....++..|+|||.+.+..++.++|+|||||++|+|++|..||...++......+.....|
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 219 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPP 219 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCC
Confidence 22335678899999999888999999999999999999999999987776666655444333
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=255.68 Aligned_cols=206 Identities=28% Similarity=0.459 Sum_probs=171.5
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 224 (387)
+|...+.||.|+||.|+. .+..||+|.++... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 577778999999998753 23579999987542 234456789999999999 79999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
.+++|||+.+++|.+++.+... +++.+...++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 9999999999999999976432 889999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHH
Q 016544 303 LTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 303 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i 366 (387)
....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+........+.
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~ 256 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL 256 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH
Confidence 5432211 1112345678999999999889999999999999999998 99999876655444333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=249.37 Aligned_cols=215 Identities=26% Similarity=0.479 Sum_probs=177.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. ++..|++|.+...... ....+.+..|+.+++.++|+||+++++.+.....+++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 366778899999987753 5789999998765433 4567889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++.....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999999988777889999999999999999999999 9999999999999999999999999987654332221
Q ss_pred c---ccCCCCCcccccccccCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCCC-cHHHHHHccCCCCC
Q 016544 311 L---TCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPF 374 (387)
Q Consensus 311 ~---~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~ 374 (387)
. ....+++.|+|||.+.+.. ++.++|+||||+++|++++|..||...... .....+.....+.+
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 227 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPI 227 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCC
Confidence 1 1245678999999998766 788999999999999999999999866433 33333444334444
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=250.19 Aligned_cols=204 Identities=32% Similarity=0.580 Sum_probs=172.0
Q ss_pred CcccceeecccEEEEEEE---cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEcc
Q 016544 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 232 (387)
+|+..+.||+|+||.++. .+..||+|.+.... ..+.+.+|+.++++++||||+++++++..+ ..+++|||+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HceeeeeeccCCCCceEecccCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 467778999999988764 77899999986432 235788899999999999999999998764 479999999
Q ss_pred CCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 233 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 233 ~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
.+++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 9999999997653 3788899999999999999999998 999999999999999999999999998654321
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
......+..|+|||.+.+..++.++|+|||||++|+|++ |+.||...+..+....+..+.++
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 216 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM 216 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC
Confidence 112234567999999998889999999999999999997 99999988877777777665443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=260.37 Aligned_cols=221 Identities=30% Similarity=0.521 Sum_probs=180.0
Q ss_pred CccccCccccCcccceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcc
Q 016544 146 PEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNV 212 (387)
Q Consensus 146 ~~~ei~~~~~~~~~~~~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i 212 (387)
+.|++.. .+|+..+.||+|+||.++.. +..||+|.+... ......+.+.+|+.+++++ +||||
T Consensus 5 ~~~~~~~--~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i 80 (334)
T cd05100 5 PKWELSR--TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNI 80 (334)
T ss_pred cccccCH--hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCe
Confidence 4455543 35778889999999887621 236899988743 2344567788999999999 79999
Q ss_pred eeeeeEEeeCCceEEEEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 016544 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276 (387)
Q Consensus 213 v~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 276 (387)
+++++++...+.+++++||+.+++|.+++.+.. .+++.++..++.|++.||.|||+++ ++|
T Consensus 81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH 157 (334)
T cd05100 81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH 157 (334)
T ss_pred eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 999999999999999999999999999997532 3677888999999999999999999 999
Q ss_pred CCCCCCCEEeCCCCCEEEEeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 016544 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF 354 (387)
Q Consensus 277 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf 354 (387)
|||||+||+++.++.++|+|||+++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus 158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred cccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999998765432111 1122234567999999999899999999999999999998 99999
Q ss_pred CCCCCCcHHHHHHccCCCC
Q 016544 355 TMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~ 373 (387)
.+.+..++...+.....++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~ 256 (334)
T cd05100 238 PGIPVEELFKLLKEGHRMD 256 (334)
T ss_pred CCCCHHHHHHHHHcCCCCC
Confidence 9888788877776655443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=254.05 Aligned_cols=196 Identities=32% Similarity=0.593 Sum_probs=169.5
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||+|+||.|+. ++..||+|.+...... .........|+.++++++||||+++++++......+++||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhccccccccccccccccccccccccccccc
Confidence 45678899999999874 5678999999865332 22223345699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
+.+++|.+++.....++..++..++.|+++||.+||+++ ++|+||||+||+++.++.++|+|||.+.... ......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~ 155 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENF 155 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEB
T ss_pred ccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccccc
Confidence 999999999997788999999999999999999999999 9999999999999999999999999987542 122333
Q ss_pred ccCCCCCccccccccc-CCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 312 TCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
....++..|+|||++. +..++.++|+||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4456788999999998 788899999999999999999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=256.62 Aligned_cols=214 Identities=29% Similarity=0.497 Sum_probs=176.6
Q ss_pred cCcccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCC
Q 016544 155 LDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 223 (387)
.+|...+.||+|+||.|+.. ...+|+|.+.... .......+.+|+.+++++ +||||+++++++..++
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 35667788999999887632 2579999987542 234456788999999999 7999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHc----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC
Q 016544 224 PMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~ 287 (387)
.++++|||+++++|.+++.+. ..+++..+..++.|++.||.|||+++ |+|+||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999999642 34788899999999999999999998 99999999999999
Q ss_pred CCCCEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHH
Q 016544 288 DSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKA 365 (387)
Q Consensus 288 ~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~ 365 (387)
.++.++|+|||+++......... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....++.+.
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 99999999999987654322111 122234577999999998889999999999999999997 9999998877777777
Q ss_pred HHccCCCC
Q 016544 366 YAARQRPP 373 (387)
Q Consensus 366 i~~~~~~~ 373 (387)
+..+..+.
T Consensus 247 ~~~~~~~~ 254 (293)
T cd05053 247 LKEGYRME 254 (293)
T ss_pred HHcCCcCC
Confidence 76555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=252.66 Aligned_cols=215 Identities=27% Similarity=0.411 Sum_probs=176.9
Q ss_pred ccCcccceeecccEEEEEEE----c-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee-CC
Q 016544 154 ELDFTNSVEITKGTFILAFW----R-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SS 223 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~----~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~ 223 (387)
..+|...+.||+|+||.|+. . +..|++|.+... ......+.+.+|+.+++.++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 34677778999999998762 2 578999988643 345556778899999999999999999998765 46
Q ss_pred ceEEEEEccCCCCHHHHHHHc--------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEE
Q 016544 224 PMMIVTEYLPKGDLRAFLKRK--------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 295 (387)
..++++||+.+++|.+++... ..+++.+++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999999753 34889999999999999999999998 9999999999999999999999
Q ss_pred eecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 296 DFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 296 Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
|||+++.+....... .....++..|+|||.+.+..++.++|||||||++|++++ |+.||...+..++...+..+.++.
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA 239 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence 999987553322111 112234667999999998889999999999999999998 999999887777777666554433
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=255.54 Aligned_cols=205 Identities=30% Similarity=0.486 Sum_probs=164.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC---CCCcceeeeeEEeeC-----
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQS----- 222 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~----- 222 (387)
+|...+.||+|+||.|+. +|+.||+|.+........ ....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 366778999999998863 578999999875432221 122345566666655 799999999988643
Q ss_pred CceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
..++++||++. ++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 35899999997 4899888764 34899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
...... .......++..|+|||++.+..++.++|||||||++|+|++|++||.+........++.
T Consensus 156 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~ 220 (288)
T cd07863 156 RIYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 220 (288)
T ss_pred ccccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHH
Confidence 765432 12223457889999999998899999999999999999999999998876665555543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=263.42 Aligned_cols=202 Identities=28% Similarity=0.429 Sum_probs=167.2
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC------C
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~ 223 (387)
..|+..+.||.|+||.|+. ++..||+|.+..... .....+.+.+|+.++++++||||+++++++... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 3677888999999998863 567899999875432 223345677899999999999999999987543 3
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
..+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceec
Confidence 478999988 7799888764 45899999999999999999999999 999999999999999999999999998764
Q ss_pred ccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
... .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...++
T Consensus 169 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07878 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228 (343)
T ss_pred CCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 322 233457899999999877 46889999999999999999999999876655555544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=266.97 Aligned_cols=213 Identities=28% Similarity=0.504 Sum_probs=183.0
Q ss_pred CcccceeecccEEEEEE---Ec---C--eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAF---WR---G--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~---~~---g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+.+..++||.|.||+|. |+ | ..||||.++..... ....+|.+|+.+|.+++|||+++|||+..+ ..+.+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 44556789999999886 42 2 57999999876543 267889999999999999999999999987 77899
Q ss_pred EEEccCCCCHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 228 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
|||+++.|||.+.+.+ +..+.......++.||+.||.||.+++ +|||||-.+|+|+-....+||+|||+.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999999987 344888899999999999999999999 99999999999999988999999999988765
Q ss_pred CCCCCc--ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 306 KEDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 306 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.++... ....-.+.|+|||.+...+|+.++|+|+|||++|||+| |+.||.|.+...|+++|..+.|-+-
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR 336 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR 336 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC
Confidence 544321 12234678999999999999999999999999999997 9999999999999999986665444
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=248.16 Aligned_cols=209 Identities=31% Similarity=0.568 Sum_probs=175.5
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|+..+.||.|+||.++. .+..+|+|.+...... ...+..|+++++++.||+|+++++++......++++||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 455667899999988763 4788999998755432 24578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++++|.+++... +.+++..+..++.|++.++.+||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999999764 45889999999999999999999998 9999999999999999999999999987553322211
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......++.+.+..+.+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 219 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR 219 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCC
Confidence 222234578999999998889999999999999999998 9999998777777777765543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=269.09 Aligned_cols=210 Identities=33% Similarity=0.559 Sum_probs=172.3
Q ss_pred ceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 160 ~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
...||+|+||+||. +...+|||.+.... ....+-+..|+.+-++++|.|||+++|.+..++.+-|.||-++|
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 34689999999985 34689999987543 33456688899999999999999999999999999999999999
Q ss_pred CCHHHHHHH-cCCC--ChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC-CCCCEEEEeecCccccccCCCCC
Q 016544 235 GDLRAFLKR-KGAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 235 ~sL~~~l~~-~~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|||.+++.. .+++ .+.+...+.+||++||.|||++. |||||||-+|+|++ ..|.+||+|||.++....- .-.
T Consensus 657 GSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~ 732 (1226)
T KOG4279|consen 657 GSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPC 732 (1226)
T ss_pred CcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-Ccc
Confidence 999999975 4677 67788889999999999999999 99999999999998 5688999999998876532 223
Q ss_pred cccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHH-H-HccCCCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA-Y-AARQRPPFKA 376 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~-i-~~~~~~~~~~ 376 (387)
...+.||..|||||++..+ .|++++|||||||++.||.||++||........... + .-...|++++
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPe 802 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPE 802 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcH
Confidence 3456799999999999775 688999999999999999999999986554443222 1 1122676643
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=249.21 Aligned_cols=203 Identities=28% Similarity=0.424 Sum_probs=162.6
Q ss_pred eecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 162 ~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
.||+|+||.||. .+..+|+|.+..... ......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 589999988763 235799998875432 23345688899999999999999999999998999999999999
Q ss_pred CCHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 235 GDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 235 ~sL~~~l~~~~-----~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
++|.+++.... ..++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 99999997532 2456777889999999999999998 999999999999999999999999998653322111
Q ss_pred -CcccCCCCCcccccccccCC-------CCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHcc
Q 016544 310 -PLTCQDTSCRYVAPEVFKNE-------EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 310 -~~~~~~~~~~y~aPE~~~~~-------~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~ 369 (387)
......++..|+|||++.+. .++.++|+||||+++|+|++ |..||....+.+........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 225 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE 225 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc
Confidence 11223467789999998642 35789999999999999996 99999887766655444333
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=250.24 Aligned_cols=201 Identities=31% Similarity=0.525 Sum_probs=171.1
Q ss_pred eecccEEEEEEE------cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccC
Q 016544 162 EITKGTFILAFW------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 162 ~lg~G~~~~v~~------~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
.||+|++|.++. .+ ..||+|.+...... ...+.+..|+.++++++||||+++++.+.. ...++++||++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 578999987762 12 36999999876443 566789999999999999999999999988 88999999999
Q ss_pred CCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC--
Q 016544 234 KGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-- 309 (387)
Q Consensus 234 ~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 309 (387)
+++|.+++.+.. .+++..+..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999998754 5889999999999999999999998 999999999999999999999999998766432211
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHc
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~ 368 (387)
......++..|+|||++.+..++.++|+|||||++|+|++ |+.||...+..++.+.+..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 215 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK 215 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 1112345778999999998889999999999999999998 9999988887777777654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=254.18 Aligned_cols=206 Identities=28% Similarity=0.461 Sum_probs=170.7
Q ss_pred CcccceeecccEEEEEEEc---------------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCccee
Q 016544 156 DFTNSVEITKGTFILAFWR---------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~~---------------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 214 (387)
+|+..+.||.|+||.|+.. +..||+|.+.... .....+.+.+|+.+++.++||||++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4777788999999988742 3469999987542 3445577899999999999999999
Q ss_pred eeeEEeeCCceEEEEEccCCCCHHHHHHHcC-----------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCC
Q 016544 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283 (387)
Q Consensus 215 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~N 283 (387)
+++++...+..+++|||+++++|.+++.... .+++.++..++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999997642 2566789999999999999999999 9999999999
Q ss_pred EEeCCCCCEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCCC
Q 016544 284 ILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHDN 360 (387)
Q Consensus 284 ill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt--g~~pf~~~~~~ 360 (387)
|+++.++.++|+|||++.......... ......++.|++||...+..++.++|+|||||++|||++ |..||...+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999987553322111 111233578999999888889999999999999999998 88999887766
Q ss_pred cHHHHH
Q 016544 361 EVPKAY 366 (387)
Q Consensus 361 ~~~~~i 366 (387)
++....
T Consensus 241 ~~~~~~ 246 (296)
T cd05095 241 QVIENT 246 (296)
T ss_pred HHHHHH
Confidence 665543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=257.39 Aligned_cols=190 Identities=26% Similarity=0.466 Sum_probs=154.6
Q ss_pred ceeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee--CCceEEEEE
Q 016544 160 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE 230 (387)
Q Consensus 160 ~~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e 230 (387)
...||+|+||.|+. .+..||+|.+..... ...+.+|+.++++++||||+++++++.. +..++++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 35799999998873 346899999875432 2346779999999999999999998864 456899999
Q ss_pred ccCCCCHHHHHHHc---------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----CCCCCEEEEee
Q 016544 231 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADF 297 (387)
Q Consensus 231 ~~~~~sL~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Df 297 (387)
|+. ++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +..+.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 995 5898887532 24788899999999999999999999 9999999999999 45678999999
Q ss_pred cCccccccCCC--CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 298 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
|+++....... .......+|+.|+|||++.+. .++.++|+|||||++|+|++|++||....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 99976543211 122345678999999999774 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=255.91 Aligned_cols=204 Identities=25% Similarity=0.481 Sum_probs=168.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.||. ++..||+|.+...... .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 577788999999998873 4788999998654322 223456789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+. ++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 159 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 159 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence 996 5999888764 45889999999999999999999999 9999999999999999999999999987543222 1
Q ss_pred CcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
......+++.|+|||.+.+. .++.++|||||||++|+|++|++||...+..+....+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~ 217 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 22233467899999998764 5788999999999999999999999887665544444
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=263.19 Aligned_cols=209 Identities=30% Similarity=0.460 Sum_probs=169.4
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~ 224 (387)
++...+.||.|+||.|+. .+..||+|++.... .....+.+..|+.++.++. ||||+++++++...+.
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 455677899999998873 23589999997543 2334457889999999997 9999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC-----------------------------------------------------------
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG----------------------------------------------------------- 245 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~----------------------------------------------------------- 245 (387)
.++||||+.+|+|.+++.+..
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999996532
Q ss_pred ---------------------------------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 016544 246 ---------------------------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (387)
Q Consensus 246 ---------------------------------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill 286 (387)
.+++.....++.|++.||.|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 2456677889999999999999998 9999999999999
Q ss_pred CCCCCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHH
Q 016544 287 DDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK 364 (387)
Q Consensus 287 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~ 364 (387)
+.++.++|+|||++........ .......+++.|+|||.+.+..++.++|+|||||++|||++ |..||......+...
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 9999999999999876432211 11112345778999999998889999999999999999998 999998766555544
Q ss_pred HHHcc
Q 016544 365 AYAAR 369 (387)
Q Consensus 365 ~i~~~ 369 (387)
.....
T Consensus 353 ~~~~~ 357 (401)
T cd05107 353 NAIKR 357 (401)
T ss_pred HHHHc
Confidence 44333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=250.64 Aligned_cols=205 Identities=31% Similarity=0.496 Sum_probs=170.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCC-------CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-------DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 223 (387)
+|...+.||.|+|+.+|. +|..||+|.+...... .....+.+..|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466777899999998873 5789999987642211 1123456888999999999999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.+++||||+.+++|.+++.+.+.++...+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999999988888999999999999999999999998 999999999999999999999999998754
Q ss_pred ccCCC-CCcccCCCCCcccccccccCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHH
Q 016544 304 TVKED-RPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363 (387)
Q Consensus 304 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~ 363 (387)
..... .......++..|+|||.+.+.. ++.++|+||||+++|++++|..||......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 221 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM 221 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH
Confidence 32211 1122235688999999987654 788999999999999999999999765544333
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=248.11 Aligned_cols=207 Identities=29% Similarity=0.480 Sum_probs=175.5
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccC--CCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
|+..+.||+|+||.++. ++..|++|.+..... ..++..+.+.+|+.+++.++||||+++++++.....+++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 55667899999988763 578999998864322 23445677899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 99999999999988877899999999999999999999998 9999999999999999999999999987654332
Q ss_pred CcccCCCCCcccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 310 PLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
......++..|++||.+.... ++.++|+||||+++|+|++|+.||..........++..
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 216 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR 216 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh
Confidence 223345788899999987766 88999999999999999999999987665555555443
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=248.01 Aligned_cols=205 Identities=28% Similarity=0.443 Sum_probs=174.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||.|+|+.++. ++..+++|.+.... ..+.+.+|+.++++++||||+++++.+......++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 3577778899999987652 36899999986431 2578999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999999976 345899999999999999999999998 99999999999999999999999999876543321
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
......++..|+|||++.+..++.++|+||||+++|+|++|+.||...++......+..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~ 213 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN 213 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc
Confidence 22234467889999999998899999999999999999999999988766555544433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=250.86 Aligned_cols=190 Identities=25% Similarity=0.424 Sum_probs=157.3
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHH---HHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL---ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
||.|+||.||. +++.||+|.+.+...........+..|. ..++...||+|+++++.+......++||||+.+
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g 81 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 81 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence 78999988872 5789999998765443222222233343 344455799999999999999999999999999
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccC
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 314 (387)
++|.+++...+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ....
T Consensus 82 ~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~ 155 (278)
T cd05606 82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (278)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCc
Confidence 999999988888999999999999999999999998 9999999999999999999999999987543221 1234
Q ss_pred CCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 315 DTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 315 ~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
.++..|+|||.+.+. .++.++|+||+||++|+|++|+.||.+..
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 578999999999754 68899999999999999999999998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=230.02 Aligned_cols=213 Identities=25% Similarity=0.424 Sum_probs=173.4
Q ss_pred cccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEE
Q 016544 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.....+||+|+||.+. ++|+..|+|.+.... . ....+++.+|+++..+. .+|.+|.+||....++.+++.||
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-N-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-C-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3445689999998763 689999999998643 2 34456677788877665 79999999999999999999999
Q ss_pred ccCCCCHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 231 YLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 231 ~~~~~sL~~~l~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
.|. .||..+.. ..+.+++...-+|+..++.||+|||++- .+||||+||+|||++..|++|+||||.+-.+..+
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 995 58877664 3455889889999999999999999974 4999999999999999999999999998766433
Q ss_pred CCCCcccCCCCCcccccccccC----CCCCCchhHHHHHHHHHHHHcCCCCCC-CCCCCcHHHHHHccCCCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKN----EEYDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVPKAYAARQRPPFKA 376 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~elltg~~pf~-~~~~~~~~~~i~~~~~~~~~~ 376 (387)
- ..+...|--.|||||.+.. ..|+-++||||||+++.||.+++.||. ..++.+.+++++....|-++.
T Consensus 203 i--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 203 I--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred h--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 2 2222346677999999854 378899999999999999999999997 477788889988777665543
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=248.39 Aligned_cols=208 Identities=31% Similarity=0.523 Sum_probs=167.1
Q ss_pred eecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEe-eCCceEEEEEcc
Q 016544 162 EITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYL 232 (387)
Q Consensus 162 ~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~~lv~e~~ 232 (387)
.||+|+||.++. .+..||+|.+... ......+.+.+|..+++.++||||+++++++. .++..++++||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 579999988762 2357999988532 23445677888999999999999999999775 455689999999
Q ss_pred CCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC---
Q 016544 233 PKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--- 308 (387)
Q Consensus 233 ~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 308 (387)
.+++|.+++.+.. ..++.....++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||+++.......
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999997643 3677788899999999999999998 99999999999999999999999999875432111
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.......+++.|+|||.+.+..++.++|||||||++|||++ |.+||...+..++...+..+..++.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ 223 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 11112335678999999988889999999999999999999 6778887777677776665554443
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=252.09 Aligned_cols=206 Identities=26% Similarity=0.431 Sum_probs=171.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+....||.|+|+.++. +|+.||+|.+..... .....+.+.+|+.++++++||||+++++++......+++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 466677899999988763 578999998865432 12233557889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|..++.....+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 9999888888777667999999999999999999999998 99999999999999999999999999876643321 2
Q ss_pred cccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 311 LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||.+.+..+....+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 213 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI 213 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 223456788999999876 45788999999999999999999999987765544443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=249.53 Aligned_cols=210 Identities=28% Similarity=0.517 Sum_probs=176.0
Q ss_pred CcccceeecccEEEEEEE-----cC----eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 156 DFTNSVEITKGTFILAFW-----RG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
+|...+.||.|+||.++. +| ..+|+|.+.... .......+.+|+.++++++||||+++++++.. ...+
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 566678899999998764 22 369999887553 24556778899999999999999999999987 7899
Q ss_pred EEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
+++||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999874 45899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCc-ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 306 KEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 306 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
...... ....++..|+|||.+....++.++|+||||+++|++++ |+.||.+....++.+.+..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 229 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER 229 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC
Confidence 221111 11223567999999988889999999999999999998 9999999888888887776653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=246.30 Aligned_cols=205 Identities=30% Similarity=0.504 Sum_probs=170.7
Q ss_pred eecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 162 EITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 162 ~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
.||.|+||.++. .++.|++|.+..... ......+.+|+++++++.||||+++++++......+++|||+.+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 578888877652 388999999876533 24556789999999999999999999999999999999999999999
Q ss_pred HHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc-ccCC
Q 016544 238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-TCQD 315 (387)
Q Consensus 238 ~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~ 315 (387)
.+++... ..++......++.+++.+|.|||+++ ++|+||||+||+++.++.++|+|||++........... ....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9999764 45788999999999999999999999 99999999999999999999999999875432111111 1122
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
.+..|+|||.+.+..++.++|+|||||++|+|+| |..||...........+....+
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~ 213 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR 213 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC
Confidence 3567999999998889999999999999999998 8999998877777777655443
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=246.70 Aligned_cols=213 Identities=24% Similarity=0.446 Sum_probs=179.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. ++..+|+|.+...... ....+.+.+|+.++++++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 366778899999987762 6789999998765433 3446778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 307 (387)
|+++++|.+++... ..+++..+..++.|++.+|.|||+++ ++|+||+|+||+++.++ .++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999999764 34889999999999999999999998 99999999999998554 57999999987654322
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+......++.....+++
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI 221 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCC
Confidence 22224578899999999988889999999999999999999999998887777777766554443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=253.59 Aligned_cols=209 Identities=29% Similarity=0.488 Sum_probs=175.3
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||.|+|+.+|. ++..||+|.+.... .....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 55567799999988763 46789999987442 234557789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
+++++|.+++.. +.+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06642 84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-hhh
Confidence 999999998865 45889999999999999999999998 9999999999999999999999999987654321 122
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
....++..|+|||.+.+..++.++|+|||||++|+|++|+.||....+......+.....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 219 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP 219 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC
Confidence 2335678899999999988999999999999999999999999877766666555444333
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=246.38 Aligned_cols=196 Identities=28% Similarity=0.473 Sum_probs=177.7
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|...+.||+|+|..|. .+.+.+|+|+++++...+.+...-.+.|..+..+. +||.+|-+..+|+.+.++|+|.
T Consensus 251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 56677889999997653 46789999999998888877777788899998887 6999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+.||+|--+++++.+++++.+..+...|+-||.|||+.| ||.||||.+|+|++..|++||.|+|+.+.--. ...
T Consensus 331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~-~gd 406 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG-PGD 406 (593)
T ss_pred EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC-CCc
Confidence 99999999999999889999999999999999999999999 99999999999999999999999999876433 334
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
..+.+.|||.|+|||++++..|..++|+|+|||+++||+.|+.||.
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 4456789999999999999999999999999999999999999996
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=252.45 Aligned_cols=196 Identities=26% Similarity=0.439 Sum_probs=170.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+..+.||+|+||.++. +|..||+|.+.... .....+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 566778899999998863 47899999886432 23445778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++++|.+++.+.+.+++..+..++.+++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 99999999999887789999999999999999999997 46 999999999999999999999999987654221
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
......++..|+|||.+.+..++.++|+|||||++|++++|..||.....
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 11234578899999999888899999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=290.83 Aligned_cols=222 Identities=25% Similarity=0.411 Sum_probs=187.2
Q ss_pred CccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 151 ~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
...+.+|..+..||.|.||.||- +|.-.|+|.+.-.... ......+.+|.+++..++|||+|++||+-......
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34455777888999999999984 6888999988754433 44556788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
+|.||||++|+|.+.+...+..++.....+..|++.|+.|||++| ||||||||.||+++.+|.+|++|||.|..+..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999999988776777777788899999999999999 99999999999999999999999999987665
Q ss_pred CCCC---CcccCCCCCcccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-HHHHHHccCCCCCCC
Q 016544 306 KEDR---PLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPFKA 376 (387)
Q Consensus 306 ~~~~---~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~ 376 (387)
.... ......||+.|||||++.+. ....+.|||||||++.||+||+.||...+++. |.-++..+..|.++.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~ 1464 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE 1464 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCch
Confidence 4311 12456799999999999875 45678999999999999999999999877654 555666777777744
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=262.71 Aligned_cols=215 Identities=29% Similarity=0.524 Sum_probs=184.0
Q ss_pred ccccCccccCcccceeecccEEEEEE---Ec--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee
Q 016544 147 EYEIDPHELDFTNSVEITKGTFILAF---WR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (387)
Q Consensus 147 ~~ei~~~~~~~~~~~~lg~G~~~~v~---~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~ 221 (387)
.||++..+ ++-...||-|.||.|| |. .-.||||.+++. ...+++|..|+.+|+.++|||+|+++|+|..
T Consensus 261 kWEmeRtd--ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 261 KWEMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred hhhccchh--eeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 56655443 3445689999998776 43 468999999865 3457889999999999999999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecC
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 299 (387)
+..+|||+|||..|.|.+|+.++.. ++.-..+.++.||.+|++||..++ +|||||-.+|+|+.++..+|++|||+
T Consensus 335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccch
Confidence 9999999999999999999987644 666777889999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
++++....-........++.|.|||-+....++.++|||+|||+|||+.| |-.||.+.+-..++.-..++-
T Consensus 412 sRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy 483 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY 483 (1157)
T ss_pred hhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc
Confidence 99887554444444445788999999999999999999999999999997 999999988877777765554
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=247.46 Aligned_cols=210 Identities=30% Similarity=0.455 Sum_probs=177.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+++.++. ++..|++|.+..... ......+.+|+..+.+++||||+++++++......++++|
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 456677899999987653 488999999876532 2456778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++++|.+++.....+++...+.++.|+++++.|||+ .+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 99999999999987889999999999999999999999 98 999999999999999999999999998765433222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC---CCcHHHHHHccCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH---DNEVPKAYAARQR 371 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~---~~~~~~~i~~~~~ 371 (387)
. ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.... ..+..+.+.....
T Consensus 157 ~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 220 (264)
T cd06623 157 C-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP 220 (264)
T ss_pred c-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC
Confidence 1 23356788999999999889999999999999999999999998774 2334445443333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=249.40 Aligned_cols=190 Identities=27% Similarity=0.439 Sum_probs=163.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+|+.++. ++..||+|.+.... .....+.+.+|+.+++++.||||+++++.+......+++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 355667899999988763 57899999986542 34455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|..+ ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...... .
T Consensus 80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~ 149 (279)
T cd06619 80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I 149 (279)
T ss_pred cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence 9999999754 34678889999999999999999999 999999999999999999999999998754322 2
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
.....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 22346788999999999988999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=249.08 Aligned_cols=205 Identities=32% Similarity=0.513 Sum_probs=175.4
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
||.|+|+.++. +|..+++|.+...........+.+.+|+.++++++||||+++++.+......++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 47788876652 4889999998765444445667889999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC-------CC
Q 016544 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-------RP 310 (387)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-------~~ 310 (387)
.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999998778999999999999999999999998 99999999999999999999999999875433211 02
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....++..|++||.+.+...+.++|+||||+++|++++|..||......+....+..+.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~ 217 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK 217 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 223456788999999988888999999999999999999999999888777777776644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=255.75 Aligned_cols=203 Identities=24% Similarity=0.424 Sum_probs=170.5
Q ss_pred cceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccC
Q 016544 159 NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 159 ~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
....||.|+||.++. ++..||+|.+..... ...+.+.+|+.+++.+.||||+++++++..++..++++||++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 344689999987752 578999999864322 234567889999999999999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCccc
Q 016544 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (387)
Q Consensus 234 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 313 (387)
+++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....... .....
T Consensus 102 ~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~ 176 (297)
T cd06659 102 GGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS 176 (297)
T ss_pred CCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccc
Confidence 9999998765 45889999999999999999999999 9999999999999999999999999986543221 11223
Q ss_pred CCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
..++..|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+...
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 232 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS 232 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Confidence 45788999999999888999999999999999999999999877766666655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=249.44 Aligned_cols=209 Identities=25% Similarity=0.460 Sum_probs=175.3
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+...+.||.|++|.++. ++..+++|.+... .....+.+.+|+.+++.++||||+++++++...+..++++||
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 44456899999988762 5678999987532 233445688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
+++++|.+++.. ..++..++..++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||++........ ..
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 999999999887 56899999999999999999999999 99999999999999999999999998765432211 11
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...++.....++.....+.
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPK 234 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCC
Confidence 22457889999999998889999999999999999999999998877777777766554333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=250.35 Aligned_cols=215 Identities=26% Similarity=0.467 Sum_probs=180.4
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
....|.....+|.|+++.++. .+..+++|.+..... ..+.+.+|+.++++++|+||+++++.+......++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 334567777899999987763 478899999875422 45678889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
++||+++++|.+++.... .++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999999999876 7999999999999999999999998 999999999999999999999999987654432
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 375 (387)
.. ......++..|++||.+.+..++.++|+|||||++|+|++|+.||...++......+.....+...
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLK 237 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 21 222334678899999999888999999999999999999999999987776666666555544443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=249.75 Aligned_cols=207 Identities=30% Similarity=0.495 Sum_probs=174.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. +|..||+|.+...... ......+.+|+.++++++||||+++++++......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 366778899999987763 5789999998765432 2344678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+ +++|.+++.. ...+++.++..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99 9999999875 345899999999999999999999999 999999999999999999999999998766543332
Q ss_pred CcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
......++..|+|||.+.+. .++.++||||||+++|+|++|.+||.+.++.....++.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 214 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVF 214 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHH
Confidence 33445678899999998764 46889999999999999999999998776655555543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=252.30 Aligned_cols=212 Identities=25% Similarity=0.468 Sum_probs=175.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||.|+||.++. ++..|++|.+... .....+.+.+|+.+++.++||||+++++.+......++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 4677778999999998763 5788999998643 2233467888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++.+. .+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999999998764 4788999999999999999999999 99999999999999999999999998865543222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......+++.|++||.+.+..++.++|+|||||++|++++|+.||...+.......+...+.|.+
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCC
Confidence 22234578889999999888899999999999999999999999987665444444433444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=247.88 Aligned_cols=210 Identities=30% Similarity=0.503 Sum_probs=176.7
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||.|+||.||. ++..||+|.+.... .......+.+|+.++++++||||+++++++..+...++||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 55667899999998873 56899999886432 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
+++++|.+++.. ..+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence 999999999875 45889999999999999999999998 9999999999999999999999999987554321 112
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
....++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+.....|.
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 220 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT 220 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC
Confidence 23356788999999988888999999999999999999999998877766666665554443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=250.15 Aligned_cols=199 Identities=30% Similarity=0.513 Sum_probs=165.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+++.++. ++..||+|.+...... ......+.+|+.+++++.||||+++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 366778899999988764 5789999998754322 2233567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~---~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|++ ++|.+++... ..+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 997 5898888653 45889999999999999999999999 9999999999999999999999999987543321
Q ss_pred CCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
.......+++.|+|||++.+. .++.++|+|||||++|+|+||++||.+.+..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~ 208 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI 208 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 222233467889999988764 5688999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=246.32 Aligned_cols=204 Identities=25% Similarity=0.403 Sum_probs=161.6
Q ss_pred eecccEEEEEEE----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 162 EITKGTFILAFW----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 162 ~lg~G~~~~v~~----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
.||+|+||.|+. ++ ..+++|.+.... .....+.+.+|+.+++.++||||+++++.+......+++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 589999998863 22 246677665432 234457789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC-CC
Q 016544 235 GDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-DR 309 (387)
Q Consensus 235 ~sL~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 309 (387)
++|.+++.+.. ..+......++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||++....... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999997642 3566677889999999999999998 9999999999999999999999999875422111 11
Q ss_pred CcccCCCCCcccccccccC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
......++..|+|||++.. ..++.++|||||||++|||++ |..||...++.+...++..+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 225 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQ 225 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhc
Confidence 1123456788999998753 245788999999999999996 688998877777776665444
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=249.92 Aligned_cols=206 Identities=29% Similarity=0.493 Sum_probs=169.1
Q ss_pred eecccEEEEEEEc-----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 162 EITKGTFILAFWR-----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 162 ~lg~G~~~~v~~~-----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.||.|+||.||.. +..+|+|.+.... .......+.+|+.+++.++||||+++++++......+++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 5899999988731 2579999886432 22345678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-----CEEEEeec
Q 016544 231 YLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFG 298 (387)
Q Consensus 231 ~~~~~sL~~~l~~~-------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-----~~kl~Dfg 298 (387)
|+++++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999742 23778899999999999999999998 99999999999999877 89999999
Q ss_pred CccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 299 VSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 299 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
++......... ......++..|+|||.+.+..++.++|+|||||++|+|++ |+.||...+..+....+..+.++
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL 232 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc
Confidence 98754322111 1112234678999999999899999999999999999998 99999887777777776655533
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=246.27 Aligned_cols=212 Identities=24% Similarity=0.434 Sum_probs=177.2
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee--CCceEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVT 229 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~ 229 (387)
|.....||.|+||.++. ++..+|+|.+..... .....+.+..|+.+++.++||||+++++.+.. ....+++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 55667899999988762 578899999875433 34556778899999999999999999998764 34689999
Q ss_pred EccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHH-----hCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLH-----ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 230 e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH-----~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
||+++++|.+++.. ..++++.+++.++.|++.||.||| +.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 99999999999975 356899999999999999999999 777 999999999999999999999999998
Q ss_pred cccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+...+.+.+..+..+.
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR 229 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC
Confidence 77653322 1223457889999999999888999999999999999999999999887777777776655443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=251.29 Aligned_cols=208 Identities=29% Similarity=0.470 Sum_probs=173.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||.|+||.++. +|+.||+|.+...........+.+.+|+.+++.++||||+++++++......++|+|
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 477778899999988763 588999999875544455556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+. |++.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 996 578777764 456899999999999999999999998 999999999999999999999999998654322
Q ss_pred CcccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
....+++.|+|||.+. ...++.++||||||+++|+|++|..||.+.+.......+.....|
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~ 232 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP 232 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCC
Confidence 2235678899999884 356788999999999999999999999887665555555444333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=251.48 Aligned_cols=206 Identities=30% Similarity=0.488 Sum_probs=172.1
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
|...+.||.|+|+.++. +|+.||+|.+...... .......+..|+.++++++|+||+++++++..+..+++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 55667899999987763 5789999999765433 1233456778999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+ +++|.+++.... .+++..+..++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999 889999998766 7999999999999999999999999 99999999999999999999999999876543321
Q ss_pred CCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.++.+...++.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~ 216 (298)
T cd07841 158 -KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIF 216 (298)
T ss_pred -cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHH
Confidence 2222345778999999865 457889999999999999999999998877766555553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=252.93 Aligned_cols=201 Identities=25% Similarity=0.458 Sum_probs=170.1
Q ss_pred ceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 160 ~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
...||.|+|+.++. ++..||+|.+... .....+.+.+|+.+++.++||||+++++.+...+..+++|||+++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 45689999988762 5789999988643 234456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccC
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 314 (387)
++|.+++.. +.+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....... ......
T Consensus 104 ~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~ 178 (292)
T cd06658 104 GALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSL 178 (292)
T ss_pred CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCcee
Confidence 999998865 45889999999999999999999998 9999999999999999999999999986543221 112234
Q ss_pred CCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+..
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 232 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD 232 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 578899999999988899999999999999999999999998776665555543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=237.47 Aligned_cols=211 Identities=28% Similarity=0.465 Sum_probs=172.0
Q ss_pred cccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEE
Q 016544 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e 230 (387)
......+|.|+-|.|. -.|...|||.+.+. .+.+..+++.+.+.++...+ .|+||+.+|+|..+..+++.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3345578998887653 35799999999865 45667778888888877765 8999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
.|. ..+..++.+ .+++++..+-++..-+++||.||-++. +|+|||+||+|||+|+.|++||||||++.++-. ..
T Consensus 172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd--Sk 246 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD--SK 246 (391)
T ss_pred HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec--cc
Confidence 984 466777665 566888888889999999999999876 499999999999999999999999999876543 33
Q ss_pred CcccCCCCCcccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCC-CCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMK-HDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~ 374 (387)
..+...|-+.|||||.+.-. .|..++||||||++++||.||+.||.+. .+.+++-+|.....|.+
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L 315 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLL 315 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCC
Confidence 34445678899999999654 6888999999999999999999999984 45677888877544444
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=243.91 Aligned_cols=197 Identities=32% Similarity=0.570 Sum_probs=163.8
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.++.....||+|+||.|+. ++..|++|.+... .....+.+.+|+.++++++|+||+++++++..++.+++++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3444556899999998863 4578999988643 2344567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHc-CCC--ChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-CCCEEEEeecCcccccc
Q 016544 230 EYLPKGDLRAFLKRK-GAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTV 305 (387)
Q Consensus 230 e~~~~~sL~~~l~~~-~~l--~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~ 305 (387)
||+++++|.+++... ..+ +...+..++.|++.||.|||+.+ |+|+||||+||+++. ++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999999999764 445 77888899999999999999998 999999999999986 67899999999875532
Q ss_pred CCCCCcccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
.. .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus 162 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 162 IN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred CC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 21 222234578899999998664 37889999999999999999999997543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=263.17 Aligned_cols=189 Identities=23% Similarity=0.298 Sum_probs=161.2
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
...|.....||+|+||.||. .+..||||.... ..+.+|+.++++++||||+++++++...+..+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 34688889999999998874 467899996431 2356799999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||++. ++|.+++... ..+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||+++......
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 99995 6888888754 45999999999999999999999999 9999999999999999999999999997654322
Q ss_pred CC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 308 DR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 308 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 21 1223468999999999999999999999999999999999876653
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=253.25 Aligned_cols=190 Identities=26% Similarity=0.468 Sum_probs=153.8
Q ss_pred ceeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee--CCceEEEEE
Q 016544 160 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE 230 (387)
Q Consensus 160 ~~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e 230 (387)
...||+|+||.||. .+..||+|.+..... ...+.+|+.+++.++||||+++++++.. +..+++++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 35799999998873 336899998875422 2346789999999999999999998854 457899999
Q ss_pred ccCCCCHHHHHHHc---------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----CCCCCEEEEee
Q 016544 231 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADF 297 (387)
Q Consensus 231 ~~~~~sL~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Df 297 (387)
|+. ++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 985 5888877521 23788889999999999999999999 9999999999999 45678999999
Q ss_pred cCccccccCCC--CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 298 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
|+++....... .......+|+.|+|||++.+. .++.++|||||||++|+|+||++||....
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 99986543221 122334578899999998774 57899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=253.98 Aligned_cols=212 Identities=29% Similarity=0.482 Sum_probs=168.4
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC-C
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-S 223 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~-~ 223 (387)
+|...+.||.|+||.|+. .++.||||.+.... .......+.+|+.++.++ +||||+++++++... .
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 577888999999998873 35789999997543 233456788899999999 689999999988654 4
Q ss_pred ceEEEEEccCCCCHHHHHHHcC----------------------------------------------------------
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKG---------------------------------------------------------- 245 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~---------------------------------------------------------- 245 (387)
.++++|||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6899999999999999986421
Q ss_pred ---------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC-CcccCC
Q 016544 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQD 315 (387)
Q Consensus 246 ---------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~ 315 (387)
.+++..+..++.|+++||+|||+++ |+||||||+||+++.++.++|+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 2567788899999999999999998 999999999999999999999999998764322111 111223
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCc-HHHHHHccCCC
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNE-VPKAYAARQRP 372 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~-~~~~i~~~~~~ 372 (387)
+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+..... +...+..+.++
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 301 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC
Confidence 4667999999988889999999999999999996 999998765443 33334344343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=245.97 Aligned_cols=179 Identities=24% Similarity=0.400 Sum_probs=148.4
Q ss_pred eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCHHHHHHH-cCCCChHHHHH
Q 016544 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVR 254 (387)
Q Consensus 176 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~ 254 (387)
..|++|.+... .......+.+|+.+++.++||||+++++++......++||||+++++|..++.+ .+.+++..+..
T Consensus 45 ~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~ 121 (274)
T cd05076 45 LRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT 121 (274)
T ss_pred eeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHH
Confidence 35899988643 233446688899999999999999999999999999999999999999999876 45689999999
Q ss_pred HHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-------CEEEEeecCccccccCCCCCcccCCCCCccccccccc
Q 016544 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327 (387)
Q Consensus 255 i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 327 (387)
++.|++.||+|||+++ |+||||||+||+++..+ .++++|||++...... ....++..|+|||.+.
T Consensus 122 i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~ 193 (274)
T cd05076 122 VAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVP 193 (274)
T ss_pred HHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhc
Confidence 9999999999999998 99999999999998643 3799999987543211 1234577899999887
Q ss_pred C-CCCCCchhHHHHHHHHHHHH-cCCCCCCCCCCCcHHHH
Q 016544 328 N-EEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKA 365 (387)
Q Consensus 328 ~-~~~~~~~Dv~slG~il~ell-tg~~pf~~~~~~~~~~~ 365 (387)
+ ..++.++|+|||||++||++ +|+.||....+.+....
T Consensus 194 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 194 GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 6 46789999999999999985 79999988766555443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=245.66 Aligned_cols=203 Identities=33% Similarity=0.552 Sum_probs=166.4
Q ss_pred eecccEEEEEEE-----cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccC
Q 016544 162 EITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 162 ~lg~G~~~~v~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
.||.|+||.|+. ++ ..+++|.+... ......+.+..|+.++.++ +||||+++++++...+..+++|||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 479999987763 23 35788888743 2344556788999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 234 KGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 234 ~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
+++|.+++.... .+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence 999999997542 3678899999999999999999998 999999999999999999999999
Q ss_pred cCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
|++...... ........+..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+..+.+..+.+
T Consensus 157 gl~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 229 (270)
T cd05047 157 GLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 229 (270)
T ss_pred CCccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC
Confidence 997532211 11111223567999999988889999999999999999997 9999998877777777655443
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=251.36 Aligned_cols=199 Identities=26% Similarity=0.416 Sum_probs=167.0
Q ss_pred cccceeecccEEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceE
Q 016544 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~ 226 (387)
|...+.||.|+|+.+|. ++..||+|.+.+.... .....+.+..|+.++.++ +||+|+++++.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 55677899999988763 4578999998753221 223345678899999999 5999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+||||+.+++|.+++.....+++..+..++.|++++|.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 82 LILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 99999999999999988777899999999999999999999998 999999999999999999999999998765433
Q ss_pred CCCCcccCCCCCcccccccccCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
.........++..|++||.+.+.. .+.++|+||||+++|+|++|..||....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 212 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 222222345788999999987754 7789999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=247.86 Aligned_cols=216 Identities=29% Similarity=0.398 Sum_probs=174.1
Q ss_pred CccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC--
Q 016544 151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS-- 222 (387)
Q Consensus 151 ~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~-- 222 (387)
.....+|.....||.|+|+.++. +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 33456788888999999998763 57899999986431 2235677899999998 799999999998754
Q ss_pred ---CceEEEEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEE
Q 016544 223 ---SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (387)
Q Consensus 223 ---~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 295 (387)
..+++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 358999999999999998863 345889999999999999999999998 9999999999999999999999
Q ss_pred eecCccccccCCCCCcccCCCCCcccccccccCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|||++........ ......++..|+|||.+... .++.++|+|||||++|+|++|++||...........+....
T Consensus 171 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~ 249 (291)
T cd06639 171 DFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP 249 (291)
T ss_pred ecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC
Confidence 9999876542211 11223568889999998653 36789999999999999999999999877666666665554
Q ss_pred CCCC
Q 016544 371 RPPF 374 (387)
Q Consensus 371 ~~~~ 374 (387)
.+.+
T Consensus 250 ~~~~ 253 (291)
T cd06639 250 PPTL 253 (291)
T ss_pred CCCC
Confidence 4444
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=251.16 Aligned_cols=202 Identities=27% Similarity=0.460 Sum_probs=169.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. +++.||+|.+....... ...+.+.+|+.+++.++||||+++++++..+...++++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 466678899999988763 47899999987543322 344567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.++......+++.+++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~ 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cc
Confidence 9999999988777666899999999999999999999998 9999999999999999999999999987654332 22
Q ss_pred cccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
.....++..|+|||++.+. .++.++|+||||+++|+|++|++||...+..+.
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~ 209 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ 209 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH
Confidence 2334568889999998764 467899999999999999999999986654333
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=243.05 Aligned_cols=202 Identities=28% Similarity=0.426 Sum_probs=163.0
Q ss_pred Ccccc-eeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC----Cc
Q 016544 156 DFTNS-VEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----SP 224 (387)
Q Consensus 156 ~~~~~-~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~----~~ 224 (387)
+|++. ..||-|.-|.|. .+|+.+|+|++... ...++|++.--+. .|||||.++++|... ..
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34443 357887777653 47889999998632 2345666654443 799999999988753 45
Q ss_pred eEEEEEccCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC---CCCEEEEeecC
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV 299 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfg~ 299 (387)
+.+|||.|+||.|...+++++. +++.++..|++||+.|+.|||+.+ |.||||||+|+|... +..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 7899999999999999988765 999999999999999999999999 999999999999974 44699999999
Q ss_pred ccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC----CcHHHHHHccC
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD----NEVPKAYAARQ 370 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~----~~~~~~i~~~~ 370 (387)
|+.-... ........||.|.|||++...+|+..+|+||+||++|-|++|.+||..+.. ..+..+|..++
T Consensus 211 AK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 211 AKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ 283 (400)
T ss_pred ccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC
Confidence 9865432 223334569999999999999999999999999999999999999986544 33567777777
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=249.20 Aligned_cols=194 Identities=32% Similarity=0.520 Sum_probs=167.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. +++.+++|.+..... ......+.+|+.+++++.||||+++++.+......++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 355567899999987753 478999999876432 3455678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+.+++|.+++... ..+++.....++.|++.+|.|||+ .+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999999876 678999999999999999999999 88 99999999999999999999999999865532211
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
. ...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1 145778899999999989999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=223.82 Aligned_cols=205 Identities=26% Similarity=0.494 Sum_probs=174.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||+|+. ++..||+|.++...-+.+ .-....+|+-+++.++|.|||++++...++..+.+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg-vpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 345567899999999984 467899999876543322 23445679999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||. .+|..+... ++.++...+..++.|+++||.++|+++ ++|||+||.|.|++.+|.+|++|||+++.++.+. .
T Consensus 82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv-r 156 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-R 156 (292)
T ss_pred Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-E
Confidence 995 599999876 566999999999999999999999999 9999999999999999999999999999876542 2
Q ss_pred CcccCCCCCcccccccccCCC-CCCchhHHHHHHHHHHHH-cCCCCCCCCCCCcHHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ell-tg~~pf~~~~~~~~~~~i 366 (387)
-.+....|..|.+|.++.+.+ |+++.|+||.||++.|+. .|++.|.+.+..+.+++|
T Consensus 157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkri 215 (292)
T KOG0662|consen 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_pred eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHH
Confidence 233345688999999998864 788999999999999998 599999998888877777
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=250.11 Aligned_cols=208 Identities=28% Similarity=0.467 Sum_probs=174.8
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||.|+|+.++. ++..||+|.+........+....+..|+.++++++|||++++++++..+...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 66777899999987763 5789999998765444555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+.+ +|.+++.. ..++++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 965 78777754 456899999999999999999999999 999999999999999999999999987654321
Q ss_pred cccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
....+++.|+|||.+. ...++.++|+|||||++|+|++|..||...........+.....++
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT 243 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC
Confidence 2235788899999974 4568889999999999999999999998877777777776665443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=248.61 Aligned_cols=212 Identities=26% Similarity=0.500 Sum_probs=181.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|...+.||.|+|+.++. +|..||+|++.............+..|+.+++++. ||||+++++++......+++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 466778899999988763 68899999997654445555677889999999998 999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC-
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED- 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 308 (387)
|++++++|.+++.+.+.+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999999999998878999999999999999999999999 99999999999999999999999999876543221
Q ss_pred ------------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 309 ------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 309 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......++..|+|||.+.+..++.++|+||||++++++++|+.||...+.....+.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence 11223456788999999988888999999999999999999999999877666666665433
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=247.46 Aligned_cols=203 Identities=28% Similarity=0.500 Sum_probs=170.4
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC---CCcceeeeeEEeeCCceEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~lv 228 (387)
|+..+.||.|+||.++. ++..||+|.+.... .......+.+|+.++++++ |||++++++++......+++
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 55667899999987763 67899999987542 2334567888999999986 99999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|||+++++|.+++... .+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 81 MEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred EecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 9999999999998664 6899999999999999999999999 9999999999999999999999999987665432
Q ss_pred CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 309 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.........+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 214 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc
Confidence 222334578899999998754 5688999999999999999999999877655544444
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-32 Score=239.98 Aligned_cols=214 Identities=28% Similarity=0.531 Sum_probs=182.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+++.++. .+..|++|.+...... ....+.+.+|+++++++.|||++++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 356678899999988764 5789999999865432 3456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++...+.+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999999988888999999999999999999999998 999999999999999999999999998766543221
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+......++.....+.+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 219 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPL 219 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCC
Confidence 2234568889999999888888999999999999999999999987776555555554444444
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=248.19 Aligned_cols=209 Identities=28% Similarity=0.386 Sum_probs=168.9
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEe-----e
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT-----Q 221 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-----~ 221 (387)
...+|...+.||+|+|+.++. +++.+|+|.+.... .....+..|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 445778888999999998863 57899999876421 2235677899999999 6999999999874 3
Q ss_pred CCceEEEEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
+..++++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccC
Confidence 4568999999999999998753 245788889999999999999999998 999999999999999999999999
Q ss_pred cCccccccCCCCCcccCCCCCcccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
|++...... ........+++.|+|||++.. ..++.++|+|||||++|+|++|+.||..........++...
T Consensus 169 g~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 169 GVSAQLTST-RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred CceeecccC-CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 998765432 122233457889999999853 35788999999999999999999999877665555444333
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=248.79 Aligned_cols=204 Identities=29% Similarity=0.503 Sum_probs=172.0
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. ++..||+|.+..... .....+.+.+|+.++++++|+||+++++++...+..++++|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 466778899999987763 478999999875432 23345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|++++.+..+..+...+++.++..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9988777766666666899999999999999999999999 9999999999999999999999999987665443323
Q ss_pred cccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHH
Q 016544 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~ 363 (387)
.....++..|+|||++.+. .++.++|+||||+++|+|++|++||.+.+..+..
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 211 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 3345567889999999888 7889999999999999999999999876544333
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=249.52 Aligned_cols=213 Identities=25% Similarity=0.498 Sum_probs=172.3
Q ss_pred cCcccceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
.+|...+.||.|+||.+|. +|. .||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 3566677899999998874 233 57999887542 234445688899999999999999999998754 56
Q ss_pred EEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
++++||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++...
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 78999999999999998754 4889999999999999999999998 9999999999999999999999999997654
Q ss_pred cCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 305 VKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 305 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
..... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.....+...+..+.+++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC
Confidence 32221 1122334678999999998899999999999999999997 999998876666666655544443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=246.39 Aligned_cols=204 Identities=27% Similarity=0.418 Sum_probs=166.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS------ 222 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~------ 222 (387)
-.|...+.||.|+||.++. .++.||+|.+.... .....+..|+.+++++ +||||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3466677899999998863 56789999986432 1235678899999998 699999999998753
Q ss_pred CceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
..++++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4589999999999999999863 35889999999999999999999998 999999999999999999999999998
Q ss_pred cccccCCCCCcccCCCCCcccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
....... .......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...........+
T Consensus 159 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~ 228 (272)
T cd06637 159 AQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228 (272)
T ss_pred eeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence 7643221 22233457889999999863 35788999999999999999999999876655444444
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=255.98 Aligned_cols=203 Identities=27% Similarity=0.378 Sum_probs=168.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 223 (387)
.+|...+.||+|+||.|+. +|..||+|.+..... .......+.+|+.++++++||||+++++++....
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 3577888999999998863 688999999875432 2334456778999999999999999999886443
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
..|+||||+. ++|.+.+... ++...+..++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 4799999995 5888888754 888999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+......++
T Consensus 169 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 229 (353)
T cd07850 169 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229 (353)
T ss_pred CCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 432 1122345688899999999999999999999999999999999999876654444444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=247.00 Aligned_cols=195 Identities=27% Similarity=0.527 Sum_probs=164.3
Q ss_pred CcccceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--Cc
Q 016544 156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~ 224 (387)
-|+..+.||+|+||.++. .+..||+|.+.... .......+.+|+.++++++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 456778899999998862 46789999987542 344556789999999999999999999998775 56
Q ss_pred eEEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.+++|||+++++|.+++.+.. .+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 899999999999999997653 4899999999999999999999999 999999999999999999999999998765
Q ss_pred ccCCCC--CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 304 TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 304 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
...... ......++..|+|||.+.+..++.++|+|||||++|+|+++..|+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 433221 1123345677999999998889999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=243.99 Aligned_cols=183 Identities=25% Similarity=0.463 Sum_probs=154.9
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCCC
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~s 236 (387)
+|.|+||.++. ++..+|+|.+....... .|......+ +||||+++++.+...+..++||||+++++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 95 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGD 95 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCc
Confidence 69999998763 57889999987543221 122222222 69999999999999999999999999999
Q ss_pred HHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEeecCccccccCCCCCcccCC
Q 016544 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 237 L~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
|.+++.....+++.++..++.|+++||.|||+.+ ++|+||||+||+++.++ .++|+|||++...... ....
T Consensus 96 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~ 167 (267)
T PHA03390 96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYD 167 (267)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCC
Confidence 9999988778999999999999999999999999 99999999999999988 9999999998765322 1235
Q ss_pred CCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 016544 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (387)
Q Consensus 316 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~ 361 (387)
++..|+|||++.+..++.++|+||||+++|+|++|..||.......
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 7889999999999899999999999999999999999998665443
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=267.89 Aligned_cols=196 Identities=18% Similarity=0.273 Sum_probs=155.0
Q ss_pred cCcccceeecccEEEEEEEc------CeEEEEE--------------EcCcccCCCHHHHHHHHHHHHHHHcCCCCccee
Q 016544 155 LDFTNSVEITKGTFILAFWR------GIQVAVK--------------KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~~------g~~vavK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 214 (387)
.+|...+.||+|+||.||.. +..++.| .+.+...........+.+|+.++++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 46888899999999988741 1111111 111111122334566889999999999999999
Q ss_pred eeeEEeeCCceEEEEEccCCCCHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC
Q 016544 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289 (387)
Q Consensus 215 l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~ 289 (387)
+++++......|++++++. ++|.+++.... .....++..++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 9999999999999999995 57777765421 2345667889999999999999999 9999999999999999
Q ss_pred CCEEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 016544 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354 (387)
Q Consensus 290 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf 354 (387)
+.+||+|||++..+............|++.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999876543332333456899999999999999999999999999999999987644
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-32 Score=241.61 Aligned_cols=190 Identities=23% Similarity=0.388 Sum_probs=157.4
Q ss_pred eecccEEEEEEEc-----------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 162 EITKGTFILAFWR-----------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 162 ~lg~G~~~~v~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
.||+|+||.||.. ...|++|.+... .......+.+|+.+++.++||||+++++++..+..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 5789999877642 235899987643 23345678889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC-------EEEEe
Q 016544 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-------LKVAD 296 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-------~kl~D 296 (387)
.+++|||+++++|..++... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++. ++++|
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999999988764 45899999999999999999999998 999999999999987664 89999
Q ss_pred ecCccccccCCCCCcccCCCCCccccccccc-CCCCCCchhHHHHHHHHHHHH-cCCCCCCCCCCCcH
Q 016544 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEV 362 (387)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~ell-tg~~pf~~~~~~~~ 362 (387)
||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+.
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~ 218 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK 218 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH
Confidence 9988654321 2234678899999987 457889999999999999997 69999987654443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=245.46 Aligned_cols=196 Identities=29% Similarity=0.507 Sum_probs=163.2
Q ss_pred cCcccceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee--CC
Q 016544 155 LDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SS 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~ 223 (387)
..|...+.||+|+||.++. ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 3566778899999998864 4678999998643 34456778999999999999999999998754 34
Q ss_pred ceEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
.+++++||+++++|.+++.+. ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 689999999999999999764 45899999999999999999999999 99999999999999999999999999886
Q ss_pred cccCCCCC--cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 303 LTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 303 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
........ .....++..|+|||++.+..++.++|+|||||++|||++|..|+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 54322211 1122234569999999988899999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=242.74 Aligned_cols=211 Identities=28% Similarity=0.480 Sum_probs=179.8
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||.|+|+.++. ++..+++|.+...... ......+..|+.++++++||||+++++++......++++||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 56677899999987753 5789999998764432 34456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 232 LPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 232 ~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
+++++|.+++.+ ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999876 345888999999999999999999999 999999999999999999999999998765433
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+..++...+..+..+++
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 221 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI 221 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 22224567899999999998899999999999999999999999998887777777766665554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=247.21 Aligned_cols=198 Identities=26% Similarity=0.511 Sum_probs=162.9
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+|+.|+. +|..||+|.+...... .....+.+|+.+++.++|+||+++++++..+...++|+
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4677888999999998864 5789999998654322 12235677999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS- 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence 9995 677777654 345788889999999999999999998 9999999999999999999999999987543221
Q ss_pred CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
.......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 112233468899999998764 578899999999999999999999986543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=244.12 Aligned_cols=213 Identities=29% Similarity=0.422 Sum_probs=173.2
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCC----
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS---- 223 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~---- 223 (387)
.-+|+..+.||.|+++.++. ++..+++|.+.... ...+.+.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 34677788999999987753 56789999986432 2346788999999999 6999999999997654
Q ss_pred --ceEEEEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 224 --PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 224 --~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
.++++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence 48999999999999999865 246899999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCCCCcccCCCCCcccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
|++....... .......++..|+|||.+.. ..++.++|+|||||++|+|++|+.||..........++.....+
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (275)
T cd06608 158 GVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP 236 (275)
T ss_pred ccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence 9987543322 12223457889999998854 24677899999999999999999999877666666666555444
Q ss_pred CC
Q 016544 373 PF 374 (387)
Q Consensus 373 ~~ 374 (387)
.+
T Consensus 237 ~~ 238 (275)
T cd06608 237 TL 238 (275)
T ss_pred CC
Confidence 43
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=244.58 Aligned_cols=205 Identities=28% Similarity=0.578 Sum_probs=169.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+++.++. +|..||+|.+..... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 366778899999987763 578999999875432 2223556789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|+++ +|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9975 8988887543 4899999999999999999999998 9999999999999999999999999987543321
Q ss_pred CCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
. ......++..|++||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+...++.
T Consensus 155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 214 (284)
T cd07836 155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF 214 (284)
T ss_pred c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 1 11223457889999998664 56889999999999999999999999887776666554
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=238.14 Aligned_cols=210 Identities=30% Similarity=0.509 Sum_probs=177.3
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||.|+++.++. ++..+++|++..... ...+.+.+|+.+++++.||+|+++++++......++++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 56667899999887763 478899999975432 3457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++++|.+++... ..+++..+..++.|++.+|.+||+++ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 9999999999876 56899999999999999999999998 99999999999999999999999999876654321
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.....++..|++||.+.+..++.++|+||||+++|+|++|+.||...+.......+.....+.+
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 217 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL 217 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc
Confidence 2334578889999999988889999999999999999999999988765555555544333333
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=246.66 Aligned_cols=196 Identities=27% Similarity=0.514 Sum_probs=163.0
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+++.++. +++.||+|.+...... .....+.+|+.++++++||||+++++++......++|||
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 577778999999988863 5789999998754321 112345679999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+.+ +|.+++... ..+++..+..++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~ 158 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-K 158 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC-c
Confidence 9975 999988764 45889999999999999999999999 9999999999999999999999999986543221 1
Q ss_pred CcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+..
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1122235788999999876 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-32 Score=243.20 Aligned_cols=210 Identities=29% Similarity=0.457 Sum_probs=169.7
Q ss_pred cccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC-----
Q 016544 157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----- 223 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----- 223 (387)
|...+.||+|+||.++. ++..||+|.+..... .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 34556799999987762 368899999976543 3445677889999999999999999999886532
Q ss_pred -ceEEEEEccCCCCHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEe
Q 016544 224 -PMMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (387)
Q Consensus 224 -~~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 296 (387)
..++++||+.+++|..++... ..++......++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECc
Confidence 247889999999999887532 13788889999999999999999998 99999999999999999999999
Q ss_pred ecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 297 FGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 297 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
||+++........ ......+++.|++||.+.+..++.++|||||||++|+|++ |++||.+.+..++...+....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 232 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9998765332211 1122334578999999998889999999999999999999 999999887777777766554
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-32 Score=239.48 Aligned_cols=203 Identities=32% Similarity=0.501 Sum_probs=175.9
Q ss_pred ecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
||.|+|+.++. ++..+++|.+.............+..|+.++++++||||+++++.+..+..++++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 57888877652 4789999999876655555677889999999999999999999999999999999999999999
Q ss_pred HHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCC
Q 016544 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317 (387)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 317 (387)
.+++.....+++.....++.|+++|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT 156 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence 999998877999999999999999999999998 9999999999999999999999999987654322 122334567
Q ss_pred CcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 318 ~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
..|++||.+.+...+.++|+||||+++|++++|..||...+.....+.+...
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 208 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD 208 (250)
T ss_pred ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 8899999999888899999999999999999999999877766667776553
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=253.74 Aligned_cols=185 Identities=25% Similarity=0.391 Sum_probs=157.2
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||.|+||.||. ++..||+|..... ....|+.++++++||||+++++++......++|+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 4688889999999998874 4568999985432 1245899999999999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|++. ++|.+++.. ...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.++|+|||++......
T Consensus 137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 9995 588888865 455899999999999999999999999 999999999999999999999999998653221
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf 354 (387)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1222345789999999999999999999999999999999855444
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=248.81 Aligned_cols=193 Identities=25% Similarity=0.508 Sum_probs=161.1
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||.|+|+.++. +|..||+|.+..... .......+.+|+.++++++||||+++++++.+....++++||
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 56677899999988763 588999999865432 222334577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+. ++|.+++.. .+.+++..+..++.||++||.|||+++ ++|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RC 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CC
Confidence 96 588888765 456899999999999999999999999 9999999999999999999999999987654322 22
Q ss_pred cccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
.....+++.|+|||.+.+. .++.++|+|||||++|+|+||..||.
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 2234567889999998775 46889999999999999999988854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=239.97 Aligned_cols=214 Identities=26% Similarity=0.472 Sum_probs=181.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+|+.++. ++..+++|.+..... .......+..|+++++.++|||++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 356677899999987752 478999999875433 33556678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 231 YLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 231 ~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|+++++|.+++.+. ..+++.++..++.+++.||.+||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999999764 56899999999999999999999998 999999999999999999999999998765433
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
. .......+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+..++...+.....+++
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 223 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI 223 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 2 122234578889999999988899999999999999999999999988877777777766554444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=245.03 Aligned_cols=206 Identities=27% Similarity=0.422 Sum_probs=167.0
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEee-----
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ----- 221 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~----- 221 (387)
..-.|+..+.+|.|+|+.++. .++.+|+|.+... ......+..|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 334677778999999998863 5789999987543 23345678899999998 69999999999853
Q ss_pred -CCceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeec
Q 016544 222 -SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (387)
Q Consensus 222 -~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 298 (387)
...++++|||+.+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCc
Confidence 35689999999999999999763 34788888999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCCCCcccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
++....... .......+++.|+|||.+. ...++.++|+|||||++|+|++|..||....+......+
T Consensus 167 ~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 238 (282)
T cd06636 167 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238 (282)
T ss_pred chhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence 987543221 1223345788999999986 346788999999999999999999999876654444433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=240.61 Aligned_cols=193 Identities=25% Similarity=0.433 Sum_probs=159.7
Q ss_pred eecccEEEEEEE---c--C----------eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 162 EITKGTFILAFW---R--G----------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 162 ~lg~G~~~~v~~---~--g----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
.||+|+|+.|+. . + ..+++|.+.... .....+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 589999987752 1 2 247888765432 115778899999999999999999999988 7789
Q ss_pred EEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-------CEEEEeec
Q 016544 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-------NLKVADFG 298 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-------~~kl~Dfg 298 (387)
+||||+++++|.+++.... .++...+..++.|++.||.|||+++ |+|+||||+||+++.++ .++|+|||
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999999998765 6899999999999999999999998 99999999999999887 79999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHH
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~ 367 (387)
++..... .....++..|+|||++.+. .++.++|+|||||++|+|++ |..||...+.......+.
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~ 220 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ 220 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh
Confidence 9876432 1223456789999999876 78899999999999999999 688998776554444443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-32 Score=242.71 Aligned_cols=212 Identities=23% Similarity=0.426 Sum_probs=174.1
Q ss_pred CcccceeecccEEEEEEE------cCeEEEEEEcCcccC-------CCHHHHHHHHHHHHHHHc-CCCCcceeeeeEEee
Q 016544 156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVI-------SDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQ 221 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~ 221 (387)
+|+..+.||.|+|+.++. .+..+|+|.+..... ........+..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 366677899999987762 357899998753221 223445667788888865 799999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEe
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~D 296 (387)
.+..+++|||+++++|.+++.. ...+++..++.++.|++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988753 3358899999999999999999996 56 99999999999999999999999
Q ss_pred ecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
||.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|+.||...........+.....+
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 99987654332 233445788999999999988999999999999999999999999877766666666555533
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=243.96 Aligned_cols=209 Identities=27% Similarity=0.452 Sum_probs=163.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHH-HHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|+..+.||.|+||.|+. +|..||+|.+...... .. ...+..|... ++..+||||+++++++..++.++++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 467778899999998874 5889999998754322 22 2344445554 66678999999999999999999999
Q ss_pred EccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 230 e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
||++ ++|.+++.. ...+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++....
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 9996 688888764 23588999999999999999999997 7 9999999999999999999999999987653
Q ss_pred cCCCCCcccCCCCCcccccccccC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCC-CCcHHHHHHccCCC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKN----EEYDTKVDVFSFALILQEMIEGCPPFTMKH-DNEVPKAYAARQRP 372 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~elltg~~pf~~~~-~~~~~~~i~~~~~~ 372 (387)
.. .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.... ..+.+..+..+..+
T Consensus 156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd06617 156 DS--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP 226 (283)
T ss_pred cc--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCC
Confidence 22 11122356788999998865 356889999999999999999999997533 22334444333333
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=243.29 Aligned_cols=194 Identities=29% Similarity=0.459 Sum_probs=163.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv 228 (387)
+|...+.||.|+++.++. ++..+|+|.+.... .......+.+|++++++++||||+++++++... ..++++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 356677899999987762 57899999987542 234456788999999999999999999988654 468999
Q ss_pred EEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
|||+++++|.+++.. ...++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999988753 344788899999999999999999999 9999999999999999999999999986543
Q ss_pred cCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
.... ....++..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 2211 1234677899999999989999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=246.41 Aligned_cols=206 Identities=29% Similarity=0.456 Sum_probs=170.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv 228 (387)
+|...+.||.|+||.++. +++.+++|.+...... ......+.+|+.++++++||||+++++++... ...+++
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 577778899999988763 5788999998754332 22234567799999999999999999998877 889999
Q ss_pred EEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
+||+. ++|.+++.... .+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99996 49999887644 4899999999999999999999999 9999999999999999999999999987654332
Q ss_pred CCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
.......+++.|+|||.+.+. .++.++|+||||+++|+|++|++||...+......++.
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~ 220 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF 220 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 122233467889999998765 46889999999999999999999999877666655553
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=242.71 Aligned_cols=210 Identities=24% Similarity=0.427 Sum_probs=175.1
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||.|+|+.++. +|..+|+|.+...... ....+.+.+|+.+++.++|+||+++++.+......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 56677899999987763 5788999998754332 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC-EEEEeecCccccccCCC
Q 016544 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKED 308 (387)
Q Consensus 232 ~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~ 308 (387)
+++++|.+++.+.. .+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++. ++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999997643 3788999999999999999999998 999999999999998764 69999999876543222
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 371 (387)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.....
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 219 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF 219 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC
Confidence 22234578899999999888899999999999999999999999988776666666655543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=245.14 Aligned_cols=204 Identities=23% Similarity=0.412 Sum_probs=170.5
Q ss_pred ceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 160 ~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
...||.|+||.++. +|..||+|.+... .......+.+|+.+++.++|+||+++++.+......+++|||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 35689999987763 5789999987532 233456688899999999999999999999999999999999999
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccC
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 314 (387)
++|.+++.. ..+++..+..++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 102 ~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 176 (292)
T cd06657 102 GALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 176 (292)
T ss_pred CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence 999998754 45889999999999999999999998 9999999999999999999999999886543221 122334
Q ss_pred CCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCC
Q 016544 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 371 (387)
.+++.|++||.+.+..++.++|+||||+++|+|++|..||.+....+....+.....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~ 233 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 233 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCC
Confidence 578899999999888889999999999999999999999998766655555543333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=244.19 Aligned_cols=207 Identities=31% Similarity=0.480 Sum_probs=172.2
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVT 229 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv~ 229 (387)
|...+.||.|+||.++. +|..+|+|.+.... ........+.+|+.++++++|||++++++++... +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 44567899999987763 46899999998653 2333446678899999999999999999999988 7899999
Q ss_pred EccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+++ +|.+++... ..+++.+++.++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 99964 899988765 56899999999999999999999998 99999999999999999999999999876654432
Q ss_pred CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 309 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+......++..
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~ 216 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 223334567889999987653 578899999999999999999999988776665555543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-31 Score=245.07 Aligned_cols=207 Identities=28% Similarity=0.460 Sum_probs=171.9
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|.....||.|+||.++. +|..|++|.+...........+.+..|+.+++.++|||++++++++.+....+++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 34445699999988764 5789999998765444555567788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+. +++.+++.. ..++++.++..++.|++.++.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 95 578777765 456899999999999999999999999 99999999999999999999999998754321
Q ss_pred cccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
.....++..|+|||++. ...++.++|+|||||++|+|++|..||...+......++.....|
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~ 238 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP 238 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC
Confidence 12345788899999984 456788999999999999999999999887766666666544443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=246.85 Aligned_cols=208 Identities=32% Similarity=0.498 Sum_probs=170.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv 228 (387)
+|...+.||.|+|+.++. +|..||+|.+....... .....+.+|+.++++++|+||+++++++... ..+++|
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 577778899999998763 57899999986543222 1123456799999999999999999998765 468999
Q ss_pred EEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|||+. ++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 87 MEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99996 4898888763 56899999999999999999999999 9999999999999999999999999987654332
Q ss_pred CCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
.......+++.|+|||.+.+ ..++.++|+|||||++|+|++|++||...++.+.+..+...
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~ 224 (309)
T cd07845 163 -KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQL 224 (309)
T ss_pred -CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 12222334778999999876 45788999999999999999999999988877777766553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=249.89 Aligned_cols=210 Identities=25% Similarity=0.339 Sum_probs=171.7
Q ss_pred cCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
..|++.+.||+||-..||. +.+.||+|++..... +......|.+|+..|.++ .|.+|++++++-..++.+|+||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4688889999999877763 457899998875543 567788999999999999 5999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCC-CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+-+ .+|..++++... .+...+..+..|++.++.++|.+| |||.||||.|+|+-. |.+||+|||+|..+.....
T Consensus 440 E~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred eccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 9874 599999987655 333477889999999999999999 999999999999986 6899999999988765533
Q ss_pred CC-cccCCCCCcccccccccCC-----------CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 309 RP-LTCQDTSCRYVAPEVFKNE-----------EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 309 ~~-~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
.- .....||+.||+||.+... +.++++||||||||+|+|+.|+.||..-. ..++++.....|
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~P 588 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITDP 588 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcCC
Confidence 22 3557899999999998532 36789999999999999999999998632 134444444444
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=243.64 Aligned_cols=205 Identities=26% Similarity=0.501 Sum_probs=167.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+..+.||.|+++.++. +|..||+|.+..... .......+.+|+.++++++||||+++++++.+....+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 366777899999987763 578999999875432 22233568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+. ++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 995 6899988753 45889999999999999999999998 9999999999999999999999999987553321
Q ss_pred CCcccCCCCCcccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.......+++.|+|||.+.+.. ++.++|+||||+++|+|+||+.||.+.+......++
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~ 213 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 213 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 2222234578899999887644 588999999999999999999999876654444433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=242.67 Aligned_cols=198 Identities=28% Similarity=0.499 Sum_probs=166.1
Q ss_pred CcccceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee--CCc
Q 016544 156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~ 224 (387)
.|...+.||+|+||.++. .+..+|+|.+...... ...+.+..|+.+++.+.||||+++++++.. ...
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 455667899999998763 2678999999755332 456789999999999999999999999877 557
Q ss_pred eEEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.+++|||+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 899999999999999998754 4899999999999999999999998 999999999999999999999999998776
Q ss_pred ccCCCCC--cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 304 TVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 304 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
....... .....++..|++||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 5222211 112234567999999988899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=247.26 Aligned_cols=200 Identities=26% Similarity=0.439 Sum_probs=164.0
Q ss_pred cccceeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEE
Q 016544 157 FTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI 227 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~l 227 (387)
|.....||+|+||.++. .+..||+|.+...........+.+.+|+.+++.++||||+++++++... ..+++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 56677899999987763 5789999999864322333345677899999999999999999999988 78999
Q ss_pred EEEccCCCCHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC----CCCEEEEeec
Q 016544 228 VTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD----SGNLKVADFG 298 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~----~~~~kl~Dfg 298 (387)
||||+++ +|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999964 777777532 25788999999999999999999999 999999999999999 8999999999
Q ss_pred CccccccCCC--CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 299 VSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 299 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
++........ .......+++.|+|||.+.+. .++.++|+|||||++|+|++|++||.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 9876543222 112234567889999988764 5788999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-31 Score=235.99 Aligned_cols=198 Identities=31% Similarity=0.546 Sum_probs=172.4
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVT 229 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv~ 229 (387)
|...+.||.|++|.++. ++..|++|.+...... ....+.+.+|+.++++++||||+++++.+... ...++++
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 56677899999987763 4889999998765432 45567889999999999999999999999988 8899999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+.+++|.+++.+...+++.++..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999999988778999999999999999999999998 999999999999999999999999998766543221
Q ss_pred -CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 310 -PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 310 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
......++..|++||.+.+...+.++|+||||+++|+|++|..||....
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223457889999999998889999999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=251.62 Aligned_cols=205 Identities=25% Similarity=0.419 Sum_probs=168.4
Q ss_pred cCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee----CCce
Q 016544 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~ 225 (387)
.+|...+.||.|+|+.++ .+|..||+|.+..... .......+.+|+.++++++||||+++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 467777889999998776 3588999999875432 22345667789999999999999999998763 3468
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
++||||+. ++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 99999995 699999987777999999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCC---cccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHH
Q 016544 306 KEDRP---LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 364 (387)
Q Consensus 306 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~ 364 (387)
..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~ 222 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK 222 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH
Confidence 22111 123457888999999866 467899999999999999999999998766544333
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-31 Score=241.35 Aligned_cols=205 Identities=27% Similarity=0.478 Sum_probs=165.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+++.++. +|+.||+|.+...... ......+.+|+.++++++||||+++++++......++|||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 466778899999987763 5789999998654322 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-CCCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~ 307 (387)
|+. ++|.+++..... +++..+..++.|++.||+|||+++ ++|+||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 588888865443 577888899999999999999998 999999999999985 4579999999987654321
Q ss_pred CCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.......+++.|+|||.+.+. .++.++|+|||||++|+|+||++||...+..+...++
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~ 216 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 112233467889999998764 5788999999999999999999999876655544443
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=241.27 Aligned_cols=203 Identities=30% Similarity=0.536 Sum_probs=166.9
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|+..+.||.|+++.++. +|..||+|++...... ......+.+|+.+++.++|||++++++++......++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 45567899999987763 6889999998754322 22335677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+. ++|.+++.... .+++..+..++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~ 154 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-R 154 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-c
Confidence 95 69999998765 5899999999999999999999998 9999999999999999999999999987543221 1
Q ss_pred CcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~ 365 (387)
......+++.|+|||++.+. .++.++|+||||+++|+|++|++||...+......+
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 211 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 12223457889999988764 568899999999999999999999987655433333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-31 Score=243.38 Aligned_cols=199 Identities=19% Similarity=0.337 Sum_probs=163.4
Q ss_pred cceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCC
Q 016544 159 NSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235 (387)
Q Consensus 159 ~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~ 235 (387)
..+.+|.|+++.++ .++..||+|++..... .......+..|+.++++++||||+++++++......+++|||+.++
T Consensus 6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 34455666665443 3689999999876432 3455678999999999999999999999999999999999999999
Q ss_pred CHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC-----
Q 016544 236 DLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED----- 308 (387)
Q Consensus 236 sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----- 308 (387)
+|.+++... ..+++..+..++.|+++||.|||+++ |+|+||||+||+++.++.++|+|||.+........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999999864 34888999999999999999999999 99999999999999999999999998765432211
Q ss_pred -CCcccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 016544 309 -RPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (387)
Q Consensus 309 -~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~~~ 361 (387)
.......++..|+|||++.+. .++.++|+|||||++|+|++|+.||.+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~ 217 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 111233467789999998763 57889999999999999999999998765443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-33 Score=237.95 Aligned_cols=214 Identities=27% Similarity=0.386 Sum_probs=168.9
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+.+...+||.|.||+|. ..|+..|||.++.... +...+++..|.+...+. +.||||++||....++..++.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 34455689999999986 4789999999986643 56677888888866655 6999999999999999999999
Q ss_pred EccCCCCHHHHHH-----HcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 230 EYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 230 e~~~~~sL~~~l~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
|+|. -||..+.+ ++..+++...-.|..-.+.||.||-+.- .|||||+||+|||++..|.+||||||.+....
T Consensus 143 ELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 9995 58876654 3455888888888888899999998763 39999999999999999999999999986543
Q ss_pred cCCCCCcccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCC-CcHHHHHHccCCCCCCC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYAARQRPPFKA 376 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~ 376 (387)
.+ ...+.-.|-..|||||.+... .+..+||+||||+++||+.||..||.+-+. .+-+.+++.+..|.+..
T Consensus 220 ~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 220 DS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLF 292 (361)
T ss_pred HH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecC
Confidence 22 222334567789999998654 588899999999999999999999987544 33444555555554433
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=239.30 Aligned_cols=189 Identities=22% Similarity=0.371 Sum_probs=155.9
Q ss_pred eecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 162 EITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 162 ~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.||.|+|+.||.. ...|++|.+... .....+.+..|..+++.+.||||+++++++......++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 5899999887632 234888887533 2344567888999999999999999999999989999999
Q ss_pred EccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC--------EEEEeecCc
Q 016544 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--------LKVADFGVS 300 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~--------~kl~Dfg~~ 300 (387)
||+.+|+|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+||+++.++. ++++|||++
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999998654 4889999999999999999999999 999999999999987665 699999987
Q ss_pred cccccCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCc
Q 016544 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEG-CPPFTMKHDNE 361 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg-~~pf~~~~~~~ 361 (387)
...... ....+++.|+|||.+.+. .++.++|+|||||++|+|++| ..||...+...
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~ 213 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence 654321 223467889999999874 578899999999999999998 56776655443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=241.42 Aligned_cols=205 Identities=28% Similarity=0.433 Sum_probs=165.0
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCc-----
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP----- 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~----- 224 (387)
+|...+.||.|+||.+|. +|+.||+|.+..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 467778899999998863 578999998865432 1223356778999999995 6999999999987665
Q ss_pred eEEEEEccCCCCHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-CCCEEEEeec
Q 016544 225 MMIVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFG 298 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg 298 (387)
.|++|||+++ +|.+++... ..+++..++.++.||+.||.|||+++ ++|+||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 898888643 24789999999999999999999998 999999999999998 8899999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
++..+..... ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.++.....++
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~ 224 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 9876533211 1122345788999998865 45789999999999999999999999887665544443
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=240.00 Aligned_cols=200 Identities=16% Similarity=0.165 Sum_probs=152.5
Q ss_pred cCcccceeecccEEEEEEEc--------CeEEEEEEcCcccCCC--HHH------HHHHHHHHHHHHcCCCCcceeeeeE
Q 016544 155 LDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISD--DDR------VRAFRDELALLQKIRHPNVVQFLGA 218 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~~--------g~~vavK~~~~~~~~~--~~~------~~~~~~E~~~l~~l~h~~iv~l~~~ 218 (387)
.+|...+.||+|+||.||.. +..+|+|+........ +.. ......+...+..+.|++|++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 46888889999999998741 3466777543221110 000 0112223445566789999999997
Q ss_pred EeeCC----ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEE
Q 016544 219 VTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (387)
Q Consensus 219 ~~~~~----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 294 (387)
+.... ..++++|++. .++.+.+......++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEE
Confidence 66543 3477888874 478777776555788889999999999999999998 999999999999999999999
Q ss_pred EeecCccccccCCC------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 295 ADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 295 ~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999976542211 11123468999999999999999999999999999999999999998874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=265.24 Aligned_cols=143 Identities=29% Similarity=0.526 Sum_probs=130.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||.|+||.||. .+..||||++.............+..|+.+++.++||||+++++++.....+|+|||
T Consensus 5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE 84 (669)
T cd05610 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME 84 (669)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence 577788999999998873 478999999986555556666788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
|+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.++|+|||+++
T Consensus 85 y~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999988778899999999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=242.14 Aligned_cols=206 Identities=26% Similarity=0.412 Sum_probs=165.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC-------
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------- 223 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------- 223 (387)
+|...+.||.|+|+.++. ++..||+|.+....... .....+.+|+.++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 677888999999998763 57899999886543222 12234567999999999999999999887654
Q ss_pred -ceEEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 224 -PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 224 -~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
..++||||+. ++|.+++.... .+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 3599999995 58888877543 5899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCC---CcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 302 LLTVKEDR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 302 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+.......+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~ 236 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 65432221 11233467889999998764 4688999999999999999999999877655444433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=240.28 Aligned_cols=194 Identities=31% Similarity=0.473 Sum_probs=159.6
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e 230 (387)
|.....||.|+||.|+. ++..||+|.+..... ......+.+|+.++.++. ||||+++++++..++..+++||
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 44556799999998863 578999999875432 244567888999999996 9999999999999899999999
Q ss_pred ccCCCCHHHHHH-----HcCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 231 YLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 231 ~~~~~sL~~~l~-----~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
|+. +++.++.. ....+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 985 46655432 235689999999999999999999985 7 9999999999999999999999999987543
Q ss_pred cCCCCCcccCCCCCcccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
... ......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||....
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 160 DSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred cCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 221 11223568889999999876 68899999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=242.72 Aligned_cols=208 Identities=28% Similarity=0.470 Sum_probs=171.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||.|+||.++. ++..+|+|.+...........+++.+|+.+++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 366667899999987762 567899999875434444556678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+. +++.+++.. ..++++.++..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 996 588877754 445889999999999999999999998 999999999999999999999999998764322
Q ss_pred CcccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
....+++.|+|||.+. ...++.++|||||||++|+|++|..||...........+.....|
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCC
Confidence 2234678899999975 346788999999999999999999999877666555555554443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=247.16 Aligned_cols=209 Identities=29% Similarity=0.459 Sum_probs=175.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC-----ce
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~ 225 (387)
+|...+.||.|+++.++. ++..||+|.+.... ......+.+..|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 356678899999987762 47899999987543 22344567889999999999999999999988765 78
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
|++|||+. ++|.+++.+...+++..+..++.|++.||.+||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999996 589999988778999999999999999999999999 99999999999999999999999999887654
Q ss_pred CCC--CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 306 KED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 306 ~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
... .......++..|+|||.+.+. .++.++|+||||+++|+|++|++||.+.+..+....+...
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 222 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV 222 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHh
Confidence 321 122334568889999999887 7899999999999999999999999988776666665443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=246.55 Aligned_cols=206 Identities=28% Similarity=0.454 Sum_probs=167.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC--CceE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS--SPMM 226 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~--~~~~ 226 (387)
.+|...+.||.|+|+.++. +|..+|+|.+..... .......+..|+.+++++ +||||+++++++... ..++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 3577778899999987763 578999998865322 223345677899999999 999999999988654 3589
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+||||+. ++|.+++... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 9999996 5999988765 6888899999999999999999998 999999999999999999999999998765433
Q ss_pred CC----CCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 307 ED----RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 307 ~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+......++
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~ 225 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI 225 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 22 12223457889999998765 45788999999999999999999999876655544443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=251.43 Aligned_cols=201 Identities=27% Similarity=0.445 Sum_probs=164.8
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l 227 (387)
..+|.....+|.|+|+.+.+ +++..++|++.+...+ -.+|..++.+. +||||+++.+.+.+....|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceeee
Confidence 34566667799999987754 6788999999865222 24466565555 79999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe-CCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR-DDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|||.+.|+-+.+-+....... .++..|+.+|+.|+.|||++| ++||||||+|||+ +..++++|+|||.++.....
T Consensus 394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999998877776655444 788889999999999999999 9999999999999 68899999999998765433
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-cHHHHHHcc
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAAR 369 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~-~~~~~i~~~ 369 (387)
.....-|..|.|||++....+++++||||||++||+|++|+.||...... ++..+|..+
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~ 529 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP 529 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC
Confidence 11223478899999999999999999999999999999999999865555 666666444
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=246.22 Aligned_cols=198 Identities=29% Similarity=0.505 Sum_probs=162.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-----Cc
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~ 224 (387)
.+|...+.||.|+||.++. +|..||+|.+... ........+.+|+.++++++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3677888999999988763 5789999998642 2233445677899999999999999999987654 34
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
.++++||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 799999996 588887754 45899999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCCC--CcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 305 VKEDR--PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 305 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
..... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~ 215 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 32211 1123457889999998755 4688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=245.27 Aligned_cols=202 Identities=27% Similarity=0.447 Sum_probs=167.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------c
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------P 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------~ 224 (387)
+|+..+.||.|+||.|+. +|..||+|.+.... ........+.+|+.++++++||||+++++++.... .
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 577888999999998863 57899999986542 23334556888999999999999999999987654 3
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
+++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 95 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 58999999 7799988865 46899999999999999999999999 9999999999999999999999999987543
Q ss_pred cCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
.. .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+......++.
T Consensus 170 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~ 229 (343)
T cd07880 170 SE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIM 229 (343)
T ss_pred cC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 22 223356788999999876 457889999999999999999999998776554444443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=245.80 Aligned_cols=204 Identities=28% Similarity=0.447 Sum_probs=166.5
Q ss_pred ccCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC------
Q 016544 154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------ 222 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------ 222 (387)
..+|...+.||+|+||.++ .+|..||+|++..... .....+.+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 3467888899999998875 3578999999875422 233345677899999999999999999988643
Q ss_pred CceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
...+++++++ +++|.+++... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccc
Confidence 3467888887 78998887654 5899999999999999999999999 99999999999999999999999999875
Q ss_pred cccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 303 LTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+.
T Consensus 170 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 170 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred ccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 422 2223456888999999876 467889999999999999999999998766555544443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=245.46 Aligned_cols=199 Identities=27% Similarity=0.457 Sum_probs=166.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-----Cc
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~ 224 (387)
.+|...+.||.|+|+.++. ++..||+|.+..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 3577888999999988763 578999999875432 223345667899999999999999999988654 34
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
.++++||+. ++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 899999995 699999988788999999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+.
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 214 (337)
T cd07858 160 EKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214 (337)
T ss_pred CCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh
Confidence 322 22233456888999998865 4688999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=261.84 Aligned_cols=221 Identities=31% Similarity=0.516 Sum_probs=185.6
Q ss_pred ccccCccccCcccceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcce
Q 016544 147 EYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVV 213 (387)
Q Consensus 147 ~~ei~~~~~~~~~~~~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv 213 (387)
.||++...+.+.. .+|.|.||.|... ...||||.++..... ...+.+..|+++++.+ +||||+
T Consensus 290 ~~e~~~~~l~~~~--~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 290 KWEIPRENLKLGK--YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred ceeechhhccccc--eeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchh
Confidence 6777777665444 8999999877531 468999999876443 6678899999999999 599999
Q ss_pred eeeeEEeeCCceEEEEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 016544 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (387)
Q Consensus 214 ~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 277 (387)
.++|++...+..++|+||++.|+|..++..+. .++..+.+.++.||+.|++||++.. +|||
T Consensus 366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR 442 (609)
T KOG0200|consen 366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR 442 (609)
T ss_pred hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence 99999999999999999999999999998765 3888999999999999999999998 9999
Q ss_pred CCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCC--CCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 016544 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF 354 (387)
Q Consensus 278 Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf 354 (387)
||-.+|||+..+..+||+|||+++.............. -+..|||||.+....|+.++|||||||++||++| |..||
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence 99999999999999999999999865433332222112 2456999999999999999999999999999998 99999
Q ss_pred CCCC-CCcHHHHHHccCCCCC
Q 016544 355 TMKH-DNEVPKAYAARQRPPF 374 (387)
Q Consensus 355 ~~~~-~~~~~~~i~~~~~~~~ 374 (387)
.+.. .+++.+.+..|.|...
T Consensus 523 p~~~~~~~l~~~l~~G~r~~~ 543 (609)
T KOG0200|consen 523 PGIPPTEELLEFLKEGNRMEQ 543 (609)
T ss_pred CCCCcHHHHHHHHhcCCCCCC
Confidence 9866 6777777777776554
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=236.92 Aligned_cols=204 Identities=29% Similarity=0.506 Sum_probs=167.4
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC---CCCcceeeeeEEeeCCc----
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSP---- 224 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~~---- 224 (387)
|...+.||.|+|+.++. ++..||+|.+....... .....+..|+.+++++ .||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 45567899999987752 47899999997543322 2234566677777666 59999999999988776
Q ss_pred -eEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 225 -MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 225 -~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
++++|||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 999999996 48999887643 4899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
...... ......++..|+|||.+.+..++.++|+|||||++|+|++|++||.+.+..+...++.
T Consensus 156 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~ 219 (287)
T cd07838 156 IYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIF 219 (287)
T ss_pred eccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHH
Confidence 654321 1122346788999999999889999999999999999999999999888777666663
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=240.11 Aligned_cols=215 Identities=29% Similarity=0.471 Sum_probs=171.0
Q ss_pred cccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC--CCCcceeeeeEEeeCC----ceEE
Q 016544 157 FTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQSS----PMMI 227 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~l~~~~~~~~----~~~l 227 (387)
......+|+|.||.|+ .+++.||||++. ....+.|++|.+++... +|+||+++++.-.... .++|
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDNRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred hhhHHHhhcCccceeehhhccCceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3445678999999887 478999999996 34568899999999875 7999999999876544 7999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC------CCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK------PVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~------~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
|++|.+.|||.+|++.+. ++|....+++..+++||+|||+.- .++|+|||||++|||+..+++..|+|||+|.
T Consensus 286 Vt~fh~kGsL~dyL~~nt-isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT-ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred EeeeccCCcHHHHHHhcc-ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999999999864 899999999999999999999743 3479999999999999999999999999998
Q ss_pred ccccCCC-CCcccCCCCCcccccccccCCC-CC-----CchhHHHHHHHHHHHHcCCC------------CCC-----CC
Q 016544 302 LLTVKED-RPLTCQDTSCRYVAPEVFKNEE-YD-----TKVDVFSFALILQEMIEGCP------------PFT-----MK 357 (387)
Q Consensus 302 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~-----~~~Dv~slG~il~elltg~~------------pf~-----~~ 357 (387)
.+..... ...-..+||.+|||||++.+.. +. .+.||||+|.++||++++-. ||. ..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 7764432 2233468999999999998752 22 36899999999999997543 232 22
Q ss_pred CCCcHHHHHHccC-CCCCCCCh
Q 016544 358 HDNEVPKAYAARQ-RPPFKAPA 378 (387)
Q Consensus 358 ~~~~~~~~i~~~~-~~~~~~~~ 378 (387)
+-+++.+-++..+ ||-++...
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W 466 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAW 466 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhh
Confidence 3344555555555 77765543
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=242.09 Aligned_cols=202 Identities=22% Similarity=0.389 Sum_probs=162.0
Q ss_pred eeccc--EEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 162 EITKG--TFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 162 ~lg~G--~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
.||+| +|+.|+ ..|+.||+|.+..... .....+.+.+|+.+++.++||||++++++|..+...++++||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 45655 776665 2689999999875433 344567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC--
Q 016544 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-- 310 (387)
Q Consensus 235 ~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-- 310 (387)
++|.+++.+.. .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999998643 4888899999999999999999998 9999999999999999999999997543221111100
Q ss_pred ----cccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 311 ----LTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 311 ----~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
.....++..|+|||++.+. .++.++|+|||||++|+|++|..||.+....+....+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 223 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKL 223 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHh
Confidence 0112345679999999774 47889999999999999999999998876555444443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=241.71 Aligned_cols=209 Identities=28% Similarity=0.447 Sum_probs=168.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 223 (387)
.+|...+.||.|+|+.++. +|+.||+|.+...... ......+.+|+.++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 3577778899999988763 5789999998754321 222345678999999999999999999987654
Q ss_pred ----ceEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeec
Q 016544 224 ----PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (387)
Q Consensus 224 ----~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 298 (387)
.+++++||+++ ++...+... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999975 777777654 45899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
++...............++..|+|||.+.+. .++.++|+|||||++|+|++|++||...+..+.+..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9876544332222333457789999988653 568899999999999999999999987666555544433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=237.36 Aligned_cols=201 Identities=24% Similarity=0.397 Sum_probs=161.9
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeC--CceEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMMIV 228 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~--~~~~lv 228 (387)
|...+.||.|+|+.++. ++..||+|.++.... ..... ....|+.+++++. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 44567899999987763 578999999875432 22222 2346888888885 99999999999987 889999
Q ss_pred EEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
+||+. ++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++.......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 99996 5888887753 46899999999999999999999998 999999999999999 999999999987654322
Q ss_pred CCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+
T Consensus 154 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~ 211 (282)
T cd07831 154 --PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI 211 (282)
T ss_pred --CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH
Confidence 2223456888999997654 45688999999999999999999999887665544444
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=243.82 Aligned_cols=205 Identities=27% Similarity=0.402 Sum_probs=167.9
Q ss_pred cceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHH-----------HHHHHHHHHHHHHcCCCCcceeeeeEEeeC
Q 016544 159 NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDD-----------RVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (387)
Q Consensus 159 ~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~ 222 (387)
..+.||.|+||.+|. .++.||+|.+......... ....+.+|+.++++++||||+++++++..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 345799999998863 5789999998654322110 012467899999999999999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
...+++|||+. ++|.+++.....+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceee
Confidence 99999999996 599999988777999999999999999999999999 99999999999999999999999999876
Q ss_pred cccCC-------------CCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 303 LTVKE-------------DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 303 ~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
..... ........+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.++.+....+.
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 54111 1111223457789999998764 46889999999999999999999999887766555553
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=243.16 Aligned_cols=205 Identities=24% Similarity=0.386 Sum_probs=165.0
Q ss_pred cccceeecccEEEEEEE-----c--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC----Cc
Q 016544 157 FTNSVEITKGTFILAFW-----R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----SP 224 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~----~~ 224 (387)
|...+.||.|+||.++. . +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 56677899999988763 3 6689999987532 2233445677899999999 599999999875432 45
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
+++++|++. ++|.+++.....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 788999985 699999988778999999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCCC---CcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 305 VKEDR---PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 305 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
..... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+......++
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~ 222 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQI 222 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHH
Confidence 32211 1123457889999998766 46889999999999999999999999876654444433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=236.97 Aligned_cols=205 Identities=28% Similarity=0.487 Sum_probs=171.1
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||.|+++.++. +|..+++|.+...... ......+..|+.++++++||||+++++++..+..+++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 34567899999987763 5788999998765433 23446778899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++ +|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||.+....... ..
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 975 888888763 56899999999999999999999999 9999999999999999999999999987665432 12
Q ss_pred cccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
.....++..|+|||.+.+. .++.++|+||||+++|+|+||+.||...+..+.+.++.
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 212 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF 212 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2234567889999999876 78899999999999999999999998877655555543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=254.53 Aligned_cols=211 Identities=26% Similarity=0.489 Sum_probs=183.9
Q ss_pred cCcccceeecccEEEEEEEc---------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 155 LDFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
.+....+.||.|.||+||.. ..+||+|++.... ..+...++..|+-+|.++.|||++++++++..+. +
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence 35566778999999998742 3589999987543 3455678899999999999999999999998765 8
Q ss_pred EEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
.||++|++.|+|.++++.+ +++.....+.|..||++||.|||.+. ++||||-.+|||+..-..+||.|||+++...
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 8999999999999999864 45889999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCCc-ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 305 VKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 305 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
....... ....-.+.|||-|.+..+.|+.++|||||||++||++| |..||.+.+.++|...+..+.|
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR 918 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER 918 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc
Confidence 5544332 33344778999999999999999999999999999998 9999999999999999988886
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=235.82 Aligned_cols=211 Identities=30% Similarity=0.463 Sum_probs=165.1
Q ss_pred cCcccceeecccEEEEEE---E--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEE
Q 016544 155 LDFTNSVEITKGTFILAF---W--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~---~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 228 (387)
.+|...+.||.|+|+.++ + ++..||||.+..... ......+..|..++.+. .||||+++++++......+++
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 356778899999998776 2 388999999875432 22344555677666666 599999999999999999999
Q ss_pred EEccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|||+. +++.+++.. ...+++..+..++.|++.||+|||+ .+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 93 ~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 93 MELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 99985 578877765 4568899999999999999999997 46 999999999999999999999999998755322
Q ss_pred CCCCcccCCCCCcccccccccCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCC-CcHHHHHHccCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYAARQRPP 373 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~ 373 (387)
.. .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||..... .+.+.++.....+.
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T cd06618 169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS 238 (296)
T ss_pred Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC
Confidence 11 12234678899999987653 78899999999999999999999976332 34555555444333
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=236.34 Aligned_cols=203 Identities=30% Similarity=0.542 Sum_probs=170.0
Q ss_pred ccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEcc
Q 016544 158 TNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (387)
Q Consensus 158 ~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 232 (387)
+....||+|+|+.++. +++.+|+|.+.... ......+.+..|+.++++++|+||+++++++......++++||+
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4456789999987763 57899999998653 22333456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 233 PKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 233 ~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
. ++|.+++.+. ..+++..+..++.|++.||.+||+++ ++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TY 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-cc
Confidence 7 5999999876 56999999999999999999999999 99999999999999999999999999876543221 22
Q ss_pred ccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 312 TCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.....+..|+|||.+.+. .++.++|+|||||++|++++|++||...+......++
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 233456789999998776 7889999999999999999999999887765555544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=239.81 Aligned_cols=208 Identities=31% Similarity=0.473 Sum_probs=166.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 223 (387)
.+|...+.||.|+|+.++. ++..+|+|.+........ ....+.+|+.++++++||||+++++++....
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4678888999999998763 578999998865432221 1234678999999999999999999875433
Q ss_pred --ceEEEEEccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 224 --PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 224 --~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
.+++++||+.+ +|...+.. ...+++.++..++.|+++||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccc
Confidence 46999999964 77777764 346999999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCCCC----------cccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 301 KLLTVKEDRP----------LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 301 ~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
.......... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|++||.+.+.....+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 7554322111 1223457789999988654 57889999999999999999999999877766555554
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=235.08 Aligned_cols=220 Identities=30% Similarity=0.475 Sum_probs=170.6
Q ss_pred cCcccceeecccEEEEE---EEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC--CCCcceeeeeEEeeCC----ce
Q 016544 155 LDFTNSVEITKGTFILA---FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQSS----PM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v---~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~l~~~~~~~~----~~ 225 (387)
.+.+..+.||+|.||.| .|.|..||||++... + -+++.+|.++++.+ +|+||+.+++.-..+. .+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr---d---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR---D---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEeccc---c---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 35566778999999865 599999999999743 1 25677888888765 9999999998765443 48
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-----CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-----NKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-----~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
+||++|.+.|||.+|+.+. .++....++++..+++||++||. +|.+.|.|||||+.|||+.+++..-|+|+|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r~-tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN-TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EEeeecccCCcHHHHHhhc-cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 9999999999999999984 58999999999999999999995 56677999999999999999999999999999
Q ss_pred cccccCC---CCCcccCCCCCcccccccccCCC----CC--CchhHHHHHHHHHHHHcC----------CCCCCCCCC--
Q 016544 301 KLLTVKE---DRPLTCQDTSCRYVAPEVFKNEE----YD--TKVDVFSFALILQEMIEG----------CPPFTMKHD-- 359 (387)
Q Consensus 301 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~----~~--~~~Dv~slG~il~elltg----------~~pf~~~~~-- 359 (387)
-...... +......+||-+|||||++...- |. ..+||||||.++||+..+ ++||.+.-+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 7655432 23335678999999999997641 22 358999999999998732 478875322
Q ss_pred ---CcHHHHHHccC-CCCCCCChhhh
Q 016544 360 ---NEVPKAYAARQ-RPPFKAPAKLY 381 (387)
Q Consensus 360 ---~~~~~~i~~~~-~~~~~~~~~~~ 381 (387)
+++.+-+--.+ ||+++......
T Consensus 444 Ps~eeMrkVVCv~~~RP~ipnrW~s~ 469 (513)
T KOG2052|consen 444 PSFEEMRKVVCVQKLRPNIPNRWKSD 469 (513)
T ss_pred CCHHHHhcceeecccCCCCCcccccC
Confidence 22222222222 88876655443
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=238.47 Aligned_cols=197 Identities=31% Similarity=0.502 Sum_probs=163.9
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee-CCceE
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMM 226 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~~~ 226 (387)
...+|+..+.||.|+|+.++. ++..||+|.+..... .....+.+..|+.++++++||||+++++++.. ....+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 345688889999999998863 678999998865432 22344667889999999999999999999875 45789
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+++||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence 999998 5689888765 35788888999999999999999999 999999999999999999999999998754321
Q ss_pred CCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
.....++..|+|||.+.+ ..++.++|+|||||++|+|++|++||.....
T Consensus 162 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 162 ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred ----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 122356788999998766 5688999999999999999999999986554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=232.99 Aligned_cols=213 Identities=28% Similarity=0.435 Sum_probs=169.1
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
|...+.||+|+||.++. .+..+++|.++..... .......+..|+.+++.++||||+++++++......++++
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 66678899999998873 2344666665432221 1222345667899999999999999999999989999999
Q ss_pred EccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 230 e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
||+++++|.+++.+ ...+++.+++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998864 345899999999999999999999998 999999999999985 5699999999876543
Q ss_pred CCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..........++..+..|.+
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL 225 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCC
Confidence 221 22234568889999999888889999999999999999999999987666666666655444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=242.11 Aligned_cols=204 Identities=29% Similarity=0.441 Sum_probs=169.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc-----
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----- 224 (387)
.+|.....||.|++|.++. ++..||+|.+..... .....+.+.+|+.+++++.||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 3677888999999988763 478999999875432 22334567789999999999999999998876554
Q ss_pred -eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 225 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 -~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 6799998876 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+......+.++..
T Consensus 169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~ 230 (343)
T cd07851 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230 (343)
T ss_pred ccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 322 223356788999999865 3678899999999999999999999988776655555544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=235.17 Aligned_cols=200 Identities=27% Similarity=0.336 Sum_probs=167.7
Q ss_pred ccCcccceeecccEEEEEE--E---cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC--CC----cceeeeeEEeeC
Q 016544 154 ELDFTNSVEITKGTFILAF--W---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HP----NVVQFLGAVTQS 222 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~--~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~----~iv~l~~~~~~~ 222 (387)
...|.+...+|.|+||.|. | .+..||||+++.- ....+..+-|+++++++. .| -++++.++|...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 4478888899999999875 2 4789999998732 344566677999999993 33 388889999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC------------
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD------------ 288 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~------------ 288 (387)
++++||+|.+ |.|+.+++..++ +++...+..+++|+++++.+||+.+ ++|.||||+|||+..
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999 779999998765 4888999999999999999999999 999999999999842
Q ss_pred --------CCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 289 --------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 289 --------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
+..++++|||.|.... ...+..+.|..|.|||++.+-+++.++||||+||||+||+||...|++.++.
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDH----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred cceeccCCCcceEEEecCCcceec----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 2358999999987643 2234456789999999999999999999999999999999999999988877
Q ss_pred cHHHH
Q 016544 361 EVPKA 365 (387)
Q Consensus 361 ~~~~~ 365 (387)
+-++.
T Consensus 316 EHLaM 320 (415)
T KOG0671|consen 316 EHLAM 320 (415)
T ss_pred HHHHH
Confidence 74433
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=241.43 Aligned_cols=202 Identities=27% Similarity=0.439 Sum_probs=163.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------c
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------P 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------~ 224 (387)
+|.....||.|+||.++. +|..||+|.+..... .......+.+|+.+++.+.||||+++++++.... .
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 677778999999987762 578999999875432 2233456788999999999999999999987543 4
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
+++++||+. .+|..+.. ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++|+|||++....
T Consensus 95 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred EEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 699999995 47776653 35889999999999999999999999 9999999999999999999999999987542
Q ss_pred cCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......+..
T Consensus 169 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~ 229 (342)
T cd07879 169 A----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229 (342)
T ss_pred C----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2 1223346788999999876 4678899999999999999999999998765555544433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-33 Score=233.34 Aligned_cols=205 Identities=27% Similarity=0.466 Sum_probs=174.8
Q ss_pred cccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC-----ceE
Q 016544 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PMM 226 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-----~~~ 226 (387)
..-.+-||.|.||+|. .+|+.||+|++.. .+..-...+.+.+|++++..++|.|++..++..+-.. .+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3445679999999875 4799999999864 3444555677888999999999999999988776443 478
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+++|.|. .+|..++-....++...++.++.||++||.|||+.+ |+||||||.|.|++.+..+||+|||+++.....
T Consensus 134 V~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 8899995 589999888888999999999999999999999999 999999999999999999999999999987766
Q ss_pred CCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
+....+....|..|.|||++.|. .|+.+.||||.|||+.||+.++..|+..++-+-++.|
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI 270 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI 270 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH
Confidence 55555555668899999999885 6889999999999999999999999988776666655
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=231.83 Aligned_cols=202 Identities=25% Similarity=0.436 Sum_probs=165.9
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEE
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e 230 (387)
|...+.||.|++|.++. .+..|++|.+...... . ......+|+..++++. ||||+++++++..+...++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-W-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-h-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 45567899999988762 4678999998754322 1 1223456889999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+ +++|.+++.... .+++.++..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 99 789999888754 6899999999999999999999999 9999999999999999999999999987654321
Q ss_pred CCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
......++..|+|||.+.+ ..++.++|+||||+++++|++|++||...+..+...++
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~ 211 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKI 211 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHH
Confidence 2223456788999998854 45789999999999999999999999877665555444
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=236.95 Aligned_cols=201 Identities=27% Similarity=0.422 Sum_probs=166.0
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHH----HHHHHHHHHHHHcCCCCcceeeeeEEe-eCCce
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVT-QSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 225 (387)
.|.....||+|+|..|| ...+-||||+-.......++. .+...+|..+-+.+.||.||++|++|. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 45556679999997664 456789999865544333222 344567999999999999999999997 45679
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC---CCCEEEEeecCccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKL 302 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfg~~~~ 302 (387)
|-|+|||+|.+|.-+++....+++.++..|+.||+.||.||.+.. .||||-||||.|||+.. .|.+||.|||++++
T Consensus 544 CTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred eeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 999999999999999999888999999999999999999999987 47999999999999864 56799999999998
Q ss_pred cccCCC------CCcccCCCCCcccccccccC----CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 303 LTVKED------RPLTCQDTSCRYVAPEVFKN----EEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 303 ~~~~~~------~~~~~~~~~~~y~aPE~~~~----~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
+..... ...+...||+.|++||++.- .+.+.++||||.|||+|.++.|+.||...
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 764322 22345679999999998843 36788999999999999999999999753
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=227.41 Aligned_cols=176 Identities=22% Similarity=0.286 Sum_probs=147.8
Q ss_pred cEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCHHHH
Q 016544 166 GTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240 (387)
Q Consensus 166 G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~ 240 (387)
|+|+.|+ .+++.||+|.+.... .+..|...+....||||+++++++......+++|||+++++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 5555554 367899999987542 123344445556799999999999999999999999999999999
Q ss_pred HHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCCCcc
Q 016544 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320 (387)
Q Consensus 241 l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y 320 (387)
+.+...+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++++|||.+...... .....++..|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 988777999999999999999999999998 999999999999999999999999987654322 1122346679
Q ss_pred cccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 321 VAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 321 ~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
+|||.+.+..++.++|+||+|+++|+|++|+.||..
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 999999888889999999999999999999998764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=243.70 Aligned_cols=195 Identities=24% Similarity=0.383 Sum_probs=169.1
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHH-----HHHHHHHHHHHcCC---CCcceeeeeEEeeC
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRV-----RAFRDELALLQKIR---HPNVVQFLGAVTQS 222 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~-----~~~~~E~~~l~~l~---h~~iv~l~~~~~~~ 222 (387)
+|+..+.+|.|.||.|. .+...|+||++.++.+--...+ -..-.|+.+|..++ |+||++++++|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 68888899999999874 2567899999987655322221 22466999999996 99999999999999
Q ss_pred CceEEEEEccC-CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 223 SPMMIVTEYLP-KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 223 ~~~~lv~e~~~-~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
+.+||+||--. |-+|.+++..+..+++.++..|++|++.|+++||+++ |||||||-+|+.++.+|.+||+|||.+.
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchh
Confidence 99999999863 4589999999988999999999999999999999999 9999999999999999999999999986
Q ss_pred ccccCCCCCcccCCCCCcccccccccCCCCC-CchhHHHHHHHHHHHHcCCCCCCC
Q 016544 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~pf~~ 356 (387)
... ..+...+.||..|.|||++.|.+|- ..-|||+||+++|.++..+.||..
T Consensus 719 ~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 643 3455667899999999999998874 678999999999999999999974
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=219.94 Aligned_cols=212 Identities=31% Similarity=0.530 Sum_probs=176.9
Q ss_pred ccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEcc
Q 016544 158 TNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (387)
Q Consensus 158 ~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 232 (387)
.....||.|+++.++. ++..+++|.+...... ...+.+.+|+..+++++|+|++++++++......++++|++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 4556789998877652 3689999999865332 24678889999999999999999999999989999999999
Q ss_pred CCCCHHHHHHHcCC-CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 233 PKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 233 ~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
.+++|.+++..... +++.....++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999999988766 899999999999999999999998 99999999999999999999999999877654321122
Q ss_pred ccCCCCCcccccccc-cCCCCCCchhHHHHHHHHHHHHcCCCCCCC--CCCCcHHHHHHccCCCCC
Q 016544 312 TCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPFTM--KHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg~~pf~~--~~~~~~~~~i~~~~~~~~ 374 (387)
....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .+...+.+.|..+..+++
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 222 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLW 222 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccc
Confidence 234567789999998 666788899999999999999999999987 444467777776665544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=239.16 Aligned_cols=204 Identities=26% Similarity=0.453 Sum_probs=163.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------- 222 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------- 222 (387)
.+|...+.||.|+||.|+. +|..||+|.+..... ...+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 4677888999999998873 578999998865432 3346678899999999999999999876544
Q ss_pred -------CceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC-CCCCEEE
Q 016544 223 -------SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKV 294 (387)
Q Consensus 223 -------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl 294 (387)
...++++||+. ++|.+++.. +.+++..+..++.|+++||.|||+.+ ++|+||||+||+++ .++.++|
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 34789999996 589888864 45899999999999999999999999 99999999999998 4557899
Q ss_pred EeecCccccccCCCC--CcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 295 ADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 295 ~Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
+|||++......... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.++.+....+
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999998754322111 1122346788999998754 46788999999999999999999999877654444443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=227.46 Aligned_cols=206 Identities=26% Similarity=0.442 Sum_probs=168.4
Q ss_pred cccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--------C
Q 016544 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--------S 223 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--------~ 223 (387)
|.....+|+|+||.|+ .+|+.||+|+...+....+-...+ .+|++++..++|+|++.+++.|... .
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpita-lreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITA-LREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHH-HHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4445679999999765 467889999775433332222333 4599999999999999998877532 3
Q ss_pred ceEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
.+|+||.+|+. +|.-++... ..++..++..++.++.+||.|+|++. |+|||+|+.|+||+.+|.+||+|||+++.
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 48999999965 888888754 55999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCCC---cccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 303 LTVKEDRP---LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 303 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
++...... .+..+.|..|.+||.+.|. .++++.|+|..||++.||+||.+-|++.++...+..|.
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 76543322 2344568999999999875 78999999999999999999999999988877766663
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=241.86 Aligned_cols=211 Identities=29% Similarity=0.440 Sum_probs=174.8
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEee-----CCc
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-----SSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~-----~~~ 224 (387)
.|.+.+.+|.|++|.|+ .+++.+|+|+..... +..+++..|.++++.. .|||++.+|++|.. .+.
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 34555678999998876 367889999887543 2335678899999998 59999999999864 357
Q ss_pred eEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
++||||||.+||.-++++.. ..+.+..+..|++.++.|+.+||.+. ++|||||-.|||++.++.+||+|||.+..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeee
Confidence 99999999999999999753 34888889999999999999999999 99999999999999999999999999877
Q ss_pred cccCCCCCcccCCCCCcccccccccCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 303 LTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
....... .....|||.|||||++.-. .|+.++|+||||++..||-.|.+|+.++-+...+=+|-...+|.+
T Consensus 173 ldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkL 248 (953)
T KOG0587|consen 173 LDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 248 (953)
T ss_pred eeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccc
Confidence 6544333 3446789999999998543 567789999999999999999999999998887777644444444
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=262.00 Aligned_cols=185 Identities=25% Similarity=0.430 Sum_probs=154.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.+.....||+|+||.||. +|..||+|.+...... ...|+..+++++||||+++++++......++|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 355567899999998873 5789999998643221 1346788999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++|+|.++++. +++.++..++.|+++||+|||...+.+|+||||||+||+++.++..++. ||.+......
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 9999999999964 7899999999999999999995533449999999999999998888775 6654432211
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
....+++.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 836 -~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 836 -TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred -CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 123568899999999999999999999999999999999999964
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-30 Score=252.17 Aligned_cols=205 Identities=32% Similarity=0.518 Sum_probs=161.2
Q ss_pred cCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-------
Q 016544 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------- 222 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------- 222 (387)
.+|.+...||+|+||.|+ .+|..||||++.... +......+.+|+.++.+++|||||+++..+.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 356777789999999886 489999999998664 455667788899999999999999986533100
Q ss_pred --------------------------------------------------------------------------------
Q 016544 223 -------------------------------------------------------------------------------- 222 (387)
Q Consensus 223 -------------------------------------------------------------------------------- 222 (387)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CceEEEEEccCCCCHHHHHHHcCCC-ChHHHHHHHHHHHHHHHHHHhC
Q 016544 223 --------------------------------SPMMIVTEYLPKGDLRAFLKRKGAL-KPSTAVRFALDIARGMNYLHEN 269 (387)
Q Consensus 223 --------------------------------~~~~lv~e~~~~~sL~~~l~~~~~l-~~~~~~~i~~qi~~~l~~LH~~ 269 (387)
..+||-||||+..++.+++.++... ....+++++++|++||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 1246889999886777777765443 4678899999999999999999
Q ss_pred CCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc-----------------cCCCCCcccCCCCCcccccccccCCC--
Q 016544 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT-----------------VKEDRPLTCQDTSCRYVAPEVFKNEE-- 330 (387)
Q Consensus 270 ~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~-----------------~~~~~~~~~~~~~~~y~aPE~~~~~~-- 330 (387)
| +|||||||.||+++.++.+||+|||++.... ...+...+...||.-|+|||++.+..
T Consensus 717 g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 G---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred c---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 9 9999999999999999999999999997611 11122346678999999999998764
Q ss_pred -CCCchhHHHHHHHHHHHHcCCCCCCC-CCCCcHHHHHH
Q 016544 331 -YDTKVDVFSFALILQEMIEGCPPFTM-KHDNEVPKAYA 367 (387)
Q Consensus 331 -~~~~~Dv~slG~il~elltg~~pf~~-~~~~~~~~~i~ 367 (387)
|+.|+|+||||++++||+. ||.. +....++....
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR 829 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR 829 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc
Confidence 8999999999999999984 4653 22233444444
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=215.74 Aligned_cols=198 Identities=36% Similarity=0.570 Sum_probs=165.6
Q ss_pred ccEEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCHHHHHH
Q 016544 165 KGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242 (387)
Q Consensus 165 ~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~ 242 (387)
.|..+.+.. +|..+++|++........ .+.+.+|+..+++++|+||+++++++......++++|++.+++|.+++.
T Consensus 2 ~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 2 FGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred ceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 345555554 468999999976533221 5788999999999999999999999999899999999999999999998
Q ss_pred HcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCCCcccc
Q 016544 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322 (387)
Q Consensus 243 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~a 322 (387)
....++...+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|++
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 7766899999999999999999999998 9999999999999999999999999987665432 2233456788999
Q ss_pred cccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCCCcHHHHHHcc
Q 016544 323 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM-KHDNEVPKAYAAR 369 (387)
Q Consensus 323 PE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~-~~~~~~~~~i~~~ 369 (387)
||.+.+..++.++|+||||++++++++|..||.. .....+.+.+...
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~ 202 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKP 202 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc
Confidence 9999988889999999999999999999999987 4444444444333
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=216.61 Aligned_cols=203 Identities=28% Similarity=0.383 Sum_probs=165.3
Q ss_pred cCcccceeecccEEEEE----EEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC------Cc
Q 016544 155 LDFTNSVEITKGTFILA----FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v----~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~~ 224 (387)
..|...+.+|.|.-.++ ...+++||+|+...+... ....++..+|..++..+.|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCceEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34555555666654222 146899999999877433 33445567799999999999999999999644 34
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
.|+|||+|. .+|.+++.. .++-.....++.|++.|+.|||+.+ |+||||||+||++..++.+||.|||+++...
T Consensus 96 ~y~v~e~m~-~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM--ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccC
Confidence 799999995 599998884 3678889999999999999999999 9999999999999999999999999997654
Q ss_pred cCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.. ...+....+..|.|||++.+..+...+||||+||++.||++|+.-|.|.+.-+-.-++
T Consensus 170 ~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki 229 (369)
T KOG0665|consen 170 TD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKI 229 (369)
T ss_pred cc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHH
Confidence 32 3445667788999999999999999999999999999999999999987654444444
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=208.48 Aligned_cols=224 Identities=17% Similarity=0.285 Sum_probs=188.7
Q ss_pred ccccCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCce
Q 016544 152 PHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 225 (387)
-.-..|.+++.||+|+||+.+ +++..||||.-.... ...+++.|...++.+ ..++|+..|-+.+...+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 345579999999999999875 578999999765432 234678899999998 589999999999998888
Q ss_pred EEEEEccCCCCHHHHHHHcCC-CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-----CEEEEeecC
Q 016544 226 MIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFGV 299 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-----~~kl~Dfg~ 299 (387)
.||+|++ |.||+++..-++. ++.++++.++.|++.-++++|++. +|.|||||+|+||...+ .+.++|||+
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccc
Confidence 9999999 8999999987665 999999999999999999999999 99999999999998544 489999999
Q ss_pred ccccccCCCCCc------ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC---
Q 016544 300 SKLLTVKEDRPL------TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--- 370 (387)
Q Consensus 300 ~~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~--- 370 (387)
++.+........ ....||.+||+-....|...+++.|+-|||-++++.|-|.+||++.......+++.+.+
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 998776544332 45679999999999999999999999999999999999999999988887777776665
Q ss_pred -CCCCCCChhhhhhc
Q 016544 371 -RPPFKAPAKLYARG 384 (387)
Q Consensus 371 -~~~~~~~~~~~~~~ 384 (387)
..++......+|.+
T Consensus 256 r~T~i~~Lc~g~P~e 270 (449)
T KOG1165|consen 256 RSTPIEVLCEGFPEE 270 (449)
T ss_pred ccCCHHHHHhcCHHH
Confidence 44555555566654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=227.64 Aligned_cols=200 Identities=20% Similarity=0.257 Sum_probs=146.5
Q ss_pred ccCcccceeecccEEEEEEE---------------------cCeEEEEEEcCcccCCCH-----------HHHHHHHHHH
Q 016544 154 ELDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDD-----------DRVRAFRDEL 201 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~---------------------~g~~vavK~~~~~~~~~~-----------~~~~~~~~E~ 201 (387)
..+|...+.||+|+||.||. .++.||||.+........ ...+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 44788889999999999873 245799999864321100 0011233466
Q ss_pred HHHHcCCCCcc-----eeeeeEEee--------CCceEEEEEccCCCCHHHHHHHcC-----------------------
Q 016544 202 ALLQKIRHPNV-----VQFLGAVTQ--------SSPMMIVTEYLPKGDLRAFLKRKG----------------------- 245 (387)
Q Consensus 202 ~~l~~l~h~~i-----v~l~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~----------------------- 245 (387)
.++.+++|.++ ++++++|.. .+..++|+||+++++|.+++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 67777765543 667776653 356899999999999999886421
Q ss_pred -CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCCCcccccc
Q 016544 246 -ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324 (387)
Q Consensus 246 -~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE 324 (387)
.+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.++|+|||++...............+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1345678889999999999999998 999999999999999999999999998654432222222233478999999
Q ss_pred cccCCCC----------------------CCchhHHHHHHHHHHHHcCCC-CCCC
Q 016544 325 VFKNEEY----------------------DTKVDVFSFALILQEMIEGCP-PFTM 356 (387)
Q Consensus 325 ~~~~~~~----------------------~~~~Dv~slG~il~elltg~~-pf~~ 356 (387)
.+..... ..+.|+||+||++|+|++|.. ||.+
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 8864321 124799999999999999886 7764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=224.14 Aligned_cols=204 Identities=25% Similarity=0.362 Sum_probs=170.1
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCC------CcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH------PNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~iv~l~~~~~~~~~ 224 (387)
.|.+....|+|.|+.|. ..|..||||++..+.. ..+.-..|+.+|+++.. -|+++++-.|....+
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 46666677999998775 3578999999986533 23445679999999952 389999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEeecCc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVS 300 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~ 300 (387)
+|||||.+ ...|.+++++-+. +....+..++.|+.-||..|-..+ |+|+||||.|||+++.- .+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999998 4699999987553 888999999999999999999998 99999999999999655 4799999999
Q ss_pred cccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
...+..+. +.+..+..|.|||++.|-+|+...|+||.||+||||+||+..|.|.++..++.-...-+
T Consensus 585 ~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 585 SFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred cccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 87654332 33344667999999999999999999999999999999999999999988877664433
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=200.39 Aligned_cols=197 Identities=21% Similarity=0.438 Sum_probs=161.8
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeC--CceEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~--~~~~l 227 (387)
+|+..+.+|+|.|..|+ .++..++||++++- ..+.+.+|+.+|+.+. ||||+++++...+. ....+
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 67778899999997665 46789999998742 3467899999999995 99999999998754 56889
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-CCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~ 306 (387)
|+|++.+.+...+... ++..++..++.+++.||.|+|+.| |.|||+||.|++++. ...++|+|+|+|.++...
T Consensus 113 iFE~v~n~Dfk~ly~t---l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYPT---LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred HhhhhccccHHHHhhh---hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999988877766554 777889999999999999999999 999999999999995 456999999999988755
Q ss_pred CCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCC-CCCCCCcHHHHH
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPKAY 366 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf-~~~~~~~~~~~i 366 (387)
.. ......+..|-.||.+.. ..+..+-|+|||||++..|+..+.|| .|.++.+.+-+|
T Consensus 187 ~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkI 246 (338)
T KOG0668|consen 187 KE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKI 246 (338)
T ss_pred ce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHH
Confidence 33 333455677899998865 46788999999999999999988887 466665554444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-29 Score=236.86 Aligned_cols=192 Identities=29% Similarity=0.432 Sum_probs=155.6
Q ss_pred cccceeecccEEE----EEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFI----LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~----~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.+|.|+-| .+.+.|+.||||.+..+. .....+|+..++.- .||||+++++.-.+....||..|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 3444556776654 345789999999987543 24567899999998 699999999999999999999999
Q ss_pred cCCCCHHHHHHHcCC----CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC---C--CCEEEEeecCccc
Q 016544 232 LPKGDLRAFLKRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---S--GNLKVADFGVSKL 302 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~----l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~--~~~kl~Dfg~~~~ 302 (387)
|. .+|.+++...+. ...-..+.++.|+++||++||+.+ ||||||||.||||+. + ..++|+|||+++.
T Consensus 585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 95 599999987421 111345788999999999999998 999999999999986 3 3589999999988
Q ss_pred cccCCC--CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCC
Q 016544 303 LTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKH 358 (387)
Q Consensus 303 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~pf~~~~ 358 (387)
...... .......||.+|+|||++....-+.++|||||||++|+.++| ..||.+..
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~ 719 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL 719 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH
Confidence 765433 223556789999999999998888899999999999999985 99998643
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=231.62 Aligned_cols=193 Identities=21% Similarity=0.277 Sum_probs=136.1
Q ss_pred cccCcccceeecccEEEEEEE-----c----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeE-----
Q 016544 153 HELDFTNSVEITKGTFILAFW-----R----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA----- 218 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~----- 218 (387)
...+|...+.||+|+||.||. + +..||+|.+..... .+....| .++...+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 334788889999999999874 3 68999998764321 1111111 1112222222222211
Q ss_pred -EeeCCceEEEEEccCCCCHHHHHHHcCC--------------------CChHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 016544 219 -VTQSSPMMIVTEYLPKGDLRAFLKRKGA--------------------LKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (387)
Q Consensus 219 -~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 277 (387)
.......++|+||+.+++|.+++..... .....+..++.|++.||.|||+++ |+||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHR 279 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHR 279 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 2345679999999999999999875421 112345679999999999999998 9999
Q ss_pred CCCCCCEEeCC-CCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCCC----------------------CCCc
Q 016544 278 DLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE----------------------YDTK 334 (387)
Q Consensus 278 Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----------------------~~~~ 334 (387)
||||+|||++. ++.+||+|||++...............+++.|+|||.+.... +..+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999985 578999999999765433333334456789999999764322 2345
Q ss_pred hhHHHHHHHHHHHHcCCCCCC
Q 016544 335 VDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 335 ~Dv~slG~il~elltg~~pf~ 355 (387)
+|||||||++|||+++..|+.
T Consensus 360 ~DVwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCc
Confidence 699999999999999877654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=202.25 Aligned_cols=218 Identities=20% Similarity=0.347 Sum_probs=164.9
Q ss_pred CccccCccc--cCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeee
Q 016544 146 PEYEIDPHE--LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLG 217 (387)
Q Consensus 146 ~~~ei~~~~--~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~ 217 (387)
+..|+...+ ..|.+.+.+|.|-||... ...+.+++|.+..+ ....++|.+|..---.+ .|.||+.-|+
T Consensus 13 ~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~ 88 (378)
T KOG1345|consen 13 PMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYE 88 (378)
T ss_pred ccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHH
Confidence 344443333 368888999999999764 35688999998865 34467888888766556 4899998877
Q ss_pred -EEeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC--CCCCEEE
Q 016544 218 -AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNLKV 294 (387)
Q Consensus 218 -~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~--~~~~~kl 294 (387)
.|+..+.+++++||++.|+|.+-+...+ +-+.....++.|+++|+.|+|+.+ +||||||.+|||+- +...+||
T Consensus 89 vaFqt~d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 89 VAFQTSDAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred HHhhcCceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEe
Confidence 5677788999999999999998777644 778888999999999999999999 99999999999985 3347999
Q ss_pred EeecCccccccCCCCCcccCCCCCcccccccccCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCC----CcHHHH
Q 016544 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHD----NEVPKA 365 (387)
Q Consensus 295 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~elltg~~pf~~~~~----~~~~~~ 365 (387)
+|||.++..+... .....+..|.+||.+..- ...+.+|+|.||+++|.++||.+||+.... ..-..+
T Consensus 165 cDFG~t~k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~ 240 (378)
T KOG1345|consen 165 CDFGLTRKVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ 240 (378)
T ss_pred eecccccccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH
Confidence 9999986543221 112235668899876432 456889999999999999999999984222 223455
Q ss_pred HHccCCCCCC
Q 016544 366 YAARQRPPFK 375 (387)
Q Consensus 366 i~~~~~~~~~ 375 (387)
++.+..|..+
T Consensus 241 w~~rk~~~~P 250 (378)
T KOG1345|consen 241 WLKRKNPALP 250 (378)
T ss_pred HhcccCccCc
Confidence 5556655443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=204.28 Aligned_cols=221 Identities=23% Similarity=0.313 Sum_probs=176.6
Q ss_pred cccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-Cce
Q 016544 157 FTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPM 225 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-~~~ 225 (387)
++....+.+|+||.+|. +.+.|-+|.++.. .++-....+..|.-.+..+.|||++++.+++..+ ...
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 44455678999998763 2356777777643 3456677788899999999999999999988654 467
Q ss_pred EEEEEccCCCCHHHHHHHc--------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 226 MIVTEYLPKGDLRAFLKRK--------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~--------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
+.++.++.-|.|..|+... ..++.-+...++.|++.|++|||+++ +||.||..+|.+|++.-++||+|=
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccc
Confidence 8889999889999999832 12566678889999999999999999 999999999999999999999999
Q ss_pred cCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCCC
Q 016544 298 GVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK 375 (387)
Q Consensus 298 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 375 (387)
.+++..-+.+- -.....-.+..||+||.+....|+..+|+|||||++|||+| |+.||...++.++..-++.|.|..-
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ- 519 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ- 519 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC-
Confidence 98875432211 11122234678999999999999999999999999999997 9999999999999988888875443
Q ss_pred CChhhhhhcc
Q 016544 376 APAKLYARGL 385 (387)
Q Consensus 376 ~~~~~~~~~l 385 (387)
|-+||++|
T Consensus 520 --P~NCPDeL 527 (563)
T KOG1024|consen 520 --PFNCPDEL 527 (563)
T ss_pred --CCCCcHHH
Confidence 34555554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=185.80 Aligned_cols=205 Identities=19% Similarity=0.226 Sum_probs=168.5
Q ss_pred CcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|...+.||+|+||..| ..|..||||+-+...- -.++..|..+++.++ -.+|+.+..++.+...-.+||
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 67788899999998765 4789999998764422 135677999999996 568888888888888899999
Q ss_pred EccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC---CCCEEEEeecCcccccc
Q 016544 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTV 305 (387)
Q Consensus 230 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfg~~~~~~~ 305 (387)
+.. |.||+++..-+ ..++..+++-++-|++.-++|+|.++ +|||||||+|+|..- ...+.++|||+|+.+..
T Consensus 91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 999 89999998743 44899999999999999999999999 999999999999873 34689999999987654
Q ss_pred CCCCCc------ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 306 KEDRPL------TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 306 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
...... ....||.+|.+-....+-..+.+.|+-|+|.++..+--|..||++.....-.++....
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 332221 3346899999998888888899999999999999999999999998776655554433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-24 Score=183.82 Aligned_cols=179 Identities=38% Similarity=0.650 Sum_probs=151.4
Q ss_pred ecccEEEEEE---Ec--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 163 ITKGTFILAF---WR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 163 lg~G~~~~v~---~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
||.|.++.++ .. +..+++|.+....... ..+.+.+|+..++.+.|++|+++++++......++++|++.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 4667776554 33 8899999997553221 346789999999999999999999999998999999999998999
Q ss_pred HHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-CCCEEEEeecCccccccCCCCCcccCC
Q 016544 238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQD 315 (387)
Q Consensus 238 ~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 315 (387)
.+++... ..++...+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 9999876 46899999999999999999999998 999999999999999 89999999999876543321 122244
Q ss_pred CCCcccccccccCC-CCCCchhHHHHHHHHHHH
Q 016544 316 TSCRYVAPEVFKNE-EYDTKVDVFSFALILQEM 347 (387)
Q Consensus 316 ~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el 347 (387)
+...|++||.+... .++.++|+|++|++++++
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 67789999999887 778899999999999999
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-26 Score=213.30 Aligned_cols=208 Identities=27% Similarity=0.415 Sum_probs=178.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|.....+|.|+||.||. .+...|+|+++.+- .+...-++.|+-+++..+||||+.+++.+......+++||
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 445556899999998874 57889999987653 3345667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
||.+|+|.+..+-.+++++.+...+++..++++.|||+.+ =+|||||-.||++++.|.+|++|||.+..+...- ..
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-~K 168 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AK 168 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-hh
Confidence 9999999999999999999999999999999999999999 8999999999999999999999999987655332 22
Q ss_pred cccCCCCCcccccccc---cCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
...+.||+.|||||+- +.+.|...+|+|++|+...|+-.-++|..+..+.+.+....+-.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~ 231 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSG 231 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccC
Confidence 3456899999999976 44578889999999999999999999988888877776665544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=194.31 Aligned_cols=208 Identities=22% Similarity=0.326 Sum_probs=166.2
Q ss_pred CcccceeecccEEEEEEE----c--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCC----CcceeeeeEE-eeCCc
Q 016544 156 DFTNSVEITKGTFILAFW----R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH----PNVVQFLGAV-TQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~~iv~l~~~~-~~~~~ 224 (387)
.|...+.||+|+||.|+. . ...+|+|.......... ..+..|..++..+.. ++++.+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 788899999999998873 1 24789998765422211 156778888888862 6899999999 47778
Q ss_pred eEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC-----CCEEEEee
Q 016544 225 MMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-----GNLKVADF 297 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-----~~~kl~Df 297 (387)
.|+||+.+ |.+|.++.... +.++..++..++.|++.+|++||+.| ++||||||.|+++... ..+.|.||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 89999998 88999988654 45999999999999999999999999 9999999999999865 35999999
Q ss_pred cCcc--ccccCCCC------C-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 298 GVSK--LLTVKEDR------P-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 298 g~~~--~~~~~~~~------~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
|+++ .+...... . .....||.+|.++.+..+...+++.|+||++.++.+++.|..||.+........++..
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~ 251 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK 251 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence 9998 33222111 1 1234599999999999999999999999999999999999999987765544444433
Q ss_pred cC
Q 016544 369 RQ 370 (387)
Q Consensus 369 ~~ 370 (387)
..
T Consensus 252 ~~ 253 (322)
T KOG1164|consen 252 DP 253 (322)
T ss_pred Hh
Confidence 33
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=193.32 Aligned_cols=200 Identities=22% Similarity=0.367 Sum_probs=161.6
Q ss_pred CcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceE
Q 016544 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~ 226 (387)
.|.....||.|+|+.|+. ....||+|.+..... ...+..|+++|..+ .+.||+++.+++..++...
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 566777899999998862 467899999875433 24588899999999 5999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-CCCEEEEeecCcccccc
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTV 305 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~ 305 (387)
+|+||++.....++... ++..++..+++.++.||.++|.+| ||||||||+|+|.+. .+.-.|+|||++.....
T Consensus 112 ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred EEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999999888888776 668899999999999999999999 999999999999984 45678999999862110
Q ss_pred CC------C------CC-------------------------------cccCCCCCcccccccccCC-CCCCchhHHHHH
Q 016544 306 KE------D------RP-------------------------------LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFA 341 (387)
Q Consensus 306 ~~------~------~~-------------------------------~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG 341 (387)
.. . .. .....||++|.|||++... ..++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0 00 0124589999999999764 568899999999
Q ss_pred HHHHHHHcCCCCCCCC-CCCcHHHHH
Q 016544 342 LILQEMIEGCPPFTMK-HDNEVPKAY 366 (387)
Q Consensus 342 ~il~elltg~~pf~~~-~~~~~~~~i 366 (387)
||+..+++++.||-.. ++...+..|
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei 291 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEI 291 (418)
T ss_pred ceeehhhccccccccCccccchHHHH
Confidence 9999999999998643 334444444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=192.81 Aligned_cols=167 Identities=20% Similarity=0.221 Sum_probs=126.0
Q ss_pred ccCccccCcccceeecccEEEEEEE------cCeEEEEEEcCcccC--CCHHHHHHHHHHHHHHHcCCCCccee-eeeEE
Q 016544 149 EIDPHELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQ-FLGAV 219 (387)
Q Consensus 149 ei~~~~~~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~-l~~~~ 219 (387)
+.......|.....||+|+||.||. ++..||||++..... ......+.+.+|+.++++++|+|+++ +++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 3344455788899999999999873 356789998753321 13344567999999999999999985 443
Q ss_pred eeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC-CCCCEEeCCCCCEEEEeec
Q 016544 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSNILRDDSGNLKVADFG 298 (387)
Q Consensus 220 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dl-kp~Nill~~~~~~kl~Dfg 298 (387)
.+..|+||||++|++|... . +.. ...++.|++++|.|||+++ |+|||| ||+|||++.++.++|+|||
T Consensus 90 --~~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred --cCCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 2468999999999999732 1 111 2467899999999999999 999999 9999999999999999999
Q ss_pred CccccccCCCCCc-------ccCCCCCcccccccccCC
Q 016544 299 VSKLLTVKEDRPL-------TCQDTSCRYVAPEVFKNE 329 (387)
Q Consensus 299 ~~~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~ 329 (387)
+++.+........ ....+++.|+|||.+...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9987654321111 234567789999998653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=224.28 Aligned_cols=146 Identities=16% Similarity=0.216 Sum_probs=113.0
Q ss_pred CCC-CcceeeeeEE-------eeCCceEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 016544 207 IRH-PNVVQFLGAV-------TQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (387)
Q Consensus 207 l~h-~~iv~l~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 277 (387)
++| +||++++++| .....++.++|++ +++|.+++... ..+++.+++.++.||++||.|||+++ |+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 345 5788888877 2234577889988 56999999753 45899999999999999999999999 9999
Q ss_pred CCCCCCEEeCCCC-------------------CEEEEeecCccccccCCC---------------CCcccCCCCCccccc
Q 016544 278 DLEPSNILRDDSG-------------------NLKVADFGVSKLLTVKED---------------RPLTCQDTSCRYVAP 323 (387)
Q Consensus 278 Dlkp~Nill~~~~-------------------~~kl~Dfg~~~~~~~~~~---------------~~~~~~~~~~~y~aP 323 (387)
||||+|||++..+ .+|++|||+++....... .......+|+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 9999999996544 455666666543211000 000113468889999
Q ss_pred ccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 324 EVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 324 E~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
|++.+..++.++|||||||++|||++|.+||..
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 999999999999999999999999999999864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=188.71 Aligned_cols=126 Identities=29% Similarity=0.377 Sum_probs=104.4
Q ss_pred cCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-----C---CcceeeeeEEee
Q 016544 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----H---PNVVQFLGAVTQ 221 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~iv~l~~~~~~ 221 (387)
-.|.+.+.||-|-|.+|- ...+.||+|+.+.. +-..+....|+.+|+++. | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 468888999999997763 35789999998743 334566677999999883 2 369999999975
Q ss_pred C----CceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC
Q 016544 222 S----SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287 (387)
Q Consensus 222 ~----~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~ 287 (387)
. .++++|+|++ |..|..+|... ..++...++.|++||+.||.|||+.. +|||.||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4 3699999999 77999999864 34999999999999999999999975 599999999999984
|
|
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-24 Score=168.11 Aligned_cols=109 Identities=34% Similarity=0.341 Sum_probs=72.0
Q ss_pred CCCCCCcchHHHHHHhhCCHHHHHHHHHc-CCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccc
Q 016544 34 DGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (387)
Q Consensus 34 ~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~-g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~ 112 (387)
+.+|-.||||||+||..|+.++|+.|+.. |+|+|+.+..|.|+||+|+..|+.+|+++|+++|+.++++|..|.||||-
T Consensus 66 ddkDdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtplHR 145 (226)
T KOG4412|consen 66 DDKDDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTPLHR 145 (226)
T ss_pred CCccccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCchhHH
Confidence 33344566667777777777777776666 66777666666777777776667777777777676677777777777776
Q ss_pred ccccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 113 AIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 113 a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
|+.-|..+++++|.+.|+.++.+.....++
T Consensus 146 AAavGklkvie~Li~~~a~~n~qDk~G~Tp 175 (226)
T KOG4412|consen 146 AAAVGKLKVIEYLISQGAPLNTQDKYGFTP 175 (226)
T ss_pred HHhccchhhHHHHHhcCCCCCcccccCccH
Confidence 666666667777766666665554444443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-21 Score=177.47 Aligned_cols=211 Identities=29% Similarity=0.498 Sum_probs=174.0
Q ss_pred cccceeecccEEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCC-cceeeeeEEeeCCceEEEEEccC
Q 016544 157 FTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
|.....+|.|+|+.++. .-..+++|.+.............+.+|..+++.+.|+ +|+++++.+......+++++++.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 45566789999977663 2367899999876655444677889999999999988 79999999977777899999999
Q ss_pred CCCHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEeecCccccccCCCC
Q 016544 234 KGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 234 ~~sL~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~ 309 (387)
++++.+++.... .++......++.|++.++.++|+.+ ++|||+||+||+++..+ .++++|||++.........
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999998877664 6899999999999999999999999 99999999999999988 6999999998755433222
Q ss_pred -----CcccCCCCCcccccccccC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC----CcHHHHHHccC
Q 016544 310 -----PLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHD----NEVPKAYAARQ 370 (387)
Q Consensus 310 -----~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~pf~~~~~----~~~~~~i~~~~ 370 (387)
......++..|++||.+.+ ...+...|+||+|++++++++|..||..... ......+....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 231 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence 2355678999999999988 5788899999999999999999999887664 34445444443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-22 Score=166.76 Aligned_cols=115 Identities=23% Similarity=0.358 Sum_probs=97.7
Q ss_pred CCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCccc
Q 016544 235 GDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (387)
Q Consensus 235 ~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 313 (387)
|+|.+++... ..+++.+++.++.|++.||.|||+++ ||+|||++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999874 45999999999999999999999975 999999999999999 99987654321
Q ss_pred CCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-CcHHHHH
Q 016544 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAY 366 (387)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~-~~~~~~i 366 (387)
..+++.|+|||++.+..++.++|||||||++|||+||+.||..... ....+.+
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 117 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEIL 117 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHH
Confidence 2478999999999999999999999999999999999999976544 2334444
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-22 Score=172.10 Aligned_cols=168 Identities=10% Similarity=0.171 Sum_probs=130.3
Q ss_pred CcccceeecccEEEEEEE---cCeEEEEEEcCcccCCCHHHHHH------HHHHHHHHHcCCCCcceeeeeEEeeC----
Q 016544 156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRA------FRDELALLQKIRHPNVVQFLGAVTQS---- 222 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~---~g~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~~iv~l~~~~~~~---- 222 (387)
+|...+.+|.|+|+.|+. ++..+|+|.+.+.....+...+. +.+|+..+.++.||+|..+.+++...
T Consensus 32 ~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~ 111 (232)
T PRK10359 32 NIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKT 111 (232)
T ss_pred ceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccc
Confidence 677788899999988763 56789999998776655555444 57899999999999999999886643
Q ss_pred ----CceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeec
Q 016544 223 ----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (387)
Q Consensus 223 ----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 298 (387)
+..+++|||++|.+|.++.. ++. ....+++.++..+|+.| ++|||+||+||+++.++ ++|+|||
T Consensus 112 ~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 112 LRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred ccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECC
Confidence 35789999999999988732 222 24569999999999999 99999999999999988 9999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHH
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 348 (387)
........ ... ..++....+..++|+||||+++..+.
T Consensus 180 ~~~~~~e~--~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQR--KAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred Ccccccch--hhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 76543211 110 11344455667899999999987543
|
|
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-22 Score=160.80 Aligned_cols=108 Identities=28% Similarity=0.380 Sum_probs=100.5
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
+.|++..+..|.|+|||||..|..+++++|+++|+.++.+|..|.||||.|+..|+.+++++|+..|+.+|.+|++|+||
T Consensus 96 ~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtplHRAAavGklkvie~Li~~~a~~n~qDk~G~Tp 175 (226)
T KOG4412|consen 96 GADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTPLHRAAAVGKLKVIEYLISQGAPLNTQDKYGFTP 175 (226)
T ss_pred CCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCchhHHHHhccchhhHHHHHhcCCCCCcccccCccH
Confidence 56666677777888999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhCCCCCCCCc
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
||.|...++.++..+|++.|++......
T Consensus 176 L~~al~e~~~d~a~lLV~~gAd~~~edk 203 (226)
T KOG4412|consen 176 LHHALAEGHPDVAVLLVRAGADTDREDK 203 (226)
T ss_pred HHHHHhccCchHHHHHHHhccceeeccc
Confidence 9999888999999999999999866554
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.6e-21 Score=159.46 Aligned_cols=186 Identities=13% Similarity=0.067 Sum_probs=135.3
Q ss_pred cceeecccEEEEEEE---cCeEEEEEEcCcccCCCHH-HHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEEccC
Q 016544 159 NSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDD-RVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 159 ~~~~lg~G~~~~v~~---~g~~vavK~~~~~~~~~~~-~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
....|++|+|+.+++ .+.+++.+.+......... ....+.+|+++++++. ++++++++++ ...+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 345789999999885 4567777766543221111 1225789999999995 5889999886 44699999999
Q ss_pred CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC-CCCCEEeCCCCCEEEEeecCccccccCCCC---
Q 016544 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSNILRDDSGNLKVADFGVSKLLTVKEDR--- 309 (387)
Q Consensus 234 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 309 (387)
|.+|.+.... ....++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 82 GAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred CccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9998754322 12357789999999999999 999999 799999999999999999999754432210
Q ss_pred -C--------cccCCCCCcccccccccCC-CCC-CchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 310 -P--------LTCQDTSCRYVAPEVFKNE-EYD-TKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 310 -~--------~~~~~~~~~y~aPE~~~~~-~~~-~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
. ......++.|++|+...-- ..+ .+.++++.|+-+|.++|+..|+-+..
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0112246677777643221 233 57899999999999999999876543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-22 Score=191.15 Aligned_cols=196 Identities=23% Similarity=0.327 Sum_probs=165.8
Q ss_pred ecccEEEEEE--------EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEEccC
Q 016544 163 ITKGTFILAF--------WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 163 lg~G~~~~v~--------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
+|.|.||.|+ ..|.-+|+|++.+......... ....|..++..++ ||.++++.-.++.+...++++++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 5778887664 3567899999887666544444 5677889999996 9999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCccc
Q 016544 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (387)
Q Consensus 234 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 313 (387)
||.|...+.....+.+.....+...++-++.++|+.+ ++|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 9999988887777888888889999999999999999 999999999999999999999999998765322211
Q ss_pred CCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 314 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
.||..|||||++. .+..++|+||||+++++|+||..||.+ ++..+|...+.+.
T Consensus 154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~ 206 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEM 206 (612)
T ss_pred -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCC
Confidence 6799999999999 567889999999999999999999998 6777776655333
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-21 Score=162.17 Aligned_cols=137 Identities=19% Similarity=0.214 Sum_probs=105.1
Q ss_pred eeecccEEEEEEE----cCeEEEEEEcCcccCCCHH-----------------------HHHHHHHHHHHHHcCCCCcce
Q 016544 161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDD-----------------------RVRAFRDELALLQKIRHPNVV 213 (387)
Q Consensus 161 ~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~~iv 213 (387)
..||.|+|+.||. +|+.||||+++........ .......|...+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 4689999998873 5899999999754321111 011234599999999888775
Q ss_pred eeeeEEeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHH-HhCCCCCeEeCCCCCCCEEeCCCCCE
Q 016544 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL-HENKPVPIIHRDLEPSNILRDDSGNL 292 (387)
Q Consensus 214 ~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~L-H~~~~~~iiH~Dlkp~Nill~~~~~~ 292 (387)
....... ...++||||++++++.........++..++..++.|++.+|.++ |+.+ |+||||||+|||++ ++.+
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcE
Confidence 4443322 22389999999887766544556789999999999999999999 6888 99999999999998 4789
Q ss_pred EEEeecCcccc
Q 016544 293 KVADFGVSKLL 303 (387)
Q Consensus 293 kl~Dfg~~~~~ 303 (387)
+|+|||+|...
T Consensus 157 ~LiDFG~a~~~ 167 (190)
T cd05147 157 YIIDVSQSVEH 167 (190)
T ss_pred EEEEccccccC
Confidence 99999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-21 Score=191.58 Aligned_cols=160 Identities=32% Similarity=0.525 Sum_probs=139.8
Q ss_pred HHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 016544 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276 (387)
Q Consensus 197 ~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 276 (387)
+..|+-+-..++|||++..+..+.......-.||||++ +|..++.+.+.+...++..++.|++.|+.|+|+.| +.|
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iah 443 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAH 443 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---cee
Confidence 66788888889999998888877776666666999999 99999999878999999999999999999999999 999
Q ss_pred CCCCCCCEEeCCCCCEEEEeecCccccccCCC---CCcccCCCCCcccccccccCCCCCC-chhHHHHHHHHHHHHcCCC
Q 016544 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKED---RPLTCQDTSCRYVAPEVFKNEEYDT-KVDVFSFALILQEMIEGCP 352 (387)
Q Consensus 277 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~elltg~~ 352 (387)
||+|++|+++..+|.+||+|||.+..+..... .......|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.
T Consensus 444 rdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~ 523 (601)
T KOG0590|consen 444 RDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRF 523 (601)
T ss_pred ccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCC
Confidence 99999999999999999999999877665433 2334567899999999999999986 5899999999999999999
Q ss_pred CCCCCCCC
Q 016544 353 PFTMKHDN 360 (387)
Q Consensus 353 pf~~~~~~ 360 (387)
||.-....
T Consensus 524 ~Wk~a~~~ 531 (601)
T KOG0590|consen 524 PWKVAKKS 531 (601)
T ss_pred cccccccc
Confidence 99765444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-19 Score=154.73 Aligned_cols=138 Identities=19% Similarity=0.162 Sum_probs=106.7
Q ss_pred eeecccEEEEEEE----cCeEEEEEEcCcccCCCH-----------------------HHHHHHHHHHHHHHcCCCCcce
Q 016544 161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDD-----------------------DRVRAFRDELALLQKIRHPNVV 213 (387)
Q Consensus 161 ~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~h~~iv 213 (387)
..||+|+++.||. +|+.||||+++....... .....+..|...+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 4689999988863 589999999876522100 0122346789999999999875
Q ss_pred eeeeEEeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCE
Q 016544 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNL 292 (387)
Q Consensus 214 ~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~ 292 (387)
....+... ..++||||++|+++.........++..++..++.|++.++.++|+ .| |+||||||+||+++ ++.+
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCE
Confidence 55444333 248999999887654443344567888999999999999999999 88 99999999999999 7899
Q ss_pred EEEeecCccccc
Q 016544 293 KVADFGVSKLLT 304 (387)
Q Consensus 293 kl~Dfg~~~~~~ 304 (387)
+|+|||++....
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.3e-20 Score=156.37 Aligned_cols=136 Identities=18% Similarity=0.300 Sum_probs=104.1
Q ss_pred cccceeecccEEEEEEEc--CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-----CCCcceeeeeEEeeCC---ceE
Q 016544 157 FTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-----RHPNVVQFLGAVTQSS---PMM 226 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~l~~~~~~~~---~~~ 226 (387)
+.....||+|+|+.||.. ....+||++..... ...+.+.+|+.+++.+ .||||++++++++++. .++
T Consensus 4 L~~~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAHPEDAQRCIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEECCCCcCeEEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 455678999999999852 12236887764322 2346789999999999 5799999999999874 334
Q ss_pred -EEEEc--cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHH-HHHHhCCCCCeEeCCCCCCCEEeCCC----CCEEEEe-e
Q 016544 227 -IVTEY--LPKGDLRAFLKRKGALKPSTAVRFALDIARGM-NYLHENKPVPIIHRDLEPSNILRDDS----GNLKVAD-F 297 (387)
Q Consensus 227 -lv~e~--~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l-~~LH~~~~~~iiH~Dlkp~Nill~~~----~~~kl~D-f 297 (387)
+|+|| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++ |+||||||+|||++.. +.++|+| |
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 5578999999764 45555 35678888777 9999999 9999999999999743 3799999 4
Q ss_pred cCcc
Q 016544 298 GVSK 301 (387)
Q Consensus 298 g~~~ 301 (387)
|...
T Consensus 155 G~~~ 158 (210)
T PRK10345 155 GEST 158 (210)
T ss_pred CCcc
Confidence 5433
|
|
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.3e-20 Score=152.84 Aligned_cols=108 Identities=19% Similarity=0.163 Sum_probs=97.4
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHH---HHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEG---IKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLE-RGADVDPKD 103 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~---~~~Ll~~g~~~n~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~~~~ 103 (387)
++.+.+.++.+|+||||+||..|+.+. +++|+++|+++|.+| ..|+||||+|+..++.+++++|++ .|++++.+|
T Consensus 46 ~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d 125 (166)
T PHA02743 46 DGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAIN 125 (166)
T ss_pred cchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcC
Confidence 455667777889999999999988654 899999999999998 589999999999999999999995 799999999
Q ss_pred cCCCCccccccccchHHHHHHHHhhCCCCCCCC
Q 016544 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 104 ~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~ 136 (387)
..|.||||+|+..++.+++++|+++|+++..+.
T Consensus 126 ~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~ 158 (166)
T PHA02743 126 YQHETAYHIAYKMRDRRMMEILRANGAVCDDPL 158 (166)
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcc
Confidence 999999999999999999999999999875443
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.1e-20 Score=172.42 Aligned_cols=115 Identities=28% Similarity=0.312 Sum_probs=106.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
++.+++..|.+|.|+|||||.+++++++++||++|||||+.+ .-|.||||+||++|+..+|.+|+++|||++.+|.+|.
T Consensus 67 ~g~~v~~~D~~g~tlLHWAAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~ 146 (600)
T KOG0509|consen 67 EGESVNNPDREGVTLLHWAAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGL 146 (600)
T ss_pred cCcCCCCCCcCCccceeHHHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCC
Confidence 367788888899999999999999999999999999999998 4599999999999999999999999999999999999
Q ss_pred CccccccccchHHHHHHHHhhCCCCCCCCccccccC
Q 016544 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (387)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~~ 143 (387)
||+|+|+.+++.-++.+++..++++.+......++.
T Consensus 147 ~~lHla~~~~~~~~vayll~~~~d~d~~D~~grTpL 182 (600)
T KOG0509|consen 147 TPLHLAAQFGHTALVAYLLSKGADIDLRDNNGRTPL 182 (600)
T ss_pred cHHHHHHHhCchHHHHHHHHhcccCCCcCCCCCCHH
Confidence 999999999999999999999999988776666653
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-19 Score=142.24 Aligned_cols=97 Identities=27% Similarity=0.230 Sum_probs=77.0
Q ss_pred CCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcc
Q 016544 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (387)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl 110 (387)
.-+|.+|.+|+||||-|+++|+.++|+.|+..|||++++...||||||-||.+++.+|+-+||++|||+|.......|||
T Consensus 88 n~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va~~LLqhgaDVnA~t~g~ltpL 167 (228)
T KOG0512|consen 88 NHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVAGRLLQHGADVNAQTKGLLTPL 167 (228)
T ss_pred ccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHHHHHHhccCcccccccccchhh
Confidence 34677777888888888888888888888888888888888888888888888888888888888888888888788888
Q ss_pred ccccccchH-HHHHHHHh
Q 016544 111 GDAIYYKNH-EVIKLLEK 127 (387)
Q Consensus 111 ~~a~~~~~~-~~~~~L~~ 127 (387)
|+|+...+. ..+.+|+.
T Consensus 168 hlaa~~rn~r~t~~~Ll~ 185 (228)
T KOG0512|consen 168 HLAAGNRNSRDTLELLLH 185 (228)
T ss_pred HHhhcccchHHHHHHHhh
Confidence 888765544 44455543
|
|
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.8e-19 Score=147.24 Aligned_cols=102 Identities=21% Similarity=0.274 Sum_probs=93.8
Q ss_pred CCCCCCCCCCcchHHHHHHhhCC----HHHHHHHHHcCCCCCCCCC-CCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCC
Q 016544 30 GLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDI-DNRTALHVAACQGFTEVVSLLLE-RGADVDPKD 103 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~----~~~~~~Ll~~g~~~n~~d~-~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~~~~ 103 (387)
+.+.+.++..|+||||+|+..|+ .+++++|+++|+++|.+|. +|+||||+|+..++.+++++|+. .|++++.+|
T Consensus 50 ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n 129 (169)
T PHA02741 50 AAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQEMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCN 129 (169)
T ss_pred hhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCCCcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCC
Confidence 45566777788899999999999 5899999999999999985 89999999999999999999998 599999999
Q ss_pred cCCCCccccccccchHHHHHHHHhhCCC
Q 016544 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK 131 (387)
Q Consensus 104 ~~g~tpl~~a~~~~~~~~~~~L~~~g~~ 131 (387)
..|.||||+|...++.+++++|.+.++.
T Consensus 130 ~~g~tpL~~A~~~~~~~iv~~L~~~~~~ 157 (169)
T PHA02741 130 ADNKSPFELAIDNEDVAMMQILREIVAT 157 (169)
T ss_pred CCCCCHHHHHHHCCCHHHHHHHHHHHHH
Confidence 9999999999999999999999998765
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-19 Score=159.28 Aligned_cols=217 Identities=19% Similarity=0.321 Sum_probs=135.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC----------CCcceeeeeEEe
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR----------HPNVVQFLGAVT 220 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------h~~iv~l~~~~~ 220 (387)
.+..+..||.|+++.|+. +|+++|+|++...........+++++|.-....+. |-.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 455677899999988763 67999999887655444556777877775555532 223333333322
Q ss_pred eC------------C-----ceEEEEEccCCCCHHHHHH---HcCCC----ChHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 016544 221 QS------------S-----PMMIVTEYLPKGDLRAFLK---RKGAL----KPSTAVRFALDIARGMNYLHENKPVPIIH 276 (387)
Q Consensus 221 ~~------------~-----~~~lv~e~~~~~sL~~~l~---~~~~l----~~~~~~~i~~qi~~~l~~LH~~~~~~iiH 276 (387)
.. . ..+++|+-+. ++|.+++. ..... .......+..|+++.+++||+.| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11 1 2367888884 58888764 22222 22334556689999999999999 999
Q ss_pred CCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCC--------CCCCchhHHHHHHHHHHHH
Q 016544 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--------EYDTKVDVFSFALILQEMI 348 (387)
Q Consensus 277 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~Dv~slG~il~ell 348 (387)
+||+|+|++++.+|.++|+||+.....+.. ......+..|.+||..... .++.+.|.|+||+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999876543321 1112335678999976442 4678899999999999999
Q ss_pred cCCCCCCCCCCCcHHHHHHccCCCCCCCChhhh
Q 016544 349 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381 (387)
Q Consensus 349 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 381 (387)
+|..||....+.......-..++ .++++.+.+
T Consensus 245 C~~lPf~~~~~~~~~~~~f~~C~-~~Pe~v~~L 276 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEWDFSRCR-DMPEPVQFL 276 (288)
T ss_dssp HSS-STCCCGGGSTSGGGGTTSS----HHHHHH
T ss_pred HccCCCCCCCccccccccchhcC-CcCHHHHHH
Confidence 99999997766555443223334 444444443
|
|
| >PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=129.40 Aligned_cols=87 Identities=44% Similarity=0.583 Sum_probs=82.1
Q ss_pred HHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHHHH
Q 016544 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123 (387)
Q Consensus 44 l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~ 123 (387)
||+||..|+.+++++|++.+++++. |+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..++.++++
T Consensus 1 L~~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~ 76 (89)
T PF12796_consen 1 LHIAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVK 76 (89)
T ss_dssp HHHHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHH
T ss_pred CHHHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHH
Confidence 7999999999999999999999987 899999999999999999999999999999999999999999999999999
Q ss_pred HHHhhCCCCCC
Q 016544 124 LLEKHGAKPLM 134 (387)
Q Consensus 124 ~L~~~g~~~~~ 134 (387)
+|+++|+++..
T Consensus 77 ~Ll~~g~~~~~ 87 (89)
T PF12796_consen 77 LLLEHGADVNI 87 (89)
T ss_dssp HHHHTTT-TTS
T ss_pred HHHHcCCCCCC
Confidence 99999998754
|
These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B .... |
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=149.54 Aligned_cols=98 Identities=21% Similarity=0.253 Sum_probs=49.9
Q ss_pred CcchHHHHHHhh---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH--cCCHHHHHHHHHCCCCCCCCCcCCCCcccc-
Q 016544 39 KPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAAC--QGFTEVVSLLLERGADVDPKDRWGSTPLGD- 112 (387)
Q Consensus 39 ~g~t~l~~a~~~---~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~--~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~- 112 (387)
.|+||||+|+.. ++.+++++|+++|+|+|.+|.+|.||||+|+. .++.+++++|+++|++++.+|..|.||||.
T Consensus 86 ~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~~~~~~iv~~Li~~gadin~~d~~g~t~Lh~~ 165 (209)
T PHA02859 86 NNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDGKNLLHMYMCNFNVRINVIKLLIDSGVSFLNKDFDNNNILYSY 165 (209)
T ss_pred CCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCcccccCCCCcHHHHH
Confidence 445555554432 24555555555555555555555555555443 234555555555555555555555555552
Q ss_pred ccccchHHHHHHHHhhCCCCCCCC
Q 016544 113 AIYYKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 113 a~~~~~~~~~~~L~~~g~~~~~~~ 136 (387)
|...++.+++++|++.|+++....
T Consensus 166 a~~~~~~~iv~~Ll~~Gadi~~~d 189 (209)
T PHA02859 166 ILFHSDKKIFDFLTSLGIDINETN 189 (209)
T ss_pred HHhcCCHHHHHHHHHcCCCCCCCC
Confidence 333445555555555555544333
|
|
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=155.55 Aligned_cols=100 Identities=26% Similarity=0.272 Sum_probs=92.7
Q ss_pred CCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccc
Q 016544 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (387)
Q Consensus 34 ~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a 113 (387)
+..|.+|+||||+||..|+.+++++|+++|+++|..| |+||||+|+..|+.+++++|+++|++++.+|..|+||||+|
T Consensus 24 ~~~D~~G~TpLh~Aa~~g~~eiv~~Ll~~ga~~n~~d--~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~A 101 (284)
T PHA02791 24 FKADVHGHSALYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYA 101 (284)
T ss_pred CCCCCCCCcHHHHHHHcCCHHHHHHHHHCcCCCcCCC--CCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence 3567789999999999999999999999999998875 68999999999999999999999999999999999999999
Q ss_pred cccchHHHHHHHHhhCCCCCCC
Q 016544 114 IYYKNHEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 114 ~~~~~~~~~~~L~~~g~~~~~~ 135 (387)
+..++.+++++|+++|+++...
T Consensus 102 a~~g~~eivk~Ll~~gadin~~ 123 (284)
T PHA02791 102 VDSGNMQTVKLFVKKNWRLMFY 123 (284)
T ss_pred HHcCCHHHHHHHHHCCCCcCcc
Confidence 9999999999999999987543
|
|
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=155.19 Aligned_cols=91 Identities=24% Similarity=0.198 Sum_probs=63.9
Q ss_pred cchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC-Cccccccccch
Q 016544 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS-TPLGDAIYYKN 118 (387)
Q Consensus 40 g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~-tpl~~a~~~~~ 118 (387)
|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+||..|+.+++++|+++|++++.++..|+ ||||+|+..++
T Consensus 61 ~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~Aa~~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~ 140 (284)
T PHA02791 61 NEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLND 140 (284)
T ss_pred CCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCC
Confidence 46777777777777777777777777777777777777777777777777777777777776666664 66777776677
Q ss_pred HHHHHHHHhhCC
Q 016544 119 HEVIKLLEKHGA 130 (387)
Q Consensus 119 ~~~~~~L~~~g~ 130 (387)
.+++++|++.+.
T Consensus 141 ~eivk~LL~~~~ 152 (284)
T PHA02791 141 VSIVSYFLSEIP 152 (284)
T ss_pred HHHHHHHHhcCC
Confidence 777776666654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.3e-19 Score=175.94 Aligned_cols=195 Identities=23% Similarity=0.308 Sum_probs=155.1
Q ss_pred ccCccccCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC---CCcceeeeeEEee
Q 016544 149 EIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQ 221 (387)
Q Consensus 149 ei~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~ 221 (387)
++......|.+.+++|.|+||.||+ +|+.||+|+-+...... |.-=.+++.+++ -+.|..+..++..
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 3334445788899999999999986 68999999987665432 111223334444 2345555555566
Q ss_pred CCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-------CCCEEE
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-------SGNLKV 294 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-------~~~~kl 294 (387)
.+.-++|+||.+.|+|.+++...+.+++..+..++.|++..++.||..+ |||+||||+|+||.. .-.++|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 6777899999999999999998778999999999999999999999999 999999999999963 234899
Q ss_pred EeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCC
Q 016544 295 ADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352 (387)
Q Consensus 295 ~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~ 352 (387)
+|||.+--+..-.+. ......+|-.+-++|+..|++++..+|.|-|+.+++.||.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999988655443333 4455677889999999999999999999999999999999874
|
|
| >KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-18 Score=142.52 Aligned_cols=105 Identities=27% Similarity=0.276 Sum_probs=99.3
Q ss_pred CCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccc
Q 016544 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~ 112 (387)
+|.-|..|.|||+||+.+|++.+|++|++.|||++...+...|+|.+|+..|..+||++|++++.|+|..|.+|-|||-|
T Consensus 153 VN~~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgTpLly 232 (296)
T KOG0502|consen 153 VNACDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGTPLLY 232 (296)
T ss_pred ccCccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCceeee
Confidence 55667789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchHHHHHHHHhhCCCCCCCCc
Q 016544 113 AIYYKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 113 a~~~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
|+..++.++++.|+..|+++.....
T Consensus 233 Avrgnhvkcve~Ll~sGAd~t~e~d 257 (296)
T KOG0502|consen 233 AVRGNHVKCVESLLNSGADVTQEDD 257 (296)
T ss_pred eecCChHHHHHHHHhcCCCcccccc
Confidence 9999999999999999999865543
|
|
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.2e-19 Score=144.97 Aligned_cols=99 Identities=20% Similarity=0.227 Sum_probs=91.4
Q ss_pred CCCCCCcchHHHHHHhhCCH---HHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCCcCCCC
Q 016544 34 DGEEIKPEFRLMFLANERDV---EGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDRWGST 108 (387)
Q Consensus 34 ~~~~~~g~t~l~~a~~~~~~---~~~~~Ll~~g~~~n~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~~~~~~g~t 108 (387)
+..|..|+||||+||..|+. +++++|++.|+++|.+| .+|+||||+|+..++.+++++|++ .|++++.+|..|.|
T Consensus 49 ~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~t 128 (154)
T PHA02736 49 LEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKT 128 (154)
T ss_pred HHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCC
Confidence 34577899999999999987 46899999999999998 589999999999999999999998 49999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCC
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
|||+|+..++.+++++|++.|++.
T Consensus 129 pL~~A~~~~~~~i~~~Ll~~ga~~ 152 (154)
T PHA02736 129 PYYVACERHDAKMMNILRAKGAQC 152 (154)
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCC
Confidence 999999999999999999999875
|
|
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=144.65 Aligned_cols=110 Identities=20% Similarity=0.176 Sum_probs=95.2
Q ss_pred CCCCCCCcchHHHHHHhhCCHHHHHHHHH------cCCCCCCCCCCCCcHHHHHHHcCC----HHHHHHHHHCCCCCCCC
Q 016544 33 DDGEEIKPEFRLMFLANERDVEGIKELLD------SGIDVNFRDIDNRTALHVAACQGF----TEVVSLLLERGADVDPK 102 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~------~g~~~n~~d~~g~t~Lh~A~~~~~----~~~~~~Ll~~ga~~~~~ 102 (387)
.+.++..|.||||+||..|+.++++.|+. .|+++|.+|..|+||||+|+..|+ .+++++|+++|++++.+
T Consensus 14 ~~~~~~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~ 93 (169)
T PHA02741 14 IAEKNSEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQ 93 (169)
T ss_pred hhccccCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCC
Confidence 34556678899999999999999999853 378999999999999999999999 58999999999999999
Q ss_pred Cc-CCCCccccccccchHHHHHHHHh-hCCCCCCCCcccccc
Q 016544 103 DR-WGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHVKHA 142 (387)
Q Consensus 103 ~~-~g~tpl~~a~~~~~~~~~~~L~~-~g~~~~~~~~~~~~~ 142 (387)
+. .|+||||+|+..++.+++++|+. .|+++........++
T Consensus 94 ~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~tp 135 (169)
T PHA02741 94 EMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKSP 135 (169)
T ss_pred CcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCCH
Confidence 85 99999999999999999999997 588876554443333
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-18 Score=166.13 Aligned_cols=107 Identities=31% Similarity=0.438 Sum_probs=100.5
Q ss_pred cCCCCCCCCCC-cchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC
Q 016544 29 NGLDDDGEEIK-PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~-g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
+|.|++..+.. |.||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 156 ~gadin~~~~~~g~tpLh~A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~ 235 (477)
T PHA02878 156 YGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGN 235 (477)
T ss_pred cCCCCCccCCCCCCCHHHHHHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCC
Confidence 57788888887 99999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc-chHHHHHHHHhhCCCCCCC
Q 016544 108 TPLGDAIYY-KNHEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 108 tpl~~a~~~-~~~~~~~~L~~~g~~~~~~ 135 (387)
||||+|+.. ++.+++++|+++|+++...
T Consensus 236 TpLh~A~~~~~~~~iv~~Ll~~gadvn~~ 264 (477)
T PHA02878 236 TPLHISVGYCKDYDILKLLLEHGVDVNAK 264 (477)
T ss_pred CHHHHHHHhcCCHHHHHHHHHcCCCCCcc
Confidence 999999975 6899999999999998654
|
|
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.9e-19 Score=158.28 Aligned_cols=104 Identities=29% Similarity=0.395 Sum_probs=96.3
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
.++++|..+....|||--||..|+.++|++|+++|||++..|..|.|.||+||+.|+.+|+++|++.|||+|.++..|.|
T Consensus 106 ~ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~kGNT 185 (615)
T KOG0508|consen 106 RGASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYKGNT 185 (615)
T ss_pred hcCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcccCch
Confidence 45666777777789999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCC
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
+||.+++.|+.|++++|+++|+.+
T Consensus 186 ALH~caEsG~vdivq~Ll~~ga~i 209 (615)
T KOG0508|consen 186 ALHDCAESGSVDIVQLLLKHGAKI 209 (615)
T ss_pred HHHhhhhcccHHHHHHHHhCCcee
Confidence 999999999999999999988765
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.7e-18 Score=163.00 Aligned_cols=109 Identities=32% Similarity=0.472 Sum_probs=102.2
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
.+.|.+.++..|.||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 113 ~g~d~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~g~t 192 (434)
T PHA02874 113 CGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGES 192 (434)
T ss_pred CcCCCCCCCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCC
Confidence 45677778888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCCCCCCc
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
|||+|+..|+.+++++|++.|+++.....
T Consensus 193 pL~~A~~~g~~~iv~~Ll~~g~~i~~~~~ 221 (434)
T PHA02874 193 PLHNAAEYGDYACIKLLIDHGNHIMNKCK 221 (434)
T ss_pred HHHHHHHcCCHHHHHHHHhCCCCCcCCCC
Confidence 99999999999999999999998755443
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.7e-18 Score=160.98 Aligned_cols=116 Identities=31% Similarity=0.408 Sum_probs=102.2
Q ss_pred hhhhhhcCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCC
Q 016544 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102 (387)
Q Consensus 23 ~~~~~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 102 (387)
+++|++|.... .-+.|||||||++|++.+|++|+++|||++.+|.+|.||||.|+..|+.-++-+||.+|+|+|.+
T Consensus 99 ~~gadvn~~gG----~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~ 174 (600)
T KOG0509|consen 99 SHGADVNAIGG----VLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLR 174 (600)
T ss_pred HcCCCccccCC----CCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCc
Confidence 45555555554 34678999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCccccccccchHHHHHHHHhhCCCCCCCC-cccccc
Q 016544 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP-MHVKHA 142 (387)
Q Consensus 103 ~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~-~~~~~~ 142 (387)
|.+|.|||++|+..+....+..|+..|+.+.... .+..++
T Consensus 175 D~~grTpLmwAaykg~~~~v~~LL~f~a~~~~~d~~~g~Tp 215 (600)
T KOG0509|consen 175 DNNGRTPLMWAAYKGFALFVRRLLKFGASLLLTDDNHGNTP 215 (600)
T ss_pred CCCCCCHHHHHHHhcccHHHHHHHHhcccccccccccCCch
Confidence 9999999999999999988999999999886655 444433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-18 Score=171.56 Aligned_cols=179 Identities=30% Similarity=0.465 Sum_probs=133.8
Q ss_pred ccCccccCcccceeecccEEEEEEEc-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC
Q 016544 149 EIDPHELDFTNSVEITKGTFILAFWR-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (387)
Q Consensus 149 ei~~~~~~~~~~~~lg~G~~~~v~~~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 223 (387)
...+.+.+|...+.+..|.||.||.- .+.+|+|+-+.+.+ +++ ++.....|.+|
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li--------lRn---ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI--------LRN---ILTFAGNPFVV---------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhcccccchh--------hhc---cccccCCccee----------
Confidence 45566778888899999999988753 45677743221110 111 33444455444
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
|+-...++.-++++..- +-+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++..
T Consensus 136 -----------gDc~tllk~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 -----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred -----------chhhhhcccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 44445555544444432 67899999999 999999999999999999999999998754
Q ss_pred ccCCC--------------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 304 TVKED--------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 304 ~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
..... .......||+.|.|||++....|+..+|||++|+|+||.+-|..||.+.+++++..++...
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd 273 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 273 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh
Confidence 32111 0113356899999999999999999999999999999999999999999999999998766
Q ss_pred C
Q 016544 370 Q 370 (387)
Q Consensus 370 ~ 370 (387)
.
T Consensus 274 ~ 274 (1205)
T KOG0606|consen 274 D 274 (1205)
T ss_pred h
Confidence 6
|
|
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.1e-18 Score=145.10 Aligned_cols=105 Identities=26% Similarity=0.279 Sum_probs=91.9
Q ss_pred CCCCCCCcchHHHHHHhhC--CHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHc---CCHHHHHHHHHCCCCCCCCCcCC
Q 016544 33 DDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRD-IDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWG 106 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~--~~~~~~~Ll~~g~~~n~~d-~~g~t~Lh~A~~~---~~~~~~~~Ll~~ga~~~~~~~~g 106 (387)
.+..+..|.||||+|+..+ +.+++++|+++|+|+|.++ ..|+||||+|+.. ++.+++++|+++|+++|.+|..|
T Consensus 44 ~n~~~~~g~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G 123 (209)
T PHA02859 44 VNDCNDLYETPIFSCLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDG 123 (209)
T ss_pred hhccCccCCCHHHHHHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCC
Confidence 3455678899999999854 8999999999999999997 4799999998864 47999999999999999999999
Q ss_pred CCccccccc--cchHHHHHHHHhhCCCCCCCCc
Q 016544 107 STPLGDAIY--YKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 107 ~tpl~~a~~--~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
.||||+|+. .++.+++++|++.|+++.....
T Consensus 124 ~TpLh~a~~~~~~~~~iv~~Li~~gadin~~d~ 156 (209)
T PHA02859 124 KNLLHMYMCNFNVRINVIKLLIDSGVSFLNKDF 156 (209)
T ss_pred CCHHHHHHHhccCCHHHHHHHHHcCCCcccccC
Confidence 999999875 4689999999999999865443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.9e-17 Score=141.69 Aligned_cols=134 Identities=23% Similarity=0.362 Sum_probs=111.5
Q ss_pred eeecccEEEEEE---EcCeEEEEEEcCcccCCCH-----HHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEcc
Q 016544 161 VEITKGTFILAF---WRGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (387)
Q Consensus 161 ~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 232 (387)
+.||+|++|.|| +.|..+++|.......... .....+.+|+.++..+.|++|+....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 358999998776 5688999998765433222 12345778999999999999888777777778889999999
Q ss_pred CCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 233 ~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
+|++|.+++..... ....++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999876432 78889999999999999999 99999999999999 78899999998865
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.7e-18 Score=161.02 Aligned_cols=109 Identities=21% Similarity=0.249 Sum_probs=96.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC--CHHHHHHHHHCCCCCCC-CCcC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDP-KDRW 105 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~--~~~~~~~Ll~~ga~~~~-~~~~ 105 (387)
++.|++.++..|+||||+||..|+.+++++|+++|||+|.+|.+|+||||+|+..+ ..+++++|+++|++++. .|..
T Consensus 61 ~Gadvn~~d~~G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~~ 140 (446)
T PHA02946 61 RGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDEE 140 (446)
T ss_pred CcCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCCC
Confidence 67777888888999999999999999999999999999999999999999998866 48999999999999995 6889
Q ss_pred CCCccccccccchHHHHHHHHhhCCCCCCCCcc
Q 016544 106 GSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (387)
Q Consensus 106 g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~ 138 (387)
|.|||+ |+..++.+++++|++.|+++......
T Consensus 141 g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~ 172 (446)
T PHA02946 141 GCGPLL-ACTDPSERVFKKIMSIGFEARIVDKF 172 (446)
T ss_pred CCcHHH-HHHCCChHHHHHHHhccccccccCCC
Confidence 999997 56678899999999999987655443
|
|
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=160.33 Aligned_cols=101 Identities=24% Similarity=0.224 Sum_probs=93.1
Q ss_pred CCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccc
Q 016544 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (387)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~ 115 (387)
.+..|.||||+||..|+.+++++|+++|+|+|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus 98 ~~~~g~tpL~~A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~ 177 (413)
T PHA02875 98 FYKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMA 177 (413)
T ss_pred ccCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Confidence 34568999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cchHHHHHHHHhhCCCCCCCC
Q 016544 116 YKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 116 ~~~~~~~~~L~~~g~~~~~~~ 136 (387)
.|+.+++++|++.|+++....
T Consensus 178 ~g~~eiv~~Ll~~ga~~n~~~ 198 (413)
T PHA02875 178 KGDIAICKMLLDSGANIDYFG 198 (413)
T ss_pred cCCHHHHHHHHhCCCCCCcCC
Confidence 999999999999999886544
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.4e-18 Score=173.24 Aligned_cols=111 Identities=27% Similarity=0.282 Sum_probs=99.0
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH--------------------------
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC-------------------------- 82 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~-------------------------- 82 (387)
.+.|.+..|..|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+.
T Consensus 547 ~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g~~~iv~~L~~~~~~~~~~~~~~~L 626 (823)
T PLN03192 547 AKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHHKIFRILYHFASISDPHAAGDLL 626 (823)
T ss_pred CCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHhcCcccCcccCchHH
Confidence 577888888899999999999999999999999999999999999999886554
Q ss_pred -----cCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHHHHHHHhhCCCCCCCCccc
Q 016544 83 -----QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (387)
Q Consensus 83 -----~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~ 139 (387)
.|+.+++++|+++|+|+|.+|..|.||||+|+..|+.+++++|+++|+++.......
T Consensus 627 ~~Aa~~g~~~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAdv~~~~~~g 688 (823)
T PLN03192 627 CTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDKANTDD 688 (823)
T ss_pred HHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCCCCCC
Confidence 555666777888999999999999999999999999999999999999987665443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.3e-17 Score=140.81 Aligned_cols=130 Identities=25% Similarity=0.367 Sum_probs=105.5
Q ss_pred ecccEEEEEE---EcCeEEEEEEcCcccCCC-----HHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 163 ITKGTFILAF---WRGIQVAVKKLGEEVISD-----DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 163 lg~G~~~~v~---~~g~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
||+|+++.|| ++|..|++|......... .....++.+|+.+++.+.|+++.....++......+++|||++|
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 7899998776 578899999865433222 12245678899999999988766665566667778999999999
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
++|.+++..... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++...
T Consensus 82 ~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 82 KPLKDVIEEGND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998765321 78899999999999999 99999999999999 789999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=149.83 Aligned_cols=91 Identities=21% Similarity=0.140 Sum_probs=47.9
Q ss_pred HHHHHhhCCHHHHHHHHHcCCCCCCCC----CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCC-CcCCCCccccccccch
Q 016544 44 LMFLANERDVEGIKELLDSGIDVNFRD----IDNRTALHVAACQGFTEVVSLLLERGADVDPK-DRWGSTPLGDAIYYKN 118 (387)
Q Consensus 44 l~~a~~~~~~~~~~~Ll~~g~~~n~~d----~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~-~~~g~tpl~~a~~~~~ 118 (387)
||.|+..|+.+++++|+++|||+|.++ ..|.||||+|+..++.+++++|+++||++|.+ +..|.||||+|+..++
T Consensus 37 L~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~~ 116 (300)
T PHA02884 37 LYSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHGC 116 (300)
T ss_pred HHHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcCC
Confidence 334444455555555555555555542 34555555555555555555555555555553 2345555555555555
Q ss_pred HHHHHHHHhhCCCCCC
Q 016544 119 HEVIKLLEKHGAKPLM 134 (387)
Q Consensus 119 ~~~~~~L~~~g~~~~~ 134 (387)
.+++++|+..|+++..
T Consensus 117 ~eivklLL~~GAdin~ 132 (300)
T PHA02884 117 LKCLEILLSYGADINI 132 (300)
T ss_pred HHHHHHHHHCCCCCCC
Confidence 5555555555555543
|
|
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.4e-18 Score=156.78 Aligned_cols=98 Identities=26% Similarity=0.210 Sum_probs=90.2
Q ss_pred CCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccccccc
Q 016544 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116 (387)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~ 116 (387)
+..|.||+|.|+..++.+++++|+++|||+|.+|..|.||||+|+..|+.+++++|+++||+++.+|..|.||||+|+..
T Consensus 185 ~~~~~t~l~~a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa~~ 264 (437)
T PHA02795 185 KIIQYTRGFLVDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTCLDVAVDR 264 (437)
T ss_pred hhhccchhHHHHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHc
Confidence 34578999999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred c--------hHHHHHHHHhhCCCCCC
Q 016544 117 K--------NHEVIKLLEKHGAKPLM 134 (387)
Q Consensus 117 ~--------~~~~~~~L~~~g~~~~~ 134 (387)
| +.+++++|+++|+++..
T Consensus 265 g~~~~~~~~~~eIvelLL~~gadI~~ 290 (437)
T PHA02795 265 GSVIARRETHLKILEILLREPLSIDC 290 (437)
T ss_pred CCcccccccHHHHHHHHHhCCCCCCc
Confidence 7 46999999999987754
|
|
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=147.59 Aligned_cols=98 Identities=22% Similarity=0.261 Sum_probs=88.0
Q ss_pred cCCCCCCC----CCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCC-CCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Q 016544 29 NGLDDDGE----EIKPEFRLMFLANERDVEGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103 (387)
Q Consensus 29 ~~~~~~~~----~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~-d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 103 (387)
+|+|++.+ +..|.||||+|+..|+.+++++|+++|||+|.+ +..|.||||+|+..++.+++++|+++|++++.+|
T Consensus 55 ~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~~~eivklLL~~GAdin~kd 134 (300)
T PHA02884 55 LGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHGCLKCLEILLSYGADINIQT 134 (300)
T ss_pred CCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Confidence 45555554 347999999999999999999999999999996 4679999999999999999999999999999999
Q ss_pred cCCCCccccccccchHHHHHHHH
Q 016544 104 RWGSTPLGDAIYYKNHEVIKLLE 126 (387)
Q Consensus 104 ~~g~tpl~~a~~~~~~~~~~~L~ 126 (387)
..|.||||+|+..++.+++..+.
T Consensus 135 ~~G~TpL~~A~~~~~~~~~~~~~ 157 (300)
T PHA02884 135 NDMVTPIELALMICNNFLAFMIC 157 (300)
T ss_pred CCCCCHHHHHHHhCChhHHHHhc
Confidence 99999999999988888876554
|
|
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2e-17 Score=158.37 Aligned_cols=106 Identities=25% Similarity=0.325 Sum_probs=100.1
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC-
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS- 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~- 107 (387)
.|.|++..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++..+..|.
T Consensus 124 ~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~eiv~~Ll~~ga~~n~~~~~~~~ 203 (413)
T PHA02875 124 RGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGANIDYFGKNGCV 203 (413)
T ss_pred CCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCc
Confidence 5778888888899999999999999999999999999999999999999999999999999999999999999998875
Q ss_pred CccccccccchHHHHHHHHhhCCCCCC
Q 016544 108 TPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (387)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~g~~~~~ 134 (387)
||+|+|+..++.+++++|+++|+++..
T Consensus 204 t~l~~A~~~~~~~iv~~Ll~~gad~n~ 230 (413)
T PHA02875 204 AALCYAIENNKIDIVRLFIKRGADCNI 230 (413)
T ss_pred hHHHHHHHcCCHHHHHHHHHCCcCcch
Confidence 789999999999999999999999854
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-17 Score=165.07 Aligned_cols=109 Identities=21% Similarity=0.199 Sum_probs=82.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCC--HHHHHHHHHcCCCCCCCCCCCCcHHHHH--------------------------
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERD--VEGIKELLDSGIDVNFRDIDNRTALHVA-------------------------- 80 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~--~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A-------------------------- 80 (387)
+|.|++.++..|+||||+|+..|+ .++|++|+++|||+|.+|..|+||||+|
T Consensus 201 ~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~~ 280 (764)
T PHA02716 201 NGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYIINIDNINPEITNIYIESLDGNKVKN 280 (764)
T ss_pred cCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhcccccccc
Confidence 566777777778888888888874 4788888888888888888888888864
Q ss_pred -----------HHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccc--cchHHHHHHHHhhCCCCCCCCc
Q 016544 81 -----------ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY--YKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 81 -----------~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~--~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
+..|+.+++++|+++|++++.+|..|+||||+|+. .++.+++++|++.|+++.....
T Consensus 281 ~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~kD~ 350 (764)
T PHA02716 281 IPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEPDN 350 (764)
T ss_pred chhhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccCCC
Confidence 34467778888888888888888888888887653 4567888888888887755443
|
|
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.1e-17 Score=138.88 Aligned_cols=109 Identities=20% Similarity=0.197 Sum_probs=92.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCH----HHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH---HHHHHHCCCCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDV----EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV---VSLLLERGADVDP 101 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~----~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~---~~~Ll~~ga~~~~ 101 (387)
|+.|.+..+.++.++||.||+.|+. +++++|++.|+++|.+|.+|+||||+|+..|+.++ +++|+++|++++.
T Consensus 9 ~~~~~~~~~~~~~~~l~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~ 88 (166)
T PHA02743 9 NNLGAVEIDEDEQNTFLRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINA 88 (166)
T ss_pred cchHHhhhccCCCcHHHHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCC
Confidence 3444444455566779999999998 67778889999999999999999999999988654 8999999999999
Q ss_pred CC-cCCCCccccccccchHHHHHHHHh-hCCCCCCCCc
Q 016544 102 KD-RWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPM 137 (387)
Q Consensus 102 ~~-~~g~tpl~~a~~~~~~~~~~~L~~-~g~~~~~~~~ 137 (387)
+| ..|.||||+|+..++.+++++|+. .|+++.....
T Consensus 89 ~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~ 126 (166)
T PHA02743 89 RELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAINY 126 (166)
T ss_pred CCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcCC
Confidence 98 589999999999999999999995 7988765443
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.3e-17 Score=160.73 Aligned_cols=111 Identities=29% Similarity=0.335 Sum_probs=100.9
Q ss_pred cCCCCCCCCCCcchHHHHHHhhC---CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC-CHHHHHHHHHCCCCCCCCCc
Q 016544 29 NGLDDDGEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDR 104 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~---~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~-~~~~~~~Ll~~ga~~~~~~~ 104 (387)
+|.|++.++..|.||||+|+..+ +.+++++|+++|+|+|.+|..|+||||+|+..| +.+++++|+++|++++.+|.
T Consensus 36 ~ga~vn~~~~~g~t~Lh~a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~iv~lLl~~ga~in~~~~ 115 (471)
T PHA03095 36 AGADVNFRGEYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAKDK 115 (471)
T ss_pred cCCCcccCCCCCCCHHHHHHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHHHHHHHHcCCCCCCCCC
Confidence 56777778888999999999998 999999999999999999999999999999999 59999999999999999999
Q ss_pred CCCCcccccc--ccchHHHHHHHHhhCCCCCCCCccc
Q 016544 105 WGSTPLGDAI--YYKNHEVIKLLEKHGAKPLMAPMHV 139 (387)
Q Consensus 105 ~g~tpl~~a~--~~~~~~~~~~L~~~g~~~~~~~~~~ 139 (387)
.|.||||+|+ ..++.+++++|++.|+++.......
T Consensus 116 ~g~tpLh~a~~~~~~~~~iv~~Ll~~gad~~~~d~~g 152 (471)
T PHA03095 116 VGRTPLHVYLSGFNINPKVIRLLLRKGADVNALDLYG 152 (471)
T ss_pred CCCCHHHHHhhCCcCCHHHHHHHHHcCCCCCccCCCC
Confidence 9999999999 5668899999999999986654443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-18 Score=170.53 Aligned_cols=194 Identities=23% Similarity=0.311 Sum_probs=143.0
Q ss_pred CcccceeecccEEEEEE---EcCeEEEEEEcCccc--CCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEV--ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
++...+.+|++.|-++. -+...|+||++-+.. ..=....++++ |++ ...+++||++++.-+-..+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~-~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLE-EIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHH-HHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 45566789999996543 233449999886543 11122223333 444 566689999999888777888899999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+.. +|.+.+....-+..-+.+-|+.|++.||..+|..| |.|||||.+|||++.=..+.|+||..-+..-.+++.+
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9954 99998887666777788889999999999999999 9999999999999988889999997644322222222
Q ss_pred c--cc----CCCCCcccccccccCC----------C-CCCchhHHHHHHHHHHHHc-CCCCCC
Q 016544 311 L--TC----QDTSCRYVAPEVFKNE----------E-YDTKVDVFSFALILQEMIE-GCPPFT 355 (387)
Q Consensus 311 ~--~~----~~~~~~y~aPE~~~~~----------~-~~~~~Dv~slG~il~ellt-g~~pf~ 355 (387)
. .. ...-..|+|||.+... + .+++-||||+||++.||++ |++||.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 1 11 1112249999987541 2 5778999999999999996 899995
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.3e-17 Score=129.89 Aligned_cols=94 Identities=35% Similarity=0.449 Sum_probs=88.9
Q ss_pred HHHHHhhCCHHHHHHHHHcCCC-CCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHHH
Q 016544 44 LMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122 (387)
Q Consensus 44 l~~a~~~~~~~~~~~Ll~~g~~-~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~ 122 (387)
+.+|+..+....|+.||+..|| +|.+|.+|.||||.|+++|+.+|++.|+..||+++.+...||||||-||...+.+++
T Consensus 67 ~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va 146 (228)
T KOG0512|consen 67 LLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVA 146 (228)
T ss_pred HHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHH
Confidence 6789999999999999998776 899999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCc
Q 016544 123 KLLEKHGAKPLMAPM 137 (387)
Q Consensus 123 ~~L~~~g~~~~~~~~ 137 (387)
.+|+++|+++.....
T Consensus 147 ~~LLqhgaDVnA~t~ 161 (228)
T KOG0512|consen 147 GRLLQHGADVNAQTK 161 (228)
T ss_pred HHHHhccCccccccc
Confidence 999999999865543
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-17 Score=159.25 Aligned_cols=112 Identities=24% Similarity=0.249 Sum_probs=100.9
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc-CCHHHHHHHHHCCCCCCCCCc-CC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ-GFTEVVSLLLERGADVDPKDR-WG 106 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~-~~~~~~~~Ll~~ga~~~~~~~-~g 106 (387)
.+.|.+..+..|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+.. ++.+++++|+++|++++.++. .|
T Consensus 190 ~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~~~~g 269 (477)
T PHA02878 190 YGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILG 269 (477)
T ss_pred CCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhcCCHHHHHHHHHcCCCCCccCCCCC
Confidence 4667777888899999999999999999999999999999999999999999975 789999999999999999986 79
Q ss_pred CCccccccccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 107 STPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 107 ~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
.||||+| .++.+++++|+++|+++........++
T Consensus 270 ~TpLh~A--~~~~~~v~~Ll~~gadin~~d~~g~Tp 303 (477)
T PHA02878 270 LTALHSS--IKSERKLKLLLEYGADINSLNSYKLTP 303 (477)
T ss_pred CCHHHHH--ccCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence 9999999 567899999999999997766555544
|
|
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2e-17 Score=161.48 Aligned_cols=107 Identities=25% Similarity=0.306 Sum_probs=98.4
Q ss_pred cCCCCCCCCCCcchHHHHHHhh-----CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC---CHHHHHHHHHCCCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANE-----RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG---FTEVVSLLLERGADVD 100 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~-----~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~---~~~~~~~Ll~~ga~~~ 100 (387)
+|.|++..+..|.||||+|+.+ ++.+++++|+++|||+|.+|.+|+||||+|+..+ +.+++++|+++||+++
T Consensus 60 ~Gadvn~~d~~g~TpL~~~~~n~~~~~~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn 139 (489)
T PHA02798 60 LGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADTT 139 (489)
T ss_pred CCCCCCCCCCCCCChHHHHHHhHHhHHhHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCcc
Confidence 6788888888999999998864 6799999999999999999999999999999875 7899999999999999
Q ss_pred CCCcCCCCccccccccch---HHHHHHHHhhCCCCCCC
Q 016544 101 PKDRWGSTPLGDAIYYKN---HEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 101 ~~~~~g~tpl~~a~~~~~---~~~~~~L~~~g~~~~~~ 135 (387)
.+|..|.||||+|+..++ .+++++|++.|+++...
T Consensus 140 ~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~ 177 (489)
T PHA02798 140 LLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTH 177 (489)
T ss_pred ccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCcccc
Confidence 999999999999999887 89999999999997543
|
|
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-17 Score=169.48 Aligned_cols=105 Identities=35% Similarity=0.375 Sum_probs=101.6
Q ss_pred hcCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC
Q 016544 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 28 ~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
-.+++.+-++.+|+||||.||..|+.++|++||++|||+|.+|+.|+||||.||..|+.+|+++|+++||++|..|.+|.
T Consensus 528 ~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLlk~GA~vna~d~~g~ 607 (1143)
T KOG4177|consen 528 EHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLLKHGASVNAADLDGF 607 (1143)
T ss_pred hcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHHHcCCCCCcccccCc
Confidence 36889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccccchHHHHHHHHhhCCCC
Q 016544 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
|||++|+..|..++++.+...++++
T Consensus 608 TpL~iA~~lg~~~~~k~l~~~~~~~ 632 (1143)
T KOG4177|consen 608 TPLHIAVRLGYLSVVKLLKVVTATP 632 (1143)
T ss_pred chhHHHHHhcccchhhHHHhccCcc
Confidence 9999999999999999999999983
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.7e-16 Score=156.39 Aligned_cols=135 Identities=24% Similarity=0.227 Sum_probs=109.3
Q ss_pred cccceeecccEEEEEEE---cCeEEEEEEcCcccCCC-----HHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 157 FTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISD-----DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~---~g~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
|...+.||+|+|+.||. .+..+++|+........ ....+.+.+|+.+++.++|++++.+..++......++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 35567899999999875 45566666533222111 12345688999999999999999888877777788999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
|||+++++|.+++. ....++.+++.+|.+||+.+ ++||||||+|||+ .++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999876 34678999999999999999 9999999999999 5778999999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.5e-17 Score=141.51 Aligned_cols=140 Identities=20% Similarity=0.143 Sum_probs=105.7
Q ss_pred cccceeecccEEEEEE------EcCeEEEEEEcCcccCCC---------------------HHHHHHHHHHHHHHHcCCC
Q 016544 157 FTNSVEITKGTFILAF------WRGIQVAVKKLGEEVISD---------------------DDRVRAFRDELALLQKIRH 209 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~------~~g~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~h 209 (387)
|...+.||.|+++.|+ .+|..||+|.+....... ......+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4455679999998764 357899999987542210 0012346789999999975
Q ss_pred C--cceeeeeEEeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC
Q 016544 210 P--NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287 (387)
Q Consensus 210 ~--~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~ 287 (387)
. .++++++. ...++||||+.+.+|..+......+...++..++.|++.++.+||+++ .++|+||||+||+++
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~ 183 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH 183 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE
Confidence 3 34455543 235899999999888776544455666677899999999999999986 399999999999999
Q ss_pred CCCCEEEEeecCcccc
Q 016544 288 DSGNLKVADFGVSKLL 303 (387)
Q Consensus 288 ~~~~~kl~Dfg~~~~~ 303 (387)
++.++|+|||.+...
T Consensus 184 -~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 -DGKVVIIDVSQSVEL 198 (237)
T ss_pred -CCCEEEEEChhhhcc
Confidence 788999999987654
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.6e-17 Score=159.47 Aligned_cols=104 Identities=23% Similarity=0.270 Sum_probs=75.4
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCH--HHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDV--EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~--~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g 106 (387)
.+.|++.++..|+||||+||..|+. .+++.|+..|+++|.+|..|+||||+|+..|+.+++++|+++||+++.+|..|
T Consensus 211 ~g~~~~~~d~~g~tpLh~Aa~~~~~~~~~v~~ll~~g~din~~d~~g~TpLh~A~~~~~~~~v~~LL~~gad~n~~~~~g 290 (471)
T PHA03095 211 AGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDG 290 (471)
T ss_pred cCCCCcccCCCCCCHHHHHHhcCCchHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCC
Confidence 4556666666777777777777653 56677777777777777777777777777777777777777777777777777
Q ss_pred CCccccccccchHHHHHHHHhhCCCC
Q 016544 107 STPLGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 107 ~tpl~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
.|||++|+..++.++++.|++.++++
T Consensus 291 ~tpl~~A~~~~~~~~v~~LL~~~~~~ 316 (471)
T PHA03095 291 NTPLSLMVRNNNGRAVRAALAKNPSA 316 (471)
T ss_pred CCHHHHHHHhCCHHHHHHHHHhCCCH
Confidence 77777777777777777777776654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=6e-17 Score=144.47 Aligned_cols=170 Identities=22% Similarity=0.292 Sum_probs=122.2
Q ss_pred CCCcceeeeeEEeeC---------------------------CceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHH
Q 016544 208 RHPNVVQFLGAVTQS---------------------------SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260 (387)
Q Consensus 208 ~h~~iv~l~~~~~~~---------------------------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~ 260 (387)
+|||||++..+|.++ ..+|+||.... .+|.+++..+. .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHHH
Confidence 599999998887542 34789999885 49999998765 46677888999999
Q ss_pred HHHHHHHhCCCCCeEeCCCCCCCEEeCC--CC--CEEEEeecCccccccCCC-----CCcccCCCCCcccccccccCCC-
Q 016544 261 RGMNYLHENKPVPIIHRDLEPSNILRDD--SG--NLKVADFGVSKLLTVKED-----RPLTCQDTSCRYVAPEVFKNEE- 330 (387)
Q Consensus 261 ~~l~~LH~~~~~~iiH~Dlkp~Nill~~--~~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~- 330 (387)
+|+.|||.+| |.|||+|++|||+.- ++ .+.|+|||.+-......- +..-...|....||||+....+
T Consensus 352 Eav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 9999999999 999999999999863 33 378999997643222111 1111234566789999986532
Q ss_pred ----C-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcH-HHHHHccCCCCCCCChhhhhhcc
Q 016544 331 ----Y-DTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 331 ----~-~~~~Dv~slG~il~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
. -.++|.|+.|.+.||+++...||.+.....+ ...++..+-|++ +..+|+.+
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPal---p~~vpp~~ 486 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPAL---PSRVPPVA 486 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCC---cccCChHH
Confidence 1 2479999999999999999999987333222 223444556665 34455544
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.6e-17 Score=157.53 Aligned_cols=109 Identities=37% Similarity=0.514 Sum_probs=71.4
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCC------CcHHHHHHHcCC--HHHHHHHHHCCCCCCC
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN------RTALHVAACQGF--TEVVSLLLERGADVDP 101 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g------~t~Lh~A~~~~~--~~~~~~Ll~~ga~~~~ 101 (387)
+.|.+.++..|.||||+|+..|+.+++++|+++|++++..+..| .||||+|+..++ .+++++|+++|++++.
T Consensus 166 g~din~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~iv~~Ll~~g~din~ 245 (480)
T PHA03100 166 GVDINAKNRYGYTPLHIAVEKGNIDVIKFLLDNGADINAGDIETLLFTIFETPLHIAACYNEITLEVVNYLLSYGVPINI 245 (480)
T ss_pred CCCcccccCCCCCHHHHHHHhCCHHHHHHHHHcCCCccCCCCCCCcHHHHHhHHHHHHHhCcCcHHHHHHHHHcCCCCCC
Confidence 44555555566666666666666666666666666666666666 666666666666 6666666666677777
Q ss_pred CCcCCCCccccccccchHHHHHHHHhhCCCCCCCCcc
Q 016544 102 KDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (387)
Q Consensus 102 ~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~ 138 (387)
+|..|.||||+|+..++.+++++|++.|+++......
T Consensus 246 ~d~~g~TpL~~A~~~~~~~iv~~Ll~~gad~n~~d~~ 282 (480)
T PHA03100 246 KDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKY 282 (480)
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCC
Confidence 7777777777777777777777777777766544433
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.9e-16 Score=136.63 Aligned_cols=139 Identities=19% Similarity=0.202 Sum_probs=106.8
Q ss_pred cccceeecccEEEEEEEcCeEEEEEEcCcccC----------CCHHHHHHHHHHHHHHHcCCCCcc--eeeeeEEeeCCc
Q 016544 157 FTNSVEITKGTFILAFWRGIQVAVKKLGEEVI----------SDDDRVRAFRDELALLQKIRHPNV--VQFLGAVTQSSP 224 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~~g~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i--v~l~~~~~~~~~ 224 (387)
+..++..|.|+++.++..+..++||.+..... .+......+.+|+.++.++.|++| ++++++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 33345678899999999999999998854221 112334567889999999998875 677776543322
Q ss_pred ----eEEEEEccCC-CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecC
Q 016544 225 ----MMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (387)
Q Consensus 225 ----~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 299 (387)
.++|||+++| .+|.+++... +++.. .+.+++.+|.+||+.| |+|+||||.|||++.++.++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCC
Confidence 3599999997 6999888653 44443 3578999999999999 99999999999999988999999998
Q ss_pred cccc
Q 016544 300 SKLL 303 (387)
Q Consensus 300 ~~~~ 303 (387)
+...
T Consensus 189 ~~~~ 192 (239)
T PRK01723 189 GELR 192 (239)
T ss_pred cccC
Confidence 7653
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=159.11 Aligned_cols=85 Identities=22% Similarity=0.225 Sum_probs=76.8
Q ss_pred cC-CCCCCC-CCCcchHHHHHHh--hCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC--HHHHHHHHHCCCCCCCC
Q 016544 29 NG-LDDDGE-EIKPEFRLMFLAN--ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF--TEVVSLLLERGADVDPK 102 (387)
Q Consensus 29 ~~-~~~~~~-~~~g~t~l~~a~~--~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~--~~~~~~Ll~~ga~~~~~ 102 (387)
++ .|++.+ +..|.||||+|+. .++.+++++|+++|+|+|.+|..|+||||+|+..|+ .+++++|+++|||+|.+
T Consensus 164 ~G~ADIN~~~d~~G~TpLH~A~~n~~~~~eIVklLLe~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~k 243 (764)
T PHA02716 164 VGIVNLNYVCKKTGYGILHAYLGNMYVDIDILEWLCNNGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMK 243 (764)
T ss_pred CCCCCcccccCCCCCcHHHHHHHhccCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCC
Confidence 45 677777 7789999999865 467999999999999999999999999999999995 59999999999999999
Q ss_pred CcCCCCccccc
Q 016544 103 DRWGSTPLGDA 113 (387)
Q Consensus 103 ~~~g~tpl~~a 113 (387)
|..|.||||+|
T Consensus 244 D~~G~TPLh~A 254 (764)
T PHA02716 244 CVNGMSPIMTY 254 (764)
T ss_pred CCCCCCHHHHH
Confidence 99999999975
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=156.48 Aligned_cols=107 Identities=27% Similarity=0.421 Sum_probs=88.9
Q ss_pred cCCCCCCCCCCcchHHHHHH--hhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC--CHHHHHHHHHCCCCCCCCCc
Q 016544 29 NGLDDDGEEIKPEFRLMFLA--NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDPKDR 104 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~--~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~--~~~~~~~Ll~~ga~~~~~~~ 104 (387)
++.|.+..+..|.||||+|+ ..|+.+++++|+++|++++.+|..|.||||+|+..| +.+++++|+++|++++.+|.
T Consensus 95 ~ga~i~~~d~~g~tpL~~A~~~~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~~d~ 174 (480)
T PHA03100 95 YGANVNAPDNNGITPLLYAISKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNR 174 (480)
T ss_pred CCCCCCCCCCCCCchhhHHHhcccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCcccccC
Confidence 45666666777888888888 888888888888888888888888888888888888 88888888888888888888
Q ss_pred CCCCccccccccchHHHHHHHHhhCCCCCCC
Q 016544 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 105 ~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~ 135 (387)
.|.||||+|+..++.+++++|+++|+++...
T Consensus 175 ~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~ 205 (480)
T PHA03100 175 YGYTPLHIAVEKGNIDVIKFLLDNGADINAG 205 (480)
T ss_pred CCCCHHHHHHHhCCHHHHHHHHHcCCCccCC
Confidence 8888888888888888888888888877544
|
|
| >KOG4214 consensus Myotrophin and similar proteins [Transcription] | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.6e-17 Score=113.41 Aligned_cols=77 Identities=22% Similarity=0.245 Sum_probs=66.2
Q ss_pred CCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccc
Q 016544 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (387)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a 113 (387)
...|+||||+||-.|+.+++++|+..|||++.+|++|.|||.-|++.||.++|++|++.||+-..+..+|.+.+..+
T Consensus 31 ~~ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVklLL~~GAdrt~~~PdG~~~~eat 107 (117)
T KOG4214|consen 31 IYGGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVKLLLQNGADRTIHAPDGTALIEAT 107 (117)
T ss_pred HhCCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHHHHHHcCcccceeCCCchhHHhhc
Confidence 34788889999999999999999999999999999999999999999999999999999998888888887766544
|
|
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-16 Score=144.46 Aligned_cols=130 Identities=28% Similarity=0.270 Sum_probs=111.5
Q ss_pred cccCCCcchhhhhhhhc---CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHH
Q 016544 13 KQSSLAPDRERKEAELN---GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89 (387)
Q Consensus 13 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~ 89 (387)
.-..+.+..++-++++. ...-++.+..|-+||..|+..||.++|+.|+++||+||.......|||--||.-|+.+++
T Consensus 54 H~~vVeyLle~~~a~~e~~GsV~FDge~IegappLWaAsaAGHl~vVk~L~~~ga~VN~tT~TNStPLraACfDG~leiv 133 (615)
T KOG0508|consen 54 HADVVEYLLEHCRASPEQGGSVRFDGETIEGAPPLWAASAAGHLEVVKLLLRRGASVNDTTRTNSTPLRAACFDGHLEIV 133 (615)
T ss_pred cHHHHHHHHHHhcCCccCCceEEeCCcccCCCchhhHHhccCcHHHHHHHHHhcCccccccccCCccHHHHHhcchhHHH
Confidence 33344444454444443 234567788899999999999999999999999999999988889999999999999999
Q ss_pred HHHHHCCCCCCCCCcCCCCccccccccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 90 ~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
++|+++|||+++.|+.|.|.|++|+..|+.+++++|++.|++++.......++
T Consensus 134 KyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~kGNTA 186 (615)
T KOG0508|consen 134 KYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYKGNTA 186 (615)
T ss_pred HHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcccCchH
Confidence 99999999999999999999999999999999999999999998776555444
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.8e-16 Score=151.34 Aligned_cols=104 Identities=36% Similarity=0.411 Sum_probs=59.1
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcC-----------------------CCCCCCCCCCCcHHHHHHHcCCH
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-----------------------IDVNFRDIDNRTALHVAACQGFT 86 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g-----------------------~~~n~~d~~g~t~Lh~A~~~~~~ 86 (387)
|.|.+..+..|.||||+|+..|+.+++++|+++| +|+|.+|..|.||||+|+..|+.
T Consensus 58 Ga~~n~~~~~~~t~L~~A~~~~~~~iv~~Ll~~g~~~~~~~~~~~~~~~i~~ll~~g~d~n~~~~~g~T~Lh~A~~~~~~ 137 (434)
T PHA02874 58 GADINHINTKIPHPLLTAIKIGAHDIIKLLIDNGVDTSILPIPCIEKDMIKTILDCGIDVNIKDAELKTFLHYAIKKGDL 137 (434)
T ss_pred CCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcchhccCCHHHHHHHHHCcCCCCCCCCCCccHHHHHHHCCCH
Confidence 3444444444555555555555555555555443 23444555566666666666666
Q ss_pred HHHHHHHHCCCCCCCCCcCCCCccccccccchHHHHHHHHhhCCCCC
Q 016544 87 EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133 (387)
Q Consensus 87 ~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~ 133 (387)
+++++|+++|++++.+|..|.||||+|+..++.+++++|++.|+++.
T Consensus 138 ~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n 184 (434)
T PHA02874 138 ESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYAN 184 (434)
T ss_pred HHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCC
Confidence 66666666666666666666666666666666666666666655543
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.1e-16 Score=140.12 Aligned_cols=86 Identities=37% Similarity=0.448 Sum_probs=45.0
Q ss_pred cchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHC-CCCCCCCCcCCCCccccccccch
Q 016544 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKN 118 (387)
Q Consensus 40 g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~-ga~~~~~~~~g~tpl~~a~~~~~ 118 (387)
|+|+|++|+.+|..++|+.||.+|||||.+|.+|.|+|++||.+||+||+++||.. +.|+...|.+|.|+|.+|...|+
T Consensus 340 gQTALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgSTAl~IAleagh 419 (452)
T KOG0514|consen 340 GQTALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGSTALSIALEAGH 419 (452)
T ss_pred cchhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCchhhhhHHhcCc
Confidence 45555555555555555555555555555555555555555555555555555543 44555555555555555555555
Q ss_pred HHHHHHH
Q 016544 119 HEVIKLL 125 (387)
Q Consensus 119 ~~~~~~L 125 (387)
.||..+|
T Consensus 420 ~eIa~ml 426 (452)
T KOG0514|consen 420 REIAVML 426 (452)
T ss_pred hHHHHHH
Confidence 5544333
|
|
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.8e-16 Score=159.62 Aligned_cols=114 Identities=28% Similarity=0.313 Sum_probs=95.0
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC-HHHHHHHHHCCCCCCCCCcCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-TEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~-~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
.+.|++.++..|.||||+|+..|+.+++++|+++|++++..+..|.||||+|+..++ ..++++|+++|+++|.+|..|+
T Consensus 364 ~gadin~~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A~~~~~~~~~vk~Ll~~gadin~~d~~G~ 443 (682)
T PHA02876 364 LGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNPYMSVKTLIDRGANVNSKNKDLS 443 (682)
T ss_pred cCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCCCchHHHHHHcCCHHHHHHHHHhCCCCCCcCCCCCC
Confidence 466677777788888999999999999999999999999888888999999887665 5678899999999999999999
Q ss_pred Cccccccccc-hHHHHHHHHhhCCCCCCCCcccccc
Q 016544 108 TPLGDAIYYK-NHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 108 tpl~~a~~~~-~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
||||+|+..+ +.+++++|++.|+++........++
T Consensus 444 TpLh~Aa~~~~~~~iv~lLl~~Gad~n~~d~~g~tp 479 (682)
T PHA02876 444 TPLHYACKKNCKLDVIEMLLDNGADVNAINIQNQYP 479 (682)
T ss_pred hHHHHHHHhCCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 9999998866 6799999999999887665544443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2e-16 Score=148.83 Aligned_cols=165 Identities=28% Similarity=0.465 Sum_probs=133.0
Q ss_pred HHcCCCCcceeeeeEEeeCCceEEEEEccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 016544 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (387)
Q Consensus 204 l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~ 282 (387)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ...+++.....++++++.||+|||+.- . ..|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeeccc
Confidence 3567899999999999999999999999999999999987 445888889999999999999999974 2 299999999
Q ss_pred CEEeCCCCCEEEEeecCccccccC-CCCCcccCCCCCcccccccccCCC-------CCCchhHHHHHHHHHHHHcCCCCC
Q 016544 283 NILRDDSGNLKVADFGVSKLLTVK-EDRPLTCQDTSCRYVAPEVFKNEE-------YDTKVDVFSFALILQEMIEGCPPF 354 (387)
Q Consensus 283 Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Dv~slG~il~elltg~~pf 354 (387)
|.+++....+||+|||+....... ............-|.|||.+.+.. .+.+.|+||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998765421 111111112345699999997741 356799999999999999999999
Q ss_pred CC----CCCCcHHHHHHccC
Q 016544 355 TM----KHDNEVPKAYAARQ 370 (387)
Q Consensus 355 ~~----~~~~~~~~~i~~~~ 370 (387)
.. .++.+++.++..++
T Consensus 159 ~~~~~~~~~~eii~~~~~~~ 178 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGG 178 (484)
T ss_pred ccccccCChHHHHHHHHhcC
Confidence 75 22345777776634
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.2e-16 Score=132.68 Aligned_cols=134 Identities=21% Similarity=0.120 Sum_probs=101.5
Q ss_pred cccceeecccEEEEEEE----cCeEEEEEEcCcccCCCH-------------------HHHHHHHHHHHHHHcCCCC--c
Q 016544 157 FTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDD-------------------DRVRAFRDELALLQKIRHP--N 211 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~h~--~ 211 (387)
|...+.||.|+|+.+|. +|+.||||++........ ........|..++..+.++ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 55567799999998862 588999998764321100 1112356788888888777 4
Q ss_pred ceeeeeEEeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC
Q 016544 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (387)
Q Consensus 212 iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 291 (387)
++..++ ....+++|||++|++|...... .....++.+++.++.++|+.+ ++|+||||+||+++.++.
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCc
Confidence 455544 2456899999999998765331 345678899999999999998 999999999999999999
Q ss_pred EEEEeecCcccc
Q 016544 292 LKVADFGVSKLL 303 (387)
Q Consensus 292 ~kl~Dfg~~~~~ 303 (387)
++|+|||++...
T Consensus 164 ~~liDfg~~~~~ 175 (198)
T cd05144 164 IYIIDWPQMVST 175 (198)
T ss_pred EEEEECCccccC
Confidence 999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.3e-16 Score=152.67 Aligned_cols=108 Identities=18% Similarity=0.151 Sum_probs=92.1
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCC----HHHHHHHHHcCC--CCCCCCCCCCcHHHH---HHHcC---------CHHHHH
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGI--DVNFRDIDNRTALHV---AACQG---------FTEVVS 90 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~----~~~~~~Ll~~g~--~~n~~d~~g~t~Lh~---A~~~~---------~~~~~~ 90 (387)
+|+|++.. ..|.||||+|+..++ .+++++||++|+ |+|.+|.+|.||||. |...+ ..++++
T Consensus 368 ~GAdIN~k-~~G~TpLH~Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~~~e~~~~~ivk 446 (672)
T PHA02730 368 NGATMDKT-TDNNYPLHDYFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYHCYETILIDVFD 446 (672)
T ss_pred CCCCCCcC-CCCCcHHHHHHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHHHHHhccccccccchhHHHHHH
Confidence 56666654 579999999998875 899999999998 699999999999994 33332 235799
Q ss_pred HHHHCCCCCCCCCcCCCCccccccccchHHHHHHHHhhCCCCCCCCc
Q 016544 91 LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 91 ~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
+|+++||++|.+|..|.||||+|+..++.+++++|+++|+++.....
T Consensus 447 ~LIs~GADINakD~~G~TPLh~Aa~~~~~eive~LI~~GAdIN~~d~ 493 (672)
T PHA02730 447 ILSKYMDDIDMIDNENKTLLYYAVDVNNIQFARRLLEYGASVNTTSR 493 (672)
T ss_pred HHHhcccchhccCCCCCCHHHHHHHhCCHHHHHHHHHCCCCCCCCCC
Confidence 99999999999999999999999999999999999999999866553
|
|
| >KOG0510 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.5e-16 Score=150.99 Aligned_cols=113 Identities=32% Similarity=0.320 Sum_probs=89.8
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHH-cC-CCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCC---CCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLD-SG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD---PKDR 104 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~-~g-~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~---~~~~ 104 (387)
|.|++.++.++.||||.||..|+.++|+.|++ .| ..+|..|-.|.||||+|+..||..++++||+.||+.. ..|.
T Consensus 296 Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHlaa~~gH~~v~qlLl~~GA~~~~~~e~D~ 375 (929)
T KOG0510|consen 296 GASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLAAKSGHDRVVQLLLNKGALFLNMSEADS 375 (929)
T ss_pred CCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchhhhhhcCHHHHHHHHHhcChhhhccccccc
Confidence 44555555666677888888888888888888 43 4578888888999999998899999999999998877 5588
Q ss_pred CCCCccccccccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 105 ~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
+|.||||.|+.+|+...++.|+++|+++........++
T Consensus 376 dg~TaLH~Aa~~g~~~av~~Li~~Ga~I~~~n~~g~SA 413 (929)
T KOG0510|consen 376 DGNTALHLAAKYGNTSAVQKLISHGADIGVKNKKGKSA 413 (929)
T ss_pred CCchhhhHHHHhccHHHHHHHHHcCCceeecccccccc
Confidence 89999999999999999999999999886554444444
|
|
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.3e-16 Score=154.60 Aligned_cols=106 Identities=21% Similarity=0.190 Sum_probs=92.3
Q ss_pred cCCCCCCCCCCcchHHHHHHhh---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC---------------------
Q 016544 29 NGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--------------------- 84 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~---~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~--------------------- 84 (387)
++.+.+.+|.+|+||||+||.. |+.++|++||++|+|++.+|..|+||||+|+..|
T Consensus 21 ~~~~~~~~d~~g~t~Lh~a~~~~~~~~~~~v~~Ll~~ga~v~~~~~~g~TpL~~Aa~~g~~~v~~~~~~~Ll~~~~~~n~ 100 (661)
T PHA02917 21 DRDPNDTRNQFKNNALHAYLFNEHCNNVEVVKLLLDSGTNPLHKNWRQLTPLEEYTNSRHVKVNKDIAMALLEATGYSNI 100 (661)
T ss_pred ccCcccccCCCCCcHHHHHHHhhhcCcHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCChhHHHHHHHHHHhccCCCCC
Confidence 5666677788899999997665 8899999999999999999999999999887644
Q ss_pred --------------CHHHHHHHHHCCCCCCCCCcCCCCccccc--cccchHHHHHHHHhhCCCCCC
Q 016544 85 --------------FTEVVSLLLERGADVDPKDRWGSTPLGDA--IYYKNHEVIKLLEKHGAKPLM 134 (387)
Q Consensus 85 --------------~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a--~~~~~~~~~~~L~~~g~~~~~ 134 (387)
+.+++++|+++|+|+|.+|..|.||||.| +..++.+++++|+++|+++..
T Consensus 101 ~~~~~~~~~a~~~~~~e~vk~Ll~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~ 166 (661)
T PHA02917 101 NDFNIFSYMKSKNVDVDLIKVLVEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLY 166 (661)
T ss_pred CCcchHHHHHhhcCCHHHHHHHHHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCccc
Confidence 45788999999999999999999999954 467899999999999999864
|
|
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.4e-16 Score=150.46 Aligned_cols=107 Identities=24% Similarity=0.331 Sum_probs=96.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhC---CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC---HHHHHHHHHCCCCCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---TEVVSLLLERGADVDPK 102 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~---~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~---~~~~~~Ll~~ga~~~~~ 102 (387)
+|.|++.++..|+||||+|+..+ +.+++++|+++|||+|.+|.+|.||||+|+..++ .+++++|+++|++++.+
T Consensus 98 ~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~ 177 (489)
T PHA02798 98 NGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTH 177 (489)
T ss_pred CCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCcccc
Confidence 67888888888999999999975 7899999999999999999999999999999998 99999999999999988
Q ss_pred C-cCCCCcccccccc----chHHHHHHHHhhCCCCCCC
Q 016544 103 D-RWGSTPLGDAIYY----KNHEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 103 ~-~~g~tpl~~a~~~----~~~~~~~~L~~~g~~~~~~ 135 (387)
+ ..|.||||.+... ++.+++++|+++|+++...
T Consensus 178 ~~~~~~t~Lh~~~~~~~~~~~~~ivk~Li~~Ga~i~~~ 215 (489)
T PHA02798 178 NNKEKYDTLHCYFKYNIDRIDADILKLFVDNGFIINKE 215 (489)
T ss_pred cCcCCCcHHHHHHHhccccCCHHHHHHHHHCCCCcccC
Confidence 5 5789999987653 4799999999999988654
|
|
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.2e-16 Score=150.36 Aligned_cols=105 Identities=24% Similarity=0.290 Sum_probs=85.1
Q ss_pred cCCCCCCCCCCcchHHHHHHhhC------CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc---CCHHHHHHHHHCCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANER------DVEGIKELLDSGIDVNFRDIDNRTALHVAACQ---GFTEVVSLLLERGADV 99 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~------~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~---~~~~~~~~Ll~~ga~~ 99 (387)
+|+|++.++ .+.||||.|+..+ +.+++++|+++|||+|.+|..|+||||.|+.. ++.+++++|+++|||+
T Consensus 59 ~GAdvn~~~-~~~tpL~~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadi 137 (494)
T PHA02989 59 NGADVNYKG-YIETPLCAVLRNREITSNKIKKIVKLLLKFGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGINV 137 (494)
T ss_pred cCCCccCCC-CCCCcHHHHHhccCcchhhHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCc
Confidence 455555544 4678899887654 46889999999999999999999999987765 6789999999999999
Q ss_pred -CCCCcCCCCccccccc--cchHHHHHHHHhhCCCCCC
Q 016544 100 -DPKDRWGSTPLGDAIY--YKNHEVIKLLEKHGAKPLM 134 (387)
Q Consensus 100 -~~~~~~g~tpl~~a~~--~~~~~~~~~L~~~g~~~~~ 134 (387)
+.+|..|.||||+|+. .++.+++++|+++|+++..
T Consensus 138 n~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~ 175 (494)
T PHA02989 138 NDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFE 175 (494)
T ss_pred ccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccc
Confidence 7888999999998764 3578999999999988765
|
|
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=152.45 Aligned_cols=105 Identities=30% Similarity=0.253 Sum_probs=94.4
Q ss_pred cCCCCCCCCCCcchHHHHHHhhC-----------------------CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANER-----------------------DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~-----------------------~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~ 85 (387)
+|.+.+..+.+|+||||.||+.+ ..+++++|+++|||+|.+|..|+||||+|+..++
T Consensus 385 ~ga~~~~~~~~G~TpL~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~Ll~~GAdIN~kd~~G~TpLh~Aa~~~~ 464 (661)
T PHA02917 385 EGGDAVNHLDDGEIPIGHLCKSNYGCYNFYTYTYKKGLCDMSYACPILSTINICLPYLKDINMIDKRGETLLHKAVRYNK 464 (661)
T ss_pred cCCCccccCCCCCChhHHHHHhcccchhhhhhhhhhccchhhhhhhhHHHHHHHHHCCCCCCCCCCCCcCHHHHHHHcCC
Confidence 56666666667999999998543 3678899999999999999999999999999999
Q ss_pred HHHHHHHHHCCCCCCCCCcCCCCccccccc-cchHHHHHHHHhhCCCCC
Q 016544 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIY-YKNHEVIKLLEKHGAKPL 133 (387)
Q Consensus 86 ~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~-~~~~~~~~~L~~~g~~~~ 133 (387)
.+++++|+++|++++.+|..|.||||+|+. .++.+++++++++|+++.
T Consensus 465 ~~~v~~Ll~~GAdin~~d~~G~T~L~~A~~~~~~~~iv~~LL~~ga~i~ 513 (661)
T PHA02917 465 QSLVSLLLESGSDVNIRSNNGYTCIAIAINESRNIELLKMLLCHKPTLD 513 (661)
T ss_pred HHHHHHHHHCcCCCCCCCCCCCCHHHHHHHhCCCHHHHHHHHHcCCChh
Confidence 999999999999999999999999999996 678999999999998864
|
|
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.4e-16 Score=130.92 Aligned_cols=105 Identities=26% Similarity=0.332 Sum_probs=84.2
Q ss_pred CCCCCCCcchHHHHHHhhCCHHHHHHHHHcCC--C-----CCCCCCCCCcHHHHHHHcCCH---HHHHHHHHCCCCCCCC
Q 016544 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGI--D-----VNFRDIDNRTALHVAACQGFT---EVVSLLLERGADVDPK 102 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~--~-----~n~~d~~g~t~Lh~A~~~~~~---~~~~~Ll~~ga~~~~~ 102 (387)
.+..+.+|.||||+||..|+. +++++..+. + ++.+|.+|+||||+|+..|+. +++++|+++|++++.+
T Consensus 10 ~~~~d~~g~tpLh~A~~~g~~--~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~ 87 (154)
T PHA02736 10 ASEPDIEGENILHYLCRNGGV--TDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGK 87 (154)
T ss_pred HHhcCCCCCCHHHHHHHhCCH--HHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCcccc
Confidence 445566789999999999983 444433332 2 345789999999999999987 4689999999999999
Q ss_pred C-cCCCCccccccccchHHHHHHHHh-hCCCCCCCCccc
Q 016544 103 D-RWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHV 139 (387)
Q Consensus 103 ~-~~g~tpl~~a~~~~~~~~~~~L~~-~g~~~~~~~~~~ 139 (387)
| ..|+||||+|+..++.+++++|+. .|+++.......
T Consensus 88 ~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g 126 (154)
T PHA02736 88 ERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAF 126 (154)
T ss_pred CCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCC
Confidence 8 599999999999999999999997 488876554433
|
|
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.5e-16 Score=149.90 Aligned_cols=108 Identities=20% Similarity=0.253 Sum_probs=96.0
Q ss_pred cCCCCCCCCCCcchHHHHHHhh---CCHHHHHHHHHcCCCC-CCCCCCCCcHHHHHHHc--CCHHHHHHHHHCCCCCCC-
Q 016544 29 NGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDV-NFRDIDNRTALHVAACQ--GFTEVVSLLLERGADVDP- 101 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~---~~~~~~~~Ll~~g~~~-n~~d~~g~t~Lh~A~~~--~~~~~~~~Ll~~ga~~~~- 101 (387)
+|.|++.++..|.||||.|+.. |+.+++++|+++|||+ +.+|..|+||||+|+.. ++.+++++|+++|++++.
T Consensus 97 ~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~~ 176 (494)
T PHA02989 97 FGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFEK 176 (494)
T ss_pred CCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCcccc
Confidence 6788888888999999988765 6899999999999999 89999999999998764 689999999999999998
Q ss_pred CCcCCCCcccccccc----chHHHHHHHHhhCCCCCCCC
Q 016544 102 KDRWGSTPLGDAIYY----KNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 102 ~~~~g~tpl~~a~~~----~~~~~~~~L~~~g~~~~~~~ 136 (387)
.+..|.||||+|+.. ++.+++++|++.|+++....
T Consensus 177 ~~~~g~tpL~~a~~~~~~~~~~~iv~~Ll~~Ga~vn~~~ 215 (494)
T PHA02989 177 TSLYGLTPMNIYLRNDIDVISIKVIKYLIKKGVNIETNN 215 (494)
T ss_pred ccccCCChHHHHHhcccccccHHHHHHHHhCCCCccccC
Confidence 688999999988654 48999999999999986544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.1e-17 Score=150.30 Aligned_cols=120 Identities=32% Similarity=0.514 Sum_probs=103.7
Q ss_pred ceEEEEEccCCCCHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
.+||.|++|...+|.+|+.... ..+....+.++.|++.++.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 4789999999999999997433 26778889999999999999 77 999999999999999999999999997
Q ss_pred cccccCC-----CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc
Q 016544 301 KLLTVKE-----DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349 (387)
Q Consensus 301 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt 349 (387)
....... ....+...||..||+||.+.+..|+.++||||||++++||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 6544332 223355678999999999999999999999999999999997
|
|
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-15 Score=142.35 Aligned_cols=111 Identities=17% Similarity=0.047 Sum_probs=89.2
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCC------CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD------IDNRTALHVAACQGFTEVVSLLLERGADVDPK 102 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d------~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 102 (387)
+|+|++.. ++.||||.|+..|+.+++++|+++|++.+... ..|.|++|.|+..++.+++++|+++||++|.+
T Consensus 140 ~GADIn~~--~~~t~lh~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~a~~~~~~eIve~LIs~GADIN~k 217 (437)
T PHA02795 140 HGAVIYKI--ECLNAYFRGICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFLVDEPTVLEIYKLCIPYIEDINQL 217 (437)
T ss_pred CCCCCCCC--CCCCHHHHHHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHHHHhcCHHHHHHHHHhCcCCcCcC
Confidence 45555443 33678888888888888888888887433221 34778888888888999999999999999999
Q ss_pred CcCCCCccccccccchHHHHHHHHhhCCCCCCCCccccc
Q 016544 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141 (387)
Q Consensus 103 ~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~ 141 (387)
|..|.||||+|+..|+.+++++|+++|+++........+
T Consensus 218 D~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~T 256 (437)
T PHA02795 218 DAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYT 256 (437)
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCC
Confidence 999999999999999999999999999998765544433
|
|
| >PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=112.96 Aligned_cols=64 Identities=42% Similarity=0.587 Sum_probs=59.7
Q ss_pred cchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Q 016544 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103 (387)
Q Consensus 40 g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 103 (387)
|+||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++.+|
T Consensus 26 ~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~n 89 (89)
T PF12796_consen 26 GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVKLLLEHGADVNIRN 89 (89)
T ss_dssp SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHHHHHHTTT-TTSS-
T ss_pred CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence 7889999999999999999999999999999999999999999999999999999999999876
|
These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B .... |
| >PF13637 Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A 3B7B_A 3F6Q_A 2KBX_A 3IXE_A 2DWZ_C 2DVW_A 3AJI_A 1S70_B 2HE0_A | Back alignment and domain information |
|---|
Probab=99.63 E-value=8.1e-16 Score=102.13 Aligned_cols=54 Identities=39% Similarity=0.524 Sum_probs=46.4
Q ss_pred cchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHH
Q 016544 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93 (387)
Q Consensus 40 g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll 93 (387)
|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++||
T Consensus 1 g~t~lh~A~~~g~~~~~~~Ll~~~~din~~d~~g~t~lh~A~~~g~~~~~~~Ll 54 (54)
T PF13637_consen 1 GRTPLHWAARSGNLEIVKLLLEHGADINAQDEDGRTPLHYAAKNGNIDIVKFLL 54 (54)
T ss_dssp SSBHHHHHHHTT-HHHHHHHHHTTSGTT-B-TTS--HHHHHHHTT-HHHHHHHH
T ss_pred CChHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHccCHHHHHHHC
Confidence 689999999999999999999999999999999999999999999999999986
|
... |
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.3e-15 Score=146.07 Aligned_cols=112 Identities=18% Similarity=0.246 Sum_probs=87.3
Q ss_pred cCCCCCCCCCCcchHHHHHHhhC--CHHHHHHHHHcCCCCCC-CCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNF-RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW 105 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~--~~~~~~~Ll~~g~~~n~-~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~ 105 (387)
++.|++.++..|+||||+|+..+ +.+++++|+++|+++|. .|.+|.|||| ||..++.+++++|+++|++++.+|..
T Consensus 94 ~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~ 172 (446)
T PHA02946 94 HGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDEEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDKF 172 (446)
T ss_pred CcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCCCCCcHHH-HHHCCChHHHHHHHhccccccccCCC
Confidence 56677777778888899888765 47888889988988885 5788888887 66678888888888888888888888
Q ss_pred CCCccccccccc--hHHHHHHHHhhCCCCCCCCccccc
Q 016544 106 GSTPLGDAIYYK--NHEVIKLLEKHGAKPLMAPMHVKH 141 (387)
Q Consensus 106 g~tpl~~a~~~~--~~~~~~~L~~~g~~~~~~~~~~~~ 141 (387)
|+||||+|+..+ +.+++++|++.|+++........+
T Consensus 173 G~t~Lh~A~~~~~~~~~~v~~Ll~~Gadin~~d~~G~T 210 (446)
T PHA02946 173 GKNHIHRHLMSDNPKASTISWMMKLGISPSKPDHDGNT 210 (446)
T ss_pred CCCHHHHHHHhcCCCHHHHHHHHHcCCCCcccCCCCCC
Confidence 888888876544 457888888888887655444333
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-15 Score=149.08 Aligned_cols=103 Identities=16% Similarity=0.168 Sum_probs=89.5
Q ss_pred CCC-CCCCCcchHHHHHHhhC---CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC--CHHHHHHHHHCCC--CCCCCC
Q 016544 32 DDD-GEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGA--DVDPKD 103 (387)
Q Consensus 32 ~~~-~~~~~g~t~l~~a~~~~---~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~--~~~~~~~Ll~~ga--~~~~~~ 103 (387)
+++ .+|..|+||||+|+..| +.++|++||++|||+|.+|..|+||||+|+..+ +.+++++|+++|+ +++..+
T Consensus 32 ~in~~kd~~G~TaLh~A~~~~~~~~~eivklLLs~GAdin~kD~~G~TPLh~Aa~~~~~~~eIv~~Ll~~~~~~~~~~~~ 111 (672)
T PHA02730 32 NLSKHIDRRGNNALHCYVSNKCDTDIKIVRLLLSRGVERLCRNNEGLTPLGVYSKRKYVKSQIVHLLISSYSNASNELTS 111 (672)
T ss_pred chhhhcCCCCCcHHHHHHHcCCcCcHHHHHHHHhCCCCCcccCCCCCChHHHHHHcCCCcHHHHHHHHhcCCCCCccccc
Confidence 444 66778999999999997 599999999999999999999999999999977 7999999999965 557888
Q ss_pred cCCCCccccccc--cchHHHHHHHHh-hCCCCCC
Q 016544 104 RWGSTPLGDAIY--YKNHEVIKLLEK-HGAKPLM 134 (387)
Q Consensus 104 ~~g~tpl~~a~~--~~~~~~~~~L~~-~g~~~~~ 134 (387)
..+.+||+.++. .++.+++++|+. .++++..
T Consensus 112 ~~~d~~l~~y~~s~n~~~~~vk~Li~~~~~~~~~ 145 (672)
T PHA02730 112 NINDFDLYSYMSSDNIDLRLLKYLIVDKRIRPSK 145 (672)
T ss_pred ccCCchHHHHHHhcCCcHHHHHHHHHhcCCChhh
Confidence 889999998877 889999999996 5666543
|
|
| >PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.4e-16 Score=105.21 Aligned_cols=55 Identities=53% Similarity=0.668 Sum_probs=28.0
Q ss_pred HHHcC-CCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccc
Q 016544 59 LLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (387)
Q Consensus 59 Ll~~g-~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a 113 (387)
||++| +++|.+|..|.||||+||..|+.+++++|++.|+|++.+|..|+||+|+|
T Consensus 1 LL~~~~~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A 56 (56)
T PF13857_consen 1 LLEHGPADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA 56 (56)
T ss_dssp -----T--TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred CCccCcCCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence 56666 77888888888888888888888888888888888888888888888776
|
|
| >KOG4214 consensus Myotrophin and similar proteins [Transcription] | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.4e-16 Score=108.19 Aligned_cols=92 Identities=28% Similarity=0.504 Sum_probs=86.6
Q ss_pred HHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHHH
Q 016544 43 RLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122 (387)
Q Consensus 43 ~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~ 122 (387)
-+.|++++|.++-|+..+..|.|||..- .|+||||+|+-.|..+++++|+..||+++.+|+.|-|||-.|++.|+.+.+
T Consensus 5 ~~~W~vkNG~~DeVk~~v~~g~nVn~~~-ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cV 83 (117)
T KOG4214|consen 5 SVAWNVKNGEIDEVKQSVNEGLNVNEIY-GGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCV 83 (117)
T ss_pred hHhhhhccCcHHHHHHHHHccccHHHHh-CCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHH
Confidence 3789999999999999999999999775 899999999999999999999999999999999999999999999999999
Q ss_pred HHHHhhCCCCCCC
Q 016544 123 KLLEKHGAKPLMA 135 (387)
Q Consensus 123 ~~L~~~g~~~~~~ 135 (387)
++|++.|++-...
T Consensus 84 klLL~~GAdrt~~ 96 (117)
T KOG4214|consen 84 KLLLQNGADRTIH 96 (117)
T ss_pred HHHHHcCccccee
Confidence 9999999986443
|
|
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.9e-15 Score=152.28 Aligned_cols=108 Identities=33% Similarity=0.370 Sum_probs=87.9
Q ss_pred cCCCCCCCCCCcchHHHHHHhhC-CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc-CCHHHHHHHHHCCCCCCCCCcCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANER-DVEGIKELLDSGIDVNFRDIDNRTALHVAACQ-GFTEVVSLLLERGADVDPKDRWG 106 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~-~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~-~~~~~~~~Ll~~ga~~~~~~~~g 106 (387)
.+.|.+.++..|.||||+|+..| +.++++.|+..|+++|.+|..|+||||+|+.. ++.+++++|+++|++++.+|..|
T Consensus 296 ~gadin~~d~~g~TpLh~Aa~~g~~~~~v~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~iv~lLl~~gadin~~d~~G 375 (682)
T PHA02876 296 RGADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNARDYCD 375 (682)
T ss_pred CCCCCCCcCCCCCCHHHHHHHhCCCHHHHHHHHHcCCCCCCcccCCCcHHHHHHHhCCcHHHHHHHHHcCCCCccCCCCC
Confidence 45666667777888888888888 58888888888888888888888888888875 46888888888888888888888
Q ss_pred CCccccccccchHHHHHHHHhhCCCCCCCC
Q 016544 107 STPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 107 ~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~ 136 (387)
.||||+|+..++.+++++|+++|+++....
T Consensus 376 ~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~ 405 (682)
T PHA02876 376 KTPIHYAAVRNNVVIINTLLDYGADIEALS 405 (682)
T ss_pred CCHHHHHHHcCCHHHHHHHHHCCCCccccC
Confidence 888888888888888888888888875443
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2e-15 Score=132.36 Aligned_cols=120 Identities=28% Similarity=0.248 Sum_probs=97.3
Q ss_pred hhhhhhhcCCCCCCCCCCcchHHHHHHhh-----CCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHHC
Q 016544 22 ERKEAELNGLDDDGEEIKPEFRLMFLANE-----RDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLER 95 (387)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~g~t~l~~a~~~-----~~~~~~~~Ll~~g~~~n~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~~ 95 (387)
=+.-.|...-|++..+.-|+||+++|+.. .+.++|+.|.+.| |||++- ..|+|+|++|+.+|++++|+.||..
T Consensus 284 V~~LLDSgvC~VD~qNrAGYtpiMLaALA~lk~~~d~~vV~~LF~mg-nVNaKAsQ~gQTALMLAVSHGr~d~vk~LLac 362 (452)
T KOG0514|consen 284 VSILLDSGVCDVDQQNRAGYTPVMLAALAKLKQPADRTVVERLFKMG-DVNAKASQHGQTALMLAVSHGRVDMVKALLAC 362 (452)
T ss_pred HHHHhccCcccccccccccccHHHHHHHHhhcchhhHHHHHHHHhcc-CcchhhhhhcchhhhhhhhcCcHHHHHHHHHc
Confidence 34555566777777777888888887763 4678888888876 888874 5699999999999999999999999
Q ss_pred CCCCCCCCcCCCCccccccccchHHHHHHHHhh-CCCCCCCCcccccc
Q 016544 96 GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH-GAKPLMAPMHVKHA 142 (387)
Q Consensus 96 ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~-g~~~~~~~~~~~~~ 142 (387)
|||+|++|.+|.|+|+.|+.+|++|++++|+.. ++++........++
T Consensus 363 gAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgSTA 410 (452)
T KOG0514|consen 363 GADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGSTA 410 (452)
T ss_pred cCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCchh
Confidence 999999999999999999999999999999864 44554444444443
|
|
| >KOG0510 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2e-15 Score=144.87 Aligned_cols=100 Identities=29% Similarity=0.346 Sum_probs=92.8
Q ss_pred CCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHH-CC-CCCCCCCcCCCCccc
Q 016544 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RG-ADVDPKDRWGSTPLG 111 (387)
Q Consensus 34 ~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~-~g-a~~~~~~~~g~tpl~ 111 (387)
+-+|.+|.||||+||+.|+.+.++.|+..|+++|.++.++.||||.||..|+.++++-||+ .| ...|..|-.|.||||
T Consensus 267 ~~~d~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLH 346 (929)
T KOG0510|consen 267 NDEDNDGCTPLHYAARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLH 346 (929)
T ss_pred hcccccCCchHHHHHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchh
Confidence 4456678899999999999999999999999999999999999999999999999999998 44 567899999999999
Q ss_pred cccccchHHHHHHHHhhCCCCC
Q 016544 112 DAIYYKNHEVIKLLEKHGAKPL 133 (387)
Q Consensus 112 ~a~~~~~~~~~~~L~~~g~~~~ 133 (387)
+|+..|+.++++.|+..|+...
T Consensus 347 laa~~gH~~v~qlLl~~GA~~~ 368 (929)
T KOG0510|consen 347 LAAKSGHDRVVQLLLNKGALFL 368 (929)
T ss_pred hhhhcCHHHHHHHHHhcChhhh
Confidence 9999999999999999999876
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.3e-15 Score=124.51 Aligned_cols=133 Identities=23% Similarity=0.223 Sum_probs=92.7
Q ss_pred eeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHH---------------------HHHHHHHHHcCCCC--cce
Q 016544 161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRA---------------------FRDELALLQKIRHP--NVV 213 (387)
Q Consensus 161 ~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~h~--~iv 213 (387)
+.||+|+|+.+|. +|+.||||++............. ...|...+..+.+. .++
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 4689999998874 58999999987543221111111 13466666666433 345
Q ss_pred eeeeEEeeCCceEEEEEccCCCCHHH-HHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCC
Q 016544 214 QFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGN 291 (387)
Q Consensus 214 ~l~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~ 291 (387)
+++++ ...+++|||++++++.. .+.... . ..++..++.+++.++.++|+ .+ ++|+||||+||+++ ++.
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGK 152 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCc
Confidence 55543 24589999999854321 111111 1 15678899999999999999 88 99999999999999 889
Q ss_pred EEEEeecCcccc
Q 016544 292 LKVADFGVSKLL 303 (387)
Q Consensus 292 ~kl~Dfg~~~~~ 303 (387)
++|+|||.+...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.9e-16 Score=126.26 Aligned_cols=129 Identities=21% Similarity=0.117 Sum_probs=113.2
Q ss_pred cccccccccccccCCCcchhhhhhhhcCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH
Q 016544 3 TKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82 (387)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~ 82 (387)
++-+++|+..|...+.+-.--+-.--+|.|++.-..+..|+|.+|++.|..++|++|+..+.|||.-|.+|-|||-+|+.
T Consensus 156 ~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgTpLlyAvr 235 (296)
T KOG0502|consen 156 CDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGTPLLYAVR 235 (296)
T ss_pred ccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCceeeeeec
Confidence 57789999999988887766555556788888888888899999999999999999999999999999999999999999
Q ss_pred cCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHHHHHHHhhCCCC
Q 016544 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 83 ~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
-|+.+|++.|++.||+++..+..|.+++.+|+..|.. +++..++..+..
T Consensus 236 gnhvkcve~Ll~sGAd~t~e~dsGy~~mdlAValGyr-~Vqqvie~h~lk 284 (296)
T KOG0502|consen 236 GNHVKCVESLLNSGADVTQEDDSGYWIMDLAVALGYR-IVQQVIEKHALK 284 (296)
T ss_pred CChHHHHHHHHhcCCCcccccccCCcHHHHHHHhhhH-HHHHHHHHHHHH
Confidence 9999999999999999999999999999999999988 444444444443
|
|
| >KOG0505 consensus Myosin phosphatase, regulatory subunit [Posttranslational modification, protein turnover, chaperones; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.1e-15 Score=137.66 Aligned_cols=71 Identities=39% Similarity=0.465 Sum_probs=49.4
Q ss_pred CCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHHHHHHHhhCCCCCCCCccccccC
Q 016544 73 NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (387)
Q Consensus 73 g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~~ 143 (387)
|-|+||+|+.+|..+++++|+++|.+++++|.+||||||.|+..+..+++++|+.+|+++.+.......+.
T Consensus 198 G~T~lHvAaa~Gy~e~~~lLl~ag~~~~~~D~dgWtPlHAAA~Wg~~~~~elL~~~ga~~d~~t~~g~~p~ 268 (527)
T KOG0505|consen 198 GATALHVAAANGYTEVAALLLQAGYSVNIKDYDGWTPLHAAAHWGQEDACELLVEHGADMDAKTKMGETPL 268 (527)
T ss_pred cchHHHHHHhhhHHHHHHHHHHhccCcccccccCCCcccHHHHhhhHhHHHHHHHhhcccchhhhcCCCCc
Confidence 44555556666666677777777777777777778888877777777777777777777766555444443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.8e-14 Score=117.67 Aligned_cols=131 Identities=19% Similarity=0.182 Sum_probs=106.7
Q ss_pred ceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCC--CcceeeeeEEeeCCceEEEEEccCC
Q 016544 160 SVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 160 ~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
.+.+|.|.++.++ ..+..+++|....... ...+..|..+++.+.+ .++++++.++...+..++++||+.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 3568888887665 4567999999865432 3568889999999976 5899999988888889999999988
Q ss_pred CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 235 ~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
+++..+ +......++.++++++.++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 4556677899999999999986333499999999999999988999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.2e-15 Score=125.11 Aligned_cols=102 Identities=25% Similarity=0.355 Sum_probs=88.4
Q ss_pred CCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccc
Q 016544 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~ 112 (387)
+|..+....||||+||..||.++|+.|++..+|+|+.+..|+|||||||.+|.-.+++-|+..||.+++.|+.|.|||.-
T Consensus 60 vn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgntplhyacfwgydqiaedli~~ga~v~icnk~g~tpldk 139 (448)
T KOG0195|consen 60 VNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTPLHYACFWGYDQIAEDLISCGAAVNICNKKGMTPLDK 139 (448)
T ss_pred cccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCchhhhhhhcHHHHHHHHHhccceeeecccCCCCchhh
Confidence 33344445677999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred ccccchHHHHHHHHhhCCCCCC
Q 016544 113 AIYYKNHEVIKLLEKHGAKPLM 134 (387)
Q Consensus 113 a~~~~~~~~~~~L~~~g~~~~~ 134 (387)
|.-.-..-+.+.-.++|-.+..
T Consensus 140 akp~l~~~l~e~aek~gq~~nr 161 (448)
T KOG0195|consen 140 AKPMLKNTLLEIAEKHGQSPNR 161 (448)
T ss_pred hchHHHHHHHHHHHHhCCCCCc
Confidence 8766556666666777776643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.1e-16 Score=155.36 Aligned_cols=202 Identities=28% Similarity=0.438 Sum_probs=162.8
Q ss_pred ccCcccceeecccEEEEEE------EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceE
Q 016544 154 ELDFTNSVEITKGTFILAF------WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~ 226 (387)
...|...+.||.|+|+.+. .....+|+|.+.... ...........|..+-+.+. |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 3456666679999997653 233567777766543 33444556667888888886 999999999999999999
Q ss_pred EEEEccCCCCHHHHH-HHcC-CCChHHHHHHHHHHHHHHHHHH-hCCCCCeEeCCCCCCCEEeCCCC-CEEEEeecCccc
Q 016544 227 IVTEYLPKGDLRAFL-KRKG-ALKPSTAVRFALDIARGMNYLH-ENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKL 302 (387)
Q Consensus 227 lv~e~~~~~sL~~~l-~~~~-~l~~~~~~~i~~qi~~~l~~LH-~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~ 302 (387)
+.+++..++++.+.+ .... ..+...+..++.|+..++.|+| ..+ +.|+|+||+|.+++..+ ..+++|||+|..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999999888 5443 5778888999999999999999 877 99999999999999999 999999999987
Q ss_pred ccc--CCCCCcccCCC-CCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 303 LTV--KEDRPLTCQDT-SCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 303 ~~~--~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
+.. ..........| ++.|+|||...+. ...+..|+||.|+++..+++|..||.....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~ 235 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR 235 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccc
Confidence 765 22333344556 8999999999885 446789999999999999999999975443
|
|
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.1e-15 Score=149.62 Aligned_cols=111 Identities=36% Similarity=0.449 Sum_probs=99.7
Q ss_pred CCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccc
Q 016544 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (387)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~ 111 (387)
+.+-....|-|+||.|+..+.+.+++.++++|++++.++..|+||||.||..|+.++|++|+++|||++.+++.|+||||
T Consensus 499 ~~~~~~~~~l~~lhla~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH 578 (1143)
T KOG4177|consen 499 NDNLDAKKGLTPLHLAADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLH 578 (1143)
T ss_pred ccCccchhccchhhhhhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhh
Confidence 34444456788888888888899999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 112 DAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 112 ~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
.|+..|+.+++.+|+++|++++.......++
T Consensus 579 ~Aa~~G~~~i~~LLlk~GA~vna~d~~g~Tp 609 (1143)
T KOG4177|consen 579 QAAQQGHNDIAELLLKHGASVNAADLDGFTP 609 (1143)
T ss_pred HHHHcChHHHHHHHHHcCCCCCcccccCcch
Confidence 9999999999999999999997766555544
|
|
| >cd00204 ANK ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.1e-14 Score=112.98 Aligned_cols=100 Identities=44% Similarity=0.573 Sum_probs=92.7
Q ss_pred CCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccc
Q 016544 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (387)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~ 115 (387)
++.+|.||||+|+..++.+++++|++.|++.+..+..|.||||+|+..++.+++++|++.|++++..+..|.||+|+|+.
T Consensus 3 ~~~~g~t~l~~a~~~~~~~~i~~li~~~~~~~~~~~~g~~~l~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~l~~a~~ 82 (126)
T cd00204 3 RDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAAR 82 (126)
T ss_pred cCcCCCCHHHHHHHcCcHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHH
Confidence 34578899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cchHHHHHHHHhhCCCCCCC
Q 016544 116 YKNHEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 116 ~~~~~~~~~L~~~g~~~~~~ 135 (387)
.++.+++++|.+.+.+....
T Consensus 83 ~~~~~~~~~L~~~~~~~~~~ 102 (126)
T cd00204 83 NGNLDVVKLLLKHGADVNAR 102 (126)
T ss_pred cCcHHHHHHHHHcCCCCccc
Confidence 99999999999988555443
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. |
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-14 Score=149.93 Aligned_cols=96 Identities=28% Similarity=0.460 Sum_probs=87.9
Q ss_pred CCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccc
Q 016544 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (387)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~ 115 (387)
.+..+.++||.||..|+.++++.|+++|+|+|..|.+|+||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+.
T Consensus 521 ~~~~~~~~L~~Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~ 600 (823)
T PLN03192 521 DDPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAIS 600 (823)
T ss_pred CCccchhHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHH
Confidence 34457789999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred cchHHHHHHHHhhCCC
Q 016544 116 YKNHEVIKLLEKHGAK 131 (387)
Q Consensus 116 ~~~~~~~~~L~~~g~~ 131 (387)
.|+.+++++|.+.++.
T Consensus 601 ~g~~~iv~~L~~~~~~ 616 (823)
T PLN03192 601 AKHHKIFRILYHFASI 616 (823)
T ss_pred hCCHHHHHHHHhcCcc
Confidence 8888888877765543
|
|
| >PHA02792 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.5e-15 Score=141.85 Aligned_cols=103 Identities=17% Similarity=0.123 Sum_probs=78.6
Q ss_pred CCCCCCCCCC--cchHHHHHHhhCCH---HHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCc
Q 016544 30 GLDDDGEEIK--PEFRLMFLANERDV---EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104 (387)
Q Consensus 30 ~~~~~~~~~~--g~t~l~~a~~~~~~---~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~ 104 (387)
|+|++.++.+ +.||||+|+..... +++++|+++|||+|.+|..|+||||+|+..++.+++++|+++|++++.+|.
T Consensus 362 GADIN~kD~~g~~~TpLh~A~~n~~~~v~~IlklLIs~GADIN~kD~~G~TPLh~Aa~~~n~eivelLLs~GADIN~kD~ 441 (631)
T PHA02792 362 GNVVVEDDDNIINIMPLFPTLSIHESDVLSILKLCKPYIDDINKIDKHGRSILYYCIESHSVSLVEWLIDNGADINITTK 441 (631)
T ss_pred CCchhhhcCCCCChhHHHHHHHhccHhHHHHHHHHHhcCCccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCcCC
Confidence 4444444433 45888887776654 357888888999999998899999999998999999999999999999999
Q ss_pred CCCCccccccc----------cchHHHHHHHHhhCCCC
Q 016544 105 WGSTPLGDAIY----------YKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 105 ~g~tpl~~a~~----------~~~~~~~~~L~~~g~~~ 132 (387)
.|.|||++|.. ....++++.+++++.++
T Consensus 442 ~G~TpL~~A~~~~~~~~~~i~~~~~~il~lLLs~~p~i 479 (631)
T PHA02792 442 YGSTCIGICVILAHACIPEIAELYIKILEIILSKLPTI 479 (631)
T ss_pred CCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHhcCCCh
Confidence 99999998865 12345677888777654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 387 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-32 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-32 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-27 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-26 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-26 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-26 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-26 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-26 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-25 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-24 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-24 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-24 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-24 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-24 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-24 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-24 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-24 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-24 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-24 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-24 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-24 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-24 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-24 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-23 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-23 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-23 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-23 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-23 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-22 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-22 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-22 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-22 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-22 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-22 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-22 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-22 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-22 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-22 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-22 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-21 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-21 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-21 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-21 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 9e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-20 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-20 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-20 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-20 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-19 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-19 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-19 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-19 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-19 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-19 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-19 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-19 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-19 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-19 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-19 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-19 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-19 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-19 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-19 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-19 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-19 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-19 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-19 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-19 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-19 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-18 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-18 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-18 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-18 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-18 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-18 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-18 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-18 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-18 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-18 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-18 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-18 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-18 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-18 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-18 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-18 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-18 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-18 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-18 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-18 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-18 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-18 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-18 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-18 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-18 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-18 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-18 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-18 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-18 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-18 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-18 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-18 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-18 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-17 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-17 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-17 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-17 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-17 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-17 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-17 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-17 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-17 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-16 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-16 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-16 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-16 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-16 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-15 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-15 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-15 | ||
| 4hqd_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 7e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-15 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-15 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-13 | ||
| 4gpm_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 1e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-13 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-13 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-13 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-13 | ||
| 4gmr_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-13 | ||
| 1n0r_A | 126 | 4ank: A Designed Ankyrin Repeat Protein With Four I | 3e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-13 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-13 | ||
| 1n0q_A | 93 | 3ank: A Designed Ankyrin Repeat Protein With Three | 3e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-13 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-13 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-12 | ||
| 4dui_A | 169 | Darpin D1 Binding To Tubulin Beta Chain (not In Com | 1e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-12 | ||
| 4hb5_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 1e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-12 | ||
| 4drx_E | 169 | Gtp-Tubulin In Complex With A Darpin Length = 169 | 2e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-12 | ||
| 4atz_D | 154 | Ad5 Knob In Complex With A Designed Ankyrin Repeat | 3e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-12 | ||
| 2l6b_A | 115 | Nrc Consensus Ankyrin Repeat Protein Solution Struc | 6e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-12 | ||
| 1mj0_A | 166 | Sank E3_5: An Artificial Ankyrin Repeat Protein Len | 8e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-12 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-11 | ||
| 2xeh_A | 157 | Structural Determinants For Improved Thermal Stabil | 2e-11 | ||
| 2y0b_G | 136 | Caspase-3 In Complex With An Inhibitory Darpin-3.4_ | 3e-11 | ||
| 2xee_A | 157 | Structural Determinants For Improved Thermal Stabil | 3e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-11 | ||
| 3zu7_B | 169 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-11 | ||
| 2qyj_A | 166 | Crystal Structure Of A Designed Full Consensus Anky | 5e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-11 | ||
| 3q9u_C | 158 | In Silico And In Vitro Co-Evolution Of A High Affin | 6e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-11 | ||
| 2bkg_A | 166 | Crystal Structure Of E3_19 An Designed Ankyrin Repe | 8e-11 | ||
| 1svx_A | 169 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-11 | ||
| 4f6r_D | 169 | Tubulin:stathmin-Like Domain Complex Length = 169 | 1e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-10 | ||
| 2xzd_G | 136 | Caspase-3 In Complex With An Inhibitory Darpin-3.4 | 2e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3utm_A | 351 | Crystal Structure Of A Mouse Tankyrase-Axin Complex | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-10 | ||
| 2p2c_P | 169 | Inhibition Of Caspase-2 By A Designed Ankyrin Repea | 7e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-10 | ||
| 2v4h_C | 136 | Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 13 | 8e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 2xzt_G | 136 | Caspase-3 In Complex With Darpin-3.4_i78s Length = | 1e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4HQD|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or265. Length = 169 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4GPM|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or264. Length = 169 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GMR|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or266. Length = 169 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1N0R|A Chain A, 4ank: A Designed Ankyrin Repeat Protein With Four Identical Consensus Repeats Length = 126 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1N0Q|A Chain A, 3ank: A Designed Ankyrin Repeat Protein With Three Identical Consensus Repeats Length = 93 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4DUI|A Chain A, Darpin D1 Binding To Tubulin Beta Chain (not In Complex) Length = 169 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4HB5|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or267. Length = 169 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DRX|E Chain E, Gtp-Tubulin In Complex With A Darpin Length = 169 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4ATZ|D Chain D, Ad5 Knob In Complex With A Designed Ankyrin Repeat Protein Length = 154 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2L6B|A Chain A, Nrc Consensus Ankyrin Repeat Protein Solution Structure Length = 115 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1MJ0|A Chain A, Sank E3_5: An Artificial Ankyrin Repeat Protein Length = 166 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2XEH|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157 | Back alignment and structure |
|
| >pdb|2Y0B|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4_s76r Length = 136 | Back alignment and structure |
|
| >pdb|2XEE|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ZU7|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 169 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QYJ|A Chain A, Crystal Structure Of A Designed Full Consensus Ankyrin Length = 166 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3Q9U|C Chain C, In Silico And In Vitro Co-Evolution Of A High Affinity Complementary Protein-Protein Interface Length = 158 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2BKG|A Chain A, Crystal Structure Of E3_19 An Designed Ankyrin Repeat Protein Length = 166 | Back alignment and structure |
|
| >pdb|1SVX|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Maltose Binding Protein Length = 169 | Back alignment and structure |
|
| >pdb|4F6R|D Chain D, Tubulin:stathmin-Like Domain Complex Length = 169 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XZD|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4 Length = 136 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3UTM|A Chain A, Crystal Structure Of A Mouse Tankyrase-Axin Complex Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2P2C|P Chain P, Inhibition Of Caspase-2 By A Designed Ankyrin Repeat Protein (Darpin) Length = 169 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2V4H|C Chain C, Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 136 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XZT|G Chain G, Caspase-3 In Complex With Darpin-3.4_i78s Length = 136 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 2e-79
Identities = 73/237 (30%), Positives = 111/237 (46%), Gaps = 22/237 (9%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
+ ID E++ + +G F A WR VA+K++ + +AF EL
Sbjct: 2 LHMIDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIKQI-----ESESERKAFIVELRQ 54
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL---KRKGALKPSTAVRFALDIA 260
L ++ HPN+V+ GA P+ +V EY G L L + + A+ + L +
Sbjct: 55 LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKEDRPLTCQDTSCR 319
+G+ YLH +P +IHRDL+P N+L G LK+ DFG + + +T S
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAA 168
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPF 374
++APEVF+ Y K DVFS+ +IL E+I PF +A RPP
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL 225
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 6e-79
Identities = 87/253 (34%), Positives = 137/253 (54%), Gaps = 16/253 (6%)
Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEE 186
P ++ + A + + +I +L+ +I G+F A W G VAVK L E+
Sbjct: 14 DIPTTENLYFQGAMDGDDMDIPWCDLNIKE--KIGAGSFGTVHRAEWHGSDVAVKILMEQ 71
Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA 246
+ RV F E+A+++++RHPN+V F+GAVTQ + IVTEYL +G L L + GA
Sbjct: 72 DFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130
Query: 247 ---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
L + A D+A+GMNYLH P PI+HR+L+ N+L D +KV DFG+S+
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSR-- 187
Query: 304 TVKEDRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361
+K L+ + + ++APEV ++E + K DV+SF +IL E+ P+ + +
Sbjct: 188 -LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246
Query: 362 VPKAYAAR-QRPP 373
V A + +R
Sbjct: 247 VVAAVGFKCKRLE 259
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 5e-75
Identities = 74/238 (31%), Positives = 106/238 (44%), Gaps = 19/238 (7%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISD-DDRVRAFRDELALL 204
EID EL I G F AFW G +VAVK + D + R E L
Sbjct: 3 EIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN 264
++HPN++ G + + +V E+ G L L K + P V +A+ IARGMN
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 119
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSG--------NLKVADFGVSKLLTVKEDRPLTCQDT 316
YLH+ VPIIHRDL+ SNIL LK+ DFG+++
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAG 176
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP 373
+ ++APEV + + DV+S+ ++L E++ G PF V A + P
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP 234
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 3e-71
Identities = 67/248 (27%), Positives = 111/248 (44%), Gaps = 29/248 (11%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFW--RGIQVAVKKLGEEVISDD----DRVRAF 197
+ +E+++ +I KG F VA+K L + ++ + F
Sbjct: 13 LPTLADNEIEYEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFA 256
+ E+ ++ + HPN+V+ G + P +V E++P GDL L + +K S +R
Sbjct: 71 QREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFGVSKLLTVKEDRPL 311
LDIA G+ Y+ P PI+HRDL NI KVADFG+S+ +
Sbjct: 129 LDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSV 183
Query: 312 TCQDTSCRYVAPEVF--KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
+ + +++APE + E Y K D +SFA+IL ++ G PF ++ R
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243
Query: 370 Q---RPPF 374
+ RP
Sbjct: 244 EEGLRPTI 251
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 1e-69
Identities = 62/238 (26%), Positives = 102/238 (42%), Gaps = 21/238 (8%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
ID +L+F ++ + W+G + VK L S + R F +E
Sbjct: 4 HSGIDFKQLNFLT--KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPR 60
Query: 204 LQKIRHPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFL--KRKGALKPSTAVRFALDI 259
L+ HPNV+ LGA + ++T ++P G L L + S AV+FALD+
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
ARGM +LH +P I L +++ D+ +++ V +
Sbjct: 121 ARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM------YAPA 173
Query: 320 YVAPEVFKNEEYDT---KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP 373
+VAPE + + DT D++SFA++L E++ PF + E+ A RP
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT 231
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 3e-69
Identities = 60/244 (24%), Positives = 108/244 (44%), Gaps = 25/244 (10%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
E++I +L+ I KG F W G +VA++ + E ++D+++AF+ E+
Sbjct: 27 EWDIPFEQLEIGE--LIGKGRFGQVYHGRWHG-EVAIRLIDIERD-NEDQLKAFKREVMA 82
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
++ RH NVV F+GA + I+T L + + K L + + A +I +G
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV----KEDRPLTCQDTSC 318
M YLH I+H+DL+ N+ D+ G + + DFG+ + V + + L Q+
Sbjct: 143 MGYLHAK---GILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 319 RYVAPEVFKNEE---------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
++APE+ + + DVF+ I E+ PF + +
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258
Query: 370 QRPP 373
+P
Sbjct: 259 MKPN 262
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 3e-67
Identities = 77/262 (29%), Positives = 119/262 (45%), Gaps = 35/262 (13%)
Query: 145 VPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRD 199
+P P +L + KG F I R G + +K+L D++ R F
Sbjct: 2 MPHRIFRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLK 56
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALD 258
E+ +++ + HPNV++F+G + + + +TEY+ G LR +K S V FA D
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-- 316
IA GM YLH IIHRDL N L ++ N+ VADFG+++L+ ++ +P +
Sbjct: 117 IASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 317 -----------SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI------EGCPPFTMKHD 359
+ ++APE+ YD KVDVFSF ++L E+I P TM
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 360 NEVPKAYAARQRPPFKAPAKLY 381
V + P P +
Sbjct: 234 LNVRGFL--DRYCPPNCPPSFF 253
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 9e-66
Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
++EI ++ I G+F W G VAVK L +++AF++E+ +
Sbjct: 18 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHG-DVAVKMLNVTAP-TPQQLQAFKNEVGV 73
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
L+K RH N++ F+G T + IVT++ L L + + + A ARG
Sbjct: 74 LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYV 321
M+YLH IIHRDL+ +NI + +K+ DFG++ + Q + S ++
Sbjct: 133 MDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 322 APEVFKNEE---YDTKVDVFSFALILQEMIEGCPPF 354
APEV + ++ Y + DV++F ++L E++ G P+
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 2e-62
Identities = 55/249 (22%), Positives = 99/249 (39%), Gaps = 28/249 (11%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
++ +I KG + + WRG +VAVK + ++ E+
Sbjct: 31 VQRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEKVAVKVF----FTTEEASWFRETEIYQ 84
Query: 204 LQKIRHPNVVQFLGAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
+RH N++ F+ A + + + ++T+Y G L +LK L + ++ A
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSS 143
Query: 260 ARGMNYLHENKPV-----PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
G+ +LH I HRDL+ NIL +G +AD G++ +
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 315 DTSC---RYVAPEV------FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365
+T RY+ PEV + + D++SF LIL E+ C + + ++P
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
Query: 366 YAARQRPPF 374
P +
Sbjct: 264 DLVPSDPSY 272
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 3e-60
Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 26/222 (11%)
Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
+ KG + W+G VAVK R EL +RH N++ F+ +
Sbjct: 16 VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRET----ELYNTVMLRHENILGFIASD 71
Query: 220 TQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV--- 272
S + ++T Y G L +L+ L + +R L IA G+ +LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 273 --PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK 327
I HRDL+ NIL +G +AD G++ + + ++ + RY+APEV
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 328 NE------EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
+ +VD+++F L+L E+ + D + P
Sbjct: 191 ETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 7e-58
Identities = 56/238 (23%), Positives = 92/238 (38%), Gaps = 28/238 (11%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
+ I KG F WRG +VAVK R E+
Sbjct: 36 VQRTIARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA----EIYQ 89
Query: 204 LQKIRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
+RH N++ F+ A + + + +V++Y G L +L R + ++ AL
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALST 148
Query: 260 ARGMNYLHENKPV-----PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
A G+ +LH I HRDL+ NIL +G +AD G++ D
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
Query: 315 DTSC---RYVAPEVFKNE------EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
+ RY+APEV + E + D+++ L+ E+ C + D ++P
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 7e-56
Identities = 59/250 (23%), Positives = 99/250 (39%), Gaps = 28/250 (11%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
L +G F A VAVK + D + E+
Sbjct: 17 ENLYFQSMPLQLLE--VKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVY 70
Query: 203 LLQKIRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
L ++H N++QF+GA + + + ++T + KG L FLK + + A
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAET 129
Query: 259 IARGMNYLHENKPV-------PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
+ARG+ YLHE+ P I HRD++ N+L ++ +ADFG++ +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 312 TCQDT-SCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPK 364
T + RY+APEV + ++D+++ L+L E+ C D +P
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 365 AYAARQRPPF 374
Q P
Sbjct: 250 EEEIGQHPSL 259
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 4e-53
Identities = 62/264 (23%), Positives = 97/264 (36%), Gaps = 42/264 (15%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
E +D L I +G + VAVK S +R + F +E
Sbjct: 4 AASEPSLDLDNLKLLEL--IGRGRYGAVYKGSLDERPVAVKVF-----SFANR-QNFINE 55
Query: 201 LA--LLQKIRHPNVVQFLGA-----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
+ + H N+ +F+ ++V EY P G L +L ++
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114
Query: 254 RFALDIARGMNYLHENKPV------PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
R A + RG+ YLH P I HRDL N+L + G ++DFG+S LT
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 308 DRPLTCQDTSC-------RYVAPEVFKN-------EEYDTKVDVFSFALILQEMIEGC-- 351
+D + RY+APEV + E +VD+++ LI E+ C
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 352 -PPFTMKHDNEVPKAYAARQRPPF 374
P + ++ P F
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTF 258
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 2e-49
Identities = 67/277 (24%), Positives = 127/277 (45%), Gaps = 19/277 (6%)
Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
+ + + + A P + ++E++ ++ + ++ G +
Sbjct: 182 HSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKH--KLGGGQYGEVYEG 239
Query: 172 FWRG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
W+ + VAVK L E+ + ++ F E A++++I+HPN+VQ LG T+ P I+T
Sbjct: 240 VWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295
Query: 230 EYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
E++ G+L +L+ + + + A I+ M YL + IHR+L N L
Sbjct: 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVG 352
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
++ +KVADFG+S+L+T ++ APE ++ K DV++F ++L E+
Sbjct: 353 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412
Query: 348 I-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
G P+ ++V + R P P K+Y
Sbjct: 413 ATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY 449
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 5e-48
Identities = 76/246 (30%), Positives = 128/246 (52%), Gaps = 23/246 (9%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
++ IDP EL F EI G F L +W +VA+K + E +S++D F +E
Sbjct: 2 KWVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAE 55
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 261
++ K+ HP +VQ G + +P+ +VTE++ G L +L+ ++G T + LD+
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---C 318
GM YL E +IHRDL N L ++ +KV+DFG+++ + D T +
Sbjct: 116 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPV 169
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFK 375
++ +PEVF Y +K DV+SF +++ E+ EG P+ + ++EV + + R P
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL 229
Query: 376 APAKLY 381
A +Y
Sbjct: 230 ASTHVY 235
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 7e-48
Identities = 72/270 (26%), Positives = 111/270 (41%), Gaps = 25/270 (9%)
Query: 127 KHGAKPLMAPMHVKHAREVP--EYEIDPHELDFTNSVEITKGTF---ILAFWRG--IQVA 179
+PL V R VP ++ ++ +L +I +G F R VA
Sbjct: 86 LSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGE--QIGRGNFGEVFSGRLRADNTLVA 143
Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
VK E + D F E +L++ HPN+V+ +G TQ P+ IV E + GD
Sbjct: 144 VKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT 201
Query: 240 FLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
FL+ L+ T ++ D A GM YL IHRDL N L + LK++DFG
Sbjct: 202 FLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFG 258
Query: 299 VSKLLTVKEDRPLTCQDTSC----RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPP 353
+S+ D ++ APE Y ++ DV+SF ++L E G P
Sbjct: 259 MSREE---ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315
Query: 354 FTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
+ + + + R P P ++
Sbjct: 316 YPNLSNQQTREFVEKGGRLPCPELCPDAVF 345
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-47
Identities = 66/246 (26%), Positives = 120/246 (48%), Gaps = 19/246 (7%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG--IQVAVKKLGEEVISDDDRVRAFRDE 200
++E++ ++ + ++ G + W+ + VAVK L E+ + ++ F E
Sbjct: 6 DKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKE 59
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALD 258
A++++I+HPN+VQ LG T+ P I+TE++ G+L +L+ + + + A
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
I+ M YL + IHRDL N L ++ +KVADFG+S+L+T
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFK 375
++ APE ++ K DV++F ++L E+ G P+ ++V + R P
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236
Query: 376 APAKLY 381
P K+Y
Sbjct: 237 CPEKVY 242
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-47
Identities = 73/289 (25%), Positives = 120/289 (41%), Gaps = 26/289 (8%)
Query: 114 IYYKNH--EVIKLLEKHGAKPLMAPMHVKHAREVPEY-------EIDPHELDFTNSV--- 161
+++ +H + L G P H E P EI+ + +
Sbjct: 1 MHHHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSG 60
Query: 162 ---EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
E+ G + R + VA+K L + + R F E +++ + HPN+++ G
Sbjct: 61 DSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNIIRLEGV 118
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
VT+ MIVTEY+ G L FL+ G V + GM YL + +HR
Sbjct: 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHR 175
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--RYVAPEVFKNEEYDTKV 335
DL N+L D + KV+DFG+S++L D T R+ APE + +
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSAS 235
Query: 336 DVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
DV+SF +++ E++ G P+ + +V + R P P L+
Sbjct: 236 DVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALH 284
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-47
Identities = 70/248 (28%), Positives = 119/248 (47%), Gaps = 29/248 (11%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
+ ++ EL I KG F +L +RG +VAVK + + + F E +
Sbjct: 14 SGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-----FLAEAS 66
Query: 203 LLQKIRHPNVVQFLGAVTQSSP-MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDI 259
++ ++RH N+VQ LG + + + IVTEY+ KG L +L+ + L ++F+LD+
Sbjct: 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR---PLTCQDT 316
M YL N +HRDL N+L + KV+DFG++K + +D P+
Sbjct: 127 CEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV----- 178
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PP 373
++ APE + +++ TK DV+SF ++L E+ G P+ +V + P
Sbjct: 179 --KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 236
Query: 374 FKAPAKLY 381
P +Y
Sbjct: 237 DGCPPAVY 244
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-46
Identities = 72/244 (29%), Positives = 119/244 (48%), Gaps = 23/244 (9%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALL 204
E+ E+ E+ G F L W+G VAVK + E +S+D+ F E +
Sbjct: 4 ELKREEITLLK--ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE----FFQEAQTM 57
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGM 263
K+ HP +V+F G ++ P+ IVTEY+ G L +L+ L+PS + D+ GM
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRY 320
+L ++ IHRDL N L D +KV+DFG+++ + D + ++
Sbjct: 118 AFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKW 171
Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAP 377
APEVF +Y +K DV++F +++ E+ G P+ + ++EV + R P A
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLAS 231
Query: 378 AKLY 381
+Y
Sbjct: 232 DTIY 235
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-46
Identities = 71/246 (28%), Positives = 118/246 (47%), Gaps = 23/246 (9%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
+EIDP +L F E+ G F WRG VA+K + E +S+D+ F +E
Sbjct: 18 SWEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAK 71
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 261
++ + H +VQ G T+ P+ I+TEY+ G L +L+ + + + D+
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---C 318
M YL + +HRDL N L +D G +KV+DFG+S+ + D T S
Sbjct: 132 AMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPV 185
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFK 375
R+ PEV ++ +K D+++F +++ E+ G P+ ++E + A R P
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL 245
Query: 376 APAKLY 381
A K+Y
Sbjct: 246 ASEKVY 251
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 8e-46
Identities = 75/264 (28%), Positives = 126/264 (47%), Gaps = 29/264 (10%)
Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEE 186
K + + + + ++ EL I KG F +L +RG +VAVK
Sbjct: 170 PKVMEGTVAAQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVK----- 222
Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVTEYLPKGDLRAFLKRKG 245
I +D +AF E +++ ++RH N+VQ LG + + + IVTEY+ KG L +L+ +G
Sbjct: 223 CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 282
Query: 246 --ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
L ++F+LD+ M YL N +HRDL N+L + KV+DFG++K
Sbjct: 283 RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339
Query: 304 TVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHD 359
+ +D P+ ++ APE + +++ TK DV+SF ++L E+ G P+
Sbjct: 340 SSTQDTGKLPV-------KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392
Query: 360 NEVPKAYAARQR--PPFKAPAKLY 381
+V + P P +Y
Sbjct: 393 KDVVPRVEKGYKMDAPDGCPPAVY 416
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-45
Identities = 77/276 (27%), Positives = 118/276 (42%), Gaps = 21/276 (7%)
Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
YY H L +EI L ++ +G F +
Sbjct: 148 YYSKHA--DGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEV--KLGQGCFGEVWMG 203
Query: 172 FWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
W G +VA+K L +S + F E +++K+RH +VQ V++ P+ IVTE
Sbjct: 204 TWNGTTRVAIKTLKPGTMSPEA----FLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTE 258
Query: 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
Y+ KG L FLK + L+ V A IA GM Y+ +HRDL +NIL +
Sbjct: 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGE 315
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
+ KVADFG+++L+ E ++ APE + K DV+SF ++L E+
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375
Query: 349 -EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
+G P+ + EV R P + P L+
Sbjct: 376 TKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH 411
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-45
Identities = 73/244 (29%), Positives = 114/244 (46%), Gaps = 19/244 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
+EI L ++ +G F + W G +VA+K L +S + F E
Sbjct: 261 AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 314
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIA 260
+++K+RH +VQ V++ P+ IVTEY+ KG L FLK + L+ V A IA
Sbjct: 315 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
GM Y+ +HRDL +NIL ++ KVADFG+++L+ E ++
Sbjct: 374 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAP 377
APE + K DV+SF ++L E+ +G P+ + EV R P + P
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 490
Query: 378 AKLY 381
L+
Sbjct: 491 ESLH 494
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-45
Identities = 62/254 (24%), Positives = 107/254 (42%), Gaps = 32/254 (12%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFRD 199
E +D L + E+ G F +++ VAVK L E +D
Sbjct: 10 EVYLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLA 67
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
E ++Q++ +P +V+ +G M+V E G L +L++ +K + +
Sbjct: 68 EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR---------P 310
+ GM YL E+ +HRDL N+L K++DFG+SK L E+ P
Sbjct: 127 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAAR 369
+ ++ APE ++ +K DV+SF +++ E G P+ +EV
Sbjct: 184 V-------KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236
Query: 370 QR--PPFKAPAKLY 381
+R P P ++Y
Sbjct: 237 ERMGCPAGCPREMY 250
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-45
Identities = 74/245 (30%), Positives = 116/245 (47%), Gaps = 17/245 (6%)
Query: 149 EIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
E+D + V E+ G L + I VA+K L + + R F E +
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEAS 98
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIAR 261
++ + HPN+++ G VT+S P+MIVTEY+ G L +FL K V IA
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--R 319
GM YL + +HRDL NIL + + KV+DFG+ ++L + T + R
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKA 376
+ +PE ++ + DV+S+ ++L E++ G P+ + +V KA R PP
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275
Query: 377 PAKLY 381
PA LY
Sbjct: 276 PAALY 280
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-45
Identities = 69/250 (27%), Positives = 111/250 (44%), Gaps = 22/250 (8%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
EI P + I G F + + VA+K L ++ R F
Sbjct: 38 TTEIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQR-VDF 93
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFA 256
E ++ + H N+++ G +++ PMMI+TEY+ G L FL+ + G V
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
IA GM YL +HRDL NIL + + KV+DFG+S++L + T
Sbjct: 154 RGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 317 SC--RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR-- 371
R+ APE ++ + DV+SF +++ E++ G P+ ++EV KA R
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 270
Query: 372 PPFKAPAKLY 381
P P+ +Y
Sbjct: 271 TPMDCPSAIY 280
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-45
Identities = 59/216 (27%), Positives = 110/216 (50%), Gaps = 16/216 (7%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELAL 203
+ +EI +G+F ++VA +L + ++ +R + F++E +
Sbjct: 20 GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEM 78
Query: 204 LQKIRHPNVVQFLGA----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
L+ ++HPN+V+F + V +++VTE + G L+ +LKR +K + I
Sbjct: 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 138
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
+G+ +LH P PIIHRDL+ NI +G++K+ D G++ L + T
Sbjct: 139 LKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPE 195
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
++APE+++ E+YD VDV++F + + EM P+
Sbjct: 196 -FMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPY 229
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-44
Identities = 65/300 (21%), Positives = 123/300 (41%), Gaps = 42/300 (14%)
Query: 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---IL 170
++ +H + A R+ + + L F ++ KG F +
Sbjct: 4 YHHHHHHDYDIPTTENLYFQGAMGSAFEDRD--PTQFEERHLKFLQ--QLGKGNFGSVEM 59
Query: 171 AFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS- 223
+ VAVKKL S ++ +R F E+ +L+ ++H N+V++ G +
Sbjct: 60 CRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116
Query: 224 -PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
+ ++ EYLP G LR +L++ K + +++ I +GM YL + IHRDL
Sbjct: 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLAT 173
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
NIL ++ +K+ DFG++K+L ++ + ++ + APE ++ DV+S
Sbjct: 174 RNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWS 233
Query: 340 FALILQEMI----------------EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
F ++L E+ G + + R P P ++Y
Sbjct: 234 FGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY 293
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-44
Identities = 64/250 (25%), Positives = 105/250 (42%), Gaps = 21/250 (8%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVRAFR 198
I +L ++ G+F W + VAVK L +V+S + + F
Sbjct: 12 TCLIGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFAL 257
E+ + + H N+++ G V PM +VTE P G L L+ +G T R+A+
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT- 316
+A GM YL + IHRDL N+L +K+ DFG+ + L +D + +
Sbjct: 129 QVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 317 -SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKA-YAARQR-- 371
+ APE K + D + F + L EM G P+ + +++ +R
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 372 PPFKAPAKLY 381
P P +Y
Sbjct: 246 RPEDCPQDIY 255
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-44
Identities = 62/267 (23%), Positives = 115/267 (43%), Gaps = 40/267 (14%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
+ + L F ++ KG F + + VAVKKL S ++ +R F
Sbjct: 4 PTQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDF 58
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVR 254
E+ +L+ ++H N+V++ G + + ++ EYLP G LR +L++ K + ++
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLT 312
+ I +GM YL + IHRDL NIL ++ +K+ DFG++K+L ++ +
Sbjct: 119 YTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI----------------EGCPPFTM 356
++ + APE ++ DV+SF ++L E+ G
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235
Query: 357 KHDNEVPKAYAARQR--PPFKAPAKLY 381
+ + R P P ++Y
Sbjct: 236 MIVFHLIELLKNNGRLPRPDGCPDEIY 262
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 1e-43
Identities = 75/248 (30%), Positives = 121/248 (48%), Gaps = 25/248 (10%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDEL 201
E+E+ L + G F + ++ G +VAVK L + +S D F E
Sbjct: 6 DEWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----FLAEA 59
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDI 259
L+++++H +V+ VTQ P+ I+TEY+ G L FLK L + + A I
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-- 317
A GM ++ E IHRDL +NIL D+ + K+ADFG+++L+ ED T ++ +
Sbjct: 119 AEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKF 172
Query: 318 -CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PP 373
++ APE + K DV+SF ++L E++ G P+ + EV + R P
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
Query: 374 FKAPAKLY 381
P +LY
Sbjct: 233 DNCPEELY 240
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-43
Identities = 46/183 (25%), Positives = 94/183 (51%), Gaps = 7/183 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G Q +K++ +S +R + R E+A+L ++HPN+VQ+ + ++ + IV +Y
Sbjct: 49 GRQYVIKEINISRMSSKEREESRR-EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107
Query: 235 GDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
GDL + + + + + I + ++H+ K I+HRD++ NI G +
Sbjct: 108 GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTV 164
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
++ DFG++++L + C T Y++PE+ +N+ Y+ K D+++ +L E+
Sbjct: 165 QLGDFGIARVLNSTVELARACIGTPY-YLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
Query: 353 PFT 355
F
Sbjct: 224 AFE 226
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-43
Identities = 58/256 (22%), Positives = 106/256 (41%), Gaps = 34/256 (13%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFR 198
+ + L + +E+ G F +R I VA+K L + ++
Sbjct: 2 KKLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMM 58
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
E ++ ++ +P +V+ +G + +M+V E G L FL ++ + S
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 117
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-------- 309
++ GM YL E +HRDL N+L + K++DFG+SK L +
Sbjct: 118 QVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 310 -PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYA 367
PL ++ APE ++ ++ DV+S+ + + E + G P+ EV
Sbjct: 175 WPL-------KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
Query: 368 ARQR--PPFKAPAKLY 381
+R P + P +LY
Sbjct: 228 QGKRMECPPECPPELY 243
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-43
Identities = 56/230 (24%), Positives = 109/230 (47%), Gaps = 26/230 (11%)
Query: 165 KGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
KG +I + I VA+K+L E + + DE ++ + +P+V + LG S
Sbjct: 33 KGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89
Query: 224 PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ ++T+ +P G L ++ + K + + + + IA+GMNYL + + ++HRDL
Sbjct: 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEYDTK 334
N+L ++K+ DFG++KLL +E P+ +++A E + Y +
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-------KWMALESILHRIYTHQ 199
Query: 335 VDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
DV+S+ + + E++ G P+ +E+ +R P +Y
Sbjct: 200 SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 249
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-43
Identities = 58/251 (23%), Positives = 116/251 (46%), Gaps = 22/251 (8%)
Query: 144 EVPEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAF 197
+YEI ++ + ++ +G ++ + VA+K + D F
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKF 63
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFA 256
E +++ HP++V+ +G +T++ P+ I+ E G+LR+FL+ RK +L ++ + +A
Sbjct: 64 LQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
++ + YL + +HRD+ N+L + +K+ DFG+S+ + ED
Sbjct: 123 YQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASK 176
Query: 317 S---CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR- 371
+++APE + + DV+ F + + E++ G PF +N+V +R
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 236
Query: 372 -PPFKAPAKLY 381
P P LY
Sbjct: 237 PMPPNCPPTLY 247
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-43
Identities = 65/249 (26%), Positives = 112/249 (44%), Gaps = 22/249 (8%)
Query: 146 PEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
P+Y I ++ + E+ +G + I VAVK ++ D F
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMS 62
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
E +++ + HP++V+ +G + + P I+ E P G+L +L+R K +LK T V ++L
Sbjct: 63 EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS- 317
I + M YL +HRD+ NIL +K+ DFG+S+ + ED +
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTR 175
Query: 318 --CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--P 372
++++PE + T DV+ FA+ + E++ G PF + +V R
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK 235
Query: 373 PFKAPAKLY 381
P P LY
Sbjct: 236 PDLCPPVLY 244
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-43
Identities = 62/270 (22%), Positives = 117/270 (43%), Gaps = 40/270 (14%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWR------GIQVAVKKLGEEVISDDDRV 194
EV + L ++ +G F L + G QVAVK L E S + +
Sbjct: 12 EVDPTHFEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHI 67
Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYLPKGDLRAFLKR-KGALKPST 251
+ E+ +L+ + H N+V++ G T+ + + ++ E+LP G L+ +L + K +
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--R 309
+++A+ I +GM+YL + +HRDL N+L + +K+ DFG++K + ++
Sbjct: 128 QLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 184
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI----------------EGCPP 353
+D+ + APE ++ DV+SF + L E++ G
Sbjct: 185 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244
Query: 354 FTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
M + +R P P ++Y
Sbjct: 245 GQMTV-TRLVNTLKEGKRLPCPPNCPDEVY 273
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-43
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 22/216 (10%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
+ L + + ++ KG F L + VAVK+L S D+ R F
Sbjct: 17 PTIFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDF 71
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVR 254
+ E+ +L+ + +V++ G + +V EYLP G LR FL + + L S +
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLT 312
++ I +GM YL + +HRDL NIL + ++K+ADFG++KLL + +D
Sbjct: 132 YSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 188
Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
+ + APE + + + DV+SF ++L E+
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-43
Identities = 46/205 (22%), Positives = 77/205 (37%), Gaps = 13/205 (6%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
F + G++ + G AVK+ DR R + + + +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHEN 269
V+ A + + + TE L+ + GA L + + D + +LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
++H D++P+NI G K+ DFG+ L + RY+APE+
Sbjct: 177 G---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQEGD-PRYMAPELL-QG 230
Query: 330 EYDTKVDVFSFALILQEMIEGCPPF 354
Y T DVFS L + E+
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELP 255
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-42
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 25/266 (9%)
Query: 134 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGE 185
++ ++ + + V I P L + I +G F I AVK L
Sbjct: 4 LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63
Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFL-KR 243
I+D V F E +++ HPNV+ LG +S ++V Y+ GDLR F+
Sbjct: 64 --ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 121
Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
+ F L +A+GM YL K +HRDL N + D+ +KVADFG+++
Sbjct: 122 THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD- 177
Query: 304 TVKEDRPLTCQDTSC-----RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMK 357
+ + + + + +++A E + +++ TK DV+SF ++L E++ G PP+
Sbjct: 178 -MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236
Query: 358 HDNEVPKAYAARQR--PPFKAPAKLY 381
+ ++ +R P P LY
Sbjct: 237 NTFDITVYLLQGRRLLQPEYCPDPLY 262
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 50/208 (24%), Positives = 96/208 (46%), Gaps = 13/208 (6%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I +G F A G+ VA+KK+ + D E+ LL+++ HPNV+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA----LKPSTAVRFALDIARGMNYLHENKPV 272
+ + + + IV E GDL +K + T ++ + + + ++H +
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-- 156
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD 332
++HRD++P+N+ +G +K+ D G+ + + K + T Y++PE Y+
Sbjct: 157 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSPERIHENGYN 214
Query: 333 TKVDVFSFALILQEMIEGCPPFTMKHDN 360
K D++S +L EM PF N
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFYGDKMN 242
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 71/271 (26%), Positives = 117/271 (43%), Gaps = 26/271 (9%)
Query: 127 KHGAKPLM-------APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG- 175
K G L + E +EI L ++ G F +A +
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEK--KLGAGQFGEVWMATYNKH 212
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
+VAVK + +S + F E +++ ++H +V+ VT+ P+ I+TE++ KG
Sbjct: 213 TKVAVKTMKPGSMSVEA----FLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKG 267
Query: 236 DLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
L FLK + F+ IA GM ++ + IHRDL +NIL S K
Sbjct: 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCK 324
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCP 352
+ADFG+++++ E ++ APE + K DV+SF ++L E++ G
Sbjct: 325 IADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 384
Query: 353 PFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
P+ + EV +A R P P +LY
Sbjct: 385 PYPGMSNPEVIRALERGYRMPRPENCPEELY 415
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-42
Identities = 48/189 (25%), Positives = 92/189 (48%), Gaps = 10/189 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSSPMMIVTEYL 232
G + K+L +++ ++ E+ LL++++HPN+V++ + ++ + IV EY
Sbjct: 31 GKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 233 PKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVP--IIHRDLEPSNILR 286
GDL + + + + L +R + + H ++HRDL+P+N+
Sbjct: 90 EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
D N+K+ DFG++++L T T Y++PE Y+ K D++S +L E
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAKTFVGTPY-YMSPEQMNRMSYNEKSDIWSLGCLLYE 208
Query: 347 MIEGCPPFT 355
+ PPFT
Sbjct: 209 LCALMPPFT 217
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-42
Identities = 69/284 (24%), Positives = 122/284 (42%), Gaps = 25/284 (8%)
Query: 116 YKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAF 172
E + + ++ ++ + + V I P L + I +G F
Sbjct: 50 KAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGT 109
Query: 173 WRG-----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMM 226
I AVK L I+D V F E +++ HPNV+ LG +S +
Sbjct: 110 LLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167
Query: 227 IVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
+V Y+ GDLR F+ + F L +A+GM +L K +HRDL N +
Sbjct: 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCM 224
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC-----RYVAPEVFKNEEYDTKVDVFSF 340
D+ +KVADFG+++ + + + + + +++A E + +++ TK DV+SF
Sbjct: 225 LDEKFTVKVADFGLARD--MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 282
Query: 341 ALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
++L E++ G PP+ + ++ +R P P LY
Sbjct: 283 GVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 326
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-42
Identities = 63/247 (25%), Positives = 109/247 (44%), Gaps = 22/247 (8%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
EL + G F W I V +K + ++ S +A D
Sbjct: 9 IFKETELRKLK--VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTD 64
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALD 258
+ + + H ++V+ LG S + +VT+YLP G L ++ +GAL P + + +
Sbjct: 65 HMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTS 317
IA+GM YL E+ ++HR+L N+L ++VADFGV+ LL + + T
Sbjct: 124 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPF 374
+++A E +Y + DV+S+ + + E++ G P+ EVP +R P
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ 240
Query: 375 KAPAKLY 381
+Y
Sbjct: 241 ICTIDVY 247
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-42
Identities = 71/256 (27%), Positives = 117/256 (45%), Gaps = 25/256 (9%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVR 195
EV + I + + I KG F + IQ A+K L I++ +V
Sbjct: 10 EVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVE 67
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPM-MIVTEYLPKGDLRAFLK-RKGALKPSTAV 253
AF E L++ + HPNV+ +G + + ++ Y+ GDL F++ + +
Sbjct: 68 AFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI 127
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
F L +ARGM YL E K +HRDL N + D+S +KVADFG+++ + + +
Sbjct: 128 SFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSV 182
Query: 314 QDTSC-----RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367
Q ++ A E + + TK DV+SF ++L E++ G PP+ ++ A
Sbjct: 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242
Query: 368 ARQR--PPFKAPAKLY 381
+R P P LY
Sbjct: 243 QGRRLPQPEYCPDSLY 258
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-41
Identities = 62/264 (23%), Positives = 111/264 (42%), Gaps = 40/264 (15%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
L ++ +G F L + VAVK L + + ++
Sbjct: 27 VFHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQ 82
Query: 200 ELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
E+ +L+ + H +++++ G + + + +V EY+P G LR +L + ++ + + FA
Sbjct: 83 EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQ 141
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQD 315
I GM YLH IHRDL N+L D+ +K+ DFG++K + + R D
Sbjct: 142 QICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI----------------EGCPPFTMKHD 359
+ + APE K ++ DV+SF + L E++ G M
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV- 257
Query: 360 NEVPKAYAARQR--PPFKAPAKLY 381
+ + +R P K PA++Y
Sbjct: 258 LRLTELLERGERLPRPDKCPAEVY 281
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 65/281 (23%), Positives = 115/281 (40%), Gaps = 35/281 (12%)
Query: 127 KHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQV 178
H + L+ + ++ + ID + L + +G F + + ++V
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLKV 65
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVTEYLP 233
AVK + + S + F E A ++ HPNV++ LG + S M++ ++
Sbjct: 66 AVKTMKLDNSSQREI-EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124
Query: 234 KGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
GDL +L + T ++F +DIA GM YL +HRDL N +
Sbjct: 125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLR 181
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC----RYVAPEVFKNEEYDTKVDVFSFALI 343
D + VADFG+SK + Q +++A E + Y +K DV++F +
Sbjct: 182 DDMTVCVADFGLSKKI---YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238
Query: 344 LQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
+ E+ G P+ ++E+ R P +LY
Sbjct: 239 MWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELY 279
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-41
Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+A+K L + + R E+ + +RHPN+++ G ++ + ++ EY P
Sbjct: 34 KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G + L++ + ++A ++Y H + +IHRD++P N+L +G LK+
Sbjct: 94 GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKI 150
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
ADFG S P + + C Y+ PE+ + +D KVD++S ++ E + G
Sbjct: 151 ADFGWSVHA------PSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
Query: 352 PPFTMKHDNEVPKAY 366
PPF N + Y
Sbjct: 205 PPF---EANTYQETY 216
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-41
Identities = 53/206 (25%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+A+K L + + + R E+ + +RHPN+++ + ++ E+ P+
Sbjct: 39 KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G+L L++ G + F ++A ++Y HE K +IHRD++P N+L G LK+
Sbjct: 99 GELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKI 155
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
ADFG S P + T C Y+ PE+ + + +D KVD++ ++ E + G
Sbjct: 156 ADFGWSVH------APSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAP 377
PPF + + K P
Sbjct: 210 PPF---DSPSHTETHRRIVNVDLKFP 232
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-41
Identities = 76/277 (27%), Positives = 114/277 (41%), Gaps = 55/277 (19%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
++E + L F + G F + A G+ VAVK L +
Sbjct: 16 HKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTERE 71
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
A EL +L + H N+V LGA T P +++TEY GDL FL+RK
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 245 --------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
AL + F+ +A+GM +L IHRDL NIL K+ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188
Query: 297 FGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
FG+++ + VK + P+ +++APE N Y + DV+S+ + L E+
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPV-------KWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 349 E--GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
P M D++ K R P APA++Y
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY 278
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 8e-41
Identities = 66/270 (24%), Positives = 110/270 (40%), Gaps = 46/270 (17%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVR 195
++ + I + + KG F A + ++VAVK L ++I+ D
Sbjct: 14 KLEDVLIPEQQFTLGR--MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI-E 70
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRAFLKR------ 243
F E A +++ HP+V + +G +S M++ ++ GDL AFL
Sbjct: 71 EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
L T VRF +DIA GM YL IHRDL N + + + VADFG+S
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLS--- 184
Query: 304 TVKEDRPLTCQDTSC---------RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPP 353
R + D +++A E + Y DV++F + + E++ G P
Sbjct: 185 -----RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
Query: 354 FTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
+ + E+ R P + ++Y
Sbjct: 240 YAGIENAEIYNYLIGGNRLKQPPECMEEVY 269
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-41
Identities = 54/259 (20%), Positives = 104/259 (40%), Gaps = 40/259 (15%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRG---------IQVAVKKLGEEVISDDDRVR 195
++I +L F + +GTF R +V +K L + + +
Sbjct: 3 HKIRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK---AHRNYSE 57
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVR 254
+F + +++ K+ H ++V G ++V E++ G L +LK+ K + +
Sbjct: 58 SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE 117
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNIL--------RDDSGNLKVADFGVSKLLTVK 306
A +A M++L EN +IH ++ NIL + +K++D G+S + K
Sbjct: 118 VAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 307 E--DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEV 362
+ + +V PE +N + + D +SF L E+ G P +
Sbjct: 175 DILQERI-------PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227
Query: 363 PKAYAARQRPPFKAPAKLY 381
+ Y R + P A+L
Sbjct: 228 LQFYEDRHQLPAPKAAELA 246
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-41
Identities = 55/227 (24%), Positives = 107/227 (47%), Gaps = 20/227 (8%)
Query: 165 KGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
KG +I + I VA+K+L E + + DE ++ + +P+V + LG S
Sbjct: 33 KGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89
Query: 224 PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ ++T+ +P G L ++ + K + + + + IA+GMNYL + + ++HRDL
Sbjct: 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKVDV 337
N+L ++K+ DFG++KLL +E +++A E + Y + DV
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEK----EYHAEGGKVPIKWMALESILHRIYTHQSDV 202
Query: 338 FSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
+S+ + + E++ G P+ +E+ +R P +Y
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 249
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-40
Identities = 59/234 (25%), Positives = 105/234 (44%), Gaps = 19/234 (8%)
Query: 142 AREVPEYEIDPHEL-DFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVR 195
A+E+PE +DP + + KG F I A K + + ++ +
Sbjct: 1 AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
E+++ + + H +VV F G + + +V E + L KR+ AL A +
Sbjct: 61 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 120
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
I G YLH N+ +IHRDL+ N+ ++ +K+ DFG++ + +R +
Sbjct: 121 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER----KK 173
Query: 316 TSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366
C Y+APEV + + +VDV+S I+ ++ G PPF + + + Y
Sbjct: 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETY 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 57/220 (25%), Positives = 91/220 (41%), Gaps = 21/220 (9%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 200
+YE T+ + +G+F + G Q AVKK+ EV + E
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------E 100
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
L + P +V GAV + + I E L G L +K+ G L A+ +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNL-KVADFGVSKLLTVKEDRPLTCQDTSCR 319
G+ YLH + I+H D++ N+L G+ + DFG + L
Sbjct: 161 EGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 320 ----YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
++APEV + D KVD++S ++ M+ GC P+T
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT 257
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 63/271 (23%), Positives = 119/271 (43%), Gaps = 53/271 (19%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
E+E+ ++ + E+ +G+F +G+ +VA+K + E S +R
Sbjct: 18 DEWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRER-I 73
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------G 245
F +E +++++ +VV+ LG V+Q P +++ E + +GDL+++L+
Sbjct: 74 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
S ++ A +IA GM YL+ NK +HRDL N + + +K+ DFG++
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT----- 185
Query: 306 KEDRPLTCQDTSCRYV------------APEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
R + D Y +PE K+ + T DV+SF ++L E+
Sbjct: 186 ---RDIYETDY---YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 239
Query: 353 PFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
P+ + +V + P P L+
Sbjct: 240 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF 270
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-40
Identities = 59/235 (25%), Positives = 103/235 (43%), Gaps = 42/235 (17%)
Query: 147 EYEIDPHEL-DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 200
+ +D DF I G F A R G +K++ + +A R E
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAER-E 54
Query: 201 LALLQKIRHPNVVQFLGA----------------VTQSSPMMIVTEYLPKGDLRAFLKRK 244
+ L K+ H N+V + G +++ + I E+ KG L +++++
Sbjct: 55 VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114
Query: 245 GA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
L A+ I +G++Y+H K +I+RDL+PSNI D+ +K+ DFG+
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 303 LTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
L R S RY++PE +++Y +VD+++ LIL E++ C
Sbjct: 172 LKNDGKR-----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-40
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
A K + + ++ + E+++ + + H +VV F G + + +V E +
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
L KR+ AL A + I G YLH N+ +IHRDL+ N+ ++ +K+
Sbjct: 126 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKI 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
DFG++ + +R + C Y+APEV + + +VDV+S I+ ++ G
Sbjct: 183 GDFGLATKVEYDGER----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
Query: 352 PPFTMKHDNEVPKAY 366
PPF + + + Y
Sbjct: 239 PPF---ETSCLKETY 250
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-40
Identities = 49/232 (21%), Positives = 83/232 (35%), Gaps = 37/232 (15%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
+F +I G F R G A+K+ + + D A R+ A +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYL 266
+VV++ A + M+I EY G L + K + L + RG+ Y+
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNL-------------------KVADFGVSKLLTVKE 307
H ++H D++PSNI + K+ D G ++
Sbjct: 132 HSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS--- 185
Query: 308 DRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358
P + R++A EV + N + K D+F+ AL + P
Sbjct: 186 -SPQVEEGD-SRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-40
Identities = 59/240 (24%), Positives = 94/240 (39%), Gaps = 42/240 (17%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF + +G F + A A+KK+ +++ E+ LL + H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILS-EVMLLASLNHQ 62
Query: 211 NVVQFLGA-------------VTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFA 256
VV++ A V + S + I EY G L + + + R
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD- 315
I ++Y+H IIHRDL+P NI D+S N+K+ DFG++K + D
Sbjct: 123 RQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 316 ---------TSC---RYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
++ YVA EV Y+ K+D++S +I EMI P T +
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNI 237
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-39
Identities = 58/253 (22%), Positives = 116/253 (45%), Gaps = 30/253 (11%)
Query: 146 PEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
+YEI ++ + ++ +G ++ + VA+K + D F
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQ 440
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
E +++ HP++V+ +G +T++ P+ I+ E G+LR+FL RK +L ++ + +A
Sbjct: 441 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL-------TVKEDRPL 311
++ + YL + +HRD+ N+L + +K+ DFG+S+ + K P+
Sbjct: 500 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQ 370
+++APE + + DV+ F + + E++ G PF +N+V +
Sbjct: 557 -------KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 609
Query: 371 R--PPFKAPAKLY 381
R P P LY
Sbjct: 610 RLPMPPNCPPTLY 622
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 76/280 (27%), Positives = 124/280 (44%), Gaps = 50/280 (17%)
Query: 138 HVKHAREVPEY----EIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEE 186
H H + P+ +D +++ F + I +G F + A + + A+K++ E
Sbjct: 6 HHHHGKNNPDPTIYPVLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY 63
Query: 187 VISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK- 244
S DD R F EL +L K+ HPN++ LGA + + EY P G+L FL++
Sbjct: 64 A-SKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 121
Query: 245 ---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
L + FA D+ARGM+YL + + IHRDL NIL ++
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 178
Query: 290 GNLKVADFGVSKLLTVKEDR-----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
K+ADFG+S+ V + P+ R++A E Y T DV+S+ ++L
Sbjct: 179 YVAKIADFGLSRGQEVYVKKTMGRLPV-------RWMAIESLNYSVYTTNSDVWSYGVLL 231
Query: 345 QEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
E++ G P+ E+ + R P ++Y
Sbjct: 232 WEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVY 271
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 67/271 (24%), Positives = 115/271 (42%), Gaps = 47/271 (17%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
++E + L F + G F + A G+ +VAVK L + D
Sbjct: 39 EKWEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKE 94
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--------- 245
A EL ++ + +H N+V LGA T P++++TEY GDL FL+RK
Sbjct: 95 ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 246 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
+ F+ +A+GM +L IHRD+ N+L + K+ DFG++
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLA 211
Query: 301 KLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCP 352
+ + VK + L +++APE + Y + DV+S+ ++L E+ P
Sbjct: 212 RDIMNDSNYIVKGNARLP-----VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
Query: 353 PFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
+ +++ K + P AP +Y
Sbjct: 267 YPGILVNSKFYKLVKDGYQMAQPAFAPKNIY 297
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-39
Identities = 77/307 (25%), Positives = 120/307 (39%), Gaps = 67/307 (21%)
Query: 124 LLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---- 176
LL++ P+ M + ++ E + +++ +I +G F A G+
Sbjct: 18 LLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYE 75
Query: 177 ---QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVK L EE S D + F+ E AL+ + +PN+V+ LG PM ++ EY+
Sbjct: 76 PFTMVAVKMLKEEA-SADMQ-ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMA 133
Query: 234 KGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHEN 269
GDL FL+ L + + A +A GM YL E
Sbjct: 134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV-------- 321
K +HRDL N L ++ +K+ADFG+S R + D Y
Sbjct: 194 K---FVHRDLATRNCLVGENMVVKIADFGLS--------RNIYSADY---YKADGNDAIP 239
Query: 322 ----APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPF 374
PE Y T+ DV+++ ++L E+ G P+ EV P
Sbjct: 240 IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPE 299
Query: 375 KAPAKLY 381
P +LY
Sbjct: 300 NCPLELY 306
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 73/282 (25%), Positives = 115/282 (40%), Gaps = 54/282 (19%)
Query: 141 HAREVPEY-------EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKL 183
H E P+Y I ++ E+ +G F LA + VAVK L
Sbjct: 22 HIIENPQYFSDACVHHIKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL 79
Query: 184 GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 243
E S+ R + F+ E LL ++H ++V+F G T+ P+++V EY+ GDL FL+
Sbjct: 80 KEA--SESAR-QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRS 136
Query: 244 ---------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
G L + A +A GM YL +HRDL N L
Sbjct: 137 HGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ 193
Query: 289 SGNLKVADFGVSKLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
+K+ DFG+S+ + V L R++ PE ++ T+ DV+SF +
Sbjct: 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTML-----PIRWMPPESILYRKFTTESDVWSFGV 248
Query: 343 ILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
+L E+ G P+ + E + P P ++Y
Sbjct: 249 VLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVY 290
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 49/214 (22%), Positives = 84/214 (39%), Gaps = 33/214 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA------------VTQS 222
A+K++ + R + R E+ L K+ HP +V++ A +
Sbjct: 30 DCNYAIKRIRLPN-RELAREKVMR-EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDL 279
+ I + K +L+ ++ + ++ S + L IA + +LH ++HRDL
Sbjct: 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDL 144
Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----------CRYVAPEVFKN 328
+PSNI +KV DFG+ + E+ Y++PE
Sbjct: 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204
Query: 329 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
Y KVD+FS LIL E++ P T
Sbjct: 205 NSYSHKVDIFSLGLILFELL--YPFSTQMERVRT 236
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-39
Identities = 71/275 (25%), Positives = 109/275 (39%), Gaps = 60/275 (21%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRAFR 198
I ++ E+ +G F LA + VAVK L + + R + F+
Sbjct: 11 HIKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAAR-KDFQ 65
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---------------- 242
E LL ++H ++V+F G P+++V EY+ GDL FL+
Sbjct: 66 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
KG L S + A IA GM YL +HRDL N L + +K+ DFG+S
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMS-- 180
Query: 303 LTVKEDRPLTCQDTSCRYV------------APEVFKNEEYDTKVDVFSFALILQEMI-E 349
R + D Y PE ++ T+ DV+SF +IL E+
Sbjct: 181 ------RDVYSTDY---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 231
Query: 350 GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYA 382
G P+ + EV + + P P ++Y
Sbjct: 232 GKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYD 266
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-39
Identities = 70/268 (26%), Positives = 112/268 (41%), Gaps = 47/268 (17%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRAFR 198
EI + F E+ + F G VA+K L ++ R FR
Sbjct: 5 EISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLR-EEFR 60
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--------------- 243
E L +++HPNVV LG VT+ P+ ++ Y GDL FL
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 244 -KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
K AL+P V IA GM YL + ++H+DL N+L D N+K++D G+ +
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 303 L------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT 355
+ + + L R++APE ++ D++S+ ++L E+ G P+
Sbjct: 178 VYAADYYKLLGNSLL-----PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 232
Query: 356 MKHDNEVPKAYAARQR--PPFKAPAKLY 381
+ +V + RQ P PA +Y
Sbjct: 233 GYSNQDVVEMIRNRQVLPCPDDCPAWVY 260
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 4e-39
Identities = 47/207 (22%), Positives = 82/207 (39%), Gaps = 30/207 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYL 232
G A+K V E +L+K+ H N+V+ +++ + E+
Sbjct: 34 GDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91
Query: 233 PKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--- 286
P G L L+ L S + D+ GMN+L EN I+HR+++P NI+R
Sbjct: 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148
Query: 287 -DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK--------NEEYDTK 334
D K+ DFG ++ L +D + Y+ P++++ ++Y
Sbjct: 149 EDGQSVYKLTDFGAARELE--DDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 335 VDVFSFALILQEMIEGCPPFTMKHDNE 361
VD++S + G PF
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPR 230
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-39
Identities = 72/266 (27%), Positives = 110/266 (41%), Gaps = 45/266 (16%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
E+ + + G F G+ QVAVK L E S+ D
Sbjct: 24 LKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDE-LD 79
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-------KGALKP 249
F E ++ K H N+V+ +G QS P I+ E + GDL++FL+ +L
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLL--- 303
+ A DIA G YL EN IHRD+ N L G K+ DFG+++ +
Sbjct: 140 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 304 --TVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMK 357
K P+ +++ PE F + +K D +SF ++L E+ G P+ K
Sbjct: 197 SYYRKGGCAMLPV-------KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249
Query: 358 HDNEVPKAYAARQR--PPFKAPAKLY 381
+ EV + + R PP P +Y
Sbjct: 250 SNQEVLEFVTSGGRMDPPKNCPGPVY 275
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-39
Identities = 76/307 (24%), Positives = 130/307 (42%), Gaps = 54/307 (17%)
Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
++ + I E + ++A + E P +E+ L + +G F +LA
Sbjct: 31 HHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGK--PLGEGAFGQVVLA 88
Query: 172 FWRGI---------QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221
G+ +VAVK L + ++ D E+ +++ I +H N++ LGA TQ
Sbjct: 89 EAIGLDKDKPNRVTKVAVKMLKSDA-TEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQ 146
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNY 265
P+ ++ EY KG+LR +L+ + L V A +ARGM Y
Sbjct: 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL------TVKEDR--PLTCQDTS 317
L K IHRDL N+L + +K+ADFG+++ + + P+
Sbjct: 207 LASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV------ 257
Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPF 374
+++APE + Y + DV+SF ++L E+ G P+ E+ K R P
Sbjct: 258 -KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS 316
Query: 375 KAPAKLY 381
+LY
Sbjct: 317 NCTNELY 323
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-39
Identities = 70/282 (24%), Positives = 117/282 (41%), Gaps = 61/282 (21%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
P++E L + +G F + A + VAVK L E + +R
Sbjct: 16 PKWEFPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELR 71
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------- 244
E +L+++ HP+V++ GA +Q P++++ EY G LR FL+
Sbjct: 72 DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
AL + FA I++GM YL E K ++HRDL NIL +
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRK 188
Query: 292 LKVADFGVSKLLTVKEDRPLTCQD----TSC-----RYVAPEVFKNEEYDTKVDVFSFAL 342
+K++DFG+S R + +D S +++A E + Y T+ DV+SF +
Sbjct: 189 MKISDFGLS--------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240
Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
+L E++ G P+ + R P ++Y
Sbjct: 241 LLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMY 282
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-39
Identities = 71/283 (25%), Positives = 113/283 (39%), Gaps = 62/283 (21%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
++E L+F + G F + A GI QVAVK L E+ +D
Sbjct: 38 LKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSERE 93
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
A EL ++ ++ H N+V LGA T S P+ ++ EY GDL +L+ K
Sbjct: 94 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 153
Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L + FA +A+GM +L +HRDL N+L
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKV 210
Query: 292 LKVADFGVSKLLTVKEDRPLTCQD-----TSC----RYVAPEVFKNEEYDTKVDVFSFAL 342
+K+ DFG++ R + + +++APE Y K DV+S+ +
Sbjct: 211 VKICDFGLA--------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262
Query: 343 ILQEMIE-GCPPF-TMKHDNEVPKAYAARQR--PPFKAPAKLY 381
+L E+ G P+ + D K + PF A ++Y
Sbjct: 263 LLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIY 305
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-39
Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 26/223 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
A+K + E + + ++R+E+A L K++ + +++ + +V E
Sbjct: 33 KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 90
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+N L D G L
Sbjct: 91 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 146
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN-----------EEYDTKVDVF 338
K+ DFG++ + + D +D+ Y+ PE K+ + K DV+
Sbjct: 147 KLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204
Query: 339 SFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQRPPFKAPAKL 380
S IL M G PF + N++ K +A + P
Sbjct: 205 SLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIP 246
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-39
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ KGT+ +++A+K E+ D + +E+AL + ++H N+VQ+L
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIK----EIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAV--RFALDIARGMNYLHENKPVP 273
G+ +++ + I E +P G L A L+ K G LK + + I G+ YLH+N+
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 274 IIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-- 330
I+HRD++ N+L + SG LK++DFG SK L T T Y+APE+
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ-YMAPEIIDKGPRG 201
Query: 331 YDTKVDVFSFALILQEMIEGCPPF 354
Y D++S + EM G PPF
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPF 225
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 9e-39
Identities = 50/209 (23%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
A+K + E + + ++R+E+A L K++ + +++ + +V E
Sbjct: 52 KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 109
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+N L D G L
Sbjct: 110 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 165
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN-----------EEYDTKVDVF 338
K+ DFG++ + + D +D+ Y+ PE K+ + K DV+
Sbjct: 166 KLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223
Query: 339 SFALILQEMIEGCPPFTMKHDNEVPKAYA 367
S IL M G PF + N++ K +A
Sbjct: 224 SLGCILYYMTYGKTPFQ-QIINQISKLHA 251
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 56/250 (22%), Positives = 105/250 (42%), Gaps = 20/250 (8%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFR 198
+ + L + +E+ G F +R I VA+K L + ++
Sbjct: 328 KKLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMM 384
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
E ++ ++ +P +V+ +G + +M+V E G L FL ++ + S
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
++ GM YL E +HR+L N+L + K++DFG+SK L +
Sbjct: 444 QVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 318 --CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--P 372
++ APE ++ ++ DV+S+ + + E + G P+ EV +R
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 560
Query: 373 PFKAPAKLYA 382
P + P +LYA
Sbjct: 561 PPECPPELYA 570
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 72/291 (24%), Positives = 126/291 (43%), Gaps = 54/291 (18%)
Query: 131 KPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---------QV 178
P++A + E P++E +L + +G F ++A GI V
Sbjct: 13 DPMLAGVSEYELPEDPKWEFPRDKLTLGK--PLGEGAFGQVVMAEAVGIDKDKPKEAVTV 70
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++ ++ D E+ +++ I +H N++ LGA TQ P+ ++ EY KG+L
Sbjct: 71 AVKMLKDDA-TEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 238 RAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
R +L+ + + V +ARGM YL K IHRDL
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAA 185
Query: 282 SNILRDDSGNLKVADFGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDT 333
N+L ++ +K+ADFG+++ + + P+ +++APE + Y
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV-------KWMAPEALFDRVYTH 238
Query: 334 KVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
+ DV+SF +++ E+ G P+ E+ K R P +LY
Sbjct: 239 QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY 289
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 50/209 (23%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
A+K + E + + ++R+E+A L K++ + +++ + +V E
Sbjct: 80 KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 137
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
DL ++LK+K ++ P + ++ ++ +H++ I+H DL+P+N L D G L
Sbjct: 138 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 193
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN-----------EEYDTKVDVF 338
K+ DFG++ + + D +D+ Y+ PE K+ + K DV+
Sbjct: 194 KLIDFGIANQM--QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 339 SFALILQEMIEGCPPFTMKHDNEVPKAYA 367
S IL M G PF + N++ K +A
Sbjct: 252 SLGCILYYMTYGKTPFQ-QIINQISKLHA 279
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-38
Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 54/292 (18%)
Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---------Q 177
P++A + E P++E +L + +G F ++A GI
Sbjct: 58 DTPMLAGVSEYELPEDPKWEFPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVT 115
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VAVK L ++ + + + E+ +++ I +H N++ LGA TQ P+ ++ EY KG+
Sbjct: 116 VAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 173
Query: 237 LRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
LR +L+ + + V +ARGM YL K IHRDL
Sbjct: 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLA 230
Query: 281 PSNILRDDSGNLKVADFGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYD 332
N+L ++ +K+ADFG+++ + + P+ +++APE + Y
Sbjct: 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV-------KWMAPEALFDRVYT 283
Query: 333 TKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
+ DV+SF +++ E+ G P+ E+ K R P +LY
Sbjct: 284 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY 335
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 71/268 (26%), Positives = 107/268 (39%), Gaps = 47/268 (17%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
E+ + + G F G+ QVAVK L E S+ D
Sbjct: 64 DLKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDE-L 119
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-------KGALK 248
F E ++ K H N+V+ +G QS P I+ E + GDL++FL+ +L
Sbjct: 120 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 179
Query: 249 PSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTV 305
+ A DIA G YL EN IHRD+ N L G K+ DFG++
Sbjct: 180 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA----- 231
Query: 306 KEDRPLTCQDTSC---------RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFT 355
R + +++ PE F + +K D +SF ++L E+ G P+
Sbjct: 232 ---RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288
Query: 356 MKHDNEVPKAYAARQR--PPFKAPAKLY 381
K + EV + + R PP P +Y
Sbjct: 289 SKSNQEVLEFVTSGGRMDPPKNCPGPVY 316
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 16/210 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VA+K + + ++ + FR E+ +++ + HPN+V+ + + ++ EY
Sbjct: 40 GREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G++ +L G +K A I + Y H+ + I+HRDL+ N+L D N+K+
Sbjct: 99 GEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKI 155
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEG 350
ADFG S L D C Y APE+F+ ++YD +VDV+S +IL ++ G
Sbjct: 156 ADFGFSNE--FTVGGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210
Query: 351 CPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380
PF + + R ++ P +
Sbjct: 211 SLPF---DGQNLKELRERVLRGKYRIPFYM 237
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 47/200 (23%), Positives = 82/200 (41%), Gaps = 30/200 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYL 232
G A+K V E +L+K+ H N+V+ +++ + E+
Sbjct: 34 GDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91
Query: 233 PKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--- 286
P G L L+ L S + D+ GMN+L EN I+HR+++P NI+R
Sbjct: 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148
Query: 287 -DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK--------NEEYDTK 334
D K+ DFG ++ L +D + Y+ P++++ ++Y
Sbjct: 149 EDGQSVYKLTDFGAARELE--DDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203
Query: 335 VDVFSFALILQEMIEGCPPF 354
VD++S + G PF
Sbjct: 204 VDLWSIGVTFYHAATGSLPF 223
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 25/195 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL------GAVTQSSPMMIV 228
G QVA+K+ + +S +R R E+ +++K+ HPNVV + + ++
Sbjct: 39 GEQVAIKQC-RQELSPKNRERWCL-EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96
Query: 229 TEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
EY GDLR +L + LK DI+ + YLHEN+ IIHRDL+P NI+
Sbjct: 97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIV 153
Query: 286 RDDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFS 339
K+ D G +K L + T +Y+APE+ + ++Y VD +S
Sbjct: 154 LQPGPQRLIHKIIDLGYAKEL--DQGELCT---EFVGTLQYLAPELLEQKKYTVTVDYWS 208
Query: 340 FALILQEMIEGCPPF 354
F + E I G PF
Sbjct: 209 FGTLAFECITGFRPF 223
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-38
Identities = 51/196 (26%), Positives = 98/196 (50%), Gaps = 14/196 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G++VA+K + ++ + V+ ++E+ + +++HP++++ S+ + +V E
Sbjct: 36 GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G++ +LK R + A F I GM YLH + I+HRDL SN+L + N+K
Sbjct: 96 GEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIK 152
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
+ADFG++ L + ++ T C Y++PE+ + + DV+S + ++ G
Sbjct: 153 IADFGLATQLKMPHEK----HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208
Query: 351 CPPFTMKHDNEVPKAY 366
PPF + V
Sbjct: 209 RPPF---DTDTVKNTL 221
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 75/275 (27%), Positives = 116/275 (42%), Gaps = 54/275 (19%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
++E L + +G F I A GI VAVK L E + RA
Sbjct: 21 KWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRA 76
Query: 197 FRDELALLQKI-RHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKR----------- 243
EL +L I H NVV LGA T+ P+M++ E+ G+L +L+
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 244 -----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
K L + ++ +A+GM +L K IHRDL NIL + +K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFG 193
Query: 299 VSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 349
+++ + K D PL +++APE + Y + DV+SF ++L E+
Sbjct: 194 LARDIYKDPDYVRKGDARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246
Query: 350 GCPPF-TMKHDNEVPKAYAARQR--PPFKAPAKLY 381
G P+ +K D E + R P ++Y
Sbjct: 247 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 281
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-36
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 15/207 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G +VAVK L + I D V + E+ L+ RHP++++ ++ + +V EY+
Sbjct: 36 GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G+L ++ + G ++ A R I ++Y H + ++HRDL+P N+L D N K+
Sbjct: 96 GELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKI 152
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEG 350
ADFG+S ++ + L TSC Y APEV Y +VD++S +IL ++ G
Sbjct: 153 ADFGLSNMM--SDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207
Query: 351 CPPFTMKHDNEVPKAYAARQRPPFKAP 377
PF D VP + + F P
Sbjct: 208 TLPF---DDEHVPTLFKKIRGGVFYIP 231
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-36
Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 38/220 (17%)
Query: 165 KGTF---ILAFWRGIQVAVKKL--------------GEEVISDDDRVRAFRDELALLQKI 207
+G F IL A+KK + IS + F++EL ++ I
Sbjct: 41 QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR------ 261
++ + G +T + I+ EY+ + F + L + + + +
Sbjct: 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV 160
Query: 262 --GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 318
+Y+H K I HRD++PSNIL D +G +K++DFG S+ + D+ + S
Sbjct: 161 LNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIK---GSRG 212
Query: 319 --RYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPF 354
++ PE F NE KVD++S + L M PF
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 45/219 (20%), Positives = 83/219 (37%), Gaps = 25/219 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM----IVTE 230
G A+K++ + + + E + + HPN+++ + + ++
Sbjct: 54 GHFYALKRI---LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
+ +G L ++R L + L I RG+ +H HRDL+P+NIL
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILL 167
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTC--------QDTSCRYVAPEVFKNEEY---DTKV 335
D G + D G + + Q + Y APE+F + + D +
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227
Query: 336 DVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374
DV+S +L M+ G P+ M A A + +
Sbjct: 228 DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-35
Identities = 55/192 (28%), Positives = 95/192 (49%), Gaps = 15/192 (7%)
Query: 175 GIQVAVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVK + + + + ++ + E+ + + + H NVV+F G + + + EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIK--K-EICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G+L ++ + A RF + G+ YLH I HRD++P N+L D+ NLK
Sbjct: 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK 145
Query: 294 VADFGVSKLLT-VKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMI 348
++DFG++ + +R L + C YVAPE+ K E+ VDV+S ++L M+
Sbjct: 146 ISDFGLATVFRYNNRERLL---NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 349 EGCPPFTMKHDN 360
G P+ D+
Sbjct: 203 AGELPWDQPSDS 214
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
+VA++ K + D E+ +L+K+ HP +++ + IV
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 218
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---R 286
E + G+L + LK +T + + + YLHEN IIHRDL+P N+L +
Sbjct: 219 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQ 275
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---YDTKVDVFSF 340
++ +K+ DFG SK+ + E + T C Y+APEV + Y+ VD +S
Sbjct: 276 EEDCLIKITDFGHSKI--LGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 341 ALILQEMIEGCPPF 354
+IL + G PPF
Sbjct: 331 GVILFICLSGYPPF 344
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 16/207 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+VA+K + +++ D E++ L+ +RHP++++ +T + +++V EY
Sbjct: 34 QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G+L ++ K + RF I + Y H +K I+HRDL+P N+L DD+ N+K+
Sbjct: 93 GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKI 149
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEG 350
ADFG+S ++ + L TSC Y APEV + Y +VDV+S ++L M+ G
Sbjct: 150 ADFGLSNIM--TDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204
Query: 351 CPPFTMKHDNEVPKAYAARQRPPFKAP 377
PF D +P + + P
Sbjct: 205 RLPF---DDEFIPNLFKKVNSCVYVMP 228
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 55/192 (28%), Positives = 95/192 (49%), Gaps = 15/192 (7%)
Query: 175 GIQVAVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVK + + + + ++ + E+ + + + H NVV+F G + + + EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIK--K-EICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
G+L ++ + A RF + G+ YLH I HRD++P N+L D+ NLK
Sbjct: 89 GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK 145
Query: 294 VADFGVSKLLT-VKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMI 348
++DFG++ + +R L + C YVAPE+ K E+ VDV+S ++L M+
Sbjct: 146 ISDFGLATVFRYNNRERLL---NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 349 EGCPPFTMKHDN 360
G P+ D+
Sbjct: 203 AGELPWDQPSDS 214
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-34
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G+ +A K + E I R + R EL +L + P +V F GA + I E++
Sbjct: 58 GLVMARKLIHLE-IKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
G L LK+ G + + ++ + +G+ YL E I+HRD++PSNIL + G +K+
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKL 173
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQEM 347
DFGVS L D+ Y++PE + Y + D++S L L EM
Sbjct: 174 CDFGVSGQLI----------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
Query: 348 IEGCPPFTMKHDNEVPKAYAARQRPP 373
G P E+ + +
Sbjct: 224 AVGRYPIPPPDAKELELMFGCQVEGD 249
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-34
Identities = 70/233 (30%), Positives = 113/233 (48%), Gaps = 18/233 (7%)
Query: 134 MAPMHVKHA-REVPEYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEV 187
MA V+ + + DP EL FT +I KG+F F VA+K + E
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE- 58
Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
+D + + E+ +L + P V ++ G+ + + + I+ EYL G L+
Sbjct: 59 -EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD 117
Query: 248 KPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
+ A R L +G++YLH K IHRD++ +N+L + G +K+ADFGV+ LT
Sbjct: 118 ETQIATILREIL---KGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171
Query: 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358
+ + T T ++APEV K YD+K D++S + E+ G PP + H
Sbjct: 172 TQIKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-34
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
+VA+K + ++ ++ F E+ ++ H N+V + + +V EY+
Sbjct: 38 KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L +++ G L TA+ F I G+ + H+ + I+HRD++P NIL D + LK+ D
Sbjct: 98 LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFD 154
Query: 297 FGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
FG++K L+ + LT + + +Y +PE K E D D++S ++L EM+ G PP
Sbjct: 155 FGIAKALS---ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
Query: 354 FTMKHDNEVPKAYAARQRPPFKAPAKL 380
F + V A Q +
Sbjct: 212 FN--GETAVSIAIKHIQDSVPNVTTDV 236
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 75/252 (29%), Positives = 117/252 (46%), Gaps = 25/252 (9%)
Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVIS 189
PM K + I + L T + GTF + G +VAVK L + I
Sbjct: 1 GPMAEKQKHDGRVK-IGHYILGDT----LGVGTFGKVKVGKHELTGHKVAVKILNRQKIR 55
Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
D V R E+ L+ RHP++++ ++ S + +V EY+ G+L ++ + G L
Sbjct: 56 SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE 115
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
+ R I G++Y H + ++HRDL+P N+L D N K+ADFG+S ++ +
Sbjct: 116 KESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGE 170
Query: 310 PLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365
L TSC Y APEV Y +VD++S +IL ++ G PF D+ VP
Sbjct: 171 FL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF---DDDHVPTL 224
Query: 366 YAARQRPPFKAP 377
+ F P
Sbjct: 225 FKKICDGIFYTP 236
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-34
Identities = 49/197 (24%), Positives = 79/197 (40%), Gaps = 16/197 (8%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
VA+K + E + SD + E +++ P+VV + + + D
Sbjct: 61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L A L+R+G L P AV I ++ H HRD++P NIL + D
Sbjct: 121 LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVD 177
Query: 297 FGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
FG++ T D LT + Y+APE F + D+++ +L E + G PP
Sbjct: 178 FGIASATT---DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
Query: 354 FT-------MKHDNEVP 363
+ H N+
Sbjct: 235 YQGDQLSVMGAHINQAI 251
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 50/210 (23%), Positives = 89/210 (42%), Gaps = 23/210 (10%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
+V VK K+ E+ +D ++ E+A+L ++ H N+++ L +V
Sbjct: 49 NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108
Query: 230 E-YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
E + DL AF+ R L A + + YL IIHRD++ NI+ +
Sbjct: 109 EKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAE 165
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALIL 344
+K+ DFG + ++ + T C Y APEV Y +++++S + L
Sbjct: 166 DFTIKLIDFGSAAY--LERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374
++ PF E+ + A PP+
Sbjct: 221 YTLVFEENPF-----CELEETVEAAIHPPY 245
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 51/188 (27%), Positives = 89/188 (47%), Gaps = 23/188 (12%)
Query: 200 ELALLQKIRHPNVVQF---LGAVTQSSPMMIVTEYLPKGDLRAF-LKRKGALKPSTAVRF 255
E+A+L+K+ HPNVV+ L + + +V E + +G + + L A +
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDH-LYMVFELVNQGPV--MEVPTLKPLSEDQARFY 142
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
D+ +G+ YLH K IIHRD++PSN+L + G++K+ADFGVS D L+
Sbjct: 143 FQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GSDALLS--- 195
Query: 316 TSC---RYVAPEVFKNE--EYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
+ ++APE + +DV++ + L + G PF D + ++
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF---MDERIMCLHSKI 252
Query: 370 QRPPFKAP 377
+ + P
Sbjct: 253 KSQALEFP 260
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 23/194 (11%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
+VA+K K + D E+ +L+K+ HP +++ + IV
Sbjct: 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 93
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---R 286
E + G+L + LK +T + + + YLHEN IIHRDL+P N+L +
Sbjct: 94 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQ 150
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---YDTKVDVFSF 340
++ +K+ DFG SK+ + E + T C Y+APEV + Y+ VD +S
Sbjct: 151 EEDCLIKITDFGHSKI--LGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 205
Query: 341 ALILQEMIEGCPPF 354
+IL + G PPF
Sbjct: 206 GVILFICLSGYPPF 219
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 42/190 (22%), Positives = 75/190 (39%), Gaps = 19/190 (10%)
Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
+ + +S + A ++ + N V L + + I + K +L+
Sbjct: 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD 150
Query: 240 FLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
++ R+ +L+ + + IA + +LH ++HRDL+PSNI +KV D
Sbjct: 151 WMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 207
Query: 297 FGVSKLLTVKEDRPLTCQDTSCR-----------YVAPEVFKNEEYDTKVDVFSFALILQ 345
FG+ + E+ Y++PE Y KVD+FS LIL
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILF 267
Query: 346 EMIEGCPPFT 355
E++ T
Sbjct: 268 ELL--YSFST 275
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-33
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 29/205 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP--------M 225
G + A+K+L + +++++ RA E+ ++K+ HPN+VQF A +
Sbjct: 53 GREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109
Query: 226 MIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
+++TE + K +G L T ++ R + ++H KP PIIHRDL+ N
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVEN 168
Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----------TSCRYVAPEVF---KNE 329
+L + G +K+ DFG + ++ D + Q T+ Y PE+ N
Sbjct: 169 LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF 228
Query: 330 EYDTKVDVFSFALILQEMIEGCPPF 354
K D+++ IL + PF
Sbjct: 229 PIGEKQDIWALGCILYLLCFRQHPF 253
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 59/235 (25%), Positives = 112/235 (47%), Gaps = 14/235 (5%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP + +T +I +G + G +VA++++ + + +E+ +++
Sbjct: 17 DPKKK-YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
+ ++PN+V +L + + +V EYL G L + + A + + + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEF 131
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
LH N+ +IHRD++ NIL G++K+ DFG +T ++ + T T ++APEV
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEV 187
Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380
+ Y KVD++S ++ EMIEG PP+ ++ A P + P KL
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 29/201 (14%)
Query: 175 GIQVAVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
G +VA+K+ + + + F E+ L RHP++V +G + + M+++ +Y+
Sbjct: 63 GAKVALKRR-----TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 233 PKGDLRAFLKRKGALKP----STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
G+L+ L + + ARG++YLH IIHRD++ NIL D+
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDE 174
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDT--SCR------YVAPEVFKNEEYDTKVDVFSF 340
+ K+ DFG+SK T + T S Y+ PE F K DV+SF
Sbjct: 175 NFVPKITDFGISKKGTELD-------QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227
Query: 341 ALILQEMIEGCPPFTMKHDNE 361
++L E++ E
Sbjct: 228 GVVLFEVLCARSAIVQSLPRE 248
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 67/243 (27%), Positives = 101/243 (41%), Gaps = 35/243 (14%)
Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVIS 189
P+ + + Y+ +I G F L + VAVK +
Sbjct: 9 GPLDMPIMHDSDRYDFVK---------DIGSGNFGVARLMRDKLTKELVAVKYIERGAA- 58
Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
D+ V+ R E+ + +RHPN+V+F + + + I+ EY G+L + G
Sbjct: 59 IDENVQ--R-EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSE 115
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE 307
A F + G++Y H + I HRDL+ N L D S LK+ DFG SK
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VL 170
Query: 308 DRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
++ Y+APEV +EYD DV+S + L M+ G PF D E P
Sbjct: 171 HSQP---KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF---EDPEEP 224
Query: 364 KAY 366
+ Y
Sbjct: 225 RDY 227
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 51/192 (26%), Positives = 84/192 (43%), Gaps = 22/192 (11%)
Query: 175 GIQVAVKKLGEEVISD----DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIV 228
+ VA+K + ++ ISD + R E+ LL+K+ V++ L + +++
Sbjct: 68 NLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126
Query: 229 TEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
E P DL F+ +GAL+ A F + + + H ++HRD++ NIL D
Sbjct: 127 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILID 183
Query: 288 -DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFAL 342
+ G LK+ DFG LL D Y PE + Y V+S +
Sbjct: 184 LNRGELKLIDFGSGALLK---DTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237
Query: 343 ILQEMIEGCPPF 354
+L +M+ G PF
Sbjct: 238 LLYDMVCGDIPF 249
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-32
Identities = 47/194 (24%), Positives = 92/194 (47%), Gaps = 15/194 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G++ A K + + +S D + E + +K++HPN+V+ ++ + S +V + +
Sbjct: 31 GLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + + + A I + Y H N I+HR+L+P N+L +
Sbjct: 90 GELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 146
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
+K+ADFG++ V + Y++PEV K + Y VD+++ +IL ++
Sbjct: 147 VKLADFGLAIE--VNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201
Query: 349 EGCPPFTMKHDNEV 362
G PPF + + +
Sbjct: 202 VGYPPFWDEDQHRL 215
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 56/195 (28%), Positives = 88/195 (45%), Gaps = 29/195 (14%)
Query: 175 GIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
VAVKKL V + + F E+ ++ K +H N+V+ LG + + +V Y+P
Sbjct: 54 NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113
Query: 234 KGDLRAFLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
G L L P + A A G+N+LHEN IHRD++ +NIL D++
Sbjct: 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAF 170
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCR------YVAPEVFKNEEYDT-----KVDVFS 339
K++DFG+++ + R Y+AP E K D++S
Sbjct: 171 TAKISDFGLARASEKFAQ-----TVMTSRIVGTTAYMAP------EALRGEITPKSDIYS 219
Query: 340 FALILQEMIEGCPPF 354
F ++L E+I G P
Sbjct: 220 FGVVLLEIITGLPAV 234
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-32
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL--GAVTQSSPMM--IVTEYL 232
VAVK L ++ D FR E + HP +V G + + IV EY+
Sbjct: 39 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
LR + +G + P A+ D + +N+ H+N IIHRD++P+NI+ + +
Sbjct: 99 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAV 155
Query: 293 KVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
KV DFG+++ + +T + +Y++PE + + D + DV+S +L E++
Sbjct: 156 KVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 350 GCPPFT--------MKHDNEVPKA 365
G PPFT +H E P
Sbjct: 215 GEPPFTGDSPVSVAYQHVREDPIP 238
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-32
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G F L R G A+K + + D + +E+A+L+KI+H N+V
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLE 72
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
++ +V + + G+L + +G A + + YLHEN I+H
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVH 129
Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE 330
RDL+P N+L +++ + + DFG+SK+ ++ ++ T+C YVAPEV +
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMS---TACGTPGYVAPEVLAQKP 183
Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
Y VD +S +I ++ G PPF + ++++
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPPFYEETESKL 215
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-32
Identities = 56/235 (23%), Positives = 104/235 (44%), Gaps = 14/235 (5%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP L + V+I +G+ + G QVAVK + + R +E+ +++
Sbjct: 42 DPRLL-LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 97
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
+H NVV+ + + ++ E+L G L + + L + + + Y
Sbjct: 98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAY 156
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
LH +IHRD++ +IL G +K++DFG ++ + + T ++APEV
Sbjct: 157 LHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY-WMAPEV 212
Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380
Y T+VD++S +++ EM++G PP+ + K P K K+
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV 267
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 3e-31
Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 20/185 (10%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK E + A R E+ +L++++HPN+V L + + +V EY +
Sbjct: 31 VAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TV 88
Query: 238 RAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L R P V+ + +N+ H++ IHRD++P NIL +K+ D
Sbjct: 89 LHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCD 145
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFALILQEMIE 349
FG ++LLT V +PE+ + +Y VDV++ + E++
Sbjct: 146 FGFARLLTG-PSDYYDD------EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198
Query: 350 GCPPF 354
G P +
Sbjct: 199 GVPLW 203
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-31
Identities = 50/194 (25%), Positives = 92/194 (47%), Gaps = 18/194 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
I+ A KK+ + + D DR + E+ +++ + HPN+++ ++ + +V E
Sbjct: 34 RIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + K + S A R D+ + Y H+ + HRDL+P N L
Sbjct: 91 GELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSP 147
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
LK+ DFG++ K + + T YV+P+V + Y + D +S +++ ++
Sbjct: 148 LKLIDFGLAAR--FKPGKMMR---TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLL 201
Query: 349 EGCPPFTMKHDNEV 362
G PPF+ D+EV
Sbjct: 202 CGYPPFSAPTDSEV 215
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-31
Identities = 48/214 (22%), Positives = 87/214 (40%), Gaps = 21/214 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTE 230
+ AVK L ++ + + E+ LL+++RH NV+Q + + + V E
Sbjct: 30 LCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME 88
Query: 231 YLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
Y G + A + + G+ YLH I+H+D++P N+L
Sbjct: 89 YCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTG 145
Query: 290 GNLKVADFGVSKLL-TVKEDRPLTCQDTSC---RYVAPEVFKNEE-YD-TKVDVFSFALI 343
G LK++ GV++ L D TS + PE+ + + KVD++S +
Sbjct: 146 GTLKISALGVAEALHPFAADDTC---RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVT 202
Query: 344 LQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
L + G PF + + K + + + P
Sbjct: 203 LYNITTGLYPF---EGDNIYKLFENIGKGSYAIP 233
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 52/191 (27%), Positives = 94/191 (49%), Gaps = 9/191 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G + AVK + + + + E+ LL+++ HPN+++ +V E
Sbjct: 51 GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + + A R + G+ Y+H+NK I+HRDL+P N+L + N
Sbjct: 111 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDAN 167
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
+++ DFG+S + + + + + Y+APEV YD K DV+S +IL ++ GC
Sbjct: 168 IRIIDFGLSTH--FEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGC 224
Query: 352 PPFTMKHDNEV 362
PPF ++ ++
Sbjct: 225 PPFNGANEYDI 235
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 58/181 (32%), Positives = 104/181 (57%), Gaps = 12/181 (6%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K++ + ++D+ + A R E++LL+++ HPN+V + + + +V E++ K
Sbjct: 48 VALKRIRLD--AEDEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
DL+ L K L+ S + + RG+ + H+++ I+HRDL+P N+L + G LK+
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKL 160
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPP 353
ADFG+++ + R T + + Y AP+V +++Y T VD++S I EMI G P
Sbjct: 161 ADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL 219
Query: 354 F 354
F
Sbjct: 220 F 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 36/251 (14%), Positives = 82/251 (32%), Gaps = 35/251 (13%)
Query: 138 HVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR-------GIQVAVKKLGEEV 187
+ + E+++ + + + +G F A + +K
Sbjct: 50 KLPAIKPKTEFQLGSKLVYVHH--LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN 107
Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA- 246
+ + L+ ++F A + ++V E G L +
Sbjct: 108 PWEFYIGT---QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT 164
Query: 247 ----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-----------RDDSGN 291
+ + FA+ + + +H+ + IIH D++P N + D S
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 292 LKVADFGVSKLLTV-KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
L + D G S + + + T + + + E+ N+ ++ ++D F A + M+ G
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
Query: 351 CPPFTMKHDNE 361
E
Sbjct: 282 TYMKVKNEGGE 292
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 54/246 (21%), Positives = 107/246 (43%), Gaps = 24/246 (9%)
Query: 132 PLMAPMHVKHAREVPEYEIDPHELDFTNSVEITK----GTF---ILAFWR--GIQVAVKK 182
P MA M + F+++ ++ + G F + G++ A K
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
+ + +S D + E + +K++HPN+V+ ++ + S +V + + G+L +
Sbjct: 62 INTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGV 299
+ + A I + Y H N I+HR+L+P N+L + +K+ADFG+
Sbjct: 121 AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177
Query: 300 SKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356
+ V + Y++PEV K + Y VD+++ +IL ++ G PPF
Sbjct: 178 AIE--VNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232
Query: 357 KHDNEV 362
+ + +
Sbjct: 233 EDQHRL 238
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 54/194 (27%), Positives = 79/194 (40%), Gaps = 24/194 (12%)
Query: 175 GIQVAVKKLG----EEVISDDDRVRAFRDELALLQKIR----HPNVVQFLGAVTQSSPMM 226
+QVA+K + D V E+ALL K+ HP V++ L M
Sbjct: 56 RLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114
Query: 227 IVTEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
+V E LP DL ++ KG L + F + + + H ++HRD++ NIL
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENIL 171
Query: 286 RD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSF 340
D G K+ DFG LL D P Y PE +Y V+S
Sbjct: 172 IDLRRGCAKLIDFGSGALL---HDEPY---TDFDGTRVYSPPEWISRHQYHALPATVWSL 225
Query: 341 ALILQEMIEGCPPF 354
++L +M+ G PF
Sbjct: 226 GILLYDMVCGDIPF 239
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDEL 201
Y+ + ++L+ E+ GT + G +AVK++ + ++ R D
Sbjct: 19 RYQAEINDLENLG--EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDLD 75
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 261
+L+ P +VQ G ++ + I E + + + +G + + + I +
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-Y 320
+ YL E +IHRD++PSNIL D+ G +K+ DFG+S L + + + C Y
Sbjct: 136 ALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAY 190
Query: 321 VAPEVFKNEE-----YDTKVDVFSFALILQEMIEGCPPF 354
+APE + YD + DV+S + L E+ G P+
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 56/181 (30%), Positives = 103/181 (56%), Gaps = 12/181 (6%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
A+KK+ E +D+ + R E+++L++++H N+V+ + +++V E+L +
Sbjct: 29 FALKKIRLE--KEDEGIPSTTIR-EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
DL+ L +G L+ TA F L + G+ Y H+ + ++HRDL+P N+L + G LK+
Sbjct: 85 DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKI 141
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPP 353
ADFG+++ + R T + + Y AP+V +++Y T +D++S I EM+ G P
Sbjct: 142 ADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200
Query: 354 F 354
F
Sbjct: 201 F 201
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-30
Identities = 55/194 (28%), Positives = 97/194 (50%), Gaps = 16/194 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+ AVK + + + D E+ LL+K+ HPN+++ + SS IV E
Sbjct: 47 QQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + ++ A R + G+ Y+H++ I+HRDL+P NIL ++ +
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCD 162
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
+K+ DFG+S +++ + Y+APEV + YD K DV+S +IL ++
Sbjct: 163 IKIIDFGLSTC--FQQNTKMK---DRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILL 216
Query: 349 EGCPPFTMKHDNEV 362
G PPF K++ ++
Sbjct: 217 SGTPPFYGKNEYDI 230
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 22/195 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G VAVK+L EE + F+ E+ ++ H N+++ G + ++V Y+
Sbjct: 54 GTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 111
Query: 235 GDLRAFLKRKGALKP----STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
G + + L+ + +P R AL ARG+ YLH++ IIHRD++ +NIL D+
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDT--SCR------YVAPEVFKNEEYDTKVDVFSFAL 342
V DFG++KL+ K DT + ++APE + K DVF + +
Sbjct: 172 EAVVGDFGLAKLMDYK--------DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 223
Query: 343 ILQEMIEGCPPFTMK 357
+L E+I G F +
Sbjct: 224 MLLELITGQRAFDLA 238
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 45/242 (18%), Positives = 87/242 (35%), Gaps = 26/242 (10%)
Query: 134 MAPMHVKHAREVPEYEI----DPHELDFTNSVEITKGTFILAF-WRGIQ------VAVKK 182
MA H H + + + I KG L V V++
Sbjct: 1 MAHHHHHHMENLYFQGMSSFLPEGG-CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRR 59
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
+ E S++ V + EL + + HPN+V + + + +VT ++ G + +
Sbjct: 60 INLEACSNEM-VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118
Query: 243 --RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
+ + + ++Y+H +HR ++ S+IL G + ++ +
Sbjct: 119 THFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN 175
Query: 301 KLLTVKEDRPLTCQDTSCRYV------APEVFK--NEEYDTKVDVFSFALILQEMIEGCP 352
+ R D V +PEV + + YD K D++S + E+ G
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
Query: 353 PF 354
PF
Sbjct: 236 PF 237
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 46/187 (24%), Positives = 91/187 (48%), Gaps = 12/187 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + I +++V E ++ ++ HP V+ + Y G+L
Sbjct: 59 AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118
Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++++ G+ + RF +I + YLH IIHRDL+P NIL ++ ++++ DF
Sbjct: 119 KYIRKIGSFDETCT-RFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDF 174
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G +K+L+ + + + +YV+PE+ + D+++ I+ +++ G PPF
Sbjct: 175 GTAKVLSPESKQARAN--SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232
Query: 355 TMKHDNE 361
+ NE
Sbjct: 233 --RAGNE 237
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 21/198 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G++ +K + ++ + E+ +L+ + HPN+++ M IV E
Sbjct: 47 GLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG 104
Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RD 287
G+L + R AL + + Y H ++H+DL+P NIL
Sbjct: 105 GELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTS 161
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 344
+K+ DFG+++L K D T + Y+APEVFK + K D++S +++
Sbjct: 162 PHSPIKIIDFGLAEL--FKSDEHST---NAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215
Query: 345 QEMIEGCPPFTMKHDNEV 362
++ GC PFT EV
Sbjct: 216 YFLLTGCLPFTGTSLEEV 233
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 47/197 (23%), Positives = 86/197 (43%), Gaps = 16/197 (8%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G++ A K + E+++L+++ H NV+ + ++++
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVS--REEIEREVSILRQVLHHNVITLHDVYENRTDVVLIL 94
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
E + G+L FL +K +L A F I G+NYLH K I H DL+P NI+
Sbjct: 95 ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
++K+ DFG++ + ++ + +VAPE+ E + D++S +I
Sbjct: 152 NIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 346 EMIEGCPPFTMKHDNEV 362
++ G PF E
Sbjct: 210 ILLSGASPFLGDTKQET 226
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 24/196 (12%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVR-AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227
+ AVK G + +R A E+ +L+K+ HPN++Q ++ +
Sbjct: 42 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
V + + KG+L +L K L + + + LH+ I+HRDL+P NIL D
Sbjct: 102 VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLD 158
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE------YDTKVDVF 338
D N+K+ DFG S + L C Y+APE+ + Y +VD++
Sbjct: 159 DDMNIKLTDFGFSCQ--LDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 213
Query: 339 SFALILQEMIEGCPPF 354
S +I+ ++ G PPF
Sbjct: 214 STGVIMYTLLAGSPPF 229
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 25/222 (11%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
D+ I G + + +VA+K++ E + E+ + + HP
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE--KCQTSMDELLKEIQAMSQCHHP 73
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA-LDIA-------RG 262
N+V + + + +V + L G + +K A + IA G
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----TS 317
+ YLH+N IHRD++ NIL + G++++ADFGVS L D T
Sbjct: 134 LEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 318 CRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358
C ++APEV + YD K D++SF + E+ G P+
Sbjct: 191 C-WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + ++ + + VR EL ++Q + HP +V + M +V + L GDLR
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR 103
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L++ K T F ++ ++YL + IIHRD++P NIL D+ G++ + DF
Sbjct: 104 YHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFN 160
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCP 352
++ + + + +T T Y+APE+F + + Y VD +S + E++ G
Sbjct: 161 IAAM--LPRETQIT---TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKL 380
P+ ++ + + P+
Sbjct: 216 PYHIRSSTSSKEIVHTFETTVVTYPSAW 243
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 61/182 (33%), Positives = 96/182 (52%), Gaps = 11/182 (6%)
Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VA+KK+ D A R E+ LLQ++ HPN++ L A S + +V +++
Sbjct: 38 VAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 96
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
DL +K L PS + L +G+ YLH++ I+HRDL+P+N+L D++G LK
Sbjct: 97 -DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLK 152
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 352
+ADFG++K +R T Q + Y APE+ F Y VD+++ IL E++ P
Sbjct: 153 LADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211
Query: 353 PF 354
Sbjct: 212 FL 213
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-30
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 23/195 (11%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV 228
G + AVK ++ A R E +L+++ HP+++ + + SS M +V
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
+ + KG+L +L K AL + +++LH N I+HRDL+P NIL DD
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDD 235
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE------YDTKVDVFS 339
+ ++++DFG S ++ L C Y+APE+ K Y +VD+++
Sbjct: 236 NMQIRLSDFGFSCH--LEPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWA 290
Query: 340 FALILQEMIEGCPPF 354
+IL ++ G PPF
Sbjct: 291 CGVILFTLLAGSPPF 305
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
P E+ F ++ +G++ + G VA+K + + ++ E++++Q
Sbjct: 26 QPEEV-FDVLEKLGEGSYGSVYKAIHKETGQIVAIK-----QVPVESDLQEIIKEISIMQ 79
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
+ P+VV++ G+ +++ + IV EY G + ++ R L +G+
Sbjct: 80 QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YLH + IHRD++ NIL + G+ K+ADFGV+ LT + T T ++APE
Sbjct: 140 YLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPE 195
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
V + Y+ D++S + EM EG PP+
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPY 225
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-30
Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 8/179 (4%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
VA+KK E + A R E+ LL+++RH N+V L + +V E++ +
Sbjct: 53 VAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TI 110
Query: 238 RAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L+ L ++ I G+ + H + IIHRD++P NIL SG +K+ D
Sbjct: 111 LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCD 167
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
FG ++ L + + Y APE+ + +Y VDV++ ++ EM G P F
Sbjct: 168 FGFARTLAAP-GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 22/192 (11%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G + A K +L E+ +L++IRHPN++ + ++++
Sbjct: 30 GKEYAAKFIKKRRLSSSRRGVS--REEIEREVNILREIRHPNIITLHDIFENKTDVVLIL 87
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
E + G+L FL K +L A +F I G++YLH + I H DL+P NI+
Sbjct: 88 ELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDK 144
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFAL 342
+ +K+ DFG++ + + +VAPE+ E + D++S +
Sbjct: 145 NVPNPRIKLIDFGIAHKI--EAGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGV 199
Query: 343 ILQEMIEGCPPF 354
I ++ G PF
Sbjct: 200 ITYILLSGASPF 211
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 50/191 (26%), Positives = 97/191 (50%), Gaps = 10/191 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++ A+K + + +S + +E+A+L+ + HPN+++ +V E
Sbjct: 62 HVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + + A + G+ YLH++ I+HRDL+P N+L ++
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDAL 177
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
+K+ DFG+S + + + + + + Y+APEV + ++YD K DV+S +IL ++ G
Sbjct: 178 IKIVDFGLSAV--FENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY 234
Query: 352 PPFTMKHDNEV 362
PPF + D E+
Sbjct: 235 PPFGGQTDQEI 245
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-30
Identities = 53/187 (28%), Positives = 87/187 (46%), Gaps = 20/187 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
++ AVK I D + + LL+ +HPN++ + +VTE +
Sbjct: 47 NMEFAVK------IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSG 290
G+L + R+ A I + + YLH ++HRDL+PSNIL +
Sbjct: 101 GELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPE 157
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEM 347
++++ DFG +K L E+ L T C +VAPEV + + YD D++S ++L M
Sbjct: 158 SIRICDFGFAKQLR-AENGLLM---TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTM 213
Query: 348 IEGCPPF 354
+ G PF
Sbjct: 214 LTGYTPF 220
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 1e-29
Identities = 49/181 (27%), Positives = 93/181 (51%), Gaps = 12/181 (6%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K++ + DD+ V A R E+ LL++++H N+V+ + + +V E+ +
Sbjct: 30 VALKRVRLD--DDDEGVPSSALR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
DL+ + G L P F + +G+ + H ++HRDL+P N+L + +G LK+
Sbjct: 86 DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKL 142
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPP 353
A+FG+++ + R + + + Y P+V F + Y T +D++S I E+ P
Sbjct: 143 ANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
Query: 354 F 354
Sbjct: 202 L 202
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 16/197 (8%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G+Q A K + E+++L++I+HPNV+ + ++++
Sbjct: 36 GLQYAAKFIKKRRTKSSRRGVS--REDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 93
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
E + G+L FL K +L A F I G+ YLH + I H DL+P NI+
Sbjct: 94 ELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDR 150
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
+K+ DFG++ + + +VAPE+ E + D++S +I
Sbjct: 151 NVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 346 EMIEGCPPFTMKHDNEV 362
++ G PF E
Sbjct: 209 ILLSGASPFLGDTKQET 225
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 53/182 (29%), Positives = 93/182 (51%), Gaps = 15/182 (8%)
Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VA+K++ EE A R E++LL+ ++H N+V + + +V EYL K
Sbjct: 30 VALKEIRLEHEEGAP----CTAIR-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK 84
Query: 235 GDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
DL+ +L G + F + RG+ Y H K ++HRDL+P N+L ++ G LK
Sbjct: 85 -DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELK 140
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 352
+ADFG+++ ++ + + + Y P++ + +Y T++D++ I EM G P
Sbjct: 141 LADFGLARAKSI-PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199
Query: 353 PF 354
F
Sbjct: 200 LF 201
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 55/191 (28%), Positives = 99/191 (51%), Gaps = 10/191 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
+ AVK + + + D E+ LL+K+ HPN+++ + SS IV E
Sbjct: 47 QQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
G+L + ++ A R + G+ Y+H++ I+HRDL+P NIL ++ +
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCD 162
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
+K+ DFG+S +++ + + + Y+APEV + YD K DV+S +IL ++ G
Sbjct: 163 IKIIDFGLSTC--FQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT 219
Query: 352 PPFTMKHDNEV 362
PPF K++ ++
Sbjct: 220 PPFYGKNEYDI 230
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 29/229 (12%)
Query: 142 AREVPEYEIDPHELDFTNSV-----EITKGTF---ILAFWR--GIQVAVKKLGEEVISDD 191
A VP+Y ID D + E+ +G + A+K V+
Sbjct: 35 ASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK-----VLKKT 89
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
+ R E+ +L ++ HPN+++ + + +V E + G+L + KG
Sbjct: 90 VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD 149
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKED 308
A I + YLHEN I+HRDL+P N+L LK+ADFG+SK+ V+
Sbjct: 150 AADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQ 204
Query: 309 RPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
+ T C Y APE+ + Y +VD++S +I ++ G PF
Sbjct: 205 VLMK---TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-29
Identities = 50/229 (21%), Positives = 98/229 (42%), Gaps = 22/229 (9%)
Query: 148 YEIDPHELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
E+ +L+ E+ +G + + G +AVK++ V + ++ R D
Sbjct: 2 MEVKADDLEPIM--ELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDI 58
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG---DLRAFLKRKGALKPSTAVRFALDI 259
++ + P V F GA+ + + I E + + + + + + A+ I
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
+ + +LH +IHRD++PSN+L + G +K+ DFG+S L + D C+
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCK 173
Query: 320 -YVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPF-TMKHDNEV 362
Y+APE E Y K D++S + + E+ P+ + +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ 222
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 53/227 (23%), Positives = 86/227 (37%), Gaps = 29/227 (12%)
Query: 166 GTFILA-FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223
GT + + VAVK++ E S DR E+ LL++ HPNV+++
Sbjct: 38 GTIVYRGMFDNRDVAVKRILPECFSFADR------EVQLLRESDEHPNVIRYFCTEKDRQ 91
Query: 224 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
I E L+ ++++K A + G+ +LH I+HRDL+P
Sbjct: 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPH 147
Query: 283 NILRDDSGN-----LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK---NEEY 331
NIL ++DFG+ K L + + ++APE+ E
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLA-VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206
Query: 332 DTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
VD+FS + +I EG PF + +A
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHPF---GKSLQRQANILLGACSLDCL 250
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 24/223 (10%)
Query: 147 EYEIDPHELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDEL 201
++ +L EI +G + ++ G +AVK++ V + ++ + D
Sbjct: 16 HWDFTAEDLKDLG--EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLD 72
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST-----AVRFA 256
+++ P +VQF GA+ + I E + F K ++ +
Sbjct: 73 VVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
L + +N+L EN IIHRD++PSNIL D SGN+K+ DFG+S L D +D
Sbjct: 132 LATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDA 186
Query: 317 SCR-YVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPF 354
CR Y+APE YD + DV+S + L E+ G P+
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 48/185 (25%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
VA+K++ E +++ V A R E++LL++++H N+++ + + + ++ EY
Sbjct: 62 VAIKRIRLE--HEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN- 117
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-----RDDSG 290
DL+ ++ + + F + G+N+ H + +HRDL+P N+L ++
Sbjct: 118 DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETP 174
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIE 349
LK+ DFG+++ + R T + + Y PE+ + Y T VD++S A I EM+
Sbjct: 175 VLKIGDFGLARAFGI-PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233
Query: 350 GCPPF 354
P F
Sbjct: 234 KTPLF 238
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-29
Identities = 51/194 (26%), Positives = 87/194 (44%), Gaps = 20/194 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
AVK +IS + E+ L+ HPN+V+ +V E L
Sbjct: 36 NQAFAVK-----IISKRMEANTQK-EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 290
G+L +K+K + A + ++++H+ ++HRDL+P N+L +D+
Sbjct: 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNL 146
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEM 347
+K+ DFG ++L +++PL T C Y APE+ YD D++S +IL M
Sbjct: 147 EIKIIDFGFARLKPP-DNQPLK---TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTM 202
Query: 348 IEGCPPFTMKHDNE 361
+ G PF +
Sbjct: 203 LSGQVPFQSHDRSL 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-29
Identities = 49/195 (25%), Positives = 86/195 (44%), Gaps = 25/195 (12%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G Q AVK K + ++ E ++ ++HP++V+ L + + +V
Sbjct: 49 GQQFAVKIVDVAKFTSSPGLSTEDLK---REASICHMLKHPHIVELLETYSSDGMLYMVF 105
Query: 230 EYLPKGDLRAFLKRKGALKPS----TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
E++ DL + ++ A + I + Y H+N IIHRD++P +L
Sbjct: 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVL 162
Query: 286 ---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFS 339
+++S +K+ FGV+ L + ++APEV K E Y VDV+
Sbjct: 163 LASKENSAPVKLGGFGVAIQLG-ESGLVAG---GRVGTPHFMAPEVVKREPYGKPVDVWG 218
Query: 340 FALILQEMIEGCPPF 354
+IL ++ GC PF
Sbjct: 219 CGVILFILLSGCLPF 233
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-29
Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 16/189 (8%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
G++ A K + E+++L+++ HPN++ + ++++
Sbjct: 37 GLEYAAKFIKKRQSRASRRGVC--REEIEREVSILRQVLHPNIITLHDVYENRTDVVLIL 94
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
E + G+L FL +K +L A F I G+NYLH K I H DL+P NI+
Sbjct: 95 ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
++K+ DFG++ +++ + +VAPE+ E + D++S +I
Sbjct: 152 NIPIPHIKLIDFGLAHE--IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 346 EMIEGCPPF 354
++ G PF
Sbjct: 210 ILLSGASPF 218
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 14/183 (7%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL- 237
A KKL ++ + + E +L K+ +V A + + +V + GD+
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273
Query: 238 ---RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
+ + A+ + I G+ +LH+ II+RDL+P N+L DD GN+++
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRI 330
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
+D G++ L + + ++APE+ EEYD VD F+ + L EMI
Sbjct: 331 SDLGLAVELKAGQTKT----KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
Query: 352 PPF 354
PF
Sbjct: 387 GPF 389
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 53/187 (28%), Positives = 97/187 (51%), Gaps = 20/187 (10%)
Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
VA+K++ EE A R E++L+++++H N+V+ + + + +V E++
Sbjct: 33 VALKEVKLDSEEGTP----STAIR-EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN 87
Query: 235 GDLRAFLK------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
DL+ ++ L+ + F + +G+ + HENK I+HRDL+P N+L +
Sbjct: 88 -DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINK 143
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEM 347
G LK+ DFG+++ + + + + Y AP+V + Y T +D++S IL EM
Sbjct: 144 RGQLKLGDFGLARAFGI-PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEM 202
Query: 348 IEGCPPF 354
I G P F
Sbjct: 203 ITGKPLF 209
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 31/222 (13%)
Query: 149 EIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
++DP+E+ + E+ G F + G A K + ++ + + E+ +
Sbjct: 14 DLDPNEV-WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEI 69
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARG 262
L HP +V+ LGA + I+ E+ P G + A + ++ +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV- 321
+N+LH + IIHRDL+ N+L G++++ADFGVS + + ++
Sbjct: 130 LNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-------FIG 179
Query: 322 -----APEV-----FKNEEYDTKVDVFSFALILQEMIEGCPP 353
APEV K+ YD K D++S + L EM + PP
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 43/212 (20%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
E+ KG F G + A + + +S D + E + + ++HPN+V+
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHPNIVRLH 76
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
++++ ++ + + G+L + + + A I + + H+ ++H
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVH 133
Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE 330
R+L+P N+L + +K+ADFG++ + E + Y++PEV + +
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWF---GFAGTPGYLSPEVLRKDP 189
Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
Y VD+++ +IL ++ G PPF + + +
Sbjct: 190 YGKPVDLWACGVILYILLVGYPPFWDEDQHRL 221
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 61/252 (24%), Positives = 103/252 (40%), Gaps = 38/252 (15%)
Query: 136 PMHVKHAREVPEYEIDPHELDFTNSVEITK-----GTF---ILAFWR--GIQVAVKKLGE 185
H EV +P + T+ +++K G + F R G + A+K L
Sbjct: 5 HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-- 62
Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGA----VTQSSPMMIVTEYLPKGDLRAFL 241
D +A ++ Q P++V L ++I+ E + G+L + +
Sbjct: 63 -----YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI 117
Query: 242 KRKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVAD 296
+ +G + A DI + +LH + I HRD++P N+L ++ LK+ D
Sbjct: 118 QERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTD 174
Query: 297 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
FG +K L T C YVAPEV E+YD D++S +I+ ++ G PP
Sbjct: 175 FGFAKET---TQNALQ---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
Query: 354 FTMKHDNEVPKA 365
F +
Sbjct: 229 FYSNTGQAISPG 240
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 51/240 (21%), Positives = 82/240 (34%), Gaps = 58/240 (24%)
Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
A+K K+ + D +R++ E+ L++K+ HPN+ + + +V
Sbjct: 51 RAIRAIKIMNKNKIRQINPKDVERIK---TEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107
Query: 230 EYLPKGDLRAFLKRKGALKPST-------------------------------------- 251
E G L L
Sbjct: 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167
Query: 252 --AVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKE 307
I ++YLH I HRD++P N L + S +K+ DFG+SK
Sbjct: 168 KLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN 224
Query: 308 DRPLTCQDTSC---RYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
+ T +VAPEV NE Y K D +S ++L ++ G PF +D +
Sbjct: 225 NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT 284
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 175 GIQVAVK----------KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
+ A+K + ++ + + +E++LL+ + HPN+++
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+VTE+ G+L + + A I G+ YLH++ I+HRD++P NI
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENI 177
Query: 285 L---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
L ++ N+K+ DFG+S +D L + + Y+APEV K ++Y+ K DV+S
Sbjct: 178 LLENKNSLLNIKIVDFGLSSF--FSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCG 234
Query: 342 LILQEMIEGCPPFTMKHDNEV 362
+I+ ++ G PPF ++D ++
Sbjct: 235 VIMYILLCGYPPFGGQNDQDI 255
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 47/197 (23%), Positives = 86/197 (43%), Gaps = 18/197 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLP 233
G + A K L + D R E+A+L+ + P V+ +S ++++ EY
Sbjct: 54 GQEYAAKFLKKRRRGQDCR-AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAA 112
Query: 234 KGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDD 288
G++ + + + +R I G+ YLH+N I+H DL+P NIL
Sbjct: 113 GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYP 169
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQ 345
G++K+ DFG+S+ + L Y+APE+ + T D+++ +I
Sbjct: 170 LGDIKIVDFGMSRKI--GHACELR---EIMGTPEYLAPEILNYDPITTATDMWNIGIIAY 224
Query: 346 EMIEGCPPFTMKHDNEV 362
++ PF + + E
Sbjct: 225 MLLTHTSPFVGEDNQET 241
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 43/229 (18%)
Query: 166 GTFILA-FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223
GT + ++G VAVK++ D E+ LL + HPNV+++ + T
Sbjct: 29 GTVVFQGSFQGRPVAVKRM------LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDR 82
Query: 224 PMMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ I E +L+ ++ K K + IA G+ +LH K IIH
Sbjct: 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIH 138
Query: 277 RDLEPSNIL-------------RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RY 320
RDL+P NIL ++ + ++DFG+ K L + T + +
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198
Query: 321 VAPEVFKNEE-------YDTKVDVFSFALILQEMI-EGCPPFTMKHDNE 361
APE+ + +D+FS + ++ +G PF K+ E
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 39/193 (20%), Positives = 85/193 (44%), Gaps = 15/193 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G K + D V+ +E++++ ++ HP ++ A M+++ E+L
Sbjct: 76 GRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
G+L F + + + + G+ ++HE+ I+H D++P NI+ +
Sbjct: 133 GEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKA 187
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
++K+ DFG++ L D + + + APE+ E D+++ ++ ++
Sbjct: 188 SSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 245
Query: 350 GCPPFTMKHDNEV 362
G PF + D E
Sbjct: 246 GLSPFAGEDDLET 258
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 55/182 (30%), Positives = 87/182 (47%), Gaps = 13/182 (7%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A KKL ++ I +E +L+K+ VV A + +V + GDL+
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 239 AFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
+ G + AV +A +I G+ LH + I++RDL+P NIL DD G+++++D
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISD 329
Query: 297 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
G++ V E + + Y+APEV KNE Y D ++ +L EMI G P
Sbjct: 330 LGLAV--HVPEGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
Query: 354 FT 355
F
Sbjct: 385 FQ 386
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 10/187 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +EVI D V E +LQ RHP + A + V EY G+L
Sbjct: 34 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L R+ A + +I + YLH +++RD++ N++ D G++K+ DFG
Sbjct: 94 FHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG 150
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
+ K T C Y+APEV ++ +Y VD + +++ EM+ G PF
Sbjct: 151 LCKEGISDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
Query: 356 MKHDNEV 362
+ +
Sbjct: 207 NQDHERL 213
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 37/185 (20%), Positives = 75/185 (40%), Gaps = 16/185 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
K + + + E+++L RH N++ + ++++ E++
Sbjct: 30 KKTYMAKFVKVKGTDQVL----VKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85
Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
D+ F L V + + + +LH + I H D+ P NI+ S
Sbjct: 86 LDI--FERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRS 140
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
+K+ +FG ++ L K T+ Y APEV +++ T D++S ++ ++
Sbjct: 141 STIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 350 GCPPF 354
G PF
Sbjct: 199 GINPF 203
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 67/246 (27%), Positives = 106/246 (43%), Gaps = 41/246 (16%)
Query: 131 KPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGI----------QVAV 180
PL P V + E+ +TN I G+F G+ +VA+
Sbjct: 16 NPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSF------GVVFQAKLVESDEVAI 69
Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IVTEYLPK 234
KK + D R R EL +++ ++HPNVV + +V EY+P+
Sbjct: 70 KK-----VLQDKR-FKNR-ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE 122
Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DS 289
+ R + K K + + + R + Y+H I HRD++P N+L D S
Sbjct: 123 -TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPS 178
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMI 348
G LK+ DFG +K+L P S Y APE+ F Y T +D++S ++ E++
Sbjct: 179 GVLKLIDFGSAKILI--AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236
Query: 349 EGCPPF 354
+G P F
Sbjct: 237 QGQPLF 242
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 15/193 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
G A K + SD + VR E+ + +RHP +V A + M+++ E++
Sbjct: 182 GNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238
Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
G+L F + AV + + +G+ ++HEN +H DL+P NI+ S
Sbjct: 239 GEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRS 293
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
LK+ DFG++ L + + + + APEV + + D++S ++ ++
Sbjct: 294 NELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351
Query: 350 GCPPFTMKHDNEV 362
G PF ++D+E
Sbjct: 352 GLSPFGGENDDET 364
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 48/209 (22%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 179 AVKKLGEEVISDDDRVRAFRDE---LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
A+K L ++ I +E L+L+ P +V A + + + + G
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
DL L + G + +A +I G+ ++H +++RDL+P+NIL D+ G+++++
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 334
Query: 296 DFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGC 351
D G++ + +P S Y+APEV K YD+ D FS +L +++ G
Sbjct: 335 DLGLACD--FSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKL 380
PF + + + P
Sbjct: 389 SPFRQHKTKDKHEIDRMTLTMAVELPDSF 417
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 60/279 (21%), Positives = 117/279 (41%), Gaps = 26/279 (9%)
Query: 95 RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVP---EYEID 151
R + K+ W + L + + K+ L A P + A++ Y +
Sbjct: 33 RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVS 92
Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
E + G F G+++A K + + D + V+ +E++++ +
Sbjct: 93 KTE-------ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQ 142
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGALKPSTAVRFALDIARGMNY 265
+ H N++Q A + +++V EY+ G+L + L + F I G+ +
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRH 202
Query: 266 LHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 323
+H+ I+H DL+P NIL D+ +K+ DFG+++ K L + ++AP
Sbjct: 203 MHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFLAP 257
Query: 324 EVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
EV + D++S +I ++ G PF +D E
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET 296
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 53/187 (28%), Positives = 87/187 (46%), Gaps = 9/187 (4%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +EVI D V E +LQ RHP + + + V EY G+L
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 236
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L R+ A + +I ++YLH K +++RDL+ N++ D G++K+ DFG
Sbjct: 237 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFG 294
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
+ K T C Y+APEV ++ +Y VD + +++ EM+ G PF
Sbjct: 295 LCKEGIKDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350
Query: 356 MKHDNEV 362
+ ++
Sbjct: 351 NQDHEKL 357
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-27
Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP +L F++ EI G+F + VA+KK+ +++ + E+ LQ
Sbjct: 51 DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
K+RHPN +Q+ G + +V EY K L+ +G+ Y
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED---RPLTCQDTSCRYVA 322
LH + +IHRD++ NIL + G +K+ DFG + ++ P ++A
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY--------WMA 218
Query: 323 PEV---FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
PEV +YD KVDV+S + E+ E PP
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 56/192 (29%), Positives = 89/192 (46%), Gaps = 25/192 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
G VA+KK + D R R EL +++K+ H N+V+ S +V
Sbjct: 79 GELVAIKK-----VLQDKR-FKNR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131
Query: 229 TEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+Y+P+ + R + + K L + + R + Y+H I HRD++P N+
Sbjct: 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNL 187
Query: 285 LRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFAL 342
L D D+ LK+ DFG +K L P S Y APE+ F +Y + +DV+S
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 245
Query: 343 ILQEMIEGCPPF 354
+L E++ G P F
Sbjct: 246 VLAELLLGQPIF 257
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-27
Identities = 23/237 (9%), Positives = 44/237 (18%), Gaps = 41/237 (17%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT----- 229
A+K + + + ++ + + P V
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 230 --------------------EYLPKGDLRAFLKR-------KGALKPSTAVRFALDIARG 262
DL +G + R
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
L ++H P N+ G L + D K Y
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL----WKVGTRGPASSVPVTYAP 259
Query: 323 PEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
E + ++ + L + + PF + R P
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDS 316
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 51/180 (28%), Positives = 90/180 (50%), Gaps = 13/180 (7%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L ++ + ++ +E +LQ + P +V+ + +S + +V EY+ G++
Sbjct: 70 AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+ L+R G A +A I YLH +I+RDL+P N+L D G ++V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG 186
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
+ K + T T C +APE+ ++ Y+ VD ++ +++ EM G PPF
Sbjct: 187 FA-----KRVKGRT--WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF 239
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 58/188 (30%), Positives = 92/188 (48%), Gaps = 11/188 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDE-LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++V+ DD V E L + P + Q + V EY+ GDL
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+++ G K AV +A +IA G+ +L II+RDL+ N++ D G++K+ADF
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 486
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K T C Y+APE+ + Y VD ++F ++L EM+ G PF
Sbjct: 487 GMCKENIWDGVTT----KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 542
Query: 355 TMKHDNEV 362
+ ++E+
Sbjct: 543 EGEDEDEL 550
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 50/224 (22%), Positives = 89/224 (39%), Gaps = 24/224 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
+ AVK + ++ RV E+ +L + + H NV++ + + +V E +
Sbjct: 38 SQEYAVKIIEKQPGHIRSRVF---REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 290
G + + + ++ A D+A +++LH I HRDL+P NIL +
Sbjct: 95 GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVS 151
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQD---TSC---RYVAPEVFK-----NEEYDTKVDVFS 339
+K+ DF + + + D T C Y+APEV + YD + D++S
Sbjct: 152 PVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS 211
Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
+IL ++ G PPF R L+
Sbjct: 212 LGVILYILLSGYPPF---VGRCGSDCGWDRGEACPACQNMLFES 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 58/188 (30%), Positives = 93/188 (49%), Gaps = 11/188 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++V+ DD V E +L + P + Q + V EY+ GDL
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+++ G K AV +A +IA G+ +L II+RDL+ N++ D G++K+ADF
Sbjct: 109 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 165
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K T C Y+APE+ + Y VD ++F ++L EM+ G PF
Sbjct: 166 GMCKENIWDGVTT----KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 221
Query: 355 TMKHDNEV 362
+ ++E+
Sbjct: 222 EGEDEDEL 229
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 58/188 (30%), Positives = 94/188 (50%), Gaps = 11/188 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K L ++V+ DD V E +L HP + + V EYL GDL
Sbjct: 46 AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL 105
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++ S A +A +I G+ +LH I++RDL+ NIL D G++K+ADF
Sbjct: 106 MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADF 162
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K + + + +T C Y+APE+ ++Y+ VD +SF ++L EM+ G PF
Sbjct: 163 GMCKENMLGDAKT----NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218
Query: 355 TMKHDNEV 362
+ + E+
Sbjct: 219 HGQDEEEL 226
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 41/216 (18%), Positives = 76/216 (35%), Gaps = 34/216 (15%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVTEY 231
V +K L D + E L ++ HP++VQ V + IV EY
Sbjct: 108 PVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY 165
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
+ L+ L + A+ + L+I ++YLH +++ DL+P NI+ +
Sbjct: 166 VGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEEQ- 219
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
LK+ D G + + + APE+ + D+++ L
Sbjct: 220 LKLIDLGAVSRIN----------SFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAA 268
Query: 347 MIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382
+ P ++ + +P P K
Sbjct: 269 LTLDLPTRNGRYVDGLP-----EDDPVLKTYDSYGR 299
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-26
Identities = 56/191 (29%), Positives = 100/191 (52%), Gaps = 11/191 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K + +E+++DD+ + + E + ++ HP +V S + V EY+ GDL
Sbjct: 38 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R+ L A ++ +I+ +NYLHE II+RDL+ N+L D G++K+ D+
Sbjct: 98 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 154
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K D T T C Y+APE+ + E+Y VD ++ +++ EM+ G PF
Sbjct: 155 GMCKEGLRPGDT--T--STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210
Query: 355 TMKHDNEVPKA 365
+ ++ P
Sbjct: 211 DIVGSSDNPDQ 221
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 46/188 (24%), Positives = 78/188 (41%), Gaps = 17/188 (9%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K + + + V FR+E +L + Q A + + +V EY GDL
Sbjct: 90 AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149
Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L + G P+ RF +I ++ +H +HRD++P NIL D G++++ADF
Sbjct: 150 TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE-------YDTKVDVFSFALILQEM 347
G L + Y++PE+ + Y + D ++ + EM
Sbjct: 207 GSCLKLRADGT---VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263
Query: 348 IEGCPPFT 355
G PF
Sbjct: 264 FYGQTPFY 271
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 9e-26
Identities = 53/179 (29%), Positives = 94/179 (52%), Gaps = 13/179 (7%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L +E++ +V DE +L + HP +++ G + + ++ +Y+ G+L
Sbjct: 35 AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 94
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
+ L++ A +A ++ + YLH II+RDL+P NIL D +G++K+ DFG
Sbjct: 95 SLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG 151
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
+ K +T T C Y+APEV + Y+ +D +SF +++ EM+ G PF
Sbjct: 152 FA-----KYVPDVT--YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 29/203 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGA----VTQSSPMMIVT 229
+ A+K ++ D + R E+ L + + P++V+ + ++IV
Sbjct: 87 QEKFALK-----MLQDCPKAR---REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138
Query: 230 EYLPKGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 285
E L G+L R + A A I + YLH I HRD++P N+L
Sbjct: 139 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYT 195
Query: 286 -RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFA 341
+ + LK+ DFG +K LT T C YVAPEV E+YD D++S
Sbjct: 196 SKRPNAILKLTDFGFAKE--TTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLG 250
Query: 342 LILQEMIEGCPPFTMKHDNEVPK 364
+I+ ++ G PPF H +
Sbjct: 251 VIMYILLCGYPPFYSNHGLAISP 273
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 59/190 (31%), Positives = 90/190 (47%), Gaps = 20/190 (10%)
Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSP-----MM 226
VA+K + + R E+ALL+++ HPNVV+ + S +
Sbjct: 37 VALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT 95
Query: 227 IVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+V E++ + DLR +L + L T RG+++LH N I+HRDL+P NI
Sbjct: 96 LVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENI 151
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
L G +K+ADFG++++ + LT + Y APEV Y T VD++S I
Sbjct: 152 LVTSGGTVKLADFGLARIYSY--QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 209
Query: 345 QEMIEGCPPF 354
EM P F
Sbjct: 210 AEMFRRKPLF 219
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 28/227 (12%)
Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
DP + F + GT+ + G A+K + +V D++ + E+ +L+
Sbjct: 21 DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEE--EIKQEINMLK 75
Query: 206 KI-RHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFA 256
K H N+ + GA + +P + +V E+ G + +K + LK
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
+I RG+++LH++K +IHRD++ N+L ++ +K+ DFGVS L R T T
Sbjct: 136 REILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192
Query: 317 SCRYVAPEVFKNEE-----YDTKVDVFSFALILQEMIEGCPPFTMKH 358
++APEV +E YD K D++S + EM EG PP H
Sbjct: 193 PY-WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 54/191 (28%), Positives = 99/191 (51%), Gaps = 11/191 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A++ + +E+++DD+ + + E + ++ HP +V S + V EY+ GDL
Sbjct: 81 AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
++R+ L A ++ +I+ +NYLHE II+RDL+ N+L D G++K+ D+
Sbjct: 141 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K D T C Y+APE+ + E+Y VD ++ +++ EM+ G PF
Sbjct: 198 GMCKEGLRPGDT----TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253
Query: 355 TMKHDNEVPKA 365
+ ++ P
Sbjct: 254 DIVGSSDNPDQ 264
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 55/188 (29%), Positives = 91/188 (48%), Gaps = 11/188 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++VI DD V E +L HP + Q + V E++ GDL
Sbjct: 52 AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
+++ + A +A +I + +LH+ II+RDL+ N+L D G+ K+ADF
Sbjct: 112 MFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 168
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K T T C Y+APE+ + Y VD ++ ++L EM+ G PF
Sbjct: 169 GMCKEGICNGVT--T--ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF 224
Query: 355 TMKHDNEV 362
++++++
Sbjct: 225 EAENEDDL 232
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 56/189 (29%), Positives = 96/189 (50%), Gaps = 21/189 (11%)
Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIR---HPNVVQFLGAVTQSSP-----MMI 227
VA+K++ + + ++ + R E+A+L+ + HPNVV+ T S + +
Sbjct: 40 VALKRVRVQ--TGEEGMPLSTIR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96
Query: 228 VTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
V E++ + DL +L + + T + RG+++LH ++ ++HRDL+P NIL
Sbjct: 97 VFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNIL 152
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
SG +K+ADFG++++ + LT + Y APEV Y T VD++S I
Sbjct: 153 VTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 210
Query: 346 EMIEGCPPF 354
EM P F
Sbjct: 211 EMFRRKPLF 219
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 11/187 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + DRVR + E +L ++ HP +V+ A + ++ ++L GDL
Sbjct: 56 AMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 114
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L ++ + ++A +++LH II+RDL+P NIL D+ G++K+ DFG
Sbjct: 115 TRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG 171
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
+SK E + + C Y+APEV + D +SF +++ EM+ G PF
Sbjct: 172 LSKESIDHEKK----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227
Query: 356 MKHDNEV 362
K E
Sbjct: 228 GKDRKET 234
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 55/186 (29%), Positives = 84/186 (45%), Gaps = 15/186 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
VA+KKL + RA+R EL L++ + H N++ L T + IV
Sbjct: 50 ERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
E + +L ++ + L + G+ +LH IIHRDL+PSNI+
Sbjct: 109 MELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 162
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
LK+ DFG+++ T +T + Y APEV Y VD++S I+ EMI
Sbjct: 163 DCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220
Query: 349 EGCPPF 354
+G F
Sbjct: 221 KGGVLF 226
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 44/186 (23%), Positives = 79/186 (42%), Gaps = 15/186 (8%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + FR+E +L + A + + +V +Y GDL
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL 162
Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L + P RF ++ ++ +H+ +HRD++P NIL D +G++++ADF
Sbjct: 163 TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE-----YDTKVDVFSFALILQEMIE 349
G L + Y++PE+ + E Y + D +S + + EM+
Sbjct: 220 GSCLKLMEDGT---VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
Query: 350 GCPPFT 355
G PF
Sbjct: 277 GETPFY 282
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 96.7 bits (242), Expect = 3e-24
Identities = 21/87 (24%), Positives = 37/87 (42%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ LA + ++ + ++ +N D + T L AA G VV LL+ GAD
Sbjct: 7 VHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLG 66
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ + L A +++K+L G
Sbjct: 67 KGRESALSLACSKGYTDIVKMLLDCGV 93
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 93.2 bits (233), Expect = 6e-23
Identities = 29/106 (27%), Positives = 44/106 (41%), Gaps = 5/106 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+ L E L ++ + +K LLD G+DVN D + T L A
Sbjct: 60 ADPQLLGKGRE--SA---LSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNH 114
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+ V +LLE GAD + G + A+ V +++E H K
Sbjct: 115 VKCVKMLLESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHLLK 160
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 92.1 bits (230), Expect = 2e-22
Identities = 33/107 (30%), Positives = 58/107 (54%), Gaps = 5/107 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+E +N D++G P LM+ A + ++ LL +G D +AL +A +
Sbjct: 25 QENVINHTDEEGF--TP---LMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSK 79
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G+T++V +LL+ G DV+ D G TPL A++ + + +K+L + GA
Sbjct: 80 GYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGA 126
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 75.5 bits (187), Expect = 2e-16
Identities = 17/61 (27%), Positives = 30/61 (49%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
N ++H A QG ++ +E+ ++ D G TPL A + V++ L ++GA
Sbjct: 2 ANSLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGAD 61
Query: 132 P 132
P
Sbjct: 62 P 62
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 66.6 bits (164), Expect = 2e-13
Identities = 15/79 (18%), Positives = 32/79 (40%), Gaps = 5/79 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++N D +G P L++ + V+ +K LL+SG D ++ +A G+
Sbjct: 93 VDVNEYDWNGG--TP---LLYAVHGNHVKCVKMLLESGADPTIETDSGYNSMDLAVALGY 147
Query: 86 TEVVSLLLERGADVDPKDR 104
V ++ + +
Sbjct: 148 RSVQQVIESHLLKLLQNIK 166
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 95.6 bits (239), Expect = 3e-24
Identities = 29/89 (32%), Positives = 45/89 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + + D+ ++ LL +G D N +D T LH A G +VV LLL+ A V+
Sbjct: 14 LHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTG 73
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+PL DA + +++KLL +GA
Sbjct: 74 YQNDSPLHDAAKNGHVDIVKLLLSYGASR 102
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 95.2 bits (238), Expect = 6e-24
Identities = 27/105 (25%), Positives = 44/105 (41%), Gaps = 5/105 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++ N D G P L N ++ ++ LL VN N + LH AA G
Sbjct: 34 SDPNVKDHAGW--TP---LHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGH 88
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
++V LLL GA + + +G P+ ++ L EK+ +
Sbjct: 89 VDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLPEKNES 133
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 2e-20
Identities = 25/68 (36%), Positives = 39/68 (57%), Gaps = 1/68 (1%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
GID + T LH+A+ +G V LL+ G+D + KD G TPL +A + + +V+
Sbjct: 1 GIDPF-TNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVV 59
Query: 123 KLLEKHGA 130
+LL +H A
Sbjct: 60 ELLLQHKA 67
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 49.3 bits (119), Expect = 1e-07
Identities = 13/73 (17%), Positives = 24/73 (32%), Gaps = 5/73 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A +N + P L A V+ +K LL G N +I + +
Sbjct: 67 ALVNTTGYQND--SP---LHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESM 121
Query: 86 TEVVSLLLERGAD 98
++ L + +
Sbjct: 122 KSLLLLPEKNESS 134
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 38.9 bits (92), Expect = 6e-04
Identities = 9/37 (24%), Positives = 16/37 (43%), Gaps = 1/37 (2%)
Query: 96 GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G D + G T L A + ++ L ++G+ P
Sbjct: 1 GIDPF-TNHRGETLLHIASIKGDIPSVEYLLQNGSDP 36
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 48/190 (25%), Positives = 85/190 (44%), Gaps = 18/190 (9%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MMIVT 229
VA+KK+ E + + A R E+ +LQ ++H NVV + + + +V
Sbjct: 45 VALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 103
Query: 230 EYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
++ DL L S R + G+ Y+H NK I+HRD++ +N+L
Sbjct: 104 DFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITR 159
Query: 289 SGNLKVADFGVSKLLTV---KEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALIL 344
G LK+ADFG+++ ++ + T + + Y PE+ +Y +D++ I+
Sbjct: 160 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 219
Query: 345 QEMIEGCPPF 354
EM P
Sbjct: 220 AEMWTRSPIM 229
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 68/231 (29%), Positives = 99/231 (42%), Gaps = 31/231 (13%)
Query: 145 VPEYEIDPHELD-FTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
E E+D F +GTF L + G+ VA+KK+ D R
Sbjct: 12 AAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV------IQDPRFRNR 65
Query: 199 D--ELALLQKIRHPNVVQFLGAVTQSSP-------MMIVTEYLPKGDL----RAFLKRKG 245
+ + L + HPN+VQ + +V EY+P L R + +R+
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQV 124
Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLT 304
A P F + R + LH V + HRD++P N+L + G LK+ DFG +K L+
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 305 VKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
P S Y APE+ F N+ Y T VD++S I EM+ G P F
Sbjct: 184 --PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 51/188 (27%), Positives = 95/188 (50%), Gaps = 11/188 (5%)
Query: 179 AVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
A+K L ++ + + E +L++++HP +V + A + ++ EYL G+L
Sbjct: 49 AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 108
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L+R+G TA + +I+ + +LH+ II+RDL+P NI+ + G++K+ DF
Sbjct: 109 FMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDF 165
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K T C Y+APE+ ++ VD +S ++ +M+ G PPF
Sbjct: 166 GLCKESIHDGTV----THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221
Query: 355 TMKHDNEV 362
T ++ +
Sbjct: 222 TGENRKKT 229
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 58/188 (30%), Positives = 91/188 (48%), Gaps = 11/188 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDE-LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
AVK L ++ I + E LL+ ++HP +V + + + V +Y+ G+L
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
L+R+ A +A +IA + YLH I++RDL+P NIL D G++ + DF
Sbjct: 127 FYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDF 183
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
G+ K T T C Y+APEV + YD VD + +L EM+ G PPF
Sbjct: 184 GLCKENIEHNST--T--STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239
Query: 355 TMKHDNEV 362
++ E+
Sbjct: 240 YSRNTAEM 247
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 94.8 bits (237), Expect = 5e-24
Identities = 30/89 (33%), Positives = 45/89 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
M+ D++ +K+ + G DVN R LH AA G E++ LL +GAD++ D
Sbjct: 11 FMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPD 70
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ TPL A+Y + +KLL GA
Sbjct: 71 KHHITPLLSAVYEGHVSCVKLLLSKGADK 99
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 77.4 bits (192), Expect = 1e-17
Identities = 28/100 (28%), Positives = 43/100 (43%), Gaps = 5/100 (5%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
K ++N + G KP L + A+ +E ++ LL G D+N D + T L A +
Sbjct: 29 KGEDVNRTLEGGR--KP---LHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYE 83
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
G V LLL +GAD K G T +++
Sbjct: 84 GHVSCVKLLLSKGADKTVKGPDGLTAFEATDNQAIKALLQ 123
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 71.7 bits (177), Expect = 1e-15
Identities = 14/59 (23%), Positives = 21/59 (35%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
A G + V + +G DV+ G PL A E+++ L GA
Sbjct: 6 MCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGA 64
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-24
Identities = 31/209 (14%), Positives = 64/209 (30%), Gaps = 40/209 (19%)
Query: 172 FWRGI------QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
FW+ + QVA+ + + + DD ++ L +I P V + L V +
Sbjct: 47 FWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG 106
Query: 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
++V E++ G L+ + P A+R +A + H + PS +
Sbjct: 107 LVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVR 161
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
G++ +A + + + D+ L
Sbjct: 162 VSIDGDVVLAYPA---------------------TMPDA-------NPQDDIRGIGASLY 193
Query: 346 EMIEGCPPFTMK-HDNEVPKAYAARQRPP 373
++ P + + A P
Sbjct: 194 ALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 30/193 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
G +VA+KKL S+ RA+R EL LL+ ++H NV+ L T +S + +V
Sbjct: 49 GEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
++ DL+ + K + +G+ Y+H ++HRDL+P N+ ++
Sbjct: 108 MPFMQT-DLQKIMGLK--FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNE 161
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFA 341
LK+ DFG+++ D +T YV APEV Y+ VD++S
Sbjct: 162 DCELKILDFGLAR----HADAEMT------GYVVTRWYRAPEVILSWMHYNQTVDIWSVG 211
Query: 342 LILQEMIEGCPPF 354
I+ EM+ G F
Sbjct: 212 CIMAEMLTGKTLF 224
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 7e-24
Identities = 25/89 (28%), Positives = 39/89 (43%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ A ++ L+ G VN D+ + LH A G V +LL+ GA V+
Sbjct: 63 MHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVT 122
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
TPL +A + + + LL +HGA
Sbjct: 123 ADWHTPLFNACVSGSWDCVNLLLQHGASV 151
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-20
Identities = 25/105 (23%), Positives = 41/105 (39%), Gaps = 7/105 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++ P L + +K+LL+SG DVN + + LH
Sbjct: 181 GNIDHKISHLG--TP---LYLACENQQRACVKKLLESGADVN-QGKGQDSPLHAVVRTAS 234
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
E+ LL++ GAD K+ G P+ ++ LE+ GA
Sbjct: 235 EELACLLMDFGADTQAKNAEGKRPVELVP-PESPLAQLFLEREGA 278
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 4e-20
Identities = 20/77 (25%), Positives = 35/77 (45%), Gaps = 1/77 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ L+ G +++ + T L++A V LLE GADV+ + + +PL +
Sbjct: 173 VNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVN-QGKGQDSPLHAVVR 231
Query: 116 YKNHEVIKLLEKHGAKP 132
+ E+ LL GA
Sbjct: 232 TASEELACLLMDFGADT 248
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 3e-19
Identities = 28/107 (26%), Positives = 43/107 (40%), Gaps = 6/107 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+N + D P L + +K LL G VN D T L A G
Sbjct: 83 WAVNIITADHV--SP---LHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGS 137
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ V+LLL+ GA V P+ ++P+ +A + E + L +G
Sbjct: 138 WDCVNLLLQHGASVQPESD-LASPIHEAARRGHVECVNSLIAYGGNI 183
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 7e-18
Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 6/107 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++NG+ D P L + + LL G V + D + +H AA +G
Sbjct: 116 AQVNGVTADWH--TP---LFNACVSGSWDCVNLLLQHGASVQ-PESDLASPIHEAARRGH 169
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
E V+ L+ G ++D K TPL A + +K L + GA
Sbjct: 170 VECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADV 216
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 1e-17
Identities = 22/84 (26%), Positives = 40/84 (47%), Gaps = 3/84 (3%)
Query: 49 NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108
RD GI+ LL + + + + + + +H AA G + L+ +G V+ +
Sbjct: 38 GPRDFPGIR-LLSNPLMGD--AVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVS 94
Query: 109 PLGDAIYYKNHEVIKLLEKHGAKP 132
PL +A + +K+L KHGA+
Sbjct: 95 PLHEACLGGHLSCVKILLKHGAQV 118
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 56.7 bits (138), Expect = 3e-09
Identities = 12/80 (15%), Positives = 22/80 (27%), Gaps = 12/80 (15%)
Query: 56 IKELLDSGIDVNFRD-----IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
L+ G + D +D G LL D +P+
Sbjct: 11 SSGLVPRGSHMASMDGKQGGMDGSKPAGPRDFPGI-----RLLSNPLMGDAVS--DWSPM 63
Query: 111 GDAIYYKNHEVIKLLEKHGA 130
+A + + ++ L G
Sbjct: 64 HEAAIHGHQLSLRNLISQGW 83
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 3e-08
Identities = 7/45 (15%), Positives = 17/45 (37%), Gaps = 1/45 (2%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
L+D G D ++ + + + + + + L GA +
Sbjct: 238 ACLLMDFGADTQAKNAEGKRPVELVPPESPLAQL-FLEREGASLP 281
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 7e-24
Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 33/198 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYLPKG 235
A+K++ IS A R E+ALL++++HPNV+ + + + +Y
Sbjct: 51 YALKQIEGTGISMS----ACR-EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 104
Query: 236 DLRAFLK---------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL- 285
DL +K + L I G++YLH N ++HRDL+P+NIL
Sbjct: 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILV 161
Query: 286 ---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-----YVAPEV-FKNEEYDTKVD 336
+ G +K+AD G ++L +PL D Y APE+ Y +D
Sbjct: 162 MGEGPERGRVKIADMGFARLFNS-PLKPLA--DLDPVVVTFWYRAPELLLGARHYTKAID 218
Query: 337 VFSFALILQEMIEGCPPF 354
+++ I E++ P F
Sbjct: 219 IWAIGCIFAELLTSEPIF 236
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 14/183 (7%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
A+K L + + F +E ++ P VVQ A + +V EY+P GDL
Sbjct: 98 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL- 156
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
L + A + ++ ++ +H IHRD++P N+L D SG+LK+ADFG
Sbjct: 157 VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213
Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGC 351
+ + DT+ Y++PEV K++ Y + D +S + L EM+ G
Sbjct: 214 TCMKMNKEGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
Query: 352 PPF 354
PF
Sbjct: 271 TPF 273
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 50/203 (24%), Positives = 81/203 (39%), Gaps = 35/203 (17%)
Query: 174 RGIQVAVKKLGEEVISDDDRV---------RAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
GI VA+K++ V R R E+ LL HPN++
Sbjct: 45 EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-EIRLLNHFHHPNILGLRDIFVHFEE 103
Query: 225 MM-----IVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
+VTE + DL + ++ + P F I G++ LHE ++HRD
Sbjct: 104 PAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRD 159
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEY 331
L P NIL D+ ++ + DF +++ D T YV APE+ + + +
Sbjct: 160 LHPGNILLADNNDITICDFNLAR--EDTADANKT------HYVTHRWYRAPELVMQFKGF 211
Query: 332 DTKVDVFSFALILQEMIEGCPPF 354
VD++S ++ EM F
Sbjct: 212 TKLVDMWSAGCVMAEMFNRKALF 234
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 97.5 bits (244), Expect = 2e-23
Identities = 30/105 (28%), Positives = 48/105 (45%), Gaps = 4/105 (3%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A +N +++G P L + ++ LL G D R + T +AA G
Sbjct: 29 ANVNFQEEEGGWT-P---LHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGS 84
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+++ L L +GADV+ D +G T +A Y + +K L K GA
Sbjct: 85 VKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGA 129
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 5e-22
Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNR-TALHVAACQGFTEVVSLLLERGADVDPK 102
L+ DV+ +++LL+ G +VNF++ + T LH A ++V LLL GAD +
Sbjct: 9 LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLR 68
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ G+TP A + +++KL GA
Sbjct: 69 KKNGATPFLLAAIAGSVKLLKLFLSKGA 96
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 3e-21
Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 10/112 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKE----LLDSGIDVNFRDIDNRTALHVAA 81
A++N D+ G L+ D ++ LLD G DVN R +T L +A
Sbjct: 173 ADVNACDNMGR--NA---LIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAV 227
Query: 82 CQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ +V LLE+ +++ D G T L A+ K ++ +LL K GA
Sbjct: 228 EKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAST 279
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 1e-18
Identities = 34/116 (29%), Positives = 51/116 (43%), Gaps = 16/116 (13%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+ +G P + A V+ +K L G DVN D TA AA G
Sbjct: 63 ADPVLRKKNGA--TP---FLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGK 117
Query: 86 TEVVSLLLERGADVDPKD----------RWGSTPLGDAIYYKNHEVIK-LLEKHGA 130
+ + L +RGA+V+ + + G+T L DA + EV+K LL++ GA
Sbjct: 118 VKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGA 173
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 9e-16
Identities = 37/120 (30%), Positives = 49/120 (40%), Gaps = 20/120 (16%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN----------RT 75
A++N D G M A V+ +K L G +VN R T
Sbjct: 96 ADVNECDFYGF--TA---FMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGAT 150
Query: 76 ALHVAACQGFTEVVSLLL-ERGADVDPKDRWGSTPLGDAIYYKNH----EVIKLLEKHGA 130
AL AA +G EV+ +LL E GADV+ D G L A+ + + LL HGA
Sbjct: 151 ALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGA 210
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 1e-15
Identities = 19/62 (30%), Positives = 35/62 (56%), Gaps = 1/62 (1%)
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKH 128
+++ L A ++V LLE GA+V+ ++ G TPL +A+ ++++LL +H
Sbjct: 2 AVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRH 61
Query: 129 GA 130
GA
Sbjct: 62 GA 63
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 5e-13
Identities = 22/79 (27%), Positives = 40/79 (50%), Gaps = 6/79 (7%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
A++N + G+ P L+ ++ + ++ LL+ I++N D D +TAL +A
Sbjct: 210 ADVNVRGERGK--TP---LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELK 264
Query: 85 FTEVVSLLLERGADVDPKD 103
++ LL +RGA D D
Sbjct: 265 LKKIAELLCKRGASTDCGD 283
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 98.7 bits (247), Expect = 2e-23
Identities = 35/106 (33%), Positives = 53/106 (50%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
A+ + ++ L+ A + E + LL ++ + D T LH+AA
Sbjct: 15 AKAVLTGEYKKDE-----LLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYN 69
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+V LLL+ GADV KD+ G PL +A Y ++EV +LL KHGA
Sbjct: 70 RVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGA 115
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 8e-23
Identities = 35/89 (39%), Positives = 42/89 (47%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A V ++ LL G DV+ +D LH A G EV LLL+ GA V+ D
Sbjct: 62 LHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMD 121
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
W TPL +A EV LL HGA P
Sbjct: 122 LWQFTPLHEAASKNRVEVCSLLLSHGADP 150
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 9e-22
Identities = 25/77 (32%), Positives = 41/77 (53%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ LL G +VN ++ D T LHVAA + +V+ +L + GA ++ D G T L A
Sbjct: 230 AELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTALHRAAL 289
Query: 116 YKNHEVIKLLEKHGAKP 132
+ + +LL +G+ P
Sbjct: 290 AGHLQTCRLLLSYGSDP 306
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 6e-21
Identities = 32/110 (29%), Positives = 45/110 (40%), Gaps = 6/110 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+++ D G P L + E + LL G VN D+ T LH AA +
Sbjct: 82 ADVHAKDKGGL--VP---LHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNR 136
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135
EV SLLL GAD + G + + A + E + K + L A
Sbjct: 137 VEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFKGHS-LLQA 185
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 9e-21
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---TEVVSLLLERGADVD 100
L+ A E D+ +K+ L I + + TALH A +V LLL +GA+V+
Sbjct: 182 LLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVN 241
Query: 101 PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
K++ TPL A +++V+++L KHGAK
Sbjct: 242 EKNKDFMTPLHVAAERAHNDVMEVLHKHGAKM 273
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 5e-19
Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 1/76 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
+L D + L AA G ++++LL + D STPL A
Sbjct: 7 ALDLADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAA 66
Query: 115 YYKNHEVIKLLEKHGA 130
Y +++LL +HGA
Sbjct: 67 GYNRVRIVQLLLQHGA 82
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 82.5 bits (205), Expect = 8e-18
Identities = 19/77 (24%), Positives = 29/77 (37%), Gaps = 5/77 (6%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
++ L G +N D +TALH AA G + LLL G+D G T
Sbjct: 263 MEVLHKHGAKMNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMG-- 320
Query: 116 YKNHEVIKLLEKHGAKP 132
+E ++ +
Sbjct: 321 ---NEAVQQILSESTPM 334
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 9e-14
Identities = 26/131 (19%), Positives = 43/131 (32%), Gaps = 29/131 (22%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVA----- 80
A +N +D P L A++ VE LL G D + ++A+ +A
Sbjct: 115 ACVNAMDLWQF--TP---LHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPEL 169
Query: 81 ----------------ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA---IYYKNHEV 121
A + V L + + T L A ++ K +V
Sbjct: 170 RERLTYEFKGHSLLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQV 229
Query: 122 IKLLEKHGAKP 132
+LL + GA
Sbjct: 230 AELLLRKGANV 240
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 61.7 bits (151), Expect = 9e-11
Identities = 17/83 (20%), Positives = 28/83 (33%), Gaps = 10/83 (12%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N LD G+ L A ++ + LL G D + + TA +
Sbjct: 271 AKMNALDSLGQTA-----LHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGN---- 321
Query: 86 TEVVSLLLERGADVDPKDRWGST 108
E V +L + D
Sbjct: 322 -EAVQQILSESTPMRTSDVDYRL 343
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 2e-05
Identities = 9/60 (15%), Positives = 17/60 (28%), Gaps = 14/60 (23%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH-EVIKLLEKHGA 130
++AL L + A + L +A N +++ LL
Sbjct: 3 FGKSALD-------------LADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNV 49
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 53/192 (27%), Positives = 82/192 (42%), Gaps = 27/192 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
VA+KKL + RA+R EL L++ + H N++ L T + +V
Sbjct: 87 DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
E + +L ++ + L + G+ +LH IIHRDL+PSNI+
Sbjct: 146 MELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 199
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEVFKNEEYDTKVDVFSFAL 342
LK+ DFG+++ T +T YV APEV Y VD++S
Sbjct: 200 DCTLKILDFGLAR--TAGTSFMMT------PYVVTRYYRAPEVILGMGYKENVDIWSVGC 251
Query: 343 ILQEMIEGCPPF 354
I+ EM+ F
Sbjct: 252 IMGEMVRHKILF 263
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 92.4 bits (231), Expect = 3e-23
Identities = 38/87 (43%), Positives = 51/87 (58%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A E +K+LL G DVN R D T LH+AA G E+V LLL +GADV+ +
Sbjct: 13 LHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARS 72
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ G+TP A +HE++KLL+ GA
Sbjct: 73 KDGNTPEHLAKKNGHHEIVKLLDAKGA 99
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 78.6 bits (195), Expect = 3e-18
Identities = 27/68 (39%), Positives = 35/68 (51%), Gaps = 2/68 (2%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G D T LH AA G E V LL +GADV+ + + G+TPL A + E++
Sbjct: 1 GHMWG--SKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIV 58
Query: 123 KLLEKHGA 130
KLL GA
Sbjct: 59 KLLLAKGA 66
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 74.0 bits (183), Expect = 1e-16
Identities = 30/85 (35%), Positives = 38/85 (44%), Gaps = 5/85 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N DG P L A E +K LL G DVN R D T H+A G
Sbjct: 33 ADVNARSKDGN--TP---LHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGH 87
Query: 86 TEVVSLLLERGADVDPKDRWGSTPL 110
E+V LL +GADV+ + S
Sbjct: 88 HEIVKLLDAKGADVNARSWGSSHHH 112
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 95.6 bits (239), Expect = 4e-23
Identities = 28/113 (24%), Positives = 54/113 (47%), Gaps = 6/113 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N +DD G+ L + A +V+ LL +G + + ++ T L +AA +G
Sbjct: 116 ADVNAVDDLGK--SA---LHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGS 170
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
E +LL+ A+ D D P A +H++++LL+++ +H
Sbjct: 171 YETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDEYNLVRS-PQLH 222
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 91.3 bits (228), Expect = 1e-21
Identities = 27/87 (31%), Positives = 44/87 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A +++L++S DVN D ++ALH AA + +LL+ GA+ D ++
Sbjct: 96 LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 155
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
TPL A ++E K+L H A
Sbjct: 156 NREETPLFLAAREGSYETAKVLLDHFA 182
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 86.7 bits (216), Expect = 6e-20
Identities = 25/90 (27%), Positives = 37/90 (41%), Gaps = 1/90 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPK 102
L A + K LL++ D N +D RT LH A V +L+ A D+D +
Sbjct: 29 LHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDAR 88
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G+TPL A +++ L A
Sbjct: 89 MHDGTTPLILAARLAVEGMLEDLINSHADV 118
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 85.9 bits (214), Expect = 1e-19
Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 1/77 (1%)
Query: 56 IKELLDSGIDV-NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
I + + G + N D TALH+AA ++ LLE AD + +D G TPL A+
Sbjct: 7 ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 66
Query: 115 YYKNHEVIKLLEKHGAK 131
V ++L ++ A
Sbjct: 67 SADAQGVFQILIRNRAT 83
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 83.6 bits (208), Expect = 6e-19
Identities = 27/106 (25%), Positives = 44/106 (41%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
A+ N D+ G P L + + L+ + D++ R D T L +AA
Sbjct: 49 ADANIQDNMGR--TP---LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLA 103
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
++ L+ ADV+ D G + L A N + +L K+GA
Sbjct: 104 VEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGA 149
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 50.9 bits (123), Expect = 1e-07
Identities = 14/48 (29%), Positives = 21/48 (43%), Gaps = 1/48 (2%)
Query: 84 GFTEVVSLLLERGADV-DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
V+S + +GA + + DR G T L A Y + K L + A
Sbjct: 2 DAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASA 49
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 4e-23
Identities = 32/107 (29%), Positives = 47/107 (43%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
G + G P L + + +K LL G N ++ T LH+AA G
Sbjct: 5 ISGGGGGESGL--TP---LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGH 59
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
TEV LL+ A V+ K + TPL A + ++KLL ++ A P
Sbjct: 60 TEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANP 106
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 32/107 (29%), Positives = 45/107 (42%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
N G P L A E E + LL + N + T LH+ A +G
Sbjct: 236 GSANAESVQGV--TP---LHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGH 290
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V +L++ G VD R G TPL A +Y N +++K L +H A
Sbjct: 291 VPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADV 337
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 5/109 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
K+A N + G P L +A E V L+ G+ V+ T LHVA+
Sbjct: 267 KQANGNLGNKSGL--TP---LHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHY 321
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G ++V LL+ ADV+ K + G +PL A + +++ LL K+GA P
Sbjct: 322 GNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASP 370
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 36/107 (33%), Positives = 46/107 (42%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A N G P L A E VE + LL+ T LHVAA G
Sbjct: 104 ANPNLATTAGH--TP---LHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGK 158
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V LLLER A + + G TPL A+++ N +++KLL G P
Sbjct: 159 VRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSP 205
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 29/109 (26%), Positives = 46/109 (42%), Gaps = 5/109 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
++A N +G P L + +++ +K LL G + + T LH+AA Q
Sbjct: 168 RDAHPNAAGKNGL--TP---LHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQ 222
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
EV LL+ G + + G TPL A + E++ LL A
Sbjct: 223 NQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANG 271
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 4e-22
Identities = 33/110 (30%), Positives = 48/110 (43%), Gaps = 5/110 (4%)
Query: 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
+ +A++N D + P L A +K LL++ + N T LH+AA
Sbjct: 68 QNKAKVNAKAKDDQT--P---LHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAR 122
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+G E V LLE+ A + G TPL A Y V +LL + A P
Sbjct: 123 EGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHP 172
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 96.0 bits (240), Expect = 4e-22
Identities = 31/109 (28%), Positives = 40/109 (36%), Gaps = 5/109 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
KEA + G P L A V + LL+ N + T LHVA
Sbjct: 135 KEASQACMTKKGF--TP---LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHH 189
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
++V LLL RG G TPL A EV + L ++G
Sbjct: 190 NNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSA 238
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 95.6 bits (239), Expect = 7e-22
Identities = 34/109 (31%), Positives = 46/109 (42%), Gaps = 5/109 (4%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+ A N + E P L A E K LL + VN + D++T LH AA
Sbjct: 36 RGASPNVSNVKVE--TP---LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARI 90
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G T +V LLLE A+ + G TPL A + E + L + A
Sbjct: 91 GHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQ 139
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 9e-22
Identities = 29/106 (27%), Positives = 48/106 (45%), Gaps = 5/106 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++ G P L ++ +++ +K LL DVN + + LH AA QG
Sbjct: 302 VMVDATTRMGY--TP---LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGH 356
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
T++V+LLL+ GA + G+TPL A V +L+ +
Sbjct: 357 TDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDE 402
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 93.3 bits (233), Expect = 4e-21
Identities = 31/107 (28%), Positives = 47/107 (43%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ +G P L A + VE + LL G N + T LH+AA +G
Sbjct: 203 GSPHSPAWNGY--TP---LHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGH 257
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
E+V+LLL + A+ + ++ G TPL + V +L KHG
Sbjct: 258 AEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMV 304
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 24/70 (34%), Positives = 32/70 (45%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
GI T LHVA+ G +V LL+RGA + + TPL A + EV
Sbjct: 4 GISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVA 63
Query: 123 KLLEKHGAKP 132
K L ++ AK
Sbjct: 64 KYLLQNKAKV 73
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 2e-05
Identities = 11/38 (28%), Positives = 16/38 (42%)
Query: 95 RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G G TPL A + + ++K L + GA P
Sbjct: 3 PGISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASP 40
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 5e-23
Identities = 34/141 (24%), Positives = 57/141 (40%), Gaps = 17/141 (12%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ DDG + + D E + LL+ G D+N+ ++D TALH A
Sbjct: 32 KKTKVKFDDGAV------FLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDN 85
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PLMA 135
++V L+E GA+++ D G PL A ++ + L GA PL
Sbjct: 86 VDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDI 145
Query: 136 PMHVKHAREVPEYEIDPHELD 156
E+ + E++ +D
Sbjct: 146 AEEEAM-EELLQNEVNRQGVD 165
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 5e-21
Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 1/78 (1%)
Query: 56 IKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
++ L+S I+ TALHVAA +G+TEV+ LL++ DV+ KD G TPL A
Sbjct: 181 ARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAA 240
Query: 115 YYKNHEVIKLLEKHGAKP 132
++ E ++L ++
Sbjct: 241 HWGKEEACRILVENLCDM 258
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 3e-20
Identities = 22/76 (28%), Positives = 35/76 (46%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+K L+ + DVN +D D T LH AA G E +L+E D++ ++ G T A
Sbjct: 215 LKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADE 274
Query: 116 YKNHEVIKLLEKHGAK 131
+ +L +K
Sbjct: 275 DILGYLEELQKKQNLL 290
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 2e-16
Identities = 22/77 (28%), Positives = 35/77 (45%), Gaps = 1/77 (1%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
++ + + D+ A G TE V LLERGAD++ + G T L A
Sbjct: 22 TDLEPPVVKRKKTKVKF-DDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQA 80
Query: 114 IYYKNHEVIKLLEKHGA 130
N +++K L ++GA
Sbjct: 81 CIDDNVDMVKFLVENGA 97
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 4e-13
Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 11/105 (10%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A + ++ +G+ P L E E ++ ++ +D A
Sbjct: 130 AHVGAVNSEGD--TP---LDIAEEEAMEELLQNEVNRQ------GVDIEAARKEEERIML 178
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ L + + G T L A EV+KLL +
Sbjct: 179 RDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARY 223
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 64.8 bits (159), Expect = 5e-12
Identities = 10/67 (14%), Positives = 20/67 (29%), Gaps = 1/67 (1%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
+ D + + G + + + K G+ L A + E + L
Sbjct: 1 MKMADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFL-AACSSGDTEEVLRL 59
Query: 126 EKHGAKP 132
+ GA
Sbjct: 60 LERGADI 66
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 51.3 bits (124), Expect = 1e-07
Identities = 16/78 (20%), Positives = 29/78 (37%), Gaps = 5/78 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++N D DG P L A+ E + L+++ D+ + +TA VA
Sbjct: 223 YDVNIKDYDGWT--P---LHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADEDIL 277
Query: 86 TEVVSLLLERGADVDPKD 103
+ L ++ K
Sbjct: 278 GYLEELQKKQNLLHSEKR 295
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 93.6 bits (234), Expect = 5e-23
Identities = 27/107 (25%), Positives = 46/107 (42%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+ + L + E L + + + LL+ +D+N D + T L A
Sbjct: 60 ADPHILAKERE--SA---LSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNH 114
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ V LL RGAD+ + G TP+ A+ +V +++E H K
Sbjct: 115 VKCVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVIENHILKL 161
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 90.9 bits (227), Expect = 4e-22
Identities = 27/87 (31%), Positives = 50/87 (57%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L++ + ++E ++ LL+ G D + + +AL +A+ G+T++V LLLER D++ D
Sbjct: 40 LIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYD 99
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A+ + + ++ L GA
Sbjct: 100 WNGGTPLLYAVRGNHVKCVEALLARGA 126
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 89.8 bits (224), Expect = 1e-21
Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 44 LMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
+ LA + +++ +KE L G + VN D T L A+ G E V LLE GAD
Sbjct: 6 IHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHIL 65
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ + L A +++ LL +
Sbjct: 66 AKERESALSLASTGGYTDIVGLLLERDVDI 95
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 75.9 bits (188), Expect = 1e-16
Identities = 15/84 (17%), Positives = 33/84 (39%), Gaps = 5/84 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++N D +G P L++ V+ ++ LL G D+ T + +A G+
Sbjct: 93 VDINIYDWNGG--TP---LLYAVRGNHVKCVEALLARGADLTTEADSGYTPMDLAVALGY 147
Query: 86 TEVVSLLLERGADVDPKDRWGSTP 109
+V ++ + + + P
Sbjct: 148 RKVQQVIENHILKLFQSNLVPADP 171
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 68.6 bits (169), Expect = 6e-14
Identities = 18/61 (29%), Positives = 30/61 (49%), Gaps = 1/61 (1%)
Query: 73 NRTALHVAACQGFTEVVSLLLERGAD-VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+ ++H A QG + + L +G + V+ D G TPL A + E ++ L + GA
Sbjct: 2 DSLSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGAD 61
Query: 132 P 132
P
Sbjct: 62 P 62
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 95.6 bits (239), Expect = 6e-23
Identities = 27/105 (25%), Positives = 50/105 (47%), Gaps = 5/105 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N +DD G+ L + A +V+ LL +G + + ++ T L +AA +G
Sbjct: 148 ADVNAVDDLGK--SA---LHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGS 202
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
E +LL+ A+ D D P A +H++++LL+
Sbjct: 203 YETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDLEHH 247
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 1e-21
Identities = 27/87 (31%), Positives = 44/87 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A +++L++S DVN D ++ALH AA + +LL+ GA+ D ++
Sbjct: 128 LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 187
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
TPL A ++E K+L H A
Sbjct: 188 NREETPLFLAAREGSYETAKVLLDHFA 214
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 87.1 bits (217), Expect = 6e-20
Identities = 27/106 (25%), Positives = 44/106 (41%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
A+ N D+ G P L + + L+ + D++ R D T L +AA
Sbjct: 81 ADANIQDNMGR--TP---LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLA 135
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
++ L+ ADV+ D G + L A N + +L K+GA
Sbjct: 136 VEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGA 181
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-19
Identities = 25/88 (28%), Positives = 37/88 (42%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPK 102
L A + K LL++ D N +D RT LH A V +L+ A D+D +
Sbjct: 61 LHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDAR 120
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G+TPL A +++ L A
Sbjct: 121 MHDGTTPLILAARLAVEGMLEDLINSHA 148
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 82.9 bits (206), Expect = 2e-18
Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 1/77 (1%)
Query: 56 IKELLDSGIDV-NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
I + + G + N D TALH+AA ++ LLE AD + +D G TPL A+
Sbjct: 39 ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 98
Query: 115 YYKNHEVIKLLEKHGAK 131
V ++L ++ A
Sbjct: 99 SADAQGVFQILIRNRAT 115
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 72.9 bits (180), Expect = 7e-15
Identities = 24/83 (28%), Positives = 34/83 (40%), Gaps = 14/83 (16%)
Query: 64 IDVNFRDIDNRTALHVAACQGFT-------------EVVSLLLERGADV-DPKDRWGSTP 109
+DVN R D T L +A+C G V+S + +GA + + DR G T
Sbjct: 1 MDVNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETA 60
Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
L A Y + K L + A
Sbjct: 61 LHLAARYSRSDAAKRLLEASADA 83
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 56.3 bits (137), Expect = 3e-09
Identities = 17/77 (22%), Positives = 27/77 (35%), Gaps = 5/77 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A + ++ E P L A E E K LLD + + D +R +A +
Sbjct: 181 ANKDMQNNREE--TP---LFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMH 235
Query: 86 TEVVSLLLERGADVDPK 102
++V LL
Sbjct: 236 HDIVRLLDLEHHHHHHH 252
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 8e-23
Identities = 59/193 (30%), Positives = 89/193 (46%), Gaps = 29/193 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
G +VA+KKL S+ RA+R EL LL+ +RH NV+ L T + +V
Sbjct: 50 GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
++ DL +K + L + +G+ Y+H IIHRDL+P N+ ++
Sbjct: 109 MPFMGT-DLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNE 163
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFA 341
LK+ DFG+++ + D +T YV APEV Y VD++S
Sbjct: 164 DCELKILDFGLAR----QADSEMT------GYVVTRWYRAPEVILNWMRYTQTVDIWSVG 213
Query: 342 LILQEMIEGCPPF 354
I+ EMI G F
Sbjct: 214 CIMAEMITGKTLF 226
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 9e-23
Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 2/108 (1%)
Query: 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
RK P L+ A ++E +++ + D + + + TALH A C
Sbjct: 6 RKAGSPRKARRARLN--PLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAIC 63
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+V L+ GA+V+ D G TPL A + + L +HGA
Sbjct: 64 GANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGA 111
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-18
Identities = 20/109 (18%), Positives = 37/109 (33%), Gaps = 8/109 (7%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ + +++G L + + L+ +G +VN D T LH AA
Sbjct: 45 NDPSQPNEEGI--TA---LHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCND 99
Query: 86 TEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKN--HEVIKLLEKHGAK 131
T + L++ GA + G+T Y+ + L
Sbjct: 100 TVICMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCATYLADVEQS 148
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 10/67 (14%), Positives = 18/67 (26%), Gaps = 1/67 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
L D + + AL + F + +S V +D T A
Sbjct: 139 ATYLADVEQSMGLMNSGAVYALWDYS-AEFGDELSFREGESVTVLRRDGPEETDWWWAAL 197
Query: 116 YKNHEVI 122
+ +
Sbjct: 198 HGQEGYV 204
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 11/88 (12%), Positives = 21/88 (23%), Gaps = 7/88 (7%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
E + ++ ++ + + + + V RD T AA
Sbjct: 145 VEQSMGLMNSGAVY------ALWDYSAEFGDELSFREGESVTVLRRDGPEETDWWWAALH 198
Query: 84 GFTEVV-SLLLERGADVDPKDRWGSTPL 110
G V V P+
Sbjct: 199 GQEGYVPRNYFGLFPRVKPQRSKVKHHH 226
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 6e-05
Identities = 9/47 (19%), Positives = 14/47 (29%), Gaps = 3/47 (6%)
Query: 89 VSLLLERGADVDPKDRW---GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ +L + R L DA EV++ K P
Sbjct: 1 MRSVLRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDP 47
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 90.1 bits (225), Expect = 1e-22
Identities = 40/74 (54%), Positives = 50/74 (67%)
Query: 57 KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
K LL++G DVN +D + RT LH+AA G EVV LLLE GADV+ KD+ G TPL A
Sbjct: 19 KLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 78
Query: 117 KNHEVIKLLEKHGA 130
+ EV+KLL + GA
Sbjct: 79 GHLEVVKLLLEAGA 92
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 75.1 bits (186), Expect = 4e-17
Identities = 32/59 (54%), Positives = 39/59 (66%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ RT LH+AA G EVV LLLE GADV+ KD+ G TPL A + EV+KLL + GA
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 53.5 bits (130), Expect = 2e-09
Identities = 32/74 (43%), Positives = 42/74 (56%), Gaps = 5/74 (6%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
A++N D +G P L A +E +K LL++G DVN +D + RT LH+AA
Sbjct: 24 AGADVNAKDKNGR--TP---LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 78
Query: 84 GFTEVVSLLLERGA 97
G EVV LLLE GA
Sbjct: 79 GHLEVVKLLLEAGA 92
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 92.1 bits (230), Expect = 1e-22
Identities = 32/87 (36%), Positives = 48/87 (55%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A + LL +G+ + R +RT LH+AA +G +V +LL+ GADV+ KD
Sbjct: 38 LHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKD 97
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
T L A + + EV++LL K+GA
Sbjct: 98 MLKMTALHWATEHNHQEVVELLIKYGA 124
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 87.1 bits (217), Expect = 8e-21
Identities = 28/83 (33%), Positives = 44/83 (53%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A+E ++ LL G DVN +D+ TALH A EVV LL++ GADV +
Sbjct: 71 LHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQS 130
Query: 104 RWGSTPLGDAIYYKNHEVIKLLE 126
++ T +I N ++ ++L+
Sbjct: 131 KFCKTAFDISIDNGNEDLAEILQ 153
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 86.7 bits (216), Expect = 1e-20
Identities = 23/87 (26%), Positives = 39/87 (44%), Gaps = 1/87 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A + ++ L+ +G D + LH+AA G +LL G D +
Sbjct: 6 LLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDART 64
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ TPL A + ++++L KHGA
Sbjct: 65 KVDRTPLHMAASEGHANIVEVLLKHGA 91
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 70.5 bits (174), Expect = 6e-15
Identities = 17/59 (28%), Positives = 26/59 (44%), Gaps = 1/59 (1%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
D L AA G + V +L+ GA D G++PL A Y + ++L + G
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGV 58
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 92.9 bits (232), Expect = 1e-22
Identities = 20/85 (23%), Positives = 33/85 (38%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+++LL D+N + LH A G +V L+ GA V +++G P+ A
Sbjct: 88 VQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAKA 147
Query: 116 YKNHEVIKLLEKHGAKPLMAPMHVK 140
+ + EK G P
Sbjct: 148 PLRELLRERAEKMGQNLNRIPYKDT 172
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 89.8 bits (224), Expect = 1e-21
Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 5/111 (4%)
Query: 22 ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
+ E +LN DD G P L + E ++ L+ G +N + + T LH+AA
Sbjct: 26 DNTENDLNQGDDHGF--SP---LHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAA 80
Query: 82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G ++V LL+ AD++ + G+ PL A ++ +V + L +GA
Sbjct: 81 SHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALV 131
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 68.2 bits (168), Expect = 7e-14
Identities = 14/62 (22%), Positives = 24/62 (38%), Gaps = 1/62 (1%)
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGA-DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
+ + +G V L L+ D++ D G +PL A V+++L
Sbjct: 2 SPEFMDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMR 61
Query: 129 GA 130
GA
Sbjct: 62 GA 63
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-22
Identities = 24/108 (22%), Positives = 39/108 (36%), Gaps = 8/108 (7%)
Query: 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQG 84
+ +DG+ L + + LL ++ ++ +TALH+AA G
Sbjct: 2 FGYVTEDGD--TA---LHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILG 56
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V L GA V +R G T L A + H +L +
Sbjct: 57 EASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSH 104
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 3e-22
Identities = 36/108 (33%), Positives = 51/108 (47%), Gaps = 6/108 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQG 84
+L + DG P L +D E ++ L D+G D+N + RT LH+A
Sbjct: 149 LQLEAENYDGH--TP---LHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQ 203
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V+ LLL+ GAD + G TPLG A+ N + +LL HGA
Sbjct: 204 AASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPE 251
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 2e-20
Identities = 30/115 (26%), Positives = 47/115 (40%), Gaps = 1/115 (0%)
Query: 19 PDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALH 78
R+ + L D + + + E D + + + D T LH
Sbjct: 104 HPRDASDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLH 163
Query: 79 VAACQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
VA E+V LL + GAD++ + G TPL A+ + V++LL K GA P
Sbjct: 164 VAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADP 218
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 2e-18
Identities = 14/74 (18%), Positives = 26/74 (35%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
++ LL +G D R RT L A + + LL GA +P +
Sbjct: 208 LELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSSSGS 267
Query: 116 YKNHEVIKLLEKHG 129
+ + +++
Sbjct: 268 DSDSDNRDEGDEYD 281
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 14/101 (13%), Positives = 24/101 (23%), Gaps = 14/101 (13%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A + +++L +G V + TALH+A +LL+
Sbjct: 49 LHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDA 108
Query: 104 RWGSTPLGDAIYYKN--------------HEVIKLLEKHGA 130
+E E
Sbjct: 109 SDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRL 149
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 94.0 bits (235), Expect = 2e-22
Identities = 30/88 (34%), Positives = 43/88 (48%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A V+ L+ +G +++ D RT L AA E V L++ GA VDPKD
Sbjct: 15 LHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKD 74
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
GST L A ++EV++ L +G
Sbjct: 75 AEGSTCLHLAAKKGHYEVVQYLLSNGQM 102
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 89.4 bits (223), Expect = 7e-21
Identities = 21/75 (28%), Positives = 34/75 (45%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ LL + D++ +I + LH+AA + + V L L R +DV K++ G TPL A
Sbjct: 160 AEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASL 219
Query: 116 YKNHEVIKLLEKHGA 130
+ K
Sbjct: 220 NSQVWSALQMSKALQ 234
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 89.0 bits (222), Expect = 9e-21
Identities = 21/75 (28%), Positives = 34/75 (45%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+K LL G D+N RD + LH AA G ++ +LL D+ + G +PL A
Sbjct: 127 VKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAAR 186
Query: 116 YKNHEVIKLLEKHGA 130
++ + L +
Sbjct: 187 ENRYDCVVLFLSRDS 201
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 88.6 bits (221), Expect = 2e-20
Identities = 20/67 (29%), Positives = 34/67 (50%)
Query: 64 IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
++ + R+ LH AA G ++ +L++ GA++D TPL +A + E +K
Sbjct: 2 MNFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVK 61
Query: 124 LLEKHGA 130
L K GA
Sbjct: 62 YLIKAGA 68
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 88.2 bits (220), Expect = 2e-20
Identities = 25/108 (23%), Positives = 48/108 (44%), Gaps = 6/108 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
A ++ D +G L A + E ++ LL +G +DVN +D T + A
Sbjct: 68 ALVDPKDAEGS--TC---LHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYK 122
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
++V LLL +G+D++ +D + L A + ++ ++L
Sbjct: 123 HVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDL 170
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 54.0 bits (131), Expect = 1e-08
Identities = 13/75 (17%), Positives = 27/75 (36%), Gaps = 5/75 (6%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+ +L+ ++ G+ P L A E + + L DV ++ + T L A+
Sbjct: 166 AKCDLHAVNIHGD--SP---LHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASLN 220
Query: 84 GFTEVVSLLLERGAD 98
+ + D
Sbjct: 221 SQVWSALQMSKALQD 235
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 91.7 bits (229), Expect = 2e-22
Identities = 26/77 (33%), Positives = 39/77 (50%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
E + LL G + + +D +H AA GF + + LLE ADV+ +D G+ PL A
Sbjct: 51 EIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLA 110
Query: 114 IYYKNHEVIKLLEKHGA 130
+ V++ L KH A
Sbjct: 111 AKEGHLRVVEFLVKHTA 127
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 87.4 bits (218), Expect = 8e-21
Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 1/87 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A D+E + LL + ++VN ++ RTAL V G E+ LL RGA+ D KD
Sbjct: 9 LASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKD 67
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
R G + DA + ++ L + A
Sbjct: 68 RTGFAVIHDAARAGFLDTLQTLLEFQA 94
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 87.1 bits (217), Expect = 9e-21
Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A + D G + A ++ ++ LL+ DVN D + LH+AA +G
Sbjct: 61 ANPDLKDRTGF--AV---IHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGH 115
Query: 86 TEVVSLLLERGA-DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
VV L++ A +V ++ G T A Y +EV+ L++ +GA
Sbjct: 116 LRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANGA 161
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 70.9 bits (175), Expect = 7e-15
Identities = 17/61 (27%), Positives = 28/61 (45%), Gaps = 1/61 (1%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
L AA +G E ++ LL+ +V+ ++ +G T L N E+ + L GA
Sbjct: 4 PWGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGAN 62
Query: 132 P 132
P
Sbjct: 63 P 63
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 69/246 (28%), Positives = 107/246 (43%), Gaps = 41/246 (16%)
Query: 134 MAPMHVKHAREVPEY---EIDPHELDFTNSVEITK-------GTFILAFWR--GIQVAVK 181
MA H H++E P + E++ + + G+ AF G++VAVK
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 182 KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IVTEYLPKG 235
KL S R +R EL LL+ ++H NV+ L T + + +VT +
Sbjct: 61 KLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA- 118
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
DL +K + L I RG+ Y+H IIHRDL+PSN+ ++ LK+
Sbjct: 119 DLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 174
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFALILQEMI 348
DFG++ R + T YV APE+ Y+ VD++S I+ E++
Sbjct: 175 DFGLA--------RHTADEMTG--YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 349 EGCPPF 354
G F
Sbjct: 225 TGRTLF 230
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-22
Identities = 19/120 (15%), Positives = 36/120 (30%), Gaps = 18/120 (15%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANE------RDVEGIKELLDSGIDVNFRDIDNRTALHV 79
A++ +G L E K L+ G D+ + +
Sbjct: 66 ADIKSRTKEGT--TL---FFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFK 120
Query: 80 AACQGFTEVVS-------LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
F + + + G + KD+WG T L + +K++E + K
Sbjct: 121 NIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKKY 180
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 9e-16
Identities = 16/96 (16%), Positives = 34/96 (35%), Gaps = 9/96 (9%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN---RTALHVAACQGFTEVVSLLLERGADVD 100
+ A E EL + G + + + L + ++ L+ +GAD+
Sbjct: 10 VSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFLINKGADIK 69
Query: 101 PKDRWGSTPLGDAIYYKNH------EVIKLLEKHGA 130
+ + G+T + E+ K+ + GA
Sbjct: 70 SRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGA 105
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-11
Identities = 10/85 (11%), Positives = 25/85 (29%), Gaps = 12/85 (14%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKE-------LLDSGIDVNFRDIDNRTALH 78
A++ L + + V+ + SG+ + +D TAL
Sbjct: 105 ADITALYKPYK--IV---VFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALE 159
Query: 79 VAACQGFTEVVSLLLERGADVDPKD 103
+ ++ + + K+
Sbjct: 160 FVKRCQKPIALKMMEDYIKKYNLKE 184
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-08
Identities = 12/63 (19%), Positives = 20/63 (31%), Gaps = 3/63 (4%)
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADV---DPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
+ + AA G E L E+G + K L + +++ L
Sbjct: 4 MSEYRTVSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFLIN 63
Query: 128 HGA 130
GA
Sbjct: 64 KGA 66
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 91.7 bits (229), Expect = 3e-22
Identities = 35/89 (39%), Positives = 46/89 (51%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L F A V ++ LL G DV+ +D LH A G EV LL++ GA V+ D
Sbjct: 46 LHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVAD 105
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
W TPL +A +E+ KLL +HGA P
Sbjct: 106 LWKFTPLHEAAAKGKYEICKLLLQHGADP 134
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 85.5 bits (213), Expect = 4e-20
Identities = 28/72 (38%), Positives = 39/72 (54%), Gaps = 1/72 (1%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
L+ G VN D+ T LH AA +G E+ LLL+ GAD K+R G+TPL D + +
Sbjct: 94 LVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPL-DLVKDGD 152
Query: 119 HEVIKLLEKHGA 130
++ LL A
Sbjct: 153 TDIQDLLRGDAA 164
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 84.7 bits (211), Expect = 8e-20
Identities = 35/88 (39%), Positives = 47/88 (53%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L+ A DVE +K+L ++ + T LH AA VV LL+ GADV K
Sbjct: 12 LLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAK 71
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
D+ G PL +A Y ++EV +LL KHGA
Sbjct: 72 DKGGLVPLHNACSYGHYEVAELLVKHGA 99
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 69.0 bits (170), Expect = 4e-14
Identities = 20/69 (28%), Positives = 26/69 (37%), Gaps = 4/69 (5%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEV 121
G N + L AA G E V L + + STPL A Y V
Sbjct: 1 GAMGN---SEADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSV 57
Query: 122 IKLLEKHGA 130
++ L +HGA
Sbjct: 58 VEYLLQHGA 66
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 47.0 bits (113), Expect = 1e-06
Identities = 20/72 (27%), Positives = 27/72 (37%), Gaps = 6/72 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A +N D P L A + E K LL G D ++ D T L + G
Sbjct: 99 AVVNVADLWKF--TP---LHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLVK-DGD 152
Query: 86 TEVVSLLLERGA 97
T++ LL A
Sbjct: 153 TDIQDLLRGDAA 164
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 47/216 (21%), Positives = 84/216 (38%), Gaps = 32/216 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVT 229
VA+KK+ D R R E+ +L +++ +++ + + IV
Sbjct: 51 EKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
E DL+ K L ++ G N++HE+ IIHRDL+P+N L +
Sbjct: 110 EIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQD 165
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR---------------YV------APEV-FK 327
++KV DFG+++ + ++D + +V APE+
Sbjct: 166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225
Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
E Y +D++S I E++ N P
Sbjct: 226 QENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 90.9 bits (227), Expect = 3e-22
Identities = 26/88 (29%), Positives = 45/88 (51%), Gaps = 2/88 (2%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L A DV+ ++ LL + + + +TAL V G T + LL++GA + +
Sbjct: 6 LSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQ 64
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
D G++P+ DA + +K+L +HGA
Sbjct: 65 DTSGTSPVHDAARTGFLDTLKVLVEHGA 92
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 89.4 bits (223), Expect = 1e-21
Identities = 23/73 (31%), Positives = 36/73 (49%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
ELL G N +D + +H AA GF + + +L+E GADV+ D G+ P+ A+
Sbjct: 51 ALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQ 110
Query: 116 YKNHEVIKLLEKH 128
+ V+ L
Sbjct: 111 EGHTAVVSFLAAE 123
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 85.2 bits (212), Expect = 5e-20
Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 6/103 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A N D G P + A ++ +K L++ G DVN D +H+A +G
Sbjct: 59 ASPNVQDTSGT--SP---VHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGH 113
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
T VVS L +D+ +D G TPL A+ +++ +L+ H
Sbjct: 114 TAVVSFLAA-ESDLHRRDARGLTPLELALQRGAQDLVDILQGH 155
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 63.2 bits (155), Expect = 3e-12
Identities = 17/60 (28%), Positives = 24/60 (40%), Gaps = 4/60 (6%)
Query: 75 TALHVAACQGFTEVV-SLLLERGADVDPKDRWGSTPLGDAIYYKNH-EVIKLLEKHGAKP 132
L AA +G + V LL D +R+G T L ++ + L K GA P
Sbjct: 4 DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMF--GSTAIALELLKQGASP 61
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 92.5 bits (231), Expect = 3e-22
Identities = 24/88 (27%), Positives = 44/88 (50%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L+ AN+RD + +KE+L V+ D + T L++A E+ L++RGAD++ +
Sbjct: 9 LLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQ 68
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ +P A E++ + KH
Sbjct: 69 NSISDSPYLYAGAQGRTEILAYMLKHAT 96
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 81.7 bits (203), Expect = 2e-18
Identities = 28/91 (30%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 44 LMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAAC-----QGFTEVVSLLLERGA 97
L+ A + ++ +K LL+ G D++F++ TAL A Q + ++V LL+E GA
Sbjct: 110 LIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGNQLYQDIVKLLMENGA 169
Query: 98 DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
D KD G T + A E+ K+L ++
Sbjct: 170 DQSIKDNSGRTAMDYANQKGYTEISKILAQY 200
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 3e-17
Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 7/82 (8%)
Query: 56 IKELLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGSTPLGDA 113
+ +L D+N + AL AA +G + V LLLE G D+D ++ +G T L +A
Sbjct: 88 LAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEA 147
Query: 114 IYY----KNH-EVIKLLEKHGA 130
+ + + +++KLL ++GA
Sbjct: 148 VGLREGNQLYQDIVKLLMENGA 169
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 76.7 bits (190), Expect = 1e-16
Identities = 17/62 (27%), Positives = 28/62 (45%)
Query: 69 RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
+ + L A + +V +L + VD D G+TPL A++ + E+ K L
Sbjct: 2 KTYEVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDR 61
Query: 129 GA 130
GA
Sbjct: 62 GA 63
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 91.3 bits (228), Expect = 3e-22
Identities = 33/87 (37%), Positives = 51/87 (58%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A + ++ L+ +G DVN D T LH+AA G E+V +LL+ GADV+ D
Sbjct: 18 LLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVD 77
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A + + E++++L K+GA
Sbjct: 78 HAGMTPLRLAALFGHLEIVEVLLKNGA 104
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 90.5 bits (226), Expect = 6e-22
Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N D G P L A +E ++ LL +G DVN D T L +AA G
Sbjct: 38 ADVNAEDASGW--TP---LHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGH 92
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
E+V +LL+ GADV+ D G TPL A + + E++++L K+GA
Sbjct: 93 LEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGA 137
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 89.3 bits (223), Expect = 2e-21
Identities = 36/103 (34%), Positives = 59/103 (57%), Gaps = 5/103 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N +D G P L A +E ++ LL +G DVN D++ T LH+AA G
Sbjct: 71 ADVNAVDHAGM--TP---LRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGH 125
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
E+V +LL+ GADV+ +D++G T +I N ++ ++L+K
Sbjct: 126 LEIVEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEILQKL 168
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 74.3 bits (184), Expect = 4e-16
Identities = 22/61 (36%), Positives = 34/61 (55%)
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
D L AA G + V +L+ GADV+ +D G TPL A + + E++++L K+G
Sbjct: 11 GSDLGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNG 70
Query: 130 A 130
A
Sbjct: 71 A 71
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-22
Identities = 30/107 (28%), Positives = 53/107 (49%), Gaps = 6/107 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQG 84
+++ +D++G L+F+A + ++ L ++G D++ RD+ TALH+AA
Sbjct: 68 RDVDAVDENGR--TA---LLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYV 122
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
EVV L+E GAD++ +D G T L A + G +
Sbjct: 123 RPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRR 169
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-21
Identities = 33/90 (36%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
A + D + + +LL DV+ D + RTAL A G + V LL E GAD+D +D
Sbjct: 49 WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD 107
Query: 104 -RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
R G T L A Y EV++ L + GA
Sbjct: 108 MRGGLTALHMAAGYVRPEVVEALVELGADI 137
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 18/87 (20%), Positives = 35/87 (40%), Gaps = 3/87 (3%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A E ++ L++ G D+ D TAL +A T ++ G + +
Sbjct: 115 LHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEK 174
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ + ++ EV +++EK G
Sbjct: 175 ---VINVLEGQVFEYAEVDEIVEKRGK 198
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 5e-10
Identities = 9/69 (13%), Positives = 17/69 (24%), Gaps = 4/69 (5%)
Query: 64 IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
I + + + G + ADV + TP A + + +
Sbjct: 6 IIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPWWTAARKADEQALS 62
Query: 124 LLEKHGAKP 132
L
Sbjct: 63 QL-LEDRDV 70
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 12/106 (11%), Positives = 27/106 (25%), Gaps = 16/106 (15%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++ D+ G L + G + + + +
Sbjct: 135 ADIEVEDERGL--TA---LELAREILKTTPKGNPMQFGRRIGLEKV---INVLEGQVFEY 186
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
EV ++ +RG G + + + H A+
Sbjct: 187 AEVDEIVEKRGK--------GKDVEYLVRWKDGGDCEWVKGVHVAE 224
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 2e-05
Identities = 4/48 (8%), Positives = 14/48 (29%), Gaps = 2/48 (4%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
++ + + ++ + + + A+ KD L
Sbjct: 189 VDEIVEKRGKGKDVEYLVRWKDGGDCEWVKGVHVAEDVAKD--YEDGL 234
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 90.2 bits (225), Expect = 4e-22
Identities = 21/76 (27%), Positives = 34/76 (44%), Gaps = 1/76 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
+ LL G + N D T +H AA +GF + + +L GA +D D WG P+ A
Sbjct: 60 AELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAE 119
Query: 115 YYKNHEVIKLLEKHGA 130
+ ++ + L
Sbjct: 120 EQGHRDIARYLHAATG 135
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 2e-21
Identities = 27/106 (25%), Positives = 45/106 (42%), Gaps = 7/106 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
++ L + L A VE +++LL++G D N + R + V G
Sbjct: 3 PGIHMLGGSSD--AG---LATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMM-MGS 56
Query: 86 TEVVSLLLERGADVDPKDRWGST-PLGDAIYYKNHEVIKLLEKHGA 130
+V LLL GA+ + D T P+ DA + + +L + GA
Sbjct: 57 AQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGA 102
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 84.8 bits (211), Expect = 4e-20
Identities = 22/71 (30%), Positives = 34/71 (47%), Gaps = 3/71 (4%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH-EV 121
++ + L AA +G E V LLE GAD + +R+G P+ + +V
Sbjct: 2 SPGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM--GSAQV 59
Query: 122 IKLLEKHGAKP 132
+LL HGA+P
Sbjct: 60 AELLLLHGAEP 70
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 59.8 bits (146), Expect = 3e-11
Identities = 16/73 (21%), Positives = 28/73 (38%), Gaps = 4/73 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
AE N D +P + A E ++ + L +G ++ D R + +A QG
Sbjct: 68 AEPNCADPATLT-RP---VHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAEEQGH 123
Query: 86 TEVVSLLLERGAD 98
++ L D
Sbjct: 124 RDIARYLHAATGD 136
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 90.1 bits (225), Expect = 4e-22
Identities = 32/87 (36%), Positives = 50/87 (57%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A + ++ L+ +G DVN +D T L++A G E+V +LL+ GADV+ D
Sbjct: 18 LLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVD 77
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A + + E+ ++L KHGA
Sbjct: 78 AIGFTPLHLAAFIGHLEIAEVLLKHGA 104
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 85.9 bits (214), Expect = 2e-20
Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 5/103 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N D+ G P L +E ++ LL +G DVN D T LH+AA G
Sbjct: 38 ADVNAKDEYGL--TP---LYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGH 92
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
E+ +LL+ GADV+ +D++G T +I N ++ ++L+K
Sbjct: 93 LEIAEVLLKHGADVNAQDKFGKTAFDISIGNGNEDLAEILQKL 135
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 72.4 bits (179), Expect = 1e-15
Identities = 23/59 (38%), Positives = 35/59 (59%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
D L AA G + V +L+ GADV+ KD +G TPL A + + E++++L K+GA
Sbjct: 13 DLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGA 71
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 91.0 bits (227), Expect = 6e-22
Identities = 33/90 (36%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
A + D + + +LL DV+ D + RTAL A G + V LL E GAD+D +D
Sbjct: 48 WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD 106
Query: 104 -RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
R G T L A Y EV++ L + GA
Sbjct: 107 MRGGLTALHMAAGYVRPEVVEALVELGADI 136
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-21
Identities = 31/109 (28%), Positives = 54/109 (49%), Gaps = 10/109 (9%)
Query: 26 AELNGLDDDGEEIKPEFR--LMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAAC 82
+++ +D++G R L+F+A + ++ L ++G D++ RD+ TALH+AA
Sbjct: 67 RDVDAVDENG-------RTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAG 119
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
EVV L+E GAD++ +D G T L A + G +
Sbjct: 120 YVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRR 168
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 9e-12
Identities = 17/85 (20%), Positives = 28/85 (32%), Gaps = 17/85 (20%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A E ++ L++ G D+ D TAL +A T ++ G + +
Sbjct: 114 LHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEK 173
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKH 128
VI +LE
Sbjct: 174 -----------------VINVLEGQ 181
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 59.8 bits (146), Expect = 8e-11
Identities = 9/69 (13%), Positives = 18/69 (26%), Gaps = 4/69 (5%)
Query: 62 SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
+ I + + + G + ADV + TP A + +
Sbjct: 3 NKIIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPWWTAARKADEQA 59
Query: 122 IKLLEKHGA 130
+ L
Sbjct: 60 LSQL-LEDR 67
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 92.5 bits (231), Expect = 6e-22
Identities = 21/105 (20%), Positives = 36/105 (34%), Gaps = 19/105 (18%)
Query: 47 LANERDVEG-------------------IKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87
+A D +G + G +++ + +T LH+A
Sbjct: 1 MATRADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPS 60
Query: 88 VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
VV LL+ GA DR G T A +++ ++ L A
Sbjct: 61 VVRLLVTAGASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAPG 105
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 90.6 bits (226), Expect = 3e-21
Identities = 22/87 (25%), Positives = 39/87 (44%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ + ++ LL G +VN + +ALH A+ +G +V L+ GAD K+
Sbjct: 154 LIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKN 213
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
TPL A + ++++ A
Sbjct: 214 CHNDTPLMVARSRRVIDILRGKATRPA 240
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 87.9 bits (219), Expect = 3e-20
Identities = 23/78 (29%), Positives = 40/78 (51%), Gaps = 1/78 (1%)
Query: 56 IKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
++ LL+ G D++ DI + R+ L A +V LLL+ GA+V+ + GS+ L A
Sbjct: 132 VQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSAS 191
Query: 115 YYKNHEVIKLLEKHGAKP 132
+++ L + GA
Sbjct: 192 GRGLLPLVRTLVRSGADS 209
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 85.2 bits (212), Expect = 3e-19
Identities = 24/109 (22%), Positives = 45/109 (41%), Gaps = 9/109 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
EL+ ++ + P L ++ L+ +G D +TA H+A
Sbjct: 37 RELDIYNNLRQ--TP---LHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLACEHRS 91
Query: 86 TEVVSLLLERGA----DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ LL+ A D++ ++ G T L A+ + E ++LL + GA
Sbjct: 92 PTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGA 140
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 84.8 bits (211), Expect = 3e-19
Identities = 39/110 (35%), Positives = 53/110 (48%), Gaps = 10/110 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG----IDVNFRDIDNRTALHVAA 81
A LD G+ R ++ LLDS +D+ R+ D TALHVA
Sbjct: 70 ASPMALDRHGQ--TA---AHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAV 124
Query: 82 CQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKHGA 130
E V LLLERGAD+D D G +PL A+ + +++LL +HGA
Sbjct: 125 NTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGA 174
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 92.5 bits (231), Expect = 6e-22
Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 1/90 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
++ E +EL+++G DV D +N T LH AA ++V + +GA VD
Sbjct: 13 IVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLG 72
Query: 104 R-WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
STPL A + ++ L K+GA P
Sbjct: 73 GDLNSTPLHWATRQGHLSMVVQLMKYGADP 102
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 89.8 bits (224), Expect = 6e-21
Identities = 30/84 (35%), Positives = 41/84 (48%), Gaps = 3/84 (3%)
Query: 49 NERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
+ D + LL + VN D TALH A G T V+SLLLE GA+VD ++ G
Sbjct: 154 HSVDP--TRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIKGE 211
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAK 131
+ L A KN +I L++
Sbjct: 212 SALDLAKQRKNVWMINHLQEARQA 235
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 86.3 bits (215), Expect = 9e-20
Identities = 24/76 (31%), Positives = 40/76 (52%), Gaps = 1/76 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ +L+ G D + D + + +H+AA G T +V+ L+ +G DVD D+ G TPL A Y
Sbjct: 92 VVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAY 151
Query: 116 YKNH-EVIKLLEKHGA 130
+ + +LL
Sbjct: 152 RTHSVDPTRLLLTFNV 167
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 86.3 bits (215), Expect = 1e-19
Identities = 28/134 (20%), Positives = 49/134 (36%), Gaps = 16/134 (11%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-NRTALHVAACQG 84
++ D + L + A ++ +K + G V+ D N T LH A QG
Sbjct: 33 YDVRQPDKENV--TL---LHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQG 87
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PLM 134
+V L++ GAD D G + + A + + ++ L G PLM
Sbjct: 88 HLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLM 147
Query: 135 APMHVKHAREVPEY 148
+ H+ +
Sbjct: 148 WAAYRTHSVDPTRL 161
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 84.8 bits (211), Expect = 4e-19
Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 7/107 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A+ + +D +G + A + L+ G DV+ D + T L AA +
Sbjct: 100 ADPSLIDGEGC--SC---IHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTH 154
Query: 86 T-EVVSLLLERGADVDPKDRW-GSTPLGDAIYYKNHEVIKLLEKHGA 130
+ + LLL V+ D++ +T L A+ N VI LL + GA
Sbjct: 155 SVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGA 201
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 79.0 bits (196), Expect = 4e-17
Identities = 16/65 (24%), Positives = 24/65 (36%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
+ D + + A G E L+E G DV D+ T L A +++K
Sbjct: 2 MTHIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYY 61
Query: 126 EKHGA 130
GA
Sbjct: 62 ISKGA 66
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 57.8 bits (141), Expect = 7e-10
Identities = 12/60 (20%), Positives = 27/60 (45%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + + I LL++G +V+ ++I +AL +A + +++ L E +
Sbjct: 181 LHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLAKQRKNVWMINHLQEARQAKGYDN 240
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 88.9 bits (222), Expect = 8e-22
Identities = 40/75 (53%), Positives = 51/75 (68%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+K LL++G DVN +D + RT LH+AA G EVV LLLE GADV+ KD+ G TPL A
Sbjct: 18 VKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAAR 77
Query: 116 YKNHEVIKLLEKHGA 130
+ EV+KLL + GA
Sbjct: 78 NGHLEVVKLLLEAGA 92
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 88.9 bits (222), Expect = 9e-22
Identities = 40/74 (54%), Positives = 50/74 (67%)
Query: 57 KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
K LL++G DVN +D + RT LH+AA G EVV LLLE GADV+ KD+ G TPL A
Sbjct: 52 KLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 111
Query: 117 KNHEVIKLLEKHGA 130
+ EV+KLL + GA
Sbjct: 112 GHLEVVKLLLEAGA 125
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 75.1 bits (186), Expect = 7e-17
Identities = 32/59 (54%), Positives = 39/59 (66%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ RT LH+AA G EVV LLLE GADV+ KD+ G TPL A + EV+KLL + GA
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 54.3 bits (132), Expect = 2e-09
Identities = 24/42 (57%), Positives = 30/42 (71%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA 97
+K LL++G DVN +D + RT LH+AA G EVV LLLE GA
Sbjct: 84 VKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 125
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 8e-22
Identities = 25/87 (28%), Positives = 39/87 (44%), Gaps = 2/87 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ + +V + LL++G N + N LH AA T++V +LL G D D
Sbjct: 35 SYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFD 92
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G+T L A+ N + +KL K
Sbjct: 93 DKGNTALYYAVDSGNMQTVKLFVKKNW 119
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 9e-21
Identities = 19/85 (22%), Positives = 33/85 (38%), Gaps = 3/85 (3%)
Query: 48 ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
N + +K L S D D+ +A + A +V LL GA + +
Sbjct: 7 INTWKSKQLKSFL-SSKDTFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NE 63
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132
PL A ++ +++K+L G
Sbjct: 64 FPLHQAATLEDTKIVKILLFSGLDD 88
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-20
Identities = 20/88 (22%), Positives = 35/88 (39%), Gaps = 1/88 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A D + +K LL SG+D + D TAL+ A G + V L +++ +
Sbjct: 66 LHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYG 125
Query: 104 RWG-STPLGDAIYYKNHEVIKLLEKHGA 130
+ G T A+ + ++
Sbjct: 126 KTGWKTSFYHAVMLNDVSIVSYFLSEIP 153
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 6e-18
Identities = 18/106 (16%), Positives = 35/106 (33%), Gaps = 6/106 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
L G + DV + L F + +H+ G
Sbjct: 119 WRLMFYGKTGWKT-S---FYHAVMLNDVSIVSYFLSEI-PSTFDLAILLSCIHITIKNGH 173
Query: 86 TEVVSLLLERGADVDPKDRWGSTP-LGDAIYYKNHEVIKLLEKHGA 130
+++ LLL+ + + P + AI K+ E+++ L K+
Sbjct: 174 VDMMILLLDYMTSTNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDI 219
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 10/81 (12%), Positives = 29/81 (35%), Gaps = 8/81 (9%)
Query: 53 VEGIKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111
V+ + LLD N + + +A E++ L + ++ +
Sbjct: 174 VDMMILLLDYMTSTNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDINIY-------SANL 226
Query: 112 DAIYYKNHEVIKLLEKHGAKP 132
+ + + E+ K++ + +
Sbjct: 227 ENVLLDDAEIAKMIIEKHVEY 247
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 7e-11
Identities = 11/97 (11%), Positives = 29/97 (29%), Gaps = 13/97 (13%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
N + + + +D+E ++ L I++ +A
Sbjct: 185 TSTNTNNSLLFIPD----IKLAIDNKDIEMLQALFKYDINIY-------SANLENVLLDD 233
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
E+ +++E+ + + K E+I
Sbjct: 234 AEIAKMIIEKHVEYKSDSYTKDLDI--VKNNKLDEII 268
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 51/196 (26%), Positives = 83/196 (42%), Gaps = 24/196 (12%)
Query: 175 GIQVAVKKLGEEVISDD-DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IV 228
G VA+KK+ E +R R E+ +L+ +H N++ S I+
Sbjct: 36 GEIVAIKKI--EPFDKPLFALRTLR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92
Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
E + DL + + L F R + LH + +IHRDL+PSN+L +
Sbjct: 93 QELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINS 147
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YV------APEV-FKNEEYDTKVDVF 338
+ +LKV DFG+++++ +V APEV + +Y +DV+
Sbjct: 148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVW 207
Query: 339 SFALILQEMIEGCPPF 354
S IL E+ P F
Sbjct: 208 SCGCILAELFLRRPIF 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 49/221 (22%), Positives = 83/221 (37%), Gaps = 37/221 (16%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVT 229
VA+KK+ D R R E+A+L ++ H +VV+ L V +V
Sbjct: 78 KRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
E D + + L ++ G+ Y+H I+HRDL+P+N L +
Sbjct: 137 EIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQD 192
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR--------------------YV------AP 323
++KV DFG+++ + E+ + +V AP
Sbjct: 193 CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP 252
Query: 324 EV-FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
E+ E Y +DV+S I E++ H + P
Sbjct: 253 ELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 19/191 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI--VTEY 231
+V VK + + + R E+ +L+ +R PN++ V V E+
Sbjct: 61 NEKVVVKI-----LKPVKKKKIKR-EIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSG 290
+ D + + L + +I + ++Y H I+HRD++P N++ D +
Sbjct: 115 VNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHR 168
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIE 349
L++ D+G+++ + + S + PE+ + + YD +D++S +L MI
Sbjct: 169 KLRLIDWGLAE--FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226
Query: 350 GCPPFTMKHDN 360
PF HDN
Sbjct: 227 RKEPFFHGHDN 237
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 94.4 bits (234), Expect = 2e-21
Identities = 27/237 (11%), Positives = 64/237 (27%), Gaps = 43/237 (18%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR----------------------HPNV 212
G V + ++ ++E+ L+ +R P
Sbjct: 103 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162
Query: 213 VQFLGAVTQSSPMMIVTEYLPK-----------GDLRAFLKRKGALKPSTAVRFALDIAR 261
+ + M +++ + L + +L ++ L + R
Sbjct: 163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
+ LH ++H L P +I+ D G + + F P+
Sbjct: 223 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETT 279
Query: 322 APEVFKNEEYDTK-----VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373
A + ++ D ++ L + + P T D + + +
Sbjct: 280 AERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT--DDAALGGSEWIFRSCK 334
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-21
Identities = 27/93 (29%), Positives = 44/93 (47%), Gaps = 6/93 (6%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP- 101
L+ A E DV+ + +LL G +V+ R TALH+AA E +L+E ++
Sbjct: 7 LLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFE 66
Query: 102 ----KDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ G T L A+ +N +++ L GA
Sbjct: 67 PMTSELYEGQTALHIAVINQNVNLVRALLARGA 99
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 28/105 (26%), Positives = 40/105 (38%), Gaps = 17/105 (16%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN-------------RTALHVAACQGFTEVVS 90
L ++V ++ LL G V+ R + L AAC G E+V
Sbjct: 79 LHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVR 138
Query: 91 LLLERGADVDPKDRWGSTPLGDAIYYKNHEV----IKLLEKHGAK 131
LL+E GAD+ +D G+T L I N LL +
Sbjct: 139 LLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGG 183
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-16
Identities = 29/123 (23%), Positives = 49/123 (39%), Gaps = 23/123 (18%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV-----NFRDIDNRTALHVA 80
E++ GE L A ++E L+++ ++ + +TALH+A
Sbjct: 28 CEVHQRGAMGETA-----LHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIA 82
Query: 81 ACQGFTEVVSLLLERGADVDPKDR-------------WGSTPLGDAIYYKNHEVIKLLEK 127
+V LL RGA V + +G PL A + E+++LL +
Sbjct: 83 VINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIE 142
Query: 128 HGA 130
HGA
Sbjct: 143 HGA 145
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-16
Identities = 22/97 (22%), Positives = 33/97 (34%), Gaps = 10/97 (10%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS----LLLERGADV 99
L F A E ++ L++ G D+ +D T LH+ Q LLL
Sbjct: 125 LSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGD 184
Query: 100 DPK------DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
K + G TP A N + + L +
Sbjct: 185 HLKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRK 221
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-13
Identities = 18/67 (26%), Positives = 30/67 (44%), Gaps = 1/67 (1%)
Query: 75 TALHVAACQGFTEVVS-LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
+ L +AA + + +S LL G +V + G T L A Y N E +L + + +
Sbjct: 5 SPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELV 64
Query: 134 MAPMHVK 140
PM +
Sbjct: 65 FEPMTSE 71
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-21
Identities = 28/87 (32%), Positives = 46/87 (52%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ + E + + ++ ++ D + + + TALH A C G TE+V L++ G +V+ D
Sbjct: 41 LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 100
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A N +V K L + GA
Sbjct: 101 SDGWTPLHCAASCNNVQVCKFLVESGA 127
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-19
Identities = 26/110 (23%), Positives = 41/110 (37%), Gaps = 8/110 (7%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ + +D+G I L E +K L+ G++VN D D T LH AA
Sbjct: 61 DDPSLPNDEG--ITA---LHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNN 115
Query: 86 TEVVSLLLERGADV---DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+V L+E GA V D + + + + + L K
Sbjct: 116 VQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKM 165
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-18
Identities = 16/77 (20%), Positives = 33/77 (42%), Gaps = 1/77 (1%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
+ E + G+ V F L ++ +G ++V ++ D + G T L +A
Sbjct: 19 KTGSERIAHGMRVKFNP-LPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNA 77
Query: 114 IYYKNHEVIKLLEKHGA 130
+ + E++K L + G
Sbjct: 78 VCAGHTEIVKFLVQFGV 94
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 4e-13
Identities = 8/63 (12%), Positives = 19/63 (30%), Gaps = 1/63 (1%)
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
+I + +L + S + G V L D+ ++++ +
Sbjct: 2 EITGQVSLPPGKRTNLRKTGSERIAHGMRVKFNPL-PLALLLDSSLEGEFDLVQRIIYEV 60
Query: 130 AKP 132
P
Sbjct: 61 DDP 63
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-12
Identities = 25/124 (20%), Positives = 44/124 (35%), Gaps = 13/124 (10%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVN---FRDIDNRTALHVAAC 82
+N D DG P L A+ +V+ K L++SG V + D+
Sbjct: 94 VNVNAADSDGW--TP---LHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEME 148
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142
+G+T+ L + ++ L Y+ +L K G M +H +
Sbjct: 149 EGYTQCSQFLYGVQEKMGIMNKGVIYAL---WDYEPQNDDELPMKEGDC--MTIIHREDE 203
Query: 143 REVP 146
E+
Sbjct: 204 DEIE 207
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 89.8 bits (224), Expect = 2e-21
Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 15/100 (15%)
Query: 46 FLANERDVEG---------------IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS 90
FL N RD I +L+++ + +DI+ TAL A +
Sbjct: 26 FLRNYRDSYNRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAE 85
Query: 91 LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
LL +G++V+ KD G TPL +I + E+ L +HGA
Sbjct: 86 KLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGA 125
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 89.4 bits (223), Expect = 3e-21
Identities = 28/87 (32%), Positives = 47/87 (54%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L++ + ++LL G +VN +D +T L + G++E+ LLE GA+V+ ++
Sbjct: 72 LIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRN 131
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TPL A Y E++K L + GA
Sbjct: 132 LEGETPLIVASKYGRSEIVKKLLELGA 158
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 87.4 bits (218), Expect = 2e-20
Identities = 30/87 (34%), Positives = 44/87 (50%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
LM+ E LL+ G +VN R+++ T L VA+ G +E+V LLE GAD+ +D
Sbjct: 105 LMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARD 164
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G T A + EVIK+ +
Sbjct: 165 LTGLTAEASARIFGRQEVIKIFTEVRR 191
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 51.6 bits (125), Expect = 5e-08
Identities = 9/64 (14%), Positives = 19/64 (29%), Gaps = 6/64 (9%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
+ D + + + + + L +D + TPL A I L
Sbjct: 2 SHMDKNGEIVEKIKDEKSINQNLDFLRNY------RDSYNRTPLMVACMLGMENAIDKLV 55
Query: 127 KHGA 130
++
Sbjct: 56 ENFD 59
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 47/224 (20%), Positives = 86/224 (38%), Gaps = 57/224 (25%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-------- 226
G + A+KK + D R R EL +++ + H N+++ + +
Sbjct: 32 GKRFALKK-----VLQDPR-YKNR-ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84
Query: 227 ------------------------------IVTEYLPKGDL----RAFLKRKGALKPSTA 252
++ EY+P L ++F++ ++ +
Sbjct: 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLI 143
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPL 311
+ + R + ++H I HRD++P N+L + LK+ DFG +K L P
Sbjct: 144 SIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI--PSEPS 198
Query: 312 TCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
S Y APE+ EY +D++S + E+I G P F
Sbjct: 199 VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 31/196 (15%)
Query: 175 GIQVAVKKLG--EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----I 227
++VA+KK+ E R R E+ +L + RH N++ + + I
Sbjct: 52 KVRVAIKKISPFEHQT---YCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
V + + DL L + L F I RG+ Y+H ++HRDL+PSN+L +
Sbjct: 108 VQDLMET-DLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 162
Query: 288 DSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYV------APEV-FKNEEYDTKVDVF 338
+ +LK+ DFG++++ D LT YV APE+ ++ Y +D++
Sbjct: 163 TTCDLKICDFGLARVADPDHDHTGFLT------EYVATRWYRAPEIMLNSKGYTKSIDIW 216
Query: 339 SFALILQEMIEGCPPF 354
S IL EM+ P F
Sbjct: 217 SVGCILAEMLSNRPIF 232
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-21
Identities = 26/108 (24%), Positives = 46/108 (42%), Gaps = 6/108 (5%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD-SGIDVNFRDIDNRTALHVAACQG 84
+NGLD G L + + + ++ L I++N ++ TALH AA +G
Sbjct: 97 VGVNGLDKAGS--TA---LYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKG 151
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ ++V LLL +GA D ++ A ++K + A
Sbjct: 152 YADIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVR 199
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-18
Identities = 18/108 (16%), Positives = 39/108 (36%), Gaps = 11/108 (10%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+E ++ + D + ++ + L V + LH AA +
Sbjct: 34 EEGDIIYITDMSDT-----NWWKGTSK-----GRTGLIPSNYVAEQAESIDNPLHEAAKR 83
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK-LLEKHGA 130
G + L+ V+ D+ GST L A + + ++++ L +
Sbjct: 84 GNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNI 131
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-14
Identities = 11/89 (12%), Positives = 24/89 (26%), Gaps = 5/89 (5%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ + EL D+ + + T +G T ++ V +
Sbjct: 16 VFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLI-----PSNYVAEQA 70
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
PL +A N ++ +
Sbjct: 71 ESIDNPLHEAAKRGNLSWLRECLDNRVGV 99
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-14
Identities = 9/58 (15%), Positives = 20/58 (34%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
++ LL G + R+I+ + A +A ++ A + D+
Sbjct: 156 VQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSNAEDYLDDEDS 213
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 9e-08
Identities = 7/66 (10%), Positives = 12/66 (18%), Gaps = 5/66 (7%)
Query: 74 RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL-----EKH 128
+ + A L D+ T +I +
Sbjct: 13 QVKVFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLIPSNYVAEQAES 72
Query: 129 GAKPLM 134
PL
Sbjct: 73 IDNPLH 78
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 3e-21
Identities = 27/225 (12%), Positives = 63/225 (28%), Gaps = 52/225 (23%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-------------------------H 209
G V + ++ ++E+ L+ +R
Sbjct: 98 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157
Query: 210 PNVVQFLGAVTQSSPMMIVTEY-LPKGD-------LRAFLKRKGALKPSTAVRFALDIAR 261
+++ + Y + + L + +L ++ L + R
Sbjct: 158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
+ LH ++H L P +I+ D G + + F V++ + S +
Sbjct: 218 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL----VRDGARVVS-SVSRGFE 269
Query: 322 APEVFKNEE-----------YDTKVDVFSFALILQEMIEGCPPFT 355
PE+ D ++ L++ + P T
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 4e-21
Identities = 22/76 (28%), Positives = 35/76 (46%), Gaps = 1/76 (1%)
Query: 56 IKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
+ LL G + N D T +H AA +GF + + +L GA +D +D WG P+ A
Sbjct: 60 AELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAE 119
Query: 115 YYKNHEVIKLLEKHGA 130
+ +V + L
Sbjct: 120 ELGHRDVARYLRAAAG 135
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 7e-20
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 2/90 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A VE ++ LL++G + N + R + V G V LLL GA+ + D
Sbjct: 16 LATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCAD 74
Query: 104 RWGST-PLGDAIYYKNHEVIKLLEKHGAKP 132
T P+ DA + + +L + GA+
Sbjct: 75 PATLTRPVHDAAREGFLDTLVVLHRAGARL 104
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 1e-16
Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 5/74 (6%)
Query: 60 LDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
++ + + L AA +G E V LLE GA+ + + +G P+ +
Sbjct: 1 MEPAAGSS--MEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMMM--GS 56
Query: 120 -EVIKLLEKHGAKP 132
V +LL HGA+P
Sbjct: 57 ARVAELLLLHGAEP 70
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 66.7 bits (164), Expect = 2e-13
Identities = 18/96 (18%), Positives = 31/96 (32%), Gaps = 9/96 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
AE N D +P + A E ++ + L +G ++ RD R + +A G
Sbjct: 68 AEPNCADPATLT-RP---VHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGH 123
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
+V L GS ++
Sbjct: 124 RDVARYLRAAAGGTR-----GSNHARIDAAEGPSDI 154
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-21
Identities = 47/205 (22%), Positives = 84/205 (40%), Gaps = 40/205 (19%)
Query: 175 GIQVAVKKLGEEVISDDDRV---RAFRDELALLQKIRHPNVVQFLGAVTQSSPMM----- 226
+VA+KK I D A R E+ +++++ H N+V+ + S +
Sbjct: 36 DKRVAIKK-----IVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89
Query: 227 ---------IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
IV EY+ DL L +G L A F + RG+ Y+H ++HR
Sbjct: 90 SLTELNSVYIVQEYMET-DLANVL-EQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHR 144
Query: 278 DLEPSNILRDDSG-NLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNE 329
DL+P+N+ + LK+ DFG+++ + + + +P +
Sbjct: 145 DLKPANLFINTEDLVLKIGDFGLAR--IMDPHYSHKGHLSE--GLVTKWYRSPRLLLSPN 200
Query: 330 EYDTKVDVFSFALILQEMIEGCPPF 354
Y +D+++ I EM+ G F
Sbjct: 201 NYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-20
Identities = 26/91 (28%), Positives = 44/91 (48%), Gaps = 1/91 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPK 102
L + + ++ L+ G DVN ++ N RTALH+A ++VSLLL+ GADV+
Sbjct: 121 LHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRV 180
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
G +P + + + L + + L
Sbjct: 181 TYQGYSPYQLTWGRPSTRIQQQLGQLTLENL 211
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 3e-20
Identities = 21/87 (24%), Positives = 38/87 (43%)
Query: 50 ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
+E I+++ +NF++ +T LH+A E+ LL G D + +D G+TP
Sbjct: 22 ALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTP 81
Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAP 136
L A + +L + P +
Sbjct: 82 LHLACEQGCLASVGVLTQSCTTPHLHS 108
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-18
Identities = 28/114 (24%), Positives = 48/114 (42%), Gaps = 12/114 (10%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID------VNFRDIDNRTALHV 79
+ D G P L + + + L S + + + T LH+
Sbjct: 69 CDPELRDFRGN--TP---LHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHL 123
Query: 80 AACQGFTEVVSLLLERGADVDPKDRW-GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
A+ G+ +V LL+ GADV+ ++ G T L A+ +N +++ LL K GA
Sbjct: 124 ASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADV 177
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 9e-13
Identities = 15/67 (22%), Positives = 26/67 (38%), Gaps = 4/67 (5%)
Query: 70 DIDNRTALHVAACQGFT----EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
D + LH+A EV+ + A ++ ++ TPL A+ E+ + L
Sbjct: 5 TEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEAL 64
Query: 126 EKHGAKP 132
G P
Sbjct: 65 LGAGCDP 71
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 4e-12
Identities = 9/66 (13%), Positives = 17/66 (25%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
+ LL G DVN + + + T + L + +
Sbjct: 167 VSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLENLQMLPESEDEESYDTE 226
Query: 116 YKNHEV 121
+ E
Sbjct: 227 SEFTEF 232
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 46/193 (23%), Positives = 90/193 (46%), Gaps = 13/193 (6%)
Query: 179 AVKKLG-EEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGD 236
A+K L ++ R E +L+ IR P +V A + + ++ +Y+ G+
Sbjct: 86 AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 145
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L L ++ + +I + +LH+ II+RD++ NIL D +G++ + D
Sbjct: 146 LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD 202
Query: 297 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGC 351
FG+SK V ++ C Y+AP++ + + +D VD +S +++ E++ G
Sbjct: 203 FGLSK-EFVADETERA--YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
Query: 352 PPFTMKHDNEVPK 364
PFT+ +
Sbjct: 260 SPFTVDGEKNSQA 272
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 22/78 (28%), Positives = 35/78 (44%), Gaps = 1/78 (1%)
Query: 55 GIKELLD-SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
G + D ++ D +N +HVAA +G T+ V L+E G ++R+G T L A
Sbjct: 1 GPGSMTDFPKLNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLA 60
Query: 114 IYYKNHEVIKLLEKHGAK 131
+ + K L G
Sbjct: 61 CKFGCVDTAKYLASVGEV 78
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 20/111 (18%), Positives = 41/111 (36%), Gaps = 5/111 (4%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ A + + ++ L+++G+ ++ TALH+A G + L G
Sbjct: 24 IHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLACKFGCVDTAKYLASVGEVHSLWH 83
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV---KHAREVPEYEID 151
G P+ A+ +++ L + + P + REV E
Sbjct: 84 --GQKPIHLAVMANKTDLVVALVEGAKERGQMPESLLNECDEREVNEIGSH 132
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 8e-20
Identities = 24/125 (19%), Positives = 47/125 (37%), Gaps = 10/125 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-----GIDVNFRDIDNRTALHVA 80
A D E P LM R+ E + ++D+ + +++ + + LH A
Sbjct: 164 ASPTAKDKADE--TP---LMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWA 218
Query: 81 ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
+ +V +E G DV+ +D + PL ++ + K L + L+
Sbjct: 219 ILINWEDVAMRFVEMGIDVNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQACPYH 278
Query: 141 HAREV 145
+ V
Sbjct: 279 NGTTV 283
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 9e-19
Identities = 14/86 (16%), Positives = 23/86 (26%)
Query: 47 LANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
L +G V + + AA EV+ LL E+ +V G
Sbjct: 264 LQKTDVFLIQACPYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTG 323
Query: 107 STPLGDAIYYKNHEVIKLLEKHGAKP 132
+ V ++ A
Sbjct: 324 AGGAVKRKKKAAPAVKRMKLAPSAPV 349
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 17/82 (20%), Positives = 31/82 (37%), Gaps = 5/82 (6%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-----GADVDPKDRWGSTPL 110
IK L+ G +D + T L A E + L+++ +D ++ G++ L
Sbjct: 156 IKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHL 215
Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
AI +V + G
Sbjct: 216 HWAILINWEDVAMRFVEMGIDV 237
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 20/75 (26%), Positives = 35/75 (46%), Gaps = 7/75 (9%)
Query: 63 GIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
I + + +TALH G + E++ +L++ GA KD+ TPL A+ ++N E
Sbjct: 128 EIGSHVKHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNRE 187
Query: 121 VIKLL-----EKHGA 130
+ L+ K
Sbjct: 188 ALDLMMDTVPSKSSL 202
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 13/100 (13%), Positives = 29/100 (29%), Gaps = 2/100 (2%)
Query: 11 LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
LL+++ + NG + + + A+ E ++ L + +V
Sbjct: 263 LLQKT--DVFLIQACPYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSL 320
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+ V + L A V + R +
Sbjct: 321 NTGAGGAVKRKKKAAPAVKRMKLAPSAPVRTRSRSRARSS 360
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 6e-09
Identities = 14/91 (15%), Positives = 27/91 (29%), Gaps = 14/91 (15%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ + + L++ + + + EV K
Sbjct: 88 IHLAVMANKTDLVVALVEGAKE------RGQMPESLLNECDEREVN------EIGSHVKH 135
Query: 104 RWGSTPLGDAIYY-KNH-EVIKLLEKHGAKP 132
G T L + + E+IK+L + GA P
Sbjct: 136 CKGQTALHWCVGLGPEYLEMIKILVQLGASP 166
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 5e-04
Identities = 6/43 (13%), Positives = 13/43 (30%)
Query: 90 SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
S+ + D + A + ++ L + G P
Sbjct: 4 SMTDFPKLNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSP 46
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 87.9 bits (219), Expect = 2e-20
Identities = 29/93 (31%), Positives = 39/93 (41%), Gaps = 4/93 (4%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV--- 99
L E + ++ELL S + +D D R LH + E+ S LL + +V
Sbjct: 6 LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD 65
Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
D D G TP A N EV+K L KP
Sbjct: 66 DYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKP 98
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 1e-19
Identities = 23/76 (30%), Positives = 35/76 (46%), Gaps = 3/76 (3%)
Query: 58 ELL---DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
+ L D+N T LH+A + + EV L+E GA V KD++ PL A
Sbjct: 89 KSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAA 148
Query: 115 YYKNHEVIKLLEKHGA 130
+ ++I+LL G
Sbjct: 149 SVGSLKLIELLCGLGK 164
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 1e-19
Identities = 31/109 (28%), Positives = 54/109 (49%), Gaps = 7/109 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+LN + + G L ++ E + L+++G V +D N+ LH AA G
Sbjct: 98 PDLNKITNQGV--TC---LHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGS 152
Query: 86 TEVVSLLLERG-ADVDPKDRWGSTPLGDAIYYKNHEVIKLL-EKHGAKP 132
+++ LL G + V+ +D+ G TPL A+ + + LL EK+GA+
Sbjct: 153 LKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEY 201
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 82.5 bits (205), Expect = 2e-18
Identities = 32/110 (29%), Positives = 45/110 (40%), Gaps = 10/110 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI---DNRTALHVAAC 82
+ L D DG P L + + + E LL +VN D T H+A
Sbjct: 27 SLLLQKDQDGR--IP---LHWSVSFQAHEITSFLLSKMENVNLDDYPDDSGWTPFHIACS 81
Query: 83 QGFTEVVSLLLER--GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G EVV L +R D++ G T L A+ K EV + L ++GA
Sbjct: 82 VGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGA 131
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 4e-15
Identities = 26/105 (24%), Positives = 42/105 (40%), Gaps = 10/105 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAACQG 84
A + D + P L A+ ++ I+ L G VN++D T L A +G
Sbjct: 131 ASVRIKDKFNQ--IP---LHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEG 185
Query: 85 FTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
+ LL+E+ GA+ D D G+ N +V K +
Sbjct: 186 HGDAAVLLVEKYGAEYDLVDNKGAKAE---DVALNEQVKKFFLNN 227
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 70.9 bits (175), Expect = 2e-14
Identities = 15/59 (25%), Positives = 27/59 (45%), Gaps = 1/59 (1%)
Query: 73 NRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ LH A + F +V LL + + + KD+ G PL ++ ++ HE+ L
Sbjct: 2 SNYPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKME 60
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 3e-20
Identities = 44/183 (24%), Positives = 67/183 (36%), Gaps = 11/183 (6%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
+ LA ++ +KE + + D D+RTALH A G TE+V LL+ G V+ K
Sbjct: 10 ICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 69
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL------MAPMHV---KHAREVPEYEIDPH 153
D G +PL A E++K L GA P+H K+ E+ ++
Sbjct: 70 DDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLE-G 128
Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213
+ A +G V L S + + L L
Sbjct: 129 GANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEA 188
Query: 214 QFL 216
+FL
Sbjct: 189 KFL 191
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 2e-15
Identities = 11/60 (18%), Positives = 23/60 (38%)
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ N ++A E+ +L + D+ T L A + E+++ L + G
Sbjct: 5 VSNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGV 64
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 2e-14
Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 5/106 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A +N ++ +G L + A++ E LL+ G + + +D + TA+H AA +G
Sbjct: 97 AHVNAVNQNGCTP-----LHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGN 151
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
++V +LL A + +D G+TPL A + E K L GA
Sbjct: 152 LKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQGAS 197
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 2e-14
Identities = 21/107 (19%), Positives = 40/107 (37%), Gaps = 7/107 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A + D + A + +++ + LL N +D + T LH+A +
Sbjct: 130 ANPDAKDHYDATA-----MHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEER 184
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
E L+ +GA + +++ TPL A +I G +
Sbjct: 185 VEEAKFLVTQGASIYIENKEEKTPLQVA--KGGLGLILKRLAEGEEA 229
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 18/75 (24%), Positives = 28/75 (37%), Gaps = 7/75 (9%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A N D +G L +E VE K L+ G + + + +T L VA G
Sbjct: 163 ASTNIQDTEGNTP-----LHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAK--GG 215
Query: 86 TEVVSLLLERGADVD 100
++ L G +
Sbjct: 216 LGLILKRLAEGEEAS 230
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-20
Identities = 28/75 (37%), Positives = 37/75 (49%), Gaps = 3/75 (4%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
L+ G + D L AA G + V +L+ GADV KD+ GSTPL A
Sbjct: 10 SSGLVPRGSHMG---SDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAAR 66
Query: 116 YKNHEVIKLLEKHGA 130
+ EV+KLL + GA
Sbjct: 67 NGHLEVVKLLLEAGA 81
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 6e-19
Identities = 30/83 (36%), Positives = 48/83 (57%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L+ A + ++ L+ +G DV +D + T LH+AA G EVV LLLE GADV +D
Sbjct: 28 LLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQD 87
Query: 104 RWGSTPLGDAIYYKNHEVIKLLE 126
++G T +I N ++ ++L+
Sbjct: 88 KFGKTAFDISIDNGNEDLAEILQ 110
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 9e-10
Identities = 9/51 (17%), Positives = 19/51 (37%), Gaps = 3/51 (5%)
Query: 80 AACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
+ S L+ RG+ + L +A + +++L +GA
Sbjct: 1 GSSHHHHHHSSGLVPRGSHMGSD---LGKKLLEAARAGQDDEVRILMANGA 48
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-20
Identities = 45/190 (23%), Positives = 75/190 (39%), Gaps = 44/190 (23%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGA----VTQSSPMMIVT 229
+ A+K ++ D + R E+ L + + P++V+ + ++IV
Sbjct: 43 QEKFALK-----MLQDCPKAR---REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94
Query: 230 EYLPKGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 285
E L G+L R + A A I + YLH I HRD++P N+L
Sbjct: 95 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYT 151
Query: 286 -RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
+ + LK+ DFG A E E+YD D++S +I+
Sbjct: 152 SKRPNAILKLTDFG----------------------FAKETTG-EKYDKSCDMWSLGVIM 188
Query: 345 QEMIEGCPPF 354
++ G PPF
Sbjct: 189 YILLCGYPPF 198
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 6e-20
Identities = 23/110 (20%), Positives = 53/110 (48%), Gaps = 4/110 (3%)
Query: 26 AELNGLDDDGEEIKPEFR---LMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAA 81
A+++ ++ + L + A ++ +K L+ + G + + +D D +T + +AA
Sbjct: 262 AKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAA 321
Query: 82 CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+G EVV L+++GA V+ D T A +H ++ + ++ +
Sbjct: 322 QEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDRCRPE 371
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 18/72 (25%), Positives = 33/72 (45%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
KE + +G DVN D D T L +A +V+ L++ GAD ++ + L A
Sbjct: 147 HEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQA 206
Query: 114 IYYKNHEVIKLL 125
++ ++ +
Sbjct: 207 AANRDFGMMVYM 218
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 31/124 (25%), Positives = 50/124 (40%), Gaps = 11/124 (8%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N +D D P LM R + L+ +G D + R+ALH AA
Sbjct: 157 ADVNAMDCDEN--TP---LMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRD 211
Query: 86 TEVVSLLLE---RGADVDPKDRWGSTPLGDAIYYKNHEVI---KLLEKHGAKPLMAPMHV 139
++ +L D++ DR G T L + + + + KLL + GAK
Sbjct: 212 FGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDYDGAAR 271
Query: 140 KHAR 143
K +
Sbjct: 272 KDSE 275
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 9/87 (10%)
Query: 53 VEGIKELLDSGIDVNFR--------DIDNRTALHVAACQGFTEVVSLLL-ERGADVDPKD 103
V K L++ G V++ RTALH AA +V L+ E+G++ D +D
Sbjct: 251 VASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQD 310
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G TP+ A EV+ L + GA
Sbjct: 311 EDGKTPIMLAAQEGRIEVVMYLIQQGA 337
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 21/83 (25%), Positives = 33/83 (39%), Gaps = 9/83 (10%)
Query: 56 IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL--------ERGADVDPKDRWGS 107
+ + +++ NRT LH A E L+ GADV+ D +
Sbjct: 109 TEPITRESVNII-DPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDEN 167
Query: 108 TPLGDAIYYKNHEVIKLLEKHGA 130
TPL A+ + ++ L K GA
Sbjct: 168 TPLMLAVLARRRRLVAYLMKAGA 190
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-15
Identities = 14/111 (12%), Positives = 29/111 (26%), Gaps = 7/111 (6%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+ + N L + + + + ++ LH A
Sbjct: 50 IKRQRNELQHYSL-----YPNPQGYGNGNDFLGDFNHTNLQIPTEPEPESPIKLHTEA-A 103
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134
G + + ++ R T L + E + L H AK +
Sbjct: 104 GSYAITEPITRESVNII-DPRHNRTVLHWIASNSSAEKSEDLIVHEAKECI 153
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 9/116 (7%), Positives = 26/116 (22%), Gaps = 5/116 (4%)
Query: 19 PDRERKEAELNGL----DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNR 74
+R RK +N + EE + +++ + N +
Sbjct: 3 GNRTRKRRMINASVWMPPMENEEKNRKNHQSITSSQHSLLEASYDGYIKRQRNELQHYSL 62
Query: 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G + + L ++ + + + +
Sbjct: 63 YPNPQGYGNGNDFLGDFNHTNLQIPTEPEPESPIKLHTEAAG-SYAITEPITRESV 117
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 8e-11
Identities = 16/75 (21%), Positives = 30/75 (40%), Gaps = 5/75 (6%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
+ + D+DG+ P +M A E +E + L+ G V D + TA +A
Sbjct: 304 SNKDKQDEDGK--TP---IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNH 358
Query: 86 TEVVSLLLERGADVD 100
+V + + +
Sbjct: 359 HNIVDIFDRCRPERE 373
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 6/72 (8%), Positives = 18/72 (25%), Gaps = 9/72 (12%)
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
+ + ++ +L A+ G+ + + + P N
Sbjct: 25 EKNRKNHQSITSSQHSLLEASYDGYIKRQ---------RNELQHYSLYPNPQGYGNGNDF 75
Query: 121 VIKLLEKHGAKP 132
+ + P
Sbjct: 76 LGDFNHTNLQIP 87
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 34/206 (16%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM----IVT 229
G VAVKK+ + + D R FR E+ +L ++ H N+V L + + +V
Sbjct: 34 GEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLLNVLR--ADNDRDVYLVF 90
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
+Y+ DL A + R L+P + + + YLH ++HRD++PSNIL +
Sbjct: 91 DYMET-DLHAVI-RANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAE 145
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR--------------YV------APEV-FKN 328
++KVADFG+S+ + YV APE+ +
Sbjct: 146 CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS 205
Query: 329 EEYDTKVDVFSFALILQEMIEGCPPF 354
+Y +D++S IL E++ G P F
Sbjct: 206 TKYTKGIDMWSLGCILGEILCGKPIF 231
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 9e-18
Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 41/219 (18%)
Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIR---------- 208
G F LA VA+K ++ D A DE+ LLQ++
Sbjct: 29 WGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 209 -HPNVVQFLGAVTQSSPMM----IVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIAR 261
++++ L P +V E L +L A +K+ P V+ + +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDS------GNLKVADFGVSKLLTVKEDRPLTCQD 315
G++Y+H IIH D++P N+L + +K+AD G + D T
Sbjct: 143 GLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSI 196
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
+ Y +PEV + D++S A ++ E+I G F
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 8e-17
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRH------PNV 212
KG+F + A+ VA+K ++ ++ R R +E+ +L+ +R NV
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALK-----MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP--STAVR-FALDIARGMNYLHEN 269
+ L T + + + E L +L +K K + VR FA I + ++ LH+N
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIK-KNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 270 KPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
+ IIH DL+P NIL + +KV DFG S E + + S Y APEV
Sbjct: 220 R---IIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRFYRAPEVIL 272
Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361
Y +D++S IL E++ G P + + +
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 41/149 (27%), Positives = 68/149 (45%), Gaps = 18/149 (12%)
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
K L + ++ +A+GM +L K IHRDL NIL + +K+ DFG+++
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 303 L------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF- 354
+ K D L +++APE + Y + DV+SF ++L E+ G P+
Sbjct: 243 IYKDPDYVRKGDARL-----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 297
Query: 355 TMKHDNEVPKAYAA--RQRPPFKAPAKLY 381
+K D E + R R P ++Y
Sbjct: 298 GVKIDEEFCRRLKEGTRMRAPDYTTPEMY 326
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 8e-13
Identities = 35/110 (31%), Positives = 49/110 (44%), Gaps = 16/110 (14%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
++E L + +G F I A GI VAVK L E + RA
Sbjct: 16 KWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRA 71
Query: 197 FRDELALLQKI-RHPNVVQFLGAVTQSS-PMMIVTEYLPKGDLRAFLKRK 244
EL +L I H NVV LGA T+ P+M++ E+ G+L +L+ K
Sbjct: 72 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-16
Identities = 47/199 (23%), Positives = 79/199 (39%), Gaps = 22/199 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMM 226
VA+K +I + + E+ LL+ + +V + +
Sbjct: 78 EQEWVAIK-----IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132
Query: 227 IVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+V E L +L L+ R FA + + +L + + IIH DL+P NI
Sbjct: 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENI 190
Query: 285 L--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
L +K+ DFG S + + + S Y +PEV YD +D++S
Sbjct: 191 LLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGC 246
Query: 343 ILQEMIEGCPPFTMKHDNE 361
IL EM G P F+ ++ +
Sbjct: 247 ILVEMHTGEPLFSGANEVD 265
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 7e-16
Identities = 21/127 (16%), Positives = 35/127 (27%), Gaps = 2/127 (1%)
Query: 11 LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
LL +R K+ + + F ++ + LL S V
Sbjct: 66 LLCLYYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQ 125
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGSTPLGDAIYYKNHEVIKLLEKH 128
+N A +AA G V++ L E A + V+ L +
Sbjct: 126 AENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCEL 185
Query: 129 GAKPLMA 135
A
Sbjct: 186 APTEATA 192
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 17/87 (19%), Positives = 24/87 (27%), Gaps = 5/87 (5%)
Query: 57 KELLDSGIDVNFRDI--DNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGSTPLGD 112
L + I +N A +AA G V++ L E
Sbjct: 145 NRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRW 204
Query: 113 AIYYKNH-EVIKLLEKHGAKPLMAPMH 138
A + H VI L A +H
Sbjct: 205 AAVGRGHHNVINFLLDCPVMLAYAEIH 231
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 15/118 (12%), Positives = 33/118 (27%), Gaps = 14/118 (11%)
Query: 24 KEAELNGLDD--DGEEIKPEFRLMFLANERDVEGIKELL---------DSGIDVNFRDID 72
K + +G+ D E F ++ R+ E + + + + D
Sbjct: 259 KLSNPDGVFDLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGD 318
Query: 73 NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
L +A G +LLL + + ++ + +H
Sbjct: 319 ANELLRLALRLGNQGACALLLSIPSVLALTKA---NNYYINETGGRLDLRAVALEHHH 373
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 14/91 (15%), Positives = 27/91 (29%), Gaps = 12/91 (13%)
Query: 56 IKELLDSGIDVNFRDI--DNRTALHVAACQ-GFTEVVSLLLERGADVDPKDRWGSTPLGD 112
+ L + I +N A AA G V++ LL+ + +
Sbjct: 179 LNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEIHEFE---- 234
Query: 113 AIYYKNHEVIKLLEKHGA--KPLMAPMHVKH 141
Y V + +H K + + +
Sbjct: 235 ---YGEKYVNPFIARHVNRLKEMHDAFKLSN 262
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 21/125 (16%), Positives = 48/125 (38%), Gaps = 8/125 (6%)
Query: 14 QSSLAPDRERKEAEL--NGLDDDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNF-R 69
Q L P+ + L + + + E + ++ + ++ + + ++ +++N
Sbjct: 68 QRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPV 127
Query: 70 DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH----EVIKLL 125
D T LH E+V L++ G++ D G + L A+ N+ LL
Sbjct: 128 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALL 187
Query: 126 EKHGA 130
+
Sbjct: 188 DYLYP 192
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 18/87 (20%), Positives = 33/87 (37%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
K+ E+ + +E + +N +D + T L++AA
Sbjct: 234 KKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARL 293
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPL 110
G +V LL+ GAD ++ G P+
Sbjct: 294 GNISIVDALLDYGADPFIANKSGLRPV 320
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 19/145 (13%), Positives = 46/145 (31%), Gaps = 22/145 (15%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG-------FTEVVSLLLERG 96
L +L + ++E +K L+ G + + D + L A F ++ L
Sbjct: 135 LHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYL---Y 191
Query: 97 ADVDPKDRWGSTPL------------GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE 144
+ +D T L A Y ++ + K +P+ + + K ++
Sbjct: 192 PCLILEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKP 251
Query: 145 VPEYEIDPHELDFTNSVEITKGTFI 169
+ + ++ +
Sbjct: 252 NDKNGERKDSILENLDLKWIIANML 276
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 12/83 (14%), Positives = 25/83 (30%), Gaps = 4/83 (4%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAA----CQGFTEVVSLLLERGADVDPKDRWGSTP 109
+ ++ + + + E + L ++ +D G T
Sbjct: 227 ILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTC 286
Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
L A N ++ L +GA P
Sbjct: 287 LNIAARLGNISIVDALLDYGADP 309
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 16/121 (13%), Positives = 30/121 (24%), Gaps = 21/121 (17%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLA---NERDVEGIKELLDSGI-DVNFRDIDNRTALHVAA 81
+ D+ GE L+ N D + LLD + D NRT LH
Sbjct: 155 SNRLYGDNMGE--SC---LVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHHII 209
Query: 82 CQGFTE------------VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
++ ++++ + + + I
Sbjct: 210 ITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLK 269
Query: 130 A 130
Sbjct: 270 W 270
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 27/93 (29%), Positives = 44/93 (47%)
Query: 48 ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
AN+ + + ++ +G ++ + D TALH AA + + LLL+ A V + G
Sbjct: 201 ANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGE 260
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
T L A + E +LLE+ A P+HV
Sbjct: 261 TALDIARKKHHKECEELLEQAQAGTFAFPLHVD 293
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 9/93 (9%)
Query: 49 NERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQGF---TEVVSLLLERGADV 99
RD+ + E +G D LH+A +V +++ G +
Sbjct: 160 CNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHL 219
Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
D K G+T L A Y + +KLL K A
Sbjct: 220 DAKAADGNTALHYAALYNQPDCLKLLLKGRALV 252
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 9e-15
Identities = 27/121 (22%), Positives = 46/121 (38%), Gaps = 21/121 (17%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A LN + + I + L R + +K+ + +TALH+A +
Sbjct: 61 AMLNLHNGQNDTIA-----LLLDVARKTDSLKQFV--NASYTDSYYKGQTALHIAIERRN 113
Query: 86 TEVVSLLLERGADVDPKDR--------------WGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+V+LL+E GADV +G PL A ++K L ++ +
Sbjct: 114 MTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQ 173
Query: 132 P 132
P
Sbjct: 174 P 174
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 25/112 (22%), Positives = 38/112 (33%), Gaps = 22/112 (19%)
Query: 44 LMFLANERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQG---------FTEVVSL 91
L A + +K LL + D++ RD T LH T + +
Sbjct: 152 LSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNE 211
Query: 92 LLERGADVDP-------KDRWGSTPLGDAIYYKNHEVIKLL---EKHGAKPL 133
+L GA + P +R G TPL A V+ + E H +
Sbjct: 212 ILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECR 263
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 6e-09
Identities = 11/64 (17%), Positives = 22/64 (34%), Gaps = 8/64 (12%)
Query: 57 KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
+L + + T L +AA G V++ +L+R A ++
Sbjct: 217 AKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIH-------EPECRHAAAHH 269
Query: 117 KNHE 120
+H
Sbjct: 270 -HHH 272
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 18/88 (20%), Positives = 29/88 (32%), Gaps = 11/88 (12%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-------RGADVDPKDR-WGSTPLGDA- 113
+ +R ++ A Q + + LL R D + KD G T L A
Sbjct: 3 SAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAM 62
Query: 114 --IYYKNHEVIKLLEKHGAKPLMAPMHV 139
++ ++ I LL K V
Sbjct: 63 LNLHNGQNDTIALLLDVARKTDSLKQFV 90
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 27/142 (19%), Positives = 46/142 (32%), Gaps = 37/142 (26%)
Query: 21 RERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN------- 73
+ A+ G L +R ++ +K L+++G DV+ R
Sbjct: 76 KPLVNAQCTDEFYQGH--SA---LHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQG 130
Query: 74 ------RTALHVAACQGFTEVVSLLLERG---ADVDPKDRWGSTPL------GD------ 112
L +AAC +VV+ LLE A ++ D G+T L D
Sbjct: 131 TCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENS 190
Query: 113 ----AIYYKNHEVIKLLEKHGA 130
+Y ++ L
Sbjct: 191 ALVIHMYDGLLQMGARLCPTVQ 212
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-13
Identities = 21/91 (23%), Positives = 34/91 (37%), Gaps = 15/91 (16%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-------------WGSTP 109
+ALH+A + + V LL+E GADV + +G P
Sbjct: 80 NAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELP 139
Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
L A K +V+ L ++ +P A +
Sbjct: 140 LSLAACTKQWDVVTYLLENPHQP--ASLEAT 168
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-12
Identities = 13/76 (17%), Positives = 26/76 (34%), Gaps = 1/76 (1%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
+ + +AL + G ++ + L + + G TPL A E+ + +
Sbjct: 181 MIADNSPENSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHI 240
Query: 126 EKHGAKPLMAPMHVKH 141
+ A H H
Sbjct: 241 LQREFSG-AAAHHHHH 255
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 21/110 (19%), Positives = 36/110 (32%), Gaps = 22/110 (20%)
Query: 43 RLMFLANERDVEGIKELLDS--------GIDVNFRDIDNRTALHVAAC---QGFTEVVSL 91
RL + + E + LL+ +T L A G +
Sbjct: 5 RLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNACIMP 64
Query: 92 LLERG-----------ADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
LL+ A + G + L AI ++ + +KLL ++GA
Sbjct: 65 LLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGA 114
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 4e-08
Identities = 9/48 (18%), Positives = 18/48 (37%)
Query: 53 VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
++ L + + T L +AA +G E+ +L+R
Sbjct: 201 LQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGA 248
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 7e-05
Identities = 13/71 (18%), Positives = 20/71 (28%), Gaps = 11/71 (15%)
Query: 73 NRTALHVAACQGFTEVVSLLLE--------RGADVDPKDRWGSTPLGDAIY--YKNH-EV 121
+R L +G E ++ LLE + G T L A+
Sbjct: 2 DRDRLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNAC 61
Query: 122 IKLLEKHGAKP 132
I L +
Sbjct: 62 IMPLLQIDKDS 72
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 6e-14
Identities = 24/114 (21%), Positives = 40/114 (35%), Gaps = 26/114 (22%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN--------------RTALHVAACQGFTEVV 89
L R ++ L++ G DV+ + L +AAC +V
Sbjct: 97 LHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIV 156
Query: 90 SLLLERG---ADVDPKDRWGSTPLGDAIYYKNH---------EVIKLLEKHGAK 131
L E G AD+ +D G+T L + ++ ++ LL AK
Sbjct: 157 HYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAK 210
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 30/113 (26%), Positives = 45/113 (39%), Gaps = 25/113 (22%)
Query: 45 MFLANERDVEGIKELLDSG---------IDVNFRDIDNR--TALHVAACQGFTEVVSLLL 93
+ + + I LLD I+ FRD+ R TALH+A + V LL+
Sbjct: 54 LLNLSAGRNDTIPILLDIAEKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLV 113
Query: 94 ERGADVDPKDR--------------WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
E+GADV + R +G PL A ++ L ++G K
Sbjct: 114 EKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQ 166
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-11
Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 22/105 (20%)
Query: 48 ANERDVEGIKE----LLDSGIDVNFRDIDN----RTALHVAA---CQGFTEVVSLLLERG 96
+ +G++ LL + + +T L A G + + +LL+
Sbjct: 13 VSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDTIPILLDIA 72
Query: 97 ADVDP-----------KDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
G T L AI + ++LL + GA
Sbjct: 73 EKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGA 117
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 19/107 (17%), Positives = 34/107 (31%), Gaps = 19/107 (17%)
Query: 44 LMFLANERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQG---------FTEVVSL 91
L A + L ++G D+ +D T LH T++ L
Sbjct: 144 LSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDL 203
Query: 92 LLERGADVDPK-------DRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
LL + A + P + G +PL A + + + +
Sbjct: 204 LLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIA 250
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 14/70 (20%), Positives = 23/70 (32%), Gaps = 11/70 (15%)
Query: 73 NRTALHVAA----CQGFTEVVSLLLERGADVDPKDRW----GSTPLGDA---IYYKNHEV 121
NR L G ++S LL + ++ G T L A + ++
Sbjct: 5 NRPILFDIVSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDT 64
Query: 122 IKLLEKHGAK 131
I +L K
Sbjct: 65 IPILLDIAEK 74
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 8/59 (13%), Positives = 17/59 (28%), Gaps = 7/59 (11%)
Query: 49 NERDVEGIKELLDSGIDVN-------FRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
+ + LL + + D + L +AA G + ++ R
Sbjct: 194 TKFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADA 252
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 20/93 (21%), Positives = 40/93 (43%)
Query: 48 ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
+ + + L+ + +++ + TALH E + LLL A ++ + G
Sbjct: 180 VDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGE 239
Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
TPL A K+ +LL + + + +HV+
Sbjct: 240 TPLDIAKRLKHEHCEELLTQALSGRFNSHVHVE 272
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 61.2 bits (148), Expect = 9e-11
Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 9/93 (9%)
Query: 49 NERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQG---FTEVVSLLLERGADV 99
RD+ G+ + G+D+ + TALH+A +V L++ ++
Sbjct: 139 KTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNL 198
Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
D + GST L N E +KLL + A
Sbjct: 199 DKQTGKGSTALHYCCLTDNAECLKLLLRGKASI 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 52/234 (22%), Positives = 91/234 (38%), Gaps = 52/234 (22%)
Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRH-----PNVV 213
GTF +L AVK V+ + + + + E +L+KI++ N+V
Sbjct: 45 DGTFGRVLLCQHIDNKKYYAVK-----VVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKP 271
++ G M ++ E L L + R ++ + ++I + +NYL +
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS- 157
Query: 272 VPIIHRDLEPSNIL-------------------------RDDSGNLKVADFGVSKLLTVK 306
+ H DL+P NIL R S +K+ DFG +
Sbjct: 158 --LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA----TF 211
Query: 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360
+ + +Y APEV N +D D++SF +L E+ G F H++
Sbjct: 212 KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR-THEH 264
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 55/213 (25%), Positives = 80/213 (37%), Gaps = 41/213 (19%)
Query: 177 QVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMMIVT 229
QVA+K +I + + R A R E+ +L+KI+ V M I
Sbjct: 47 QVALK-----IIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101
Query: 230 EYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 285
E L K + FLK P VR A + + +LHEN+ + H DL+P NIL
Sbjct: 102 ELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFV 157
Query: 286 -----------------RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
+ +++VADFG + + T + Y PEV
Sbjct: 158 NSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFDHEHHTTIVATRHYRPPEVILE 213
Query: 329 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361
+ DV+S IL E G F + E
Sbjct: 214 LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 8e-12
Identities = 52/207 (25%), Positives = 77/207 (37%), Gaps = 34/207 (16%)
Query: 178 VAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMMIVTE 230
VAVK ++ + DR A R E+ +L+ + VQ L + IV E
Sbjct: 43 VAVK-----IVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97
Query: 231 YLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
L F+K G L +R A I + +N+LH NK + H DL+P NIL
Sbjct: 98 LLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQ 153
Query: 289 SGNLKVADFGVSKLLTVKEDRPL-------TC--QDTSCRYV------APEVFKNEEYDT 333
S + + + + + + + V APEV +
Sbjct: 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQ 213
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDN 360
DV+S IL E G F HD+
Sbjct: 214 PCDVWSIGCILIEYYLGFTVFP-THDS 239
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 52/256 (20%), Positives = 83/256 (32%), Gaps = 76/256 (29%)
Query: 164 TKGTFILA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----HPN---VV 213
T L+ VA+K V S + DE+ LL+ +R PN VV
Sbjct: 49 HFSTVWLSWDIQGKKFVAMKV----VKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 214 QFLGAVTQSSP----MMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLH 267
Q L S + +V E L L ++ + L + + +G++YLH
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163
Query: 268 ENKPVPIIHRDLEPSNIL------------------------------------------ 285
IIH D++P NIL
Sbjct: 164 TK--CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221
Query: 286 -------RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
+ +K+AD G + + T + +Y + EV Y+T D++
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNA----CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIW 277
Query: 339 SFALILQEMIEGCPPF 354
S A + E+ G F
Sbjct: 278 STACMAFELATGDYLF 293
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 26/99 (26%), Positives = 38/99 (38%), Gaps = 9/99 (9%)
Query: 43 RLMFLANERDVEGIKELLDSGIDVN------FRDIDNRTALHVA---ACQGFTEVVSLLL 93
RL RD+ + E +G D LH+A A Q +V ++
Sbjct: 135 RLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFII 194
Query: 94 ERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ G +D K G+T L A Y + +KLL K A
Sbjct: 195 QNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALV 233
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 61.0 bits (147), Expect = 2e-10
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 3/101 (2%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N ++ + P L+ + + LL +G +VN D R LH A G
Sbjct: 224 ADVNWVNGGQDNATP---LIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGH 280
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
T + L L+RGAD+ +D G PL A+ N +++ LL
Sbjct: 281 TGLACLFLKRGADLGARDSEGRDPLTIAMETANADIVTLLR 321
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 5e-10
Identities = 24/87 (27%), Positives = 34/87 (39%), Gaps = 2/87 (2%)
Query: 48 ANERDVEGIKELLDSGIDVNFR--DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW 105
+ + + + L G DVN+ DN T L A LL+ GA+V+ D
Sbjct: 208 GHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSA 267
Query: 106 GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
G PL A + + L K GA
Sbjct: 268 GRGPLHHATILGHTGLACLFLKRGADL 294
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 2e-05
Identities = 38/371 (10%), Positives = 98/371 (26%), Gaps = 125/371 (33%)
Query: 19 PDRER---KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRT 75
D + + E++ + + + RL + + E +++ ++ + +N+
Sbjct: 39 QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY------- 91
Query: 76 ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135
F L+ + + T + Y + + + + + A
Sbjct: 92 --------KF------LMSPIKT-EQRQPSMMTRM----YIEQRDRL-----YNDNQVFA 127
Query: 136 PMHVKHAREVPE-----YEIDPHELDFTNSVEIT----KGTFILAFWRGIQVAVKKLGEE 186
+V + + E+ P + + G+ G + +
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKN-------VLIDGVLGS-------GKTW----VALD 169
Query: 187 VISDDDRVRAF---------------RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
V L +LQK+ + + SS + +
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH- 228
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DS 289
++A L+R L ++KP L +L + ++
Sbjct: 229 ----SIQAELRR----------------------LLKSKPYE---NCLL---VLLNVQNA 256
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS-------FAL 342
+ LLT + + +T +++ + D +
Sbjct: 257 KAWNAFNLSCKILLTTR-FKQVT------DFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309
Query: 343 ILQEMIEGCPP 353
L + P
Sbjct: 310 YLDCRPQDLPR 320
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 5e-05
Identities = 32/249 (12%), Positives = 70/249 (28%), Gaps = 72/249 (28%)
Query: 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
+ + D + + L ++ E + +++ ++N ALH
Sbjct: 398 DVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK-VKLENEYALH---------- 446
Query: 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEY 148
+++ D P Y+ +H H H+K+
Sbjct: 447 -RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG------H---------HLKNIEHPERM 490
Query: 149 EIDPHE-LDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
+ LDF F L +++ D A L LQ++
Sbjct: 491 TLFRMVFLDF-------------RF----------LEQKIRHDSTAWNASGSILNTLQQL 527
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL----KPSTAVRFALDIARGM 263
+ + + + P + + FL + K + +R AL
Sbjct: 528 K-----FYKPYICDNDPKY--ERLV--NAILDFLPKIEENLICSKYTDLLRIAL------ 572
Query: 264 NYLHENKPV 272
+ E++ +
Sbjct: 573 --MAEDEAI 579
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 27/133 (20%), Positives = 54/133 (40%), Gaps = 16/133 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
+VA+K E + + E + + ++ + + ++V + L
Sbjct: 32 NEEVAIKL---E--NVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLG 86
Query: 234 K--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDD 288
DL F RK +LK T + A + + ++H +HRD++P N L
Sbjct: 87 PSLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRR 141
Query: 289 SGNLKVADFGVSK 301
+ + + DFG++K
Sbjct: 142 ANQVYIIDFGLAK 154
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 21/77 (27%), Positives = 41/77 (53%), Gaps = 6/77 (7%)
Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL- 285
+V E L DL+ + G K ST ++ + + + Y+HEN+ +H D++ +N+L
Sbjct: 129 MVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL 184
Query: 286 -RDDSGNLKVADFGVSK 301
+ + +AD+G+S
Sbjct: 185 GYKNPDQVYLADYGLSY 201
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 30/135 (22%), Positives = 50/135 (37%), Gaps = 18/135 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLP 233
VA+K + R E +++ + Q +V E L
Sbjct: 34 NEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLG 88
Query: 234 K--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
DL R +LK T + A+ + M Y+H +I+RD++P N L R +
Sbjct: 89 PSLEDLFDLCDRTFSLK--TVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGN 143
Query: 290 GNLKVA---DFGVSK 301
+V DF ++K
Sbjct: 144 KTQQVIHIIDFALAK 158
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 6e-05
Identities = 29/202 (14%), Positives = 52/202 (25%), Gaps = 52/202 (25%)
Query: 152 PHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDD-----RVRAFRDELAL 203
+I +G F VA+K + E + E+ +
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 204 LQKI---------RHPNVVQFLGA--VTQSSP---------------------------- 224
+++ R + V S P
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 225 MMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
+ IV E+ G DL + +TA + + + + HRDL N
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGN 192
Query: 284 ILRDDSGNLKVADFGVSKLLTV 305
+L + K+ K T+
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTI 214
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 22/69 (31%), Positives = 33/69 (47%), Gaps = 8/69 (11%)
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNL 292
DL F RK +LK T + A + + Y+H IHRD++P N L +
Sbjct: 93 DLFNFCSRKFSLK--TVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLV 147
Query: 293 KVADFGVSK 301
+ DFG++K
Sbjct: 148 YIIDFGLAK 156
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 21/82 (25%), Positives = 37/82 (45%), Gaps = 12/82 (14%)
Query: 227 IVTEYLPK--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
+V + L DL RK ++K T A + + +HE +++RD++P N
Sbjct: 83 LVIDLLGPSLEDLLDLCGRKFSVK--TVAMAAKQMLARVQSIHEKS---LVYRDIKPDNF 137
Query: 285 L-----RDDSGNLKVADFGVSK 301
L ++ + V DFG+ K
Sbjct: 138 LIGRPNSKNANMIYVVDFGMVK 159
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 12/68 (17%), Positives = 28/68 (41%), Gaps = 6/68 (8%)
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLK 293
+ L + ++ A + + +LHEN+ +H ++ NI +D +
Sbjct: 146 SALDVSPKH-VLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVT 201
Query: 294 VADFGVSK 301
+A +G +
Sbjct: 202 LAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 14/68 (20%), Positives = 35/68 (51%), Gaps = 7/68 (10%)
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLK 293
+ ++ + K T ++ +L I + Y+HE++ +H D++ SN+L + +
Sbjct: 140 KIYEANAKRFSRK--TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVY 194
Query: 294 VADFGVSK 301
+ D+G++
Sbjct: 195 LVDYGLAY 202
|
| >3agd_A Salt-tolerant glutaminase; glutaminase super family, hydrolase; 2.20A {Micrococcus luteus} PDB: 3age_A* 3if5_A 3ih8_A 3ih9_A 3iha_A* 3ihb_A 2dfw_A Length = 456 | Back alignment and structure |
|---|
Score = 40.9 bits (95), Expect = 6e-04
Identities = 6/85 (7%), Positives = 17/85 (20%), Gaps = 2/85 (2%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ F E ++ + +L A + +
Sbjct: 335 IRFGGAEAVLDALTDLRTGAEKPGTGWDAAVYPRWQEAAADRAALSAATGGGAVHEAAAA 394
Query: 104 RWGSTPLGD--AIYYKNHEVIKLLE 126
G + V ++ +
Sbjct: 395 AARDENDGPIRTVVLNLARVDRIDD 419
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 387 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 4gpm_A | 169 | Engineered protein OR264; de novo protein, structu | 99.92 | |
| 1n0q_A | 93 | 3ANK, 3 ankyrin repeats; structural protein; 1.26A | 99.91 | |
| 4gpm_A | 169 | Engineered protein OR264; de novo protein, structu | 99.91 | |
| 3c5r_A | 137 | BARD-1, BRCA1-associated ring domain protein 1; an | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2jab_A | 136 | H10-2-G3; HER2, darpin, ankyrin repeat protein, me | 99.87 | |
| 1d9s_A | 136 | Cyclin-dependent kinase 4 inhibitor B; helix-turn- | 99.87 | |
| 2l6b_A | 115 | NR1C; ankyrin, consensus, repeat protein, ising mo | 99.87 | |
| 1d9s_A | 136 | Cyclin-dependent kinase 4 inhibitor B; helix-turn- | 99.87 | |
| 3aaa_C | 123 | Myotrophin, protein V-1; actin capping protein, ba | 99.87 | |
| 3f6q_A | 179 | Integrin-linked protein kinase; ILK, integrin-link | 99.86 | |
| 1bi7_B | 156 | P16INK4A, MTS1, multiple tumor suppressor; cyclin | 99.86 | |
| 3twr_A | 165 | Tankyrase-2; ankyrin repeat, protein-protein inter | 99.86 | |
| 2y1l_E | 169 | Darpin-8.4; hydrolase-inhibitor complex, DEVD darp | 99.86 | |
| 1n0r_A | 126 | 4ANK, 4 ankyrin repeats; structural protein; 1.50A | 99.85 | |
| 1awc_B | 153 | Protein (GA binding protein beta 1); complex (tran | 99.85 | |
| 1dcq_A | 278 | PYK2-associated protein beta; zinc-binding module, | 99.85 | |
| 1ihb_A | 162 | P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit | 99.85 | |
| 2jab_A | 136 | H10-2-G3; HER2, darpin, ankyrin repeat protein, me | 99.85 | |
| 2vge_A | 229 | RELA-associated inhibitor; iaspp, nucleus, apoptos | 99.85 | |
| 3v31_A | 167 | Ankyrin repeat family A protein 2; structural geno | 99.85 | |
| 3f6q_A | 179 | Integrin-linked protein kinase; ILK, integrin-link | 99.85 | |
| 2rfm_A | 192 | Putative ankyrin repeat protein TV1425; ANK repeat | 99.85 | |
| 2zgd_A | 110 | 3 repeat synthetic ankyrin; ankyrin repeat, hydrox | 99.84 | |
| 3twr_A | 165 | Tankyrase-2; ankyrin repeat, protein-protein inter | 99.84 | |
| 4b93_B | 269 | Ankyrin repeat domain-containing protein 27; endoc | 99.84 | |
| 3v30_A | 172 | DNA-binding protein rfxank; structural genomics co | 99.84 | |
| 3v30_A | 172 | DNA-binding protein rfxank; structural genomics co | 99.84 | |
| 3t8k_A | 186 | Uncharacterized protein; structural genomics, PSI- | 99.84 | |
| 3aaa_C | 123 | Myotrophin, protein V-1; actin capping protein, ba | 99.84 | |
| 1ihb_A | 162 | P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit | 99.84 | |
| 3c5r_A | 137 | BARD-1, BRCA1-associated ring domain protein 1; an | 99.84 | |
| 2y1l_E | 169 | Darpin-8.4; hydrolase-inhibitor complex, DEVD darp | 99.83 | |
| 1oy3_D | 282 | Transcription factor inhibitor I-kappa-B-beta; pro | 99.83 | |
| 1awc_B | 153 | Protein (GA binding protein beta 1); complex (tran | 99.83 | |
| 1bd8_A | 156 | P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr | 99.83 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 99.83 | |
| 3lvq_E | 497 | ARF-GAP with SH3 domain, ANK repeat and PH domain | 99.83 | |
| 1bd8_A | 156 | P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr | 99.83 | |
| 1n0r_A | 126 | 4ANK, 4 ankyrin repeats; structural protein; 1.50A | 99.83 | |
| 2b0o_E | 301 | UPLC1; arfgap, structural genomics, structural gen | 99.83 | |
| 4b93_B | 269 | Ankyrin repeat domain-containing protein 27; endoc | 99.83 | |
| 2vge_A | 229 | RELA-associated inhibitor; iaspp, nucleus, apoptos | 99.83 | |
| 2rfm_A | 192 | Putative ankyrin repeat protein TV1425; ANK repeat | 99.82 | |
| 3v31_A | 167 | Ankyrin repeat family A protein 2; structural geno | 99.82 | |
| 3deo_A | 183 | Signal recognition particle 43 kDa protein; chloro | 99.82 | |
| 2dzn_A | 228 | Probable 26S proteasome regulatory subunit P28; an | 99.82 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 99.82 | |
| 1bi7_B | 156 | P16INK4A, MTS1, multiple tumor suppressor; cyclin | 99.82 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 99.81 | |
| 1ikn_D | 236 | Protein (I-kappa-B-alpha), protein (NF-kappa-B P50 | 99.81 | |
| 3t8k_A | 186 | Uncharacterized protein; structural genomics, PSI- | 99.81 | |
| 2rfa_A | 232 | Transient receptor potential cation channel subfa | 99.81 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 99.81 | |
| 1yyh_A | 253 | HN1;, notch 1, ankyrin domain; ankyrin repeats, ce | 99.81 | |
| 4hbd_A | 276 | KN motif and ankyrin repeat domain-containing Pro; | 99.81 | |
| 3aji_A | 231 | 26S proteasome non-ATPase regulatory subunit 10; g | 99.81 | |
| 2rfa_A | 232 | Transient receptor potential cation channel subfa | 99.8 | |
| 2etb_A | 256 | Transient receptor potential cation channel subfam | 99.8 | |
| 2f8y_A | 223 | Notch homolog 1, translocation-associated (drosoph | 99.8 | |
| 1k1a_A | 241 | B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa | 99.8 | |
| 3ui2_A | 244 | Signal recognition particle 43 kDa protein, chlor; | 99.8 | |
| 3deo_A | 183 | Signal recognition particle 43 kDa protein; chloro | 99.8 | |
| 2f8y_A | 223 | Notch homolog 1, translocation-associated (drosoph | 99.8 | |
| 3ui2_A | 244 | Signal recognition particle 43 kDa protein, chlor; | 99.8 | |
| 3utm_A | 351 | Tankyrase-1; tankyrase, TNKS, ankryin repeat clust | 99.8 | |
| 1s70_B | 299 | 130 kDa myosin-binding subunit of smooth muscle my | 99.8 | |
| 1ikn_D | 236 | Protein (I-kappa-B-alpha), protein (NF-kappa-B P50 | 99.8 | |
| 3jxi_A | 260 | Vanilloid receptor-related osmotically activated p | 99.8 | |
| 3hra_A | 201 | Ankyrin repeat family protein; structural protein; | 99.79 | |
| 3aji_A | 231 | 26S proteasome non-ATPase regulatory subunit 10; g | 99.79 | |
| 3b7b_A | 237 | Euchromatic histone-lysine N-methyltransferase 1; | 99.79 | |
| 2pnn_A | 273 | Transient receptor potential cation channel subfa | 99.79 | |
| 3jue_A | 368 | Arfgap with coiled-coil, ANK repeat and PH domain | 99.79 | |
| 3kea_A | 285 | K1L; tropism, ANK repeat, viral protein; 2.30A {Va | 99.79 | |
| 2xai_A | 261 | ASB-9, ankyrin repeat and SOCS box protein 9; tran | 99.79 | |
| 1yyh_A | 253 | HN1;, notch 1, ankyrin domain; ankyrin repeats, ce | 99.78 | |
| 2xai_A | 261 | ASB-9, ankyrin repeat and SOCS box protein 9; tran | 99.78 | |
| 2etb_A | 256 | Transient receptor potential cation channel subfam | 99.78 | |
| 1k1a_A | 241 | B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa | 99.78 | |
| 3jxi_A | 260 | Vanilloid receptor-related osmotically activated p | 99.78 | |
| 1sw6_A | 327 | Regulatory protein SWI6; transcription regulation, | 99.78 | |
| 1n11_A | 437 | Ankyrin; clathrin, BAND 3, anion exchanger, struct | 99.78 | |
| 3hra_A | 201 | Ankyrin repeat family protein; structural protein; | 99.78 | |
| 3d9h_A | 285 | CDNA FLJ77766, highly similar to HOMO sapiens anky | 99.78 | |
| 3ljn_A | 364 | Hypothetical protein; ankyrin, structural genomics | 99.77 | |
| 2pnn_A | 273 | Transient receptor potential cation channel subfa | 99.77 | |
| 4g8k_A | 337 | 2-5A-dependent ribonuclease; ankyrin-repeat domain | 99.77 | |
| 1n11_A | 437 | Ankyrin; clathrin, BAND 3, anion exchanger, struct | 99.77 | |
| 1wdy_A | 285 | 2-5A-dependent ribonuclease; hydrolase, RNA-bindin | 99.77 | |
| 3b7b_A | 237 | Euchromatic histone-lysine N-methyltransferase 1; | 99.77 | |
| 1oy3_D | 282 | Transcription factor inhibitor I-kappa-B-beta; pro | 99.77 | |
| 2dzn_A | 228 | Probable 26S proteasome regulatory subunit P28; an | 99.77 | |
| 3ljn_A | 364 | Hypothetical protein; ankyrin, structural genomics | 99.77 | |
| 3d9h_A | 285 | CDNA FLJ77766, highly similar to HOMO sapiens anky | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4hbd_A | 276 | KN motif and ankyrin repeat domain-containing Pro; | 99.76 | |
| 1s70_B | 299 | 130 kDa myosin-binding subunit of smooth muscle my | 99.76 | |
| 3kea_A | 285 | K1L; tropism, ANK repeat, viral protein; 2.30A {Va | 99.76 | |
| 2fo1_E | 373 | LIN-12 protein; beta-barrel, protein-DNA complex, | 99.76 | |
| 1wdy_A | 285 | 2-5A-dependent ribonuclease; hydrolase, RNA-bindin | 99.75 | |
| 3utm_A | 351 | Tankyrase-1; tankyrase, TNKS, ankryin repeat clust | 99.74 | |
| 2fo1_E | 373 | LIN-12 protein; beta-barrel, protein-DNA complex, | 99.72 | |
| 3eu9_A | 240 | Huntingtin-interacting protein 14; epigenetics, an | 99.72 | |
| 3jue_A | 368 | Arfgap with coiled-coil, ANK repeat and PH domain | 99.71 | |
| 4g8k_A | 337 | 2-5A-dependent ribonuclease; ankyrin-repeat domain | 99.71 | |
| 3eu9_A | 240 | Huntingtin-interacting protein 14; epigenetics, an | 99.7 | |
| 1n0q_A | 93 | 3ANK, 3 ankyrin repeats; structural protein; 1.26A | 99.69 | |
| 2l6b_A | 115 | NR1C; ankyrin, consensus, repeat protein, ising mo | 99.67 | |
| 3lvq_E | 497 | ARF-GAP with SH3 domain, ANK repeat and PH domain | 99.67 | |
| 2b0o_E | 301 | UPLC1; arfgap, structural genomics, structural gen | 99.67 | |
| 1dcq_A | 278 | PYK2-associated protein beta; zinc-binding module, | 99.66 | |
| 1sw6_A | 327 | Regulatory protein SWI6; transcription regulation, | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 2aja_A | 376 | Ankyrin repeat family protein; NESG, Q5ZSV0, struc | 99.56 | |
| 2aja_A | 376 | Ankyrin repeat family protein; NESG, Q5ZSV0, struc | 99.5 | |
| 2zgd_A | 110 | 3 repeat synthetic ankyrin; ankyrin repeat, hydrox | 99.46 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.07 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.02 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.99 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.75 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.58 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.42 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.29 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.01 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.73 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.69 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.57 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.21 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.95 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.59 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.56 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.49 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.47 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.32 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.29 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.28 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.72 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.61 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.1 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.88 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 88.63 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=378.04 Aligned_cols=212 Identities=22% Similarity=0.444 Sum_probs=191.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||||++.+.........+.+.+|+.++++++|||||+++++|.+++.+|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 588889999999999984 588999999976443333345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC-CC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-DR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 309 (387)
||+||+|.+++.+.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+.... ..
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999999889999999999999999999999999 9999999999999999999999999998765432 23
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|||||++.+..++.++|||||||++|+|+||++||.+.+..++..+|..+.
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~ 250 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE 250 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 3445679999999999999999999999999999999999999999999899999998766
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-52 Score=380.75 Aligned_cols=214 Identities=22% Similarity=0.430 Sum_probs=184.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.||. +|+.||||++..... .....+.+.+|+.++++++|||||++++++.+++.+|||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 688889999999998874 589999999976654 34556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+||+|.+++...+ .+++.+++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 999999999997643 4788999999999999999999999 9999999999999999999999999998764321
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.......||+.|||||++.+..++.++|||||||++|||+||++||.+.+..++..+|..+..|++
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~ 245 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV 245 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence 122345689999999999999999999999999999999999999999999999999988886655
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=372.56 Aligned_cols=221 Identities=28% Similarity=0.466 Sum_probs=189.4
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|...+.||+|+||.||. ++..||||+++.. .....++|.+|+.++++++|||||+++++|.+++.+
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 566778999999998874 3678999999753 455678899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHc-------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCE
Q 016544 226 MIVTEYLPKGDLRAFLKRK-------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~-------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 292 (387)
++|||||++|+|.+++... ..+++.++..++.||++||.|||+++ |+||||||+|||++.++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence 9999999999999999764 25899999999999999999999998 9999999999999999999
Q ss_pred EEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 293 KVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 293 kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
||+|||+|+......... .....||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++..++..+.
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999998654332222 122357999999999999999999999999999999999 999999999999999998888
Q ss_pred CCCCCCChhhhhhcc
Q 016544 371 RPPFKAPAKLYARGL 385 (387)
Q Consensus 371 ~~~~~~~~~~~~~~l 385 (387)
+++++ +.+|+++
T Consensus 248 ~~~~p---~~~~~~~ 259 (299)
T 4asz_A 248 VLQRP---RTCPQEV 259 (299)
T ss_dssp CCCCC---TTCCHHH
T ss_pred CCCCC---ccchHHH
Confidence 76653 3455544
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=373.19 Aligned_cols=221 Identities=22% Similarity=0.384 Sum_probs=191.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|+||.||. +|+.||||++....... .+.+.+|+.++++++|||||+++++|.+++.+|||||
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 477788999999999884 58899999997543332 3557889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
||+||+|.+++.+ +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 152 y~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 226 (346)
T 4fih_A 152 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 226 (346)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence 9999999999876 46999999999999999999999999 9999999999999999999999999998765432 23
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhcc
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
.....||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++..+|.....|.+..+ ..+++++
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~-~~~s~~~ 300 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL-HKVSPSL 300 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCG-GGSCHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCcc-ccCCHHH
Confidence 3456799999999999999999999999999999999999999999988888888877665555443 4455444
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=365.22 Aligned_cols=233 Identities=27% Similarity=0.456 Sum_probs=188.1
Q ss_pred ccccCccccCcccceeecccEEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 147 EYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 147 ~~ei~~~~~~~~~~~~lg~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
.||++..++ ...+.||+|+||.||. ....||||+++... ......+.|.+|+.++++++|||||++++++.. +.
T Consensus 30 ~Wei~~~~l--~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 30 YWEIEASEV--MLSTRIGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp CCBCCTTSC--CEEEECCCCSSSEEEEEESSSEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred CcEEcHHHe--EEeeEEeeCCCcEEEEEEECCcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 577776654 4567899999999984 34579999987543 345667889999999999999999999998864 57
Q ss_pred eEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
++||||||++|+|.+++... +++++.++..|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+..
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 89999999999999999764 56999999999999999999999998 999999999999999999999999999875
Q ss_pred ccCC-CCCcccCCCCCcccccccccC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC--CCCCCCC
Q 016544 304 TVKE-DRPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKAP 377 (387)
Q Consensus 304 ~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~~~~~ 377 (387)
.... ........||+.|||||++.+ .+++.++|||||||++|||+||+.||.+.++...+..+...+ .|.++..
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 262 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL 262 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence 4322 223345679999999999964 368999999999999999999999999887766555554444 5555555
Q ss_pred hhhhhhccc
Q 016544 378 AKLYARGLK 386 (387)
Q Consensus 378 ~~~~~~~l~ 386 (387)
+..+|++++
T Consensus 263 ~~~~~~~l~ 271 (307)
T 3omv_A 263 YKNCPKAMK 271 (307)
T ss_dssp CTTSCHHHH
T ss_pred cccchHHHH
Confidence 666766653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=359.59 Aligned_cols=209 Identities=28% Similarity=0.475 Sum_probs=172.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+..+.||+|+||.|+. +|+.||+|++.+.........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 577888999999998874 589999999987665555556789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+ +|+|.+++.+.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~ 167 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NF 167 (275)
T ss_dssp CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC--Cc
Confidence 99 6799999999889999999999999999999999999 999999999999999999999999999865432 22
Q ss_pred cccCCCCCcccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....||+.|+|||++.+..+ +.++|||||||++|+|+||+.||.+.+..++.++|..+.
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~ 228 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV 228 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence 334679999999999998876 579999999999999999999999988888888887665
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=370.96 Aligned_cols=218 Identities=27% Similarity=0.391 Sum_probs=185.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|+||.||. +|+.||||+++..... .+|+.++++++|||||+++++|.+++.+|||||
T Consensus 59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 466677899999999984 5889999999765332 469999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+||+|.+++.+.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.+| .+||+|||+|+........
T Consensus 131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999999999889999999999999999999999999 99999999999999887 5999999999876533211
Q ss_pred ----CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhcc
Q 016544 310 ----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 310 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
......||+.|||||++.+..++.++|||||||++|||+||++||.+.+..++..+|.....| +...++.+|+++
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~s~~~ 286 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP-IREIPPSCAPLT 286 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG-GGGSCTTSCHHH
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC-chhcCccCCHHH
Confidence 123356999999999999999999999999999999999999999999999999998776543 223334455544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=370.14 Aligned_cols=221 Identities=28% Similarity=0.458 Sum_probs=184.6
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
++...++||+|+||.||. ++..||||+++.. .....++|.+|+.++++++|||||+++++|.+...+
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 456677899999999974 3688999999743 456678899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHc---------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC
Q 016544 226 MIVTEYLPKGDLRAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~---------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~ 290 (387)
|||||||++|+|.+++... +++++.+++.|+.||+.||.|||+++ ||||||||+|||++.++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence 9999999999999999753 35899999999999999999999998 99999999999999999
Q ss_pred CEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHc
Q 016544 291 NLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 291 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~ 368 (387)
.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++...|..
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999986543322 22234568999999999999999999999999999999999 9999999999999999988
Q ss_pred cCCCCCCCChhhhhhcc
Q 016544 369 RQRPPFKAPAKLYARGL 385 (387)
Q Consensus 369 ~~~~~~~~~~~~~~~~l 385 (387)
+.+++++ +.+|+++
T Consensus 276 g~~~~~p---~~~~~~~ 289 (329)
T 4aoj_A 276 GRELERP---RACPPEV 289 (329)
T ss_dssp TCCCCCC---TTCCHHH
T ss_pred CCCCCCc---ccccHHH
Confidence 8776653 3455544
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=368.33 Aligned_cols=228 Identities=28% Similarity=0.460 Sum_probs=191.3
Q ss_pred cccCccccCcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeee
Q 016544 148 YEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217 (387)
Q Consensus 148 ~ei~~~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~ 217 (387)
.++...+++ ..+.||+|+||.||. +++.||||+++... .....++|.+|+.++++++|||||+++|
T Consensus 21 ~ei~~~~~~--~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g 96 (308)
T 4gt4_A 21 KEISLSAVR--FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLG 96 (308)
T ss_dssp CBCCGGGEE--EEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCCHHHCe--EeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcce
Confidence 344444433 456899999999874 35789999997543 2344578999999999999999999999
Q ss_pred EEeeCCceEEEEEccCCCCHHHHHHHc----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 016544 218 AVTQSSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281 (387)
Q Consensus 218 ~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp 281 (387)
+|..++.+++|||||++|+|.+++... ..+++.++..++.||++||+|||+++ ||||||||
T Consensus 97 ~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~ 173 (308)
T 4gt4_A 97 VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLAT 173 (308)
T ss_dssp EECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccc
Confidence 999999999999999999999999643 34889999999999999999999999 99999999
Q ss_pred CCEEeCCCCCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCC
Q 016544 282 SNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 359 (387)
Q Consensus 282 ~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~ 359 (387)
+|||++.++.+||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+.
T Consensus 174 ~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 174 RNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp GGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred cceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986644322 22334568999999999999999999999999999999998 8999999999
Q ss_pred CcHHHHHHccCCCCCCCChhhhhhcc
Q 016544 360 NEVPKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
.++...|..+.+++.+ ..+|+++
T Consensus 254 ~~~~~~i~~~~~~~~p---~~~~~~~ 276 (308)
T 4gt4_A 254 QDVVEMIRNRQVLPCP---DDCPAWV 276 (308)
T ss_dssp HHHHHHHHTTCCCCCC---TTCCHHH
T ss_pred HHHHHHHHcCCCCCCc---ccchHHH
Confidence 9999999888876653 3445443
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=368.95 Aligned_cols=211 Identities=26% Similarity=0.373 Sum_probs=180.5
Q ss_pred CcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|...+.||+|+||.|+. +++.||||++.+...... ....+.+|+.++++++|||||++++++.+++.+|+
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 688889999999999973 367899999976433221 12357789999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|||||+||+|.+++.+.+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999999999999889999999999999999999999999 9999999999999999999999999998654332
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 371 (387)
.......||+.|||||++.+..++.++|||||||++|||+||++||.+.+..++..+|..+..
T Consensus 181 -~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~ 243 (304)
T 3ubd_A 181 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL 243 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred -ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC
Confidence 233446799999999999999999999999999999999999999999999999999977653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=357.10 Aligned_cols=208 Identities=26% Similarity=0.528 Sum_probs=176.6
Q ss_pred ccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee----CCceEEE
Q 016544 158 TNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPMMIV 228 (387)
Q Consensus 158 ~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~~lv 228 (387)
...++||+|+||.||. ++..||+|++..... .....+.|.+|+.++++++|||||+++++|.+ +..+|+|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4456799999999984 478999999976544 34556789999999999999999999999875 3458999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC-CCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||||+||+|.+++.+.+.+++..+..|+.||+.||+|||++++ +|+||||||+|||++ .++.+||+|||+|+...
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~--- 183 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 183 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCC---
Confidence 9999999999999998899999999999999999999999873 599999999999998 47899999999997543
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-HHHHHHccCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQR 371 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~-~~~~i~~~~~ 371 (387)
........||+.|||||++.+ +++.++|||||||++|||+||++||.+.+... +...+..+.+
T Consensus 184 ~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~ 247 (290)
T 3fpq_A 184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC
Confidence 223345679999999999876 69999999999999999999999998765544 4455544433
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=373.68 Aligned_cols=221 Identities=22% Similarity=0.384 Sum_probs=191.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|+||.||. +|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 578888999999999984 58999999997543322 3568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
||+||+|.+++.. +.+++.++..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|..+.... ..
T Consensus 229 y~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 303 (423)
T 4fie_A 229 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 303 (423)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CC
T ss_pred CCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-cc
Confidence 9999999999875 45999999999999999999999999 9999999999999999999999999998765432 23
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhcc
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
.....||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++...|.....|.+..+ ..+++++
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~-~~~s~~~ 377 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL-HKVSPSL 377 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCT-TSSCHHH
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCccc-ccCCHHH
Confidence 3446789999999999999999999999999999999999999999998889998877765555433 3344433
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=353.74 Aligned_cols=222 Identities=28% Similarity=0.461 Sum_probs=184.3
Q ss_pred ccccCccccCcccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCC-Ccceee
Q 016544 147 EYEIDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQF 215 (387)
Q Consensus 147 ~~ei~~~~~~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l 215 (387)
.||++.. +|...+.||+|+||.||.. ++.||||.+.... .....+.|.+|+.++.++.| ||||++
T Consensus 58 ~wEi~~~--~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 58 KWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp HHBCCGG--GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccEecHH--HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4666654 5667789999999999741 3689999997543 34556789999999999965 999999
Q ss_pred eeEEeeC-CceEEEEEccCCCCHHHHHHHc----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Q 016544 216 LGAVTQS-SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278 (387)
Q Consensus 216 ~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~D 278 (387)
+++|... ..+++|||||++|+|.++++.. ..+++.++..++.||+.||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9998764 5689999999999999999753 23789999999999999999999999 99999
Q ss_pred CCCCCEEeCCCCCEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 016544 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTM 356 (387)
Q Consensus 279 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~ 356 (387)
|||+|||++.++.+||+|||+|+......... .....||+.|||||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765433222 233457999999999999999999999999999999998 9999998
Q ss_pred CCCCc-HHHHHHccCCCCCC
Q 016544 357 KHDNE-VPKAYAARQRPPFK 375 (387)
Q Consensus 357 ~~~~~-~~~~i~~~~~~~~~ 375 (387)
.+..+ +...+..+.+++++
T Consensus 291 ~~~~~~~~~~i~~g~~~~~p 310 (353)
T 4ase_A 291 VKIDEEFCRRLKEGTRMRAP 310 (353)
T ss_dssp CCCSHHHHHHHHHTCCCCCC
T ss_pred CCHHHHHHHHHHcCCCCCCC
Confidence 77554 45556555566653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=336.06 Aligned_cols=194 Identities=28% Similarity=0.475 Sum_probs=157.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC-------
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------- 223 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------- 223 (387)
+|...+.||+|+||.|+. +|+.||||++... ..+...+.+.+|+.++++++|||||+++++|...+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP--NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC--SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 467778999999999974 5889999998754 34556678999999999999999999999987654
Q ss_pred -----ceEEEEEccCCCCHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEE
Q 016544 224 -----PMMIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (387)
Q Consensus 224 -----~~~lv~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 295 (387)
.+|+|||||++|+|.+++...+. .++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 37999999999999999987654 345568899999999999999999 9999999999999999999999
Q ss_pred eecCccccccCCCC-----------CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 296 DFGVSKLLTVKEDR-----------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 296 Dfg~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
|||+|+........ ..+...||+.|||||++.+..++.++|||||||++|||++ ||.+.
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 99999876543221 1133569999999999999999999999999999999996 88653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=362.43 Aligned_cols=200 Identities=26% Similarity=0.421 Sum_probs=173.0
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccC---CCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|...+.||+|+||.|+. +|+.||||++.+... .........+.++.+++.++|||||+++++|.+...+|+
T Consensus 190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl 269 (689)
T 3v5w_A 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 269 (689)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence 688889999999999984 689999999975432 122223333445677778899999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||||++||+|.+++.+.+.+++..+..++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|......
T Consensus 270 VmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~- 345 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 345 (689)
T ss_dssp EECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCC-
Confidence 9999999999999999999999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 016544 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~ 361 (387)
......||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+...
T Consensus 346 --~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~ 398 (689)
T 3v5w_A 346 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398 (689)
T ss_dssp --CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC
T ss_pred --CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 2234579999999999974 579999999999999999999999998765543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=343.74 Aligned_cols=210 Identities=24% Similarity=0.391 Sum_probs=181.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC------Cc
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~~ 224 (387)
+|...+.||+|+||.|+. +|+.||||++..... .....+.+.+|+.+|+.++|||||++++++... +.
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 588889999999999974 589999999976533 345567788999999999999999999987643 57
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
+|+|||||+ |+|.+++.+.+.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 899999995 689999998888999999999999999999999999 9999999999999999999999999998654
Q ss_pred cCC---CCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 305 VKE---DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 305 ~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
... ........||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+..+.+.+|....
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL 279 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 321 2233456899999999998875 56899999999999999999999999998888888876544
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=333.80 Aligned_cols=195 Identities=28% Similarity=0.450 Sum_probs=156.7
Q ss_pred CcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC----ceEEE
Q 016544 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~~lv 228 (387)
++...+.||+|+||.|| ++|+.||||++.... ........|+..+.+++|||||++++++..++ .+|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 45667789999998876 689999999986431 22222344666667889999999999998654 57999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC-----CCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK-----PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
||||++|+|.++++.. ++++..+..++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+|+..
T Consensus 80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 9999999999999865 5899999999999999999999871 123999999999999999999999999999876
Q ss_pred ccCCCC---CcccCCCCCcccccccccCC------CCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 304 TVKEDR---PLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 304 ~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
...... ......||+.|||||++.+. .++.++|||||||++|||+||.+||.
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 543322 12335689999999999764 35678999999999999999977654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=353.08 Aligned_cols=207 Identities=23% Similarity=0.432 Sum_probs=185.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||+|.+... .....+.+.+|+.+|+.++||||++++++|.++..+|+|||
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 688889999999999874 6899999998653 34456778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC--CCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~ 307 (387)
||+||+|.+++.. .+.+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999999999964 456999999999999999999999999 9999999999999854 78999999999876532
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+++.+|....
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~ 372 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 372 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC
Confidence 33344579999999999999999999999999999999999999999999999999998776
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=326.37 Aligned_cols=201 Identities=21% Similarity=0.312 Sum_probs=166.8
Q ss_pred cCcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCce
Q 016544 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~ 225 (387)
..|...+.||+|+||.||. .++.||+|.+.... . ...+.+|+++++.+ +||||++++++|.+.+.+
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--H---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--C---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--C---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 3588889999999999974 25789999886542 1 24577899999988 699999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC-CCEEEEeecCccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLT 304 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfg~~~~~~ 304 (387)
|+||||+++|+|.+++. .+++.++..++.|++.||+|||++| |+||||||+|||++.+ +.+||+|||+|+...
T Consensus 96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 99999999999999984 4899999999999999999999999 9999999999999876 799999999997543
Q ss_pred cCCC---------------------------CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 305 VKED---------------------------RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 305 ~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
.... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 2211 112335699999999999875 589999999999999999999999965
Q ss_pred CCC-CcHHHHH
Q 016544 357 KHD-NEVPKAY 366 (387)
Q Consensus 357 ~~~-~~~~~~i 366 (387)
.++ .+.+.+|
T Consensus 250 ~~~~~~~l~~I 260 (361)
T 4f9c_A 250 ASDDLTALAQI 260 (361)
T ss_dssp CSSHHHHHHHH
T ss_pred CCCHHHHHHHH
Confidence 433 3334443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=312.31 Aligned_cols=216 Identities=25% Similarity=0.429 Sum_probs=184.4
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. ++..||+|.+...........+.+.+|+.++++++||||+++++++...+.+++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 3688889999999998873 57899999987666666777888999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++...+++++.+++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999999999998888999999999999999999999999 999999999999999999999999999876544333
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+......+......|.
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 231 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN 231 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCC
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCC
Confidence 3344568999999999999999999999999999999999999999887766655555554443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=332.48 Aligned_cols=215 Identities=23% Similarity=0.342 Sum_probs=184.4
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
...+|...+.||+|+||.|+. +++.||+|++.+...........+.+|..++..++||||++++++|.+...+|+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 344688889999999999874 478999999865321111122347889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
||||+++|+|.+++.+ .+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 9999999999999987 467999999999999999999999999 999999999999999999999999999766544
Q ss_pred CCCCcccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..++..+|....
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 297 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence 333334457899999999997 4578999999999999999999999999998888888887644
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=314.22 Aligned_cols=211 Identities=27% Similarity=0.421 Sum_probs=184.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||+|++.+...........+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 577788999999999874 588999999975432222234668889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~ 161 (337)
T 1o6l_A 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GAT 161 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCC
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC-CCc
Confidence 9999999999998888999999999999999999999999 999999999999999999999999998754322 222
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++.+.+....
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~ 221 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 334568999999999999999999999999999999999999999988888888887655
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=318.77 Aligned_cols=211 Identities=27% Similarity=0.434 Sum_probs=182.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|...+.||+|+||.|+. +|+.||+|++.+.........+.+..|..+++.+ +||||+++++++.....+|+||
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~ 103 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence 677888999999999874 4789999999764333333456678899999988 7999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 104 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-~~ 179 (353)
T 3txo_A 104 EFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-GV 179 (353)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccC-Cc
Confidence 99999999999998888999999999999999999999999 999999999999999999999999999754322 22
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++..+|..+.
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~ 240 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 240 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 3334568999999999999899999999999999999999999999999888999987766
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=327.88 Aligned_cols=214 Identities=24% Similarity=0.347 Sum_probs=183.9
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
..+|...+.||+|+||.|+. +|+.||+|++.+.........+.+.+|..++..++||||+++++++.+...+|+|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV 139 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV 139 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 34688888999999998873 5889999998753221222234578899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|||+++|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 99999999999998764 6999999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCCcccCCCCCccccccccc-------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 308 DRPLTCQDTSCRYVAPEVFK-------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
........||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..++..+|....
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 286 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 32233457899999999997 3568999999999999999999999999988888888887643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=309.70 Aligned_cols=211 Identities=27% Similarity=0.488 Sum_probs=188.3
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
.-+|...+.||+|+||.|+. +|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 34688889999999998873 689999999976543 445567788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 167 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-- 167 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC--
Confidence 999999999999998888999999999999999999999999 999999999999999999999999999765433
Q ss_pred CCcccCCCCCcccccccccCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......||+.|+|||++.+..+. +++|||||||++|+|++|+.||.+.+..++..++..+.
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 230 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 233445789999999999988765 78999999999999999999999998888888887766
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=314.33 Aligned_cols=213 Identities=25% Similarity=0.402 Sum_probs=186.7
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCC---HHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD---DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
....|...+.||+|+||.|+. +|..||+|.+....... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 344688889999999999874 58899999987654321 1124678899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC----CEEEEeecCc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVS 300 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Dfg~~ 300 (387)
+++||||+++++|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999988888999999999999999999999999 99999999999998777 7999999999
Q ss_pred cccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++..+|....
T Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~ 234 (361)
T 2yab_A 167 HEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS 234 (361)
T ss_dssp EECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred eEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence 876532 22334568999999999999999999999999999999999999999988888888887665
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=309.41 Aligned_cols=208 Identities=26% Similarity=0.492 Sum_probs=184.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||+|++.+.........+.+.+|..+++.++||||+++++++.+...+|+|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 577788999999998874 588999999875432222234667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 87 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---- 159 (318)
T 1fot_A 87 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 159 (318)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc----
Confidence 9999999999998888999999999999999999999999 999999999999999999999999999765422
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+...+|....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 219 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE 219 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 233568999999999999999999999999999999999999999988888888887665
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=301.84 Aligned_cols=222 Identities=23% Similarity=0.438 Sum_probs=190.0
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
..+|+..+.||+|+||.|+. +|+.||+|.+....... .+.+.+|+.++++++||||+++++++...+..++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 34688889999999999874 57899999987544333 35678899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|||+++++|.+++... .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 170 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (297)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-
Confidence 9999999999999875 5899999999999999999999999 9999999999999999999999999987665432
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhc
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 384 (387)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....+.+..+ ..+++.
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 245 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAI 245 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCG-GGSCHH
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCc-cccCHH
Confidence 223345689999999999999999999999999999999999999998887777777766666555443 344443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=312.51 Aligned_cols=214 Identities=29% Similarity=0.447 Sum_probs=185.1
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceE
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~ 226 (387)
...+|...+.||+|+||.|+. +|+.||+|++.+.........+.+..|..++..+ +||||+++++++.+...+|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 334688889999999998874 5889999999754321122345677899999877 8999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+||||+++|+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999998888999999999999999999999999 999999999999999999999999999754322
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++..+|....
T Consensus 172 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~ 234 (345)
T 1xjd_A 172 -DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 234 (345)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred -CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC
Confidence 222344578999999999999999999999999999999999999999988888888887655
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=318.03 Aligned_cols=212 Identities=19% Similarity=0.357 Sum_probs=186.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +|..||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 3677888999999999874 589999999876543 3445577899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC---CCCCEEEEeecCccccccC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~ 306 (387)
||+.+|+|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999999999998888999999999999999999999999 99999999999998 4678999999999766533
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 371 (387)
........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..++..++..+..
T Consensus 167 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 230 (444)
T 3soa_A 167 -QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAY 230 (444)
T ss_dssp -CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred -CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCC
Confidence 2223345789999999999999999999999999999999999999999988888998877763
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=325.85 Aligned_cols=214 Identities=25% Similarity=0.355 Sum_probs=182.7
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
...+|...+.||+|+||.|+. ++..||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 344688889999999999874 478999999864221111112347789999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||||++||+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 147 V~E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EECCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEeCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 99999999999998764 5899999999999999999999999 9999999999999999999999999997765433
Q ss_pred CCCcccCCCCCcccccccccCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..++..+|....
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 289 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Confidence 22333567899999999998765 7889999999999999999999999998888889887654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=312.32 Aligned_cols=212 Identities=29% Similarity=0.439 Sum_probs=185.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 228 (387)
.+|...+.||+|+||.|+. +|+.||+|++.+.........+.+..|..++..+ +||+|+++++++.....+|+|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 3677888999999998874 4678999998754322222346678899999988 799999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|||++||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... .
T Consensus 100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~ 175 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-G 175 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC-C
Confidence 999999999999998888999999999999999999999999 999999999999999999999999999754322 2
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.++|....
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~ 237 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 237 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC
Confidence 23344578999999999999999999999999999999999999999988888888887765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=306.88 Aligned_cols=197 Identities=28% Similarity=0.494 Sum_probs=178.0
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|...+.||+|+||.|+. +++.||+|++.+.........+.+.+|..+++++ +||||+++++++.....+|+||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 577788999999999874 4889999999877766777778899999999988 8999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 90 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-~~ 165 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GD 165 (345)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-TC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC-CC
Confidence 99999999999998888999999999999999999999999 999999999999999999999999998754322 22
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 33445789999999999999999999999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=310.81 Aligned_cols=210 Identities=23% Similarity=0.423 Sum_probs=185.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|..||+|++..... .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 578888999999999874 488999999976543 34556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC---CEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~ 307 (387)
|+++++|.+++.....+++.++..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++......
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 9999999999988888999999999999999999999999 99999999999998654 5999999999766432
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 371 (387)
.......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..++..++..+..
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~ 247 (362)
T 2bdw_A 185 -EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 247 (362)
T ss_dssp -CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred -cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 223345789999999999999999999999999999999999999999888888888877663
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=313.89 Aligned_cols=198 Identities=27% Similarity=0.488 Sum_probs=174.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|...+.||+|+||.|+. +++.||+|++.+.........+.+..|..+++++ +||||+++++++.+...+|+||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 677888999999999874 5789999999876665555666788899999887 8999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++|+|..++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 133 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~~ 208 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GD 208 (396)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TC
T ss_pred EcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC-CC
Confidence 99999999999998888999999999999999999999999 999999999999999999999999999753322 22
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 334467899999999999999999999999999999999999999643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=311.75 Aligned_cols=209 Identities=25% Similarity=0.421 Sum_probs=185.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +|..||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 3677888999999998873 58899999986543222223467888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 99999999999998888999999999999999999999999 999999999999999999999999999865432
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++.++|..+.
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~ 254 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 223457999999999999999999999999999999999999999988888888887765
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=309.23 Aligned_cols=215 Identities=28% Similarity=0.506 Sum_probs=186.3
Q ss_pred cCcccceeecccEEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEee
Q 016544 155 LDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~ 221 (387)
.+|...+.||+|+||.||. .+..||||++... ......+.+.+|+.+++++ +||||+++++++..
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4677888999999998873 2357999999754 3456677899999999999 89999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEE
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nil 285 (387)
.+.+|+||||+++|+|.+++.... .+++.+++.++.||+.||.|||+++ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 999999999999999999998653 3788999999999999999999999 999999999999
Q ss_pred eCCCCCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHH
Q 016544 286 RDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 363 (387)
Q Consensus 286 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~ 363 (387)
++.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999986543322 22233456789999999999999999999999999999999 99999999988888
Q ss_pred HHHHccCCCCC
Q 016544 364 KAYAARQRPPF 374 (387)
Q Consensus 364 ~~i~~~~~~~~ 374 (387)
..+..+.++..
T Consensus 316 ~~~~~~~~~~~ 326 (370)
T 2psq_A 316 KLLKEGHRMDK 326 (370)
T ss_dssp HHHHTTCCCCC
T ss_pred HHHhcCCCCCC
Confidence 88877766554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=309.32 Aligned_cols=214 Identities=26% Similarity=0.425 Sum_probs=180.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc----e
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----M 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----~ 225 (387)
.+|...+.||+|+||.|+. +++.||||++.............+.+|+.++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 3688889999999998873 678999999987766677777889999999999999999999999886654 4
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
|+||||+++++|.+++...+.+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999976543
Q ss_pred CCCC--CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCC
Q 016544 306 KEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 306 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 371 (387)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......++.....
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 236 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC
Confidence 3221 22334579999999999999999999999999999999999999998887777666655553
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.31 Aligned_cols=212 Identities=28% Similarity=0.452 Sum_probs=177.6
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHH-HHcCCCCcceeeeeEEeeCCceEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
.+|...+.||+|+||.|+. ++..||+|++.+...........+..|..+ ++.++||||+++++++.....+|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 3688889999999998874 578999999987665555555666777776 4678999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|||++||+|.+++.+.+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-~ 193 (373)
T 2r5t_A 118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-N 193 (373)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-C
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC-C
Confidence 999999999999998888999999999999999999999999 999999999999999999999999999754322 2
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..++.++|....
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~ 255 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP 255 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc
Confidence 23344578999999999999999999999999999999999999999988888888887665
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=300.96 Aligned_cols=212 Identities=38% Similarity=0.619 Sum_probs=175.8
Q ss_pred cCcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
.+|...+.||+|+||.|+ .+|..||||++..... .....+.+.+|+.++++++||||+++++++......++||||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 367788899999999876 5789999999976543 455667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 232 LPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
+++++|.+++...+. +++..++.++.|++.||.|||+++ .+|+||||||+||+++.++.+||+|||++...... .
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~ 193 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-F 193 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc-c
Confidence 999999999987543 899999999999999999999986 24999999999999999999999999998754332 2
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~ 254 (309)
T 3p86_A 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 254 (309)
T ss_dssp --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS
T ss_pred cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 2223456899999999999999999999999999999999999999998877777776433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=312.14 Aligned_cols=202 Identities=27% Similarity=0.492 Sum_probs=175.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. ++..||+|++.+.........+.+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 677888999999998873 578999999875432222334678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+.+|+|.+++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 96 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~ 170 (384)
T 4fr4_A 96 LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQ 170 (384)
T ss_dssp CCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT--CC
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC--Cc
Confidence 9999999999998888999999999999999999999999 999999999999999999999999999875432 33
Q ss_pred cccCCCCCcccccccccC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 311 LTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+....
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~ 225 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH
Confidence 344678999999999974 4588999999999999999999999986655443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=303.97 Aligned_cols=212 Identities=26% Similarity=0.426 Sum_probs=175.2
Q ss_pred cCcccceeecccEEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
.+|...+.||+|+||.|+. +|..||+|++.+.... .......+.+|+.+++.++||||+++++++...+.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 3678888999999998872 6789999999865332 223445678899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
|+||||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++....
T Consensus 174 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 237 (327)
T 3a62_A 174 D-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK 237 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred C-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 2 122234568999999999999999999999999999999999999999988888888887655
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=304.66 Aligned_cols=209 Identities=18% Similarity=0.347 Sum_probs=183.8
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. ++..||+|.+... ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 3678888999999999884 5889999998643 234566889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC--CCCEEEEeecCccccccC
Q 016544 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~ 306 (387)
||+++++|.+++.... .+++.++..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999997654 6999999999999999999999999 999999999999997 789999999999876432
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
.......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++..++.....+
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 221 (321)
T 1tki_A 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT 221 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred --CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCC
Confidence 2233456799999999999988899999999999999999999999998888888888776643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=303.46 Aligned_cols=211 Identities=25% Similarity=0.419 Sum_probs=183.8
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCC---HHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD---DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
..|...+.||+|+||.|+. +|..||+|.+....... ....+.+.+|+.++++++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3577888999999999874 48899999987543321 113467889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC----CEEEEeecCccc
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKL 302 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Dfg~~~~ 302 (387)
+||||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 99999999999999988888999999999999999999999999 99999999999999887 799999999987
Q ss_pred cccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 233 (326)
T 2y0a_A 168 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 233 (326)
T ss_dssp CCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTC
T ss_pred CCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcC
Confidence 64322 2234568999999999999999999999999999999999999999888777777776554
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=305.90 Aligned_cols=209 Identities=29% Similarity=0.477 Sum_probs=179.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||+|++.............+.+|+.+++.++||||+++++++.....+++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 677888999999998873 678999999865322212223568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+ +|+|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....... .
T Consensus 90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--~ 163 (336)
T 3h4j_B 90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--F 163 (336)
T ss_dssp CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--T
T ss_pred CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc--c
Confidence 99 7899999988888999999999999999999999999 9999999999999999999999999998654332 2
Q ss_pred cccCCCCCcccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....||+.|+|||++.+..+ ++++|||||||++|+|++|+.||.+.....+.+++....
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~ 224 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV 224 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSC
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC
Confidence 234568999999999998776 689999999999999999999999887777666664443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=316.85 Aligned_cols=211 Identities=27% Similarity=0.419 Sum_probs=176.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|..||||++.............+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 577888999999999873 578999999976544444555677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++++|.+++.....+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~ 304 (446)
T 4ejn_A 229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GA 304 (446)
T ss_dssp CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC-Cc
Confidence 99999999999988889999999999999999999998 88 999999999999999999999999998754322 22
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+...+....
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~ 365 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 365 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC
Confidence 2344678999999999999999999999999999999999999999988888888887665
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=300.23 Aligned_cols=216 Identities=29% Similarity=0.463 Sum_probs=184.0
Q ss_pred ccCcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
..+|...+.||+|+||.|+. .+..||||.+... ......+.+.+|+.++++++||||+++++++......
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 34677888999999998873 2446999999754 2455667899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
++||||+++++|.+++... +.+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++....
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999999764 56999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCC--cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 305 VKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 305 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
...... .....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+....++...+..+.+++.
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~ 275 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA 275 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC
Confidence 432222 122345778999999998899999999999999999999 9999999998888888877765544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=296.62 Aligned_cols=209 Identities=22% Similarity=0.321 Sum_probs=172.5
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
-+|...+.||+|+||.||. +++.||+|++...........+.+.+|+.++++++||||+++++++..++..+++|
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 3688889999999988873 57899999998765556666788999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++...+.+++.+++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.........
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 114 RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 99999999999998888999999999999999999999999 999999999999999999999999998766543333
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+...+...+
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI 247 (309)
T ss_dssp ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH
T ss_pred cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh
Confidence 334456899999999999999999999999999999999999999987655444444
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=308.78 Aligned_cols=207 Identities=31% Similarity=0.550 Sum_probs=180.2
Q ss_pred CcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC-ceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-PMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-~~~lv~e~ 231 (387)
+|...+.||+|+||.|+ +.|+.||||.++... ..+.+.+|+.++++++||||+++++++.... .+++||||
T Consensus 194 ~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 194 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred HeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 56677899999999876 578999999997543 2367889999999999999999999987665 79999999
Q ss_pred cCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++|+|.+++...+. +++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 999999999987654 789999999999999999999999 999999999999999999999999999754322
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.....+++.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+..+.+++.
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 407 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA 407 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCC
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 122356789999999999999999999999999999998 9999999999999999887766554
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=292.00 Aligned_cols=212 Identities=30% Similarity=0.524 Sum_probs=183.7
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|...+.||+|+||.|+. ++..||+|++...... .+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 577788999999998874 6789999999865432 25688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++++|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++..........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999999999764 45899999999999999999999999 9999999999999999999999999997654332222
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.....+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+..++...+..+.++..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~ 228 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 228 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC
Confidence 333456788999999998899999999999999999999 9999999988888888877654443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=291.50 Aligned_cols=215 Identities=23% Similarity=0.444 Sum_probs=173.7
Q ss_pred ccCcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
..+|...+.||+|+||.|+. .+..||+|.+... ......+.+.+|+.++++++||||+++++++. ++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 34677888999999998873 2457999998754 34566778999999999999999999999984 5678
Q ss_pred EEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999998654 5899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
...........+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..++...+..+.++++
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~ 238 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 238 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC
Confidence 433333334456788999999998899999999999999999996 9999999998889988887765554
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=289.41 Aligned_cols=214 Identities=30% Similarity=0.502 Sum_probs=184.0
Q ss_pred ccCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
..+|...+.||+|+||.|+. ++..||+|++...... .+.+.+|+.++++++||||+++++++......++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 34678888999999998873 4568999999765432 256888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+++++|.+++...+ .+++.+++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999999998754 4999999999999999999999999 99999999999999999999999999986654332
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+......++..+.++..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 226 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR 226 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC
Confidence 23333456778999999999889999999999999999999 9999999888888888776664443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=303.16 Aligned_cols=208 Identities=18% Similarity=0.383 Sum_probs=181.9
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
..|...+.||+|+||.|+. +|..||+|.+... .......+.+|+.++++++||||+++++++.....+++||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc---chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 3688889999999999874 5789999998643 2344567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC--CCCEEEEeecCccccccC
Q 016544 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~ 306 (387)
||+++++|.+++.... .+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++......
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999997654 5899999999999999999999999 999999999999974 467999999999876432
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...++....
T Consensus 205 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~ 266 (387)
T 1kob_A 205 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 266 (387)
T ss_dssp --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC
T ss_pred --cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 22333468999999999999999999999999999999999999999988777888876665
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=317.83 Aligned_cols=211 Identities=26% Similarity=0.408 Sum_probs=179.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +|+.||+|++.+.........+.+.+|+.++++++||||+++++++.....+|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 3677788999999998874 58999999997543322223466888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 230 EYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 230 e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
||++||+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999764 35899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC----CcHHHHHHcc
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD----NEVPKAYAAR 369 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~----~~~~~~i~~~ 369 (387)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+. .++.+.+...
T Consensus 342 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~ 408 (543)
T 3c4z_A 342 GQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408 (543)
T ss_dssp TC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC
T ss_pred CC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc
Confidence 32 222335789999999999999999999999999999999999999987643 3345555443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=286.98 Aligned_cols=212 Identities=24% Similarity=0.371 Sum_probs=187.6
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. ++..||+|.+...........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 4688889999999998874 47899999998766666677788999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++...+.+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 170 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-E 170 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc-c
Confidence 99999999999998888999999999999999999999999 9999999999999999999999999997654322 2
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.+....+....+....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 231 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 231 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc
Confidence 2334568999999999999889999999999999999999999999877666666665544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=303.14 Aligned_cols=210 Identities=25% Similarity=0.402 Sum_probs=176.0
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
.|...+.||+|+||.|+. +|+.||||++...... .....+.+.+|+.+++.++||||+++++++..++.+|+|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 104 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV 104 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 577888999999999874 5789999998642211 111246788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC---EEEEeecCcc
Q 016544 229 TEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSK 301 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfg~~~ 301 (387)
|||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++.
T Consensus 105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999998887643 24899999999999999999999999 999999999999986654 9999999998
Q ss_pred ccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. .++...+..+.
T Consensus 182 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~ 248 (351)
T 3c0i_A 182 QLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGK 248 (351)
T ss_dssp ECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTC
T ss_pred EecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCC
Confidence 765332 22234568999999999999999999999999999999999999998754 45566665554
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=301.81 Aligned_cols=204 Identities=24% Similarity=0.403 Sum_probs=173.6
Q ss_pred ceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 160 ~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
.+.||+|+||.||. +|..||+|++... .....+.+.+|+.++++++||||+++++++.....+++||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc---ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 56799999998874 5789999998754 234567789999999999999999999999999999999999999
Q ss_pred CCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe--CCCCCEEEEeecCccccccCCCCCc
Q 016544 235 GDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--DDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 235 ~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
++|.+++... ..+++.++..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++....... ..
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~ 245 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL 245 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence 9999988754 45899999999999999999999999 9999999999999 567789999999998764332 22
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCC
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 371 (387)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.++.....
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 305 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW 305 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Confidence 334689999999999998999999999999999999999999999888888888876653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=287.85 Aligned_cols=210 Identities=23% Similarity=0.421 Sum_probs=185.9
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +|..||+|++..... .....+.+.+|+.++++++||||+++++++......+++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4688889999999998874 478999999976543 4455677899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC---EEEEeecCccccccC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTVK 306 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~ 306 (387)
||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++. ++|+|||++......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999999999988888999999999999999999999999 999999999999986655 999999999765432
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+...+...+..+.
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 223 (284)
T 3kk8_A 162 --EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 223 (284)
T ss_dssp --CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred --ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcc
Confidence 22234568999999999999999999999999999999999999999988888888887766
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=319.37 Aligned_cols=200 Identities=29% Similarity=0.444 Sum_probs=174.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 3578888999999999874 58999999986543222223456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 230 EYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||++||+|.+++...+. +++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~- 339 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG- 339 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC-
Confidence 99999999999987543 899999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 340 -~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 340 -QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp -CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred -ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence 223345789999999999998999999999999999999999999987654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=325.44 Aligned_cols=212 Identities=29% Similarity=0.439 Sum_probs=186.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 228 (387)
.+|...+.||+|+||.|+. +++.||||++.+.........+.+..|..++..+ +||+|+++++++.+...+|+|
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 3677888999999998873 5678999998754322223345678899999988 799999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|||+++|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .
T Consensus 421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~ 496 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-G 496 (674)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCT-T
T ss_pred EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccC-C
Confidence 999999999999999888999999999999999999999999 999999999999999999999999999754322 2
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..++.++|....
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 558 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC
Confidence 23345678999999999999999999999999999999999999999999899999997766
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=293.91 Aligned_cols=211 Identities=24% Similarity=0.413 Sum_probs=182.1
Q ss_pred cccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||+|+||.|+. +|+.||||++...... ..+.+.+|+.++++++||||+++++++......++||||
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 45556899999998873 5899999998754332 245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
+++++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 124 ~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 198 (321)
T 2c30_A 124 LQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 198 (321)
T ss_dssp CCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred CCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-ccc
Confidence 999999998875 45899999999999999999999999 9999999999999999999999999987665332 222
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCC
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 375 (387)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....|.+.
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 262 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK 262 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCT
T ss_pred ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcC
Confidence 3456899999999999999999999999999999999999999988877777777666555543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=306.45 Aligned_cols=221 Identities=29% Similarity=0.477 Sum_probs=186.1
Q ss_pred ccccCccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee
Q 016544 147 EYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (387)
Q Consensus 147 ~~ei~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~ 221 (387)
.|++.. .+|...+.||+|+||.|+. ++..||||.+... ......+.+.+|+.++++++||||+++++++..
T Consensus 108 ~~~~~~--~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 108 KWVLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp TTBCCG--GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccEEch--HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence 444433 3677788999999998873 5889999998754 234556678899999999999999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
...+++||||+++|+|.+++...+ .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 184 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s 260 (377)
T 3cbl_A 184 KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMS 260 (377)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCc
Confidence 999999999999999999998654 4899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCCCCc-ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 301 KLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 301 ~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
+.......... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++.+.+..+.+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 336 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC 336 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC
T ss_pred eecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 75432211111 11123667999999998889999999999999999998 9999999988888888877776554
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=297.11 Aligned_cols=212 Identities=25% Similarity=0.396 Sum_probs=184.5
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
...|...+.||+|+||.|+. +|..||+|.+........ ...+.+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34688889999999998874 578999999876433221 1346788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC----CEEEEeecCcc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSK 301 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Dfg~~~ 301 (387)
++||||+++++|.+++.....+++..++.++.|++.||.|||+++ |+||||||+||+++.++ .++|+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 999999999999999998888999999999999999999999999 99999999999999887 79999999997
Q ss_pred ccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
..... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 234 (321)
T 2a2a_A 168 EIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234 (321)
T ss_dssp ECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred ecCcc--ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc
Confidence 66532 22233468999999999999999999999999999999999999999888777777776654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=312.29 Aligned_cols=211 Identities=25% Similarity=0.488 Sum_probs=181.2
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH----------HHHHHHHHHHHHHHcCCCCcceeeeeE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD----------DRVRAFRDELALLQKIRHPNVVQFLGA 218 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~l~~~ 218 (387)
...|...+.||+|+||.|+. ++..||+|++........ ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34788899999999999884 578999999876543211 234678899999999999999999999
Q ss_pred EeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC---CEEEE
Q 016544 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVA 295 (387)
Q Consensus 219 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~ 295 (387)
+.....+++||||+++|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEE
Confidence 9999999999999999999999988888999999999999999999999999 99999999999999776 69999
Q ss_pred eecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..++..++..+.
T Consensus 192 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 263 (504)
T 3q5i_A 192 DFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263 (504)
T ss_dssp CCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred ECCCCEEcCCC--CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 99999876533 22334568999999999875 68999999999999999999999999999888998887766
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=312.65 Aligned_cols=210 Identities=30% Similarity=0.486 Sum_probs=184.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||||++...........+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 677888999999998873 589999999875432222234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++.+.+.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--~~ 171 (476)
T 2y94_A 97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EF 171 (476)
T ss_dssp CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT--CC
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc--cc
Confidence 9999999999988888999999999999999999999999 999999999999999999999999999876432 22
Q ss_pred cccCCCCCcccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+..++..+.
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 232 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI 232 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC
Confidence 334568999999999998765 689999999999999999999999988888888887665
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=301.13 Aligned_cols=215 Identities=29% Similarity=0.497 Sum_probs=186.5
Q ss_pred cCcccceeecccEEEEEEEc------------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEee
Q 016544 155 LDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~ 221 (387)
.+|...+.||+|+||.|+.. +..||+|++... ......+.+.+|+.+++++ +||||+++++++..
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 36788889999999998742 257999999754 3456667899999999999 89999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEE
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nil 285 (387)
.+..++||||+++++|.+++.... .+++.+++.++.|++.||.|||+++ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 999999999999999999998754 4899999999999999999999999 999999999999
Q ss_pred eCCCCCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHH
Q 016544 286 RDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 363 (387)
Q Consensus 286 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~ 363 (387)
++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++.
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999986643322 22233456788999999999999999999999999999999 99999998888888
Q ss_pred HHHHccCCCCC
Q 016544 364 KAYAARQRPPF 374 (387)
Q Consensus 364 ~~i~~~~~~~~ 374 (387)
+.+..+.++..
T Consensus 304 ~~~~~~~~~~~ 314 (382)
T 3tt0_A 304 KLLKEGHRMDK 314 (382)
T ss_dssp HHHHTTCCCCC
T ss_pred HHHHcCCCCCC
Confidence 88877765544
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=298.67 Aligned_cols=208 Identities=26% Similarity=0.432 Sum_probs=165.9
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
...|...+.||+|+||.|+. +++.||||++.... ..+.+.+|+.++++++||||+++++++......++|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 34688889999999998874 46789999987542 235678899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC---CCCEEEEeecCcccccc
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTV 305 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfg~~~~~~~ 305 (387)
|||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999999988888999999999999999999999999 999999999999975 88999999999876543
Q ss_pred CCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-HHHHHHccCC
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQR 371 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~-~~~~i~~~~~ 371 (387)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... +...+.....
T Consensus 204 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~ 268 (349)
T 2w4o_A 204 Q--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY 268 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC
T ss_pred c--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC
Confidence 2 22234568999999999999999999999999999999999999998766654 5666665553
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=297.90 Aligned_cols=217 Identities=29% Similarity=0.447 Sum_probs=185.7
Q ss_pred cccCcccceeecccEEEEEEE---c-------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC
Q 016544 153 HELDFTNSVEITKGTFILAFW---R-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~---~-------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~ 222 (387)
...+|...+.||+|+||.||. . +..||+|.+.... .....+.+.+|+.++++++||||+++++++...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 344678888999999998873 2 2789999997542 455667899999999999999999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHc------------------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~------------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~D 278 (387)
...++||||+++++|.+++... ..+++.+++.++.||++||.|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 9999999999999999999863 45899999999999999999999999 99999
Q ss_pred CCCCCEEeCCCCCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 016544 279 LEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTM 356 (387)
Q Consensus 279 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~ 356 (387)
|||+||+++.++.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999876543221 12233456889999999998899999999999999999999 9999999
Q ss_pred CCCCcHHHHHHccCCCCC
Q 016544 357 KHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~ 374 (387)
.+..++...+..+..+.+
T Consensus 280 ~~~~~~~~~~~~~~~~~~ 297 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILAC 297 (343)
T ss_dssp SCHHHHHHHHHTTCCCCC
T ss_pred CChHHHHHHHhCCCcCCC
Confidence 888888888877765444
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=293.12 Aligned_cols=216 Identities=28% Similarity=0.484 Sum_probs=186.0
Q ss_pred ccCcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC
Q 016544 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 223 (387)
..+|...+.||+|+||.|+. ++..||+|.+... ......+.+.+|+.++++++||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 45688888999999998864 2378999999754 34566778999999999999999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHcCC------------------------CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGA------------------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~------------------------l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dl 279 (387)
..++||||+++++|.+++..... +++.+++.++.|++.||.|||+++ |+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 99999999999999999986543 788999999999999999999999 999999
Q ss_pred CCCCEEeCCCCCEEEEeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 016544 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMK 357 (387)
Q Consensus 280 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~ 357 (387)
||+||+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999765433221 1223456788999999998889999999999999999999 99999999
Q ss_pred CCCcHHHHHHccCCCCC
Q 016544 358 HDNEVPKAYAARQRPPF 374 (387)
Q Consensus 358 ~~~~~~~~i~~~~~~~~ 374 (387)
....+...+..+.++..
T Consensus 257 ~~~~~~~~~~~~~~~~~ 273 (314)
T 2ivs_A 257 PPERLFNLLKTGHRMER 273 (314)
T ss_dssp CGGGHHHHHHTTCCCCC
T ss_pred CHHHHHHHhhcCCcCCC
Confidence 98888888877665444
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=288.45 Aligned_cols=198 Identities=34% Similarity=0.543 Sum_probs=172.8
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. ++..||+|.+.. ......+.+.+|+.++++++||||+++++++..+...++||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 3677788999999998874 478999998854 24566788999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+++++|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999987 456999999999999999999999999 99999999999999999999999999976543322
Q ss_pred CC-------------cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 309 RP-------------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 309 ~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~ 226 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTS
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchh
Confidence 11 113568999999999999999999999999999999999999997643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=301.49 Aligned_cols=215 Identities=29% Similarity=0.497 Sum_probs=174.6
Q ss_pred ccCcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
..+|...+.||+|+||.||. .+..||||.+... ......+.+.+|+.++++++||||+++++++......
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 34788889999999999984 3567999999754 2455667899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
++||||+++++|.+++...+ .+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999998754 5999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCC--cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 305 VKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 305 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+.+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~ 270 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP 270 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 332211 122234678999999999999999999999999999998 999999988888888876665433
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=290.05 Aligned_cols=220 Identities=27% Similarity=0.486 Sum_probs=184.2
Q ss_pred CccccCccccCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee
Q 016544 146 PEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (387)
Q Consensus 146 ~~~ei~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~ 221 (387)
..|++. ..+|...+.||+|+||.|+. ++..||+|++...... .+.+.+|+.++++++||||+++++++..
T Consensus 17 ~~~~~~--~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 17 GSWEID--PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CTTBCC--GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCccCC--HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 344443 33677888999999998873 4568999999865432 2568889999999999999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
....++||||+++++|.+++.. ...+++.+++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccc
Confidence 9999999999999999999986 456999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
...............+|+.|+|||++.+..++.++||||||+++|+|+| |+.||...+..+....+..+.++..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T 3gen_A 168 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 242 (283)
T ss_dssp GGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred ccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC
Confidence 7654332222333456788999999998899999999999999999998 9999999888888888877664443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=302.77 Aligned_cols=215 Identities=30% Similarity=0.456 Sum_probs=183.0
Q ss_pred cCcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
.+|...+.||+|+||.|+. .+..||||++... ........+.+|+.++++++||||+++++++.....
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3577788999999988763 3468999999743 345556678899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC-------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC---CEEE
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKV 294 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl 294 (387)
.++||||+++|+|.+++.... .+++.+++.++.|++.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999998653 4889999999999999999999999 99999999999999555 5999
Q ss_pred EeecCccccccCC-CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 295 ~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..++.+.+..+.++
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999997543222 122233456889999999999899999999999999999998 99999999988889888877755
Q ss_pred CC
Q 016544 373 PF 374 (387)
Q Consensus 373 ~~ 374 (387)
.+
T Consensus 306 ~~ 307 (367)
T 3l9p_A 306 DP 307 (367)
T ss_dssp CC
T ss_pred CC
Confidence 44
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=314.48 Aligned_cols=209 Identities=27% Similarity=0.521 Sum_probs=185.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|+||.|+. +|..||||++...........+.+.+|+.++++++||||+++++++...+.+++|||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 106 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE 106 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 578888999999999873 678999999876554444445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---CCCCCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|+.+++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++......
T Consensus 107 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 182 (484)
T 3nyv_A 107 VYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS- 182 (484)
T ss_dssp CCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC-
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc-
Confidence 9999999999998888999999999999999999999999 9999999999999 56788999999999766433
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.......||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.+..++..++..+.
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 243 (484)
T 3nyv_A 183 -KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK 243 (484)
T ss_dssp -CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred -cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence 22334568999999999987 68999999999999999999999999999888999987776
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=295.72 Aligned_cols=201 Identities=25% Similarity=0.445 Sum_probs=153.3
Q ss_pred ceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEEccC
Q 016544 160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 160 ~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
.+.||+|+||.|+. +|+.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 35799999998874 5789999998643 2356778999999996 9999999999999999999999999
Q ss_pred CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC---CEEEEeecCccccccCCCCC
Q 016544 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 234 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++...... ...
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~ 165 (325)
T 3kn6_A 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQP 165 (325)
T ss_dssp SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CCc
Confidence 9999999999888999999999999999999999999 99999999999998765 7999999999765433 222
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-------CcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-------NEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~-------~~~~~~i~~~~ 370 (387)
.....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+. .++..++..+.
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~ 232 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC
Confidence 2344579999999999999999999999999999999999999987543 23455554444
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=308.17 Aligned_cols=212 Identities=29% Similarity=0.478 Sum_probs=181.6
Q ss_pred cCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.+|...+.||+|+||.|+. .+..||||.+..... ..+.+.+|+.++++++||||+++++++. ...+++|||
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 3567778999999998874 378899999976432 2467899999999999999999999986 567899999
Q ss_pred ccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999999753 35889999999999999999999999 99999999999999999999999999987543221
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.......+++.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...+..+.+++.
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 406 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 406 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 22223345788999999998899999999999999999999 9999999998888888877765554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=285.69 Aligned_cols=208 Identities=25% Similarity=0.433 Sum_probs=182.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|+..+.||+|+||.|+. ++..||+|++....... .+.+.+|+.++++++||||+++++++......++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 577888999999998874 46789999987654333 4678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---CCCCCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|+++++|.+++.....+++.+++.++.|++.||.|||+++ |+|+||||+||++ +.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 9999999999998888999999999999999999999999 9999999999999 78889999999999766533
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
.......+|+.|+|||++.+. ++.++||||||+++|+|++|+.||.+.+..+...++..+..+
T Consensus 163 -~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (277)
T 3f3z_A 163 -KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT 225 (277)
T ss_dssp -SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred -cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 223345689999999998774 899999999999999999999999998888888888776543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=289.87 Aligned_cols=211 Identities=28% Similarity=0.503 Sum_probs=177.1
Q ss_pred cccCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 153 HELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
...+|...+.||+|+||.|+. +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.++..+++|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 334788889999999998873 578999999975432 233446788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|||+++ +|.+++.... .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 172 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP- 172 (311)
T ss_dssp EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC-
T ss_pred EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC-
Confidence 999975 8888887643 4899999999999999999999999 999999999999999999999999999876433
Q ss_pred CCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...++...
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 235 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSI 235 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHH
T ss_pred cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 222334567999999999977 46899999999999999999999999998888888777553
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=296.89 Aligned_cols=217 Identities=18% Similarity=0.315 Sum_probs=183.0
Q ss_pred CccccCcccceeeccc--EEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC
Q 016544 151 DPHELDFTNSVEITKG--TFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223 (387)
Q Consensus 151 ~~~~~~~~~~~~lg~G--~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~ 223 (387)
....-+|...+.||+| +||.|+. +|..||||++..... .....+.+.+|+.++++++||||+++++++...+
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 3444578889999999 9988873 588999999976543 4566778899999999999999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
.+++||||+++++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||.+.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccce
Confidence 999999999999999999875 56999999999999999999999999 9999999999999999999999999876
Q ss_pred ccccCC------CCCcccCCCCCcccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCC
Q 016544 302 LLTVKE------DRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 302 ~~~~~~------~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 371 (387)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 442211 111123467889999999988 5789999999999999999999999999888887777655543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=294.07 Aligned_cols=223 Identities=28% Similarity=0.510 Sum_probs=186.9
Q ss_pred CCccccCccccCcccceeecccEEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCc
Q 016544 145 VPEYEIDPHELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPN 211 (387)
Q Consensus 145 ~~~~ei~~~~~~~~~~~~lg~G~~~~v~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 211 (387)
.+.|++. ..+|...+.||+|+||.|+. ++..||+|++... ......+.+.+|+.+++++ +|||
T Consensus 27 ~~~~~~~--~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~ 102 (334)
T 2pvf_A 27 DPKWEFP--RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKN 102 (334)
T ss_dssp CTTTBCC--GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT--CCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CccccCC--HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC--CcHHHHHHHHHHHHHHHHhhcCCC
Confidence 3444443 34677888999999998873 3568999999754 2455677899999999999 8999
Q ss_pred ceeeeeEEeeCCceEEEEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 016544 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPII 275 (387)
Q Consensus 212 iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 275 (387)
|+++++++...+..++||||+++++|.+++.... .+++.+++.++.|++.||.|||+++ |+
T Consensus 103 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 179 (334)
T 2pvf_A 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CI 179 (334)
T ss_dssp BCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 9999999999999999999999999999998653 3889999999999999999999999 99
Q ss_pred eCCCCCCCEEeCCCCCEEEEeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCC
Q 016544 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPP 353 (387)
Q Consensus 276 H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p 353 (387)
||||||+||+++.++.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |+.|
T Consensus 180 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 259 (334)
T 2pvf_A 180 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259 (334)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999976543321 11233456788999999998889999999999999999999 9999
Q ss_pred CCCCCCCcHHHHHHccCCCCC
Q 016544 354 FTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~ 374 (387)
|.+.+..++...+..+.++.+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~ 280 (334)
T 2pvf_A 260 YPGIPVEELFKLLKEGHRMDK 280 (334)
T ss_dssp STTCCHHHHHHHHHHTCCCCC
T ss_pred cCcCCHHHHHHHHhcCCCCCC
Confidence 999888888887776665444
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=309.32 Aligned_cols=210 Identities=24% Similarity=0.469 Sum_probs=178.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|+||.|+. ++..||+|++....... .....+.+|+.+++.++||||+++++++.....+++|||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 588889999999999873 57899999987643322 224668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC---CCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~~ 307 (387)
|+++|+|.+++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.. +.+||+|||++......
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 9999999999988888999999999999999999999999 9999999999999764 45999999999876533
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
.......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..++..++..+..+
T Consensus 193 -~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 255 (494)
T 3lij_A 193 -KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT 255 (494)
T ss_dssp -BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred -ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 22334568999999999875 6899999999999999999999999999988899988777633
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=290.34 Aligned_cols=217 Identities=26% Similarity=0.394 Sum_probs=181.8
Q ss_pred cccCcccce-eecccEEEEEEEc-------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 153 HELDFTNSV-EITKGTFILAFWR-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 153 ~~~~~~~~~-~lg~G~~~~v~~~-------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
...+|.... .||+|+||.|+.. +..||||.+..... .....+.+.+|+.+++.++||||+++++++ ....
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 334566666 8999999988742 57899999976532 334567899999999999999999999999 5677
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
.++||||+++++|.+++.....+++.+++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++....
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 8999999999999999998888999999999999999999999999 9999999999999999999999999997664
Q ss_pred cCCCCC--cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 305 VKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 305 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..++...+..+.++.+
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 241 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 332211 122345788999999998888999999999999999999 9999999888888888877766554
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=296.58 Aligned_cols=203 Identities=28% Similarity=0.446 Sum_probs=173.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3688889999999999874 588999999864422 223456889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC-C
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-D 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 308 (387)
||+++++|.+++.....+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..+.... .
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999999988777999999999999999999999999 9999999999999999999999999997654322 1
Q ss_pred CCcccCCCCCcccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~ 216 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 22234568999999999988765 6789999999999999999999987666533
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=290.90 Aligned_cols=212 Identities=24% Similarity=0.371 Sum_probs=187.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.||. ++..||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 4688889999999998874 47899999998766666677788999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++.....+++.+++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++....... .
T Consensus 121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~ 196 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-E 196 (335)
T ss_dssp CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc-c
Confidence 99999999999998888999999999999999999999999 9999999999999999999999999997654322 2
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......+++.|+|||++.+..++.++||||||+++|+|++|+.||......+....+....
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 257 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE 257 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC
Confidence 2334568999999999999899999999999999999999999999877666666665544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=297.21 Aligned_cols=206 Identities=25% Similarity=0.472 Sum_probs=174.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|...+.||+|+||.|+. +|..||+|++.+.... ..+|+.++.++ +||||+++++++.+...+|+||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 577788999999998874 5889999999765332 34577888777 7999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC----CCEEEEeecCcccccc
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVADFGVSKLLTV 305 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~----~~~kl~Dfg~~~~~~~ 305 (387)
||+++|+|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||+... +.+||+|||++.....
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 99999999999998888999999999999999999999999 9999999999998543 2499999999986543
Q ss_pred CCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC---CCCcHHHHHHccCCC
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK---HDNEVPKAYAARQRP 372 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~---~~~~~~~~i~~~~~~ 372 (387)
... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+. +..++..++..+..+
T Consensus 173 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 241 (342)
T 2qr7_A 173 ENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS 241 (342)
T ss_dssp TTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC
T ss_pred CCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc
Confidence 322 223456799999999999888899999999999999999999999863 334566777666533
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=295.00 Aligned_cols=210 Identities=28% Similarity=0.470 Sum_probs=181.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|+||.|+. +|..||||++...........+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 477788999999998873 588999999976555555666789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+. |+|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 997 588888864 456999999999999999999999999 999999999999999999999999998765422
Q ss_pred CcccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
....||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+.......+.....|.+
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 273 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 273 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Confidence 2346899999999985 46789999999999999999999999998877777777766665544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=296.54 Aligned_cols=199 Identities=17% Similarity=0.239 Sum_probs=171.0
Q ss_pred ccCccccCcccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC---CCcceee
Q 016544 149 EIDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQF 215 (387)
Q Consensus 149 ei~~~~~~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l 215 (387)
++.....+|...+.||+|+||.||.. +..||+|++.... ...+..|..++++++ |+||+++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 34444567888899999999988743 6789999997542 245677888888886 9999999
Q ss_pred eeEEeeCCceEEEEEccCCCCHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC--
Q 016544 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-- 288 (387)
Q Consensus 216 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-- 288 (387)
++++...+..++||||+++|+|.+++.. ...+++.+++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGF 209 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGG
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccc
Confidence 9999999999999999999999999974 345999999999999999999999999 999999999999998
Q ss_pred ---------CCCEEEEeecCccccccC-CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 289 ---------SGNLKVADFGVSKLLTVK-EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 289 ---------~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
++.+||+|||++...... .........||+.|+|||++.+..++.++|||||||++|+|+||+.||..
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 899999999999765422 22233445789999999999999999999999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=310.74 Aligned_cols=213 Identities=29% Similarity=0.488 Sum_probs=183.4
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. .+..||||.+..... ..+.+.+|+.++++++||||+++++++.....+++||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 3577778999999987763 378999999976532 2467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 230 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999999864 34899999999999999999999999 9999999999999999999999999998764332
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
........+++.|+|||++.+..++.++|||||||++|||+| |..||.+.+..++.+.+..+.+++.
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 440 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 440 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 222233445788999999998899999999999999999999 9999999998888888876655443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=289.43 Aligned_cols=206 Identities=27% Similarity=0.538 Sum_probs=164.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|..||+|.+..... ....+.+.+|+.++++++||||+++++++..++.+++|||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 577788999999999874 478999999865432 2223567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 231 YLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 231 ~~~~~sL~~~l~~~------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
|++ ++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 5999998754 34889999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 160 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 223 (317)
T 2pmi_A 160 IPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFD 223 (317)
T ss_dssp SCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 322 222334679999999999874 689999999999999999999999998887777776644
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=286.93 Aligned_cols=210 Identities=26% Similarity=0.460 Sum_probs=180.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. ++..||+|++.............+.+|+.++++++||||+++++++......++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 4678888999999998874 46789999986543222223466889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++.....+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--- 162 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 162 (279)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc---
Confidence 99999999999998888999999999999999999999998 999999999999999999999999988654322
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+..+.+....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 223 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 223 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC
Confidence 2233467999999999999999999999999999999999999999888777777776554
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=296.70 Aligned_cols=203 Identities=30% Similarity=0.419 Sum_probs=164.7
Q ss_pred ccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
....+|...+.||+|+||.|+. +++.||+|++....... +.+.+|+.+++.++||||+++++++.....++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 3445788899999999987763 68899999997543332 45778999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC--EEEEeecCccccc
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--LKVADFGVSKLLT 304 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~~ 304 (387)
+||||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999999999998888999999999999999999999999 999999999999987765 9999999987433
Q ss_pred cCCCCCcccCCCCCcccccccccCCCCCCc-hhHHHHHHHHHHHHcCCCCCCCCCCCcHH
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVP 363 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~elltg~~pf~~~~~~~~~ 363 (387)
.. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.......
T Consensus 170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~ 227 (361)
T 3uc3_A 170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY 227 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH
T ss_pred cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH
Confidence 22 22233468999999999988877655 89999999999999999999986664433
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=285.78 Aligned_cols=210 Identities=25% Similarity=0.449 Sum_probs=179.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|...+.||+|+||.|+. +|+.||+|.+........ ...+.+.+|+.++++++||||+++++++......++
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL 85 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence 477788999999998874 488999999876433211 135678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC----CEEEEeecCcccc
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLL 303 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Dfg~~~~~ 303 (387)
||||+++++|.+++.....+++.++..++.|++.||.|||+++ ++|+||||+||+++.++ .++|+|||++...
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 86 ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999999998888999999999999999999999999 99999999999999877 7999999999765
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.... ......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+....+....
T Consensus 163 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 227 (283)
T 3bhy_A 163 EAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN 227 (283)
T ss_dssp C----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred cCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcc
Confidence 4322 2233468899999999999999999999999999999999999999888777777775554
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=305.35 Aligned_cols=211 Identities=32% Similarity=0.495 Sum_probs=175.7
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|...+.||+|+||.|+. .+..||||.+...... .+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 185 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 567778999999998873 3468999999865432 3578899999999999999999999876 678999999
Q ss_pred cCCCCHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++|+|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 999999999974 345899999999999999999999999 999999999999999999999999999876533222
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+.+++.
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 402 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 402 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 2333456788999999998899999999999999999999 9999999988888888877766554
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=302.42 Aligned_cols=204 Identities=24% Similarity=0.402 Sum_probs=172.3
Q ss_pred cCcccceeecccEEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCc
Q 016544 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 224 (387)
.+|...+.||+|+||.||. +|+.||||++...... .....+.+.+|+.+++.+ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 3688889999999998873 6789999998753221 111234567799999999 69999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
+++||||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999999999998888999999999999999999999999 9999999999999999999999999997654
Q ss_pred cCCCCCcccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~~~ 361 (387)
...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 269 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc
Confidence 3333333345689999999999863 47889999999999999999999998655443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=290.81 Aligned_cols=217 Identities=29% Similarity=0.456 Sum_probs=170.1
Q ss_pred ccCcccceeecccEEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
..+|...+.||+|+||.|+. ++ ..||||.+....... ...+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34688889999999999873 22 279999997654333 4467889999999999999999999999877654
Q ss_pred ------EEEEEccCCCCHHHHHHHcC------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEE
Q 016544 226 ------MIVTEYLPKGDLRAFLKRKG------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293 (387)
Q Consensus 226 ------~lv~e~~~~~sL~~~l~~~~------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 293 (387)
+++|||+++++|.+++.... .+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 99999999999999996532 4899999999999999999999999 99999999999999999999
Q ss_pred EEeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 294 VADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 294 l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
|+|||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+..++...+..+.+
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 9999999765433221 2223446788999999999999999999999999999999 9999999999999888877764
Q ss_pred CCC
Q 016544 372 PPF 374 (387)
Q Consensus 372 ~~~ 374 (387)
+..
T Consensus 258 ~~~ 260 (323)
T 3qup_A 258 LKQ 260 (323)
T ss_dssp CCC
T ss_pred CCC
Confidence 443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=309.74 Aligned_cols=210 Identities=28% Similarity=0.491 Sum_probs=181.5
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. ++..||||++....... .....+.+|+.++++++||||+++++++.....+++||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 4688889999999998874 58899999986432221 12466889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC---CCCCEEEEeecCccccccC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~ 306 (387)
||+.+++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999999999988888999999999999999999999999 99999999999995 4567999999999765433
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 371 (387)
.......||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.+..++..++..+..
T Consensus 178 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 239 (486)
T 3mwu_A 178 --TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred --CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 22334568999999999987 589999999999999999999999999998888888877763
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=288.24 Aligned_cols=207 Identities=26% Similarity=0.441 Sum_probs=179.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||+|.+.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 577788999999998873 58899999987542 2233568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---CCCCCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|+++++|.+++...+.+++.++..++.|++.||.|||+++ |+|+||||+||++ +.++.++|+|||++......
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 9999999999988888999999999999999999999999 9999999999999 77889999999998754322
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 371 (387)
......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+...+..++..+..
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 224 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY 224 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC
Confidence 22234578999999999999999999999999999999999999999888888888877653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=286.24 Aligned_cols=226 Identities=26% Similarity=0.441 Sum_probs=173.9
Q ss_pred cCcccceeecccEEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEcc
Q 016544 155 LDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 232 (387)
-+|+..+.||+|+||.||. ....||+|++.... ......+.+.+|+.++++++||||+++++++ .....++||||+
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~ 101 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWC 101 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred cceeeeeEecCCCCeEEEEEEEcCceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEec
Confidence 3688889999999999984 45679999997653 3456678899999999999999999999965 456789999999
Q ss_pred CCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC-CCC
Q 016544 233 PKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-DRP 310 (387)
Q Consensus 233 ~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 310 (387)
++++|.+++... ..+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... ...
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 102 EGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp CEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred CCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 999999999643 45899999999999999999999999 9999999999999999999999999987654321 222
Q ss_pred cccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH-HccC-CCCCCCChhhhhhcc
Q 016544 311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY-AARQ-RPPFKAPAKLYARGL 385 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i-~~~~-~~~~~~~~~~~~~~l 385 (387)
.....+|+.|+|||++. +..++.++||||||+++|+|++|+.||.+.........+ ..+. .+.+......+|+++
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHH
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHH
Confidence 23456899999999987 567888999999999999999999999886665444444 3333 444444445555554
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=284.76 Aligned_cols=207 Identities=24% Similarity=0.475 Sum_probs=172.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.++..+++|||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 577888999999998873 578999999976543 33445678889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+.+ ++.+++.. .+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VR 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CS
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc-cc
Confidence 9976 66655554 567999999999999999999999999 999999999999999999999999999866432 22
Q ss_pred CcccCCCCCcccccccccCCC-CCCchhHHHHHHHHHHHHcCCCC-CCCCCCCcHHHHHHc
Q 016544 310 PLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAA 368 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~p-f~~~~~~~~~~~i~~ 368 (387)
......+|+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+...++..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~ 217 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 333456799999999998765 79999999999999999987777 555555555555543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=290.02 Aligned_cols=203 Identities=18% Similarity=0.261 Sum_probs=174.3
Q ss_pred cCcccceeecccEEEEEE-----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEE
Q 016544 155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 228 (387)
.+|...+.||+|+||.|+ .+|+.||||.+...... +.+.+|+.+++++ +||||+++++++......++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 367888899999998776 36899999998654322 3578899999999 899999999999999999999
Q ss_pred EEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC-----EEEEeecCccc
Q 016544 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADFGVSKL 302 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-----~kl~Dfg~~~~ 302 (387)
|||+ +++|.+++... ..+++.+++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||++..
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999 89999999874 56999999999999999999999999 999999999999998887 99999999987
Q ss_pred cccCCCC------CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 303 LTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 303 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...+.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~ 229 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY 229 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHH
Confidence 6443221 123457899999999999999999999999999999999999999987766654433
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=283.86 Aligned_cols=212 Identities=31% Similarity=0.512 Sum_probs=169.4
Q ss_pred cCcccceeecccEEEEEE---EcCeEEEEEEcCcccCCC-HHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISD-DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.+|...+.||+|+||.|+ ..|..||||++....... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 367778899999998876 578999999987543222 2335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC--------CCCEEEEeecCccc
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--------SGNLKVADFGVSKL 302 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~--------~~~~kl~Dfg~~~~ 302 (387)
|+++++|.+++.. ..+++..++.++.|++.||.|||+++.++|+||||||+||+++. ++.++|+|||++..
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~ 165 (271)
T 3dtc_A 87 FARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165 (271)
T ss_dssp CCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred cCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence 9999999998864 46899999999999999999999998555889999999999986 67899999999976
Q ss_pred cccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
..... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.......+....
T Consensus 166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (271)
T 3dtc_A 166 WHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred ccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence 54322 223468999999999999899999999999999999999999999888777766665555
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=283.69 Aligned_cols=216 Identities=26% Similarity=0.461 Sum_probs=180.1
Q ss_pred cccCcccceeecccEEEEEEEc--------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 153 HELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
...+|...+.||+|+||.|+.. +..||+|.+.... .....+.+.+|+.++++++||||+++++++.. +.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 3446788889999999988741 2369999997642 45566789999999999999999999999865 45
Q ss_pred eEEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++...
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 789999999999999998654 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
............+++.|+|||++.+..++.++||||||+++|+|++ |+.||.......+...+..+.+++.
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK 235 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC
Confidence 5443333344456889999999998899999999999999999998 9999998888888888877665544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=284.06 Aligned_cols=213 Identities=24% Similarity=0.423 Sum_probs=181.4
Q ss_pred Ccccce-eecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSV-EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~-~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|.... .||+|+||.|+. .+..||+|.+... ......+.+.+|+.++++++||||+++++++ .....++
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 344444 899999998863 4778999999764 3456678899999999999999999999999 4567999
Q ss_pred EEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999999754 45999999999999999999999999 999999999999999999999999999876433
Q ss_pred CCC--CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 307 EDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 307 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..++...+..+.++.+
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~ 234 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 234 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC
Confidence 221 1223346789999999998889999999999999999998 9999999888888888877766554
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=283.79 Aligned_cols=211 Identities=30% Similarity=0.539 Sum_probs=182.4
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|...+.||+|+||.|+. ++..||+|.+...... .+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 577788999999998874 5789999999865432 25688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++++|.+++... +.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++..........
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999999875 45899999999999999999999999 9999999999999999999999999987654322222
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
.....+++.|+|||++.+..++.++|+||||+++|+|++ |+.||.+.+..++...+..+.++.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~ 225 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY 225 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC
Confidence 233456788999999998899999999999999999999 999999988888888887765443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=296.98 Aligned_cols=224 Identities=29% Similarity=0.475 Sum_probs=178.2
Q ss_pred CccccCccccCcccceeecccEEEEEEE-----c---CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeee
Q 016544 146 PEYEIDPHELDFTNSVEITKGTFILAFW-----R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217 (387)
Q Consensus 146 ~~~ei~~~~~~~~~~~~lg~G~~~~v~~-----~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~ 217 (387)
..+.+......|...+.||+|+||.||. . +..||+|.+... ......+.+.+|+.++++++||||+++++
T Consensus 80 ~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~ 157 (373)
T 3c1x_A 80 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLG 157 (373)
T ss_dssp TTTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCE
T ss_pred cccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 3445556666778888999999998873 1 246899998753 33456678999999999999999999999
Q ss_pred EEe-eCCceEEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEE
Q 016544 218 AVT-QSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (387)
Q Consensus 218 ~~~-~~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 295 (387)
++. .++..++||||+++++|.+++.... .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~ 234 (373)
T 3c1x_A 158 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVA 234 (373)
T ss_dssp EECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEEC
T ss_pred EEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEe
Confidence 865 4567899999999999999998654 4888999999999999999999999 9999999999999999999999
Q ss_pred eecCccccccCCCC---CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 296 DFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 296 Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
|||+++........ ......+++.|+|||++.+..++.++|||||||++|+|+| |.+||.+.+..++...+..+.+
T Consensus 235 DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~ 314 (373)
T 3c1x_A 235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 314 (373)
T ss_dssp CC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC
T ss_pred eccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC
Confidence 99999765432211 1223456788999999999999999999999999999999 8999999988888888877765
Q ss_pred CCC
Q 016544 372 PPF 374 (387)
Q Consensus 372 ~~~ 374 (387)
+..
T Consensus 315 ~~~ 317 (373)
T 3c1x_A 315 LLQ 317 (373)
T ss_dssp CCC
T ss_pred CCC
Confidence 543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=295.18 Aligned_cols=207 Identities=26% Similarity=0.447 Sum_probs=167.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCC--ceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS--PMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~--~~~l 227 (387)
+|...+.||+|+||.|+. +|+.||||++.... ......+.+.+|+.+++.+. ||||+++++++..++ .+|+
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 678888999999998874 58899999987543 34556677888999999997 999999999997544 6899
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||||++ ++|.+++.. +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 999996 599999876 46899999999999999999999999 9999999999999999999999999997653211
Q ss_pred --------------------CCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 308 --------------------DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 308 --------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+.+|
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 111234578999999999987 57899999999999999999999999998887777777
Q ss_pred Hc
Q 016544 367 AA 368 (387)
Q Consensus 367 ~~ 368 (387)
..
T Consensus 244 ~~ 245 (388)
T 3oz6_A 244 IG 245 (388)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=284.35 Aligned_cols=209 Identities=26% Similarity=0.480 Sum_probs=181.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. ++..||+|.+...........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 677888999999998874 478999999865322112224568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...... .
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---~ 168 (284)
T 2vgo_A 95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---R 168 (284)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS---C
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc---c
Confidence 9999999999998888999999999999999999999999 999999999999999999999999998654422 2
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+..+....+....
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 228 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD 228 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc
Confidence 233468999999999999999999999999999999999999999887777777776544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=295.90 Aligned_cols=202 Identities=28% Similarity=0.425 Sum_probs=163.1
Q ss_pred Ccccc-eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHH-cCCCCcceeeeeEEee----CCc
Q 016544 156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQ----SSP 224 (387)
Q Consensus 156 ~~~~~-~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~l~~~~~~----~~~ 224 (387)
+|... +.||.|+||.|+. +|..||||++... ..+.+|+.++. ..+||||+++++++.. ...
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 45444 5799999999874 5789999998632 34567888774 4589999999999875 567
Q ss_pred eEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC---CCCEEEEeecC
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV 299 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfg~ 299 (387)
+|+||||+++|+|.+++...+ .+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 899999999999999998753 4899999999999999999999999 999999999999997 78899999999
Q ss_pred ccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc----HHHHHHccC
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYAARQ 370 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~----~~~~i~~~~ 370 (387)
++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... +..++..+.
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~ 283 (400)
T 1nxk_A 211 AKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC
T ss_pred ccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc
Confidence 9865432 22234567999999999999999999999999999999999999998766543 456665554
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=298.13 Aligned_cols=214 Identities=23% Similarity=0.373 Sum_probs=175.9
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCC--CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
.+|...+.||+|+||.|+. ++..||+|++...... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 4688889999999998873 5679999998654221 23345778999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc----------------------------------------CCCChHHHHHHHHHHHHHHHHHH
Q 016544 228 VTEYLPKGDLRAFLKRK----------------------------------------GALKPSTAVRFALDIARGMNYLH 267 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~----------------------------------------~~l~~~~~~~i~~qi~~~l~~LH 267 (387)
||||+++++|.+++... ..+++..++.++.|++.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999988420 01356778889999999999999
Q ss_pred hCCCCCeEeCCCCCCCEEeCCCC--CEEEEeecCccccccCCC---CCcccCCCCCcccccccccC--CCCCCchhHHHH
Q 016544 268 ENKPVPIIHRDLEPSNILRDDSG--NLKVADFGVSKLLTVKED---RPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSF 340 (387)
Q Consensus 268 ~~~~~~iiH~Dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~sl 340 (387)
+++ |+||||||+||+++.++ .+||+|||++..+..... .......+|+.|+|||++.+ ..++.++|||||
T Consensus 186 ~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 186 NQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 999 99999999999998776 899999999986543221 12344568999999999975 678899999999
Q ss_pred HHHHHHHHcCCCCCCCCCCCcHHHHHHccCC
Q 016544 341 ALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 341 G~il~elltg~~pf~~~~~~~~~~~i~~~~~ 371 (387)
||++|+|++|+.||.+.+..+...++.....
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 293 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKL 293 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhccc
Confidence 9999999999999999888888888876663
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=288.54 Aligned_cols=216 Identities=25% Similarity=0.425 Sum_probs=183.8
Q ss_pred cccCcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC
Q 016544 153 HELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~ 222 (387)
...+|...+.||+|+||.|+. .+..||+|.+... ........+.+|+.++++++||||+++++++...
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345788889999999988873 3678999999754 2345566789999999999999999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHc----------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCE
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRK----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 292 (387)
...++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 9999999999999999999753 34688999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 293 KVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 293 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
||+|||++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..++...+..+.
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 257 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 257 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC
Confidence 99999998765433221 1122345788999999999899999999999999999999 999999988888888877766
Q ss_pred CCC
Q 016544 371 RPP 373 (387)
Q Consensus 371 ~~~ 373 (387)
.++
T Consensus 258 ~~~ 260 (322)
T 1p4o_A 258 LLD 260 (322)
T ss_dssp CCC
T ss_pred cCC
Confidence 443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=286.53 Aligned_cols=210 Identities=26% Similarity=0.427 Sum_probs=171.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCC-----------------------HHHHHHHHHHHHHHHcC
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD-----------------------DDRVRAFRDELALLQKI 207 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~l 207 (387)
+|...+.||+|+||.|+. +|+.||||++....... ....+.+.+|+.+++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 677888999999998874 47899999987543211 12245688999999999
Q ss_pred CCCcceeeeeEEee--CCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEE
Q 016544 208 RHPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (387)
Q Consensus 208 ~h~~iv~l~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nil 285 (387)
+||||+++++++.. ...+++||||+++++|.+++. ...+++.++..++.|++.||.|||+++ |+||||||+|||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil 169 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLL 169 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEE
Confidence 99999999999986 567999999999999987654 346899999999999999999999999 999999999999
Q ss_pred eCCCCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 286 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
++.++.+||+|||++....... .......||+.|+|||++.+.. .+.++|||||||++|+|++|+.||.+.....+
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 248 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL 248 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence 9999999999999998765332 2223456899999999998765 36789999999999999999999998776666
Q ss_pred HHHHHccC
Q 016544 363 PKAYAARQ 370 (387)
Q Consensus 363 ~~~i~~~~ 370 (387)
...+....
T Consensus 249 ~~~~~~~~ 256 (298)
T 2zv2_A 249 HSKIKSQA 256 (298)
T ss_dssp HHHHHHCC
T ss_pred HHHHhccc
Confidence 66665544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=295.43 Aligned_cols=215 Identities=28% Similarity=0.439 Sum_probs=177.9
Q ss_pred ccCcccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC
Q 016544 154 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~ 222 (387)
..+|...+.||+|+||.||.. ++.||||++... ......+.+.+|+.++.++ +||||+++++++...
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 346788889999999998742 378999999754 3455567899999999999 799999999999876
Q ss_pred Cc-eEEEEEccCCCCHHHHHHHcCC-------------------------------------------------------
Q 016544 223 SP-MMIVTEYLPKGDLRAFLKRKGA------------------------------------------------------- 246 (387)
Q Consensus 223 ~~-~~lv~e~~~~~sL~~~l~~~~~------------------------------------------------------- 246 (387)
+. +++||||+++|+|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 54 8999999999999999986432
Q ss_pred -----------CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC-CcccC
Q 016544 247 -----------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQ 314 (387)
Q Consensus 247 -----------l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~ 314 (387)
+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......... .....
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 888999999999999999999999 999999999999999999999999999765433221 22334
Q ss_pred CCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHH-HccCCCC
Q 016544 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY-AARQRPP 373 (387)
Q Consensus 315 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i-~~~~~~~ 373 (387)
.+|+.|+|||++.+..++.++|||||||++|+|+| |+.||.+....+..... ..+.++.
T Consensus 256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 316 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 316 (359)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC
T ss_pred CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC
Confidence 56889999999999999999999999999999998 99999987765554444 3333433
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=286.81 Aligned_cols=213 Identities=30% Similarity=0.491 Sum_probs=184.2
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
..+|...+.||+|+||.|+. ++..||+|.+.... ...+.+.+|+.++++++||||+++++++......++|
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 44677888999999987764 37899999987532 2456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 229 TEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999998743 4899999999999999999999999 999999999999999999999999999876544
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPP 373 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (387)
.........+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+...+.+.+....++.
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC
Confidence 3333333445778999999999899999999999999999999 999999988888888887665443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=283.48 Aligned_cols=211 Identities=25% Similarity=0.450 Sum_probs=156.5
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +|..||+|.+...........+.+.+|+.++++++||||+++++++......++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 3677888999999998873 57899999986432211222467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+++++|.+++... ..+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999999999875 56899999999999999999999999 99999999999999999999999999876543322
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..........++...
T Consensus 168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 227 (278)
T 3cok_A 168 -KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA 227 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS
T ss_pred -cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc
Confidence 222345789999999999988999999999999999999999999987766666655433
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=291.50 Aligned_cols=211 Identities=28% Similarity=0.441 Sum_probs=175.8
Q ss_pred cCcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCC
Q 016544 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 223 (387)
.+|...+.||+|+||.|+. .+..||+|.+.... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4677888999999998863 34589999997542 233456789999999999 8999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHcC-----------------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKG-----------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~-----------------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlk 280 (387)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 9999999999999999998643 2788999999999999999999999 9999999
Q ss_pred CCCEEeCCCCCEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 016544 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKH 358 (387)
Q Consensus 281 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~ 358 (387)
|+||+++.++.++|+|||++.......... .....+|+.|+|||++.+..++.++|||||||++|+|+| |..||.+..
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999997654332221 122345788999999998899999999999999999998 999999887
Q ss_pred CCcHHHHHHccC
Q 016544 359 DNEVPKAYAARQ 370 (387)
Q Consensus 359 ~~~~~~~i~~~~ 370 (387)
.......+....
T Consensus 280 ~~~~~~~~~~~~ 291 (344)
T 1rjb_A 280 VDANFYKLIQNG 291 (344)
T ss_dssp CSHHHHHHHHTT
T ss_pred cHHHHHHHHhcC
Confidence 766655554444
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=290.34 Aligned_cols=203 Identities=26% Similarity=0.413 Sum_probs=169.8
Q ss_pred ccCccccCcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc-
Q 016544 149 EIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP- 224 (387)
Q Consensus 149 ei~~~~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~- 224 (387)
++.....+|...+.||+|+||.|+ ..++.||||++... .........|+.++++++||||+++++++.....
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred ccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence 333445578888999999998776 57899999998643 2333455668999999999999999999987543
Q ss_pred ---eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC----------CCCCeEeCCCCCCCEEeCCCCC
Q 016544 225 ---MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN----------KPVPIIHRDLEPSNILRDDSGN 291 (387)
Q Consensus 225 ---~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~----------~~~~iiH~Dlkp~Nill~~~~~ 291 (387)
+++||||+++|+|.+++... .+++..++.++.|++.||.|||+. + |+||||||+|||++.++.
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCC
T ss_pred CceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCe
Confidence 69999999999999999774 489999999999999999999998 8 999999999999999999
Q ss_pred EEEEeecCccccccCCCC-CcccCCCCCcccccccccCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 292 LKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 292 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-----~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
+||+|||++......... ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+...
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 999999999766543222 22335689999999999873 455688999999999999999999987543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=294.50 Aligned_cols=210 Identities=28% Similarity=0.454 Sum_probs=180.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCC-C----HHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCc
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-D----DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~-~----~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~ 224 (387)
+|...+.||.|+||.|+. +|+.||||++...... . ....+.+.+|+.+++++ +||||+++++++.....
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 577778999999998874 5889999998654321 1 23356688999999999 79999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
.++||||+++++|.+++.....+++..+..++.|++.||.|||+.| |+|+||||+||+++.++.++|+|||++....
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999999998888999999999999999999999999 9999999999999999999999999987665
Q ss_pred cCCCCCcccCCCCCcccccccccC------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKN------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..+.
T Consensus 252 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 321 (365)
T 2y7j_A 252 PG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ 321 (365)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 33 22334568999999999863 357889999999999999999999999877777777776655
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=282.93 Aligned_cols=212 Identities=30% Similarity=0.477 Sum_probs=180.1
Q ss_pred cCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.+|...+.||+|+||.|+. ++..||+|.+...... .+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 3677888999999998874 4678999998754322 357889999999999999999999986 456899999
Q ss_pred ccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+++++|.+++.... .+++.++..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999999997543 5899999999999999999999999 99999999999999999999999999987654332
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..++...+..+.++..
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCC
Confidence 23333456788999999998889999999999999999999 9999999888888888766654433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=289.52 Aligned_cols=213 Identities=28% Similarity=0.476 Sum_probs=180.9
Q ss_pred CCCccccCccccCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEE
Q 016544 144 EVPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (387)
Q Consensus 144 ~~~~~ei~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~ 219 (387)
.++..++.....+|...+.||+|+||.||. +|..||+|.+.... ....+.+.+|+.++++++||||+++++++
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 104 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFC 104 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345556666777899999999999998874 48899999987542 23456789999999999999999999999
Q ss_pred eeCCceEEEEEccCCCCHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEE
Q 016544 220 TQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (387)
Q Consensus 220 ~~~~~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 295 (387)
...+..++||||+++++|.+++.... .+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 105 DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEEC
T ss_pred cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999986543 4889999999999999999999999 9999999999999999999999
Q ss_pred eecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 296 DFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 296 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..+.+.
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~ 249 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM 249 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC
T ss_pred ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH
Confidence 9999976543222 222334578999999999988999999999999999999999999987665543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=288.37 Aligned_cols=216 Identities=30% Similarity=0.478 Sum_probs=178.3
Q ss_pred ccCcccceeecccEEEEEEEc---------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 154 ELDFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
...|...+.||+|+||.||.. +..||+|.+.... .......+.+|+.++++++||||+++++++.....
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 120 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence 346777789999999988741 2359999997542 45556778999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.++||||+++++|.+++... +.+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999865 56999999999999999999999999 999999999999999999999999999766
Q ss_pred ccCCCCC--cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 304 TVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 304 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
....... .....+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++...+..+.+++.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~ 271 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT 271 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC
Confidence 4332211 122345778999999999999999999999999999999 9999999888888888877765544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=290.89 Aligned_cols=215 Identities=25% Similarity=0.483 Sum_probs=175.8
Q ss_pred ccCcccceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
..+|...+.||+|+||.||. ++. +||+|.+.... .....+.+.+|+.++++++||||+++++++..+ .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~ 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-S
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-C
Confidence 34688889999999998874 233 46888886432 233456789999999999999999999999875 4
Q ss_pred eEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.++++|++.+|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 78999999999999999874 55999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 304 TVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 304 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
....... .....+|+.|+|||++.+..++.++|||||||++|+|+| |+.||.+.+..++...+..+.+++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC
Confidence 5432222 233456789999999999999999999999999999999 9999999888888888777664443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=282.65 Aligned_cols=223 Identities=29% Similarity=0.483 Sum_probs=185.8
Q ss_pred ccccCccccCcccceeecccEEEEEEEc--------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeE
Q 016544 147 EYEIDPHELDFTNSVEITKGTFILAFWR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218 (387)
Q Consensus 147 ~~ei~~~~~~~~~~~~lg~G~~~~v~~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~ 218 (387)
...+.+....|...+.||+|+||.|+.. ...||+|.+... ......+.+.+|+.++++++||||++++++
T Consensus 17 ~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (298)
T 3f66_A 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 94 (298)
T ss_dssp GGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred heecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence 4456666778888999999999998731 235899998753 455667789999999999999999999998
Q ss_pred Ee-eCCceEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEe
Q 016544 219 VT-QSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (387)
Q Consensus 219 ~~-~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 296 (387)
+. .++..+++|||+++++|.+++... ..+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D 171 (298)
T 3f66_A 95 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVAD 171 (298)
T ss_dssp ECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECS
T ss_pred EEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECc
Confidence 64 556789999999999999999864 44899999999999999999999999 99999999999999999999999
Q ss_pred ecCccccccCCC---CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 297 FGVSKLLTVKED---RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 297 fg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.+.+..++...+..+.++
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 3f66_A 172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 251 (298)
T ss_dssp CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC
T ss_pred ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC
Confidence 999976543221 12233456788999999999999999999999999999999 78889988888888888777654
Q ss_pred CC
Q 016544 373 PF 374 (387)
Q Consensus 373 ~~ 374 (387)
..
T Consensus 252 ~~ 253 (298)
T 3f66_A 252 LQ 253 (298)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=280.02 Aligned_cols=212 Identities=25% Similarity=0.381 Sum_probs=182.4
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCC------CHHHHHHHHHHHHHHHcCC-CCcceeeeeEEee
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS------DDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ 221 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~ 221 (387)
..+|...+.||+|+||.|+. +|+.||||.+...... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 34688889999999998874 5789999998654311 1233566888999999995 9999999999999
Q ss_pred CCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
....++||||+++++|.+++.....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchh
Confidence 9999999999999999999998888999999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCCCCcccCCCCCccccccccc------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 302 LLTVKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
..... .......+++.|+|||++. ...++.++||||||+++|+|++|+.||.+.+.......+..+.
T Consensus 173 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 245 (298)
T 1phk_A 173 QLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 245 (298)
T ss_dssp ECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred hcCCC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC
Confidence 65432 2223456789999999985 4567889999999999999999999999888777777776665
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=286.66 Aligned_cols=197 Identities=28% Similarity=0.528 Sum_probs=166.0
Q ss_pred ccCcccceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--
Q 016544 154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-- 222 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-- 222 (387)
..+|+..+.||+|+||.|+. ++..||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 34677888999999998863 5789999998743 456667899999999999999999999998653
Q ss_pred CceEEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
..+++||||+++++|.+++.... .+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 56899999999999999998754 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCC--CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 302 LLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 302 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
....... .......+++.|+|||.+.+..++.++||||||+++|+|+||..||..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 7643322 112233467789999999999999999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=304.20 Aligned_cols=206 Identities=25% Similarity=0.346 Sum_probs=171.5
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 223 (387)
.+|...+.||+|+||.|+. +|+.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4688889999999998874 58899999997653 34556677889999999999999999999997553
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.+|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 46999999965 57666643 4899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
... .......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+.+|...
T Consensus 215 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~ 278 (464)
T 3ttj_A 215 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278 (464)
T ss_dssp --C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 432 2334467899999999999999999999999999999999999999998877777666543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=281.65 Aligned_cols=214 Identities=25% Similarity=0.463 Sum_probs=170.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|..||+|++...........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 688889999999998874 588999999986555566777889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 231 ~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
|+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999874 345899999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--cHHHHHHccCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPP 373 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~--~~~~~i~~~~~~~ 373 (387)
. .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.... .+...+.....++
T Consensus 190 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 257 (310)
T 2wqm_A 190 T-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 257 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC
T ss_pred C-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC
Confidence 2 2223345789999999999999999999999999999999999999865433 3455555555444
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=283.92 Aligned_cols=207 Identities=25% Similarity=0.416 Sum_probs=174.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|..||+|++.... ......+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 577888999999998873 48899999987653 344556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++........ .
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 158 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-Y 158 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-c
Confidence 9999999999888888999999999999999999999999 99999999999999999999999999977653322 2
Q ss_pred cccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 311 LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
.....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR 216 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 233467899999999976 578999999999999999999999999887766655553
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=291.34 Aligned_cols=206 Identities=30% Similarity=0.485 Sum_probs=177.0
Q ss_pred CCccccCccccCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEe
Q 016544 145 VPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (387)
Q Consensus 145 ~~~~ei~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~ 220 (387)
++..++.....+|...+.||+|+||.|+. +|+.||||.+...... .....+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 34445555666899999999999999884 5789999999754321 12235888999999999999999999999
Q ss_pred eCCceEEEEEccCCCCHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHhC---CCCCeEeCCCCCCCEEeCCCCCEE
Q 016544 221 QSSPMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHEN---KPVPIIHRDLEPSNILRDDSGNLK 293 (387)
Q Consensus 221 ~~~~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~i~~qi~~~l~~LH~~---~~~~iiH~Dlkp~Nill~~~~~~k 293 (387)
.....++||||+++++|.+++.... .+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEE
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999998643 389999999999999999999999 7 99999999999999999999
Q ss_pred EEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 294 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
|+|||++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 99999998765444444445568999999999988889999999999999999999999995
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=281.08 Aligned_cols=224 Identities=29% Similarity=0.494 Sum_probs=186.2
Q ss_pred CccccCccccCcccceeecccEEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeee
Q 016544 146 PEYEIDPHELDFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217 (387)
Q Consensus 146 ~~~ei~~~~~~~~~~~~lg~G~~~~v~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~ 217 (387)
.++.+......|...+.||+|+||.|+. ++ ..||+|.+... ......+.+.+|+.++++++||||+++++
T Consensus 12 ~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 89 (298)
T 3pls_A 12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIG 89 (298)
T ss_dssp GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred hheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 3455566666777788999999999873 22 37999998753 44566788999999999999999999999
Q ss_pred EEeeCCce-EEEEEccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEE
Q 016544 218 AVTQSSPM-MIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (387)
Q Consensus 218 ~~~~~~~~-~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 295 (387)
++...... +++|||+.+++|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~ 166 (298)
T 3pls_A 90 IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVA 166 (298)
T ss_dssp EECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEEC
T ss_pred EEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeC
Confidence 99876654 999999999999999986 345889999999999999999999999 9999999999999999999999
Q ss_pred eecCccccccCC---CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCC
Q 016544 296 DFGVSKLLTVKE---DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 296 Dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~ 371 (387)
|||++....... ........+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..++...+.....
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T 3pls_A 167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR 246 (298)
T ss_dssp CTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC
T ss_pred cCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC
Confidence 999997554321 122233456889999999999999999999999999999999 6677777777888888777665
Q ss_pred CCC
Q 016544 372 PPF 374 (387)
Q Consensus 372 ~~~ 374 (387)
++.
T Consensus 247 ~~~ 249 (298)
T 3pls_A 247 LPQ 249 (298)
T ss_dssp CCC
T ss_pred CCC
Confidence 444
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=284.32 Aligned_cols=207 Identities=29% Similarity=0.523 Sum_probs=172.3
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|...+.||+|+||.|+. +|..||+|++..... .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 577788999999998874 478999999875432 122235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+.+ +|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-cc
Confidence 975 999998864 56999999999999999999999999 9999999999999999999999999987654321 22
Q ss_pred cccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
.....+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...++..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 215 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2334679999999999764 589999999999999999999999998877666666543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=283.39 Aligned_cols=199 Identities=18% Similarity=0.252 Sum_probs=171.5
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 228 (387)
.+|...+.||+|+||.|+. +|+.||+|.+..... .+.+.+|+.+++++ +|++++++++++......++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 3688889999999988873 689999999864432 23577899999999 799999999999999999999
Q ss_pred EEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC-----EEEEeecCccc
Q 016544 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADFGVSKL 302 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-----~kl~Dfg~~~~ 302 (387)
|||+ +++|.+++...+ .+++.++..++.|++.||.|||+++ |+||||||+||+++.++. ++|+|||++..
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999 899999998754 4999999999999999999999999 999999999999987776 99999999987
Q ss_pred cccCCCC------CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 303 LTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 303 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 226 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 226 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc
Confidence 6543221 22345689999999999999999999999999999999999999998655433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=311.46 Aligned_cols=207 Identities=24% Similarity=0.420 Sum_probs=174.5
Q ss_pred eecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 162 ~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
.||+|+||.|+. ++..||||+++... .....+.+.+|+.++++++||||+++++++.. +.+++||||+++
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence 799999998873 35679999998653 23345778999999999999999999999976 569999999999
Q ss_pred CCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC--c
Q 016544 235 GDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--L 311 (387)
Q Consensus 235 ~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~ 311 (387)
|+|.+++... ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......... .
T Consensus 420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 9999999754 44999999999999999999999999 9999999999999999999999999998764332211 1
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+.++++
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~ 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 560 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 22345688999999998899999999999999999998 9999999999999999988876654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=290.09 Aligned_cols=215 Identities=27% Similarity=0.494 Sum_probs=178.1
Q ss_pred ccCcccceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
..+|...+.||+|+||.||. ++. .||+|.+..... ....+.+.+|+.++++++||||+++++++. ...
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 34688889999999998874 233 488888754321 122345678999999999999999999986 467
Q ss_pred eEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.++||||+.+++|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 89999999999999999864 46899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 304 TVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 304 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
...... ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+....++...+..+.++..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ 238 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC
Confidence 543322 2234557789999999998899999999999999999999 9999999998888888877764443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=285.20 Aligned_cols=198 Identities=25% Similarity=0.427 Sum_probs=168.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC--ceEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMI 227 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--~~~l 227 (387)
.+|...+.||+|+||.|+. +|+.||||++...... ...+.+.+|+.++++++||||+++++++.... ..++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 4688889999999998874 3889999999754322 22456788999999999999999999998765 7899
Q ss_pred EEEccCCCCHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----CCCCCEEEEeecCc
Q 016544 228 VTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFGVS 300 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Dfg~~ 300 (387)
||||+++++|.+++..... +++.+++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999986433 899999999999999999999999 9999999999999 77778999999999
Q ss_pred cccccCCCCCcccCCCCCccccccccc--------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 301 KLLTVKEDRPLTCQDTSCRYVAPEVFK--------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
....... ......+|+.|+|||++. +..++.++|||||||++|+|++|+.||.....
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 228 (319)
T 4euu_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (319)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred eecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 8765332 223356899999999986 56789999999999999999999999975443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=285.84 Aligned_cols=205 Identities=26% Similarity=0.368 Sum_probs=178.8
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-----CCcceeeeeEEeeCC
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----HPNVVQFLGAVTQSS 223 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~iv~l~~~~~~~~ 223 (387)
..+|...+.||+|+||.|+. ++..||||++.. .....+.+..|+.+++.+. ||||+++++++...+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 34788899999999999874 678999999863 2445567788999999986 999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-------------
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD------------- 288 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~------------- 288 (387)
..++||||+ +++|.+++.... .+++.++..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcc
Confidence 999999999 889999998754 4899999999999999999999999 999999999999975
Q ss_pred ------------CCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 289 ------------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 289 ------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 788999999999764322 2334679999999999999999999999999999999999999998
Q ss_pred CCCCcHHHHHHccC
Q 016544 357 KHDNEVPKAYAARQ 370 (387)
Q Consensus 357 ~~~~~~~~~i~~~~ 370 (387)
.+..+....+....
T Consensus 262 ~~~~~~~~~~~~~~ 275 (360)
T 3llt_A 262 HEHMEHLAMMESII 275 (360)
T ss_dssp SSHHHHHHHHHHHT
T ss_pred CcHHHHHHHHHHhc
Confidence 88777777765544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=314.27 Aligned_cols=209 Identities=27% Similarity=0.422 Sum_probs=177.8
Q ss_pred eeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccC
Q 016544 161 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 161 ~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
+.||+|+||.|+. .+..||||+++.... .....+.+.+|+.++++++||||+++++++.. ...++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999873 357899999976533 33445779999999999999999999999864 56899999999
Q ss_pred CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC--CCc
Q 016544 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPL 311 (387)
Q Consensus 234 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 311 (387)
+|+|.+++.....+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999998888999999999999999999999999 99999999999999999999999999987653322 112
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..++...+..+.++++
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~ 593 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 593 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 23346788999999999999999999999999999998 9999999999889999888776655
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=290.48 Aligned_cols=204 Identities=27% Similarity=0.430 Sum_probs=171.2
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 223 (387)
..|...+.||+|+||.|+. +|+.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4688889999999998873 58899999997643 34556678899999999999999999999998653
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.+|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 469999999 7899999987 46899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+.+|..
T Consensus 179 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 240 (367)
T 1cm8_A 179 DS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240 (367)
T ss_dssp CS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 42 2234567999999999987 6789999999999999999999999998877666666644
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=285.53 Aligned_cols=199 Identities=24% Similarity=0.403 Sum_probs=164.5
Q ss_pred Cccc-ceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEE
Q 016544 156 DFTN-SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 156 ~~~~-~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 228 (387)
.|.. .+.||+|+||.|+. ++..||||++..... ...+.+.+|+.++.++ +||||+++++++..++.+++|
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 4555 35799999999874 588999999875432 2245678899999885 799999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC---EEEEeecCcccccc
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTV 305 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfg~~~~~~~ 305 (387)
|||+++++|.+++.....+++.++..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999998888999999999999999999999999 999999999999998776 99999999876532
Q ss_pred CCC------CCcccCCCCCcccccccccC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 306 KED------RPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 306 ~~~------~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 232 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS 232 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccc
Confidence 211 11123458999999999975 45788999999999999999999999876543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=280.58 Aligned_cols=210 Identities=30% Similarity=0.480 Sum_probs=173.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||+|.+...........+.+.+|+.+++.++||||+++++++......++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 677888999999998874 588999999865422222234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++...+.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....... .
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 166 (276)
T 2h6d_A 92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--F 166 (276)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc--c
Confidence 9999999999998888999999999999999999999999 9999999999999999999999999987654322 2
Q ss_pred cccCCCCCcccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....+++.|+|||.+.+..+ +.++|+||||+++|+|++|+.||.+.....+.+.+..+.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 227 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV 227 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 233457899999999988765 589999999999999999999999887777777775554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=279.53 Aligned_cols=211 Identities=27% Similarity=0.419 Sum_probs=178.7
Q ss_pred CcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--CceEEEEE
Q 016544 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~~lv~e 230 (387)
+|...+.||+|+||.|+ ..+..||+|++..... .....+.+.+|+.++++++||||+++++++... ...++|||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HhHHHHHhcCCCcceEEEEEECCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 57778899999998776 5799999999986533 445567799999999999999999999999877 78899999
Q ss_pred ccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+++++|.+++.... .+++.+++.++.|++.||.|||+++ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~--- 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--- 165 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC---
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc---
Confidence 999999999998765 4899999999999999999999986 3499999999999999999999999998754321
Q ss_pred CCcccCCCCCcccccccccCCCCCC---chhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC-CCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDT---KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPF 374 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~---~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~-~~~~ 374 (387)
....+|+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+.......+.... ++.+
T Consensus 166 ---~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (271)
T 3kmu_A 166 ---PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI 232 (271)
T ss_dssp ---TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred ---cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCC
Confidence 2235789999999998765544 7999999999999999999999888777777666554 4443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=283.37 Aligned_cols=217 Identities=26% Similarity=0.416 Sum_probs=173.6
Q ss_pred ccCcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC--
Q 016544 154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-- 223 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-- 223 (387)
..+|...+.||+|+||.|+. .+..||+|.+..... .....+.+.+|+.++++++||||+++++++....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 34678888999999988873 245899999976533 4555678999999999999999999999998654
Q ss_pred ---ceEEEEEccCCCCHHHHHHH------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEE
Q 016544 224 ---PMMIVTEYLPKGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (387)
Q Consensus 224 ---~~~lv~e~~~~~sL~~~l~~------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 294 (387)
..++||||+++++|.+++.. ...+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 35999999999999999953 245899999999999999999999999 999999999999999999999
Q ss_pred EeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 295 ADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 295 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.....+...+..+.++
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 268 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL 268 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC
Confidence 99999876543321 12233456788999999999999999999999999999999 99999999888888888777655
Q ss_pred CC
Q 016544 373 PF 374 (387)
Q Consensus 373 ~~ 374 (387)
.+
T Consensus 269 ~~ 270 (313)
T 3brb_A 269 KQ 270 (313)
T ss_dssp CC
T ss_pred CC
Confidence 44
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=283.34 Aligned_cols=211 Identities=28% Similarity=0.424 Sum_probs=179.6
Q ss_pred cCcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCC
Q 016544 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~ 223 (387)
.+|...+.||+|+||.|+. ++..||+|.+... ......+.+.+|+.+++++ +||||+++++++...+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc--hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 4677888999999998873 3478999999754 2345567899999999999 8999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHcC------------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEE
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKG------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~------------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nil 285 (387)
..++||||+++++|.+++.... .+++.+++.++.|++.||.|||+++ |+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 9999999999999999998653 3899999999999999999999999 999999999999
Q ss_pred eCCCCCEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHH
Q 016544 286 RDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 363 (387)
Q Consensus 286 l~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~ 363 (387)
++.++.+||+|||++.......... .....+++.|+|||++.+..++.++||||||+++|+|+| |+.||.+.......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 9999999999999997665432221 122345778999999999899999999999999999999 99999987766655
Q ss_pred HHHHccC
Q 016544 364 KAYAARQ 370 (387)
Q Consensus 364 ~~i~~~~ 370 (387)
..+....
T Consensus 258 ~~~~~~~ 264 (313)
T 1t46_A 258 YKMIKEG 264 (313)
T ss_dssp HHHHHHT
T ss_pred HHHhccC
Confidence 5554444
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=308.72 Aligned_cols=211 Identities=32% Similarity=0.495 Sum_probs=180.2
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|...+.||+|+||.|+. .+..||||++...... .+.+.+|+.++++++||||+++++++.. ..+++||||
T Consensus 268 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 567778999999998873 3468999999865432 3568899999999999999999999876 678999999
Q ss_pred cCCCCHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 232 LPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 232 ~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
+++|+|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 999999999974 345899999999999999999999999 999999999999999999999999999765432111
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......++..|+|||++.+..++.++|||||||++|||++ |+.||.+....++...+..+.+++.
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 485 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 485 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 2223346788999999998899999999999999999999 9999999988888888877765544
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=300.04 Aligned_cols=213 Identities=25% Similarity=0.406 Sum_probs=168.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCC-----CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
.+|...+.||+|+||.|+. ++..||+|++...... .......+.+|+.++++++||||+++++++.. ..
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence 3688889999999998874 4789999998764322 12223357889999999999999999999864 55
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC---CEEEEeecCcc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSK 301 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~Dfg~~~ 301 (387)
.++||||+++++|.+++...+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+++
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccce
Confidence 8999999999999999988888999999999999999999999999 99999999999997544 59999999998
Q ss_pred ccccCCCCCcccCCCCCcccccccccC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-cHHHHHHccCCCC
Q 016544 302 LLTVKEDRPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPP 373 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~ 373 (387)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.... .+...+..+..+.
T Consensus 291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~ 364 (419)
T 3i6u_A 291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC
T ss_pred ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC
Confidence 76432 22234568999999999864 56788999999999999999999999876544 4555665554433
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=279.55 Aligned_cols=194 Identities=25% Similarity=0.318 Sum_probs=160.5
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHc-CCCCcceeeeeEEeeCCceEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~~~~~~lv 228 (387)
.+|...+.||+|+||.|+. +|+.||||++.......... .....|+..+.+ .+||||+++++++...+..++|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH-HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 3578888999999999874 58899999987654433333 344445555544 4899999999999999999999
Q ss_pred EEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|||+ +++|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~- 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA- 210 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence 9999 679999887654 5999999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
.......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 211 -GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred -CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22334568999999999887 789999999999999999999776654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=287.26 Aligned_cols=209 Identities=22% Similarity=0.424 Sum_probs=170.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +|+.||||++..... .....+.+.+|+.++++++||||+++++++..+..+++||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 3688889999999998874 588999999976532 3334566788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC-----CCCCEEEEeecCccccc
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-----DSGNLKVADFGVSKLLT 304 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~-----~~~~~kl~Dfg~~~~~~ 304 (387)
||++ ++|.+++.....+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++....
T Consensus 113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9997 599999998888999999999999999999999999 99999999999995 44559999999997654
Q ss_pred cCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...++...
T Consensus 189 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 253 (329)
T 3gbz_A 189 IPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253 (329)
T ss_dssp ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred Ccc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHH
Confidence 332 222334578999999999875 4799999999999999999999999988877776666543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=279.43 Aligned_cols=208 Identities=24% Similarity=0.436 Sum_probs=173.6
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
..|...+.||+|+||.|+. ++..||+|.+...... ...+.+.+|+.++++++||||+++++++......++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3688889999999998873 5789999998765432 23467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---CCCCCEEEEeecCccc
Q 016544 230 EYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKL 302 (387)
Q Consensus 230 e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfg~~~~ 302 (387)
||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||++ +.++.++|+|||++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999988542 56999999999999999999999999 9999999999999 4567899999999976
Q ss_pred cccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.... .......+++.|+|||++.+ .++.++||||||+++|+|++|+.||.+.+..++...+....
T Consensus 177 ~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~ 241 (285)
T 3is5_A 177 FKSD--EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE 241 (285)
T ss_dssp ------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cCCc--ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC
Confidence 5432 22234568999999999865 68899999999999999999999999888777766665444
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=280.45 Aligned_cols=208 Identities=31% Similarity=0.544 Sum_probs=172.4
Q ss_pred cCcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-CceEEEEE
Q 016544 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTE 230 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-~~~~lv~e 230 (387)
.+|...+.||+|+||.|+ ..|..||+|.+.... ..+.+.+|+.++++++||||+++++++... +..++|||
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 467888899999998776 578999999987542 346788999999999999999999987654 47899999
Q ss_pred ccCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+++++|.+++...+. +++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999999999986543 889999999999999999999999 999999999999999999999999998754422
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..++...+..+.++.+
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA 235 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 122346788999999998899999999999999999998 9999999888888888766654443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=277.89 Aligned_cols=201 Identities=31% Similarity=0.505 Sum_probs=168.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHH----HHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRV----RAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
.+|...+.||+|+||.|+. +++.||+|.+........... +.+.+|+.++++++||||+++++++....
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 4678888999999988773 578999999876544332222 67889999999999999999999986554
Q ss_pred EEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC-----EEEEeecC
Q 016544 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADFGV 299 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-----~kl~Dfg~ 299 (387)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ .+|+||||||+||+++.++. +||+|||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 7999999999999988754 45999999999999999999999986 34999999999999988776 99999999
Q ss_pred ccccccCCCCCcccCCCCCccccccccc--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
+..... ......+|+.|+|||++. ...++.++|||||||++|+|++|+.||...+....
T Consensus 176 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 236 (287)
T 4f0f_A 176 SQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236 (287)
T ss_dssp CBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred cccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence 875332 233456899999999984 44578899999999999999999999998776655
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=287.01 Aligned_cols=201 Identities=24% Similarity=0.400 Sum_probs=167.9
Q ss_pred cccCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCC--CcceeeeeEEeeCCceE
Q 016544 153 HELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~~iv~l~~~~~~~~~~~ 226 (387)
....|...+.||+|+||.|+. ++..||||++.... ......+.+.+|+.+++++.| |||+++++++.....++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 344688889999999999984 57899999987553 345566789999999999976 99999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+|||+ .+++|.+++.....+++.++..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||++......
T Consensus 86 lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99995 57899999999888999999999999999999999999 99999999999997 578999999999876433
Q ss_pred CCC-CcccCCCCCcccccccccC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 307 EDR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 307 ~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 225 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh
Confidence 222 2234568999999999864 6788899999999999999999999987543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=297.01 Aligned_cols=199 Identities=26% Similarity=0.417 Sum_probs=157.4
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-----Cc
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~ 224 (387)
.+|...+.||+|+||.|+. +|+.||||++... .......+.+.+|+.+++.++||||+++++++... ..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 3688889999999998873 5789999998754 33455667889999999999999999999999543 56
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
+|+||||+ +++|.+++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 89999998 5799999998888999999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCC--------------------------CCcccCCCCCcccccccc-cCCCCCCchhHHHHHHHHHHHHc--------
Q 016544 305 VKED--------------------------RPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIE-------- 349 (387)
Q Consensus 305 ~~~~--------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~ellt-------- 349 (387)
.... .......||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 3221 122345679999999976 55679999999999999999999
Q ss_pred ---CCCCCCCCC
Q 016544 350 ---GCPPFTMKH 358 (387)
Q Consensus 350 ---g~~pf~~~~ 358 (387)
|++||.+.+
T Consensus 288 ~~~~~p~f~g~~ 299 (458)
T 3rp9_A 288 HADRGPLFPGSS 299 (458)
T ss_dssp GGGCCCSCC---
T ss_pred cccccccCCCCc
Confidence 788887754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=283.15 Aligned_cols=195 Identities=26% Similarity=0.441 Sum_probs=163.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC-------
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------- 223 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------- 223 (387)
+|...+.||+|+||.|+. +|..||||++.... .....+.+.+|+.++++++||||+++++++....
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 567788999999998873 58899999987543 2344577899999999999999999999986543
Q ss_pred --------------------------------------------------ceEEEEEccCCCCHHHHHHHcCC---CChH
Q 016544 224 --------------------------------------------------PMMIVTEYLPKGDLRAFLKRKGA---LKPS 250 (387)
Q Consensus 224 --------------------------------------------------~~~lv~e~~~~~sL~~~l~~~~~---l~~~ 250 (387)
..+++|||+++++|.+++..... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 27999999999999999987544 4556
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC-----------CCcccCCCCCc
Q 016544 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-----------RPLTCQDTSCR 319 (387)
Q Consensus 251 ~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~~~ 319 (387)
.++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999999 99999999999999999999999999987654321 12233468999
Q ss_pred ccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 320 y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
|+|||++.+..++.++|||||||++|+|++|..|+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999999987764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=279.30 Aligned_cols=221 Identities=25% Similarity=0.428 Sum_probs=179.9
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
..|...+.||+|+||.|+. +|..||+|.+..... .+.+.+|+.++++++||||+++++++......++||
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 3678888999999998874 388999999875421 356788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+++++|.+++.. ...+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 99999999999974 456999999999999999999999999 9999999999999999999999999997654322
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhcc
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
.......+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.........+.....+.+.. +..+++.+
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l 255 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK-PELWSDNF 255 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS-GGGSCHHH
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCC-cccCCHHH
Confidence 22233467899999999999999999999999999999999999999877665555554444444432 33444443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=275.58 Aligned_cols=204 Identities=26% Similarity=0.503 Sum_probs=173.2
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee----CCc
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSP 224 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~ 224 (387)
...|...+.||+|+||.|+. ++..||+|.+..... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 33467777899999998874 467899999876544 35567789999999999999999999999875 345
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC-CCCCEEEEeecCcccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~ 303 (387)
+++||||+++++|.+++...+.+++..++.++.|++.||.|||+++ .+|+|+||||+||+++ .++.++|+|||++...
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 8999999999999999998888999999999999999999999986 2499999999999998 7889999999998654
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHH
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~ 363 (387)
.. .......+++.|+|||++.+ .++.++|||||||++|+|++|+.||.+.......
T Consensus 183 ~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 238 (290)
T 1t4h_A 183 RA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI 238 (290)
T ss_dssp CT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH
T ss_pred cc---cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH
Confidence 32 22334568999999998875 5899999999999999999999999875554333
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=281.13 Aligned_cols=213 Identities=30% Similarity=0.486 Sum_probs=183.5
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
..|...+.||+|+||.|+. ++..||+|.+..... ....+.+.+|+.++++++||||+++++++......++||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3578888999999998874 478999999875432 233567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++++|.+++.. +.+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++....... .
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 174 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 174 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence 99999999999875 46899999999999999999999999 9999999999999999999999999997654332 2
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
......+++.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....+.+
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL 239 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCC
Confidence 22345689999999999999999999999999999999999999998877777777665554443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=286.71 Aligned_cols=208 Identities=25% Similarity=0.465 Sum_probs=169.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. ++..||+|++..... ......+.+|+.++++++||||+++++++......++|||
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 577888999999998874 578999999864421 1112234579999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+. ++|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~ 155 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP-TK 155 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC-cc
Confidence 996 59999988754 4899999999999999999999999 999999999999999999999999998765432 22
Q ss_pred CcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 217 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL 217 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 2233467999999999987 568999999999999999999999999988777777765543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=297.04 Aligned_cols=205 Identities=13% Similarity=0.148 Sum_probs=164.5
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH---HHHcCCCCcceeee-------eE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA---LLQKIRHPNVVQFL-------GA 218 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~~iv~l~-------~~ 218 (387)
..+|...+.||+|+||.|+. +|+.||||++...........+.+.+|+. .+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 34678888999999998873 48899999997654445556678999995 45555799999998 66
Q ss_pred EeeCC-----------------ceEEEEEccCCCCHHHHHHHcCCCCh-------HHHHHHHHHHHHHHHHHHhCCCCCe
Q 016544 219 VTQSS-----------------PMMIVTEYLPKGDLRAFLKRKGALKP-------STAVRFALDIARGMNYLHENKPVPI 274 (387)
Q Consensus 219 ~~~~~-----------------~~~lv~e~~~~~sL~~~l~~~~~l~~-------~~~~~i~~qi~~~l~~LH~~~~~~i 274 (387)
+...+ ..|++|||+ +|+|.+++...+.+++ ..++.++.||+.||.|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 66553 288999999 6799999987555555 778889999999999999999 9
Q ss_pred EeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCC-----------CCCCchhHHHHHHH
Q 016544 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----------EYDTKVDVFSFALI 343 (387)
Q Consensus 275 iH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dv~slG~i 343 (387)
+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999999997532 22334456 899999999887 89999999999999
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 344 LQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 344 l~elltg~~pf~~~~~~~~~~~i~ 367 (387)
+|+|++|+.||.+.+.......+.
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~~~ 326 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEWIF 326 (377)
T ss_dssp HHHHHHSSCCC------CCSGGGG
T ss_pred HHHHHHCCCCCcccccccchhhhh
Confidence 999999999998877666555553
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=290.18 Aligned_cols=208 Identities=24% Similarity=0.376 Sum_probs=171.4
Q ss_pred cCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC--CCcceeeeeEEeeCCceEEE
Q 016544 155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~~~~lv 228 (387)
..|...+.||+|+||.||. .+..||||++..... .....+.+.+|+.+++++. ||||+++++++..+..+++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3588889999999999984 478999999876533 4556778999999999996 59999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|| +.+++|.+++.....+++.++..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++........
T Consensus 135 ~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred Ee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 99 557899999998888999999999999999999999999 99999999999996 57899999999987643322
Q ss_pred C-CcccCCCCCcccccccccC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-cHHHHHHc
Q 016544 309 R-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAA 368 (387)
Q Consensus 309 ~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~elltg~~pf~~~~~~-~~~~~i~~ 368 (387)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.... ..+..+..
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 1 2234568999999999875 36888999999999999999999999875432 33444433
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=288.58 Aligned_cols=207 Identities=26% Similarity=0.359 Sum_probs=169.4
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 223 (387)
.+|...+.||+|+||.|+. +|..||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4688889999999998874 48899999987543 34556677889999999999999999999997665
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.+++||||+.+ +|.+++.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 68999999964 88888863 4899999999999999999999999 999999999999999999999999999765
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......++....
T Consensus 178 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 242 (371)
T 2xrw_A 178 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 242 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-C
T ss_pred ccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 422 22234568999999999999999999999999999999999999999988777777775543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=282.45 Aligned_cols=209 Identities=30% Similarity=0.449 Sum_probs=173.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCC--HHHHHHHHHHHHHHHcC---CCCcceeeeeEEeeCC-
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSS- 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~~~- 223 (387)
.+|...+.||+|+||.|+. +|+.||+|++....... ......+.+|+.+++++ .||||+++++++....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 3688889999999998873 57899999986432211 11113455676666666 5999999999998765
Q ss_pred ----ceEEEEEccCCCCHHHHHHHcCC--CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 224 ----PMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 224 ----~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
..+++|||+. ++|.+++..... +++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSC
T ss_pred CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeC
Confidence 4899999996 599999987654 899999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
|++...... .......+|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+...++...
T Consensus 165 g~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 165 GLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp SCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999765432 2233456799999999999999999999999999999999999999998887777777543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=278.01 Aligned_cols=204 Identities=29% Similarity=0.486 Sum_probs=173.0
Q ss_pred cceeecccEEEEEEE---cCeEEEEEEcCccc-CCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccCC
Q 016544 159 NSVEITKGTFILAFW---RGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 159 ~~~~lg~G~~~~v~~---~g~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
..+.||+|+||.||. ++..||+|++.... .......+.+.+|+.++++++||||+++++++......+++|||+++
T Consensus 35 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 114 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN 114 (307)
T ss_dssp TCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred cCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCC
Confidence 347899999998874 78999999987543 23345567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC-C
Q 016544 235 GDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-P 310 (387)
Q Consensus 235 ~sL~~~l~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~ 310 (387)
++|.+++.. ..++++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++......... .
T Consensus 115 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 191 (307)
T 2nru_A 115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191 (307)
T ss_dssp CBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred CcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence 999999974 345899999999999999999999999 999999999999999999999999998765433221 1
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.........+
T Consensus 192 ~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 192 TSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp CSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred ccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 233468999999999876 5789999999999999999999999887665544433
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=286.06 Aligned_cols=211 Identities=32% Similarity=0.528 Sum_probs=175.3
Q ss_pred CcccceeecccEEEEEEE-----cCeE--EEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l 227 (387)
+|...+.||+|+||.|+. +|.. +|+|.+... ......+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 677788999999988873 4554 499988643 2334456788999999999 89999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcC----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC
Q 016544 228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~----------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 291 (387)
||||+++++|.+++.... .+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999998653 5899999999999999999999999 999999999999999999
Q ss_pred EEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 292 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
+||+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..++...+..+.
T Consensus 181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~ 258 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258 (327)
T ss_dssp EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence 999999998743322 11223346788999999998888999999999999999998 999999988887887776654
Q ss_pred CCC
Q 016544 371 RPP 373 (387)
Q Consensus 371 ~~~ 373 (387)
++.
T Consensus 259 ~~~ 261 (327)
T 1fvr_A 259 RLE 261 (327)
T ss_dssp CCC
T ss_pred CCC
Confidence 443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=285.93 Aligned_cols=215 Identities=25% Similarity=0.483 Sum_probs=174.5
Q ss_pred ccCcccceeecccEEEEEEE-----cCe----EEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
..+|...+.||+|+||.||. ++. +||+|.+..... ....+.+.+|+.++++++||||+++++++..+ .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~ 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-S
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-C
Confidence 34688889999999999874 333 468887764322 23346788999999999999999999999875 4
Q ss_pred eEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.++++|++.+++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 88999999999999999874 45999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 304 TVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 304 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
...... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+..++...+..+.+++.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 240 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 433222 2233456788999999999999999999999999999999 9999999998888888877765444
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=285.40 Aligned_cols=211 Identities=26% Similarity=0.430 Sum_probs=170.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCC-----CHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|...+.||+|+||.|+. ++..||||.+...... .......+.+|+.++++++||||+++++++..+. .
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 89 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y 89 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence 577888999999998874 4789999998754321 1223345889999999999999999999987654 8
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC---EEEEeecCccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKL 302 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfg~~~~ 302 (387)
++||||+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++..
T Consensus 90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 999999999999999988888999999999999999999999999 999999999999987664 99999999976
Q ss_pred cccCCCCCcccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-cHHHHHHccCCC
Q 016544 303 LTVKEDRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRP 372 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~ 372 (387)
.... .......+|+.|+|||++. ...++.++|||||||++|+|++|+.||...... .+...+..+..+
T Consensus 167 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (322)
T 2ycf_A 167 LGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238 (322)
T ss_dssp CCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred cccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence 5422 1122345789999999974 457889999999999999999999999876554 455555555443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=277.45 Aligned_cols=201 Identities=28% Similarity=0.453 Sum_probs=173.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. ++..||+|.+..... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 577788999999988874 588999999875433 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC-C
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-R 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 309 (387)
|+++++|.+++.....+++.++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........ .
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 9999999999987777999999999999999999999999 99999999999999999999999999876543221 2
Q ss_pred CcccCCCCCcccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~pf~~~~~~~ 361 (387)
......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.+.....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 215 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 2234567999999999988765 678999999999999999999998766543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=281.78 Aligned_cols=218 Identities=23% Similarity=0.407 Sum_probs=180.5
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee--CCceEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMI 227 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~l 227 (387)
.+|...+.||+|+||.|+. +|+.||+|.+..... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 3677888999999988874 588999999976543 35566789999999999999999999998854 567999
Q ss_pred EEEccCCCCHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhCC--CCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 228 VTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENK--PVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~--~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ ..+|+|+||||+||+++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999753 23899999999999999999999976 1239999999999999999999999999987
Q ss_pred ccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
...... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..++...+..+..+.+
T Consensus 165 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~ 236 (279)
T 2w5a_A 165 ILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236 (279)
T ss_dssp HC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred eecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC
Confidence 654321 111234578999999999998999999999999999999999999999888888888877776544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=287.92 Aligned_cols=196 Identities=24% Similarity=0.415 Sum_probs=170.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH-----HHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|...+.||+|+||.|+. ++..||||.+........ ...+.+.+|+.++++++||||+++++++...+.+
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 104 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF 104 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence 678888999999988774 588999999876543221 1234567799999999999999999999999999
Q ss_pred EEEEEccCCC-CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 226 MIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 226 ~lv~e~~~~~-sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
++||||+.+| +|.+++.....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 105 ~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 105 QLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999776 99999998888999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCCcccCCCCCcccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
.. .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..
T Consensus 182 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 182 RG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp TT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred CC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 33 22233568999999999998876 7899999999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=284.70 Aligned_cols=215 Identities=30% Similarity=0.447 Sum_probs=178.4
Q ss_pred cCcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
.+|...+.||+|+||.|+. ++..||||.+... ........+.+|+.++++++||||+++++++.....
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 4688889999999987763 3457999999743 345556778999999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHHcC-------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC---CCCEEE
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKV 294 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl 294 (387)
.++||||+++++|.+++.... .+++.+++.++.|++.||.|||+++ |+||||||+||+++. +..++|
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999998753 3888999999999999999999999 999999999999994 446999
Q ss_pred EeecCccccccCCC-CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCC
Q 016544 295 ADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 295 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|+| |+.||.+....++...+..+.++
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence 99999875432221 12223456889999999998899999999999999999998 99999998888888888777654
Q ss_pred CC
Q 016544 373 PF 374 (387)
Q Consensus 373 ~~ 374 (387)
.+
T Consensus 265 ~~ 266 (327)
T 2yfx_A 265 DP 266 (327)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=289.41 Aligned_cols=204 Identities=15% Similarity=0.260 Sum_probs=164.8
Q ss_pred cccCcccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHH--------HHHHHHHHHHHcCCCCccee
Q 016544 153 HELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRV--------RAFRDELALLQKIRHPNVVQ 214 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~h~~iv~ 214 (387)
...+|...+.||+|+||.||.. +..||||++........... ..+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 3347888999999999998742 57899999865421100001 12334555667788999999
Q ss_pred eeeEEeeC----CceEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC--
Q 016544 215 FLGAVTQS----SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-- 287 (387)
Q Consensus 215 l~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~-- 287 (387)
+++++... ...++||||+ +++|.+++... +.+++.+++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence 99998765 4589999999 99999999876 56999999999999999999999999 99999999999999
Q ss_pred CCCCEEEEeecCccccccCCCC------CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 288 DSGNLKVADFGVSKLLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 288 ~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999765433211 113345899999999999999999999999999999999999999965443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=290.73 Aligned_cols=195 Identities=24% Similarity=0.431 Sum_probs=164.5
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-----Cc
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~ 224 (387)
.+|...+.||+|+||.|+. +|..||||++... .......+.+.+|+.++++++||||+++++++... ..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 3688889999999998874 4789999999754 34555667889999999999999999999999776 56
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
+|+||||+. ++|.+++.....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 899999995 599999998888999999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCCC---------------------CcccCCCCCcccccccc-cCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 016544 305 VKEDR---------------------PLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354 (387)
Q Consensus 305 ~~~~~---------------------~~~~~~~~~~y~aPE~~-~~~~~~~~~Dv~slG~il~elltg~~pf 354 (387)
..... ......||+.|+|||++ .+..++.++|||||||++|||++|..||
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 33211 22456789999999986 5567999999999999999999844443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=279.64 Aligned_cols=208 Identities=34% Similarity=0.602 Sum_probs=165.1
Q ss_pred CcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEcc
Q 016544 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 232 (387)
+|...+.||+|+||.|+ +.++.||+|.+... ...+.+.+|+.++++++||||+++++++. +..++||||+
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HeeeeeEeecCCCceEEEEEECCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 56677899999998775 57899999998643 24567899999999999999999999886 4589999999
Q ss_pred CCCCHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC-EEEEeecCccccccCCC
Q 016544 233 PKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKED 308 (387)
Q Consensus 233 ~~~sL~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~ 308 (387)
++++|.+++..... ++...++.++.|+++||.|||+.++.+|+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999986543 688899999999999999999932222999999999999998887 799999998754322
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc--HHHHHHccCCCCC
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE--VPKAYAARQRPPF 374 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~--~~~~i~~~~~~~~ 374 (387)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... +...+..+.++++
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL 225 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCC
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCc
Confidence 123358999999999999999999999999999999999999998655433 3334444444443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=283.41 Aligned_cols=207 Identities=26% Similarity=0.420 Sum_probs=174.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|..||+|++.... ......+.+.+|+.++++++||||+++++++......++|||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 688888999999987763 47899999986543 345556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++++|.+++.....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++....... ..
T Consensus 105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 180 (331)
T 4aaa_A 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 180 (331)
T ss_dssp CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc-cc
Confidence 9999999988887778999999999999999999999999 9999999999999999999999999997654322 22
Q ss_pred cccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
.....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 238 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 2345679999999999875 78899999999999999999999999887766655554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=282.95 Aligned_cols=195 Identities=28% Similarity=0.530 Sum_probs=169.2
Q ss_pred cccceeecccEEEEEE---E------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--Cce
Q 016544 157 FTNSVEITKGTFILAF---W------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM 225 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~---~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~~ 225 (387)
|...+.||+|+||.|+ + +|+.||||++... ......+.+.+|+.++++++||||+++++++... ..+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 4788899999999985 2 6789999999854 3455677899999999999999999999999874 568
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
++||||+++++|.+++.... +++.+++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999997654 899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCC--CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 306 KED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 306 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
... .......+++.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 322 1123345788899999999988999999999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=285.53 Aligned_cols=208 Identities=24% Similarity=0.410 Sum_probs=175.2
Q ss_pred cccc-eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEE
Q 016544 157 FTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 157 ~~~~-~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
|... +.||+|+||.|+. +|+.||+|++...... ......+.+|+.+++++ +||||+++++++.....+++||
T Consensus 30 y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~ 108 (327)
T 3lm5_A 30 YILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL 108 (327)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence 4444 7899999999874 4899999998765432 22346688899999999 5799999999999999999999
Q ss_pred EccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC---CCCEEEEeecCccccc
Q 016544 230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLT 304 (387)
Q Consensus 230 e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfg~~~~~~ 304 (387)
||+++++|.+++... ..+++.+++.++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||++....
T Consensus 109 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 109 EYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp ECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999999998643 56899999999999999999999999 999999999999997 7899999999998764
Q ss_pred cCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 186 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 249 (327)
T 3lm5_A 186 HAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN 249 (327)
T ss_dssp ----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred Ccc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc
Confidence 322 2233568999999999999999999999999999999999999999988877777776655
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=280.03 Aligned_cols=195 Identities=26% Similarity=0.539 Sum_probs=165.8
Q ss_pred CcccceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC--Cc
Q 016544 156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~--~~ 224 (387)
.|...+.||+|+||.|+. +++.||+|.+.... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 477888999999998862 57899999997543 223346788999999999999999999999876 66
Q ss_pred eEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
+++||||+++++|.+++... ..+++.+++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccc
Confidence 89999999999999999654 56999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCC--CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 304 TVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 304 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
..... .......+|..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 54322 12233457888999999999889999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=283.90 Aligned_cols=212 Identities=27% Similarity=0.453 Sum_probs=179.1
Q ss_pred ccCcccceeecccEEEEEEEc-----C-----eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC
Q 016544 154 ELDFTNSVEITKGTFILAFWR-----G-----IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~~-----g-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~ 222 (387)
..+|...+.||+|+||.|+.. + ..||+|.+.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 346778889999999998742 2 479999997542 445667899999999999 899999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHc--------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRK--------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~--------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~ 288 (387)
+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 9999999999999999999753 34789999999999999999999999 999999999999999
Q ss_pred CCCEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHH
Q 016544 289 SGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 289 ~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i 366 (387)
++.++|+|||++.......... .....+++.|+|||++.+..++.++|||||||++|+|+| |..||.+.........+
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 9999999999997654332211 122345778999999999899999999999999999998 99999988776666665
Q ss_pred HccC
Q 016544 367 AARQ 370 (387)
Q Consensus 367 ~~~~ 370 (387)
....
T Consensus 280 ~~~~ 283 (333)
T 2i1m_A 280 VKDG 283 (333)
T ss_dssp HHHT
T ss_pred HhcC
Confidence 5544
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=287.07 Aligned_cols=202 Identities=29% Similarity=0.452 Sum_probs=176.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. ++..||+|++... ......+.+.+|+.++++++||||+++++++..++..++||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 3678888999999998874 4789999998754 24556678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+++++|.+++...+.+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|||++......
T Consensus 111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999999999999888899999999999999999999996 7 999999999999999999999999998654322
Q ss_pred CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHH
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 364 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~ 364 (387)
......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..++..
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 240 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHH
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1223468999999999999999999999999999999999999998766554433
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=279.83 Aligned_cols=213 Identities=28% Similarity=0.479 Sum_probs=170.4
Q ss_pred ccCcccceeecccEEEEEEE------cC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 154 ELDFTNSVEITKGTFILAFW------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~------~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
..+|...+.||+|+||.|+. ++ ..||+|.+...........+.+.+|+.++++++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 34688888999999987763 12 369999998765555566788999999999999999999999998754 8
Q ss_pred EEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
++|+||+++++|.+++... +.+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999999999764 55899999999999999999999999 9999999999999999999999999997765
Q ss_pred cCCCC--CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC
Q 016544 305 VKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 305 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (387)
..... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..++...+....
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 241 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC
Confidence 33221 1223456778999999998888999999999999999999 999999988888888876655
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=284.38 Aligned_cols=212 Identities=30% Similarity=0.468 Sum_probs=172.4
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCC--HHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
...+|...+.||+|+||.||. +|+.||+|.+....... ....+.+.+|+.++++++||||+++++++......
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 344688889999999999874 47899999997543221 11234678899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
++||||+++ +|.+++.... .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 999999975 8998887653 5899999999999999999999999 9999999999999999999999999997664
Q ss_pred cCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
... .......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++...
T Consensus 164 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~ 228 (346)
T 1ua2_A 164 SPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 228 (346)
T ss_dssp SCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 332 223345679999999999764 5789999999999999999999999998877777776543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=305.93 Aligned_cols=214 Identities=23% Similarity=0.444 Sum_probs=180.4
Q ss_pred cCcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
.+|...+.||+|+||.|+. .+..||+|.+... ......+.+.+|+.++++++||||+++++++. ++..+
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 4577788999999998873 2457999998753 34556678999999999999999999999985 46789
Q ss_pred EEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 9999999999999998654 5899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
..........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++...+..+.++++
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~ 613 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 613 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 33333334456789999999998899999999999999999997 9999999988888888888776654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=280.90 Aligned_cols=215 Identities=29% Similarity=0.465 Sum_probs=178.0
Q ss_pred ccCcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeC
Q 016544 154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS 222 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~ 222 (387)
..+|...+.||+|+||.||. +++.||+|.+... ......+.+.+|+.+++++ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC--CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 44688889999999998874 3478999999754 2345567789999999999 799999999998875
Q ss_pred C-ceEEEEEccCCCCHHHHHHHcCC----------------CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEE
Q 016544 223 S-PMMIVTEYLPKGDLRAFLKRKGA----------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285 (387)
Q Consensus 223 ~-~~~lv~e~~~~~sL~~~l~~~~~----------------l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nil 285 (387)
+ .++++|||+++++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil 180 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 180 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEE
Confidence 4 58999999999999999987543 788999999999999999999999 999999999999
Q ss_pred eCCCCCEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcH-
Q 016544 286 RDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV- 362 (387)
Q Consensus 286 l~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~- 362 (387)
++.++.+||+|||++.......... .....+|+.|+|||++.+..++.++|||||||++|+|+| |..||.+......
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 9999999999999997654332211 223346788999999999899999999999999999998 9999988775544
Q ss_pred HHHHHccCCCC
Q 016544 363 PKAYAARQRPP 373 (387)
Q Consensus 363 ~~~i~~~~~~~ 373 (387)
...+..+.++.
T Consensus 261 ~~~~~~~~~~~ 271 (316)
T 2xir_A 261 CRRLKEGTRMR 271 (316)
T ss_dssp HHHHHHTCCCC
T ss_pred HHHhccCccCC
Confidence 44444444433
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=284.68 Aligned_cols=211 Identities=25% Similarity=0.392 Sum_probs=175.2
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------- 222 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------- 222 (387)
.+|...+.||+|+||.|+. +|+.||+|++....... .....+.+|+.++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4688889999999987763 57899999987654322 2234567899999999999999999999873
Q ss_pred -CceEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 223 -SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 223 -~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
+.+++||||+++ +|.+.+... ..+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 468999999975 787777654 56999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCC---CCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 301 KLLTVKE---DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 301 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
....... ........+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 245 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 7664322 122234567999999999976 457999999999999999999999999988777777765443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=280.09 Aligned_cols=208 Identities=28% Similarity=0.470 Sum_probs=178.1
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-----C
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----S 223 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~ 223 (387)
..+|+..+.||+|+||.|+. ++..||+|++... ......+.+.+|+.++++++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 34788899999999998874 5789999999743 3455667889999999999999999999999765 3
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
..++||||+. ++|.+++... .+++.++..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 6899999996 5999998764 5899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCC--cccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 304 TVKEDRP--LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 304 ~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+.++..
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 246 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHH
Confidence 5332221 2345789999999987654 589999999999999999999999999888888777754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=287.60 Aligned_cols=204 Identities=28% Similarity=0.447 Sum_probs=159.4
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC------C
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~ 223 (387)
.+|...+.||+|+||.|+. +|..||||++.... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4688889999999998874 48999999997643 3455667788999999999999999999998754 5
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
..++++|++ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 689999999 7899998876 56999999999999999999999999 999999999999999999999999999764
Q ss_pred ccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
.. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..|..
T Consensus 183 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~ 244 (367)
T 2fst_X 183 AD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 244 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 32 1233568999999999987 6789999999999999999999999998877666666644
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=278.50 Aligned_cols=216 Identities=25% Similarity=0.399 Sum_probs=173.0
Q ss_pred cCccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEee--
Q 016544 150 IDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-- 221 (387)
Q Consensus 150 i~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~-- 221 (387)
+....-+|...+.||+|+||.|+. +|+.||+|++...... .+.+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 334445788899999999998874 6789999998654322 35678899999998 79999999999987
Q ss_pred ----CCceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEE
Q 016544 222 ----SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (387)
Q Consensus 222 ----~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 295 (387)
...+++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEe
Confidence 46789999999999999999864 45899999999999999999999999 9999999999999999999999
Q ss_pred eecCccccccCCCCCcccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|||++....... .......+++.|+|||++. +..++.++|||||||++|+|++|+.||.+.........+....
T Consensus 172 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 172 DFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp CCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred eCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 999987654321 1223346799999999997 5578899999999999999999999999877766666665554
Q ss_pred CCC
Q 016544 371 RPP 373 (387)
Q Consensus 371 ~~~ 373 (387)
.|.
T Consensus 251 ~~~ 253 (326)
T 2x7f_A 251 APR 253 (326)
T ss_dssp CCC
T ss_pred ccc
Confidence 443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=274.37 Aligned_cols=194 Identities=29% Similarity=0.498 Sum_probs=160.8
Q ss_pred cCcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHc--CCCCcceeeeeEEeeC----Cce
Q 016544 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK--IRHPNVVQFLGAVTQS----SPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~l~~~~~~~----~~~ 225 (387)
.+|...+.||+|+||.|+ .+|+.||||++... ....+..|.+++.. ++||||+++++++... ..+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 467888999999999876 57999999998643 12445556666666 7899999999987643 458
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH--------hCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH--------ENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
++||||+++|+|.++++. ..+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCC
T ss_pred EEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeC
Confidence 999999999999999964 46899999999999999999999 777 999999999999999999999999
Q ss_pred cCccccccCCCCC---cccCCCCCcccccccccCC------CCCCchhHHHHHHHHHHHHcC----------CCCCCCCC
Q 016544 298 GVSKLLTVKEDRP---LTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALILQEMIEG----------CPPFTMKH 358 (387)
Q Consensus 298 g~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~Dv~slG~il~elltg----------~~pf~~~~ 358 (387)
|++.......... .....||+.|+|||++.+. .+++++|||||||++|+|++| +.||.+..
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9997654332211 2234689999999999886 445789999999999999999 89997643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=276.47 Aligned_cols=209 Identities=28% Similarity=0.498 Sum_probs=179.5
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +++.||+|++...... ....+.+.+|+.++++++||||+++++++......++||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 3678888999999998874 5789999998754332 223467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC---CCEEEEeecCccccccC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVK 306 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfg~~~~~~~~ 306 (387)
||+++++|.+++.....+++.+++.++.|++.||.|||+++ ++|+||||+||+++.+ +.+||+|||++......
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999999999988888999999999999999999999999 9999999999999754 46999999998765432
Q ss_pred CCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.. .....+++.|+|||++.+ .++.++|+||||+++|+|++|+.||.+.+..++.+.+..+.
T Consensus 178 ~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (287)
T 2wei_A 178 TK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238 (287)
T ss_dssp SS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred Cc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 21 122346788999999887 48999999999999999999999999988888888887765
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=278.69 Aligned_cols=222 Identities=25% Similarity=0.395 Sum_probs=178.8
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
..|...+.||+|+||.|+. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 3688889999999987763 47899999987542 223467888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 230 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++...... .
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 171 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-L 171 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-H
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-c
Confidence 99999999999876 455999999999999999999999999 999999999999999999999999987543211 1
Q ss_pred CCcccCCCCCcccccccc-----cCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhh
Q 016544 309 RPLTCQDTSCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 383 (387)
.......+++.|+|||++ .+..++.++||||||+++|+|++|+.||...+......++.....+.... +..+|.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 250 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLT-PSKWSV 250 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS-GGGSCH
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCC-ccccCH
Confidence 111234578999999998 46678899999999999999999999999888777777776665544432 344444
Q ss_pred c
Q 016544 384 G 384 (387)
Q Consensus 384 ~ 384 (387)
.
T Consensus 251 ~ 251 (302)
T 2j7t_A 251 E 251 (302)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=275.78 Aligned_cols=200 Identities=24% Similarity=0.371 Sum_probs=167.5
Q ss_pred cCcccceeecccEEEEEEE-----cC-------eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC
Q 016544 155 LDFTNSVEITKGTFILAFW-----RG-------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~ 222 (387)
.+|...+.||+|+||.|+. ++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++...
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 3677788999999998874 22 579999986542 23456788999999999999999999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcCC-CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC--------EE
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--------LK 293 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~--------~k 293 (387)
+..++||||+++++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+|||++.++. ++
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999987654 899999999999999999999999 999999999999998887 99
Q ss_pred EEeecCccccccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHH
Q 016544 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKA 365 (387)
Q Consensus 294 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~ 365 (387)
|+|||++...... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||...........
T Consensus 162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 9999998654321 22346788999999987 678999999999999999999 5556655544433333
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=274.73 Aligned_cols=205 Identities=17% Similarity=0.217 Sum_probs=169.2
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEE-eeCCceEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV-TQSSPMMIV 228 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~-~~~~~~~lv 228 (387)
.+|...+.||+|+||.|+. +|+.||+|++...... +.+.+|+.+++.++|++++..+..+ ......++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 4688889999999998873 5899999998654332 3578899999999988766655554 566778999
Q ss_pred EEccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC---CCCCEEEEeecCccccc
Q 016544 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLT 304 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfg~~~~~~ 304 (387)
|||+ +++|.+++.. ...+++.+++.++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999 8999999984 456999999999999999999999999 99999999999994 78899999999998765
Q ss_pred cCCCC------CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC---CcHHHHHHc
Q 016544 305 VKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD---NEVPKAYAA 368 (387)
Q Consensus 305 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~---~~~~~~i~~ 368 (387)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+. .+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence 43321 12345689999999999999999999999999999999999999987443 344444443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=281.41 Aligned_cols=198 Identities=31% Similarity=0.530 Sum_probs=170.7
Q ss_pred ccCcccceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEe--eC
Q 016544 154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT--QS 222 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~ 222 (387)
..+|...+.||+|+||.|+. .+..||+|++... .....+.+.+|+.++++++||||+++++++. ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 34678888999999998862 5789999998754 4555677999999999999999999999887 44
Q ss_pred CceEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
...++||||+++++|.+++... ..+++.+++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 5689999999999999999873 45999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCC--CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 302 LLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 302 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
........ ......+++.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 76533221 223345788899999999988999999999999999999999999653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=269.84 Aligned_cols=208 Identities=22% Similarity=0.346 Sum_probs=173.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 228 (387)
.+|...+.||+|+||.|+. ++..||+|.+........ ....+.+|+..+..+ +||||+++++++...+..++|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 3577788999999998874 589999999876544333 446677899999888 899999999999999999999
Q ss_pred EEccCCCCHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC---------------
Q 016544 229 TEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--------------- 289 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~----~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~--------------- 289 (387)
|||+++++|.+++... +.+++.+++.++.|++.||.|||+++ |+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999764 56899999999999999999999999 9999999999999844
Q ss_pred ----CCEEEEeecCccccccCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHH
Q 016544 290 ----GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 364 (387)
Q Consensus 290 ----~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~ 364 (387)
..++|+|||++...... ....+|+.|+|||++.+. .+++++|||||||++|+|++|.+|+... ....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~ 238 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWH 238 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHHH
T ss_pred cCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHHH
Confidence 47999999998765432 223478999999999876 5668999999999999999999887543 3455
Q ss_pred HHHccCCCCC
Q 016544 365 AYAARQRPPF 374 (387)
Q Consensus 365 ~i~~~~~~~~ 374 (387)
.+..+..+.+
T Consensus 239 ~~~~~~~~~~ 248 (289)
T 1x8b_A 239 EIRQGRLPRI 248 (289)
T ss_dssp HHHTTCCCCC
T ss_pred HHHcCCCCCC
Confidence 6655555444
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=286.03 Aligned_cols=203 Identities=27% Similarity=0.383 Sum_probs=175.4
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC------CCCcceeeeeEEeeCC
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI------RHPNVVQFLGAVTQSS 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~iv~l~~~~~~~~ 223 (387)
.+|...+.||+|+||.|+. ++..||||++... ....+.+.+|+.+++.+ +|+||+++++++....
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 4688889999999999884 4789999998743 34456677888888877 5779999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC--EEEEeecC
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--LKVADFGV 299 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~--~kl~Dfg~ 299 (387)
.+++||||+. ++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999995 69999998754 3899999999999999999999999 999999999999999887 99999999
Q ss_pred ccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
+..... ......+|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+...
T Consensus 249 a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~ 314 (429)
T 3kvw_A 249 SCYEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314 (429)
T ss_dssp CEETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred ceecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 875432 223356899999999999999999999999999999999999999998877777766544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=277.40 Aligned_cols=214 Identities=26% Similarity=0.447 Sum_probs=162.2
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
..+|...+.||+|+||.|+. ++..||||.+..... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34678888999999988763 578999999875422 23456788899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHH--------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCc
Q 016544 229 TEYLPKGDLRAFLKR--------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~--------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~ 300 (387)
|||+++++|.+++.. .+.+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999974 345899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCC----CCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 301 KLLTVKED----RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 301 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
........ .......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.................+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 76543221 11233468999999999876 56899999999999999999999999988777666655554433
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=283.74 Aligned_cols=203 Identities=24% Similarity=0.404 Sum_probs=168.1
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-----
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS----- 222 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~----- 222 (387)
...+|...+.||+|+||.|+. +|..||||++..... ...+|+.+++.++||||+++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345788899999999999874 578999998865422 224699999999999999999998543
Q ss_pred ---------------------------------CceEEEEEccCCCCHHHHHH----HcCCCChHHHHHHHHHHHHHHHH
Q 016544 223 ---------------------------------SPMMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNY 265 (387)
Q Consensus 223 ---------------------------------~~~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~qi~~~l~~ 265 (387)
..+++||||++ ++|.+.+. ....+++..+..++.|++.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 34889999997 48777665 34569999999999999999999
Q ss_pred HHhCCCCCeEeCCCCCCCEEeC-CCCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHH
Q 016544 266 LHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALI 343 (387)
Q Consensus 266 LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i 343 (387)
||+++ |+||||||+|||++ .++.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||+
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999 99999999999998 68899999999998664332 23345678999999998875 48999999999999
Q ss_pred HHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 344 LQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 344 l~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
+|+|++|+.||.+.+..+.+.++..
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~ 256 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQ 256 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999999999887777666644
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=272.31 Aligned_cols=209 Identities=24% Similarity=0.379 Sum_probs=159.0
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +|+.||+|.+.... ......+.+.++...++.++||||+++++++..++..++||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 4678888999999998874 68899999997543 23334445555666688889999999999999999999999
Q ss_pred EccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 230 e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
||++ ++|.+++.. ...+++..++.++.|++.||.|||++ + |+||||||+||+++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588877754 45699999999999999999999998 8 9999999999999999999999999987654
Q ss_pred cCCCCCcccCCCCCcccccccc----cCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-CCcHHHHHHccC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVF----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKH-DNEVPKAYAARQ 370 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Dv~slG~il~elltg~~pf~~~~-~~~~~~~i~~~~ 370 (387)
.. .......+|+.|+|||++ .+..++.++|||||||++|+|++|+.||.... .......+....
T Consensus 162 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 230 (290)
T 3fme_A 162 DD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP 230 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC
T ss_pred cc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC
Confidence 32 222334688999999996 55678899999999999999999999998633 233333433333
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=274.00 Aligned_cols=197 Identities=18% Similarity=0.233 Sum_probs=163.8
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEE-eeCCceEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV-TQSSPMMIV 228 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~-~~~~~~~lv 228 (387)
.+|...+.||+|+||.|+. +++.||+|++..... .+.+.+|+.+++.++|++++..+..+ ......+++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3688889999999988873 678999998654322 23578899999999888766666555 667788999
Q ss_pred EEccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---CCCCCEEEEeecCccccc
Q 016544 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 304 (387)
|||+ +++|.+++.. ...+++.++..++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999 8999999985 456999999999999999999999999 9999999999999 788899999999998765
Q ss_pred cCCC------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 016544 305 VKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360 (387)
Q Consensus 305 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~ 360 (387)
.... .......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh
Confidence 4322 1223456899999999999999999999999999999999999999875544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=286.31 Aligned_cols=210 Identities=25% Similarity=0.460 Sum_probs=178.2
Q ss_pred cCcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCH--------------HHHHHHHHHHHHHHcCCCCcceeeee
Q 016544 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDD--------------DRVRAFRDELALLQKIRHPNVVQFLG 217 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~iv~l~~ 217 (387)
.+|...+.||+|+||.|+ .+|..||+|.+........ ...+.+.+|+.++++++||||+++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred CceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 378888999999998765 4799999999875432211 11267889999999999999999999
Q ss_pred EEeeCCceEEEEEccCCCCHHHH------HHH--cCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCC
Q 016544 218 AVTQSSPMMIVTEYLPKGDLRAF------LKR--KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDD 288 (387)
Q Consensus 218 ~~~~~~~~~lv~e~~~~~sL~~~------l~~--~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~ 288 (387)
++...+..++||||+++++|.++ +.. ...+++..++.++.|++.||.|||+ ++ ++|+||||+||+++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDK 187 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcC
Confidence 99999999999999999999998 655 4669999999999999999999999 88 999999999999999
Q ss_pred CCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCC-CCCC-chhHHHHHHHHHHHHcCCCCCCCCCC-CcHHHH
Q 016544 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDT-KVDVFSFALILQEMIEGCPPFTMKHD-NEVPKA 365 (387)
Q Consensus 289 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Dv~slG~il~elltg~~pf~~~~~-~~~~~~ 365 (387)
++.++|+|||++...... ......+++.|+|||++.+. .++. ++|||||||++|+|++|+.||...+. .++...
T Consensus 188 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 999999999999765432 23345689999999999887 5665 99999999999999999999998777 566666
Q ss_pred HHccC
Q 016544 366 YAARQ 370 (387)
Q Consensus 366 i~~~~ 370 (387)
+..+.
T Consensus 265 i~~~~ 269 (348)
T 2pml_X 265 IRTKN 269 (348)
T ss_dssp HTSCC
T ss_pred HhccC
Confidence 65543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=289.23 Aligned_cols=209 Identities=25% Similarity=0.408 Sum_probs=172.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC--ceEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMI 227 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~--~~~l 227 (387)
..|...+.||+|+||.|+. +|+.||||++...... ...+.+.+|+.++++++||||+++++++.... ..++
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 4688889999999998874 4889999999754322 22456788999999999999999999998765 6899
Q ss_pred EEEccCCCCHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----CCCCCEEEEeecCc
Q 016544 228 VTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFGVS 300 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~---l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Dfg~~ 300 (387)
||||+++++|.+++..... +++.+++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999976432 899999999999999999999999 9999999999999 77778999999999
Q ss_pred cccccCCCCCcccCCCCCcccccccccC--------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC----CcHHHHHHc
Q 016544 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKN--------EEYDTKVDVFSFALILQEMIEGCPPFTMKHD----NEVPKAYAA 368 (387)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~elltg~~pf~~~~~----~~~~~~i~~ 368 (387)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .++..++..
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 8764332 2233568999999999865 4667899999999999999999999975333 334555544
Q ss_pred cC
Q 016544 369 RQ 370 (387)
Q Consensus 369 ~~ 370 (387)
+.
T Consensus 242 ~~ 243 (396)
T 4eut_A 242 GK 243 (396)
T ss_dssp SC
T ss_pred CC
Confidence 43
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=273.06 Aligned_cols=211 Identities=23% Similarity=0.368 Sum_probs=173.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHHcCCCCcceeeeeEEe--eCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~~l 227 (387)
+|...+.||+|+||.|+. ++..||+|++...... .....+.+.+|+.++++++||||+++++++. .....++
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 678888999999998873 5789999998754221 1233567899999999999999999999984 4567999
Q ss_pred EEEccCCCCHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 228 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
||||+.++ |.+++.. ...+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999775 8777765 345899999999999999999999999 99999999999999999999999999976543
Q ss_pred CC-CCCcccCCCCCcccccccccCCCC--CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 306 KE-DRPLTCQDTSCRYVAPEVFKNEEY--DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 306 ~~-~~~~~~~~~~~~y~aPE~~~~~~~--~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.. ........+++.|+|||++.+... +.++||||||+++|+|++|+.||.+.+..++.+.+..+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~ 229 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS 229 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC
Confidence 22 222234568999999999987543 679999999999999999999999887777777776554
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=283.89 Aligned_cols=197 Identities=12% Similarity=0.154 Sum_probs=153.2
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC--CCCcceeee-------eEEe
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFL-------GAVT 220 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~l~-------~~~~ 220 (387)
.+|...+.||+|+||.|+. +|+.||||++...........+.+++|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3578889999999998873 5789999999876655566677888885544444 699988755 4554
Q ss_pred eCC-----------------ceEEEEEccCCCCHHHHHHHc-CCCChHHH------HHHHHHHHHHHHHHHhCCCCCeEe
Q 016544 221 QSS-----------------PMMIVTEYLPKGDLRAFLKRK-GALKPSTA------VRFALDIARGMNYLHENKPVPIIH 276 (387)
Q Consensus 221 ~~~-----------------~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~------~~i~~qi~~~l~~LH~~~~~~iiH 276 (387)
..+ .+|+||||++ ++|.+++... ..++...+ ..++.||+.||.|||+++ |+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 333 3799999998 7999999864 33555555 677899999999999999 999
Q ss_pred CCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCCCcccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCC
Q 016544 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPF 354 (387)
Q Consensus 277 ~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf 354 (387)
|||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999865322 113346699999999987 67899999999999999999999999
Q ss_pred CCCCC
Q 016544 355 TMKHD 359 (387)
Q Consensus 355 ~~~~~ 359 (387)
.+..+
T Consensus 294 ~~~~~ 298 (371)
T 3q60_A 294 GLVTP 298 (371)
T ss_dssp TBCCT
T ss_pred CCcCc
Confidence 87644
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=279.99 Aligned_cols=200 Identities=19% Similarity=0.258 Sum_probs=162.3
Q ss_pred ccCcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHH--------HHHHHHHHHHHHHcCCCCcceeeee
Q 016544 154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDD--------RVRAFRDELALLQKIRHPNVVQFLG 217 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~~iv~l~~ 217 (387)
..+|...+.||+|+||.||. .+..||+|.+......... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 34688889999999998873 5678999998754221111 1123567888999999999999999
Q ss_pred EEee----CCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC--C
Q 016544 218 AVTQ----SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG--N 291 (387)
Q Consensus 218 ~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~--~ 291 (387)
++.. ....++||||+ +++|.+++...+.+++.+++.++.|++.||.|||+++ |+||||||+|||++.++ .
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCc
Confidence 9988 67899999999 9999999988778999999999999999999999999 99999999999999877 9
Q ss_pred EEEEeecCccccccCCC------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 292 LKVADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 292 ~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
+||+|||+++.+..... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99999999976643221 1123457899999999999999999999999999999999999999653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=285.65 Aligned_cols=193 Identities=15% Similarity=0.225 Sum_probs=165.6
Q ss_pred ccCcccceeecccEEEEEEE-------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCccee------
Q 016544 154 ELDFTNSVEITKGTFILAFW-------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ------ 214 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~------ 214 (387)
..+|...+.||+|+||.||. .+..||+|.+... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 45788899999999998873 2789999998643 35788999999999999887
Q ss_pred ---------eeeEEee-CCceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 016544 215 ---------FLGAVTQ-SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282 (387)
Q Consensus 215 ---------l~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~ 282 (387)
+++++.. +...++||||+ +++|.+++... ..+++.+++.++.|++.||.|||+++ |+||||||+
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~ 188 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAE 188 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHH
Confidence 6777776 67889999999 99999999875 67999999999999999999999999 999999999
Q ss_pred CEEeCCCC--CEEEEeecCccccccCCCC------CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 016544 283 NILRDDSG--NLKVADFGVSKLLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354 (387)
Q Consensus 283 Nill~~~~--~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf 354 (387)
|||++.++ .+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999988 8999999999765533221 123346899999999999999999999999999999999999999
Q ss_pred CCCC
Q 016544 355 TMKH 358 (387)
Q Consensus 355 ~~~~ 358 (387)
.+..
T Consensus 269 ~~~~ 272 (352)
T 2jii_A 269 TNCL 272 (352)
T ss_dssp GGGT
T ss_pred ccCC
Confidence 8764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=284.52 Aligned_cols=203 Identities=28% Similarity=0.434 Sum_probs=165.9
Q ss_pred ccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC----
Q 016544 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS---- 222 (387)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~---- 222 (387)
+...+|...+.||+|+||.||. +|..||||++..... ...+|+.+++.++||||++++++|...
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 3445788889999999999873 488999999865321 234699999999999999999988542
Q ss_pred --CceEEEEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC-CCEEEE
Q 016544 223 --SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVA 295 (387)
Q Consensus 223 --~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~ 295 (387)
..+++||||+++ +|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~ 199 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLC 199 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEEC
T ss_pred cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEec
Confidence 236799999975 67666542 456999999999999999999999999 9999999999999965 568999
Q ss_pred eecCccccccCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+.+|.
T Consensus 200 DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~ 270 (420)
T 1j1b_A 200 DFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 270 (420)
T ss_dssp CCTTCEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cchhhhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999998654322 22345689999999999775 78999999999999999999999999887666555554
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=274.53 Aligned_cols=196 Identities=23% Similarity=0.403 Sum_probs=164.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee----CCce
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~ 225 (387)
.+|...+.||+|+||.|+. +|+.||+|.+... .....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 4688889999999998863 6789999988643 45566788999999999999999999999873 3468
Q ss_pred EEEEEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 226 MIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
++||||+++++|.+++.. ...+++.+++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 999999999999999976 356999999999999999999999999 9999999999999999999999999887
Q ss_pred ccccCCCCC--------cccCCCCCcccccccccCCC---CCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 302 LLTVKEDRP--------LTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 302 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~---~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
......... .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 543211110 11234689999999997654 68899999999999999999999964
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=274.45 Aligned_cols=206 Identities=24% Similarity=0.371 Sum_probs=171.9
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-----C
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----S 223 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~ 223 (387)
..+|...+.||+|+||.|+. +|+.||||.+... ........+.+|+.++++++||||+++++++... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 44788889999999998874 4889999999643 3455667788999999999999999999988754 6
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
..+++|||+. ++|.+++.. +.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 7899999996 599999886 46899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCC---------CcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 304 TVKEDR---------PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 304 ~~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 235 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 432111 1123467999999998765 67899999999999999999999999987755544444
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=272.92 Aligned_cols=202 Identities=27% Similarity=0.376 Sum_probs=173.9
Q ss_pred cCcccceeecccEEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCc------ceeeeeEEeeC
Q 016544 155 LDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN------VVQFLGAVTQS 222 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~l~~~~~~~ 222 (387)
.+|...+.||+|+||.|+. ++..||+|++... ....+.+.+|+.+++.++|++ ++++++++...
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 3688889999999998873 4789999998642 445677889999999887654 99999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC------------
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD------------ 288 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~------------ 288 (387)
+.+++||||+ +++|.+++...+ ++++.++..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 9999999999 889999998765 5889999999999999999999999 999999999999987
Q ss_pred -------CCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 016544 289 -------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (387)
Q Consensus 289 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~ 361 (387)
++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 668999999998764322 233468999999999999999999999999999999999999999877666
Q ss_pred HHHHHHc
Q 016544 362 VPKAYAA 368 (387)
Q Consensus 362 ~~~~i~~ 368 (387)
....+..
T Consensus 242 ~~~~~~~ 248 (339)
T 1z57_A 242 HLAMMER 248 (339)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 5555543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=278.34 Aligned_cols=203 Identities=25% Similarity=0.436 Sum_probs=171.9
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce----
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM---- 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~---- 225 (387)
.+|...+.||+|+||.|+. +|+.||||++.... ......+.+.+|+.+++.++||||+++++++......
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3688889999999999874 48999999997653 3455667889999999999999999999999877654
Q ss_pred --EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 226 --MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 226 --~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
++||||+. ++|.+++.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999996 588887743 4899999999999999999999999 999999999999999999999999999764
Q ss_pred ccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...++..
T Consensus 195 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 256 (371)
T 4exu_A 195 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 256 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 322 233467999999999987 6889999999999999999999999998877766666644
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=273.64 Aligned_cols=196 Identities=28% Similarity=0.519 Sum_probs=168.1
Q ss_pred cCcccceeecccEEEEEEE---------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC--
Q 016544 155 LDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-- 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~-- 223 (387)
.+|...+.||+|+||.|+. +|..||+|.+... .....+.+.+|+.++++++||||+++++++....
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 4577788999999998863 5789999998753 3455678999999999999999999999987654
Q ss_pred ceEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
.+++||||+++++|.+++... ..+++.+++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++..
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 789999999999999999875 35899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCCC--CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 303 LTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 303 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
....... ......++..|+|||.+.+..++.++||||||+++|+|+||..||..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 6543221 12233467789999999988889999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=280.06 Aligned_cols=191 Identities=26% Similarity=0.474 Sum_probs=148.2
Q ss_pred ceeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee--CCceEEEEE
Q 016544 160 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE 230 (387)
Q Consensus 160 ~~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e 230 (387)
.+.||+|+||.|+. ++..||+|.+...... ..+.+|+.++++++||||+++++++.. ...+++|||
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 45799999998873 3678999999755332 357789999999999999999999954 668999999
Q ss_pred ccCCCCHHHHHHHc---------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe----CCCCCEEEEee
Q 016544 231 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADF 297 (387)
Q Consensus 231 ~~~~~sL~~~l~~~---------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Df 297 (387)
|+. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+||
T Consensus 101 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 101 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp CCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred CCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 996 5888887532 14899999999999999999999999 9999999999999 67789999999
Q ss_pred cCccccccCCC--CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 298 g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
|+++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+...
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 99987643211 222345689999999999874 589999999999999999999999986554
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=272.89 Aligned_cols=211 Identities=27% Similarity=0.483 Sum_probs=154.9
Q ss_pred ccCccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEe--
Q 016544 149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVT-- 220 (387)
Q Consensus 149 ei~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-- 220 (387)
.+.....+|...+.||+|+||.|+. +|+.||+|.+... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 3444455788899999999998873 6789999988543 4555677899999999996 999999999994
Q ss_pred ------eCCceEEEEEccCCCCHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC
Q 016544 221 ------QSSPMMIVTEYLPKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (387)
Q Consensus 221 ------~~~~~~lv~e~~~~~sL~~~l~~---~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 291 (387)
....++++|||+. |+|.+++.. .+.+++.+++.++.|++.||.|||+++ .+|+||||||+|||++.++.
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSC
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCC
Confidence 3345899999995 699998865 456999999999999999999999986 24999999999999999999
Q ss_pred EEEEeecCccccccCCCCC-----------cccCCCCCcccccccc---cCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 292 LKVADFGVSKLLTVKEDRP-----------LTCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 292 ~kl~Dfg~~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~---~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
+||+|||++.......... .....+|+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999998765332211 1134578999999998 5667889999999999999999999999876
Q ss_pred CCCcHHH
Q 016544 358 HDNEVPK 364 (387)
Q Consensus 358 ~~~~~~~ 364 (387)
....+..
T Consensus 257 ~~~~~~~ 263 (337)
T 3ll6_A 257 AKLRIVN 263 (337)
T ss_dssp -------
T ss_pred hHHHhhc
Confidence 6554433
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=269.52 Aligned_cols=197 Identities=30% Similarity=0.535 Sum_probs=164.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
++.....||+|+||.|+. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 445556899999988873 57899999987542 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-CCCEEEEeecCccccccC
Q 016544 231 YLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~ 306 (387)
|+++++|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++. ++.++|+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999998652 3568888999999999999999999 999999999999987 889999999999765432
Q ss_pred CCCCcccCCCCCcccccccccCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
. .......+++.|+|||++.+.. ++.++||||||+++|+|++|+.||.....
T Consensus 177 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (295)
T 2clq_A 177 N-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE 230 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred C-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence 1 1223346799999999997643 78899999999999999999999976543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=279.95 Aligned_cols=202 Identities=28% Similarity=0.455 Sum_probs=165.4
Q ss_pred ccCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc-----
Q 016544 154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 224 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----- 224 (387)
..+|...+.||+|+||.|+. .+..||+|++..... ...+|+.+++.++||||+++++++...+.
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 34688899999999999873 456699998764322 12369999999999999999999965443
Q ss_pred -eEEEEEccCCCCHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC-CCCCEEEEeec
Q 016544 225 -MMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFG 298 (387)
Q Consensus 225 -~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg 298 (387)
+++||||+.+ ++.+.+. ....+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 8899999976 4444332 2456999999999999999999999999 99999999999999 78999999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
+++..... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 188 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~ 256 (394)
T 4e7w_A 188 SAKILIAG--EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256 (394)
T ss_dssp TCEECCTT--CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CcccccCC--CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99876433 223345679999999999765 589999999999999999999999999887666666544
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=277.43 Aligned_cols=202 Identities=25% Similarity=0.435 Sum_probs=169.5
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc-----
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----- 224 (387)
.+|...+.||+|+||.|+. +|..||||.+.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 3688889999999998874 48999999997643 345566788999999999999999999999987654
Q ss_pred -eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 225 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 -~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
++++|||+. ++|.+++.. .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999996 588877643 4899999999999999999999999 999999999999999999999999998764
Q ss_pred ccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus 177 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~ 237 (353)
T 3coi_A 177 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHH
T ss_pred CCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 322 233467899999999987 678999999999999999999999999877655555543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=275.49 Aligned_cols=195 Identities=28% Similarity=0.464 Sum_probs=164.7
Q ss_pred cCcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHc--CCCCcceeeeeEEeeCC----ce
Q 016544 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK--IRHPNVVQFLGAVTQSS----PM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~iv~l~~~~~~~~----~~ 225 (387)
.+|...+.||+|+||.|+ .+|+.||||.+... ....+..|..+++. ++||||+++++++.... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 367888899999998776 57999999998643 13456778888887 68999999999998776 78
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH--------hCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH--------ENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH--------~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
++||||+++++|.+++.+. .+++.+++.++.|++.||.||| +.+ |+||||||+||+++.++.+||+||
T Consensus 116 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEEC
Confidence 9999999999999999764 5899999999999999999999 777 999999999999999999999999
Q ss_pred cCccccccCCCC---CcccCCCCCcccccccccCCC------CCCchhHHHHHHHHHHHHcC----------CCCCCCCC
Q 016544 298 GVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEG----------CPPFTMKH 358 (387)
Q Consensus 298 g~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~Dv~slG~il~elltg----------~~pf~~~~ 358 (387)
|++......... ......+|+.|+|||++.+.. ++.++|||||||++|+|+|| ..||.+..
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 999766543221 123446899999999998762 33689999999999999999 88998754
Q ss_pred C
Q 016544 359 D 359 (387)
Q Consensus 359 ~ 359 (387)
.
T Consensus 272 ~ 272 (342)
T 1b6c_B 272 P 272 (342)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=285.82 Aligned_cols=201 Identities=16% Similarity=0.235 Sum_probs=169.2
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCC-CcceeeeeEEeeCCceEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~~~lv 228 (387)
.+|...+.||+|+||.||. ++..||||++...... ..+..|+.+++.+.| ++|..+..++......++|
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 3678888999999998874 4889999987654322 247789999999976 5666777777788889999
Q ss_pred EEccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe---CCCCCEEEEeecCccccc
Q 016544 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~ 304 (387)
|||+ +++|.+++.. ...+++.+++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9999 8999999985 456999999999999999999999999 9999999999999 578899999999998765
Q ss_pred cCCCC------CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHH
Q 016544 305 VKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 364 (387)
Q Consensus 305 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~ 364 (387)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~ 223 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH
Confidence 43221 1224568999999999999999999999999999999999999999877654433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=278.88 Aligned_cols=210 Identities=25% Similarity=0.372 Sum_probs=169.1
Q ss_pred cccCcccceeecccEEEEEEE----cCeEEEEEEcCcccC--------CCHHHHHHHHHHHHHHHcCCCCcceeeeeEEe
Q 016544 153 HELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVI--------SDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~ 220 (387)
...+|...+.||+|+||.|+. .|..||||++..... ......+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 344788889999999999874 488999999865432 23344578899999999999999999999985
Q ss_pred e-----CCceEEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEE
Q 016544 221 Q-----SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294 (387)
Q Consensus 221 ~-----~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 294 (387)
. ...+++||||+. ++|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEE
Confidence 4 235899999997 58888887543 5899999999999999999999999 999999999999999999999
Q ss_pred EeecCccccccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 295 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
+|||++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...++..
T Consensus 176 ~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 248 (362)
T 3pg1_A 176 CDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248 (362)
T ss_dssp CCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999754332 22233467899999999987 6789999999999999999999999998877776666644
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=272.44 Aligned_cols=215 Identities=29% Similarity=0.441 Sum_probs=152.5
Q ss_pred ccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHH-HHHcCCCCcceeeeeEEeeCCce
Q 016544 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
....+|...+.||+|+||.|+. +|+.||||.+.... .......+..|.. +++.++||||+++++++...+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 3445788888999999998873 48899999997542 2334445555655 77778999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEeCCCCCEEEEeecC
Q 016544 226 MIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 299 (387)
++||||+.+ +|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCC
Confidence 999999975 88888763 45689999999999999999999998 8 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccccccc----cCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-CcHHHHHHccCCCCC
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAPEVF----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYAARQRPPF 374 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~ 374 (387)
+...... .......+++.|+|||++ .+..++.++|||||||++|+|++|+.||.+... .+...++..+..+.+
T Consensus 173 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 173 SGQLVDS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp SCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred ceecccc--cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 9765432 122233578999999998 456789999999999999999999999987443 233344444444433
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=278.26 Aligned_cols=195 Identities=25% Similarity=0.361 Sum_probs=166.5
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC--------CCcceeeeeEEe-
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--------HPNVVQFLGAVT- 220 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~iv~l~~~~~- 220 (387)
-+|...+.||+|+||.|+. +++.||||++... ....+.+.+|+.+++.+. ||||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4688889999999999884 4789999998643 445677889999999885 788999999987
Q ss_pred ---eCCceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEeCCCC----
Q 016544 221 ---QSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSG---- 290 (387)
Q Consensus 221 ---~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~---- 290 (387)
....+++||||+ +++|.+++... ..+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 455799999999 56777776654 4599999999999999999999998 8 99999999999999775
Q ss_pred ---------------------------------------------CEEEEeecCccccccCCCCCcccCCCCCccccccc
Q 016544 291 ---------------------------------------------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325 (387)
Q Consensus 291 ---------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~ 325 (387)
.+||+|||++...... .....+|+.|+|||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence 7999999999765432 233468999999999
Q ss_pred ccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 016544 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (387)
Q Consensus 326 ~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~ 361 (387)
+.+..++.++|||||||++|+|++|+.||...+...
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 300 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSS
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccc
Confidence 999999999999999999999999999998766543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=277.44 Aligned_cols=204 Identities=25% Similarity=0.317 Sum_probs=174.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CC-----cceeeeeEEeeCC
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HP-----NVVQFLGAVTQSS 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~iv~l~~~~~~~~ 223 (387)
.+|...+.||+|+||.|+. +++.||||++... ......+..|+.+++.+. |+ +|+++++++....
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 4788889999999999874 4789999998743 344567788988888874 44 4999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHh--CCCCCeEeCCCCCCCEEeC--CCCCEEEEee
Q 016544 224 PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHE--NKPVPIIHRDLEPSNILRD--DSGNLKVADF 297 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~--~~~~~iiH~Dlkp~Nill~--~~~~~kl~Df 297 (387)
..++||||+. ++|.+++... ..+++..+..++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999995 5999999875 358999999999999999999995 45 99999999999995 4778999999
Q ss_pred cCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
|++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...++....
T Consensus 206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 274 (382)
T 2vx3_A 206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274 (382)
T ss_dssp TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999765422 233568999999999999999999999999999999999999999988888777776544
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=269.45 Aligned_cols=205 Identities=29% Similarity=0.480 Sum_probs=163.1
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee---------
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------- 221 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--------- 221 (387)
+|...+.||+|+||.|+. +|..||+|.+.. .....+.+.+|+.++++++||||+++++++..
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 577788999999998874 578999999864 24556788999999999999999999998865
Q ss_pred ----CCceEEEEEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEe
Q 016544 222 ----SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296 (387)
Q Consensus 222 ----~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 296 (387)
....++||||+++++|.+++.... .+++.+++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 356899999999999999998654 4788899999999999999999999 99999999999999999999999
Q ss_pred ecCccccccCC-------------CCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCC-CCCCc
Q 016544 297 FGVSKLLTVKE-------------DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTM-KHDNE 361 (387)
Q Consensus 297 fg~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~-~~~~~ 361 (387)
||++....... ........+++.|+|||++.+. .++.++|||||||++|+|++ ||.. .....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99987654221 1112334578999999999865 68999999999999999998 5543 23334
Q ss_pred HHHHHHccC
Q 016544 362 VPKAYAARQ 370 (387)
Q Consensus 362 ~~~~i~~~~ 370 (387)
+..++....
T Consensus 237 ~~~~~~~~~ 245 (303)
T 1zy4_A 237 ILKKLRSVS 245 (303)
T ss_dssp HHHHHHSTT
T ss_pred HHHhccccc
Confidence 455554433
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=270.69 Aligned_cols=194 Identities=27% Similarity=0.460 Sum_probs=160.0
Q ss_pred cCcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC--CCCcceeeeeEEeeC----Cce
Q 016544 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQS----SPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~iv~l~~~~~~~----~~~ 225 (387)
.+|...+.||+|+||.|+ ..|..||||++.... ...+..|..++... +||||+++++++... ..+
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 368888999999998876 578999999985331 23344566666555 899999999999887 679
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC--------CCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN--------KPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~--------~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
++||||+++++|.+++... .+++..++.++.|++.||.|||++ + |+||||||+|||++.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeC
Confidence 9999999999999999765 589999999999999999999998 7 999999999999999999999999
Q ss_pred cCccccccCCCCC---cccCCCCCcccccccccCCCCCCc------hhHHHHHHHHHHHHcC----------CCCCCCCC
Q 016544 298 GVSKLLTVKEDRP---LTCQDTSCRYVAPEVFKNEEYDTK------VDVFSFALILQEMIEG----------CPPFTMKH 358 (387)
Q Consensus 298 g~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~------~Dv~slG~il~elltg----------~~pf~~~~ 358 (387)
|++.......... .....||+.|+|||++.+...+.. +|||||||++|||+|| +.||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9997654332221 124468999999999988766665 9999999999999999 78886543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=279.52 Aligned_cols=215 Identities=25% Similarity=0.419 Sum_probs=175.5
Q ss_pred cCcccceeecccEEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEcc
Q 016544 155 LDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 232 (387)
.+|...+.||+|+||.|+. .+..||+|++...... ....+.+.+|+.++++++||||+++++++.....++++|||+
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred HHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence 4677888999999988873 3456999998754322 222345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC----
Q 016544 233 PKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE---- 307 (387)
Q Consensus 233 ~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 307 (387)
++++|.+++...+ .+++.+++.++.|++.||.|||+++ ++|+||||+||+++ ++.++|+|||++.......
T Consensus 112 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 112 KGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp CSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred cCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 9999999998754 5899999999999999999999999 99999999999998 6799999999986543211
Q ss_pred CCCcccCCCCCcccccccccC---------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKN---------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
........+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.....+..++..+.+|.+
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 263 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence 122233457889999999875 3578899999999999999999999999888888888877766554
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=276.49 Aligned_cols=204 Identities=29% Similarity=0.415 Sum_probs=157.8
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc-----
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----- 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----- 224 (387)
.+|...+.||+|+||.|+. +|..||||++....... ....+|+..+..++||||+++++++...+.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 3688888999999998873 47899999886543222 345667888888999999999999976443
Q ss_pred --eEEEEEccCCCCHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHH--hCCCCCeEeCCCCCCCEEeCC-CCCEEEE
Q 016544 225 --MMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLH--ENKPVPIIHRDLEPSNILRDD-SGNLKVA 295 (387)
Q Consensus 225 --~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~i~~qi~~~l~~LH--~~~~~~iiH~Dlkp~Nill~~-~~~~kl~ 295 (387)
+++||||+.+ +|...+. ....+++..+..++.|++.||.||| +++ |+||||||+|||++. ++.+||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEEC
T ss_pred eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEe
Confidence 8899999976 5554443 4456889999999999999999999 888 999999999999996 8899999
Q ss_pred eecCccccccCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 175 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 175 DFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp CCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 999998765332 22345679999999998765 489999999999999999999999999887777777654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=266.52 Aligned_cols=189 Identities=29% Similarity=0.510 Sum_probs=164.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee---------
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------- 221 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--------- 221 (387)
+|...+.||+|+||.|+. +|+.||+|.+.... +.+.+|+.++++++||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 577788999999987763 48999999987542 346789999999999999999998864
Q ss_pred -------CCceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCE
Q 016544 222 -------SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292 (387)
Q Consensus 222 -------~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 292 (387)
...+++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 34589999999999999999764 56899999999999999999999999 9999999999999999999
Q ss_pred EEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 293 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
+|+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred EECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 999999987765332 22334689999999999999999999999999999999999999853
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=268.70 Aligned_cols=188 Identities=23% Similarity=0.428 Sum_probs=163.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEee--CCceE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMM 226 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~--~~~~~ 226 (387)
.+|+..+.||+|+||.|+. +++.||+|++.... .+.+.+|+.++++++ ||||+++++++.. ....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 3688889999999999874 57899999987432 356889999999997 9999999999987 56789
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEeecCcccccc
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTV 305 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~ 305 (387)
+||||+.+++|.+++.. +++.++..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++.....
T Consensus 110 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 99999999999998754 889999999999999999999999 99999999999999776 899999999986653
Q ss_pred CCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 184 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 184 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 32 2334567899999999987 6789999999999999999999999954
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=272.23 Aligned_cols=210 Identities=29% Similarity=0.485 Sum_probs=173.0
Q ss_pred ccccCcccceeecccEEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC---CCCcceeeeeEEe--
Q 016544 152 PHELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVT-- 220 (387)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~-- 220 (387)
....+|...+.||+|+||.|+. +|..||+|.+....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 3445788899999999998873 36889999986543221 1112355677766665 8999999999987
Q ss_pred ---eCCceEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEE
Q 016544 221 ---QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295 (387)
Q Consensus 221 ---~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 295 (387)
.....++||||+. ++|.+++.... .+++..+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999997 59999998753 3899999999999999999999999 9999999999999999999999
Q ss_pred eecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 296 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......++..
T Consensus 163 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (326)
T 1blx_A 163 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233 (326)
T ss_dssp SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 99998765432 122345679999999999999999999999999999999999999998887777666653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=268.70 Aligned_cols=207 Identities=25% Similarity=0.440 Sum_probs=166.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEe---------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT--------- 220 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--------- 220 (387)
.+|...+.||+|+||.|+. +|+.||+|.+... .....+.+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 3678889999999998874 3899999998643 4566778899999999999999999999874
Q ss_pred -----eCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC-CCCCEEE
Q 016544 221 -----QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKV 294 (387)
Q Consensus 221 -----~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl 294 (387)
.....++||||+. ++|.+++.. +++++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3367899999997 599999865 56899999999999999999999999 99999999999997 5678999
Q ss_pred EeecCccccccCCC--CCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 295 ADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 295 ~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
+|||++........ .......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999986543211 11223456889999998866 67899999999999999999999999988776666665443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=272.85 Aligned_cols=197 Identities=27% Similarity=0.412 Sum_probs=140.7
Q ss_pred cccCcccce-eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee----C
Q 016544 153 HELDFTNSV-EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----S 222 (387)
Q Consensus 153 ~~~~~~~~~-~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~ 222 (387)
...+|...+ .||+|+||.|+. +|+.||||++... ... .......++.++||||+++++++.. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 334677744 599999999874 4889999998642 222 2223344667799999999999976 4
Q ss_pred CceEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC---CCCEEEEee
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADF 297 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Df 297 (387)
..+++||||+++++|.+++...+ .+++.+++.++.|++.||.|||+++ |+||||||+||+++. ++.+||+||
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence 45899999999999999998754 5999999999999999999999999 999999999999986 445999999
Q ss_pred cCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
|++...... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.....+
T Consensus 176 g~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 176 GFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237 (336)
T ss_dssp TTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh
Confidence 999765422 22334578999999999888899999999999999999999999987665544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=274.16 Aligned_cols=191 Identities=28% Similarity=0.456 Sum_probs=153.9
Q ss_pred cCcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHH--HcCCCCcceeeeeEEee-----CCc
Q 016544 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALL--QKIRHPNVVQFLGAVTQ-----SSP 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l--~~l~h~~iv~l~~~~~~-----~~~ 224 (387)
.+|...+.||+|+||.|| .+++.||||++.... ...+..|..++ ..++||||+++++.+.. ...
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred HHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 367788899999999877 578999999986432 23344454554 45799999999986543 235
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---------CCCCeEeCCCCCCCEEeCCCCCEEEE
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN---------KPVPIIHRDLEPSNILRDDSGNLKVA 295 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~---------~~~~iiH~Dlkp~Nill~~~~~~kl~ 295 (387)
+++||||+++|+|.+++.... .++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEe
Confidence 789999999999999997654 58899999999999999999999 7 9999999999999999999999
Q ss_pred eecCccccccCC-------CCCcccCCCCCcccccccccC-------CCCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 296 DFGVSKLLTVKE-------DRPLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 296 Dfg~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
|||++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 999997654321 111223468999999999987 356678999999999999999976654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=267.02 Aligned_cols=202 Identities=25% Similarity=0.395 Sum_probs=167.1
Q ss_pred ccccCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC--CCcceeeeeEEeeCCce
Q 016544 152 PHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~~~ 225 (387)
....+|...+.||+|+||.|+. ++..||+|.+..... .....+.+.+|+.+++++. ||||+++++++......
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3445688889999999999884 478999999875433 4556678999999999997 59999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
+++|| +.+++|.+++.....+++.++..++.|+++||.|||+++ |+||||||+||++++ +.+||+|||++.....
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 99999 557899999998888999999999999999999999999 999999999999975 7899999999976543
Q ss_pred CCCC-CcccCCCCCcccccccccC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 306 KEDR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 306 ~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
.... ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 244 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence 3221 1233468999999999876 4678899999999999999999999986543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=269.78 Aligned_cols=203 Identities=27% Similarity=0.338 Sum_probs=172.2
Q ss_pred cCcccceeecccEEEEEEE-----cC-eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCc------ceeeeeEEeeC
Q 016544 155 LDFTNSVEITKGTFILAFW-----RG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN------VVQFLGAVTQS 222 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------iv~l~~~~~~~ 222 (387)
.+|...+.||+|+||.|+. ++ ..||+|++... ....+.+.+|+.++++++|++ ++.+++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 4788889999999998874 23 78999998642 445677888999999997765 99999999999
Q ss_pred CceEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe--------------
Q 016544 223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR-------------- 286 (387)
Q Consensus 223 ~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill-------------- 286 (387)
+..++||||+ +++|.+++.... .+++.++..++.||+.||.|||+++ |+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 9999999999 667877776643 5899999999999999999999999 9999999999999
Q ss_pred -----CCCCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 016544 287 -----DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (387)
Q Consensus 287 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~ 361 (387)
+.++.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 56788999999999764322 233468999999999999999999999999999999999999999877666
Q ss_pred HHHHHHcc
Q 016544 362 VPKAYAAR 369 (387)
Q Consensus 362 ~~~~i~~~ 369 (387)
....+...
T Consensus 247 ~~~~~~~~ 254 (355)
T 2eu9_A 247 HLVMMEKI 254 (355)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 55555443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=280.48 Aligned_cols=196 Identities=25% Similarity=0.377 Sum_probs=156.8
Q ss_pred ccCcccceeecccEEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEE
Q 016544 154 ELDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 228 (387)
..+|...+.||+|+||.|+ ++|+.||||++..... ..+.+|+.+++.+ +||||+++++++.+....|+|
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3467888899999998654 3689999999875432 2346799999999 799999999999999999999
Q ss_pred EEccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-----CCCEEEEeecCccc
Q 016544 229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-----SGNLKVADFGVSKL 302 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-----~~~~kl~Dfg~~~~ 302 (387)
|||+. ++|.+++.... ..+..++..++.||+.||.|||+++ |+||||||+|||++. ...++|+|||++..
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99995 59999998654 3566677899999999999999999 999999999999953 23588999999987
Q ss_pred cccCCC--CCcccCCCCCccccccccc---CCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCC
Q 016544 303 LTVKED--RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 359 (387)
Q Consensus 303 ~~~~~~--~~~~~~~~~~~y~aPE~~~---~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~ 359 (387)
...... .......||+.|+|||++. +..++.++|||||||++|+|++ |..||.....
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~ 235 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH
Confidence 653321 2223456899999999997 4567889999999999999999 9999976543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=265.30 Aligned_cols=214 Identities=28% Similarity=0.436 Sum_probs=158.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
.+|...+.||+|+||.|+. +|..||||.+..... .....+.+..+..+++.++||||+++++++.....+++||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 4677788999999998874 588999999975432 2333444555666788889999999999999999999999
Q ss_pred EccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 230 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||+ ++.+..+... ...+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD- 178 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC-
Confidence 999 5566666654 45699999999999999999999995 8 999999999999999999999999998765432
Q ss_pred CCCcccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCC-CCCcHHHHHHccCCCCCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMK-HDNEVPKAYAARQRPPFK 375 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~ 375 (387)
.......+++.|+|||++. +..++.++|||||||++|+|++|+.||... ...+...++.....+.++
T Consensus 179 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (318)
T 2dyl_A 179 -KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP 251 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC
T ss_pred -ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC
Confidence 2223345789999999995 456888999999999999999999999874 344556666655555443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=280.55 Aligned_cols=193 Identities=27% Similarity=0.403 Sum_probs=152.3
Q ss_pred cccceeecccEEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEc
Q 016544 157 FTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
|...+.||+|+||.|+ .+|+.||||.+.... .+.+.+|+.+++++ +||||+++++++.....+++||||
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 4456789999998775 368999999986432 24567899999876 899999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCC-------ChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC-------------CC
Q 016544 232 LPKGDLRAFLKRKGAL-------KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-------------GN 291 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l-------~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-------------~~ 291 (387)
+. |+|.+++...... ++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 6999999865432 23345789999999999999999 9999999999999754 47
Q ss_pred EEEEeecCccccccCCCC---CcccCCCCCcccccccccC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCC
Q 016544 292 LKVADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 359 (387)
Q Consensus 292 ~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~ 359 (387)
+||+|||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|+| |+.||.+...
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 999999999876543221 1223468999999999976 578899999999999999999 9999986543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=271.20 Aligned_cols=202 Identities=27% Similarity=0.430 Sum_probs=169.9
Q ss_pred ccCccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHHcCC--CCcceeeeeE
Q 016544 149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIR--HPNVVQFLGA 218 (387)
Q Consensus 149 ei~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~iv~l~~~ 218 (387)
+......+|...+.||+|+||.||. ++..||||.+........ ...+.+.+|+.+++++. ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3444556788999999999998874 588999999876533221 11234667999999996 5999999999
Q ss_pred EeeCCceEEEEEccCC-CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC-CCCCEEEEe
Q 016544 219 VTQSSPMMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVAD 296 (387)
Q Consensus 219 ~~~~~~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~D 296 (387)
+......++++|++.+ ++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999999976 899999998888999999999999999999999999 99999999999999 778999999
Q ss_pred ecCccccccCCCCCcccCCCCCcccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
||++...... ......+|+.|+|||++.+..+ +.++|||||||++|+|++|+.||..
T Consensus 194 fg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 194 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred Cccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 9999766432 2233468999999999987665 6789999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=262.63 Aligned_cols=174 Identities=16% Similarity=0.149 Sum_probs=153.6
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
-+|...+.||+|+||.||. +|+.||||++...........+.+.+|+.++.+++||||+++++++...+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 3688889999999988873 38999999998776666777788999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||++|++|.+++... ....++..++.|++.||.|||+++ |+||||||+|||++.++.++|++++
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999999999543 466678999999999999999999 9999999999999999999997443
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~ 361 (387)
|++ +++.++|||||||++|+|+||+.||.+.+...
T Consensus 175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~ 209 (286)
T 3uqc_A 175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRS 209 (286)
T ss_dssp ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCC
T ss_pred ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcch
Confidence 233 36889999999999999999999999877654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=285.84 Aligned_cols=194 Identities=31% Similarity=0.476 Sum_probs=168.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee------CCc
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------SSP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~~~ 224 (387)
+|...+.||.|+||.|+. +|..||||++... ......+.+.+|+.++++++||||+++++++.. .+.
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 578888999999998873 5789999998754 245666789999999999999999999998765 667
Q ss_pred eEEEEEccCCCCHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC---EEEEeec
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFG 298 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfg 298 (387)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. ++|+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999998644 5899999999999999999999999 999999999999997765 8999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
++...... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 170 ~a~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 170 YAKELDQG--ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp CCCBTTSC--CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccc--cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 99876433 222345689999999999999999999999999999999999999965
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=269.99 Aligned_cols=192 Identities=23% Similarity=0.375 Sum_probs=162.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-----------CCcceeeeeE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----------HPNVVQFLGA 218 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~l~~~ 218 (387)
.+|...+.||+|+||.|+. +++.||||++... ....+.+.+|+.+++++. ||||++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 4788889999999998873 5889999998743 345567888999998886 8999999999
Q ss_pred EeeCC----ceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCCEEeC----
Q 016544 219 VTQSS----PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRD---- 287 (387)
Q Consensus 219 ~~~~~----~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~-~~~~iiH~Dlkp~Nill~---- 287 (387)
+...+ .++++||++ +++|.+++... ..+++..+..++.||+.||.|||++ + |+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 98654 689999999 88999999863 4489999999999999999999998 8 99999999999995
Q ss_pred --CCCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 288 --DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 288 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
..+.+||+|||++...... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 3447999999999765432 223467999999999999999999999999999999999999998655
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=265.98 Aligned_cols=198 Identities=29% Similarity=0.437 Sum_probs=161.6
Q ss_pred cccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHHcC----CCCcceeeeeEEe
Q 016544 153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKI----RHPNVVQFLGAVT 220 (387)
Q Consensus 153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~~iv~l~~~~~ 220 (387)
...+|...+.||+|+||.|+. ++..||+|++........ .....+.+|+.+++++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 344788899999999998874 578999999976543221 1223456788999888 8999999999999
Q ss_pred eCCceEEEEEc-cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC-CCCCEEEEeec
Q 016544 221 QSSPMMIVTEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFG 298 (387)
Q Consensus 221 ~~~~~~lv~e~-~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg 298 (387)
..+..++++|+ +.+++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.++|+|||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCS
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcc
Confidence 99999999999 788999999998888999999999999999999999999 99999999999999 88899999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCCCCC-CchhHHHHHHHHHHHHcCCCCCCC
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~elltg~~pf~~ 356 (387)
++...... ......+++.|+|||++.+..+. .++||||||+++|+|++|+.||..
T Consensus 186 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 186 SGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp SCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred hhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 99876432 22345689999999999876664 589999999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=280.60 Aligned_cols=191 Identities=15% Similarity=0.183 Sum_probs=155.5
Q ss_pred cCcccceeecccEEEEEE---EcCeEEEEEEcCcccCC-----CHHHHHHHHHHHHHHHcCC---------CCcceeeee
Q 016544 155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIR---------HPNVVQFLG 217 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~~iv~l~~ 217 (387)
.+|...+.||+|+||.|+ .+|+.||||++...... .....+.+.+|+.+++.++ ||||+++.+
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~ 99 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS 99 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred ccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence 367788899999998876 47899999999765321 2223466788999988885 666666655
Q ss_pred EE-----------------ee-------------CCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH
Q 016544 218 AV-----------------TQ-------------SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267 (387)
Q Consensus 218 ~~-----------------~~-------------~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH 267 (387)
.+ .. ...+|+||||+++|++.+.+.+ ..+++.+++.++.||+.||.|||
T Consensus 100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH 178 (336)
T 2vuw_A 100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAE 178 (336)
T ss_dssp EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHH
T ss_pred eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH
Confidence 43 32 6789999999999976666544 45899999999999999999999
Q ss_pred -hCCCCCeEeCCCCCCCEEeCCCC--------------------CEEEEeecCccccccCCCCCcccCCCCCcccccccc
Q 016544 268 -ENKPVPIIHRDLEPSNILRDDSG--------------------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326 (387)
Q Consensus 268 -~~~~~~iiH~Dlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 326 (387)
+++ |+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||++
T Consensus 179 ~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 179 ASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGG
T ss_pred HhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhh
Confidence 898 99999999999999887 8999999999865422 23689999999999
Q ss_pred cCCCCCCchhHHHHHHH-HHHHHcCCCCCCC
Q 016544 327 KNEEYDTKVDVFSFALI-LQEMIEGCPPFTM 356 (387)
Q Consensus 327 ~~~~~~~~~Dv~slG~i-l~elltg~~pf~~ 356 (387)
.+.. +.++|||||+++ .+++++|..||.+
T Consensus 250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred cCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 9866 889999998777 7788899999965
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=288.58 Aligned_cols=189 Identities=22% Similarity=0.333 Sum_probs=162.4
Q ss_pred cCcccceeecccEEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc----
Q 016544 155 LDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP---- 224 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~---- 224 (387)
-+|...+.||+|+||.||. +|+.||||.+... ........+.+|+.++++++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4688889999999998873 4789999998753 345566778999999999999999999999987765
Q ss_pred -eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 225 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 -~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.|+||||+++++|.+++.. .+++.+++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||++...
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999988765 6899999999999999999999999 9999999999999985 8999999999765
Q ss_pred ccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~ 357 (387)
... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred ccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccc
Confidence 432 334689999999999775 488999999999999999999998753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=249.86 Aligned_cols=173 Identities=28% Similarity=0.460 Sum_probs=144.4
Q ss_pred Ccccc-eeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHH-HcCCCCcceeeeeEEee----CCc
Q 016544 156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQ----SSP 224 (387)
Q Consensus 156 ~~~~~-~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~iv~l~~~~~~----~~~ 224 (387)
+|... +.||+|+||.|+. ++..||+|.+... ..+.+|+.++ +..+||||+++++++.. ...
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 45555 6799999998873 5789999998632 3466788887 55689999999999987 677
Q ss_pred eEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC---CCCEEEEeecC
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV 299 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfg~ 299 (387)
+++||||+++++|.+++.... .+++.+++.++.|++.||.|||+++ |+||||||+||+++. ++.++|+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 999999999999999998754 5999999999999999999999999 999999999999998 78899999998
Q ss_pred ccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~ 362 (387)
+.... +..++.++|||||||++|+|++|+.||.+......
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 206 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 206 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh
Confidence 86432 13467899999999999999999999987665443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=267.34 Aligned_cols=205 Identities=13% Similarity=0.121 Sum_probs=155.1
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCC-Ccc---------ee-----
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNV---------VQ----- 214 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i---------v~----- 214 (387)
.+|...+.||+|+||.||. +|+.||||++...........+.+++|+.+++.+.| ++. +.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3466778999999999874 488999999885444444446778999999999976 211 11
Q ss_pred -------eeeEEee-----CCceEEEEEccCCCCHHHHHHH-------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 016544 215 -------FLGAVTQ-----SSPMMIVTEYLPKGDLRAFLKR-------KGALKPSTAVRFALDIARGMNYLHENKPVPII 275 (387)
Q Consensus 215 -------l~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~-------~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 275 (387)
+..++.. ...++++|+++ +++|.+++.. ...+++..++.++.|++.||.|||+++ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 1111111 12467777776 6799998852 123677788999999999999999999 99
Q ss_pred eCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCCCcccccccc----------cCCCCCCchhHHHHHHHHH
Q 016544 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF----------KNEEYDTKVDVFSFALILQ 345 (387)
Q Consensus 276 H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Dv~slG~il~ 345 (387)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998765432 233456 899999999 5556888999999999999
Q ss_pred HHHcCCCCCCCCCCCcHHHHHHc
Q 016544 346 EMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 346 elltg~~pf~~~~~~~~~~~i~~ 368 (387)
+|++|+.||.+.+..+....+..
T Consensus 309 elltg~~Pf~~~~~~~~~~~~~~ 331 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSEWIFR 331 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSGGGGS
T ss_pred HHHHCCCCCCCcchhhhHHHHHh
Confidence 99999999998776665555533
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-33 Score=273.85 Aligned_cols=174 Identities=15% Similarity=0.115 Sum_probs=131.9
Q ss_pred EEcCeEEEEEEcCcccCC-------CHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEEEEEccCCCCHHHHHHH
Q 016544 172 FWRGIQVAVKKLGEEVIS-------DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 243 (387)
Q Consensus 172 ~~~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~ 243 (387)
++.|..+++|.+.+.... .+...++|++|+++|+++ .|+||+++++++++++.+||||||++|++|.+++.+
T Consensus 256 ~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~ 335 (569)
T 4azs_A 256 YFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA 335 (569)
T ss_dssp EEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT
T ss_pred ccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh
Confidence 567899999998754322 134456799999999999 699999999999999999999999999999999999
Q ss_pred cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCCCccccc
Q 016544 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 323 (387)
Q Consensus 244 ~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aP 323 (387)
.++++.. .|+.||+.||+|+|++| ||||||||+|||++.+|.+||+|||+|+....... ......||+.|+||
T Consensus 336 ~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-~~~t~vGTp~YmAP 408 (569)
T 4azs_A 336 GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-WPTNLVQSFFVFVN 408 (569)
T ss_dssp TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C-CSHHHHHHHHHHHH
T ss_pred CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-cccCceechhhccH
Confidence 8888764 58899999999999999 99999999999999999999999999987654322 23345689999999
Q ss_pred ccccCCCCCCchhHHHHHHHHHHHHcCCCC
Q 016544 324 EVFKNEEYDTKVDVFSFALILQEMIEGCPP 353 (387)
Q Consensus 324 E~~~~~~~~~~~Dv~slG~il~elltg~~p 353 (387)
|++.+ .+..++|+||+|+++++++++..|
T Consensus 409 E~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 409 ELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHC------------------CCCCTTHHH
T ss_pred HHhCC-CCCCcccccccccchhhhccccch
Confidence 99987 456789999999998877655444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-28 Score=235.82 Aligned_cols=183 Identities=20% Similarity=0.247 Sum_probs=145.6
Q ss_pred ceeecccEEEEEE---EcCeEEEEEEcCcccCCCH-----HHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 160 SVEITKGTFILAF---WRGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 160 ~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
.+.||+|+||.|| +.+..+++|.......... ...+.+.+|+.++++++||||+++..++......|+||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 4579999999887 4788999998765433322 2245689999999999999999666666677888999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC-
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP- 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 310 (387)
+++++|.+++.. +..++.|++++|.|||+++ |+||||||+|||++. .+||+|||+++.........
T Consensus 421 ~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 421 INGKLAKDVIED--------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp CCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred CCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 999999999876 5689999999999999999 999999999999998 99999999998765432211
Q ss_pred -----cccCCCCCcccccccccC--CCCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 311 -----LTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 311 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
.....||+.|+|||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 124568999999999987 567778999999999988888887774
|
| >4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=185.45 Aligned_cols=103 Identities=43% Similarity=0.524 Sum_probs=59.4
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
+.|++.++..|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|+||
T Consensus 60 gad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~Tp 139 (169)
T 4gpm_A 60 GADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNTSDSDGRTP 139 (169)
T ss_dssp TCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred ccchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCH
Confidence 34444445555556666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cccccccchHHHHHHHHhhCCCC
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
|++|+..|+.+++++|+++|+++
T Consensus 140 L~~A~~~g~~~iv~~Ll~~GA~i 162 (169)
T 4gpm_A 140 LDLAREHGNEEVVKLLEKQGGWL 162 (169)
T ss_dssp HHHHHHTTCHHHHHHHHTC----
T ss_pred HHHHHHcCCHHHHHHHHHCCCCc
Confidence 66666666666666666666554
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=161.00 Aligned_cols=93 Identities=46% Similarity=0.578 Sum_probs=89.4
Q ss_pred CcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccch
Q 016544 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118 (387)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~ 118 (387)
+|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..++
T Consensus 1 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~ 80 (93)
T 1n0q_A 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH 80 (93)
T ss_dssp --CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred CCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC
Confidence 48999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhCCC
Q 016544 119 HEVIKLLEKHGAK 131 (387)
Q Consensus 119 ~~~~~~L~~~g~~ 131 (387)
.+++++|++.|++
T Consensus 81 ~~~~~~Ll~~ga~ 93 (93)
T 1n0q_A 81 LEVVKLLLEAGAY 93 (93)
T ss_dssp HHHHHHHHHTTCC
T ss_pred HHHHHHHHHcCCC
Confidence 9999999999874
|
| >4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.4e-24 Score=176.65 Aligned_cols=114 Identities=39% Similarity=0.476 Sum_probs=105.6
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|++.++..|+||||+|+..++.+++++|+++|+|++.+|.+|+||||+|+..|+.+++++|+++|+++|.+|..|+|
T Consensus 26 ~Gadvn~~d~~g~t~l~~a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G~T 105 (169)
T 4gpm_A 26 NGADVNASDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRT 105 (169)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred CCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCC
Confidence 46677777888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
|||+|+..|+.+++++|++.|+++........++
T Consensus 106 pLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~Tp 139 (169)
T 4gpm_A 106 PLHHAAENGHKEVVKLLISKGADVNTSDSDGRTP 139 (169)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCH
Confidence 9999999999999999999999987665544443
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=162.60 Aligned_cols=114 Identities=28% Similarity=0.332 Sum_probs=103.2
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
|.|+ .++..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 1 G~d~-~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~ 79 (137)
T 3c5r_A 1 GIDP-FTNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSP 79 (137)
T ss_dssp ---C-CCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCH
T ss_pred CCCC-CcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCH
Confidence 3455 667789999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhCCCCCCCCccccccCC
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE 144 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~~~ 144 (387)
||+|+..++.+++++|+++|+++........++..
T Consensus 80 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~ 114 (137)
T 3c5r_A 80 LHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVD 114 (137)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCGGG
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHH
Confidence 99999999999999999999998776665555543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.5e-23 Score=184.99 Aligned_cols=143 Identities=17% Similarity=0.098 Sum_probs=111.8
Q ss_pred cccceeecccEEEEEEE----cCeEEEEEEcCcccCCCH---------------HHHHHHHHHHHHHHcCCCCcceeeee
Q 016544 157 FTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDD---------------DRVRAFRDELALLQKIRHPNVVQFLG 217 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~~iv~l~~ 217 (387)
|...+.||.|+||.|+. +|..||+|.++....... .....+.+|+.++++++ | +++.+
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred EEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 44568899999998874 589999999875322111 24567899999999998 4 56666
Q ss_pred EEeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 218 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
++.. +..++||||++|++|.+ +. ......++.|++.||.|||+++ |+||||||+|||++ ++.++|+||
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCC
T ss_pred EEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEEC
Confidence 5543 56799999999999987 31 2345579999999999999999 99999999999999 999999999
Q ss_pred cCccccccCCCCCcccCCCCCcccccccccC
Q 016544 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328 (387)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 328 (387)
|++.. +..+.|||++.+
T Consensus 237 G~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 237 PQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp TTCEE--------------TTSTTHHHHHHH
T ss_pred CCCeE--------------CCCCCHHHHHHH
Confidence 99863 234678988754
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C | Back alignment and structure |
|---|
Probab=99.87 E-value=3.2e-22 Score=159.95 Aligned_cols=100 Identities=31% Similarity=0.427 Sum_probs=60.6
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
+.|.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 37 g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tp 116 (136)
T 2jab_A 37 GADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGKTA 116 (136)
T ss_dssp TCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcCcCCCCCCH
Confidence 34444445555566666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cccccccchHHHHHHHHhhC
Q 016544 110 LGDAIYYKNHEVIKLLEKHG 129 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g 129 (387)
||+|+..++.+++++|+++|
T Consensus 117 l~~A~~~~~~~~~~~Ll~~G 136 (136)
T 2jab_A 117 FDISIGNGNEDLAEILQKLN 136 (136)
T ss_dssp HHHHHHTTCHHHHHHHHHC-
T ss_pred HHHHHHCCCHHHHHHHHHcC
Confidence 66666666666666665543
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=9.6e-23 Score=162.96 Aligned_cols=101 Identities=25% Similarity=0.246 Sum_probs=49.7
Q ss_pred CCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcC-CCCccc
Q 016544 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW-GSTPLG 111 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~-g~tpl~ 111 (387)
.+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+. |+.+++++|+++|++++.+|.. |.||||
T Consensus 5 ~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~ 83 (136)
T 1d9s_A 5 IHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTRPVH 83 (136)
T ss_dssp CSCCCCCCSCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBCHHH
T ss_pred ccCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCCHHH
Confidence 33333444444555555555555555555555555555455555555555 5555555555555555555444 455555
Q ss_pred cccccchHHHHHHHHhhCCCCCC
Q 016544 112 DAIYYKNHEVIKLLEKHGAKPLM 134 (387)
Q Consensus 112 ~a~~~~~~~~~~~L~~~g~~~~~ 134 (387)
+|+..++.+++++|+++|+++..
T Consensus 84 ~A~~~~~~~~v~~Ll~~ga~~~~ 106 (136)
T 1d9s_A 84 DAAREGFLDTLVVLHRAGARLDV 106 (136)
T ss_dssp HHHHHTCHHHHHHHHHTCCCCCC
T ss_pred HHHHcCCHHHHHHHHHcCCCCCc
Confidence 55555555555555555444433
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-22 Score=156.90 Aligned_cols=103 Identities=37% Similarity=0.465 Sum_probs=97.4
Q ss_pred CCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccccc
Q 016544 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (387)
Q Consensus 35 ~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~ 114 (387)
.+|.+|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus 4 ~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~ 83 (115)
T 2l6b_A 4 WGSKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAK 83 (115)
T ss_dssp CCSCSSCCHHHHHHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHH
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHH
Confidence 45678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccchHHHHHHHHhhCCCCCCCCc
Q 016544 115 YYKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 115 ~~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
..++.+++++|+++|+++.....
T Consensus 84 ~~~~~~~~~~Ll~~ga~~n~~~~ 106 (115)
T 2l6b_A 84 KNGHHEIVKLLDAKGADVNARSW 106 (115)
T ss_dssp TTTCHHHHHHHHTTSSSHHHHSC
T ss_pred HCCCHHHHHHHHHcCCCCCcCCc
Confidence 99999999999999999755433
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=2.1e-22 Score=161.04 Aligned_cols=102 Identities=22% Similarity=0.273 Sum_probs=97.6
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCC-CCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~-g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
++.|++.++..|+||||+||. |+.+++++|+++|+++|.+|.. |+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 34 ~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 112 (136)
T 1d9s_A 34 AGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGR 112 (136)
T ss_dssp TTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBCHHHHHHHHTCHHHHHHHHHTCCCCCCCSSSSS
T ss_pred cCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCC
Confidence 467777788889999999999 9999999999999999999999 99999999999999999999999999999999999
Q ss_pred CccccccccchHHHHHHHHhhCCC
Q 016544 108 TPLGDAIYYKNHEVIKLLEKHGAK 131 (387)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~g~~ 131 (387)
||||+|+..++.+++++|+++|++
T Consensus 113 tpl~~A~~~~~~~~~~~Ll~~Gad 136 (136)
T 1d9s_A 113 LPVDLAEEQGHRDIARYLHAATGD 136 (136)
T ss_dssp CHHHHHHHHTCHHHHHHHHHHHCC
T ss_pred CHHHHHHHcCCHHHHHHHHHcCCC
Confidence 999999999999999999999975
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A | Back alignment and structure |
|---|
Probab=99.87 E-value=8e-22 Score=154.68 Aligned_cols=106 Identities=29% Similarity=0.366 Sum_probs=95.8
Q ss_pred CCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccccccc
Q 016544 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116 (387)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~ 116 (387)
+..|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..
T Consensus 4 ~~~~~~~l~~A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~ 83 (123)
T 3aaa_C 4 GSMCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYE 83 (123)
T ss_dssp ---CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHH
T ss_pred ccccchHHHHHHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHc
Confidence 34688999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred chHHHHHHHHhhCCCCCCCCcccccc
Q 016544 117 KNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 117 ~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
++.+++++|+++|+++........++
T Consensus 84 ~~~~~v~~Ll~~ga~~~~~~~~g~t~ 109 (123)
T 3aaa_C 84 GHVSCVKLLLSKGADKTVKGPDGLTA 109 (123)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 99999999999999986655444433
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.6e-21 Score=163.50 Aligned_cols=114 Identities=22% Similarity=0.265 Sum_probs=100.9
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
+.+.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 29 ~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~ 108 (179)
T 3f6q_A 29 ENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVP 108 (179)
T ss_dssp TSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred cccccccCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCH
Confidence 45667777788899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhCCCCCCCCccccccC
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~~ 143 (387)
||+|+..++.+++++|+++|+++........++.
T Consensus 109 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl 142 (179)
T 3f6q_A 109 LHYACFWGQDQVAEDLVANGALVSICNKYGEMPV 142 (179)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCSSBCCTTSCCGG
T ss_pred HHHHHHcCCHHHHHHHHHCCCCcchhccCCCCcH
Confidence 9999999999999999999998876655444443
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A | Back alignment and structure |
|---|
Probab=99.86 E-value=6.6e-23 Score=167.98 Aligned_cols=113 Identities=21% Similarity=0.256 Sum_probs=93.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCc-HHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t-~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
++.|++..+..|+||||+|+ .|+.+++++|+++|+++|.+|..|+| |||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 34 ~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 112 (156)
T 1bi7_B 34 AGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGR 112 (156)
T ss_dssp TTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTCC
T ss_pred cCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHHCCCHHHHHHHHHcCCCCcccCCCCC
Confidence 46677777888899999985 89999999999999999999999999 99999999999999999999999999999999
Q ss_pred CccccccccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
||||+|+..++.+++++|+++|+++........++
T Consensus 113 tpl~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~ 147 (156)
T 1bi7_B 113 LPVDLAEELGHRDVARYLRAAAGGTRGSNHARIDA 147 (156)
T ss_dssp CHHHHHHHHTCHHHHHHHSSCC-------------
T ss_pred CHHHHHHHhCHHHHHHHHHHcCCCCCccCcCcCcc
Confidence 99999999999999999999999986665444333
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-21 Score=160.38 Aligned_cols=114 Identities=32% Similarity=0.371 Sum_probs=104.4
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
..+.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 32 ~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 111 (165)
T 3twr_A 32 SVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTP 111 (165)
T ss_dssp TTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCH
T ss_pred CCCccccccCCCCHHHHHHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCCCH
Confidence 45566667778999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhCCCCCCCCccccccC
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~~ 143 (387)
||+|+..++.+++++|+++|+++........++.
T Consensus 112 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l 145 (165)
T 3twr_A 112 LHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPL 145 (165)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTG
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCcccCCCCCChh
Confidence 9999999999999999999999877665555544
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-21 Score=161.15 Aligned_cols=110 Identities=35% Similarity=0.413 Sum_probs=102.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|.+.++..|.||||+||..|+.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 36 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t 115 (169)
T 2y1l_E 36 NGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHT 115 (169)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred CCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCC
Confidence 46677777888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCCCCCCcc
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~~~~~~~ 138 (387)
|||+|+..++.+++++|+++|+++......
T Consensus 116 ~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~ 145 (169)
T 2y1l_E 116 PLHLAAMFGHLEIVEVLLKNGADVNAQDKF 145 (169)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCCCcCCC
Confidence 999999999999999999999997655433
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=3e-21 Score=151.54 Aligned_cols=103 Identities=44% Similarity=0.559 Sum_probs=93.0
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.+.+..+..|.||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 24 ~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t 103 (126)
T 1n0r_A 24 AGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRT 103 (126)
T ss_dssp HTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCcccCCCCCC
Confidence 35566667778888999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCC
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAK 131 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~ 131 (387)
||++|+..++.+++++|+++|++
T Consensus 104 ~l~~A~~~~~~~~~~~Ll~~Gad 126 (126)
T 1n0r_A 104 PLHLAARNGHLEVVKLLLEAGAY 126 (126)
T ss_dssp HHHHHHHTTCHHHHHHHHHHTCC
T ss_pred HHHHHHHcCcHHHHHHHHHcCCC
Confidence 99999999999999999999875
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-21 Score=157.88 Aligned_cols=104 Identities=31% Similarity=0.353 Sum_probs=97.8
Q ss_pred CCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccc
Q 016544 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (387)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~ 115 (387)
.+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus 30 ~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~ 109 (153)
T 1awc_B 30 TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATE 109 (153)
T ss_dssp CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHH
T ss_pred cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHH
Confidence 46679999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cchHHHHHHHHhhCCCCCCCCccc
Q 016544 116 YKNHEVIKLLEKHGAKPLMAPMHV 139 (387)
Q Consensus 116 ~~~~~~~~~L~~~g~~~~~~~~~~ 139 (387)
.++.+++++|+++|+++.......
T Consensus 110 ~~~~~~v~~Ll~~ga~~~~~~~~g 133 (153)
T 1awc_B 110 HNHQEVVELLIKYGADVHTQSKFC 133 (153)
T ss_dssp TTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred cCCHHHHHHHHHcCCCccccCCCC
Confidence 999999999999999986654433
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.1e-21 Score=174.44 Aligned_cols=101 Identities=20% Similarity=0.183 Sum_probs=96.4
Q ss_pred CCCCCCCcchHHHHHHhh---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 33 DDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~---~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
.+..+..|+||||+||.. |+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 162 l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tp 241 (278)
T 1dcq_A 162 LANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETP 241 (278)
T ss_dssp CSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred ccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCccCCCCCH
Confidence 555678899999999999 89999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhCCCCC
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKPL 133 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~~ 133 (387)
||+|+..|+.+++++|+++|++..
T Consensus 242 L~~A~~~~~~~~v~~Ll~~ga~~~ 265 (278)
T 1dcq_A 242 LDIAKRLKHEHCEELLTQALSGRF 265 (278)
T ss_dssp HHHHHHTTCHHHHHHHHHHHTTCC
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCC
Confidence 999999999999999999998753
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-21 Score=159.34 Aligned_cols=102 Identities=26% Similarity=0.289 Sum_probs=70.2
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
+.+.+..+..|+||||+|+. |+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 28 ~~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 106 (162)
T 1ihb_A 28 NVNVNAQNGFGRTALQVMKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLP 106 (162)
T ss_dssp CCCTTCCCTTSCCHHHHCCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CCCccccCccCccHHHHHHc-CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 44455555566666777666 77777777777777777777777777777777777777777777777777777777777
Q ss_pred cccccccchHHHHHHHHhhCCCC
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
||+|+..++.+++++|+++|++.
T Consensus 107 L~~A~~~~~~~~v~~Ll~~g~~~ 129 (162)
T 1ihb_A 107 LHLAAKEGHLRVVEFLVKHTASN 129 (162)
T ss_dssp HHHHHHTTCHHHHHHHHHHSCCC
T ss_pred HHHHHHcCCHHHHHHHHHccCCC
Confidence 77777777777777777776653
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C | Back alignment and structure |
|---|
Probab=99.85 E-value=3e-21 Score=154.21 Aligned_cols=103 Identities=31% Similarity=0.388 Sum_probs=96.0
Q ss_pred CCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccc
Q 016544 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (387)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~ 115 (387)
....|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus 10 ~~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~ 89 (136)
T 2jab_A 10 HGSDLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAF 89 (136)
T ss_dssp --CHHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHH
T ss_pred ccccccHHHHHHHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHH
Confidence 34568999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cchHHHHHHHHhhCCCCCCCCcc
Q 016544 116 YKNHEVIKLLEKHGAKPLMAPMH 138 (387)
Q Consensus 116 ~~~~~~~~~L~~~g~~~~~~~~~ 138 (387)
.++.+++++|+++|+++......
T Consensus 90 ~~~~~~v~~Ll~~g~~~~~~~~~ 112 (136)
T 2jab_A 90 IGHLEIAEVLLKHGADVNAQDKF 112 (136)
T ss_dssp HTCHHHHHHHHHTTCCTTCCCTT
T ss_pred cCCHHHHHHHHHcCCCCcCcCCC
Confidence 99999999999999987655443
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.7e-20 Score=163.64 Aligned_cols=155 Identities=15% Similarity=0.036 Sum_probs=118.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCC-cCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~-~~g~ 107 (387)
++.|++..+..|+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.++ ..|.
T Consensus 43 ~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~ 122 (229)
T 2vge_A 43 EMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGA 122 (229)
T ss_dssp HSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCSSTTC
T ss_pred cCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCCCCC
Confidence 456777788889999999999999999999999999999999999999999999999999999999999999987 6999
Q ss_pred Cccccc--cccchHHHHHHHHhhCCCCCCCCccccccCC------CCccccCc-cccCcccceeecccEEEEEEEcCeEE
Q 016544 108 TPLGDA--IYYKNHEVIKLLEKHGAKPLMAPMHVKHARE------VPEYEIDP-HELDFTNSVEITKGTFILAFWRGIQV 178 (387)
Q Consensus 108 tpl~~a--~~~~~~~~~~~L~~~g~~~~~~~~~~~~~~~------~~~~ei~~-~~~~~~~~~~lg~G~~~~v~~~g~~v 178 (387)
||||+| +..++.+++++|++.|+++.........+.. .....+.. ...+......-|......+...|..-
T Consensus 123 tpL~~A~a~~~~~~~~v~~Ll~~ga~~~~~~~~~~~~l~~~~~~~~~~~ll~~ga~~~~~~~d~~G~TpL~~A~~~g~~~ 202 (229)
T 2vge_A 123 TAFEKCDPYREGYADCATYLADVEQSMGLMNSGAVYALWDYSAEFGDELSFREGESVTVLRRDGPEETDWWWAALHGQEG 202 (229)
T ss_dssp CTGGGCCTTSTTHHHHHHHHHHHHHHTTTSGGGEEEESSCBCCSSTTBCCBCTTCEEEEEESSCTTCSSEEEEEETTEEE
T ss_pred CHHHHHHHHhcChHHHHHHHHHcCCCcccccCCchHHHHHHhhccccccCccccccccccccCCCcccHHHHHHHcCCcc
Confidence 999999 9999999999999999998665433322211 11111100 00001111122455566677788777
Q ss_pred EEEEc
Q 016544 179 AVKKL 183 (387)
Q Consensus 179 avK~~ 183 (387)
+||..
T Consensus 203 ~v~~~ 207 (229)
T 2vge_A 203 YVPRN 207 (229)
T ss_dssp EEEGG
T ss_pred eeehh
Confidence 77753
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4.3e-21 Score=158.80 Aligned_cols=109 Identities=27% Similarity=0.361 Sum_probs=100.3
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
+.+.+..+..|+||||+|+..|+.+++++|+++|++++..|..|.||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 26 ~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 105 (167)
T 3v31_A 26 ENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTP 105 (167)
T ss_dssp SSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCH
T ss_pred CCCcCCCCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCCCCH
Confidence 45667777788999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhCCCCCCCCcc
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~~~~~~~ 138 (387)
||+|+..++.+++++|+++|+++......
T Consensus 106 L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~ 134 (167)
T 3v31_A 106 LLYAVHGNHVKCVKMLLESGADPTIETDS 134 (167)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCcCCC
Confidence 99999999999999999999988665443
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A | Back alignment and structure |
|---|
Probab=99.85 E-value=8.8e-21 Score=158.91 Aligned_cols=108 Identities=21% Similarity=0.205 Sum_probs=102.4
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
.+.|++..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 61 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 140 (179)
T 3f6q_A 61 RGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEM 140 (179)
T ss_dssp TTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSSBCCTTSCC
T ss_pred cCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcchhccCCCC
Confidence 46777778888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCCCCCC
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~~~~~ 136 (387)
||++|+..++.+++++|++.|+++...+
T Consensus 141 pl~~A~~~~~~~~~~~L~~~g~~~~~~~ 168 (179)
T 3f6q_A 141 PVDKAKAPLRELLRERAEKMGQNLNRIP 168 (179)
T ss_dssp GGGGSCHHHHHHHHHHHHHTTCCCSCBC
T ss_pred cHHHHHHHHHHHHHHHHHHhhcCcccCC
Confidence 9999999999999999999999986544
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.9e-21 Score=162.89 Aligned_cols=110 Identities=26% Similarity=0.342 Sum_probs=98.3
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
+.|.+..+..|+||||+||..|+.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 58 ~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 137 (192)
T 2rfm_A 58 FDKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETP 137 (192)
T ss_dssp HCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTCCCH
T ss_pred ccccccccccCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 45566667778899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhCCCCCCCCccc
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~~~~~~~~ 139 (387)
||+|+..++.+++++|+++|+++.......
T Consensus 138 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 167 (192)
T 2rfm_A 138 LIVASKYGRSEIVKKLLELGADISARDLTG 167 (192)
T ss_dssp HHHHHHHTCHHHHHHHHHTTCCTTCBCTTS
T ss_pred HHHHHHcCCHHHHHHHHHCCCCCCCcCCCC
Confidence 999999999999999999999876654433
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A | Back alignment and structure |
|---|
Probab=99.84 E-value=4.3e-21 Score=147.45 Aligned_cols=93 Identities=32% Similarity=0.455 Sum_probs=85.9
Q ss_pred CCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccc
Q 016544 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~ 112 (387)
....+.+|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus 17 ~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~ 96 (110)
T 2zgd_A 17 GSHMGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDI 96 (110)
T ss_dssp -----CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred ccccCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcHHHH
Confidence 44556678999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchHHHHHHH
Q 016544 113 AIYYKNHEVIKLL 125 (387)
Q Consensus 113 a~~~~~~~~~~~L 125 (387)
|+..++.+++++|
T Consensus 97 A~~~~~~~~~~~L 109 (110)
T 2zgd_A 97 SIDNGNEDLAEIL 109 (110)
T ss_dssp HHHHTCHHHHHHH
T ss_pred HHHcCCHHHHHHh
Confidence 9999999999876
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* | Back alignment and structure |
|---|
Probab=99.84 E-value=9e-21 Score=156.54 Aligned_cols=101 Identities=31% Similarity=0.328 Sum_probs=94.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|++.++..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 64 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 143 (165)
T 3twr_A 64 HGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNT 143 (165)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCC
Confidence 56778888888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCC
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGA 130 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~ 130 (387)
||++|.. ++.+++++|++.|+
T Consensus 144 ~l~~a~~-~~~~i~~~L~~~gA 164 (165)
T 3twr_A 144 PLDLVKD-GDTDIQDLLRGDAA 164 (165)
T ss_dssp TGGGSCT-TCHHHHHHHHTC--
T ss_pred hhHhHhc-CChHHHHHHhhccc
Confidence 9999887 88999999998875
|
| >4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=5.9e-21 Score=170.70 Aligned_cols=103 Identities=30% Similarity=0.401 Sum_probs=79.2
Q ss_pred hHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHH
Q 016544 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121 (387)
Q Consensus 42 t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~ 121 (387)
||||+|+..++.+++++|+++|+++|.+|..|+||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.++
T Consensus 121 t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gadvn~~~~~g~t~Lh~A~~~g~~~~ 200 (269)
T 4b93_B 121 VPLHLACQQGHFQVVKCLLDSNAKPNKKDLSGNTPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEAVIEKHVFV 200 (269)
T ss_dssp CHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCGGGHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHH
T ss_pred CccccccccChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCccccCCCcHHHHHHHcCCHHH
Confidence 33333333334444445555666777788889999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCccccccCC
Q 016544 122 IKLLEKHGAKPLMAPMHVKHARE 144 (387)
Q Consensus 122 ~~~L~~~g~~~~~~~~~~~~~~~ 144 (387)
+++|+++|+++........++..
T Consensus 201 v~~Ll~~Gad~~~~d~~G~TpL~ 223 (269)
T 4b93_B 201 VELLLLHGASVQVLNKRQRTAVD 223 (269)
T ss_dssp HHHHHHTTCCSCCCCTTSCCSGG
T ss_pred HHHHHHCCCCCCCcCCCCCCHHH
Confidence 99999999988776655555543
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A | Back alignment and structure |
|---|
Probab=99.84 E-value=5.7e-21 Score=158.89 Aligned_cols=105 Identities=26% Similarity=0.339 Sum_probs=93.8
Q ss_pred CCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccc
Q 016544 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~ 112 (387)
.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus 29 ~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~ 108 (172)
T 3v30_A 29 VNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLY 108 (172)
T ss_dssp GGCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHH
T ss_pred ccCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHH
Confidence 45556678888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchHHHHHHHHhhCCCCCCCCc
Q 016544 113 AIYYKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 113 a~~~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
|+..++.+++++|+++|+++.....
T Consensus 109 A~~~~~~~~v~~Ll~~ga~~~~~~~ 133 (172)
T 3v30_A 109 AVRGNHVKCVEALLARGADLTTEAD 133 (172)
T ss_dssp HHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred HHHcCCHHHHHHHHHcCCCccccCC
Confidence 9999999999999999988765543
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A | Back alignment and structure |
|---|
Probab=99.84 E-value=3.4e-21 Score=160.24 Aligned_cols=109 Identities=25% Similarity=0.277 Sum_probs=101.1
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
.+.|.+..+..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 58 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 137 (172)
T 3v30_A 58 WGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTTEADSGYT 137 (172)
T ss_dssp HTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCC
Confidence 46677777788999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCCCCCCc
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
|||+|+..++.+++++|+++++++.....
T Consensus 138 ~l~~A~~~~~~~~~~~L~~~~~~~~~~~~ 166 (172)
T 3v30_A 138 PMDLAVALGYRKVQQVIENHILKLFQSNL 166 (172)
T ss_dssp HHHHHHHHTCHHHHHHHHHHHHHHSCC--
T ss_pred HHHHHHHhCcHHHHHHHHHHHHHHhcccC
Confidence 99999999999999999999988655443
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.3e-21 Score=162.42 Aligned_cols=110 Identities=18% Similarity=0.147 Sum_probs=95.8
Q ss_pred CCCCC-CCcchHHHHHHhhCCH----HHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC------HHHHHHHHHCCCCCCC
Q 016544 33 DDGEE-IKPEFRLMFLANERDV----EGIKELLDSGIDVNFRDIDNRTALHVAACQGF------TEVVSLLLERGADVDP 101 (387)
Q Consensus 33 ~~~~~-~~g~t~l~~a~~~~~~----~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~------~~~~~~Ll~~ga~~~~ 101 (387)
.+..+ ..|+||||+|+..|+. +++++||++|+|+|.+|.+|+||||+|+..++ .+++++|+++||++|.
T Consensus 30 ~~~~~~~~g~T~Lh~A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~ 109 (186)
T 3t8k_A 30 YEDKESVLKSNILYDVLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITA 109 (186)
T ss_dssp SSCHHHHHTTTHHHHHTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSS
T ss_pred cccccccCCCCHHHHHHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCc
Confidence 34444 6799999999999985 59999999999999999999999999999987 5789999999999999
Q ss_pred CCcCCC-Cccccccc-----cchHHHHHHHHh-hCCCCCCCCcccccc
Q 016544 102 KDRWGS-TPLGDAIY-----YKNHEVIKLLEK-HGAKPLMAPMHVKHA 142 (387)
Q Consensus 102 ~~~~g~-tpl~~a~~-----~~~~~~~~~L~~-~g~~~~~~~~~~~~~ 142 (387)
+|..|. ||||+|+. .++.+++++|++ +|+++........++
T Consensus 110 ~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~~G~Tp 157 (186)
T 3t8k_A 110 LYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTA 157 (186)
T ss_dssp CBGGGTBCTTGGGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCTTSCCH
T ss_pred cCCCcCchHHHHHHHcCCChhhHHHHHHHHHHhcCCCCcccCCCCCCH
Confidence 999999 99999998 345679999999 999987776555544
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A | Back alignment and structure |
|---|
Probab=99.84 E-value=6e-21 Score=149.66 Aligned_cols=94 Identities=27% Similarity=0.245 Sum_probs=86.6
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|.+.++..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 29 ~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 108 (123)
T 3aaa_C 29 KGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLT 108 (123)
T ss_dssp TTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 45677778888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHH
Q 016544 109 PLGDAIYYKNHEVI 122 (387)
Q Consensus 109 pl~~a~~~~~~~~~ 122 (387)
|+|+|...+..+++
T Consensus 109 ~l~~A~~~~~~~ll 122 (123)
T 3aaa_C 109 AFEATDNQAIKALL 122 (123)
T ss_dssp HHHHCCCHHHHHHH
T ss_pred HHHHhCCHHHHHHh
Confidence 99999666555543
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A | Back alignment and structure |
|---|
Probab=99.84 E-value=8.4e-21 Score=156.14 Aligned_cols=103 Identities=27% Similarity=0.350 Sum_probs=97.1
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCC-CCCCCcCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD-VDPKDRWGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~-~~~~~~~g~ 107 (387)
++.|++.++..|+||||+|+..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++ ++.+|..|.
T Consensus 59 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~ 138 (162)
T 1ihb_A 59 RGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGD 138 (162)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSC
T ss_pred cCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHccCCCCCCcCCCCC
Confidence 5677888888999999999999999999999999999999999999999999999999999999999998 699999999
Q ss_pred CccccccccchHHHHHHHHhhCCC
Q 016544 108 TPLGDAIYYKNHEVIKLLEKHGAK 131 (387)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~g~~ 131 (387)
||||+|+..++.+++++|+++|++
T Consensus 139 t~l~~A~~~~~~~~~~~Ll~~GAd 162 (162)
T 1ihb_A 139 TACDLARLYGRNEVVSLMQANGAG 162 (162)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTC--
T ss_pred cHHHHHHHcCCHHHHHHHHHhCCC
Confidence 999999999999999999999985
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=5.6e-21 Score=152.78 Aligned_cols=102 Identities=25% Similarity=0.266 Sum_probs=92.6
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|.+.++..|+||||+||..|+.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 32 ~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 111 (137)
T 3c5r_A 32 NGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLR 111 (137)
T ss_dssp TTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCC
Confidence 46677778888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCC
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGA 130 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~ 130 (387)
|+++|+..+..+++.++.+.+.
T Consensus 112 pl~~A~~~~~~~~l~~l~~~~~ 133 (137)
T 3c5r_A 112 PVDYTDDESMKSLLLLPEKNES 133 (137)
T ss_dssp GGGGCCCHHHHHHHSCC-----
T ss_pred HHHHHhhccHHHHHhhcccccc
Confidence 9999999999999888776553
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.5e-20 Score=155.94 Aligned_cols=101 Identities=34% Similarity=0.477 Sum_probs=96.2
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|.+..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 69 ~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 148 (169)
T 2y1l_E 69 NGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKFGKT 148 (169)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 56777788888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhC
Q 016544 109 PLGDAIYYKNHEVIKLLEKHG 129 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g 129 (387)
||++|+..++.+++++|++.|
T Consensus 149 ~l~~A~~~~~~~~~~~L~~~G 169 (169)
T 2y1l_E 149 AFDISIDNGNEDLAEILQKLN 169 (169)
T ss_dssp HHHHHHHTTCHHHHHHHHTC-
T ss_pred HHHHHHHhCCHHHHHHHHHcC
Confidence 999999999999999999875
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=169.68 Aligned_cols=115 Identities=30% Similarity=0.332 Sum_probs=99.8
Q ss_pred CCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCC-CCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~-g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
.+.+..+..|.||||+||..|+.+++++|+++|+++|.++.. |+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 149 ~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tp 228 (282)
T 1oy3_D 149 LQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTP 228 (282)
T ss_dssp GGTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred hcCCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCcccccCCCCH
Confidence 345666778889999999999999999999999999999865 9999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhCCCCCCCCccccccCCC
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREV 145 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~~~~ 145 (387)
||+|+..++.+++++|+++|+++........++...
T Consensus 229 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~ 264 (282)
T 1oy3_D 229 LGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSS 264 (282)
T ss_dssp HHHHHTSSCHHHHHHHHHTTCCCCCCC---------
T ss_pred HHHHHHcCCcHHHHHHHHcCCCcCcCCCcccccccc
Confidence 999999999999999999999998777666666543
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=1.5e-20 Score=153.33 Aligned_cols=97 Identities=31% Similarity=0.410 Sum_probs=93.0
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 56 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 135 (153)
T 1awc_B 56 AGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKT 135 (153)
T ss_dssp TTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCC
Confidence 46777788888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHH
Q 016544 109 PLGDAIYYKNHEVIKLL 125 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L 125 (387)
||++|+..|+.+++++|
T Consensus 136 ~l~~A~~~~~~~i~~~L 152 (153)
T 1awc_B 136 AFDISIDNGNEDLAEIL 152 (153)
T ss_dssp HHHHHHHTTCHHHHHHH
T ss_pred HHHHHHHcCCHHHHHHh
Confidence 99999999999999887
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B | Back alignment and structure |
|---|
Probab=99.83 E-value=1.6e-20 Score=153.43 Aligned_cols=106 Identities=24% Similarity=0.255 Sum_probs=93.8
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
+.+.+..+..|+||||+ |..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 26 ~~~~~~~~~~g~t~L~~-~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~ 104 (156)
T 1bd8_A 26 LVHPDALNRFGKTALQV-MMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALP 104 (156)
T ss_dssp CCCTTCCCTTSCCHHHH-SCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCH
T ss_pred CcCccccCCCCCcHHHH-HHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcH
Confidence 34667777788899999 88999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhCCCCCCCCc
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
||+|+..++.+++++|++. +++.....
T Consensus 105 L~~A~~~~~~~~v~~Ll~~-~~~~~~~~ 131 (156)
T 1bd8_A 105 IHLAVQEGHTAVVSFLAAE-SDLHRRDA 131 (156)
T ss_dssp HHHHHHHTCHHHHHHHHTT-SCTTCCCT
T ss_pred HHHHHHhChHHHHHHHHhc-cCCCCcCC
Confidence 9999999999999999988 77655443
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=99.83 E-value=7.3e-21 Score=167.17 Aligned_cols=100 Identities=29% Similarity=0.346 Sum_probs=84.6
Q ss_pred CCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccccccc
Q 016544 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116 (387)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~ 116 (387)
+..|.||||+||..|+.+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|++++.+|..|.||||+|+..
T Consensus 34 ~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~ 113 (239)
T 1ycs_B 34 NPLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASC 113 (239)
T ss_dssp ---CHHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHT
T ss_pred CchhhHHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHc
Confidence 35688888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred chHHHHHHHHhhCCCCCCCC
Q 016544 117 KNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 117 ~~~~~~~~L~~~g~~~~~~~ 136 (387)
++.+++++|+++|+++....
T Consensus 114 ~~~~~v~~Ll~~ga~~~~~~ 133 (239)
T 1ycs_B 114 NNVQVCKFLVESGAAVFAMT 133 (239)
T ss_dssp TCHHHHHHHHHTTCCTTCCC
T ss_pred CCHHHHHHHHHcCCCcceec
Confidence 88888888888888875443
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B | Back alignment and structure |
|---|
Probab=99.83 E-value=1.7e-20 Score=153.30 Aligned_cols=99 Identities=26% Similarity=0.377 Sum_probs=94.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
.+.|++.++..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++ ++++.+|..|.|
T Consensus 57 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~-~~~~~~~~~g~t 135 (156)
T 1bd8_A 57 QGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRDARGLT 135 (156)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTT-SCTTCCCTTSCC
T ss_pred CCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHhChHHHHHHHHhc-cCCCCcCCCCCC
Confidence 5677788888899999999999999999999999999999999999999999999999999999999 999999999999
Q ss_pred ccccccccchHHHHHHHHhh
Q 016544 109 PLGDAIYYKNHEVIKLLEKH 128 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~ 128 (387)
|||+|+..++.+++++|+++
T Consensus 136 ~l~~A~~~~~~~~v~~Ll~~ 155 (156)
T 1bd8_A 136 PLELALQRGAQDLVDILQGH 155 (156)
T ss_dssp HHHHHHHSCCHHHHHHHHTT
T ss_pred HHHHHHHcCcHHHHHHHHhh
Confidence 99999999999999999864
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=2.3e-20 Score=146.48 Aligned_cols=100 Identities=43% Similarity=0.524 Sum_probs=95.1
Q ss_pred CcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccch
Q 016544 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118 (387)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~ 118 (387)
+|+||||+||..|+.+++++|+++|++++..|..|.||||+|+..++.+++++|+++|++++.+|..|.||||+|+..++
T Consensus 1 ~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~ 80 (126)
T 1n0r_A 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH 80 (126)
T ss_dssp CCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred CCccHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCh
Confidence 58999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhCCCCCCCCcc
Q 016544 119 HEVIKLLEKHGAKPLMAPMH 138 (387)
Q Consensus 119 ~~~~~~L~~~g~~~~~~~~~ 138 (387)
.+++++|++.|+++......
T Consensus 81 ~~~~~~Ll~~g~~~~~~~~~ 100 (126)
T 1n0r_A 81 LEVVKLLLEAGADVNAKDKN 100 (126)
T ss_dssp HHHHHHHHHTTCCTTCCCTT
T ss_pred HHHHHHHHHcCCCCcccCCC
Confidence 99999999999987655433
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.5e-20 Score=170.81 Aligned_cols=111 Identities=27% Similarity=0.299 Sum_probs=101.6
Q ss_pred cCCCCCC------CCCCcchHHHHHHhh---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCC
Q 016544 29 NGLDDDG------EEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99 (387)
Q Consensus 29 ~~~~~~~------~~~~g~t~l~~a~~~---~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~ 99 (387)
++.|++. .+..|+||||+||.. |+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|+++
T Consensus 173 ~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~ 252 (301)
T 2b0o_E 173 NGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALV 252 (301)
T ss_dssp TTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCC
T ss_pred cCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCC
Confidence 4556655 578899999999997 8999999999999999999999999999999999999999999999999
Q ss_pred CCCCcCCCCccccccccchHHHHHHHHhhCCCCCCCCccc
Q 016544 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (387)
Q Consensus 100 ~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~ 139 (387)
+.+|..|.||||+|+..++.+++++|++.|++....+.+.
T Consensus 253 ~~~d~~G~TpL~~A~~~~~~~iv~~Ll~~ga~~g~tpLh~ 292 (301)
T 2b0o_E 253 GTVNEAGETALDIARKKHHKECEELLEQAQAGTFAFPLHV 292 (301)
T ss_dssp SCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHHTTSSCCC-
T ss_pred CCcCCCCCCHHHHHHHcCCHHHHHHHHHhcCCCCCChhHH
Confidence 9999999999999999999999999999999866555543
|
| >4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-20 Score=168.38 Aligned_cols=111 Identities=31% Similarity=0.311 Sum_probs=104.0
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
.|.|++..+.+|+||||+||..|+.+++++|++.|++++.++.+|.||||+|+..++.+++++|+++|++++.+|..|.|
T Consensus 75 ~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~T 154 (269)
T 4b93_B 75 SGLGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQAVPLHLACQQGHFQVVKCLLDSNAKPNKKDLSGNT 154 (269)
T ss_dssp CCCCTTCCCTTSCCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCC
T ss_pred CCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCCCccccccccChHHHHHHHHHCCCCCCCCCCCCCC
Confidence 56777888888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCCCCCCccc
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~ 139 (387)
|||+|+..|+.+++++|+++|+++.......
T Consensus 155 pL~~A~~~g~~~~v~~Ll~~gadvn~~~~~g 185 (269)
T 4b93_B 155 PLIYACSGGHHELVALLLQHGASINASNNKG 185 (269)
T ss_dssp HHHHHHHTTCGGGHHHHHHTTCCTTCBCTTS
T ss_pred HHHHHHHCCCHHHHHHHHHCCCCCCccccCC
Confidence 9999999999999999999999986554433
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.1e-20 Score=161.96 Aligned_cols=109 Identities=24% Similarity=0.287 Sum_probs=98.7
Q ss_pred hhhhcCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCc
Q 016544 25 EAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104 (387)
Q Consensus 25 ~~~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~ 104 (387)
+++.+..+ ..+..|.||||+||..|+.+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++|++++.+|.
T Consensus 8 ~~~~~~~~--~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~ 85 (229)
T 2vge_A 8 AGSPRKAR--RARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDS 85 (229)
T ss_dssp --CCCCCC--CTTSCHHHHHHHHHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred CCCCcccc--ccccchhHHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCC
Confidence 44444443 3455789999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCccccccccchHHHHHHHHhhCCCCCCC
Q 016544 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 105 ~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~ 135 (387)
.|.||||+|+..|+.+++++|++.|+++...
T Consensus 86 ~g~tpLh~A~~~g~~~~v~~Ll~~ga~~~~~ 116 (229)
T 2vge_A 86 HGWTPLHCAASCNDTVICMALVQHGAAIFAT 116 (229)
T ss_dssp TCCCHHHHHHHTTCHHHHHHHHTTTCCTTCC
T ss_pred CCCCHHHHHHHcCCHHHHHHHHHcCCCcccc
Confidence 9999999999999999999999999998654
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.8e-20 Score=157.59 Aligned_cols=101 Identities=31% Similarity=0.356 Sum_probs=96.5
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 90 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t 169 (192)
T 2rfm_A 90 KGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARDLTGLT 169 (192)
T ss_dssp HTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSCB
T ss_pred CCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCC
Confidence 46677777888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhC
Q 016544 109 PLGDAIYYKNHEVIKLLEKHG 129 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g 129 (387)
|+++|+..++.+++++|++++
T Consensus 170 ~l~~A~~~~~~~~v~~Ll~~~ 190 (192)
T 2rfm_A 170 AEASARIFGRQEVIKIFTEVR 190 (192)
T ss_dssp HHHHHHHTTCHHHHHHHHHHH
T ss_pred HHHHHHHhCcHHHHHHHHhcc
Confidence 999999999999999999875
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.6e-20 Score=154.08 Aligned_cols=105 Identities=30% Similarity=0.296 Sum_probs=99.3
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 58 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 137 (167)
T 3v31_A 58 NGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADPTIETDSGYN 137 (167)
T ss_dssp TTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence 46677777888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCCC
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKPL 133 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~~ 133 (387)
|+++|+..++.+++++|++++++..
T Consensus 138 ~l~~A~~~~~~~~~~~L~~~~~~~~ 162 (167)
T 3v31_A 138 SMDLAVALGYRSVQQVIESHLLKLL 162 (167)
T ss_dssp HHHHHHHHTCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHcCcHHHHHHHHHHHHHHH
Confidence 9999999999999999999987653
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.6e-20 Score=155.82 Aligned_cols=105 Identities=33% Similarity=0.316 Sum_probs=96.8
Q ss_pred CCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCC-cCCCCccccccc
Q 016544 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIY 115 (387)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~-~~g~tpl~~a~~ 115 (387)
+..|.||||+||..|+.++++.|++ |+++|.+|..|+||||+|+..|+.+++++|+++|++++.+| ..|.||||+|+.
T Consensus 41 ~~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~ 119 (183)
T 3deo_A 41 VSEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAG 119 (183)
T ss_dssp HHHHHHHHHHHHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHh
Confidence 3578999999999999999999999 99999999999999999999999999999999999999998 899999999999
Q ss_pred cchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 116 YKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 116 ~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
.++.+++++|+++|+++........++
T Consensus 120 ~~~~~~v~~Ll~~ga~~~~~d~~g~tp 146 (183)
T 3deo_A 120 YVRPEVVEALVELGADIEVEDERGLTA 146 (183)
T ss_dssp TTCHHHHHHHHHHTCCTTCCCTTSCCH
T ss_pred cCcHHHHHHHHHcCCCCcCCCCCCCCH
Confidence 999999999999999987655444333
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A | Back alignment and structure |
|---|
Probab=99.82 E-value=8.1e-20 Score=158.84 Aligned_cols=114 Identities=25% Similarity=0.226 Sum_probs=100.9
Q ss_pred CCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCC-CCCCCCCcCCCCc
Q 016544 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGSTP 109 (387)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~g-a~~~~~~~~g~tp 109 (387)
.+.+..+..|.||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++| ++++.+|..|.||
T Consensus 98 ~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~d~~g~t~ 177 (228)
T 2dzn_A 98 PDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTP 177 (228)
T ss_dssp CCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCSCCCCTTSCCH
T ss_pred cccccCCcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhcCcccccCcCCCCCCH
Confidence 667777788899999999999999999999999999999999999999999999999999999999 9999999999999
Q ss_pred cccccccchHHHHHHHH-hhCCCCCCCCccccccCC
Q 016544 110 LGDAIYYKNHEVIKLLE-KHGAKPLMAPMHVKHARE 144 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~-~~g~~~~~~~~~~~~~~~ 144 (387)
||+|+..++.+++++|+ +.|+++........++..
T Consensus 178 L~~A~~~~~~~~v~~Ll~~~ga~~~~~~~~g~t~l~ 213 (228)
T 2dzn_A 178 LFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAED 213 (228)
T ss_dssp HHHHHHTTCHHHHHHHHHHHCCCSCCBCTTSCBGGG
T ss_pred HHHHHHcCCHHHHHHHHHhcCCCCCccCCCCCcHHH
Confidence 99999999999999999 889998776655555543
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=99.82 E-value=2.4e-20 Score=163.89 Aligned_cols=108 Identities=22% Similarity=0.103 Sum_probs=100.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC-
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS- 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~- 107 (387)
.+.|++.++..|+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.++..|.
T Consensus 59 ~g~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~~~ 138 (239)
T 1ycs_B 59 EVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQ 138 (239)
T ss_dssp TTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSSSCC
T ss_pred cCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcceecCCCCc
Confidence 4567888888899999999999999999999999999999999999999999999999999999999999999998887
Q ss_pred Cccccc--cccchHHHHHHHHhhCCCCCCCC
Q 016544 108 TPLGDA--IYYKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 108 tpl~~a--~~~~~~~~~~~L~~~g~~~~~~~ 136 (387)
||||+| +..|+.+++++|++.|+++....
T Consensus 139 t~l~~a~~~~~g~~~~~~~Ll~~~a~~~~~~ 169 (239)
T 1ycs_B 139 TAADKCEEMEEGYTQCSQFLYGVQEKMGIMN 169 (239)
T ss_dssp CHHHHCCSSSTTCCCHHHHHHHHHHHTTTTG
T ss_pred chHHHHHHhhhccHHHHHHHHHhhhcccccc
Confidence 999999 78899999999999999886543
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.4e-20 Score=153.97 Aligned_cols=106 Identities=24% Similarity=0.231 Sum_probs=95.9
Q ss_pred CCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC-ccccc
Q 016544 35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST-PLGDA 113 (387)
Q Consensus 35 ~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t-pl~~a 113 (387)
..+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+ .|+.+++++|+++|++++.+|..|.| |||+|
T Consensus 7 ~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A 85 (156)
T 1bi7_B 7 SSMEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDA 85 (156)
T ss_dssp ---CCSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHH
T ss_pred CCCccchHHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHH
Confidence 44567899999999999999999999999999999999999999986 99999999999999999999999999 99999
Q ss_pred cccchHHHHHHHHhhCCCCCCCCccccc
Q 016544 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKH 141 (387)
Q Consensus 114 ~~~~~~~~~~~L~~~g~~~~~~~~~~~~ 141 (387)
+..++.+++++|+++|+++........+
T Consensus 86 ~~~~~~~~v~~Ll~~ga~~~~~d~~g~t 113 (156)
T 1bi7_B 86 AREGFLDTLVVLHRAGARLDVRDAWGRL 113 (156)
T ss_dssp HHHTCHHHHHHHHHHTCCSSCCCTTCCC
T ss_pred HHCCCHHHHHHHHHcCCCCcccCCCCCC
Confidence 9999999999999999998765544333
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=99.81 E-value=3.4e-20 Score=160.86 Aligned_cols=106 Identities=24% Similarity=0.318 Sum_probs=97.3
Q ss_pred CCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHC-CCCCCCCCcCCCCccccccc
Q 016544 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIY 115 (387)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~-ga~~~~~~~~g~tpl~~a~~ 115 (387)
+..|.||||+||..|+.+++++|++.|+++|.+|..|+||||+||..|+.+++++|+++ |++++.+|..|.||||+|+.
T Consensus 70 ~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~ 149 (222)
T 3ehr_A 70 AESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAW 149 (222)
T ss_dssp EEEESCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHH
T ss_pred ccccccccccccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHH
Confidence 34678999999999999999999999999999999999999999999999999999998 99999999999999999999
Q ss_pred cchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 116 YKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 116 ~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
.|+.+++++|+++|+++........++
T Consensus 150 ~~~~~~v~~Ll~~ga~~~~~~~~g~t~ 176 (222)
T 3ehr_A 150 KGYADIVQLLLAKGARTDLRNIEKKLA 176 (222)
T ss_dssp HTCHHHHHHHHHHTCCSCCCCTTSCCH
T ss_pred cCCHHHHHHHHHcCCCCccccCCCCCH
Confidence 999999999999999987665544444
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=159.23 Aligned_cols=100 Identities=25% Similarity=0.245 Sum_probs=77.8
Q ss_pred CCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCC-CCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccc
Q 016544 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (387)
Q Consensus 34 ~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~-~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~ 112 (387)
+..+..|.||||+|+..|+.+++++|+++|+++|.+|. .|+||||+|+..|+.+++++|+++|++++.+|..|.|||++
T Consensus 111 ~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~ 190 (236)
T 1ikn_D 111 KATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQL 190 (236)
T ss_dssp GCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGG
T ss_pred hccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCCCCHHHH
Confidence 44455677778888888888888888888888887776 78888888888888888888888888888888888888888
Q ss_pred ccccchHHHHHHHHhhCCCCC
Q 016544 113 AIYYKNHEVIKLLEKHGAKPL 133 (387)
Q Consensus 113 a~~~~~~~~~~~L~~~g~~~~ 133 (387)
|+..++.+++++|+++|+++.
T Consensus 191 A~~~~~~~~~~~Ll~~ga~~~ 211 (236)
T 1ikn_D 191 TWGRPSTRIQQQLGQLTLENL 211 (236)
T ss_dssp CTTSSCHHHHHHHHTTSCGGG
T ss_pred HHccCchHHHHHHHHcchhhh
Confidence 888888888888888877654
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-20 Score=159.32 Aligned_cols=103 Identities=18% Similarity=0.169 Sum_probs=93.8
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCC------HHHHHHHHHcCCCCCCCCCCCC-cHHHHHHHcC-----CHHHHHHHHH-C
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERD------VEGIKELLDSGIDVNFRDIDNR-TALHVAACQG-----FTEVVSLLLE-R 95 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~------~~~~~~Ll~~g~~~n~~d~~g~-t~Lh~A~~~~-----~~~~~~~Ll~-~ 95 (387)
.|.|++.++..|+||||+|+..|+ .+++++|+++|+|+|.+|..|+ ||||+|+..+ +.+++++|++ +
T Consensus 64 ~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll~~~ 143 (186)
T 3t8k_A 64 KGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQS 143 (186)
T ss_dssp TTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSSCBGGGTBCTTGGGGGCCSCHHHHHHHHHHHHTST
T ss_pred CCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCccCCCcCchHHHHHHHcCCChhhHHHHHHHHHHhc
Confidence 577788888889999999999987 6899999999999999999999 9999999954 4569999999 9
Q ss_pred CCCCCCCCcCCCCccccccccchHHHHHHHHhhCCC
Q 016544 96 GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131 (387)
Q Consensus 96 ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~ 131 (387)
|++++.+|..|.||||+|+..++.+++++|+.+..+
T Consensus 144 gad~~~~d~~G~TpL~~A~~~~~~~~v~~L~~~~~~ 179 (186)
T 3t8k_A 144 GLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKK 179 (186)
T ss_dssp TCCTTCCCTTSCCHHHHHHTTTCHHHHHHHHHHHHH
T ss_pred CCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHHHHH
Confidence 999999999999999999999999999999987543
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.2e-19 Score=158.41 Aligned_cols=107 Identities=29% Similarity=0.325 Sum_probs=61.9
Q ss_pred hhhcCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCC-------------CCCcHHHHHHHcCCHHHHHHH
Q 016544 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-------------DNRTALHVAACQGFTEVVSLL 92 (387)
Q Consensus 26 ~~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~-------------~g~t~Lh~A~~~~~~~~~~~L 92 (387)
+++...+.+..+..|+||||+||..|+.+++++|+++|++++..+. .|+||||+|+..|+.+++++|
T Consensus 61 ~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~L 140 (232)
T 2rfa_A 61 PELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLL 140 (232)
T ss_dssp GGGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHH
T ss_pred chhccccccccCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCcccCCcceeecccccccCCCCHHHHHHHcCCHHHHHHH
Confidence 3333333344455556666666666666666666666666555543 466666666666666666666
Q ss_pred HHCCCCCCCCCcCCCCccccccccchHHHH----HHHHhhCCCC
Q 016544 93 LERGADVDPKDRWGSTPLGDAIYYKNHEVI----KLLEKHGAKP 132 (387)
Q Consensus 93 l~~ga~~~~~~~~g~tpl~~a~~~~~~~~~----~~L~~~g~~~ 132 (387)
+++|++++.+|..|.||||+|+..++.+++ ++|+++|+++
T Consensus 141 l~~ga~~~~~d~~g~t~L~~A~~~~~~~~~~~i~~~Ll~~g~~~ 184 (232)
T 2rfa_A 141 IEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGD 184 (232)
T ss_dssp HHTTCCTTCCCTTSCCHHHHHHTCSCHHHHHHHHHHHHHTTCSC
T ss_pred HHCCCCCCCCCCCCCCHHHHHHHcCChHHHHHHHHHHHhcCCch
Confidence 666666666666666666666666655555 5566655554
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=99.81 E-value=2.7e-20 Score=161.48 Aligned_cols=108 Identities=21% Similarity=0.270 Sum_probs=91.8
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHc-CCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~-g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
++.|++.++..|+||||+||..|+.+++++|+++ |+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 95 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 174 (222)
T 3ehr_A 95 NRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGARTDLRNIEKK 174 (222)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCSCCCCTTSC
T ss_pred CCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccCCCC
Confidence 5677888888899999999999999999999999 999999999999999999999999999999999999999999999
Q ss_pred CccccccccchHHHHHHHHhhCCCCCCCC
Q 016544 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~g~~~~~~~ 136 (387)
|||++|+..++.++++.+...++......
T Consensus 175 t~l~~A~~~~~~~~l~~l~~~~~~~~~~~ 203 (222)
T 3ehr_A 175 LAFDMATNAACASLLKKKQGTDAVRTLSN 203 (222)
T ss_dssp CHHHHCCSHHHHHHHC-------------
T ss_pred CHHHHhcchhHHHHHHHHhccchhhhccc
Confidence 99999999999999999999998765443
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A | Back alignment and structure |
|---|
Probab=99.81 E-value=6.1e-20 Score=162.62 Aligned_cols=105 Identities=28% Similarity=0.219 Sum_probs=67.0
Q ss_pred CCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccc
Q 016544 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (387)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~ 111 (387)
+.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||
T Consensus 116 ~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpL~ 195 (253)
T 1yyh_A 116 DLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLF 195 (253)
T ss_dssp CTTCCCTTCCCHHHHHHHHTCSSHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred CccccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHH
Confidence 44555555666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cccccchHHHHHHHHhhCCCCCCCC
Q 016544 112 DAIYYKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 112 ~a~~~~~~~~~~~L~~~g~~~~~~~ 136 (387)
+|+..++.+++++|+++|+++....
T Consensus 196 ~A~~~~~~~~v~~Ll~~ga~~~~~d 220 (253)
T 1yyh_A 196 LAAREGSYETAKVLLDHFANRDITD 220 (253)
T ss_dssp HHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred HHHHCCCHHHHHHHHHcCCCccccc
Confidence 6666666666666666666654443
|
| >4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=6.2e-20 Score=164.79 Aligned_cols=100 Identities=31% Similarity=0.336 Sum_probs=83.8
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCCcCCCC
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDRWGST 108 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~~~~~~g~t 108 (387)
+.+.+..+..|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|++ .|++++.+|..|.|
T Consensus 173 g~~~~~~~~~g~tpLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~T 252 (276)
T 4hbd_A 173 GNINAKASQAGQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGST 252 (276)
T ss_dssp SCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTTSCC
T ss_pred CCCccccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCCCCC
Confidence 44555556678888888888888888888888888888888888888888888888888888888 78888888888888
Q ss_pred ccccccccchHHHHHHHHhhC
Q 016544 109 PLGDAIYYKNHEVIKLLEKHG 129 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g 129 (387)
|||+|+..|+.+++++|+++.
T Consensus 253 pL~~A~~~g~~~iv~~Ll~~~ 273 (276)
T 4hbd_A 253 ALMVALDAGQSEIASMLYSRM 273 (276)
T ss_dssp HHHHHHHHTCHHHHHHHHHHC
T ss_pred HHHHHHHcCCHHHHHHHHhcc
Confidence 888888888888888888764
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.4e-19 Score=157.77 Aligned_cols=106 Identities=27% Similarity=0.285 Sum_probs=64.1
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
+.+.+..+..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus 63 g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~ 142 (231)
T 3aji_A 63 GVPVNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATA 142 (231)
T ss_dssp TCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred CCCCCCcCCCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCcH
Confidence 44444555555566666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cccccccchHHHHHHHHhhCCCCCCC
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~~~~ 135 (387)
||+|+..++.+++++|+++|+++...
T Consensus 143 L~~A~~~~~~~~v~~Ll~~g~~~~~~ 168 (231)
T 3aji_A 143 MHRAAAKGNLKMVHILLFYKASTNIQ 168 (231)
T ss_dssp HHHHHHHTCHHHHHHHHHTTCCSCCC
T ss_pred HHHHHHcCCHHHHHHHHhcCCCcccc
Confidence 66666666666666666666555443
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=158.35 Aligned_cols=109 Identities=26% Similarity=0.329 Sum_probs=99.4
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCC-----CCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV-----NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~-----n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~ 104 (387)
+.|.+.++..|+||||+||..|+.+++++|+++|+++ +.+|..|+||||+|+..|+.+++++|+++|++++.++.
T Consensus 27 g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~ 106 (232)
T 2rfa_A 27 GCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARAT 106 (232)
T ss_dssp CSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCC
T ss_pred CCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCcccC
Confidence 6677777888999999999999999999999999987 77888999999999999999999999999999998876
Q ss_pred -------------CCCCccccccccchHHHHHHHHhhCCCCCCCCcc
Q 016544 105 -------------WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (387)
Q Consensus 105 -------------~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~ 138 (387)
.|.||||+|+..++.+++++|+++|+++......
T Consensus 107 ~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~ 153 (232)
T 2rfa_A 107 GSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSL 153 (232)
T ss_dssp SGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCCCTT
T ss_pred CcceeecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCC
Confidence 7999999999999999999999999987655433
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A | Back alignment and structure |
|---|
Probab=99.80 E-value=9.4e-20 Score=161.58 Aligned_cols=97 Identities=28% Similarity=0.379 Sum_probs=92.2
Q ss_pred CCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCC-------------CCcHHHHHHHcCCHHHHHHHHH---CCCCC
Q 016544 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-------------NRTALHVAACQGFTEVVSLLLE---RGADV 99 (387)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~-------------g~t~Lh~A~~~~~~~~~~~Ll~---~ga~~ 99 (387)
++..|+||||+||..|+.+++++|+++|+++|.+|.. |+||||+|+..|+.+++++|++ +|+++
T Consensus 86 ~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~ 165 (256)
T 2etb_A 86 EFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASL 165 (256)
T ss_dssp TTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCT
T ss_pred ccccCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCc
Confidence 4467999999999999999999999999999999886 9999999999999999999999 99999
Q ss_pred CCCCcCCCCccccccc--cchHH-------HHHHHHhhCCCC
Q 016544 100 DPKDRWGSTPLGDAIY--YKNHE-------VIKLLEKHGAKP 132 (387)
Q Consensus 100 ~~~~~~g~tpl~~a~~--~~~~~-------~~~~L~~~g~~~ 132 (387)
+.+|..|.||||+|+. .++.+ ++++|+++|+++
T Consensus 166 n~~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~~ga~~ 207 (256)
T 2etb_A 166 EATDSLGNTVLHALVMIADNSPENSALVIHMYDGLLQMGARL 207 (256)
T ss_dssp TCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CccCCCCCCHHHHHHHcccCCchhhHHHHHHHHHHHHcCCCc
Confidence 9999999999999998 78888 999999999987
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.7e-19 Score=156.38 Aligned_cols=109 Identities=27% Similarity=0.202 Sum_probs=93.1
Q ss_pred CCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccc
Q 016544 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (387)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~ 111 (387)
+.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||
T Consensus 84 ~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~ 163 (223)
T 2f8y_A 84 DLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLF 163 (223)
T ss_dssp CTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHH
T ss_pred CcccCCCCCCcHHHHHHHhCcHHHHHHHHHcCCCCcCcCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCcCHHH
Confidence 66667777888899999999999999999989999888888999999999999999999999999999888888999999
Q ss_pred cccccchHHHHHHHHhhCCCCCCCCcccc
Q 016544 112 DAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140 (387)
Q Consensus 112 ~a~~~~~~~~~~~L~~~g~~~~~~~~~~~ 140 (387)
+|+..++.+++++|+++|+++........
T Consensus 164 ~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 192 (223)
T 2f8y_A 164 LAAREGSYETAKVLLDHFANRDITDHMDR 192 (223)
T ss_dssp HHHHHTCHHHHHHHHHTTCCTTCCCTTCC
T ss_pred HHHHcCCHHHHHHHHHcCCCCccccccCC
Confidence 99888889999999998888766544433
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.8e-19 Score=156.70 Aligned_cols=113 Identities=24% Similarity=0.247 Sum_probs=100.7
Q ss_pred CCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcc
Q 016544 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (387)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl 110 (387)
+.+..+..|.||||+|+..|+.+++++|+++|++++..| ..|.||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus 108 ~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L 187 (241)
T 1k1a_A 108 DLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSAL 187 (241)
T ss_dssp CTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHH
T ss_pred cccccCcCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHH
Confidence 667777788999999999999999999999999999988 7899999999999999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHhhCCCCCCCCccccccCC
Q 016544 111 GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE 144 (387)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~~~ 144 (387)
|+|+..++.+++++|+++|+++........++..
T Consensus 188 ~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~ 221 (241)
T 1k1a_A 188 HSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLM 221 (241)
T ss_dssp HHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTT
T ss_pred HHHHHcCCHHHHHHHHhcCCCCCCcCCCCCCHHH
Confidence 9999999999999999999998776655555543
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A | Back alignment and structure |
|---|
Probab=99.80 E-value=8e-20 Score=161.01 Aligned_cols=104 Identities=34% Similarity=0.326 Sum_probs=96.3
Q ss_pred CCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCC-cCCCCcccccccc
Q 016544 38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIYY 116 (387)
Q Consensus 38 ~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~-~~g~tpl~~a~~~ 116 (387)
..|.||||+||..|+.++++.|++ |+++|.+|..|+||||+||..|+.+++++|+++|++++.++ ..|.||||+|+..
T Consensus 43 ~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~ 121 (244)
T 3ui2_A 43 SEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGY 121 (244)
T ss_dssp HHHHHHHHHHHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHT
T ss_pred cCCCCHHHHHHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHc
Confidence 468999999999999999999999 99999999999999999999999999999999999999998 8899999999999
Q ss_pred chHHHHHHHHhhCCCCCCCCcccccc
Q 016544 117 KNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 117 ~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
++.+++++|+++|+++........++
T Consensus 122 g~~~~v~~Ll~~ga~~~~~d~~g~t~ 147 (244)
T 3ui2_A 122 VRPEVVEALVELGADIEVEDERGLTA 147 (244)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTTCCCH
T ss_pred CCHHHHHHHHHCCCCCCCCCCCCCcH
Confidence 99999999999999987655444433
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=152.47 Aligned_cols=89 Identities=33% Similarity=0.348 Sum_probs=84.0
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
.+.|++.++..|+||||+||..|+.+++++|+++|+++|.+| ..|+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 65 ~~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~ 144 (183)
T 3deo_A 65 EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERGL 144 (183)
T ss_dssp TTSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSC
T ss_pred hcCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHhcCcHHHHHHHHHcCCCCcCCCCCCC
Confidence 467888888899999999999999999999999999999998 8899999999999999999999999999999999999
Q ss_pred Cccccccccc
Q 016544 108 TPLGDAIYYK 117 (387)
Q Consensus 108 tpl~~a~~~~ 117 (387)
||||+|+..+
T Consensus 145 tpl~~A~~~~ 154 (183)
T 3deo_A 145 TALELAREIL 154 (183)
T ss_dssp CHHHHHHHHH
T ss_pred CHHHHHHHhc
Confidence 9999998763
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.7e-19 Score=155.06 Aligned_cols=112 Identities=21% Similarity=0.167 Sum_probs=93.3
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCC-CCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~-~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
++.|.+..+..|+||||+|+..|+.+++++|+++++ +++..|..|.||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 47 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~ 126 (223)
T 2f8y_A 47 ASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGK 126 (223)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHBTTSCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSC
T ss_pred cCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCcHHHHHHHhCcHHHHHHHHHcCCCCcCcCCCCC
Confidence 456667777778888888888888888888888876 8888888888888888888888888888888888888888888
Q ss_pred CccccccccchHHHHHHHHhhCCCCCCCCcccc
Q 016544 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140 (387)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~ 140 (387)
||||+|+..++.+++++|++.|+++........
T Consensus 127 t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~ 159 (223)
T 2f8y_A 127 SALHWAAAVNNVDAAVVLLKNGANKDMQNNREE 159 (223)
T ss_dssp BHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCC
T ss_pred cHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCc
Confidence 888888888888888888888888766544333
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-19 Score=159.43 Aligned_cols=103 Identities=32% Similarity=0.346 Sum_probs=95.5
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
.+.|++.++..|+||||+||..|+.+++++|+++|+++|.+| ..|+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 66 ~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~ 145 (244)
T 3ui2_A 66 EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERGL 145 (244)
T ss_dssp TTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCC
T ss_pred cCCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Confidence 367888888899999999999999999999999999999998 8899999999999999999999999999999999999
Q ss_pred Ccccccc----------------ccchHHHHHHHHhhCCC
Q 016544 108 TPLGDAI----------------YYKNHEVIKLLEKHGAK 131 (387)
Q Consensus 108 tpl~~a~----------------~~~~~~~~~~L~~~g~~ 131 (387)
||||+|+ ..|+.+++++|.+.+.+
T Consensus 146 t~l~~A~~~~~~~~~~~~l~~a~~~g~~~iv~~L~~~~~~ 185 (244)
T 3ui2_A 146 TALELAREILKTTPKGNPMQFGRRIGLEKVINVLEGQVFE 185 (244)
T ss_dssp CHHHHHHHHHTTCCCSSHHHHHHHHHHHHHHHHHHHHHEE
T ss_pred cHHHHHHHHHhccCCCCHHHHHHHcChHHHHHHHHHhccc
Confidence 9999887 56888999999987654
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.9e-19 Score=165.38 Aligned_cols=110 Identities=33% Similarity=0.416 Sum_probs=102.6
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
.+.+.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 47 ~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~iv~~Ll~~g~~~~~~~~~g~t 126 (351)
T 3utm_A 47 LNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFT 126 (351)
T ss_dssp TTTTCCCSSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCC
T ss_pred cCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCC
Confidence 35667777888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCCCCCCcc
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~~~~~~~ 138 (387)
|||+|+..++.+++++|+++|+++......
T Consensus 127 ~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~ 156 (351)
T 3utm_A 127 PLHEAASKNRVEVCSLLLSHGADPTLVNCH 156 (351)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCccccCC
Confidence 999999999999999999999998665443
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.80 E-value=4.1e-19 Score=160.99 Aligned_cols=71 Identities=35% Similarity=0.379 Sum_probs=41.1
Q ss_pred CCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHHHHHHHhhCCCCCCCCccccccC
Q 016544 73 NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (387)
Q Consensus 73 g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~~ 143 (387)
|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|+++........++.
T Consensus 199 g~t~L~~A~~~g~~~~v~~Ll~~g~d~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~t~l 269 (299)
T 1s70_B 199 GGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAF 269 (299)
T ss_dssp CCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTT
T ss_pred CCCHHHHHHHCCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHhcCCHHHHHHHHHcCCCCCCcCCCCCCHH
Confidence 44555555555556666666666666666666666666666666666666666666666554444444443
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E | Back alignment and structure |
|---|
Probab=99.80 E-value=2.6e-19 Score=156.68 Aligned_cols=111 Identities=24% Similarity=0.347 Sum_probs=81.8
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCC------CCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID------VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~------~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~ 102 (387)
++.|++.++..|+||||+||..|+.+++++|++.|++ ++..|..|+||||+|+..|+.+++++|+++|++++.+
T Consensus 67 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~ 146 (236)
T 1ikn_D 67 AGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQ 146 (236)
T ss_dssp CCCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCC
T ss_pred cCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcccchhHHHHhhccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCC
Confidence 3556666666777777777777777777777777765 4566777777777777777788888888878888777
Q ss_pred Cc-CCCCccccccccchHHHHHHHHhhCCCCCCCCccc
Q 016544 103 DR-WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (387)
Q Consensus 103 ~~-~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~ 139 (387)
+. .|.||||+|+..++.+++++|+++|+++.......
T Consensus 147 ~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g 184 (236)
T 1ikn_D 147 EPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQG 184 (236)
T ss_dssp CTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTC
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCC
Confidence 76 77888888887788888888888777765554433
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=161.25 Aligned_cols=103 Identities=22% Similarity=0.236 Sum_probs=95.4
Q ss_pred CCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCC--------------CCCCcHHHHHHHcCCHHHHHHHHH--
Q 016544 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD--------------IDNRTALHVAACQGFTEVVSLLLE-- 94 (387)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d--------------~~g~t~Lh~A~~~~~~~~~~~Ll~-- 94 (387)
.+.+..+..|+||||+||..|+.+++++|+++|+++|.+| ..|+||||+|+..|+.+++++|++
T Consensus 84 ~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~ 163 (260)
T 3jxi_A 84 SPFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENG 163 (260)
T ss_dssp CCBCCSSEESBCHHHHHHHTTCHHHHHHHHHTTCCTTCCCEECCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCS
T ss_pred ccccccccCCCCHHHHHHHcCCHHHHHHHHhCCCCcCccccccccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhcc
Confidence 4455666689999999999999999999999999999999 689999999999999999999999
Q ss_pred -CCCCCCCCCcCCCCccccccccch---------HHHHHHHHhhCCCCC
Q 016544 95 -RGADVDPKDRWGSTPLGDAIYYKN---------HEVIKLLEKHGAKPL 133 (387)
Q Consensus 95 -~ga~~~~~~~~g~tpl~~a~~~~~---------~~~~~~L~~~g~~~~ 133 (387)
+|++++.+|..|.||||+|+..++ .+++++|+++|+++.
T Consensus 164 ~~ga~~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~~ 212 (260)
T 3jxi_A 164 HKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLF 212 (260)
T ss_dssp SCCCCTTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHHHHHC
T ss_pred ccCCCCcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhCcccc
Confidence 999999999999999999998776 699999999999873
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.8e-19 Score=150.87 Aligned_cols=106 Identities=24% Similarity=0.329 Sum_probs=97.8
Q ss_pred CCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHH-HCCCCCCCCCcCCCCc
Q 016544 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL-ERGADVDPKDRWGSTP 109 (387)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll-~~ga~~~~~~~~g~tp 109 (387)
.+.+..+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+ ..+++++.+|..|.||
T Consensus 30 ~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~ 109 (201)
T 3hra_A 30 YQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNA 109 (201)
T ss_dssp CCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCS
T ss_pred CCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCcH
Confidence 367777788999999999999999999999999999999999999999999999999999999 6788999999999999
Q ss_pred cccccccchHHHHHHHHhhC-CCCCCCC
Q 016544 110 LGDAIYYKNHEVIKLLEKHG-AKPLMAP 136 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g-~~~~~~~ 136 (387)
||+|+..++.+++++|++.| +++....
T Consensus 110 L~~A~~~~~~~~v~~Ll~~g~~~~~~~~ 137 (201)
T 3hra_A 110 LIPAAEKGHIDNVKLLLEDGREDIDFQN 137 (201)
T ss_dssp HHHHHHTTCHHHHHHHHHHCCCCTTCCC
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCcCCCC
Confidence 99999999999999999998 6665443
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.5e-19 Score=154.49 Aligned_cols=105 Identities=30% Similarity=0.387 Sum_probs=92.7
Q ss_pred CCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccc
Q 016544 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~ 112 (387)
.+..+..|+||||+||..|+.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus 33 ~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~ 112 (231)
T 3aji_A 33 ATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHY 112 (231)
T ss_dssp GGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred hhcCCCCCCCHHHHHHHcCcHHHHHHHHHhCCCCCCcCCCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCCHHHH
Confidence 44556678888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchHHHHHHHHhhCCCCCCCCc
Q 016544 113 AIYYKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 113 a~~~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
|+..++.+++++|++.|+++.....
T Consensus 113 A~~~~~~~~~~~Ll~~g~~~~~~~~ 137 (231)
T 3aji_A 113 AASKNRHEIAVMLLEGGANPDAKDH 137 (231)
T ss_dssp HHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred HHHcCCHHHHHHHHHcCCCCCCcCC
Confidence 9999999999999999988765543
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=4.4e-19 Score=155.21 Aligned_cols=106 Identities=22% Similarity=0.326 Sum_probs=70.6
Q ss_pred CCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcc
Q 016544 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (387)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl 110 (387)
.+.+..+..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus 102 ~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L 181 (237)
T 3b7b_A 102 MDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPL 181 (237)
T ss_dssp CCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCHHHHHHHHTTTCCTTCCCTTCCCHH
T ss_pred CCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCCHH
Confidence 44555555666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred ccccccchHHHHHHHHhhCCCCCCCC
Q 016544 111 GDAIYYKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~g~~~~~~~ 136 (387)
|+|+..++.+++++|+++|+++....
T Consensus 182 ~~A~~~~~~~~v~~Ll~~gad~~~~d 207 (237)
T 3b7b_A 182 HIAARENRYDCVVLFLSRDSDVTLKN 207 (237)
T ss_dssp HHHHHTTCHHHHHHHHTTTCCTTCCC
T ss_pred HHHHHhCCHhHHHHHHHcCCCCCccC
Confidence 66666666666666666666655443
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=8.5e-20 Score=163.50 Aligned_cols=97 Identities=25% Similarity=0.216 Sum_probs=89.3
Q ss_pred CcchHHHHHHhhCCHHHHHHHHH---cCCCCCCCCCCCCcHHHHHHHcCC---------HHHHHHHHHCCCCCC------
Q 016544 39 KPEFRLMFLANERDVEGIKELLD---SGIDVNFRDIDNRTALHVAACQGF---------TEVVSLLLERGADVD------ 100 (387)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~---~g~~~n~~d~~g~t~Lh~A~~~~~---------~~~~~~Ll~~ga~~~------ 100 (387)
.|.||||+||..|+.+++++|++ +|+++|.+|.+|+||||+|+..|+ .+++++|+++|++++
T Consensus 147 ~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n~~~~~~ 226 (273)
T 2pnn_A 147 FGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLE 226 (273)
T ss_dssp SCBSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHCTTCCGG
T ss_pred CCCCHHHHHHHcCCHHHHHHHHhcccCCCCceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhcccccccc
Confidence 79999999999999999999999 999999999999999999999998 899999999999997
Q ss_pred -CCCcCCCCccccccccchHHHHHHHHhhCC-CCCCC
Q 016544 101 -PKDRWGSTPLGDAIYYKNHEVIKLLEKHGA-KPLMA 135 (387)
Q Consensus 101 -~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~-~~~~~ 135 (387)
.+|..|.||||+|+..|+.+++++|+++|+ ++...
T Consensus 227 ~~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~dp~~~ 263 (273)
T 2pnn_A 227 EITNRKGLTPLALAASSGKIGVLAYILQREIHEPECR 263 (273)
T ss_dssp GCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTC-----
T ss_pred cccCCCCCCHHHHHHHhChHHHHHHHHHCCCCCchhh
Confidence 489999999999999999999999999999 55443
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.8e-19 Score=166.24 Aligned_cols=103 Identities=28% Similarity=0.367 Sum_probs=87.7
Q ss_pred cCCCCCCCC--CCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCC
Q 016544 29 NGLDDDGEE--IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106 (387)
Q Consensus 29 ~~~~~~~~~--~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g 106 (387)
++.|++..+ ..|.||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|
T Consensus 222 ~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~LL~~Gad~~~~d~~G 301 (368)
T 3jue_A 222 HGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLKRGADLGARDSEG 301 (368)
T ss_dssp TTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred cCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHCcCCCCCcCCCC
Confidence 456666665 678888999999999999999998899999888889999999999999999999999999998888889
Q ss_pred CCccccccccchHHHHHHHHhhCCC
Q 016544 107 STPLGDAIYYKNHEVIKLLEKHGAK 131 (387)
Q Consensus 107 ~tpl~~a~~~~~~~~~~~L~~~g~~ 131 (387)
.||||+|+..++.+++++|+..+..
T Consensus 302 ~TpL~~A~~~g~~~iv~lLl~~~~~ 326 (368)
T 3jue_A 302 RDPLTIAMETANADIVTLLRLAKMR 326 (368)
T ss_dssp CCHHHHHHHTTCHHHHHHHHHHHC-
T ss_pred CCHHHHHHHCCCHHHHHHHHHcCCC
Confidence 9999999888888988888887643
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.7e-19 Score=162.74 Aligned_cols=105 Identities=25% Similarity=0.237 Sum_probs=98.3
Q ss_pred CCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcc
Q 016544 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (387)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl 110 (387)
.+.+.+|..|+||||+||..|+.+++++|+++|+++|.+| |+||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus 22 ~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~--g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L 99 (285)
T 3kea_A 22 KDTFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTAL 99 (285)
T ss_dssp TTTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTGGGSCCT--TCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHH
T ss_pred CCCCccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCC--CCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHH
Confidence 4678888899999999999999999999999999999984 99999999999999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHhhCCCCCCCCc
Q 016544 111 GDAIYYKNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~g~~~~~~~~ 137 (387)
|+|+..++.+++++|+++|+++.....
T Consensus 100 ~~A~~~g~~~~v~~Ll~~ga~~~~~~~ 126 (285)
T 3kea_A 100 YYAVDSGNMQTVKLFVKKNWRLMFYGK 126 (285)
T ss_dssp HHHHHTTCHHHHHHHHHHCGGGGGCSS
T ss_pred HHHHHcCCHHHHHHHHhcCCCCCccCC
Confidence 999999999999999999998765443
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A | Back alignment and structure |
|---|
Probab=99.78 E-value=4.6e-19 Score=156.96 Aligned_cols=100 Identities=26% Similarity=0.261 Sum_probs=73.4
Q ss_pred CCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCC-CCCCCCcCCCCccccccc
Q 016544 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPKDRWGSTPLGDAIY 115 (387)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga-~~~~~~~~g~tpl~~a~~ 115 (387)
+..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|+ +++.+|..|.||||+|+.
T Consensus 54 d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~ 133 (253)
T 1yyh_A 54 DRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAAR 133 (253)
T ss_dssp CTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHSTTSCTTCCCTTCCCHHHHHHH
T ss_pred CCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccCCCCCcHHHHHHH
Confidence 5567777777777777777777777777777777777777777777777777777777765 677777777777777777
Q ss_pred cchHHHHHHHHhhCCCCCCCC
Q 016544 116 YKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 116 ~~~~~~~~~L~~~g~~~~~~~ 136 (387)
.++.+++++|++.|+++....
T Consensus 134 ~~~~~~v~~Ll~~g~~~~~~d 154 (253)
T 1yyh_A 134 LAVEGMLEDLINSHADVNAVD 154 (253)
T ss_dssp HTCSSHHHHHHHTTCCTTCBC
T ss_pred cChHHHHHHHHHcCCCCCCcC
Confidence 777777777777777665444
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.3e-19 Score=160.70 Aligned_cols=94 Identities=21% Similarity=0.199 Sum_probs=90.2
Q ss_pred CcchHHHHHHhhCCHHHHHHHHH---cCCCCCCCCCCCCcHHHHHHH--cCCHH-------HHHHHHHCCCCC-------
Q 016544 39 KPEFRLMFLANERDVEGIKELLD---SGIDVNFRDIDNRTALHVAAC--QGFTE-------VVSLLLERGADV------- 99 (387)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~---~g~~~n~~d~~g~t~Lh~A~~--~~~~~-------~~~~Ll~~ga~~------- 99 (387)
.|.||||+||..|+.+++++|++ +|+|+|.+|.+|+||||+|+. .++.+ ++++|+++|+++
T Consensus 135 ~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~~ga~~~~~~~~~ 214 (256)
T 2etb_A 135 FGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENSALVIHMYDGLLQMGARLCPTVQLE 214 (256)
T ss_dssp SCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHSTTCCGG
T ss_pred CCCCHHHHHHHcCCHHHHHHHHhccccCCCcCccCCCCCCHHHHHHHcccCCchhhHHHHHHHHHHHHcCCCcccccccc
Confidence 39999999999999999999999 999999999999999999999 88888 999999999999
Q ss_pred CCCCcCCCCccccccccchHHHHHHHHhhCCCC
Q 016544 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 100 ~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
+.+|..|.||||+|+..|+.+++++|+++|++.
T Consensus 215 ~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~ 247 (256)
T 2etb_A 215 EISNHQGLTPLKLAAKEGKIEIFRHILQREFSG 247 (256)
T ss_dssp GCCCTTSCCHHHHHHHTTCHHHHHHHHHHHHHH
T ss_pred cccCCCCCCHHHHHHHhCCHHHHHHHHhCCCCC
Confidence 899999999999999999999999999998764
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A | Back alignment and structure |
|---|
Probab=99.78 E-value=3.9e-19 Score=155.79 Aligned_cols=102 Identities=25% Similarity=0.293 Sum_probs=91.9
Q ss_pred cCCCCCCCC-CCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC
Q 016544 29 NGLDDDGEE-IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 29 ~~~~~~~~~-~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
.+.|.+..+ ..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 138 ~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~ 217 (241)
T 1k1a_A 138 RGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHND 217 (241)
T ss_dssp TTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred cCCCcccccccCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCcCCCCC
Confidence 566777776 6799999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccccchHHHHHHHHhhCC
Q 016544 108 TPLGDAIYYKNHEVIKLLEKHGA 130 (387)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~g~ 130 (387)
||+++|+..++.++++.|.++++
T Consensus 218 tpl~~A~~~~~~~i~~~l~~~~a 240 (241)
T 1k1a_A 218 TPLMVARSRRVIDILRGKATRPA 240 (241)
T ss_dssp CTTTTCSSHHHHHHHTC------
T ss_pred CHHHHHHhcCcHHHHhhhccCCC
Confidence 99999999999999999987764
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-19 Score=161.13 Aligned_cols=95 Identities=19% Similarity=0.140 Sum_probs=90.9
Q ss_pred CCcchHHHHHHhhCCHHHHHHHHH---cCCCCCCCCCCCCcHHHHHHHcCC---------HHHHHHHHHCCCCC------
Q 016544 38 IKPEFRLMFLANERDVEGIKELLD---SGIDVNFRDIDNRTALHVAACQGF---------TEVVSLLLERGADV------ 99 (387)
Q Consensus 38 ~~g~t~l~~a~~~~~~~~~~~Ll~---~g~~~n~~d~~g~t~Lh~A~~~~~---------~~~~~~Ll~~ga~~------ 99 (387)
..|+||||+||..|+.+++++|++ +|+|+|.+|..|+||||+|+..++ .+++++|+++|+++
T Consensus 138 ~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~~ 217 (260)
T 3jxi_A 138 YFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLFPDTNL 217 (260)
T ss_dssp CSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHHHHHCTTCCG
T ss_pred cCCCCHHHHHHHcCCHHHHHHHHhccccCCCCcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhCcccccccch
Confidence 679999999999999999999999 999999999999999999999888 79999999999999
Q ss_pred -CCCCcCCCCccccccccchHHHHHHHHhhCCCC
Q 016544 100 -DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 100 -~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
+.+|..|.||||+|+..|+.+++++|+++|+++
T Consensus 218 ~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~ 251 (260)
T 3jxi_A 218 EALLNNDGLSPLMMAAKTGKIGIFQHIIRREIAD 251 (260)
T ss_dssp GGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHHHH
T ss_pred hhcccCCCCCHHHHHHHcCCHHHHHHHHHhCCCc
Confidence 679999999999999999999999999999765
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.78 E-value=4.2e-19 Score=163.36 Aligned_cols=115 Identities=19% Similarity=0.155 Sum_probs=94.1
Q ss_pred cCCCCCC-CCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC----------------------
Q 016544 29 NGLDDDG-EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---------------------- 85 (387)
Q Consensus 29 ~~~~~~~-~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~---------------------- 85 (387)
.+.|++. ++..|+||||+||..|+.++|++||++|+|+|.+|.+|+||||+|+..|+
T Consensus 119 ~g~dvn~~~d~~g~TpLh~Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~~~ll~~~~~~~~~~d 198 (327)
T 1sw6_A 119 TQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILED 198 (327)
T ss_dssp SCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEEC
T ss_pred cCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHHHHHHHhhhccccCCC
Confidence 4688888 78899999999999999999999999999999999999999999998655
Q ss_pred -------------------HHHHHHHHHCCC---------------------------------------------CCCC
Q 016544 86 -------------------TEVVSLLLERGA---------------------------------------------DVDP 101 (387)
Q Consensus 86 -------------------~~~~~~Ll~~ga---------------------------------------------~~~~ 101 (387)
.+++++|++.++ +++.
T Consensus 199 ~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~Ll~~~~n~ 278 (327)
T 1sw6_A 199 SMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNA 278 (327)
T ss_dssp TTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTC
T ss_pred CCCCCHHHHHHHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHHHHhCCCC
Confidence 344555554422 5777
Q ss_pred CCcCCCCccccccccchHHHHHHHHhhCCCCCCCCccccccC
Q 016544 102 KDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (387)
Q Consensus 102 ~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~~ 143 (387)
+|..|+||||+|+..|+.+++++|+++|+++........++.
T Consensus 279 ~d~~G~TpLh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL 320 (327)
T 1sw6_A 279 QDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPV 320 (327)
T ss_dssp CCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGG
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHH
Confidence 888888889988888889999999999888876655554443
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.78 E-value=6.1e-19 Score=168.71 Aligned_cols=113 Identities=27% Similarity=0.316 Sum_probs=94.1
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|.+..+..|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|+++|.+|..|.|
T Consensus 267 ~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~n~~~~~g~t 346 (437)
T 1n11_A 267 KQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYS 346 (437)
T ss_dssp TTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCccCCCCCCCCCCHHHHHHHcCcHHHHHHHHhcCCCCCCCCCCCCC
Confidence 45566666777888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred ccccccccchHHHHHHHHhhCCCCCCCCccccc
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~ 141 (387)
|||+|+..++.+++++|+++|+++........+
T Consensus 347 ~L~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t 379 (437)
T 1n11_A 347 PLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTT 379 (437)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCSCCCCSSSCC
T ss_pred HHHHHHHCChHHHHHHHHHCcCCCCCCCCCCCC
Confidence 988888888888888888888887665544433
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} | Back alignment and structure |
|---|
Probab=99.78 E-value=9e-19 Score=149.17 Aligned_cols=111 Identities=25% Similarity=0.333 Sum_probs=100.1
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHH-HcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCC-CCCCCCCcCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWG 106 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll-~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~g-a~~~~~~~~g 106 (387)
++.|++..+..|+||||+|+..|+.+++++|+ ..+++++.+|..|.||||+|+..|+.+++++|+++| ++++.+|..|
T Consensus 61 ~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g 140 (201)
T 3hra_A 61 RGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDFG 140 (201)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCSHHHHHHTTCHHHHHHHHHHCCCCTTCCCTTS
T ss_pred cCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcCCCCCCC
Confidence 46777778888999999999999999999999 567899999999999999999999999999999998 9999999999
Q ss_pred CCccccccccch-----HHHHHHHHhhCCCCCCCCccc
Q 016544 107 STPLGDAIYYKN-----HEVIKLLEKHGAKPLMAPMHV 139 (387)
Q Consensus 107 ~tpl~~a~~~~~-----~~~~~~L~~~g~~~~~~~~~~ 139 (387)
.||||+|+..++ .+++++|+++|+++.......
T Consensus 141 ~t~L~~A~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~~g 178 (201)
T 3hra_A 141 YTALIEAVGLREGNQLYQDIVKLLMENGADQSIKDNSG 178 (201)
T ss_dssp CCHHHHHHHSSCCSHHHHHHHHHHHHTTCCTTCCCTTS
T ss_pred CCHHHHHHHhccchhhHHHHHHHHHHCCCCCCccCCCC
Confidence 999999998887 899999999999986655433
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.5e-19 Score=158.47 Aligned_cols=102 Identities=25% Similarity=0.272 Sum_probs=97.6
Q ss_pred CCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccc
Q 016544 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (387)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~ 111 (387)
..+.++..|+||||+||..|+.+++++|++.|+++|.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|.||||
T Consensus 51 ~~~~~~~~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~ 130 (285)
T 3d9h_A 51 PLMGDAVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLF 130 (285)
T ss_dssp TTCSSSCCSCCHHHHHHHTTCHHHHHHHHHTTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHH
T ss_pred cccCCCccCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHH
Confidence 45677888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccchHHHHHHHHhhCCCCC
Q 016544 112 DAIYYKNHEVIKLLEKHGAKPL 133 (387)
Q Consensus 112 ~a~~~~~~~~~~~L~~~g~~~~ 133 (387)
+|+..++.+++++|++.|+++.
T Consensus 131 ~A~~~~~~~~v~~Ll~~g~~~~ 152 (285)
T 3d9h_A 131 NACVSGSWDCVNLLLQHGASVQ 152 (285)
T ss_dssp HHHHHTCHHHHHHHHHTTCCSS
T ss_pred HHHHcCHHHHHHHHHHCCCCCC
Confidence 9999999999999999998864
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.77 E-value=3.8e-19 Score=166.02 Aligned_cols=104 Identities=19% Similarity=0.190 Sum_probs=81.4
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCC-----CCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID-----VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~-----~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~ 103 (387)
.+.|++.++..|+||||+||..|+.+++++|+++|++ +|.+|..|+||||+|+..|+.+++++|+++|++++.+|
T Consensus 162 ~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~~~~d 241 (364)
T 3ljn_A 162 LGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGIDVNMED 241 (364)
T ss_dssp HTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTTCCTTCCC
T ss_pred cCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCC
Confidence 3566666666777778888888888888888877777 77778888888888888888888888888888888888
Q ss_pred cCCCCccccccccchHHHHHHHHhhCCCC
Q 016544 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 104 ~~g~tpl~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
..|.||||+|+..|+.+++++|+++|+++
T Consensus 242 ~~g~tpL~~A~~~g~~~~v~~Ll~~~~~~ 270 (364)
T 3ljn_A 242 NEHTVPLYLSVRAAMVLLTKELLQKTDVF 270 (364)
T ss_dssp TTSCCHHHHHHHTCCHHHHHHHHHHSCHH
T ss_pred CCCCCHHHHHHHhChHHHHHHHHHcCCch
Confidence 88888888888888888888888877664
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=5.3e-19 Score=158.32 Aligned_cols=98 Identities=23% Similarity=0.285 Sum_probs=93.0
Q ss_pred CCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCC--------------CCCcHHHHHHHcCCHHHHHHHHH---CCCC
Q 016544 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI--------------DNRTALHVAACQGFTEVVSLLLE---RGAD 98 (387)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~--------------~g~t~Lh~A~~~~~~~~~~~Ll~---~ga~ 98 (387)
.+..|+||||+||..|+.+++++|+++|+++|.+|. .|+||||+|+..|+.+++++|++ +|++
T Consensus 97 ~d~~g~tpL~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad 176 (273)
T 2pnn_A 97 SYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPAD 176 (273)
T ss_dssp TTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBCSGGGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCCCC
T ss_pred ccCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCCCC
Confidence 456899999999999999999999999999999997 79999999999999999999999 9999
Q ss_pred CCCCCcCCCCccccccccch---------HHHHHHHHhhCCCCC
Q 016544 99 VDPKDRWGSTPLGDAIYYKN---------HEVIKLLEKHGAKPL 133 (387)
Q Consensus 99 ~~~~~~~g~tpl~~a~~~~~---------~~~~~~L~~~g~~~~ 133 (387)
++.+|..|.||||+|+..++ .+++++|++.|+++.
T Consensus 177 ~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n 220 (273)
T 2pnn_A 177 ISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLH 220 (273)
T ss_dssp TTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHC
T ss_pred ceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhcc
Confidence 99999999999999999887 799999999999875
|
| >4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=6.2e-19 Score=162.80 Aligned_cols=102 Identities=26% Similarity=0.348 Sum_probs=80.6
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHc-CCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~-g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
++.|++.++..|+||||+||..|+.++++.|+.. |+++|.+|.+|+||||+|+..|+.+++++|+++||++|.+
T Consensus 228 ~gad~n~~d~~g~t~L~~a~~~~~~~~v~~Ll~~~~~~vn~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~~----- 302 (337)
T 4g8k_A 228 HGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG----- 302 (337)
T ss_dssp TTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHTSTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHTTSCSSTTC-----
T ss_pred CCCCCCCcCCCCCCHHHHHHHhhhhHHHHHHHHhcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC-----
Confidence 4566677777788888888888888888888875 7888888888888888888888888888888888887654
Q ss_pred CccccccccchHHHHHHHHhhCCCCCCC
Q 016544 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~g~~~~~~ 135 (387)
||||+|+..++.+++++|+++||++...
T Consensus 303 ~~L~~A~~~~~~~iv~~Ll~~GA~~d~~ 330 (337)
T 4g8k_A 303 DLVMTARRNYDHSLVKVLLSHGAKEDFH 330 (337)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTTCCC---
T ss_pred CHHHHHHHcCCHHHHHHHHHCcCCCCCC
Confidence 4888888888888888888888887553
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.77 E-value=5.6e-19 Score=168.99 Aligned_cols=105 Identities=30% Similarity=0.350 Sum_probs=67.8
Q ss_pred CCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcc
Q 016544 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (387)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl 110 (387)
.+++..+..|+||||+||..|+.++|++|+++|+++|..|..|.||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus 5 ~~~~~~~~~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L 84 (437)
T 1n11_A 5 ISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPL 84 (437)
T ss_dssp ----------CCHHHHHHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHH
T ss_pred CCccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHH
Confidence 34444555566667777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred ccccccchHHHHHHHHhhCCCCCCC
Q 016544 111 GDAIYYKNHEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~g~~~~~~ 135 (387)
|+|+..|+.+++++|+++|+++...
T Consensus 85 ~~A~~~g~~~~v~~Ll~~ga~~~~~ 109 (437)
T 1n11_A 85 HCAARIGHTNMVKLLLENNANPNLA 109 (437)
T ss_dssp HHHHHHTCHHHHHHHHHHTCCTTCC
T ss_pred HHHHHCCCHHHHHHHHhCCCCCCCC
Confidence 7777777777777777777665443
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.8e-18 Score=155.07 Aligned_cols=107 Identities=28% Similarity=0.258 Sum_probs=96.6
Q ss_pred CCCCCCCCCCcchHHHHHHhhCC----HHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDR 104 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~----~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~~~~~ 104 (387)
+.+.+..+..|+||||+|+..++ .+++++|+++|+++|.+|..|+||||+|+..|+.+++++|++ .|++++.+|.
T Consensus 172 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~i~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~~~ 251 (285)
T 1wdy_A 172 GADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDS 251 (285)
T ss_dssp CCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCT
T ss_pred CCCCCccCCCCCCHHHHHHHccccchHHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhccCCCccccCC
Confidence 67777778888899999999998 899999999999999999999999999999999999999998 7999999999
Q ss_pred CCCCccccccccchHHHHHHHHhhCCCCCCCC
Q 016544 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 105 ~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~ 136 (387)
.|.||||+|+..++.+++++|+++|+++....
T Consensus 252 ~g~t~l~~A~~~~~~~i~~~Ll~~Ga~~~~~d 283 (285)
T 1wdy_A 252 DGKTALLLAVELKLKKIAELLCKRGASTDCGD 283 (285)
T ss_dssp TSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSS
T ss_pred CCCcHHHHHHHcCcHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999999999876543
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2e-18 Score=151.03 Aligned_cols=103 Identities=30% Similarity=0.271 Sum_probs=90.3
Q ss_pred CCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcc
Q 016544 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (387)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl 110 (387)
.|.+.++.+|.||||+||..|+.+++++|+++|++++..|..|+||||+|+..|+.+++++|+++|++++.++..|.|||
T Consensus 2 ~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L 81 (237)
T 3b7b_A 2 MNFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCL 81 (237)
T ss_dssp CCCCCSSCCSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCCCCCCTTSCCHH
T ss_pred CCcccccCCCCCHHHHHHHcCcHHHHHHHHHcCCCcCccCCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCcHH
Confidence 35667777888889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHhhC-CCCC
Q 016544 111 GDAIYYKNHEVIKLLEKHG-AKPL 133 (387)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~g-~~~~ 133 (387)
|+|+..++.+++++|++.| +++.
T Consensus 82 ~~A~~~~~~~~~~~Ll~~~~~~~~ 105 (237)
T 3b7b_A 82 HLAAKKGHYEVVQYLLSNGQMDVN 105 (237)
T ss_dssp HHHHHTTCHHHHHHHHTTTCCCTT
T ss_pred HHHHHcCCHHHHHHHHhCCCCCcc
Confidence 9999999999999999887 4443
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D | Back alignment and structure |
|---|
Probab=99.77 E-value=9.3e-19 Score=157.03 Aligned_cols=64 Identities=20% Similarity=0.186 Sum_probs=37.8
Q ss_pred CCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCC
Q 016544 34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA 97 (387)
Q Consensus 34 ~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga 97 (387)
+.++..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|+
T Consensus 39 ~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~ 102 (282)
T 1oy3_D 39 DLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRP 102 (282)
T ss_dssp GCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHHHHTTTTCHHHHHHHSSSCC
T ss_pred cccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCcchhHhhhccCC
Confidence 3444455566666666666666666666666666666556666666555555555555555543
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-18 Score=150.37 Aligned_cols=99 Identities=26% Similarity=0.281 Sum_probs=66.5
Q ss_pred CCCCcchHHHHHHhhCCHHHHHHHHHcC--CCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccc
Q 016544 36 EEIKPEFRLMFLANERDVEGIKELLDSG--IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (387)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~g--~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a 113 (387)
.+..|+||||+|+..|+.+++++|+++| ++++.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||||+|
T Consensus 68 ~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A 147 (228)
T 2dzn_A 68 PDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRA 147 (228)
T ss_dssp CCTTSCCHHHHHHHHCCHHHHHHHHSSSSCCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHhCCCCcccccCCcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHH
Confidence 4455666666666666666666666666 66666666666777776666666666766666666666666666777766
Q ss_pred cccchHHHHHHHHhhC-CCCCC
Q 016544 114 IYYKNHEVIKLLEKHG-AKPLM 134 (387)
Q Consensus 114 ~~~~~~~~~~~L~~~g-~~~~~ 134 (387)
+..++.+++++|++.| +++..
T Consensus 148 ~~~~~~~~v~~Ll~~g~~~~~~ 169 (228)
T 2dzn_A 148 ASVGSLKLIELLCGLGKSAVNW 169 (228)
T ss_dssp HHTTCHHHHHHHHTTTCCCSCC
T ss_pred HHcCCHHHHHHHHhcCcccccC
Confidence 6666666666666666 55443
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.9e-19 Score=165.26 Aligned_cols=108 Identities=19% Similarity=0.145 Sum_probs=99.9
Q ss_pred CCCCCCCCcchHHHHHHhhC--CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCC-----CCCCCc
Q 016544 32 DDDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD-----VDPKDR 104 (387)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~~~--~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~-----~~~~~~ 104 (387)
+.+..+..|.||||+||..| +.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++ ++.+|.
T Consensus 130 ~~~~~~~~g~t~L~~A~~~g~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~ 209 (364)
T 3ljn_A 130 GSHVKHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANK 209 (364)
T ss_dssp TTEEEEESCCCHHHHHHHSCGGGHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCT
T ss_pred ccccCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCC
Confidence 34447778999999999999 99999999999999999999999999999999999999999999999 999999
Q ss_pred CCCCccccccccchHHHHHHHHhhCCCCCCCCccc
Q 016544 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV 139 (387)
Q Consensus 105 ~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~ 139 (387)
.|.||||+|+..|+.+++++|+++|+++.......
T Consensus 210 ~g~t~L~~A~~~g~~~~v~~Ll~~gad~~~~d~~g 244 (364)
T 3ljn_A 210 QGNSHLHWAILINWEDVAMRFVEMGIDVNMEDNEH 244 (364)
T ss_dssp TCCCTTHHHHTTTCHHHHHHHHTTTCCTTCCCTTS
T ss_pred CCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCC
Confidence 99999999999999999999999999986654433
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.8e-18 Score=156.01 Aligned_cols=107 Identities=24% Similarity=0.185 Sum_probs=99.2
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|.+.++..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++..+ .|.|
T Consensus 81 ~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~-~g~t 159 (285)
T 3d9h_A 81 QGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPES-DLAS 159 (285)
T ss_dssp TTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCSC-TTSC
T ss_pred CCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCHHHHHHHHHHCCCCCCCCC-CCCC
Confidence 467788888899999999999999999999999999999999999999999999999999999999999998755 4999
Q ss_pred ccccccccchHHHHHHHHhhCCCCCCCC
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~~~~~ 136 (387)
|||+|+..++.+++++|++.|+++....
T Consensus 160 ~L~~A~~~g~~~~v~~Ll~~g~~~~~~d 187 (285)
T 3d9h_A 160 PIHEAARRGHVECVNSLIAYGGNIDHKI 187 (285)
T ss_dssp HHHHHHHHTCHHHHHHHHHTTCCTTCCB
T ss_pred HHHHHHHcCCHHHHHHHHHCCCCCCCcC
Confidence 9999999999999999999998875543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=155.03 Aligned_cols=135 Identities=21% Similarity=0.215 Sum_probs=101.5
Q ss_pred cccceeecccEEEEEEE-----cCeE--EEEEEcCcccCCC---------------------HHHHHHHHHHHHHHHcCC
Q 016544 157 FTNSVEITKGTFILAFW-----RGIQ--VAVKKLGEEVISD---------------------DDRVRAFRDELALLQKIR 208 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~-----~g~~--vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~ 208 (387)
|.....||.|+||.||. +|.. ||||+++...... ......+.+|+.+++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 34557899999988762 6888 9999876432111 112246788999999998
Q ss_pred CCcc--eeeeeEEeeCCceEEEEEccCC-C----CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH-hCCCCCeEeCCCC
Q 016544 209 HPNV--VQFLGAVTQSSPMMIVTEYLPK-G----DLRAFLKRKGALKPSTAVRFALDIARGMNYLH-ENKPVPIIHRDLE 280 (387)
Q Consensus 209 h~~i--v~l~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~~~~iiH~Dlk 280 (387)
|+++ +.+++. ...++||||+.+ | +|.++... .++..+..++.|++.+|.||| +.+ |+|||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE---LVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCC
Confidence 8764 444432 357899999932 3 77766433 235577889999999999999 888 9999999
Q ss_pred CCCEEeCCCCCEEEEeecCcccc
Q 016544 281 PSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 281 p~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
|+|||++. .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 8999999998653
|
| >4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=9.4e-19 Score=157.07 Aligned_cols=107 Identities=26% Similarity=0.266 Sum_probs=84.4
Q ss_pred CCCCCcchHHHHHHhhCCHHHHHHHHHcCC-CCCCC--------------------------------------CCCCCc
Q 016544 35 GEEIKPEFRLMFLANERDVEGIKELLDSGI-DVNFR--------------------------------------DIDNRT 75 (387)
Q Consensus 35 ~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~-~~n~~--------------------------------------d~~g~t 75 (387)
..|.+|+||||+||..|+.+++++|++.|+ ++|.. |..|+|
T Consensus 106 ~~d~~g~T~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~a~~~~~~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 185 (276)
T 4hbd_A 106 IADSNGNTALHYSVSHANFPVVQQLLDSGVCKVDKQNRAGYSPIMLTALATLKTQDDIETVLQLFRLGNINAKASQAGQT 185 (276)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHGGGCCCCSHHHHHHHHHHHHHSCTTCCCTTTCCC
T ss_pred CCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCcCCCCCCCCCCHHHHHHHHHhhhhhhHHHHHHHHHcCCCccccCCCCCC
Confidence 344456666777777777777777777776 55544 455788
Q ss_pred HHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHHHHHHHh-hCCCCCCCCccccc
Q 016544 76 ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHVKH 141 (387)
Q Consensus 76 ~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~-~g~~~~~~~~~~~~ 141 (387)
|||+|+..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|++ .|+++........+
T Consensus 186 pLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~T 252 (276)
T 4hbd_A 186 ALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGST 252 (276)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTTSCC
T ss_pred HHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCCCCC
Confidence 8899999999999999999999999999999999999999999999999998 88887665544433
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.76 E-value=1.5e-18 Score=157.29 Aligned_cols=101 Identities=26% Similarity=0.378 Sum_probs=95.6
Q ss_pred CCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccccccc
Q 016544 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116 (387)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~ 116 (387)
+..|.||||+||..|+.+++++|+++|+++|..|.+|+||||+||..|+.+++++|+++|++++.+|..|.||||+|+..
T Consensus 37 ~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~ 116 (299)
T 1s70_B 37 KFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASC 116 (299)
T ss_dssp EECHHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHH
T ss_pred ccCCccHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHc
Confidence 45789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred chHHHHHHHHhhCCCCCCCCc
Q 016544 117 KNHEVIKLLEKHGAKPLMAPM 137 (387)
Q Consensus 117 ~~~~~~~~L~~~g~~~~~~~~ 137 (387)
|+.+++++|+++|+++.....
T Consensus 117 g~~~~v~~Ll~~g~~~~~~~~ 137 (299)
T 1s70_B 117 GYLDIAEYLISQGAHVGAVNS 137 (299)
T ss_dssp TCHHHHHHHHHTTCCTTCCCT
T ss_pred CCHHHHHHHHhCCCCCCCcCC
Confidence 999999999999998765543
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} | Back alignment and structure |
|---|
Probab=99.76 E-value=4.8e-19 Score=159.72 Aligned_cols=93 Identities=24% Similarity=0.208 Sum_probs=89.8
Q ss_pred cchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCC-CCccccccccch
Q 016544 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG-STPLGDAIYYKN 118 (387)
Q Consensus 40 g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g-~tpl~~a~~~~~ 118 (387)
|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..| .||||+|+..++
T Consensus 62 g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~~t~L~~A~~~~~ 141 (285)
T 3kea_A 62 NEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLND 141 (285)
T ss_dssp TCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCSSSGGGSHHHHHHHTTC
T ss_pred CCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCCCccCCCCCCCHHHHHHHcCC
Confidence 8999999999999999999999999999999999999999999999999999999999999999999 799999999999
Q ss_pred HHHHHHHHhhCCCC
Q 016544 119 HEVIKLLEKHGAKP 132 (387)
Q Consensus 119 ~~~~~~L~~~g~~~ 132 (387)
.+++++|+++|+++
T Consensus 142 ~~~v~~Ll~~g~~~ 155 (285)
T 3kea_A 142 VSIVSYFLSEIPST 155 (285)
T ss_dssp HHHHHHHHTTSCTT
T ss_pred HHHHHHHHhCCCcc
Confidence 99999999998764
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.76 E-value=1.6e-18 Score=162.44 Aligned_cols=97 Identities=24% Similarity=0.317 Sum_probs=91.4
Q ss_pred CCCCCcchHHHHHHhhCCHHHHHHHHHcC-CCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccc
Q 016544 35 GEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (387)
Q Consensus 35 ~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g-~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a 113 (387)
..+..|+||||+||..|+.+++++|+++| +++|.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|.|||++|
T Consensus 274 ~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~~~~~~n~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gad~~~~d~~g~t~l~~A 353 (373)
T 2fo1_E 274 SEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLA 353 (373)
T ss_dssp SSSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHHHHH
T ss_pred cccccCCCHHHHHHHhCCHHHHHHHHHhcCCCccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccCCCCCCCCHHHHH
Confidence 35668999999999999999999999885 99999999999999999999999999999999999999999999999999
Q ss_pred cccchHHHHHHHHhhCCC
Q 016544 114 IYYKNHEVIKLLEKHGAK 131 (387)
Q Consensus 114 ~~~~~~~~~~~L~~~g~~ 131 (387)
+..++.+++++|++++++
T Consensus 354 ~~~g~~~iv~~Ll~~~a~ 371 (373)
T 2fo1_E 354 QANNHHNIVDIFDRCRPE 371 (373)
T ss_dssp HHTTCHHHHHHHHTTC--
T ss_pred HHcCCHHHHHHHHhcCcc
Confidence 999999999999998865
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.75 E-value=4.6e-18 Score=152.44 Aligned_cols=106 Identities=26% Similarity=0.305 Sum_probs=98.2
Q ss_pred CCCCCCC-CCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 30 GLDDDGE-EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 30 ~~~~~~~-~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
+.+.+.. +..|+||||+||..|+.+++++|+++|++++.+|.+|.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus 28 g~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 107 (285)
T 1wdy_A 28 GANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYGFT 107 (285)
T ss_dssp TCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTCCB
T ss_pred CCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCcccCC
Confidence 4555555 667899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCCCCC
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~~~~ 135 (387)
|||+|+..++.+++++|++.|+++...
T Consensus 108 ~L~~A~~~~~~~~~~~Ll~~g~~~~~~ 134 (285)
T 1wdy_A 108 AFMEAAVYGKVKALKFLYKRGANVNLR 134 (285)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred HHHHHHHhCCHHHHHHHHHhCCCcccc
Confidence 999999999999999999999887544
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.74 E-value=7.9e-18 Score=155.70 Aligned_cols=111 Identities=25% Similarity=0.285 Sum_probs=101.1
Q ss_pred CCCCCCcchHHHHHHhh---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcc
Q 016544 34 DGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (387)
Q Consensus 34 ~~~~~~g~t~l~~a~~~---~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl 110 (387)
...+..|.||||+|+.. ++.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus 205 ~~~~~~~~t~L~~A~~~~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~t~L 284 (351)
T 3utm_A 205 FKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTAL 284 (351)
T ss_dssp CCCTTTCCCHHHHHHHCCSTTHHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHH
T ss_pred ccCCCCCCCHHHHHHHHhCccHHHHHHHHHHcCCCcCCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHH
Confidence 34566789999999999 558999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHhhCCCCCCCCccccccCC
Q 016544 111 GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE 144 (387)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~~~ 144 (387)
|+|+..++.+++++|+++|+++........++..
T Consensus 285 ~~A~~~~~~~~v~~Ll~~gad~~~~~~~g~tal~ 318 (351)
T 3utm_A 285 HRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQ 318 (351)
T ss_dssp HHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred HHHHHcCcHHHHHHHHHcCCCCCCcCCCCCChhh
Confidence 9999999999999999999998777665555443
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.72 E-value=1e-17 Score=157.02 Aligned_cols=106 Identities=25% Similarity=0.263 Sum_probs=99.8
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCC---CCCCCCCcC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG---ADVDPKDRW 105 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~g---a~~~~~~~~ 105 (387)
++.|++..+..|+||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++| ++++..|..
T Consensus 155 ~ga~vn~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~d~~ 234 (373)
T 2fo1_E 155 AGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRDFGMMVYMLNSTKLKGDIEELDRN 234 (373)
T ss_dssp TCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHTTSHHHHHTTSCCCTT
T ss_pred cCCCCcCCCCCCCCHHHHHHHcChHHHHHHHHHCCCCCcccCCCCCCHHHHHHHCCCHHHHHHHHhcCccccChhhcCCC
Confidence 46677777788999999999999999999999999999999999999999999999999999999998 899999999
Q ss_pred CCCccccccccc---hHHHHHHHHhhCCCCCC
Q 016544 106 GSTPLGDAIYYK---NHEVIKLLEKHGAKPLM 134 (387)
Q Consensus 106 g~tpl~~a~~~~---~~~~~~~L~~~g~~~~~ 134 (387)
|.||||+|+..+ +.+++++|++.|+++..
T Consensus 235 g~t~L~~A~~~~~~~~~~~v~~Ll~~g~~~~~ 266 (373)
T 2fo1_E 235 GMTALMIVAHNEGRDQVASAKLLVEKGAKVDY 266 (373)
T ss_dssp SCCHHHHHHHSCSTTHHHHHHHHHHHTCCSSC
T ss_pred CCCHHHHHHHhCCcchHHHHHHHHHCCCCccc
Confidence 999999999987 89999999999998765
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=3.1e-17 Score=143.23 Aligned_cols=108 Identities=23% Similarity=0.210 Sum_probs=97.1
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
.+.|.+..+..|.||||+|+..|+.+++++|+++|++++..+ ..|+||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus 31 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~ 110 (240)
T 3eu9_A 31 AGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGC 110 (240)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred cCCCcCCCCCCCCCHHHHHHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHHHcCCHHHHHHHHHcCCCCcccCCCCC
Confidence 456777777889999999999999999999999999998765 4499999999999999999999999999999999999
Q ss_pred CccccccccchHHHHHHHHhhCCCCCCCC
Q 016544 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~g~~~~~~~ 136 (387)
||||+|+..++.+++++|++.|+++....
T Consensus 111 t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~ 139 (240)
T 3eu9_A 111 SCIHLAAQFGHTSIVAYLIAKGQDVDMMD 139 (240)
T ss_dssp CHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred CHHHHHHHcCHHHHHHHHHhcCCCccccC
Confidence 99999999999999999999998875543
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.7e-17 Score=154.20 Aligned_cols=106 Identities=25% Similarity=0.297 Sum_probs=97.0
Q ss_pred CCCcchHHHHHHhh-CCHHHHHHHHHcCCCCCCCC--CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccc
Q 016544 37 EIKPEFRLMFLANE-RDVEGIKELLDSGIDVNFRD--IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (387)
Q Consensus 37 ~~~g~t~l~~a~~~-~~~~~~~~Ll~~g~~~n~~d--~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a 113 (387)
...+.||||+|+.. |+.++++.|+++|+|+|..| ..|+||||+|+..|+.+++++|+++|+++|.+|..|.||||+|
T Consensus 196 ~~~~~t~L~~Aa~~~g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A 275 (368)
T 3jue_A 196 SLHPGALLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHA 275 (368)
T ss_dssp -CCHHHHHHHHTSSSCCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred cCCCCcHHHHHHHccCCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHH
Confidence 34578999999999 99999999999999999998 8899999999999999999999999999999999999999999
Q ss_pred cccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 114 ~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
+..++.+++++|+++|+++........++
T Consensus 276 ~~~g~~~~v~~LL~~Gad~~~~d~~G~Tp 304 (368)
T 3jue_A 276 TILGHTGLACLFLKRGADLGARDSEGRDP 304 (368)
T ss_dssp HHHTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred HHcCcHHHHHHHHHCcCCCCCcCCCCCCH
Confidence 99999999999999999987655444333
|
| >4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=3.4e-17 Score=151.07 Aligned_cols=105 Identities=29% Similarity=0.267 Sum_probs=81.8
Q ss_pred CCCCCCCCCCcchHHHHHHhhCC----HHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHC-CCCCCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDR 104 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~----~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~-ga~~~~~~~ 104 (387)
+.|++..+..|.||||.++..++ ..++++|+++|+|+|.+|..|+||||+|+..|+.+++++|++. |++++.+|.
T Consensus 192 gad~n~~d~~g~t~l~~~~~~~~~~~~~~i~~lLl~~gad~n~~d~~g~t~L~~a~~~~~~~~v~~Ll~~~~~~vn~~d~ 271 (337)
T 4g8k_A 192 GADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDS 271 (337)
T ss_dssp CCCTTCCCTTSCCHHHHHHHHSCTTTHHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHTSTTCCTTCBCT
T ss_pred CCCcCccCCCCCcHHHHHHHHcCcccHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhhhhHHHHHHHHhcCCcccCcCC
Confidence 45555555566666666555433 3466777777788888888888889999999999999888874 788999999
Q ss_pred CCCCccccccccchHHHHHHHHhhCCCCCC
Q 016544 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (387)
Q Consensus 105 ~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~ 134 (387)
.|.||||+|+..|+.+++++|+++|+++..
T Consensus 272 ~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~ 301 (337)
T 4g8k_A 272 DGKTALLLAVELKLKKIAELLCKRGASTDC 301 (337)
T ss_dssp TSCBHHHHHHHTTCHHHHHHHHTTSCSSTT
T ss_pred CCCCHHHHHHHcCCHHHHHHHHHCCCCCCC
Confidence 999999999999999999999999888754
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.7e-17 Score=142.11 Aligned_cols=105 Identities=26% Similarity=0.202 Sum_probs=59.2
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC-HHHHHHHHHCCCCCCCCCc-CCC
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-TEVVSLLLERGADVDPKDR-WGS 107 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~-~~~~~~Ll~~ga~~~~~~~-~g~ 107 (387)
+.+.+..+..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..++ .+++++|++.|++++..+. .|.
T Consensus 99 g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~~L~~~~~~~~~~~~~~g~ 178 (240)
T 3eu9_A 99 GADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKN 178 (240)
T ss_dssp TCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCSSTTHHHHHHTTCCTTCCCTTTCC
T ss_pred CCCCcccCCCCCCHHHHHHHcCHHHHHHHHHhcCCCccccCCCCCcHHHHHHHhCChHHHHHHHHhcCCCcchhhccCCC
Confidence 34444444455555555555555555555555555555555555555555554443 5555555555555555554 555
Q ss_pred CccccccccchHHHHHHHHhhCCCCCC
Q 016544 108 TPLGDAIYYKNHEVIKLLEKHGAKPLM 134 (387)
Q Consensus 108 tpl~~a~~~~~~~~~~~L~~~g~~~~~ 134 (387)
||||+|+..++.+++++|+++|+++..
T Consensus 179 t~L~~A~~~~~~~~v~~Ll~~g~~~~~ 205 (240)
T 3eu9_A 179 TALHWAVLAGNTTVISLLLEAGANVDA 205 (240)
T ss_dssp CHHHHHHHHTCHHHHHHHHHHTCCTTC
T ss_pred cHHHHHHHcCCHHHHHHHHHcCCCCCC
Confidence 666666666666666666666655543
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.69 E-value=1e-16 Score=118.73 Aligned_cols=70 Identities=41% Similarity=0.546 Sum_probs=66.1
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~ 98 (387)
++.|++.++..|+||||+|+..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++||+
T Consensus 24 ~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~~~~Ll~~ga~ 93 (93)
T 1n0q_A 24 AGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGAY 93 (93)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCC
T ss_pred cCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence 4667777788899999999999999999999999999999999999999999999999999999999985
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.5e-17 Score=128.49 Aligned_cols=82 Identities=33% Similarity=0.386 Sum_probs=75.0
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|.+..+..|+||||+||..|+.+++++|+++|++++.+|..|+||||+|+..++.+++++|+++|+++|.++..|.|
T Consensus 31 ~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~~~~~~~~~~Ll~~ga~~n~~~~~~~~ 110 (115)
T 2l6b_A 31 KGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADVNARSWGSSH 110 (115)
T ss_dssp TTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTSSSHHHHSCCCC-
T ss_pred cCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCccccc
Confidence 46677777888999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred cc
Q 016544 109 PL 110 (387)
Q Consensus 109 pl 110 (387)
|-
T Consensus 111 ~~ 112 (115)
T 2l6b_A 111 HH 112 (115)
T ss_dssp --
T ss_pred cc
Confidence 74
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-16 Score=155.12 Aligned_cols=104 Identities=25% Similarity=0.259 Sum_probs=95.1
Q ss_pred CcchHHHHHHhhCCHHHHHHHHHcCCCCCCC------CCCCCcHHHHHHH---cCCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAAC---QGFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~------d~~g~t~Lh~A~~---~~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
...+.||.|+..|+.++++.|+++|+|+|.. |..|+||||+||. .|+.+++++|+++|+++|.+|..|.||
T Consensus 131 ~~~~~L~~A~~~g~~~~v~~ll~~g~~~n~~~~~~~~~~~g~t~Lh~A~~~a~~g~~~~v~~Ll~~ga~vn~~d~~g~Tp 210 (497)
T 3lvq_E 131 PEPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTA 210 (497)
T ss_dssp -CHHHHHHHHHHTCHHHHHHHHHTTCCSSSCBCCSSSCCSCBCHHHHHHHTCCTTTHHHHHHHHHHSCCTTCCCSSSCCH
T ss_pred ccHHHHHHHHhccCHHHHHHHHhhcccccCCCCCcccccccchHHHHHHHhcccccHHHHHHHHHcCCCCCccCCCCCcH
Confidence 3457899999999999999999999999988 8899999999976 999999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
||+|+..|+.+++++|+++|+++........++
T Consensus 211 Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp 243 (497)
T 3lvq_E 211 LHYAALYNQPDCLKLLLKGRALVGTVNEAGETA 243 (497)
T ss_dssp HHHHTTTTCHHHHHHHHHTCCCCSCCCTTCCCH
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 999999999999999999999987766554444
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-16 Score=144.73 Aligned_cols=104 Identities=24% Similarity=0.247 Sum_probs=94.8
Q ss_pred CcchHHHHHHhhCCHHHHHHHHHcCCCCCC------CCCCCCcHHHHHHHc---CCHHHHHHHHHCCCCCCCCCcCCCCc
Q 016544 39 KPEFRLMFLANERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWGSTP 109 (387)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~------~d~~g~t~Lh~A~~~---~~~~~~~~Ll~~ga~~~~~~~~g~tp 109 (387)
.+.++||.|+..|+.+.++.|++.|+|+|. .|..|+||||+|+.. |+.+++++|+++|+++|.+|..|.||
T Consensus 150 ~~~~~L~~A~~~g~~~~v~~ll~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~Tp 229 (301)
T 2b0o_E 150 PEPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTA 229 (301)
T ss_dssp -CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCH
T ss_pred chHHHHhhhhhccCHHHHHHHHhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCH
Confidence 456789999999999999999999999998 699999999999997 89999999999999999999999999
Q ss_pred cccccccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
||+|+..|+.+++++|+++|+++........++
T Consensus 230 Lh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~Tp 262 (301)
T 2b0o_E 230 LHYAALYNQPDCLKLLLKGRALVGTVNEAGETA 262 (301)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCCSCCCTTSCCH
T ss_pred HHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence 999999999999999999999987665444333
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 | Back alignment and structure |
|---|
Probab=99.66 E-value=2.7e-16 Score=141.02 Aligned_cols=105 Identities=24% Similarity=0.262 Sum_probs=94.8
Q ss_pred CCcchHHHHHHhhCCHHHHHHHHHcCCCCC------CCCCCCCcHHHHHHHc---CCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 38 IKPEFRLMFLANERDVEGIKELLDSGIDVN------FRDIDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 38 ~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n------~~d~~g~t~Lh~A~~~---~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
....++|+.|+..|+.+.++.+++.|++++ ..|..|+||||+|+.. |+.+++++|+++|+++|.+|..|.|
T Consensus 128 ~~~l~~l~~a~~~~d~~~~~~ll~~g~~~~~~~~l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~T 207 (278)
T 1dcq_A 128 AAKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGST 207 (278)
T ss_dssp HHHHHHHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCC
T ss_pred chhhhhhhhHhhhcccHHHHHHHHhhcchhhhccccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCC
Confidence 346789999999999999999999999954 4588999999999999 8999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
|||+|+..|+.+++++|+++|+++........++
T Consensus 208 pLh~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tp 241 (278)
T 1dcq_A 208 ALHYCCLTDNAECLKLLLRGKASIEIANESGETP 241 (278)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred HHHHHHHcCCHHHHHHHHHcCCCCCCccCCCCCH
Confidence 9999999999999999999999987665544443
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.65 E-value=1.3e-16 Score=146.56 Aligned_cols=86 Identities=23% Similarity=0.132 Sum_probs=77.0
Q ss_pred CCCCCCCCcchHHHHHHh----hCCHHHHHHHHHcCC-------------------------------------------
Q 016544 32 DDDGEEIKPEFRLMFLAN----ERDVEGIKELLDSGI------------------------------------------- 64 (387)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~----~~~~~~~~~Ll~~g~------------------------------------------- 64 (387)
+.+.++..|+||||+||. .|+.+++++|++.++
T Consensus 193 ~~~~~d~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~Ll 272 (327)
T 1sw6_A 193 CLILEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWII 272 (327)
T ss_dssp GGGEECTTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHH
T ss_pred cccCCCCCCCCHHHHHHHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHHH
Confidence 455666778899999999 899999999998743
Q ss_pred --CCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccc
Q 016544 65 --DVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK 117 (387)
Q Consensus 65 --~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~ 117 (387)
++|.+|..|+||||+|+..|+.+++++|+++||+++.+|..|.||||+|+..|
T Consensus 273 ~~~~n~~d~~G~TpLh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL~~A~~~g 327 (327)
T 1sw6_A 273 ANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGAGLE 327 (327)
T ss_dssp HHTTTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTCC--
T ss_pred HhCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHhcC
Confidence 68889999999999999999999999999999999999999999999998764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=9.6e-17 Score=148.38 Aligned_cols=135 Identities=17% Similarity=0.106 Sum_probs=94.6
Q ss_pred cccceeecccEEEEEEE----cCeEEEEEEcCcccCC--------------C-HHH----HHHHHHHHHHHHcCCCCcce
Q 016544 157 FTNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS--------------D-DDR----VRAFRDELALLQKIRHPNVV 213 (387)
Q Consensus 157 ~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~--------------~-~~~----~~~~~~E~~~l~~l~h~~iv 213 (387)
|.+...||.|+++.||. +|+.||||+++..... . ... .-....|...+.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 66778999999999984 5899999987643211 0 000 01123466677777555443
Q ss_pred eeeeEEeeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC--
Q 016544 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-- 291 (387)
Q Consensus 214 ~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-- 291 (387)
...-+.. ...+|||||++|++|.++. .......++.|++.+|.+||+.| ||||||||.|||+++++.
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSS
T ss_pred CCeeeec--cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcc
Confidence 2222211 2347999999998886532 22345678899999999999999 999999999999997763
Q ss_pred --------EEEEeecCccc
Q 016544 292 --------LKVADFGVSKL 302 (387)
Q Consensus 292 --------~kl~Dfg~~~~ 302 (387)
+.|+||+-+-.
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 89999996643
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 | Back alignment and structure |
|---|
Probab=99.56 E-value=1.1e-16 Score=149.22 Aligned_cols=90 Identities=16% Similarity=0.070 Sum_probs=51.3
Q ss_pred CcchHHHHHHhhCCHHHHHHHHHcCCCC---CCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCC--CCcCCCCccccc
Q 016544 39 KPEFRLMFLANERDVEGIKELLDSGIDV---NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP--KDRWGSTPLGDA 113 (387)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~~g~~~---n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~--~~~~g~tpl~~a 113 (387)
.|.||||+||..|+.++|++|+++|+|+ +..+.+ +||||+||..|+.+++++|+++|++++. .|..|.||||+|
T Consensus 127 ~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpLh~Aa~~G~~eiv~~Ll~~ga~~~~~~~d~~g~TpL~~A 205 (376)
T 2aja_A 127 ENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRWA 205 (376)
T ss_dssp HHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCHHHHHHHCCCHHHHHHHHHcCCccchhccCCCCCCHHHHH
Confidence 4555666666666666666666666541 222222 5666666666666666666666665554 555566666666
Q ss_pred c-ccchHHHHHHHHhhC
Q 016544 114 I-YYKNHEVIKLLEKHG 129 (387)
Q Consensus 114 ~-~~~~~~~~~~L~~~g 129 (387)
+ ..|+.+++++|++.|
T Consensus 206 a~~~G~~eiv~~Ll~~g 222 (376)
T 2aja_A 206 AVGRGHHNVINFLLDCP 222 (376)
T ss_dssp HSTTCCHHHHHHHTTSH
T ss_pred HHHCCCHHHHHHHHhCC
Confidence 6 666666666666544
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 | Back alignment and structure |
|---|
Probab=99.50 E-value=2e-15 Score=140.77 Aligned_cols=96 Identities=17% Similarity=0.027 Sum_probs=79.2
Q ss_pred CCCcchHHHHHHhhCCHHHHHHHHHcCCCC---CCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCC---CCCCcCCCCcc
Q 016544 37 EIKPEFRLMFLANERDVEGIKELLDSGIDV---NFRDIDNRTALHVAACQGFTEVVSLLLERGADV---DPKDRWGSTPL 110 (387)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~---n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~---~~~~~~g~tpl 110 (387)
+.+++||||+||..|+.++|++|+++|+.. +..|..|+||||+||..|+.+++++|+++|+++ +..+.. .|||
T Consensus 89 g~~~~T~Lh~Aa~~G~~e~v~~Ll~~ga~~~~~~~~~~~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpL 167 (376)
T 2aja_A 89 GIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAF 167 (376)
T ss_dssp TCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHH
T ss_pred CCCcCCHHHHHHHcCCHHHHHHHHHcCCcHHHHHHhccCCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCHH
Confidence 345679999999999999999999999832 234556889999999999999999999999863 333333 8999
Q ss_pred ccccccchHHHHHHHHhhCCCCC
Q 016544 111 GDAIYYKNHEVIKLLEKHGAKPL 133 (387)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~g~~~~ 133 (387)
|+|+..|+.+++++|+++|+++.
T Consensus 168 h~Aa~~G~~eiv~~Ll~~ga~~~ 190 (376)
T 2aja_A 168 RLAAENGHLHVLNRLCELAPTEA 190 (376)
T ss_dssp HHHHHTTCHHHHHHHHHSCGGGH
T ss_pred HHHHHCCCHHHHHHHHHcCCccc
Confidence 99999999999999999998854
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1.6e-13 Score=104.80 Aligned_cols=64 Identities=27% Similarity=0.368 Sum_probs=60.2
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHH
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLL 92 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~L 92 (387)
++.|++.++..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|
T Consensus 46 ~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L 109 (110)
T 2zgd_A 46 NGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDISIDNGNEDLAEIL 109 (110)
T ss_dssp TTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHH
T ss_pred cCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcHHHHHHHcCCHHHHHHh
Confidence 4667777788899999999999999999999999999999999999999999999999999987
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=3.2e-11 Score=106.84 Aligned_cols=125 Identities=13% Similarity=0.024 Sum_probs=94.8
Q ss_pred EEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEEccCCCCHHHHHHHcCCCC
Q 016544 170 LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK 248 (387)
Q Consensus 170 ~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~ 248 (387)
.+...+..+++|......... ...+.+|+.+++.+. +..++++++++...+..|+||||++|.+|.+.+. +
T Consensus 32 ~~~~~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~ 103 (263)
T 3tm0_A 32 KLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----D 103 (263)
T ss_dssp EEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----T
T ss_pred EEECCCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----C
Confidence 334457899999987532111 135788999999884 6778899999998889999999999999886521 1
Q ss_pred hHHHHHHHHHHHHHHHHHHhCC--------------------------------------------------------CC
Q 016544 249 PSTAVRFALDIARGMNYLHENK--------------------------------------------------------PV 272 (387)
Q Consensus 249 ~~~~~~i~~qi~~~l~~LH~~~--------------------------------------------------------~~ 272 (387)
......++.+++++|..||+.. +.
T Consensus 104 ~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~ 183 (263)
T 3tm0_A 104 EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEEL 183 (263)
T ss_dssp TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCE
T ss_pred cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCc
Confidence 2234478889999999999821 13
Q ss_pred CeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 273 ~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
.++|+|++|.||+++.+..+.|+||+.+..
T Consensus 184 ~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred eEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 489999999999998765567999997643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.07 E-value=2.3e-10 Score=103.64 Aligned_cols=185 Identities=17% Similarity=0.117 Sum_probs=122.2
Q ss_pred eecccEEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCc--ceeeeeEEeeCC---ceEEEEEccCCC
Q 016544 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPN--VVQFLGAVTQSS---PMMIVTEYLPKG 235 (387)
Q Consensus 162 ~lg~G~~~~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~--iv~l~~~~~~~~---~~~lv~e~~~~~ 235 (387)
.++.|....++.-+..+++|.... ......+.+|..+++.+ .+.. +++++....... ..|+||++++|.
T Consensus 27 ~~~~G~~n~v~~v~~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~ 101 (304)
T 3sg8_A 27 ISGEGNDCIAYEINRDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV 101 (304)
T ss_dssp EEEECSSEEEEESTTSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred ecCCCCcceEEEECCEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence 477888777887778899998653 24456788999999887 3333 455555544333 358899999998
Q ss_pred CHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 016544 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK--------------------------------------------- 270 (387)
Q Consensus 236 sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------------- 270 (387)
+|...... .++..+...++.+++..+..||+..
T Consensus 102 ~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 179 (304)
T 3sg8_A 102 PLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD 179 (304)
T ss_dssp ECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred ECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence 88654332 3677788888888888888888621
Q ss_pred ----------CCCeEeCCCCCCCEEeCC--CCCEEEEeecCccccccCCCCCcccCCCCCcccccccccC-----CCC--
Q 016544 271 ----------PVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEY-- 331 (387)
Q Consensus 271 ----------~~~iiH~Dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~-- 331 (387)
+..++|+|++|.||+++. ...+.|+||+.+.......+.... .....-..|+.... +..
T Consensus 180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~--~~~~~~~~~~~~~~~l~~Y~~~~~ 257 (304)
T 3sg8_A 180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISL--MEDDEEYGMEFVSKILNHYKHKDI 257 (304)
T ss_dssp HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTT--CCTTTSCCHHHHHHHHHHHTCSCH
T ss_pred HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHH--HhhccccCHHHHHHHHHHcCCCCc
Confidence 234899999999999998 456789999987653221110000 00000012221110 011
Q ss_pred -------CCchhHHHHHHHHHHHHcCCCCCC
Q 016544 332 -------DTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 332 -------~~~~Dv~slG~il~elltg~~pf~ 355 (387)
....+.|+++.++|.+.+|..+|.
T Consensus 258 ~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 258 PTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 112589999999999999998874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.02 E-value=8.9e-10 Score=102.23 Aligned_cols=138 Identities=14% Similarity=0.182 Sum_probs=97.9
Q ss_pred eecccEEE---EEEEcCeEEEEEEcC--cccCCCHHHHHHHHHHHHHHHcCC--CCcceeeeeEEeeC---CceEEEEEc
Q 016544 162 EITKGTFI---LAFWRGIQVAVKKLG--EEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQS---SPMMIVTEY 231 (387)
Q Consensus 162 ~lg~G~~~---~v~~~g~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~---~~~~lv~e~ 231 (387)
.++.|.+. .+...+..+++|+.. .... ......+.+|..+++.+. +..+++++.++.+. +..|+||||
T Consensus 45 ~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 45 QFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp ECCC-CCSCEEEEECSSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EcCCcccceEEEEEECCceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 45555543 334457789999876 3221 112346788999999986 45688899988776 458999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK----------------------------------------- 270 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------- 270 (387)
++|.++.+. ....++..+...++.++++.|..||+..
T Consensus 123 v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (359)
T 3dxp_A 123 VSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSL 200 (359)
T ss_dssp CCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHH
T ss_pred cCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHH
Confidence 998777431 1123677888889999999999999831
Q ss_pred --------------CCCeEeCCCCCCCEEeCCCCC--EEEEeecCcccc
Q 016544 271 --------------PVPIIHRDLEPSNILRDDSGN--LKVADFGVSKLL 303 (387)
Q Consensus 271 --------------~~~iiH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~ 303 (387)
+..++|+|+++.||+++.++. +.|+||+.+...
T Consensus 201 ~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 201 MDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 245999999999999997653 689999988653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.99 E-value=5.9e-10 Score=98.33 Aligned_cols=115 Identities=20% Similarity=0.163 Sum_probs=84.1
Q ss_pred cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCc--ceeeeeEEeeCCceEEEEEccCCCCHHHHHHHcCCCChHH
Q 016544 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251 (387)
Q Consensus 174 ~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~--iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~ 251 (387)
+|..+++|...... ...+..|+.+++.+.+.+ ++++++++...+..++||||++|.+|. .. ..+
T Consensus 43 ~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~~~--- 108 (264)
T 1nd4_A 43 GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---HLA--- 108 (264)
T ss_dssp TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---CCC---
T ss_pred CCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---cCC---
Confidence 35789999976431 134678999998885434 567888888888899999999998874 11 111
Q ss_pred HHHHHHHHHHHHHHHHhCC-------------------------------------------------------CCCeEe
Q 016544 252 AVRFALDIARGMNYLHENK-------------------------------------------------------PVPIIH 276 (387)
Q Consensus 252 ~~~i~~qi~~~l~~LH~~~-------------------------------------------------------~~~iiH 276 (387)
...++.+++..|..||+.. +..++|
T Consensus 109 ~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~H 188 (264)
T 1nd4_A 109 PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTH 188 (264)
T ss_dssp HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEEC
T ss_pred HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEEC
Confidence 2356677777777777643 123999
Q ss_pred CCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 277 RDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 277 ~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
+|++|.||+++.++.+.|+||+.+..
T Consensus 189 gDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 189 GDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp SSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999998766667999998654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=4.8e-07 Score=81.76 Aligned_cols=136 Identities=18% Similarity=0.147 Sum_probs=93.1
Q ss_pred eecccEEEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCC---cceeeeeEEe-eCCceEEEEEccCCCCH
Q 016544 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP---NVVQFLGAVT-QSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 162 ~lg~G~~~~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---~iv~l~~~~~-~~~~~~lv~e~~~~~sL 237 (387)
.++.|....++.-|..+++|+.. .......+..|..+++.+.+. .+++++.++. ..+..+++||+++|.++
T Consensus 26 ~l~~G~~n~v~~vg~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 26 SLGEGFRNYAILVNGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp EEEECSSEEEEEETTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred ecCCCcceeEEEECCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 45666666666558889999853 234456789999999998642 3667777764 45567899999999888
Q ss_pred HHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC------------------------------------------------
Q 016544 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHEN------------------------------------------------ 269 (387)
Q Consensus 238 ~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~------------------------------------------------ 269 (387)
....-. .++..+...++.++...|..||+.
T Consensus 101 ~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 178 (306)
T 3tdw_A 101 GEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQS 178 (306)
T ss_dssp HHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHH
T ss_pred chhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHH
Confidence 663211 234444555555555555555542
Q ss_pred ---------CCCCeEeCCCCCCCEEeCC---CCC-EEEEeecCccccc
Q 016544 270 ---------KPVPIIHRDLEPSNILRDD---SGN-LKVADFGVSKLLT 304 (387)
Q Consensus 270 ---------~~~~iiH~Dlkp~Nill~~---~~~-~kl~Dfg~~~~~~ 304 (387)
.+..++|+|++|.||+++. ++. +.|+||+.+....
T Consensus 179 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 179 YMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2234799999999999997 455 4899999876543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.7e-06 Score=76.45 Aligned_cols=119 Identities=14% Similarity=0.160 Sum_probs=87.8
Q ss_pred cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEEccCCCCHHHHHHHcCCCChHHH
Q 016544 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA 252 (387)
Q Consensus 174 ~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~ 252 (387)
.+..+++|..... ....+..|...++.+. +--++++++++.+.+..|+|||+++|.++.+..... ....
T Consensus 49 ~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~ 118 (272)
T 4gkh_A 49 NAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSG 118 (272)
T ss_dssp TCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGH
T ss_pred CCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHH
Confidence 3567999986432 3456788999998874 334788899999999999999999998887765542 2233
Q ss_pred HHHHHHHHHHHHHHHhC-------------------------------------------------------CCCCeEeC
Q 016544 253 VRFALDIARGMNYLHEN-------------------------------------------------------KPVPIIHR 277 (387)
Q Consensus 253 ~~i~~qi~~~l~~LH~~-------------------------------------------------------~~~~iiH~ 277 (387)
..+..++...|..||+. .+..++|+
T Consensus 119 ~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HG 198 (272)
T 4gkh_A 119 ENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHG 198 (272)
T ss_dssp HHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECS
T ss_pred HHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcC
Confidence 45666677777777741 11237999
Q ss_pred CCCCCCEEeCCCCCEEEEeecCccc
Q 016544 278 DLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 278 Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
|+.+.||+++.++.+-|+||+.+..
T Consensus 199 Dl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 199 DFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCeEEEECCeEEEEEECccccc
Confidence 9999999999877677999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=3.4e-06 Score=77.79 Aligned_cols=60 Identities=5% Similarity=0.017 Sum_probs=40.7
Q ss_pred CeEEEEEEcCccc---CCCHHHHHHHHHHHHHHHcCC-C--CcceeeeeEEeeC---CceEEEEEccCCCCH
Q 016544 175 GIQVAVKKLGEEV---ISDDDRVRAFRDELALLQKIR-H--PNVVQFLGAVTQS---SPMMIVTEYLPKGDL 237 (387)
Q Consensus 175 g~~vavK~~~~~~---~~~~~~~~~~~~E~~~l~~l~-h--~~iv~l~~~~~~~---~~~~lv~e~~~~~sL 237 (387)
+..+++|...... ... ...+..|+.+++.+. + -.+++++.++.+. +..|+|||+++|.++
T Consensus 52 ~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 52 QQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp EEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCC
T ss_pred CceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCCh
Confidence 6789999876432 100 134677888888774 3 3577888887655 357899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.0007 Score=61.56 Aligned_cols=31 Identities=19% Similarity=0.317 Sum_probs=27.3
Q ss_pred CCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 272 ~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
..++|+|+++.||+++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 4599999999999998778899999997754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=7.9e-05 Score=69.66 Aligned_cols=73 Identities=18% Similarity=0.135 Sum_probs=42.1
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccC-CCH---HHHHHHHHHHHHHHcCCC--C-cceeeeeEEeeCCceEEE
Q 016544 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVI-SDD---DRVRAFRDELALLQKIRH--P-NVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~h--~-~iv~l~~~~~~~~~~~lv 228 (387)
+.+|.|..+.++. .+..++||....... ..+ .....+..|..+++.+.. | .+++++.+ +....++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 3567776655542 457899998653211 000 112346678888887732 3 45566654 34556899
Q ss_pred EEccCCC
Q 016544 229 TEYLPKG 235 (387)
Q Consensus 229 ~e~~~~~ 235 (387)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.69 E-value=7.3e-05 Score=70.50 Aligned_cols=80 Identities=14% Similarity=0.073 Sum_probs=47.3
Q ss_pred CCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCCCC---CCchhHHHHHHHHHHH
Q 016544 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY---DTKVDVFSFALILQEM 347 (387)
Q Consensus 271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~Dv~slG~il~el 347 (387)
+..++|+|++|.|||++.++ +.++||+.+......-+.......-...|.+|+......- ....++.++...+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 34599999999999999876 9999999886543221111100000123566655432111 1134555777788877
Q ss_pred HcCC
Q 016544 348 IEGC 351 (387)
Q Consensus 348 ltg~ 351 (387)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7553
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00035 Score=62.90 Aligned_cols=71 Identities=21% Similarity=0.106 Sum_probs=51.5
Q ss_pred eeecccEEE---EEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC---CCcceeeeeEEeeCCceEEEEEccCC
Q 016544 161 VEITKGTFI---LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMIVTEYLPK 234 (387)
Q Consensus 161 ~~lg~G~~~---~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~iv~l~~~~~~~~~~~lv~e~~~~ 234 (387)
+.++.|... .+..++..+++|..... ....+..|...++.+. ...+++++.++...+..++||||+++
T Consensus 42 ~~l~gG~~n~~y~v~~~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDEVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEECCSSSSEEEEEESSSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred EEeCCccceeeeEEEECCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 345666543 33345778999987532 2456788988888873 35788999988888889999999998
Q ss_pred CCH
Q 016544 235 GDL 237 (387)
Q Consensus 235 ~sL 237 (387)
.++
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0018 Score=58.71 Aligned_cols=33 Identities=30% Similarity=0.423 Sum_probs=27.8
Q ss_pred CCCeEeCCCCCCCEEeCCC----CCEEEEeecCcccc
Q 016544 271 PVPIIHRDLEPSNILRDDS----GNLKVADFGVSKLL 303 (387)
Q Consensus 271 ~~~iiH~Dlkp~Nill~~~----~~~kl~Dfg~~~~~ 303 (387)
+..++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4459999999999999874 67899999987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0018 Score=57.85 Aligned_cols=31 Identities=26% Similarity=0.372 Sum_probs=25.6
Q ss_pred CCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
+..++|+|+.+.||+ ..++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 345899999999999 5566789999997754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0019 Score=58.20 Aligned_cols=44 Identities=25% Similarity=0.301 Sum_probs=31.8
Q ss_pred HHHHHHHHHhC----CCCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 259 IARGMNYLHEN----KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 259 i~~~l~~LH~~----~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
+...+..+.+. .+..++|+|+++.||+++.++.+.|+||+.+..
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 33445555532 234599999999999999875568999987754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0027 Score=58.66 Aligned_cols=120 Identities=22% Similarity=0.298 Sum_probs=71.5
Q ss_pred CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEEccCCCCHH-----------HH--
Q 016544 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLR-----------AF-- 240 (387)
Q Consensus 175 g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~-----------~~-- 240 (387)
+..+++|+..... .. .....+|..+++.+. +.-.+++++++.+ .+|+||++|.+|. .+
T Consensus 82 ~~~~vlR~~g~~~-~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~ 153 (379)
T 3feg_A 82 PREVLLRLYGAIL-QG---VDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIAT 153 (379)
T ss_dssp CSEEEEEECC----CC---HHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHH
T ss_pred CCeEEEEECCCcc-ch---HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHH
Confidence 4689999874321 11 244567888888874 3334677776653 3899999875432 11
Q ss_pred -HH---HcC-C----CC--hHHHHHHHHHHHH-------------------HHHHHH----hC-CCCCeEeCCCCCCCEE
Q 016544 241 -LK---RKG-A----LK--PSTAVRFALDIAR-------------------GMNYLH----EN-KPVPIIHRDLEPSNIL 285 (387)
Q Consensus 241 -l~---~~~-~----l~--~~~~~~i~~qi~~-------------------~l~~LH----~~-~~~~iiH~Dlkp~Nil 285 (387)
+. ... + .. +.+..++..++.. .+..|. .. .+..++|+|+.+.||+
T Consensus 154 ~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil 233 (379)
T 3feg_A 154 KMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNIL 233 (379)
T ss_dssp HHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEE
T ss_pred HHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEE
Confidence 11 110 1 11 2344445444321 223332 22 2346899999999999
Q ss_pred eCCC----CCEEEEeecCccc
Q 016544 286 RDDS----GNLKVADFGVSKL 302 (387)
Q Consensus 286 l~~~----~~~kl~Dfg~~~~ 302 (387)
++.+ +.+.++||..+..
T Consensus 234 ~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 234 LLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EESCC---CCEEECCCTTCEE
T ss_pred EcCCCCccCcEEEEecccCCc
Confidence 9876 6899999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.49 E-value=0.026 Score=49.79 Aligned_cols=70 Identities=19% Similarity=0.114 Sum_probs=44.6
Q ss_pred ceeecccEEEEEE----EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-C--CcceeeeeEEeeCCceEEEEEcc
Q 016544 160 SVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-H--PNVVQFLGAVTQSSPMMIVTEYL 232 (387)
Q Consensus 160 ~~~lg~G~~~~v~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~~iv~l~~~~~~~~~~~lv~e~~ 232 (387)
.+.+|.|....++ .+|+.|++|......... ...+..|+..|+.+. . --+++++++. .-+++|||+
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 3456766554444 368999999876443222 235778999988874 2 2355565542 347899999
Q ss_pred CCCC
Q 016544 233 PKGD 236 (387)
Q Consensus 233 ~~~s 236 (387)
+++.
T Consensus 93 ~~~~ 96 (288)
T 3f7w_A 93 DERP 96 (288)
T ss_dssp CCCC
T ss_pred cccC
Confidence 8754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.47 E-value=0.012 Score=52.98 Aligned_cols=30 Identities=23% Similarity=0.256 Sum_probs=25.4
Q ss_pred CCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
+..++|+|+++.||+++ + .+.|+||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 34589999999999999 4 899999987754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.32 E-value=0.0036 Score=58.98 Aligned_cols=53 Identities=11% Similarity=0.145 Sum_probs=34.0
Q ss_pred CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCc-ceeeeeEEeeCCceEEEEEccCCCC
Q 016544 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSSPMMIVTEYLPKGD 236 (387)
Q Consensus 175 g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~lv~e~~~~~s 236 (387)
+..+++|+.... .. ...+..|..+++.+...+ .+++++.+.. .+|+||++|.+
T Consensus 105 ~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~ 158 (429)
T 1nw1_A 105 PNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP 158 (429)
T ss_dssp CSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred CceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcc
Confidence 478999998532 11 134456888888874333 4677776542 38999997633
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.29 E-value=0.022 Score=51.69 Aligned_cols=33 Identities=18% Similarity=0.359 Sum_probs=28.1
Q ss_pred CCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
+..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 345999999999999998788999999877543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.28 E-value=0.021 Score=47.78 Aligned_cols=101 Identities=13% Similarity=0.086 Sum_probs=66.0
Q ss_pred CCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCcc
Q 016544 235 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312 (387)
Q Consensus 235 ~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 312 (387)
.||.++++. ..++++.++|.++.|.+.+|.-+-. ..+ ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~---~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP---RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC---CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC---CceecCCcceEEecCCceeccc-cccc-----------
Confidence 479999985 5679999999999999999887622 221 1223456889999999887653 1110
Q ss_pred cCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCC
Q 016544 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353 (387)
Q Consensus 313 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~p 353 (387)
.....+.+||... ...+.+.=|||||+++|..+--..|
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123466888764 3456788999999999998864433
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.72 E-value=0.045 Score=51.87 Aligned_cols=59 Identities=8% Similarity=-0.015 Sum_probs=35.8
Q ss_pred EEEEcC--eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcc-eeeeeEEeeCCceEEEEEccCCCC
Q 016544 170 LAFWRG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV-VQFLGAVTQSSPMMIVTEYLPKGD 236 (387)
Q Consensus 170 ~v~~~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-v~l~~~~~~~~~~~lv~e~~~~~s 236 (387)
.+...+ ..+++|+.......- . .-..|..+++.+...++ +++++.+. + .+|+||++|.+
T Consensus 126 ~v~~~~~~~~~vLRi~g~~~~~~---i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 126 KVKDMSKQAKYLIRLYGPKTDEI---I-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEETTTTEEEEEEEECC-CCSC---S-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEECCCCceEEEEECCCChhhh---c-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 344444 789999885432110 0 11468888888864444 67777763 2 35999998743
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.10 E-value=0.34 Score=40.40 Aligned_cols=115 Identities=11% Similarity=0.132 Sum_probs=76.6
Q ss_pred CCCcceeeeeEEeeCCceEEEEEccCC-CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 016544 208 RHPNVVQFLGAVTQSSPMMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (387)
Q Consensus 208 ~h~~iv~l~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill 286 (387)
.||++++. .+-..++.+.+.++.-+. -++.. ++ .++....++++.+|+....++++ =+|--|+|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 68888876 455556666665554431 23332 22 26788999999999988765554 4788999999999
Q ss_pred CCCCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 287 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
+.++.+++.-.|+... ++|. ..+...=+-.+=|++..+++++..|.
T Consensus 113 ~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999986665321 1221 11222223367788888999988885
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.88 E-value=1 Score=37.66 Aligned_cols=114 Identities=11% Similarity=0.117 Sum_probs=75.5
Q ss_pred CCCcceeeeeEEeeCCceEEEEEccCCC-CHHHHHHHcCCCChHHHHHHHHHHHHHHH-HHHhCCCCCeEeCCCCCCCEE
Q 016544 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMN-YLHENKPVPIIHRDLEPSNIL 285 (387)
Q Consensus 208 ~h~~iv~l~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~l~~~~~~~i~~qi~~~l~-~LH~~~~~~iiH~Dlkp~Nil 285 (387)
.||++ -..+-..++.+.+.++.-+++ ++. .++ .++..+.++++.+|+.... ++++ -+|--|+|+|++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~---~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR---KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH---TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH---hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 68888 344446667777767665333 344 333 3678899999999888766 4544 578899999999
Q ss_pred eCCCCCEEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 016544 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355 (387)
Q Consensus 286 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~ 355 (387)
++.++.+++.-.|+-.. ++|.- .+...=+-++=|++..++.++..|.
T Consensus 117 f~~~~~p~i~hRGi~~~------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 117 FNRALEPFFLHVGVKES------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp ECTTCCEEESCCEETTT------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EeCCCcEEEEEcCCccc------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999987775322 22211 1111122367777888888887774
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=88.63 E-value=0.16 Score=46.42 Aligned_cols=30 Identities=30% Similarity=0.557 Sum_probs=24.6
Q ss_pred CCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 272 ~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
..++|+|+++.|||++.++ +.|+||+.+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 4589999999999998654 89999987653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 387 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-51 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-47 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-45 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-42 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-40 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-40 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-32 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-26 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 1e-22 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-16 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 8e-15 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 5e-14 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 8e-13 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-12 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 1e-11 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 2e-20 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 3e-14 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 1e-09 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 2e-08 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 1e-07 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-18 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 4e-17 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 1e-11 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 1e-09 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 2e-06 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 0.002 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 9e-15 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 1e-11 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 8e-10 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 2e-06 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 2e-05 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 0.004 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 1e-14 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 6e-11 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 6e-10 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 3e-07 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 2e-13 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 6e-12 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 3e-10 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 3e-08 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 4e-13 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 2e-07 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 4e-07 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 9e-07 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 6e-13 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 8e-11 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 4e-08 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 5e-08 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 2e-04 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 8e-13 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 2e-12 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 3e-11 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 5e-08 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 6e-04 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 3e-12 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 6e-06 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 4e-12 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 4e-09 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 2e-05 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 0.002 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-11 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 1e-10 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 6e-09 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 2e-08 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 8e-10 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 2e-09 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 4e-08 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 2e-06 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 2e-06 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 4e-08 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 1e-06 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 8e-05 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 1e-07 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 2e-05 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 6e-05 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 2e-07 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 9e-05 | |
| d1ycsb1 | 130 | d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) | 7e-05 | |
| d1ycsb1 | 130 | d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) | 0.004 | |
| d1bi7b_ | 125 | d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma | 5e-04 | |
| d1bi7b_ | 125 | d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma | 0.003 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 2e-51
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 12/221 (5%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF E+ G + G+ +A K + E EL +L + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
+V F GA + I E++ G L LK+ G + + ++ + +G+ YL E
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
I+HRD++PSNIL + G +K+ DFGVS L D + Y++PE +
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGTH 179
Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
Y + D++S L L EM G P E+ + +
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 220
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-51
Identities = 69/234 (29%), Positives = 115/234 (49%), Gaps = 21/234 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
+ ++ EL I KG F +L +RG +VAVK I +D +AF E +++
Sbjct: 2 WALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVM 54
Query: 205 QKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIAR 261
++RH N+VQ LG + + + IVTEY+ KG L +L+ +G L ++F+LD+
Sbjct: 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
M YL N +HRDL N+L + KV+DFG++K + + ++
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWT 167
Query: 322 APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374
APE + +++ TK DV+SF ++L E+ G P+ +V +
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA 221
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 6e-51
Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 16/233 (6%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDEL 201
++ ++ DF + KG F LA + +A+K L + + R E+
Sbjct: 2 QWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 261
+ +RHPN+++ G ++ + ++ EY P G + L++ + ++A
Sbjct: 58 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 117
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
++Y H + +IHRD++P N+L +G LK+ADFG S T + Y+
Sbjct: 118 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYL 171
Query: 322 APEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374
PE+ + +D KVD++S ++ E + G PPF E K +R F
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR-ISRVEFTF 223
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-50
Identities = 62/239 (25%), Positives = 112/239 (46%), Gaps = 16/239 (6%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
++EI ++ I G+F W G VAVK L + +AF++E+ +
Sbjct: 2 DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQL-QAFKNEVGV 57
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
L+K RH N++ F+G T + IVT++ L L + + + A A+G
Sbjct: 58 LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYV 321
M+YLH IIHRDL+ +NI + +K+ DFG++ + + Q + S ++
Sbjct: 117 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 322 APEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
APEV + ++ Y + DV++F ++L E++ G P++ ++ + R
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 232
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-49
Identities = 51/232 (21%), Positives = 102/232 (43%), Gaps = 15/232 (6%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
D+ I G++ + G + K+L +++ ++ + E+ LL++++HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHP 63
Query: 211 NVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMN 264
N+V++ + ++ + IV EY GDL + + + + L +R + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 265 YLHENKPV--PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
H ++HRDL+P+N+ D N+K+ DFG++++L T Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT-PYYMS 182
Query: 323 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374
PE Y+ K D++S +L E+ PPFT E+ +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 234
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 4e-49
Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 17/238 (7%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELA 202
++ DP +L F++ EI G+F A VA+KK+ +++ + E+
Sbjct: 9 FKDDPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
LQK+RHPN +Q+ G + +V EY K L+ +G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
+ YLH + +IHRD++ NIL + G +K+ DFG + ++ P + ++A
Sbjct: 128 LAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMA 179
Query: 323 PEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
PEV +YD KVDV+S + E+ E PP + A + P ++
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-49
Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 19/243 (7%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELAL 203
+++P + + E+ G F A + + A K + + ++ + + E+ +
Sbjct: 7 DLNPED-FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDI 62
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
L HPN+V+ L A + + I+ E+ G + A + + + L S
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
+NYLH+NK IIHRDL+ NIL G++K+ADFGVS T + + + ++A
Sbjct: 123 LNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYWMA 178
Query: 323 PEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
PEV K+ YD K DV+S + L EM E PP + V A + P P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238
Query: 378 AKL 380
++
Sbjct: 239 SRW 241
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 4e-48
Identities = 68/236 (28%), Positives = 111/236 (47%), Gaps = 17/236 (7%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDEL 201
E+E+ L + G F + ++ +VAVK L + +S D F E
Sbjct: 6 DEWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----FLAEA 59
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS--TAVRFALDI 259
L+++++H +V+ VTQ P+ I+TEY+ G L FLK +K + + A I
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
A GM ++ E IHRDL +NIL D+ + K+ADFG+++L+ E +
Sbjct: 119 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF 374
+ APE + K DV+SF ++L E++ G P+ + EV + R
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 8e-48
Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 15/231 (6%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
IDP +L F E+ G F WR VA+K + E +S+D+ F +E ++
Sbjct: 1 IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
+ H +VQ G T+ P+ I+TEY+ G L +L+ + + + D+ M
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YL +HRDL N L +D G +KV+DFG+S+ + E R+ PE
Sbjct: 115 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171
Query: 325 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF 374
V ++ +K D+++F +++ E+ G P+ ++E + A R
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR 222
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-47
Identities = 60/226 (26%), Positives = 110/226 (48%), Gaps = 16/226 (7%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
EI +G+F ++VA +L + ++ +R R F++E +L+ ++HPN+V+F
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPNIVRFY 74
Query: 217 GA----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
+ V +++VTE + G L+ +LKR +K + I +G+ +LH P
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP- 133
Query: 273 PIIHRDLEPSNIL-RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY 331
PIIHRDL+ NI +G++K+ D G++ L K + ++APE+++ +Y
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEMYEE-KY 189
Query: 332 DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
D VDV++F + + EM P++ + P
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 235
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 3e-47
Identities = 71/231 (30%), Positives = 119/231 (51%), Gaps = 15/231 (6%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
IDP EL F EI G F L +W +VA+K + E +S++D F +E ++
Sbjct: 2 IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMM 55
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIARGMN 264
K+ HP +VQ G + +P+ +V E++ G L +L+ + L T + LD+ GM
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
YL E +IHRDL N L ++ +KV+DFG+++ + + T ++ +PE
Sbjct: 116 YLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 325 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF 374
VF Y +K DV+SF +++ E+ EG P+ + ++EV + + R
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 223
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 4e-47
Identities = 54/224 (24%), Positives = 105/224 (46%), Gaps = 13/224 (5%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I +G A G +VA++++ + + +E+ ++++ ++PN+V +L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ + +V EYL G L + + + + +LH N+ +IH
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ---VIH 139
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
RD++ NIL G++K+ DFG +T ++ + + + ++APEV + Y KVD
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 337 VFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380
++S ++ EMIEG PP+ ++ A P + P KL
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 9e-46
Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 12/236 (5%)
Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
P D+ + +G + LA R VAVK + + D + E+ + +
Sbjct: 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKM 59
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
+ H NVV+F G + + + EY G+L ++ + A RF + G+ YL
Sbjct: 60 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV-KEDRPLTCQDTSCRYVAPEV 325
H I HRD++P N+L D+ NLK++DFG++ + +R L + YVAPE+
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 326 FKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380
K E+ VDV+S ++L M+ G P+ D+ + ++ K+
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 2e-45
Identities = 48/213 (22%), Positives = 99/213 (46%), Gaps = 9/213 (4%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF + +G+F +LA + A+K L + I +++V E ++ ++ HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
V+ + Y G+L ++++ G+ + + +I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK- 127
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVFKNE 329
IIHRDL+P NIL ++ ++++ DFG +K+L+ + + YV+PE+ +
Sbjct: 128 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
D+++ I+ +++ G PPF ++ +
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 218
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 6e-45
Identities = 54/239 (22%), Positives = 101/239 (42%), Gaps = 18/239 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR----GIQVAVKKLGEEVISDDDRVRAFRD 199
+ + L + +E+ G F +R I VA+K L + ++
Sbjct: 2 KLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMR 58
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
E ++ ++ +P +V+ +G V Q+ +M+V E G L FL ++ + S
Sbjct: 59 EAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDT 316
++ GM YL E +HRDL N+L + K++DFG+SK L + +
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF 374
++ APE ++ ++ DV+S+ + + E + G P+ EV +R
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 8e-45
Identities = 57/235 (24%), Positives = 102/235 (43%), Gaps = 16/235 (6%)
Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR----GIQVAVKKLGEEVISDDDRVRAFRDELA 202
+D L + E+ G F +++ VAVK L E +D E
Sbjct: 3 LDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEAN 60
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
++Q++ +P +V+ +G + ++ M+V E G L +L++ +K + ++ G
Sbjct: 61 VMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 119
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRY 320
M YL E+ +HRDL N+L K++DFG+SK L E+ ++
Sbjct: 120 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF 374
APE ++ +K DV+SF +++ E G P+ +EV +R
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 231
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-44
Identities = 70/235 (29%), Positives = 109/235 (46%), Gaps = 17/235 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELA 202
+EI L ++ +G F + W +VA+K L +S + F E
Sbjct: 11 AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 64
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIA 260
+++K+RH +VQ V++ P+ IVTEY+ KG L FLK + L+ V A IA
Sbjct: 65 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 123
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
GM Y+ +HRDL +NIL ++ KVADFG+++L+ E ++
Sbjct: 124 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF 374
APE + K DV+SF ++L E+ +G P+ + EV R P
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 154 bits (391), Expect = 2e-44
Identities = 57/246 (23%), Positives = 105/246 (42%), Gaps = 25/246 (10%)
Query: 136 PMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISD 190
P+ +KH + Y+I E+ G F R G A K + SD
Sbjct: 16 PVEIKHDHVLDHYDIHE---------ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 66
Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKP 249
+ R E+ + +RHP +V A + M+++ E++ G+L + +
Sbjct: 67 KET---VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 123
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKE 307
AV + + +G+ ++HEN +H DL+P NI+ S LK+ DFG++ L K+
Sbjct: 124 DEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180
Query: 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367
+T + APEV + + D++S ++ ++ G PF ++D+E +
Sbjct: 181 SVKVTTGT--AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238
Query: 368 ARQRPP 373
+
Sbjct: 239 SCDWNM 244
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (381), Expect = 2e-43
Identities = 64/239 (26%), Positives = 112/239 (46%), Gaps = 17/239 (7%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
++E++ ++ + ++ G + W+ + VAVK L E D V F
Sbjct: 8 NYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFL 61
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL--KRKGALKPSTAVRFA 256
E A++++I+HPN+VQ LG T+ P I+TE++ G+L +L + + + A
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
I+ M YL + IHRDL N L ++ +KVADFG+S+L+T
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF 374
++ APE ++ K DV++F ++L E+ G P+ ++V + R
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 237
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-43
Identities = 60/244 (24%), Positives = 99/244 (40%), Gaps = 26/244 (10%)
Query: 162 EITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
I KG F WRG +VAVK S ++R E+ +RH N++ F+ A
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV-- 272
+ + + +V++Y G L +L R + ++ AL A G+ +LH
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 273 ---PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVF 326
I HRDL+ NIL +G +AD G++ D + RY+APEV
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 327 ------KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380
K+ E + D+++ L+ E+ C + D ++P P + K+
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 381 YARG 384
Sbjct: 245 VCEQ 248
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-43
Identities = 66/266 (24%), Positives = 108/266 (40%), Gaps = 44/266 (16%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG-------IQVAVKKLGEEVISDDDRVR 195
++E L+F + G F + A G IQVAVK L E+ +D
Sbjct: 30 LKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSERE 85
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
A EL ++ ++ H N+V LGA T S P+ ++ EY GDL +L+ K
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145
Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
L + FA +A+GM +L +HRDL N+L
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKV 202
Query: 292 LKVADFGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-E 349
+K+ DFG+++ + + + +++APE Y K DV+S+ ++L E+
Sbjct: 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262
Query: 350 GCPPFT-MKHDNEVPKAYAARQRPPF 374
G P+ + D K +
Sbjct: 263 GVNPYPGIPVDANFYKLIQNGFKMDQ 288
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (380), Expect = 3e-43
Identities = 57/220 (25%), Positives = 104/220 (47%), Gaps = 15/220 (6%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G F ILA + VA+K + ++ + + + + +E+A+L KI+HPN+V
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ ++ + + G+L + KG A R + + YLH+ I+H
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVH 130
Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
RDL+P N+L D+ + ++DFG+SK+ L+ + YVAPEV + Y
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPYSK 188
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373
VD +S +I ++ G PPF ++D ++ + +
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF 228
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-43
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 10/213 (4%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK-IRH 209
DF + KG+F LA ++ A+K L ++V+ DD V E +L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
P + + V EYL GDL ++ S A +A +I G+ +LH
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
I++RDL+ NIL D G++K+ADFG+ K + + + T T Y+APE+ +
Sbjct: 123 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT-PDYIAPEILLGQ 178
Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
+Y+ VD +SF ++L EM+ G PF + + E+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 211
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-43
Identities = 55/238 (23%), Positives = 110/238 (46%), Gaps = 18/238 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR-----GIQVAVKKLGEEVISDDDRVRAFR 198
+YEI ++ I +G F + + VA+K + + D F
Sbjct: 1 DYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFL 56
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
E +++ HP++V+ +G +T++ P+ I+ E G+LR+FL RK +L ++ + +A
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
++ + YL + +HRD+ N+L + +K+ DFG+S+ + +
Sbjct: 116 QLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF 374
+++APE + + DV+ F + + E++ G PF +N+V +R P
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 230
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 150 bits (381), Expect = 7e-43
Identities = 40/220 (18%), Positives = 91/220 (41%), Gaps = 16/220 (7%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
E+ G F + G K + D ++E++++ ++ HP ++
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPKLINLH 92
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPII 275
A M+++ E+L G+L + + + + + + G+ ++HE+ I+
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IV 149
Query: 276 HRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
H D++P NI+ + ++K+ DFG++ L D + + + APE+ E
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGF 207
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373
D+++ ++ ++ G PF + D E +
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 247
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 4e-42
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 8/217 (3%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
+G + + + VAVK L +V+S + + F E+ + + H N+++ G V + P
Sbjct: 26 RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPP 84
Query: 225 MMIVTEYLPKGDLRAF-LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
M +VTE P G L K +G T R+A+ +A GM YL IHRDL N
Sbjct: 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARN 141
Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSFA 341
+L +K+ DFG+ + L +D + + + APE K + D + F
Sbjct: 142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 201
Query: 342 LILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
+ L EM G P+ + +++ +
Sbjct: 202 VTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 238
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (370), Expect = 7e-42
Identities = 68/240 (28%), Positives = 109/240 (45%), Gaps = 21/240 (8%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR-----GIQVAVKKLGEEVISDDDRVRAFRDE 200
EID + I G F + I VA+K L + + R F E
Sbjct: 22 EIDISCVKIEQ--VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSE 77
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDI 259
+++ + HPNV+ G VT+S+P+MI+TE++ G L +FL++ G V I
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI 137
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 318
A GM YL + +HRDL NIL + + KV+DFG+S+ L P
Sbjct: 138 AAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194
Query: 319 ---RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF 374
R+ APE + ++ + DV+S+ +++ E++ G P+ + +V A R P
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP 254
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 144 bits (363), Expect = 5e-41
Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 14/237 (5%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G LA VAVK L ++ D FR E + HP +V
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 217 GAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
+P IV EY+ LR + +G + P A+ D + +N+ H+N
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG-- 131
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT--SCRYVAPEVFKNEE 330
IIHRD++P+NI+ + +KV DFG+++ + + + +Y++PE + +
Sbjct: 132 -IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190
Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387
D + DV+S +L E++ G PPFT V + P A + + L
Sbjct: 191 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 247
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-40
Identities = 40/209 (19%), Positives = 87/209 (41%), Gaps = 17/209 (8%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
++ +G F K + + D+V + E+++L RH N++
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVL-VKKEISILNIARHRNILHLH 67
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPII 275
+ ++++ E++ D+ + L V + + + +LH + I
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IG 124
Query: 276 HRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
H D+ P NI+ S +K+ +FG ++ L K T+ Y APEV +++ T
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEV 362
D++S ++ ++ G PF + + ++
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQI 211
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 3e-40
Identities = 63/265 (23%), Positives = 101/265 (38%), Gaps = 37/265 (13%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR-------GIQVAVKKLGEEVISDDDRVR 195
++E + L F + G F + A + VAVK L +
Sbjct: 16 HKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTERE 71
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--------- 245
A EL +L + H N+V LGA T P +++TEY GDL FL+RK
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
AL + F+ +A+GM +L IHRDL NIL K+ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188
Query: 297 FGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
FG+++ + + + +++APE N Y + DV+S+ + L E+
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248
Query: 356 MKHDNEVPKAYAARQRPPFKAPAKL 380
+ ++ +P
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHA 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (357), Expect = 5e-40
Identities = 66/267 (24%), Positives = 109/267 (40%), Gaps = 43/267 (16%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF----------ILAFWRGIQVAVKKLGEEVISDDDR 193
++ E + +++ +I +G F +L + VAVK L EE + D
Sbjct: 4 KLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADM 59
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------- 245
F+ E AL+ + +PN+V+ LG PM ++ EY+ GDL FL+
Sbjct: 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 246 ----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
L + + A +A GM YL E K +HRDL N L ++
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGEN 176
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
+K+ADFG+S+ + + D R++ PE Y T+ DV+++ ++L E+
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 349 E-GCPPFTMKHDNEVPKAYAARQRPPF 374
G P+ EV
Sbjct: 237 SYGLQPYYGMAHEEVIYYVRDGNILAC 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 140 bits (354), Expect = 8e-40
Identities = 55/244 (22%), Positives = 100/244 (40%), Gaps = 23/244 (9%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIR-H 209
+ +G + + AVK + + A E+ +L+K+ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
PN++Q ++ +V + + KG+L +L K L + + + LH+
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 129
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
I+HRDL+P NIL DD N+K+ DFG S L L + Y+APE+ +
Sbjct: 130 N---IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEIIECS 184
Query: 330 E------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
Y +VD++S +I+ ++ G PPF + + + + Y+
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244
Query: 384 GLKE 387
+K+
Sbjct: 245 TVKD 248
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 142 bits (359), Expect = 1e-39
Identities = 52/234 (22%), Positives = 96/234 (41%), Gaps = 15/234 (6%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
DF+ I +G F G A+K L ++ I +E L+L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
P +V A + + + + GDL L + G + +A +I G+ ++H
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF- 326
+++RDL+P+NIL D+ G+++++D G++ + + Y+APEV
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASVGTHGYMAPEVLQ 178
Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380
K YD+ D FS +L +++ G PF + + + P
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 6e-39
Identities = 66/246 (26%), Positives = 113/246 (45%), Gaps = 19/246 (7%)
Query: 143 REVPEYEIDPHELDFTNSVEITKGTF---ILAFW-----RGIQVAVKKLGEEVISDDDRV 194
+ V I P L + I +G F + I AVK L I+D V
Sbjct: 15 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEV 72
Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLK-RKGALKPSTA 252
F E +++ HPNV+ LG +S ++V Y+ GDLR F++
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
+ F L +A+GM +L K +HRDL N + D+ +KVADFG+++ + KE +
Sbjct: 133 IGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189
Query: 313 CQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAA 368
+ + +++A E + +++ TK DV+SF ++L E++ G PP+ + ++
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 369 RQRPPF 374
+R
Sbjct: 250 GRRLLQ 255
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-39
Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 20/239 (8%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
EI P + I G F + + VA+K L + + F
Sbjct: 3 EIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLG 58
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD-LRAFLKRKGALKPSTAVRFALD 258
E ++ + H N+++ G +++ PMMI+TEY+ G + ++ G V
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-- 316
IA GM YL +HRDL NIL + + KV+DFG+S++L + T
Sbjct: 119 IAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF 374
R+ APE ++ + DV+SF +++ E++ G P+ ++EV KA R P
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT 234
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (350), Expect = 9e-39
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G+F L R G A+K L +E++ +V DE +L + HP +++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
G + + ++ +Y+ G+L + L++ A +A ++ + YLH II+
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIY 127
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
RDL+P NIL D +G++K+ DFG +K + + Y+APEV + Y+ +D
Sbjct: 128 RDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYNKSID 183
Query: 337 VFSFALILQEMIEGCPPFTMKHDNEV 362
+SF +++ EM+ G PF + +
Sbjct: 184 WWSFGILIYEMLAGYTPFYDSNTMKT 209
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-38
Identities = 53/230 (23%), Positives = 99/230 (43%), Gaps = 16/230 (6%)
Query: 156 DFTNSVEITKGTF---ILAFWR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
+F + G F W I VA+K+L E + + DE ++
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 67
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
+ +P+V + LG S+ +I L + K + + + + IA+GMNYL
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEV 325
+ + ++HRDL N+L ++K+ DFG++KLL +E +++A E
Sbjct: 128 EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 326 FKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF 374
+ Y + DV+S+ + + E++ G P+ +E+ +R P
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 234
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 5e-38
Identities = 67/251 (26%), Positives = 111/251 (44%), Gaps = 34/251 (13%)
Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFRDEL 201
+D +++ F + I +G F + A + + A+K++ + + D R F EL
Sbjct: 6 VLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGEL 61
Query: 202 ALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------------- 244
+L K+ HPN++ LGA + + EY P G+L FL++
Sbjct: 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 245 GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
L + FA D+ARGM+YL + IHRDL NIL ++ K+ADFG+S+
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-- 176
Query: 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 363
+ T R++A E Y T DV+S+ ++L E++ G P+ E+
Sbjct: 177 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236
Query: 364 KAYAARQRPPF 374
+ R
Sbjct: 237 EKLPQGYRLEK 247
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 6e-38
Identities = 67/260 (25%), Positives = 110/260 (42%), Gaps = 38/260 (14%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR---------GIQVAVKKLGEEVISDDDR 193
P +E+ L + +G F +LA +VAVK L + D
Sbjct: 6 PRWELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 61
Query: 194 VRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------- 245
+ E+ +++ I +H N++ LGA TQ P+ ++ EY KG+LR +L+ +
Sbjct: 62 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121
Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L V A +ARGM YL IHRDL N+L + +K+AD
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIAD 178
Query: 297 FGVSKLLTVKEDRPLT-CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPF 354
FG+++ + + T +++APE + Y + DV+SF ++L E+ G P+
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238
Query: 355 TMKHDNEVPKAYAARQRPPF 374
E+ K R
Sbjct: 239 PGVPVEELFKLLKEGHRMDK 258
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 9e-38
Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 17/224 (7%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDR---VRAFRDELALLQKIRHPNVV 213
E+ G F + G+Q A K + + R E+++L++I+HPNV+
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVP 273
+ ++++ E + G+L FL K +L A F I G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---Q 133
Query: 274 IIHRDLEPSNILRDDSG----NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
I H DL+P NI+ D +K+ DFG++ + + +VAPE+ E
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373
+ D++S +I ++ G PF E +A
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-37
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 10/218 (4%)
Query: 163 ITKGTF---ILAFWR--GIQVAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQF 215
+ +G F A + VA+KK+ G + D R E+ LLQ++ HPN++
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
L A S + +V +++ L PS + L +G+ YLH++ I+
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WIL 122
Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
HRDL+P+N+L D++G LK+ADFG++K T +F Y V
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 336 DVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373
D+++ IL E++ P D + P
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 220
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 7e-37
Identities = 56/250 (22%), Positives = 115/250 (46%), Gaps = 29/250 (11%)
Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
E+E+ ++ + E+ +G+F +G+ +VA+K + E +
Sbjct: 14 EWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIE 69
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------A 246
F +E +++++ +VV+ LG V+Q P +++ E + +GDL+++L+
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 247 LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
S ++ A +IA GM YL+ N +HRDL N + + +K+ DFG+++ +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
Query: 307 ED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC-PPFTMKHDNEVPK 364
+ R R+++PE K+ + T DV+SF ++L E+ P+ + +V +
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246
Query: 365 AYAARQRPPF 374
Sbjct: 247 FVMEGGLLDK 256
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-36
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 26/223 (11%)
Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
+ G + F + + A+K L D +A R+ + + P++V+ +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD 72
Query: 218 A----VTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKP 271
++IV E L G+L + ++ +G A A I + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN- 131
Query: 272 VPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
I HRD++P N+L + LK+ DFG +K T LT + YVAPEV
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGP 187
Query: 329 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
E+YD D++S +I+ ++ G PPF H + R R
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 230
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 5e-36
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 12/230 (5%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
DF + KGTF IL + G A+K L +EVI D V E +LQ RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
+ A + V EY G+L L R+ A + +I + YLH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 124
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
+++RD++ N++ D G++K+ DFG+ K + + + Y+APEV ++ +
Sbjct: 125 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAPEVLEDND 181
Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380
Y VD + +++ EM+ G PF + + + + P L
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELILMEEIRFPRTL 228
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (329), Expect = 2e-35
Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 12/206 (5%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G+F +L + G A+K L ++ + ++ +E +LQ + P +V+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ +S + +V EY+ G++ + L+R G A +A I YLH +I+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIY 164
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
RDL+P N+L D G ++V DFG +K + + +APE+ ++ Y+ VD
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVD 220
Query: 337 VFSFALILQEMIEGCPPFTMKHDNEV 362
++ +++ EM G PPF ++
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQI 246
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 3e-35
Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 21/218 (9%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I +GTF A R G +VA+KK+ E + + A R E+ +LQ ++H NVV +
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 75
Query: 217 GAVTQSSP--------MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
+ + +V ++ S R + G+ Y+H
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEV 325
NK I+HRD++ +N+L G LK+ADFG+++ ++ ++ Y PE+
Sbjct: 136 NK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 326 FKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
E +Y +D++ I+ EM P +
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 230
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 5e-35
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 21/217 (9%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRV---RAFRDELALLQKIR--HPN 211
+ G F + VA+K + ++ ISD + E+ LL+K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 212 VVQFLGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
V++ L + +++ E P DL F+ +GAL+ A F + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130
Query: 271 PVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
++HRD++ NIL D + G LK+ DFG LL +D T D + Y PE +
Sbjct: 131 ---VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYH 184
Query: 330 EYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365
Y + V+S ++L +M+ G PF +HD E+ +
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRG 219
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 127 bits (320), Expect = 8e-35
Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 8/205 (3%)
Query: 162 EITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
+I +GT+ A G A+KK+ E + R E+++L++++H N+V+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYD 67
Query: 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
+ +++V E+L + + +G L+ TA F L + G+ Y H+ + ++HR
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHR 124
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 337
DL+P N+L + G LK+ADFG+++ + + T + +++Y T +D+
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 338 FSFALILQEMIEGCPPFTMKHDNEV 362
+S I EM+ G P F + +
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQ 209
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-34
Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 26/226 (11%)
Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
P E+ +T++ I G+F A G VA+KK+ R EL +++K
Sbjct: 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRK 69
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKG---DLRAFLKRKGALKPSTAVRFAL 257
+ H N+V+ S + +V +Y+P+ R + + K L +
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
+ R + Y+H I HRD++P N+ L D+ LK+ DFG +K L V+ + ++ +
Sbjct: 130 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICS 185
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
+F +Y + +DV+S +L E++ G P F +
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (317), Expect = 3e-34
Identities = 39/239 (16%), Positives = 74/239 (30%), Gaps = 23/239 (9%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I G+F L G +VA+K + + E + + ++ + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 217 GAV-TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
+ ++V E L F T + A + + Y+H I
Sbjct: 69 RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FI 125
Query: 276 HRDLEPSNILRDDSG---NLKVADFGVSKLLTVKEDRPLTCQDT------SCRYVAPEVF 326
HRD++P N L + + DFG++K + RY +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385
E + D+ S +L G P+ + Y P ++ +G
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 3e-34
Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 21/238 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELA 202
+++ P +TN I +G + A+ ++VA+KK+ + E+
Sbjct: 4 FDVGPR---YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIK 58
Query: 203 LLQKIRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
+L + RH N++ + + + + +L DL LK + L F
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQ 117
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--T 316
I RG+ Y+H ++HRDL+PSN+L + + +LK+ DFG++++ D +
Sbjct: 118 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 317 SCRYVAPEVFKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373
+ Y APE+ N + T +D++S IL EM+ P F KH + P
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-33
Identities = 53/214 (24%), Positives = 103/214 (48%), Gaps = 12/214 (5%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
+F +I +GT+ A + G VA+KK+ + ++ A R E++LL+++ HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHEN 269
N+V+ L + + + +V E+L + + + + + +G+ + H +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
++HRDL+P N+L + G +K+ADFG+++ R T + + Y APE+
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILLGC 177
Query: 330 EY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
+Y T VD++S I EM+ F + +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 6e-33
Identities = 62/262 (23%), Positives = 104/262 (39%), Gaps = 34/262 (12%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDR 193
+ ++E L + +G F I A GI VAVK L E + R
Sbjct: 4 DASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 61
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTEYLPKGDLRAFLKRKG------- 245
+ L+ H NVV LGA T+ P+M++ E+ G+L +L+ K
Sbjct: 62 -ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
L + ++ +A+GM +L K IHRDL NIL + +K+ D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICD 177
Query: 297 FGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
FG+++ + D +++APE + Y + DV+SF ++L E+
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237
Query: 356 MKHDNEVPKAYAARQRPPFKAP 377
+ ++ +AP
Sbjct: 238 PGVKIDEEFCRRLKEGTRMRAP 259
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-32
Identities = 49/213 (23%), Positives = 93/213 (43%), Gaps = 7/213 (3%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRH-PNVVQFLGAVTQS 222
I G A+K L + I + R E +L+ IR P +V A
Sbjct: 42 LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101
Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
+ + ++ +Y+ G+L L ++ + +I + +LH+ II+RD++
Sbjct: 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLE 158
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSF 340
NIL D +G++ + DFG+SK E + Y+AP++ + + +D VD +S
Sbjct: 159 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218
Query: 341 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373
+++ E++ G PFT+ + + R
Sbjct: 219 GVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 3e-32
Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 19/230 (8%)
Query: 162 EITKGTF---ILAFWR---GIQVAVKKLGEEVISDDDRVRAFR--DELALLQKIRHPNVV 213
EI +G + A G VA+K++ + + + R L L+ HPNVV
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 214 QFLGAVTQSSP-----MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLH 267
+ T S + +V E++ + K + T + RG+++LH
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
++ ++HRDL+P NIL SG +K+ADFG++++ + + + Y APEV
Sbjct: 134 SHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLL 188
Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
Y T VD++S I EM P F D + P +
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (300), Expect = 6e-32
Identities = 48/205 (23%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+I +GT+ A R VA+K++ + + A R E+ LL++++H N+V+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLH 67
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
+ + +V E+ + + F G L P F + +G+ + H ++H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLH 124
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
RDL+P N+L + +G LK+A+FG+++ + T +F + Y T +D
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 337 VFSFALILQEMIEGCPPFTMKHDNE 361
++S I E+ P +D +
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVD 209
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 3e-30
Identities = 62/242 (25%), Positives = 97/242 (40%), Gaps = 26/242 (10%)
Query: 148 YEIDPHELDFTNSVEITK----GTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
E+ + + G + A G +VA+KKL S+ RA+R
Sbjct: 7 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 66
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEYLPKGDLRAFLKRKGALKPSTA 252
EL LL+ +RH NV+ L T + +V ++ G L + L
Sbjct: 67 -ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRI 123
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
+ +G+ Y+H IHRDL+P N+ ++ LK+ DFG+++ + D +T
Sbjct: 124 QFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMT 176
Query: 313 CQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
+ Y APEV N Y VD++S I+ EMI G F + K
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 372 PP 373
P
Sbjct: 237 TP 238
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 113 bits (283), Expect = 2e-29
Identities = 40/242 (16%), Positives = 74/242 (30%), Gaps = 23/242 (9%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
I +G+F QVA+K SD ++R LL V +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
G + ++V + L T A + + +HE +++
Sbjct: 70 G--QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVY 124
Query: 277 RDLEPSNIL-----RDDSGNLKVADFGVSKLLTVKEDRPLTCQDT------SCRYVAPEV 325
RD++P N L ++ + V DFG+ K + + RY++
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385
E + D+ + + + G P+ + Y P + G
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGF 244
Query: 386 KE 387
E
Sbjct: 245 PE 246
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (283), Expect = 4e-29
Identities = 46/239 (19%), Positives = 98/239 (41%), Gaps = 28/239 (11%)
Query: 137 MHVKHAREVPEYEIDPHELDFTNS------VEITKGTF---ILAFWR--GIQVAVKKLGE 185
V R ++ + H +++ N ++ +G + A +V VK L
Sbjct: 11 TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-- 68
Query: 186 EVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFLK 242
+ + + E+ +L+ +R PN++ V S +V E++ D + +
Sbjct: 69 ----KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSK 301
L + +I + ++Y H I+HRD++P N++ D + L++ D+G+++
Sbjct: 125 T---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178
Query: 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360
++ + + + + YD +D++S +L MI PF HDN
Sbjct: 179 FYHPGQEYNVRVA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 4e-26
Identities = 54/223 (24%), Positives = 85/223 (38%), Gaps = 20/223 (8%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
I G A+ VA+KKL + RA+R EL L++ + H N++ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLL 82
Query: 217 GAVTQSSPMM------IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
T + +V E + + + G+ +LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSA- 138
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
IIHRDL+PSNI+ LK+ DFG+++ T +T + Y APEV
Sbjct: 139 --GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373
Y VD++S I+ EM+ F + + + P
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 6e-26
Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 16/221 (7%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ G + AF G++VAVKKL S R +R EL LL+ ++H NV+ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 83
Query: 217 GAVTQSSPMMIVTEYL----PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
T + + + G + + L I RG+ Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 141
Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD 332
IIHRDL+PSN+ ++ LK+ DFG+++ +D T + Y+
Sbjct: 142 -IIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYN 197
Query: 333 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP 373
VD++S I+ E++ G F + K P
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (239), Expect = 1e-22
Identities = 36/145 (24%), Positives = 57/145 (39%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L + + +K LL G N ++ T LH+AA G TEV LL+ A V+ K
Sbjct: 4 LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKA 63
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEI 163
+ TPL A + ++KLL ++ A P +A + E + E
Sbjct: 64 KDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEA 123
Query: 164 TKGTFILAFWRGIQVAVKKLGEEVI 188
++ + + VA K V
Sbjct: 124 SQACMTKKGFTPLHVAAKYGKVRVA 148
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.1 bits (191), Expect = 2e-16
Identities = 33/119 (27%), Positives = 53/119 (44%)
Query: 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
+G+ D L ++ +++ +K LL DVN + + LH AA QG T++
Sbjct: 286 HGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDI 345
Query: 89 VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPE 147
V+LLL+ GA + G+TPL A V +L+ + + KH PE
Sbjct: 346 VTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSDKHRMSFPE 404
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.1 bits (178), Expect = 8e-15
Identities = 35/152 (23%), Positives = 56/152 (36%), Gaps = 12/152 (7%)
Query: 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK--- 131
T LHVA+ G +V LL+RGA + + TPL A + EV K L ++ AK
Sbjct: 2 TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNA 61
Query: 132 -------PLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLG 184
PL + H + + ++ + + + +A G V L
Sbjct: 62 KAKDDQTPLHCAARIGH-TNMVKLLLE-NNANPNLATTAGHTPLHIAAREGHVETVLALL 119
Query: 185 EEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
E+ S + L + K V + L
Sbjct: 120 EKEASQACMTKKGFTPLHVAAKYGKVRVAELL 151
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.4 bits (171), Expect = 5e-14
Identities = 46/217 (21%), Positives = 85/217 (39%), Gaps = 17/217 (7%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
+ + +G L A + VE + LL G N + T LH+AA +
Sbjct: 187 RGGSPHSPAWNGY-----TPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQE 241
Query: 84 GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PL 133
G E+V+LLL + A+ + ++ G TPL + V +L KHG PL
Sbjct: 242 GHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPL 301
Query: 134 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 193
H + + V +++ + + A +G V L + S ++
Sbjct: 302 HVASHYGNIKLVKFLLQHQADVNAKTKLGYS--PLHQAAQQGHTDIVTLLLKNGASPNEV 359
Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
LA+ +++ + +V L VT + ++V++
Sbjct: 360 SSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 396
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.9 bits (162), Expect = 8e-13
Identities = 41/182 (22%), Positives = 55/182 (30%), Gaps = 12/182 (6%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A V + LL+ N + T LHVA ++V LLL RG
Sbjct: 136 LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPA 195
Query: 104 RWGSTPLGDAIYYKNHEVIKLL----------EKHGAKPLMAPMHVKHAREVPEYEIDPH 153
G TPL A EV + L G PL HA V
Sbjct: 196 WNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQA 255
Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213
+ N +T L G L + + D R L + + +V
Sbjct: 256 NGNLGNKSGLT--PLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLV 313
Query: 214 QF 215
+F
Sbjct: 314 KF 315
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.2 bits (160), Expect = 2e-12
Identities = 36/143 (25%), Positives = 47/143 (32%), Gaps = 38/143 (26%)
Query: 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
++ A N + E L A E K LL + VN + D++T LH AA
Sbjct: 21 QRGASPNVSNVKVETP-----LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAAR 75
Query: 83 QGFTEVVSLLLER---------------------------------GADVDPKDRWGSTP 109
G T +V LLLE A + G TP
Sbjct: 76 IGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTP 135
Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
L A Y V +LL + A P
Sbjct: 136 LHVAAKYGKVRVAELLLERDAHP 158
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.5 bits (153), Expect = 1e-11
Identities = 40/164 (24%), Positives = 63/164 (38%), Gaps = 8/164 (4%)
Query: 61 DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
+ T LHVAA G V LLLER A + + G TPL A+++ N +
Sbjct: 120 EKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLD 179
Query: 121 VIKLLEKHGAKPL------MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGT--FILAF 172
++KLL G P P+H+ + E + + + E +G LA
Sbjct: 180 IVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAA 239
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
G V L + + + ++ L L+ + H V L
Sbjct: 240 QEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVL 283
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.1 bits (217), Expect = 2e-20
Identities = 30/112 (26%), Positives = 48/112 (42%), Gaps = 2/112 (1%)
Query: 22 ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
+ A++N D+ G + + LLD G DVN R +T L +A
Sbjct: 169 DEMGADVNACDNMGRNALIHAL-LSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAV 227
Query: 82 CQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+ +V LLE+ +++ D G T L A+ K ++ +LL K GA
Sbjct: 228 EKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAST 279
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.0 bits (170), Expect = 3e-14
Identities = 21/79 (26%), Positives = 39/79 (49%), Gaps = 6/79 (7%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
A++N + G+ L+ ++ + ++ LL+ I++N D D +TAL +A
Sbjct: 210 ADVNVRGERGKTP-----LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELK 264
Query: 85 FTEVVSLLLERGADVDPKD 103
++ LL +RGA D D
Sbjct: 265 LKKIAELLCKRGASTDCGD 283
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.9 bits (136), Expect = 1e-09
Identities = 20/72 (27%), Positives = 39/72 (54%), Gaps = 1/72 (1%)
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIYYKNHEVIKLLEKHG 129
+++ L A ++V LLE GA+V+ ++ G TPL +A+ ++++LL +HG
Sbjct: 3 VEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHG 62
Query: 130 AKPLMAPMHVKH 141
A P++ +
Sbjct: 63 ADPVLRKKNGAT 74
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.0 bits (126), Expect = 2e-08
Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 1/96 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPK 102
L+ DV+ +++LL+ G +VNF++ + T LH A ++V LLL GAD +
Sbjct: 9 LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLR 68
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
+ G+TP A + +++KL GA +
Sbjct: 69 KKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFY 104
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.3 bits (119), Expect = 1e-07
Identities = 24/72 (33%), Positives = 31/72 (43%), Gaps = 5/72 (6%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLL-ERGADVDPKDRWGSTPLGDAIYYKNH----E 120
TAL AA +G EV+ +LL E GADV+ D G L A+ +
Sbjct: 141 QERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEA 200
Query: 121 VIKLLEKHGAKP 132
+ LL HGA
Sbjct: 201 ITHLLLDHGADV 212
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 84.3 bits (207), Expect = 1e-18
Identities = 48/220 (21%), Positives = 83/220 (37%), Gaps = 37/220 (16%)
Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ-- 214
++ G F LA VA+K + D A DE+ LLQ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKED 75
Query: 215 -------------FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIA 260
F +++V E L + L K + P + + +
Sbjct: 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSG------NLKVADFGVSKLLTVKEDRPLTCQ 314
G++Y+H IIH D++P N+L + +K+AD G + D T
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYDEHYTNS 189
Query: 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
+ Y +PEV + D++S A ++ E+I G F
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 78.6 bits (192), Expect = 4e-17
Identities = 18/65 (27%), Positives = 35/65 (53%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G + + +D D +T + +AA +G EVV L+++GA V+ D T A +H ++
Sbjct: 211 GSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIV 270
Query: 123 KLLEK 127
+ ++
Sbjct: 271 DIFDR 275
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 62.1 bits (149), Expect = 1e-11
Identities = 28/110 (25%), Positives = 39/110 (35%), Gaps = 10/110 (9%)
Query: 41 EFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLL------ 93
E + I E + VN D NRT LH A E L+
Sbjct: 1 ESPIKLHTEAAGSYAITEPITR-ESVNIIDPRHNRTVLHWIASNSSAEKSEDLIVHEAKE 59
Query: 94 --ERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
GADV+ D +TPL A+ + ++ L K GA P + +
Sbjct: 60 CIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERS 109
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 56.7 bits (135), Expect = 1e-09
Identities = 12/51 (23%), Positives = 20/51 (39%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
+M A E +E + L+ G V D + TA +A +V +
Sbjct: 225 IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDR 275
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 46.3 bits (108), Expect = 2e-06
Identities = 22/71 (30%), Positives = 31/71 (43%), Gaps = 1/71 (1%)
Query: 63 GIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
+ RTALH AA V L+ E+G++ D +D G TP+ A EV
Sbjct: 177 AARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEV 236
Query: 122 IKLLEKHGAKP 132
+ L + GA
Sbjct: 237 VMYLIQQGASV 247
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 37.4 bits (85), Expect = 0.002
Identities = 18/88 (20%), Positives = 35/88 (39%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
KE + +G DVN D D T L +A +V+ L++ GAD ++ + L A
Sbjct: 55 HEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQA 114
Query: 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
++ ++ + ++
Sbjct: 115 AANRDFGMMVYMLNSTKLKGDIEELDRN 142
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 72.6 bits (177), Expect = 9e-15
Identities = 15/82 (18%), Positives = 25/82 (30%), Gaps = 2/82 (2%)
Query: 53 VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR--WGSTPL 110
++ + LL S V +N A +AA G V++ L E
Sbjct: 106 LDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAF 165
Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
A + V+ L +
Sbjct: 166 RLAAENGHLHVLNRLCELAPTE 187
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 62.6 bits (151), Expect = 1e-11
Identities = 13/83 (15%), Positives = 22/83 (26%), Gaps = 3/83 (3%)
Query: 51 RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG---FTEVVSLLLERGADVDPKDRWGS 107
+ D + + I + VAA G + + LLL V
Sbjct: 68 YYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENY 127
Query: 108 TPLGDAIYYKNHEVIKLLEKHGA 130
A + V+ L +
Sbjct: 128 QAFRLAAENGHLHVLNRLCELAP 150
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 57.2 bits (137), Expect = 8e-10
Identities = 27/166 (16%), Positives = 48/166 (28%), Gaps = 13/166 (7%)
Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID--NRTALHVAA 81
+ + + + + A + + L + I N A +AA
Sbjct: 115 SDEIVKVIQAENYQA-----FRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAA 169
Query: 82 CQGFTEVVSLLLERGADVD---PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
G V++ L E + A+ +H VI L A +
Sbjct: 170 ENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEI- 228
Query: 139 VKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLG 184
H E E ++P N ++ F L+ G+ V K
Sbjct: 229 --HEFEYGEKYVNPFIARHVNRLKEMHDAFKLSNPDGVFDLVTKSE 272
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 46.8 bits (110), Expect = 2e-06
Identities = 10/77 (12%), Positives = 20/77 (25%), Gaps = 7/77 (9%)
Query: 54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW-----GST 108
+G+ +L+ + L + + + LL +
Sbjct: 262 DGVFDLVTK--SECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANE 319
Query: 109 PLGDAIYYKNHEVIKLL 125
L A+ N LL
Sbjct: 320 LLRLALRLGNQGACALL 336
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 44.1 bits (103), Expect = 2e-05
Identities = 12/56 (21%), Positives = 19/56 (33%), Gaps = 5/56 (8%)
Query: 44 LMFLANERDVEGIKELLDSG-----IDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
L+ +E ++ I+ LL D L +A G +LLL
Sbjct: 283 LIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANELLRLALRLGNQGACALLLS 338
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 36.4 bits (83), Expect = 0.004
Identities = 11/86 (12%), Positives = 22/86 (25%), Gaps = 6/86 (6%)
Query: 55 GIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
G K + R + A ++ G ++V + + L
Sbjct: 234 GEKYVNPFIARHVNRLKEMHDAFKLSNPDGVFDLV------TKSECLQGFYMLRNLIRRN 287
Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVK 140
+ I+ L +AP
Sbjct: 288 DEVLLDDIRFLLSIPGIKALAPTATI 313
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 71.3 bits (173), Expect = 1e-14
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 4/88 (4%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
L A + E +K L+ + DVN +D D T LH AA G E +L+E D++ +
Sbjct: 203 LHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVN 262
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
+ G T + +++ LE+ K
Sbjct: 263 KVGQTAF----DVADEDILGYLEELQKK 286
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 60.5 bits (145), Expect = 6e-11
Identities = 27/115 (23%), Positives = 41/115 (35%), Gaps = 9/115 (7%)
Query: 48 ANERDVEGIKELLDSGIDVNFR---------DIDNRTALHVAACQGFTEVVSLLLERGAD 98
A ++ E +K + S D+ D+ A G TE V LLERGAD
Sbjct: 6 AKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFLAACSSGDTEEVLRLLERGAD 65
Query: 99 VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPH 153
++ + G T L A N +++K L ++GA
Sbjct: 66 INYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLD 120
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 57.4 bits (137), Expect = 6e-10
Identities = 26/74 (35%), Positives = 39/74 (52%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
L I+ TALHVAA +G+TEV+ LL++ DV+ KD G TPL A ++
Sbjct: 185 LNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGK 244
Query: 119 HEVIKLLEKHGAKP 132
E ++L ++
Sbjct: 245 EEACRILVENLCDM 258
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 48.9 bits (115), Expect = 3e-07
Identities = 34/175 (19%), Positives = 65/175 (37%), Gaps = 2/175 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ + D E + LL+ G D+N+ ++D TALH A ++V L+E GA+++ D
Sbjct: 44 FLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPD 103
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM--HVKHAREVPEYEIDPHELDFTNSV 161
G PL A ++ + L GA E + + +
Sbjct: 104 NEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQG 163
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
+ ++ A + L I+D ++ L + + V++ L
Sbjct: 164 VDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLL 218
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 67.4 bits (163), Expect = 2e-13
Identities = 24/65 (36%), Positives = 31/65 (47%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
RT LH+A V+ LLL+ GAD + G TPLG A+ N + +LL
Sbjct: 186 KPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLR 245
Query: 127 KHGAK 131
HGA
Sbjct: 246 AHGAP 250
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 63.2 bits (152), Expect = 6e-12
Identities = 15/59 (25%), Positives = 23/59 (38%), Gaps = 1/59 (1%)
Query: 45 MFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
+ ++ LL +G D R RT L A + + LL GA +P+D
Sbjct: 197 HLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAP-EPED 254
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 58.2 bits (139), Expect = 3e-10
Identities = 19/78 (24%), Positives = 28/78 (35%), Gaps = 3/78 (3%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGAD---VDPKDRWGSTPLGDAIYYKNHEVIK 123
+ D TALH+A + LL A +D ++ G T L A ++
Sbjct: 3 GYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVE 62
Query: 124 LLEKHGAKPLMAPMHVKH 141
L GA L+A
Sbjct: 63 KLYAAGAGVLVAERGGHT 80
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 52.0 bits (123), Expect = 3e-08
Identities = 24/108 (22%), Positives = 39/108 (36%), Gaps = 8/108 (7%)
Query: 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQG 84
+ +DG+ L + + LL ++ ++ +TALH+AA G
Sbjct: 2 FGYVTEDGDTA-----LHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILG 56
Query: 85 FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
V L GA V +R G T L A + H +L +
Sbjct: 57 EASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSH 104
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 66.0 bits (159), Expect = 4e-13
Identities = 25/104 (24%), Positives = 48/104 (46%), Gaps = 5/104 (4%)
Query: 23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
+A++N D+ G+ L + A + E + LL + + +D + T L +AA
Sbjct: 111 TADADINAADNSGKTA-----LHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAR 165
Query: 83 QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
+G E LL+ A+ + D P A +H++++LL+
Sbjct: 166 EGSYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLLD 209
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 48.6 bits (114), Expect = 2e-07
Identities = 15/56 (26%), Positives = 25/56 (44%), Gaps = 1/56 (1%)
Query: 87 EVVSLLLERGADVDPK-DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
+V+S LL +GA+++ D+ G T L A + + K L GA +
Sbjct: 3 QVISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRLLDAGADANSQDNTGRT 58
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.9 bits (112), Expect = 4e-07
Identities = 26/76 (34%), Positives = 39/76 (51%)
Query: 57 KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
++L+ + D+N D +TALH AA TE V++LL A+ D +D TPL A
Sbjct: 107 EDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAARE 166
Query: 117 KNHEVIKLLEKHGAKP 132
++E K L + A
Sbjct: 167 GSYEASKALLDNFANR 182
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 47.1 bits (110), Expect = 9e-07
Identities = 12/40 (30%), Positives = 19/40 (47%), Gaps = 1/40 (2%)
Query: 54 EGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLL 92
+ I +LL G ++N D T+LH+AA + L
Sbjct: 3 QVISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRL 42
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 66.6 bits (161), Expect = 6e-13
Identities = 16/58 (27%), Positives = 28/58 (48%)
Query: 53 VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
+E + +N +D + T L++AA G +V LL+ GAD ++ G P+
Sbjct: 239 LENLDLKWIIANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPV 296
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 60.1 bits (144), Expect = 8e-11
Identities = 19/129 (14%), Positives = 45/129 (34%), Gaps = 2/129 (1%)
Query: 2 ETKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD 61
E K+ + L + + + + E + ++ + ++ + +
Sbjct: 34 EQKMKLEAFLQRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFP 93
Query: 62 -SGIDVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
+ +++N D T LH E+V L++ G++ D G + L A+ N+
Sbjct: 94 NTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNN 153
Query: 120 EVIKLLEKH 128
E
Sbjct: 154 YDSGTFEAL 162
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 52.0 bits (123), Expect = 4e-08
Identities = 11/77 (14%), Positives = 26/77 (33%), Gaps = 3/77 (3%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER---GADVDPKDRWGSTPLGDAIY 115
+ + + + + + ++ L + ++ +D G T L A
Sbjct: 209 VKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAAR 268
Query: 116 YKNHEVIKLLEKHGAKP 132
N ++ L +GA P
Sbjct: 269 LGNISIVDALLDYGADP 285
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 51.6 bits (122), Expect = 5e-08
Identities = 28/132 (21%), Positives = 48/132 (36%), Gaps = 5/132 (3%)
Query: 6 PVRTT---LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS 62
P+ T L +P + K ++D+ +++K E L L E L +
Sbjct: 2 PIITFTHDLTSDFLSSPLKIMKALPSPVVNDNEQKMKLEAFLQRLLFPEIQEMPTSLNND 61
Query: 63 GIDVNFRDIDNRTALHVAACQGFT-EVVSLLLERGADVD-PKDRWGSTPLGDAIYYKNHE 120
+ N + + EV +++ P D G+TPL N E
Sbjct: 62 SSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLE 121
Query: 121 VIKLLEKHGAKP 132
++K L KHG+
Sbjct: 122 LVKHLVKHGSNR 133
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 12/57 (21%), Positives = 19/57 (33%), Gaps = 5/57 (8%)
Query: 25 EAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
LN D +G+ L A ++ + LLD G D + + A
Sbjct: 249 ANMLNAQDSNGDTC-----LNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 300
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.0 bits (157), Expect = 8e-13
Identities = 32/123 (26%), Positives = 46/123 (37%), Gaps = 34/123 (27%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG------------------ 84
+ LA +E +KE + + D D+RTALH A G
Sbjct: 7 VCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 66
Query: 85 ---------------FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
E+V LL +GA V+ ++ G TPL A HE+ +L + G
Sbjct: 67 DDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGG 126
Query: 130 AKP 132
A P
Sbjct: 127 ANP 129
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.2 bits (155), Expect = 2e-12
Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 5/107 (4%)
Query: 26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
A++N ++ +G L + A++ E LL+ G + + +D TA+H AA +G
Sbjct: 94 AQVNAVNQNGCTP-----LHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGN 148
Query: 86 TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
+++ +LL A + +D G+TPL A + E KLL GA
Sbjct: 149 LKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASI 195
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.8 bits (146), Expect = 3e-11
Identities = 24/70 (34%), Positives = 37/70 (52%)
Query: 59 LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
LL G VN + + T LH AA + E+ +LLE GA+ D KD + +T + A N
Sbjct: 89 LLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGN 148
Query: 119 HEVIKLLEKH 128
++I +L +
Sbjct: 149 LKMIHILLYY 158
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (121), Expect = 5e-08
Identities = 13/52 (25%), Positives = 23/52 (44%), Gaps = 1/52 (1%)
Query: 43 RLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
L +E VE K L+ G + + + +T L VA G ++ ++E
Sbjct: 172 PLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVAK-GGLGLILKRMVE 222
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 6e-04
Identities = 8/48 (16%), Positives = 15/48 (31%), Gaps = 1/48 (2%)
Query: 73 NRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
+ + A G E+ +L + D+ T L A +
Sbjct: 3 SNLMVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHT 50
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 61.9 bits (149), Expect = 3e-12
Identities = 24/140 (17%), Positives = 47/140 (33%), Gaps = 42/140 (30%)
Query: 43 RLMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAA---CQGFTEVVSLLL 93
L RD+ G+ + G+D+ + + TALH+A + +V L+
Sbjct: 9 SLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLV 68
Query: 94 ERGADVDPK---------------------------------DRWGSTPLGDAIYYKNHE 120
+ ++D + + G TPL A K+
Sbjct: 69 QNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEH 128
Query: 121 VIKLLEKHGAKPLMAPMHVK 140
+LL + + + +HV+
Sbjct: 129 CEELLTQALSGRFNSHVHVE 148
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 43.8 bits (102), Expect = 6e-06
Identities = 15/129 (11%), Positives = 30/129 (23%), Gaps = 12/129 (9%)
Query: 72 DNRTALHV---AACQGFTEVVSLLLERGADVDPK------DRWGSTPLGDAIYYKNH--- 119
D LH A + G D+ K T L A+ +
Sbjct: 2 DTAAKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSL 61
Query: 120 EVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVA 179
++ L ++ A + L + + + + +A
Sbjct: 62 HIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIA 121
Query: 180 VKKLGEEVI 188
+ E
Sbjct: 122 KRLKHEHCE 130
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.3 bits (152), Expect = 4e-12
Identities = 21/82 (25%), Positives = 38/82 (46%)
Query: 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP 101
L+ + ++ LL G +VN + +ALH A+ +G +V L+ GAD
Sbjct: 146 SPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSL 205
Query: 102 KDRWGSTPLGDAIYYKNHEVIK 123
K+ TPL A + ++++
Sbjct: 206 KNCHNDTPLMVARSRRVIDILR 227
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.1 bits (128), Expect = 4e-09
Identities = 15/52 (28%), Positives = 22/52 (42%), Gaps = 4/52 (7%)
Query: 72 DNRTALHVAACQGFTEVVSLLL----ERGADVDPKDRWGSTPLGDAIYYKNH 119
D T LH+A QG V L+ + G ++D + TPL A+
Sbjct: 2 DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLP 53
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (100), Expect = 2e-05
Identities = 20/102 (19%), Positives = 40/102 (39%), Gaps = 4/102 (3%)
Query: 44 LMFLANERDVEGIKELLD----SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99
L + ++ + L++ G +++ + +T LH+A VV LL+ GA
Sbjct: 7 LHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASP 66
Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
DR G T A +++ ++ L A + +
Sbjct: 67 MALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNY 108
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (84), Expect = 0.002
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 1/90 (1%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L N E ++ LL+ G D++ DI R+ L A +V LLL+ GA+V+ +
Sbjct: 114 LHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQ 173
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
GS+ L A +++ L + GA
Sbjct: 174 MYSGSSALHSASGRGLLPLVRTLVRSGADS 203
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 60.2 bits (145), Expect = 2e-11
Identities = 29/191 (15%), Positives = 61/191 (31%), Gaps = 37/191 (19%)
Query: 174 RGIQVAVKKLGEEVISDDD---------------RVRAFRDELALLQKIRHPNVVQFLGA 218
+ + VK S +R+ R+E LQK++ V +
Sbjct: 23 KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
++ E + +L + I + + I+H D
Sbjct: 83 ----EGNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAKFYHR---GIVHGD 128
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
L N+L + G + + DF S + + R + +D + + Y T+ D+
Sbjct: 129 LSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRN----IITYFSRTYRTEKDIN 183
Query: 339 SFALILQEMIE 349
S + +++
Sbjct: 184 S---AIDRILQ 191
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.8 bits (140), Expect = 1e-10
Identities = 19/67 (28%), Positives = 31/67 (46%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
+ RTALH+A ++VSLLL+ GADV+ G +P + + + L
Sbjct: 139 AQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLG 198
Query: 127 KHGAKPL 133
+ + L
Sbjct: 199 QLTLENL 205
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.7 bits (127), Expect = 6e-09
Identities = 9/55 (16%), Positives = 20/55 (36%)
Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98
L + ++ + + LL G DVN + + + T + L + +
Sbjct: 149 LHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 203
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.2 bits (123), Expect = 2e-08
Identities = 11/52 (21%), Positives = 20/52 (38%), Gaps = 4/52 (7%)
Query: 72 DNRTALHVAACQGFT----EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
D + LH+A EV+ + A ++ ++ TPL A+
Sbjct: 1 DGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQP 52
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 56.4 bits (134), Expect = 8e-10
Identities = 19/66 (28%), Positives = 30/66 (45%), Gaps = 4/66 (6%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKL 124
VN++D T L A +G + LL+E+ GA+ D D G+ A+ N +V K
Sbjct: 165 VNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKF 221
Query: 125 LEKHGA 130
+
Sbjct: 222 FLNNVV 227
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 55.2 bits (131), Expect = 2e-09
Identities = 14/68 (20%), Positives = 25/68 (36%), Gaps = 1/68 (1%)
Query: 75 TALHVAACQGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
LH A + V LL + + + KD+ G PL ++ ++ HE+ L
Sbjct: 2 YPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVN 61
Query: 134 MAPMHVKH 141
+
Sbjct: 62 LDDYPDDS 69
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 51.4 bits (121), Expect = 4e-08
Identities = 10/55 (18%), Positives = 17/55 (30%), Gaps = 4/55 (7%)
Query: 45 MFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98
E + L++ G + + D A VA + +V L D
Sbjct: 177 FHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALNE---QVKKFFLNNVVD 228
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 46.4 bits (108), Expect = 2e-06
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 2/90 (2%)
Query: 45 MFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD-VDPKD 103
++ E + L+++G V +D N+ LH AA G +++ LL G V+ +D
Sbjct: 110 HLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQD 169
Query: 104 RWGSTPLGDAIYYKNHEVIK-LLEKHGAKP 132
+ G TPL A+ + + L+EK+GA+
Sbjct: 170 KQGWTPLFHALAEGHGDAAVLLVEKYGAEY 199
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 46.0 bits (107), Expect = 2e-06
Identities = 19/99 (19%), Positives = 39/99 (39%), Gaps = 1/99 (1%)
Query: 44 LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
L E + ++ELL S + +D D R LH + E+ S LL + +V+
Sbjct: 4 LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD 63
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
D + + +++++ +PL ++
Sbjct: 64 DYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKIT 102
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.3 bits (118), Expect = 4e-08
Identities = 9/32 (28%), Positives = 18/32 (56%)
Query: 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
L AA +G E ++ LL+ +V+ ++ +G
Sbjct: 3 NELASAAARGDLEQLTSLLQNNVNVNAQNGFG 34
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (107), Expect = 1e-06
Identities = 12/31 (38%), Positives = 15/31 (48%)
Query: 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERG 96
V R+ TA +A G EVVSL+ G
Sbjct: 126 VGHRNHKGDTACDLARLYGRNEVVSLMQANG 156
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 8e-05
Identities = 9/31 (29%), Positives = 16/31 (51%)
Query: 99 VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
V ++ G T A Y +EV+ L++ +G
Sbjct: 126 VGHRNHKGDTACDLARLYGRNEVVSLMQANG 156
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 48.7 bits (114), Expect = 1e-07
Identities = 23/64 (35%), Positives = 36/64 (56%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G DVN +D+ TALH A EVV LL++ GADV + ++ T +I N ++
Sbjct: 90 GADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLA 149
Query: 123 KLLE 126
++L+
Sbjct: 150 EILQ 153
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.2 bits (97), Expect = 2e-05
Identities = 12/64 (18%), Positives = 29/64 (45%)
Query: 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
+G D + +++ L + E ++ L+ G DV+ + +TA ++ G ++
Sbjct: 89 HGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDL 148
Query: 89 VSLL 92
+L
Sbjct: 149 AEIL 152
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 40.6 bits (93), Expect = 6e-05
Identities = 23/153 (15%), Positives = 48/153 (31%), Gaps = 9/153 (5%)
Query: 72 DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
D L AA G + V +L+ GA D G++PL A Y + ++L + G
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVS 59
Query: 132 PLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDD 191
+ + E + ++ + + A + +EV+
Sbjct: 60 RDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELL 119
Query: 192 DRVRAFRDE--------LALLQKIRHPNVVQFL 216
+ A + + ++ + L
Sbjct: 120 IKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.3 bits (113), Expect = 2e-07
Identities = 22/66 (33%), Positives = 34/66 (51%), Gaps = 1/66 (1%)
Query: 63 GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
G DVN D +H+A +G T VVS L +D+ +D G TPL A+ +++
Sbjct: 91 GADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRDARGLTPLELALQRGAQDLV 149
Query: 123 KLLEKH 128
+L+ H
Sbjct: 150 DILQGH 155
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 9e-05
Identities = 13/46 (28%), Positives = 19/46 (41%), Gaps = 1/46 (2%)
Query: 75 TALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNH 119
L AA +G + V LL R D +R+G T L ++
Sbjct: 4 DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMFGSTA 49
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (92), Expect = 7e-05
Identities = 11/47 (23%), Positives = 18/47 (38%), Gaps = 3/47 (6%)
Query: 56 IKELLDSGIDVNFRDI-DNRTA--LHVAACQGFTEVVSLLLERGADV 99
K L++SG V D +TA +G+T+ L +
Sbjct: 83 CKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKM 129
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.0 bits (79), Expect = 0.004
Identities = 18/124 (14%), Positives = 34/124 (27%), Gaps = 36/124 (29%)
Query: 44 LMFLANERDVEGIKELLDSGIDVN---------------------------------FRD 70
L+ + E + + ++ ++ D + D
Sbjct: 5 LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 64
Query: 71 IDNRTALHVAACQGFTEVVSLLLERGADVDPKDR---WGSTPLGDAIYYKNHEVIKLLEK 127
D T LH AA +V L+E GA V + + + + + L
Sbjct: 65 SDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYG 124
Query: 128 HGAK 131
K
Sbjct: 125 VQEK 128
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 5e-04
Identities = 20/114 (17%), Positives = 33/114 (28%)
Query: 75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134
L AA +G E V LLE GA+ + + +G P+ + LL
Sbjct: 5 DWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMMMGSARVAELLLLHGAEPNCA 64
Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVI 188
P + E L + + +A + +V
Sbjct: 65 DPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVA 118
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.3 bits (79), Expect = 0.003
Identities = 7/28 (25%), Positives = 11/28 (39%)
Query: 67 NFRDIDNRTALHVAACQGFTEVVSLLLE 94
+ RD R + +A G +V L
Sbjct: 96 DVRDAWGRLPVDLAEELGHRDVARYLRA 123
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 387 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.9 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.86 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.85 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.84 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.83 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 99.81 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.8 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.8 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 99.77 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.77 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.77 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.76 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.75 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.75 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 99.75 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.74 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.74 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.73 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 99.72 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.72 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.71 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.7 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.7 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.69 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.68 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.67 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 99.67 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.67 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.67 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.66 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.66 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.66 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.65 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.63 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.59 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 99.57 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.54 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.27 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.87 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.72 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.73 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.99 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.16 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=352.37 Aligned_cols=209 Identities=26% Similarity=0.470 Sum_probs=186.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||+|++.+.........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 577888999999999874 578999999875433223335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++|+|.+++.+.+.+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|...... .
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---~ 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---R 160 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---C
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC---c
Confidence 9999999999998888999999999999999999999999 999999999999999999999999999765432 2
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++.+++....
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 220 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 220 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 334578999999999999999999999999999999999999999988888888887655
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=351.19 Aligned_cols=221 Identities=24% Similarity=0.443 Sum_probs=192.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.||. +|+.||||++....... .+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 688889999999999874 58999999987554332 3668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+++|+|.+++.+. .+++.++..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 98 y~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~~~ 172 (293)
T d1yhwa1 98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSK 172 (293)
T ss_dssp CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST-TCC
T ss_pred ecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc-ccc
Confidence 99999999988764 6999999999999999999999999 999999999999999999999999999876533 223
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhcc
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||.+.+..+...++.....|.+..+ ..+++++
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~ 246 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP-EKLSAIF 246 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSG-GGSCHHH
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCc-ccCCHHH
Confidence 3445789999999999999999999999999999999999999999888888888877776666443 4555544
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=353.88 Aligned_cols=212 Identities=22% Similarity=0.444 Sum_probs=185.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||||++.+.........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 588889999999999873 588999999875433223345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC-C
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-R 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 309 (387)
|+++|+|.+++...+.+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+....... .
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 9999999999999889999999999999999999999999 99999999999999999999999999987654322 2
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++.++|....
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 226 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 226 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC
Confidence 3344579999999999999999999999999999999999999999998888888887665
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=348.81 Aligned_cols=205 Identities=28% Similarity=0.444 Sum_probs=175.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||||++..... ....+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 578889999999999874 588999999875432 2334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC-CC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-DR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 309 (387)
|+++|+|.+++.+.+.+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 9999999999988778999999999999999999999999 9999999999999999999999999998765332 22
Q ss_pred CcccCCCCCcccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHH
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~ 365 (387)
......||+.|+|||++.+..+ +.++|||||||++|+|+||++||...+.......
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~ 217 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 3345679999999999988776 5789999999999999999999987665544333
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=347.26 Aligned_cols=233 Identities=27% Similarity=0.446 Sum_probs=185.5
Q ss_pred ccccCccccCcccceeecccEEEEEEE--cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc
Q 016544 147 EYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224 (387)
Q Consensus 147 ~~ei~~~~~~~~~~~~lg~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~ 224 (387)
+||++.. +|...+.||+|+||.||. .+..||||+++..... ....+.|.+|+.++++++||||+++++++. ++.
T Consensus 2 dwei~~~--~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 2 DWEIPDG--QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CCBCCTT--CCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred Ccccccc--cEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 4666554 456677999999999884 3457999999765433 445678999999999999999999999875 457
Q ss_pred eEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
+++||||+++|+|.+++... +.+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeec
Confidence 89999999999999999764 55999999999999999999999998 999999999999999999999999999776
Q ss_pred ccCCC-CCcccCCCCCcccccccccCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC--CCCCCCC
Q 016544 304 TVKED-RPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKAP 377 (387)
Q Consensus 304 ~~~~~-~~~~~~~~~~~y~aPE~~~~~---~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~--~~~~~~~ 377 (387)
..... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.++......+...+ .|.+...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~ 234 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence 53322 233445789999999999653 57889999999999999999999999887765555444443 4444555
Q ss_pred hhhhhhccc
Q 016544 378 AKLYARGLK 386 (387)
Q Consensus 378 ~~~~~~~l~ 386 (387)
+..+|++|+
T Consensus 235 ~~~~~~~l~ 243 (276)
T d1uwha_ 235 RSNCPKAMK 243 (276)
T ss_dssp CTTCCHHHH
T ss_pred cccchHHHH
Confidence 566666654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=345.34 Aligned_cols=225 Identities=23% Similarity=0.417 Sum_probs=180.0
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee--CCceEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~--~~~~~lv 228 (387)
+|...+.||+|+||.|+. +|+.||+|.+..... .+...+.+.+|+.++++++||||+++++++.+ +..+|+|
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 577888999999999874 578999999987654 45556789999999999999999999999864 4568999
Q ss_pred EEccCCCCHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCC--CCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP--VPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~----~~~l~~~~~~~i~~qi~~~l~~LH~~~~--~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
|||+++|+|.+++.+ ...+++.+++.++.|++.||.|||+.++ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999864 3569999999999999999999998641 2399999999999999999999999999987
Q ss_pred cccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhh
Q 016544 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 382 (387)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..++..+|..+..+.++ ..+|
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~s 239 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP---YRYS 239 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC---TTSC
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC---cccC
Confidence 65432 2233467899999999999999999999999999999999999999999988899999887755442 3445
Q ss_pred hcc
Q 016544 383 RGL 385 (387)
Q Consensus 383 ~~l 385 (387)
+++
T Consensus 240 ~~l 242 (269)
T d2java1 240 DEL 242 (269)
T ss_dssp HHH
T ss_pred HHH
Confidence 444
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=349.34 Aligned_cols=223 Identities=29% Similarity=0.416 Sum_probs=190.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|+||.|+. +|..||||++.... ....+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 467788999999999874 57899999987542 2335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++|+|.+++.+ .+.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|....... .
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 9999999999875 456999999999999999999999999 9999999999999999999999999987653221 1
Q ss_pred CcccCCCCCccccccccc-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhc
Q 016544 310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 384 (387)
......||+.|+|||++. +..++.++|||||||++|+|+||+.||.+.+..++..++..+..|.+..+ ..+|++
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~s~~ 244 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSSN 244 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSG-GGSCHH
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc-ccCCHH
Confidence 223456899999999984 45678999999999999999999999999999999999988776666543 456655
Q ss_pred cc
Q 016544 385 LK 386 (387)
Q Consensus 385 l~ 386 (387)
++
T Consensus 245 ~~ 246 (288)
T d2jfla1 245 FK 246 (288)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-48 Score=350.02 Aligned_cols=220 Identities=26% Similarity=0.426 Sum_probs=191.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|+..+.||+|+||.||. +|+.||||++...........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 477788999999999874 578999999987666666677889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
||.+|+|..++...+++++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 9999999888888788999999999999999999999999 999999999999999999999999999765422
Q ss_pred cccCCCCCcccccccccC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhcc
Q 016544 311 LTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~---~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+...++..+..|.+.. ..+|+++
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~s~~~ 243 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS--GHWSEYF 243 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC--TTSCHHH
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC--CCCCHHH
Confidence 33568999999999864 358899999999999999999999999988888888888777665532 3444443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=353.14 Aligned_cols=211 Identities=27% Similarity=0.421 Sum_probs=188.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||||++.+.........+.+.+|+.++++++||||+++++++.++..+|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 577788999999999873 689999999976533223345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|++||+|.+++.+.+.+++..++.++.|++.||+|||+++ |+||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~~~ 161 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GAT 161 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCC
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC-Ccc
Confidence 9999999999999989999999999999999999999999 999999999999999999999999999865432 223
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.....||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..++.+++..+.
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~ 221 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC
Confidence 344568999999999999999999999999999999999999999999888888887766
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-48 Score=350.98 Aligned_cols=223 Identities=24% Similarity=0.391 Sum_probs=175.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|+||.|+. +|+.||||++...... .....+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 478888999999998874 5889999999765432 234568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC---CCCCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|++||+|.+++.+.+.+++.++..++.||+.||+|||+++ |+||||||+|||+. .++.+||+|||++......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 9999999999998888999999999999999999999999 99999999999995 5788999999999865432
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhcc
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
.......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..++..+|..+..+......+.+|+++
T Consensus 164 -~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 240 (307)
T d1a06a_ 164 -SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred -CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence 22334568999999999999999999999999999999999999999998888999988877433323334455444
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.8e-48 Score=350.07 Aligned_cols=209 Identities=26% Similarity=0.486 Sum_probs=187.4
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||||++.+.........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 577888999999998873 588999999875433223345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|++||+|..++.....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 9999999999999888999999999999999999999999 999999999999999999999999999876432
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 371 (387)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..++..+|..+..
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~ 218 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 218 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC
Confidence 2345789999999999999999999999999999999999999999998899999877763
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-48 Score=343.72 Aligned_cols=217 Identities=26% Similarity=0.402 Sum_probs=183.1
Q ss_pred eeecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccC
Q 016544 161 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 161 ~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
+.||+|+||.||. .++.||||+++.... +....+.+.+|+.++++++||||+++++++.. +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 5799999999874 236899999976543 34556789999999999999999999999865 56789999999
Q ss_pred CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC--Cc
Q 016544 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--PL 311 (387)
Q Consensus 234 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~ 311 (387)
+|+|.+++.+...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ ..
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999999999888999999999999999999999999 999999999999999999999999999876433222 12
Q ss_pred ccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhcc
Q 016544 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
....||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..++...+..+.+++++ ..+|+++
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p---~~~~~~~ 239 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP---AGCPREM 239 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---TTCCHHH
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCC---cccCHHH
Confidence 33468899999999999999999999999999999998 89999999989999999888777763 3455544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=339.98 Aligned_cols=212 Identities=30% Similarity=0.524 Sum_probs=174.8
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|...+.||+|+||.|+. ++..||||++...... .+++.+|+.++++++||||+++++++..++.+++||||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 466678999999998874 5788999999764332 35688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999998765 45889999999999999999999999 9999999999999999999999999998765444444
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.....||+.|+|||++.+..++.++|||||||++|||+| |++||...+..++.+.+..+.++..
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~ 223 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 223 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 444568999999999999999999999999999999999 6888888888888999888776655
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-47 Score=335.96 Aligned_cols=208 Identities=26% Similarity=0.513 Sum_probs=175.6
Q ss_pred ccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee----CCceEEE
Q 016544 158 TNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPMMIV 228 (387)
Q Consensus 158 ~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~----~~~~~lv 228 (387)
...+.||+|+||.||. ++..||+|.+..... .....+.+.+|++++++++||||+++++++.+ +..+|+|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 3455799999999984 478999999876544 34556789999999999999999999999875 3458999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC-CCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|||+++|+|.+++.+...+++.++..++.||++||+|||+++ .+|+||||||+|||++ .++.+||+|||+++....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-- 167 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 167 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--
Confidence 999999999999999888999999999999999999999986 3599999999999997 578999999999976432
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-HHHHHHccCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQR 371 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~-~~~~i~~~~~ 371 (387)
.......||+.|+|||++.+ +++.++|||||||++|||++|+.||.+..... +.+++..+..
T Consensus 168 -~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~ 230 (270)
T d1t4ha_ 168 -SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 230 (270)
T ss_dssp -TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred -CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC
Confidence 23345679999999999876 69999999999999999999999998765544 4555544433
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=342.48 Aligned_cols=213 Identities=25% Similarity=0.411 Sum_probs=187.7
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCC---HHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD---DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
..|...+.||+|+||.|+. +|+.||||++.+..... ....+.+.+|+.++++++||||+++++++.++..+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3588889999999999874 48899999987544322 223577899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC----CEEEEeecCccc
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKL 302 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Dfg~~~~ 302 (387)
+||||+++|+|.+++.+.+.+++.++..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999999999998888999999999999999999999999 99999999999999776 499999999987
Q ss_pred cccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 303 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
.... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++..+|.....+
T Consensus 167 ~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 167 IDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234 (293)
T ss_dssp CTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC
T ss_pred cCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC
Confidence 6433 2233456899999999999999999999999999999999999999999988898988777643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=340.38 Aligned_cols=220 Identities=24% Similarity=0.400 Sum_probs=186.6
Q ss_pred cccce-eecccEEEEEEE-------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 157 FTNSV-EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 157 ~~~~~-~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
+.... +||+|+||.||. ++..||||+++.. ......++|.+|+.++++++||||+++++++.. +.+|+|
T Consensus 10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 33444 499999999874 2457999999754 345667889999999999999999999999865 568999
Q ss_pred EEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|||+++|+|.+++... ..+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999998654 56999999999999999999999999 9999999999999999999999999998765432
Q ss_pred C--CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhc
Q 016544 308 D--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (387)
Q Consensus 308 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 384 (387)
. .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++...|..+.+|+++ +.+|++
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p---~~~~~~ 240 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP---PECPPE 240 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCC---TTCCHH
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC---CcCCHH
Confidence 2 12233467899999999999899999999999999999998 99999999999999999888877663 345554
Q ss_pred c
Q 016544 385 L 385 (387)
Q Consensus 385 l 385 (387)
+
T Consensus 241 l 241 (285)
T d1u59a_ 241 L 241 (285)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.8e-47 Score=339.94 Aligned_cols=227 Identities=26% Similarity=0.409 Sum_probs=188.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCc----eE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----MM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~----~~ 226 (387)
+|...+.||+|+||.||. +|+.||||+++.....+....+.+.+|+.+++.++||||+++++++..... +|
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 477888999999999874 589999999988777777778889999999999999999999999986543 89
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
+||||++|++|.+++...+.+++.++..++.||+.||.|||+++ |+||||||+|||++.++..+|+|||.+......
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhccc
Confidence 99999999999999999889999999999999999999999999 999999999999999999999999998755432
Q ss_pred CC--CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhc
Q 016544 307 ED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384 (387)
Q Consensus 307 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 384 (387)
.. .......||+.|+|||++.+..+++++|||||||++|+|+||++||.+.+..++..++......+.......+|++
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 244 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHH
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 22 2234456899999999999999999999999999999999999999998888888887776644433333445554
Q ss_pred c
Q 016544 385 L 385 (387)
Q Consensus 385 l 385 (387)
+
T Consensus 245 l 245 (277)
T d1o6ya_ 245 L 245 (277)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.9e-47 Score=349.00 Aligned_cols=222 Identities=22% Similarity=0.379 Sum_probs=190.8
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.||. +|+.||||++... .....+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 688889999999999874 5899999999754 34456778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC--CCCCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|++||+|.+++.+ .+.+++.++..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 9999999999854 456999999999999999999999999 99999999999996 4578999999999876533
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhcc
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++..+|..............+++++
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 33344678999999999999999999999999999999999999999999888999987776433333334444443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-47 Score=343.38 Aligned_cols=228 Identities=28% Similarity=0.454 Sum_probs=188.6
Q ss_pred CccccCccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEe
Q 016544 146 PEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220 (387)
Q Consensus 146 ~~~ei~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~ 220 (387)
..||++.. +|...+.||+|+||.||. +|+.||||+++.... ..+++.+|+.++++++||||++++++|.
T Consensus 10 ~~wei~~~--~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (287)
T d1opja_ 10 DKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCT 83 (287)
T ss_dssp CTTBCCGG--GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccEecHH--HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEe
Confidence 35777654 466678999999988873 478999999976533 2457899999999999999999999999
Q ss_pred eCCceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeec
Q 016544 221 QSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (387)
Q Consensus 221 ~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 298 (387)
+++.+++||||+++|+|.+++.+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcccc
Confidence 999999999999999999999764 45899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCC-CCCCCCCCcHHHHHHccCCCCCCCC
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP-PFTMKHDNEVPKAYAARQRPPFKAP 377 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~-pf~~~~~~~~~~~i~~~~~~~~~~~ 377 (387)
+|+..............+++.|+|||++.+..++.++|||||||++|||++|.. ||.+.+...+.+.+..+.+++++
T Consensus 161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~-- 238 (287)
T d1opja_ 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP-- 238 (287)
T ss_dssp CTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC--
T ss_pred ceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCC--
Confidence 998765443333344457889999999999999999999999999999999655 55666666666666666566553
Q ss_pred hhhhhhcc
Q 016544 378 AKLYARGL 385 (387)
Q Consensus 378 ~~~~~~~l 385 (387)
..+|+++
T Consensus 239 -~~~~~~l 245 (287)
T d1opja_ 239 -EGCPEKV 245 (287)
T ss_dssp -TTCCHHH
T ss_pred -ccchHHH
Confidence 3444444
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-47 Score=343.07 Aligned_cols=214 Identities=31% Similarity=0.508 Sum_probs=175.6
Q ss_pred CcccceeecccEEEEEEE-----cC---eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
.|...+.||+|+||.||. +| ..||||.+... ......+.|.+|+.++++++|||||++++++..++.+++
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 456678899999998873 12 35899988754 345566789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
||||+++|+|.+++... +.+++.++..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999998874 45999999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCC----cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCC
Q 016544 307 EDRP----LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF 374 (387)
Q Consensus 307 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~ 374 (387)
.... .....+|+.|+|||.+.+..++.++|||||||++|||+| |++||.+.+..++...+..+.+++.
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 254 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP 254 (299)
T ss_dssp --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 2211 122356889999999999999999999999999999998 8999999999999999988876665
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-47 Score=337.34 Aligned_cols=227 Identities=30% Similarity=0.465 Sum_probs=189.3
Q ss_pred CccccCccccCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee
Q 016544 146 PEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (387)
Q Consensus 146 ~~~ei~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~ 221 (387)
.+||++.. +|...+.||+|+||.||. ++..||||++...... .+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~wei~~~--~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 6 DEWEVPRE--TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (272)
T ss_dssp CTTBCCGG--GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCeecCHH--HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 45677554 567778999999998873 4678999999754332 3568999999999999999999998754
Q ss_pred CCceEEEEEccCCCCHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecC
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 299 (387)
+.+++||||+++|+|.+++... .++++.+++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 80 -~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccc
Confidence 5689999999999999977533 35899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCCCCCh
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 378 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 378 (387)
|+..............+|+.|+|||++.+..++.++|||||||++|||+| |++||...+..++.+.+..+.+++.+
T Consensus 156 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p--- 232 (272)
T d1qpca_ 156 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP--- 232 (272)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---
T ss_pred eEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCc---
Confidence 98776444334445578899999999998899999999999999999999 56777777778888888877766653
Q ss_pred hhhhhcc
Q 016544 379 KLYARGL 385 (387)
Q Consensus 379 ~~~~~~l 385 (387)
..+|+++
T Consensus 233 ~~~~~~l 239 (272)
T d1qpca_ 233 DNCPEEL 239 (272)
T ss_dssp TTCCHHH
T ss_pred ccChHHH
Confidence 3444444
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.7e-47 Score=348.13 Aligned_cols=222 Identities=17% Similarity=0.341 Sum_probs=190.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
.|...+.||+|+||.|+. +|+.||||++... .....+.+.+|+.++++++||||++++++|.+++.+|+|||
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc---chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 588889999999999874 5889999998754 23445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeC--CCCCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||+||+|.+++...+ ++++.+++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||+|......
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 999999998876544 5999999999999999999999999 99999999999998 6789999999999876533
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhcc
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
.......+|+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..++..+|.....+........+++++
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 259 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA 259 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 33344568999999999999999999999999999999999999999999888999988776433333334444443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=333.28 Aligned_cols=220 Identities=26% Similarity=0.473 Sum_probs=191.4
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|...+.||+|+||.|+. ++..||||+++..... .+++.+|+.++++++||||+++++++.+++.+++||||
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 566677899999999874 5679999999865432 35688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 232 ~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
+++|+|.+++.. ...+++..+..++.|+++||.|||+++ |+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999999999765 456899999999999999999999999 9999999999999999999999999998765544444
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCCCCChhhhhhcc
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
.....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++..++..+.+++.+ ..+|+++
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p---~~~~~~l 230 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASEKV 230 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCC---TTCCHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc---ccccHHH
Confidence 445678999999999999999999999999999999998 89999999999999999887766553 3444444
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-47 Score=349.20 Aligned_cols=210 Identities=25% Similarity=0.420 Sum_probs=187.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||||++.+.........+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 688889999999999874 589999999875433223335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
|+.+|+|.+++.+.+.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 9999999999999889999999999999999999999999 999999999999999999999999999876432
Q ss_pred cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCC
Q 016544 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 372 (387)
.....||+.|+|||++.+..++.++|||||||++|+|+||++||.+.+...+..+|..+..+
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~ 256 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC
Confidence 22356899999999999999999999999999999999999999999888888888777633
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.9e-46 Score=332.16 Aligned_cols=226 Identities=24% Similarity=0.358 Sum_probs=193.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCC------HHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCC
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS 223 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~ 223 (387)
+|...+.||+|+||.|+. +|+.||||++....... +...+.+.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 677888999999999874 67899999987654322 233456888999999996 999999999999999
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.+|+||||+++|+|.+++...+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999999889999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCcccCCCCCcccccccccC------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCCCCCCCC
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKN------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 377 (387)
... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..++.++|..+........
T Consensus 161 ~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 161 DPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred cCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 543 23344678999999999863 3568899999999999999999999999998888888887764333333
Q ss_pred hhhhhhccc
Q 016544 378 AKLYARGLK 386 (387)
Q Consensus 378 ~~~~~~~l~ 386 (387)
...+|++++
T Consensus 239 ~~~~s~~~~ 247 (277)
T d1phka_ 239 WDDYSDTVK 247 (277)
T ss_dssp GGGSCHHHH
T ss_pred cccCCHHHH
Confidence 456666554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-47 Score=345.87 Aligned_cols=200 Identities=30% Similarity=0.471 Sum_probs=176.6
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEE
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv 228 (387)
..+|...+.||+|+||.|+. +|..||+|+++... .....+.+.+|+.++++++||||++++++|.++..+|+|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34688889999999998874 58999999987543 233456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
|||+++|+|.+++.+.+.+++..+..++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||+|......
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999999988889999999999999999999997 47 999999999999999999999999999865432
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~ 361 (387)
......||+.|+|||++.+.+++.++|||||||++|||++|+.||.+.+..+
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~ 210 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 2234579999999999999999999999999999999999999998766544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=333.02 Aligned_cols=228 Identities=24% Similarity=0.441 Sum_probs=182.0
Q ss_pred ccccCccccCcccceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeE
Q 016544 147 EYEIDPHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218 (387)
Q Consensus 147 ~~ei~~~~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~ 218 (387)
+||++.. +|...+.||+|+||.||. .+..||||.+... ......+.+.+|+.++++++||||++++++
T Consensus 1 ~~ei~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 76 (273)
T d1mp8a_ 1 DYEIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGV 76 (273)
T ss_dssp CCBCCGG--GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCcCHH--HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3666654 577778999999998873 1356999998643 345667789999999999999999999999
Q ss_pred EeeCCceEEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEee
Q 016544 219 VTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297 (387)
Q Consensus 219 ~~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 297 (387)
+. ++.+++||||+++|+|.+++... ..+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 77 ~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~Df 152 (273)
T d1mp8a_ 77 IT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF 152 (273)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-
T ss_pred Ee-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccc
Confidence 86 56789999999999999987654 46899999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCCCC
Q 016544 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 376 (387)
Q Consensus 298 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 376 (387)
|+|+..............+|+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+..++.+++..+.+++++
T Consensus 153 G~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~- 231 (273)
T d1mp8a_ 153 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP- 231 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC-
T ss_pred hhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC-
Confidence 9998765544444455667999999999999999999999999999999998 99999999999999999888877653
Q ss_pred Chhhhhhcc
Q 016544 377 PAKLYARGL 385 (387)
Q Consensus 377 ~~~~~~~~l 385 (387)
+.+|+++
T Consensus 232 --~~~~~~~ 238 (273)
T d1mp8a_ 232 --PNCPPTL 238 (273)
T ss_dssp --TTCCHHH
T ss_pred --CCCCHHH
Confidence 3455544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=341.37 Aligned_cols=221 Identities=27% Similarity=0.438 Sum_probs=181.1
Q ss_pred ccccCccccCcccceeecccEEEEEEEc----------CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceee
Q 016544 147 EYEIDPHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQF 215 (387)
Q Consensus 147 ~~ei~~~~~~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l 215 (387)
.||++.. +|...+.||+|+||.||.. ...||+|.+.... .......+.+|+.++.++ +|||||++
T Consensus 31 kwei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l 106 (325)
T d1rjba_ 31 KWEFPRE--NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNL 106 (325)
T ss_dssp GGBCCGG--GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHH--HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence 3555443 4667789999999998742 1369999987542 233456788999999998 89999999
Q ss_pred eeEEeeCCceEEEEEccCCCCHHHHHHHc-----------------------CCCChHHHHHHHHHHHHHHHHHHhCCCC
Q 016544 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRK-----------------------GALKPSTAVRFALDIARGMNYLHENKPV 272 (387)
Q Consensus 216 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----------------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~ 272 (387)
++++.+.+.+++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+++
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~-- 184 (325)
T d1rjba_ 107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS-- 184 (325)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 99999999999999999999999999754 24788999999999999999999999
Q ss_pred CeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-C
Q 016544 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350 (387)
Q Consensus 273 ~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g 350 (387)
|+||||||+|||++.++.+||+|||+|+......... .....+|+.|+|||++.+..++.++|||||||++|||+| |
T Consensus 185 -IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g 263 (325)
T d1rjba_ 185 -CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263 (325)
T ss_dssp -EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred -eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence 9999999999999999999999999998765443322 223456899999999999999999999999999999998 8
Q ss_pred CCCCCCCCCCcHHHHHHccC-CCCC
Q 016544 351 CPPFTMKHDNEVPKAYAARQ-RPPF 374 (387)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~-~~~~ 374 (387)
++||.+.+..+.+.++...+ ++++
T Consensus 264 ~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (325)
T d1rjba_ 264 VNPYPGIPVDANFYKLIQNGFKMDQ 288 (325)
T ss_dssp CCSSTTCCCSHHHHHHHHTTCCCCC
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 99999988777766665555 5544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=338.72 Aligned_cols=211 Identities=30% Similarity=0.463 Sum_probs=183.5
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHH-cCCCCcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|...+.||+|+||.||. +|+.||||++++.........+.+..|..++. .++||||+++++++.+++.+|+||
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 577788999999998874 68999999997543222222345566666654 689999999999999999999999
Q ss_pred EccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
||+++|+|.+++...+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ..
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-~~ 158 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DA 158 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TC
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc-cc
Confidence 99999999999999888999999999999999999999999 999999999999999999999999999865433 23
Q ss_pred CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 310 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+..++..+|..+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~ 219 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 219 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 3344578999999999999999999999999999999999999999999999998887654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-45 Score=342.65 Aligned_cols=205 Identities=25% Similarity=0.397 Sum_probs=173.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCC---HHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD---DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|...+.||+|+||.||. +|+.||||++.+..... .........|+.+++.++||||+++++++.+++.+|+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 577788999999999873 58899999986533221 2222223445777778889999999999999999999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 307 (387)
||||++||+|.+++.+...+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|......
T Consensus 85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 9999999999999999888999999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
......||+.|+|||++.+ ..++.++|||||||++|+|+||+.||.+.+.....+.+
T Consensus 161 --~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~ 218 (364)
T d1omwa3 161 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218 (364)
T ss_dssp --CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH
T ss_pred --cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2234568999999999975 56899999999999999999999999987766654443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=328.48 Aligned_cols=215 Identities=30% Similarity=0.489 Sum_probs=176.6
Q ss_pred CcccceeecccEEEEEEE---c--C----eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceE
Q 016544 156 DFTNSVEITKGTFILAFW---R--G----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~---~--g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~ 226 (387)
.|+..+.||+|+||.||. . + ..||||.+... .......+|.+|+.++++++|||||++++++......+
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc--cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 466778899999998873 2 1 47999998754 24555667899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
+||||+.++++.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999988765 56999999999999999999999999 99999999999999999999999999987644
Q ss_pred CCCC--CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCCC
Q 016544 306 KEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK 375 (387)
Q Consensus 306 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 375 (387)
.... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++.+.+..+.+++.+
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~ 235 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCC
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCc
Confidence 3222 2233467899999999999999999999999999999999 56667777777888888877777664
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=329.00 Aligned_cols=227 Identities=31% Similarity=0.473 Sum_probs=182.9
Q ss_pred CccccCccccCcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee
Q 016544 146 PEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221 (387)
Q Consensus 146 ~~~ei~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~ 221 (387)
..||++.. +|+..+.||+|+||.||. ++..||||++...... .+.|.+|+.++++++|||||++++++.
T Consensus 10 ~~~~i~~~--~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~- 82 (285)
T d1fmka3 10 DAWEIPRE--SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS- 82 (285)
T ss_dssp TCSBCCGG--GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cceEcCHH--HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEe-
Confidence 46777654 688888999999998873 4568999999755332 357899999999999999999999985
Q ss_pred CCceEEEEEccCCCCHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecC
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 299 (387)
++.+++||||+++|+|..++.. ...+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 83 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccch
Confidence 4668999999999999988854 356999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCCCCCh
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPA 378 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 378 (387)
++..............+|+.|+|||++....++.++|||||||++|||+| |++||.+....++...+..+.+++++
T Consensus 160 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~--- 236 (285)
T d1fmka3 160 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP--- 236 (285)
T ss_dssp TC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC---
T ss_pred hhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC---
Confidence 98765444444445668999999999999999999999999999999999 56667777777888888877766653
Q ss_pred hhhhhcc
Q 016544 379 KLYARGL 385 (387)
Q Consensus 379 ~~~~~~l 385 (387)
..+|+++
T Consensus 237 ~~~~~~l 243 (285)
T d1fmka3 237 PECPESL 243 (285)
T ss_dssp TTSCHHH
T ss_pred cccCHHH
Confidence 3444444
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=335.22 Aligned_cols=207 Identities=17% Similarity=0.345 Sum_probs=182.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||||.+.... .....+.+|+.++++++||||++++++|.+++.+|+|||
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 578888999999999874 58899999997542 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCC--CCEEEEeecCccccccCC
Q 016544 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE 307 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~ 307 (387)
||+||+|.+++.+.+ .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||++......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 999999999998765 6999999999999999999999999 9999999999999854 47999999999875432
Q ss_pred CCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccCC
Q 016544 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371 (387)
Q Consensus 308 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 371 (387)
.......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..++..+|.....
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~ 220 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC
T ss_pred -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 223334678999999999999999999999999999999999999999999999999877663
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=324.30 Aligned_cols=215 Identities=30% Similarity=0.542 Sum_probs=178.6
Q ss_pred cccCccccCcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee-CC
Q 016544 148 YEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SS 223 (387)
Q Consensus 148 ~ei~~~~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~ 223 (387)
|+++..+ |...+.||+|+||.|| +.|+.||||+++... ..+.+.+|+.++++++||||+++++++.+ ++
T Consensus 2 w~i~~~~--~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKE--LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGG--EEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHH--eEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 5665554 4456789999998876 689999999997542 34678999999999999999999998854 46
Q ss_pred ceEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
.+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccce
Confidence 7899999999999999997543 4899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCCCC
Q 016544 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA 376 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 376 (387)
..... .....+++.|+|||++.+..+++++|||||||++|||+| |++||...+..++..+|..+.+|+++.
T Consensus 152 ~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~ 223 (262)
T d1byga_ 152 EASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 223 (262)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCT
T ss_pred ecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 65432 222356889999999999999999999999999999998 899999999999999998888887743
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=325.43 Aligned_cols=215 Identities=28% Similarity=0.484 Sum_probs=173.4
Q ss_pred CcccceeecccEEEEEEE---c-----CeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW---R-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~---~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~l 227 (387)
+|+..+.||+|+||.||. . ...||||++.+.........+.|.+|+.++++++||||+++++++.+ ...++
T Consensus 9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l 87 (273)
T d1u46a_ 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM 87 (273)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence 577788999999998863 1 24799999987766666777889999999999999999999999975 57789
Q ss_pred EEEccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
||||++++++.+++.. .+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 9999999999988765 456999999999999999999999999 999999999999999999999999999876543
Q ss_pred CCC--CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccC-CCCC
Q 016544 307 EDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RPPF 374 (387)
Q Consensus 307 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~-~~~~ 374 (387)
... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..++..++...+ +|+.
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCC
Confidence 222 1223456889999999999999999999999999999998 899999999999999987776 5544
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=328.66 Aligned_cols=215 Identities=25% Similarity=0.487 Sum_probs=179.5
Q ss_pred cCcccceeecccEEEEEEE-----cC----eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 155 LDFTNSVEITKGTFILAFW-----RG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
.+|+..+.||+|+||.||. +| ..||+|.+.... .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT-STV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCe
Confidence 3688889999999999973 23 269999887542 23345678999999999999999999999986 467
Q ss_pred EEEEEccCCCCHHHHHHHc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
++++|++.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 7889999999999988764 45999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHccCCCCCC
Q 016544 305 VKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK 375 (387)
Q Consensus 305 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 375 (387)
...... .....||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+..++...+..+.+++.+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p 235 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 235 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 433222 233467999999999999999999999999999999998 89999999999999998888877653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-44 Score=325.34 Aligned_cols=215 Identities=29% Similarity=0.437 Sum_probs=185.6
Q ss_pred CcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~ 225 (387)
+|...+.||+|+||.||. +++.||||++... ......+++.+|+.++++++||||+++++++......
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh--cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 577788999999998873 2368999999754 3455667899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcC------------------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 016544 226 MIVTEYLPKGDLRAFLKRKG------------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~------------------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp 281 (387)
+++|||+++|+|.+++.... .+++.+++.++.|++.||+|||+++ |+||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 99999999999999996532 3788899999999999999999999 99999999
Q ss_pred CCEEeCCCCCEEEEeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCC-CCCCCCCC
Q 016544 282 SNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC-PPFTMKHD 359 (387)
Q Consensus 282 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~-~pf~~~~~ 359 (387)
+|||++.++.+||+|||+|+........ ......+++.|+|||++.+..++.++|||||||++|||++|. +||.+.+.
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 9999999999999999999765433222 223456789999999999999999999999999999999985 78999999
Q ss_pred CcHHHHHHccCCCCCC
Q 016544 360 NEVPKAYAARQRPPFK 375 (387)
Q Consensus 360 ~~~~~~i~~~~~~~~~ 375 (387)
.++...+..+.+|+++
T Consensus 249 ~e~~~~v~~~~~~~~p 264 (301)
T d1lufa_ 249 EEVIYYVRDGNILACP 264 (301)
T ss_dssp HHHHHHHHTTCCCCCC
T ss_pred HHHHHHHHcCCCCCCC
Confidence 9999999888877653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-44 Score=321.62 Aligned_cols=231 Identities=29% Similarity=0.489 Sum_probs=188.9
Q ss_pred CCccccCccccCcccceeecccEEEEEEE------------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCc
Q 016544 145 VPEYEIDPHELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPN 211 (387)
Q Consensus 145 ~~~~ei~~~~~~~~~~~~lg~G~~~~v~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 211 (387)
.+.|+++.. +|...+.||+|+||.||. ++..||||+++... .......+.+|...+.++ +|||
T Consensus 5 ~~~~~i~~~--~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~Hpn 80 (299)
T d1fgka_ 5 DPRWELPRD--RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKN 80 (299)
T ss_dssp CTTTBCCGG--GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred CCcCcccHH--HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCe
Confidence 345666555 566678999999998874 12479999997653 345567788898888888 7999
Q ss_pred ceeeeeEEeeCCceEEEEEccCCCCHHHHHHHc----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 016544 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPII 275 (387)
Q Consensus 212 iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~ii 275 (387)
|++++++|.+++.+++||||+++|+|.+++... ..+++.+++.++.||+.||+|||+++ |+
T Consensus 81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---iv 157 (299)
T d1fgka_ 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CI 157 (299)
T ss_dssp BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred EEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EE
Confidence 999999999999999999999999999999754 24899999999999999999999999 99
Q ss_pred eCCCCCCCEEeCCCCCEEEEeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCC
Q 016544 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPP 353 (387)
Q Consensus 276 H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~p 353 (387)
||||||+|||++.++.+||+|||+++........ ......+++.|+|||.+.+..+++++|||||||++|||++ |++|
T Consensus 158 HrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p 237 (299)
T d1fgka_ 158 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237 (299)
T ss_dssp CSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred eeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCC
Confidence 9999999999999999999999999876544322 2344567899999999999999999999999999999998 7999
Q ss_pred CCCCCCCcHHHHHHccCCCCCCCChhhhhhcc
Q 016544 354 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385 (387)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 385 (387)
|.+.+..++.+.+..+.+|+++ ..+|++|
T Consensus 238 ~~~~~~~~~~~~i~~~~~~~~p---~~~~~~l 266 (299)
T d1fgka_ 238 YPGVPVEELFKLLKEGHRMDKP---SNCTNEL 266 (299)
T ss_dssp STTCCHHHHHHHHHTTCCCCCC---SSCCHHH
T ss_pred CCCCCHHHHHHHHHcCCCCCCC---ccchHHH
Confidence 9999988888888887777663 3344444
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-44 Score=326.08 Aligned_cols=198 Identities=28% Similarity=0.444 Sum_probs=165.2
Q ss_pred Ccccce-eecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHc-CCCCcceeeeeEEee----CCc
Q 016544 156 DFTNSV-EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQ----SSP 224 (387)
Q Consensus 156 ~~~~~~-~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~~iv~l~~~~~~----~~~ 224 (387)
+|.+.. .||+|+||.||. +|+.||||++... ..+.+|+.++.+ .+||||++++++|.+ +..
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 566554 599999999874 5789999998642 346779988655 489999999999875 356
Q ss_pred eEEEEEccCCCCHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC---CCCEEEEeecC
Q 016544 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV 299 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfg~ 299 (387)
+|+|||||+||+|.+++.+.+ .+++.++..++.||+.||.|||+++ |+||||||+|||++. .+.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 899999999999999998753 5899999999999999999999999 999999999999985 45799999999
Q ss_pred ccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
++..... .......||+.|+|||++.+..++.++|||||||++|+|+||++||.+.+.......+
T Consensus 161 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~ 225 (335)
T d2ozaa1 161 AKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 225 (335)
T ss_dssp CEECCCC--CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------
T ss_pred eeeccCC--CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH
Confidence 9876543 2334457899999999999999999999999999999999999999987776655544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=321.36 Aligned_cols=222 Identities=28% Similarity=0.438 Sum_probs=171.5
Q ss_pred CccccCccccCcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCccee
Q 016544 146 PEYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQ 214 (387)
Q Consensus 146 ~~~ei~~~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~ 214 (387)
..||+... +|...+.||+|+||.||. +++.||||++.... .....+.+..|..++.++ +|+||+.
T Consensus 6 ~~wei~~~--~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 6 SKWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp HHHBCCGG--GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccccHH--HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence 34566543 577788999999999874 24689999987542 344556677788877776 6899999
Q ss_pred eeeEEeeC-CceEEEEEccCCCCHHHHHHHc----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 016544 215 FLGAVTQS-SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (387)
Q Consensus 215 l~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 277 (387)
+++++... ..+++||||+++|+|.+++... ..+++.+++.++.||++||.|||+++ |+||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHr 158 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 158 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCC
Confidence 99988764 4689999999999999999753 23788999999999999999999999 9999
Q ss_pred CCCCCCEEeCCCCCEEEEeecCccccccCCCC-CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcC-CCCCC
Q 016544 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFT 355 (387)
Q Consensus 278 Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~pf~ 355 (387)
||||+|||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+|| .+||.
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999865543332 23345689999999999999999999999999999999986 57898
Q ss_pred CCCCCcHHH-HHHccCCCCC
Q 016544 356 MKHDNEVPK-AYAARQRPPF 374 (387)
Q Consensus 356 ~~~~~~~~~-~i~~~~~~~~ 374 (387)
+.+..+.+. .+..+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~ 258 (299)
T d1ywna1 239 GVKIDEEFCRRLKEGTRMRA 258 (299)
T ss_dssp TCCCSHHHHHHHHHTCCCCC
T ss_pred CCCHHHHHHHHHhcCCCCCC
Confidence 876655544 4444446655
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=321.67 Aligned_cols=205 Identities=29% Similarity=0.430 Sum_probs=171.6
Q ss_pred eeecccEEEEEEE-----cCeEEEEEEcCcccCCC--HHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEccC
Q 016544 161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233 (387)
Q Consensus 161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 233 (387)
+.||+|+||.||. +|+.||||++....... ....+.+.+|+.++++++||||+++++++..++.+|+||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 5799999999984 58899999987543321 1123568899999999999999999999999999999999998
Q ss_pred CCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCccc
Q 016544 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313 (387)
Q Consensus 234 ~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 313 (387)
++++..+......+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... .....
T Consensus 84 ~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~~~ 159 (299)
T d1ua2a_ 84 TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTH 159 (299)
T ss_dssp EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCCC
T ss_pred chHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-ccccc
Confidence 8877777666667999999999999999999999999 9999999999999999999999999997655432 22334
Q ss_pred CCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 314 QDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 314 ~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
..||+.|+|||++.+. .++.++|||||||++|||+||++||.+.++.+.+.+|...
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~ 216 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 216 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHh
Confidence 5689999999998754 6799999999999999999999999998888877777543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-43 Score=317.95 Aligned_cols=221 Identities=26% Similarity=0.428 Sum_probs=189.5
Q ss_pred ccccCccccCcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeee
Q 016544 147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216 (387)
Q Consensus 147 ~~ei~~~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~ 216 (387)
.||+++. +|...+.||+|+||.||. .++.||||+++.. ........+.+|+.++++++||||++++
T Consensus 14 ~~ei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 14 EWEVARE--KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp TTBCCGG--GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred ceeecHH--HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 5777765 566778999999998873 2478999999754 3455567789999999999999999999
Q ss_pred eEEeeCCceEEEEEccCCCCHHHHHHHc----------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEe
Q 016544 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRK----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286 (387)
Q Consensus 217 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~----------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill 286 (387)
+++..+...++||||+++|+|.+++... ..+++..+..++.|+++||.|||+++ |+||||||+|||+
T Consensus 90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 166 (308)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceee
Confidence 9999999999999999999999998642 23688899999999999999999998 9999999999999
Q ss_pred CCCCCEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCcHHH
Q 016544 287 DDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPK 364 (387)
Q Consensus 287 ~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~pf~~~~~~~~~~ 364 (387)
+.++++||+|||+++......... .....+|+.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+..++..
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~ 246 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998664432222 2334578999999999999999999999999999999997 68999999999999
Q ss_pred HHHccCCCCC
Q 016544 365 AYAARQRPPF 374 (387)
Q Consensus 365 ~i~~~~~~~~ 374 (387)
.+..+.+++.
T Consensus 247 ~i~~~~~~~~ 256 (308)
T d1p4oa_ 247 FVMEGGLLDK 256 (308)
T ss_dssp HHHTTCCCCC
T ss_pred HHHhCCCCCC
Confidence 9988887665
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=319.23 Aligned_cols=220 Identities=30% Similarity=0.479 Sum_probs=180.7
Q ss_pred CcccceeecccEEEEEEE-----cCe--EEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceeeeeEEeeCCceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~~~~~~~l 227 (387)
+|+..+.||+|+||.||. +|. .||||.+... ......+.+.+|+.++.++ +||||+++++++..++.+++
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 455567899999998873 333 5788887543 2334456799999999998 79999999999999999999
Q ss_pred EEEccCCCCHHHHHHHc----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCC
Q 016544 228 VTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~----------------~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 291 (387)
||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence 99999999999999753 45899999999999999999999998 999999999999999999
Q ss_pred EEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCcHHHHHHccC
Q 016544 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 292 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg-~~pf~~~~~~~~~~~i~~~~ 370 (387)
+||+|||+++....... .....+|+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..++...+..+.
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 99999999976543322 2234578999999999999999999999999999999996 56899999999999998877
Q ss_pred CCCCCCChhhhhhcc
Q 016544 371 RPPFKAPAKLYARGL 385 (387)
Q Consensus 371 ~~~~~~~~~~~~~~l 385 (387)
+|+++ ..+|+++
T Consensus 244 ~~~~~---~~~~~~~ 255 (309)
T d1fvra_ 244 RLEKP---LNCDDEV 255 (309)
T ss_dssp CCCCC---TTBCHHH
T ss_pred CCCCC---ccCCHHH
Confidence 77663 3445444
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=315.49 Aligned_cols=221 Identities=28% Similarity=0.418 Sum_probs=186.1
Q ss_pred ccccCccccCcccceeecccEEEEEEE----------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC-CCCcceee
Q 016544 147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQF 215 (387)
Q Consensus 147 ~~ei~~~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l 215 (387)
.||++.. +|...+.||+|+||.||. .++.||||+++... .......+.+|+.+++.+ +||||+++
T Consensus 17 ~~~~~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 17 KWEFPRN--RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp GGBCCGG--GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHH--HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 4666654 555678999999999874 34689999997643 455667899999999999 69999999
Q ss_pred eeEEeeCCceEEEEEccCCCCHHHHHHHcC------------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 016544 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277 (387)
Q Consensus 216 ~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------------~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~ 277 (387)
++++.....++++|||+++|+|.+++.+.. .+++..+..++.||++||+|||+++ ++||
T Consensus 93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHr 169 (311)
T d1t46a_ 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHR 169 (311)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 999999999999999999999999997543 4889999999999999999999999 9999
Q ss_pred CCCCCCEEeCCCCCEEEEeecCccccccCCCCC-cccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHc-CCCCCC
Q 016544 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT 355 (387)
Q Consensus 278 Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt-g~~pf~ 355 (387)
||||+||+++.++.++++|||+++......... .....+|+.|+|||.+.+..++.++|||||||++|||+| |.+||.
T Consensus 170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998765433222 233567999999999999999999999999999999998 778888
Q ss_pred CCCCCcHHHHHHccC-CCCC
Q 016544 356 MKHDNEVPKAYAARQ-RPPF 374 (387)
Q Consensus 356 ~~~~~~~~~~i~~~~-~~~~ 374 (387)
..+..+.+.++...+ +|..
T Consensus 250 ~~~~~~~~~~~i~~~~~~~~ 269 (311)
T d1t46a_ 250 GMPVDSKFYKMIKEGFRMLS 269 (311)
T ss_dssp TCCSSHHHHHHHHHTCCCCC
T ss_pred CCCHHHHHHHHHhcCCCCCC
Confidence 877777776665555 5544
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=313.26 Aligned_cols=211 Identities=28% Similarity=0.458 Sum_probs=173.2
Q ss_pred ceeecccEEEEEEE--------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee-CCceEEEEE
Q 016544 160 SVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTE 230 (387)
Q Consensus 160 ~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~~~~~lv~e 230 (387)
.+.||+|+||.||. ....||||.+... ......++|.+|++++++++||||+++++++.. ++..++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 46799999999973 1236999998743 456677889999999999999999999999875 467999999
Q ss_pred ccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCC
Q 016544 231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 309 (387)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999999988544 4778889999999999999999999 999999999999999999999999999875433222
Q ss_pred ---CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCC-CCCCCCcHHHHHHccCCCCCC
Q 016544 310 ---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPKAYAARQRPPFK 375 (387)
Q Consensus 310 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~~~~ 375 (387)
......||+.|+|||.+.+..++.++||||||+++|||+||..|| ...+..++...+..+.+|..+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p 256 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 256 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCC
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 223346789999999999999999999999999999999966655 456667788888888777653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=313.98 Aligned_cols=207 Identities=26% Similarity=0.488 Sum_probs=171.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||||+++.... .+...+.+.+|++++++++||||+++++++.++..+|+|||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 677889999999998874 488999999975432 22335678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCC
Q 016544 231 YLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308 (387)
Q Consensus 231 ~~~~~sL~~~l~~--~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 308 (387)
|+.+ ++.+++.. ...+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+..... .
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-V 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-S
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC-c
Confidence 9965 55555543 345999999999999999999999999 999999999999999999999999999766433 2
Q ss_pred CCcccCCCCCcccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 309 RPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 309 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
.......||+.|+|||.+.... ++.++|+|||||++|+|++|+.||.+.+..+...++..
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~ 217 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHH
Confidence 3334456899999999887765 57899999999999999999999998877666666543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=321.20 Aligned_cols=212 Identities=24% Similarity=0.401 Sum_probs=182.8
Q ss_pred CcccceeecccEEEEEEE--------cCeEEEEEEcCcccCC-CHHHHHHHHHHHHHHHcCCC-CcceeeeeEEeeCCce
Q 016544 156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~~ 225 (387)
+|...+.||+|+||.||. +|+.||||.+.+.... .....+.+.+|+.++++++| |||+++++++.+...+
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~ 104 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 104 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence 588889999999999874 3789999998754321 12224567889999999966 8999999999999999
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
+++|||+.+|+|.+++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..+..
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 999999999999999999888999999999999999999999999 99999999999999999999999999987655
Q ss_pred CCCCCcccCCCCCcccccccccCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
..........|++.|++||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+..+.
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~ 248 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 248 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 444444456789999999999765 46789999999999999999999999988888877776655
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=310.72 Aligned_cols=197 Identities=27% Similarity=0.413 Sum_probs=167.6
Q ss_pred ccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCH---HHHHHHHHHHHHHHcCC--CCcceeeeeEEeeCC
Q 016544 154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIR--HPNVVQFLGAVTQSS 223 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~ 223 (387)
+-+|+..+.||+|+||.||. +|+.||||++.+...... ....++.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 34688889999999999873 588999999875443321 11233567999999986 899999999999999
Q ss_pred ceEEEEEccCC-CCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-CCCEEEEeecCcc
Q 016544 224 PMMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSK 301 (387)
Q Consensus 224 ~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg~~~ 301 (387)
..++||||+.+ +++.+++.+...+++.++..++.||++||.|||+++ |+||||||+|||++. ++.+||+|||+|.
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 99999999976 688899988888999999999999999999999999 999999999999985 4789999999997
Q ss_pred ccccCCCCCcccCCCCCcccccccccCCCC-CCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
.... ...+...||+.|+|||++.+..+ +.++|||||||++|+|+||+.||.+
T Consensus 160 ~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 160 LLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp ECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred eccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 6542 22344578999999999987765 5679999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.2e-42 Score=308.11 Aligned_cols=208 Identities=26% Similarity=0.478 Sum_probs=175.2
Q ss_pred CcccceeecccEEEEEEE----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEEc
Q 016544 156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 231 (387)
+|...+.||+|+||.|+. +|+.||||++..... .+...+.+.+|+.++++++||||+++++++..++..++++|+
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 577788999999999874 478999999976533 233346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCCc
Q 016544 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311 (387)
Q Consensus 232 ~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 311 (387)
+.++.+..+....+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||.+........ ..
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY 157 (286)
T ss_dssp CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc-cc
Confidence 987777777666777999999999999999999999999 99999999999999999999999999987654322 22
Q ss_pred ccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 312 TCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 312 ~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
....+++.|+|||.+.+. .++.++|+|||||++|||++|++||.+.+..+.+.++..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~ 215 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 334578999999998765 568999999999999999999999998887777666643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.1e-41 Score=303.34 Aligned_cols=200 Identities=19% Similarity=0.251 Sum_probs=170.3
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCC-CcceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~l~~~~~~~~~~~lv~ 229 (387)
+|...+.||+|+||.||. +|+.||||++...... ..+++|++.++.+.| +|++.+++++......++||
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 678889999999999874 5889999988654221 346778899999865 89999999999999999999
Q ss_pred EccCCCCHHHHHHHcC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC-----CCCEEEEeecCcccc
Q 016544 230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-----SGNLKVADFGVSKLL 303 (387)
Q Consensus 230 e~~~~~sL~~~l~~~~-~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-----~~~~kl~Dfg~~~~~ 303 (387)
||+ +++|.+++...+ .++..++..++.|++.||+|||++| |+||||||+|||++. ++.+||+|||+|+..
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999 789999997754 5999999999999999999999999 999999999999974 567999999999876
Q ss_pred ccCCC------CCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHH
Q 016544 304 TVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 364 (387)
Q Consensus 304 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~ 364 (387)
..... .......||+.|+|||++.+..+++++|||||||++|||+||+.||.+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~ 223 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence 53322 12234578999999999999999999999999999999999999999876665433
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=308.27 Aligned_cols=209 Identities=28% Similarity=0.446 Sum_probs=170.3
Q ss_pred ccCcccceeecccEEEEEEE------cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcC---CCCcceeeeeEEee---
Q 016544 154 ELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQ--- 221 (387)
Q Consensus 154 ~~~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~~iv~l~~~~~~--- 221 (387)
+.+|...+.||+|+||.|+. .++.||||++....... .....+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 45788889999999999874 25679999986543322 1122345677776655 79999999999853
Q ss_pred --CCceEEEEEccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeec
Q 016544 222 --SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298 (387)
Q Consensus 222 --~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 298 (387)
...++++||++.++++...... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 2468999999988766554443 344899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
++...... .......||+.|+|||++.+.+++.++|||||||++|||++|++||.+.++.+.+.+|..
T Consensus 162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 229 (305)
T d1blxa_ 162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229 (305)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 98765432 233456789999999999999999999999999999999999999999888777777654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=301.05 Aligned_cols=196 Identities=27% Similarity=0.449 Sum_probs=157.0
Q ss_pred CcccceeecccEEEEEE---EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC----ceEEE
Q 016544 156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMMIV 228 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~~lv 228 (387)
+|...+.||+|+||.|| ++|+.||||++... .........|+..+.+++||||+++++++..+. .+++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 45566789999998775 68999999998643 122222334555556789999999999998654 58999
Q ss_pred EEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC-----CCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK-----PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 229 ~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-----~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
|||+++|+|.+++++. .+++..+..++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 9999999999999875 5899999999999999999999741 123999999999999999999999999999876
Q ss_pred ccCCCC---CcccCCCCCcccccccccCCC------CCCchhHHHHHHHHHHHHcCCCCCCC
Q 016544 304 TVKEDR---PLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEGCPPFTM 356 (387)
Q Consensus 304 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~Dv~slG~il~elltg~~pf~~ 356 (387)
...... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 543321 223467899999999987643 56789999999999999999988753
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-40 Score=302.04 Aligned_cols=204 Identities=27% Similarity=0.427 Sum_probs=169.3
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------ 223 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~------ 223 (387)
..|...+.||+|+||.|+. +|+.||||+++... ......+.+.+|+.++++++||||++++++|...+
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4688889999999999874 48999999998654 34556678899999999999999999999998654
Q ss_pred ceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 224 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
.+|+||||+ +.+|..+++. +.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++...
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceecc
Confidence 479999999 6688877654 56999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHc
Q 016544 304 TVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368 (387)
Q Consensus 304 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~ 368 (387)
.. ..+...+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+......++..
T Consensus 172 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~ 233 (346)
T d1cm8a_ 172 DS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233 (346)
T ss_dssp CS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh
Confidence 43 23445689999999998764 568999999999999999999999998876666555543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=300.94 Aligned_cols=205 Identities=28% Similarity=0.455 Sum_probs=167.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCC----ceE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMM 226 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~----~~~ 226 (387)
+|...+.||+|+||.|+. +|+.||||++.+. ......+.+.+|+.++++++||||+++++++.... ..+
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh--cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 588889999999998874 5899999999753 34556678899999999999999999999997653 234
Q ss_pred EEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccC
Q 016544 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306 (387)
Q Consensus 227 lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 306 (387)
++++++.+|+|.+++... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 455566789999999764 5999999999999999999999999 999999999999999999999999999765443
Q ss_pred CC--CCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 307 ED--RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 307 ~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.. .......||+.|+|||++.. ..+++++||||+||++|+|++|+.||.+.+.......+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~ 225 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH
Confidence 22 22344568999999999855 46688999999999999999999999887655444443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=302.14 Aligned_cols=211 Identities=24% Similarity=0.367 Sum_probs=171.6
Q ss_pred cCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEee--------
Q 016544 155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-------- 221 (387)
Q Consensus 155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-------- 221 (387)
-+|...+.||+|+||.|+. +|+.||||++...... +....++.+|+.++++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 3678889999999998874 5789999998765432 2334567889999999999999999998865
Q ss_pred CCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcc
Q 016544 222 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301 (387)
Q Consensus 222 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~ 301 (387)
+..++++|||+.++.+..+......+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence 3458999999987766655555667999999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCC---CCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 302 LLTVKED---RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 302 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
....... .......||+.|+|||++.+. .+++++|||||||++|||++|+.||.+.++......+...
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence 6653221 222335689999999998765 6899999999999999999999999988877776666443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-40 Score=304.17 Aligned_cols=204 Identities=28% Similarity=0.419 Sum_probs=167.4
Q ss_pred ccccCcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC----
Q 016544 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS---- 222 (387)
Q Consensus 152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~---- 222 (387)
+.+.+|+..+.||+|+||.||. +|+.||||++..... ...+|+.++++++||||++++++|...
T Consensus 17 ~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~ 89 (350)
T d1q5ka_ 17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 89 (350)
T ss_dssp CEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred cccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence 3455788889999999999984 588999999875432 234699999999999999999998543
Q ss_pred --CceEEEEEccCCCCHHHHH---HHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEe
Q 016544 223 --SPMMIVTEYLPKGDLRAFL---KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVAD 296 (387)
Q Consensus 223 --~~~~lv~e~~~~~sL~~~l---~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~D 296 (387)
..+++||||++++.+..+. .....+++.++..++.||+.||+|||++| |+||||||+|||++.++ .+||+|
T Consensus 90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~D 166 (350)
T d1q5ka_ 90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD 166 (350)
T ss_dssp SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECC
T ss_pred CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEec
Confidence 3478999999765433332 23456999999999999999999999999 99999999999999765 899999
Q ss_pred ecCccccccCCCCCcccCCCCCcccccccccC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 016544 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367 (387)
Q Consensus 297 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~ 367 (387)
||++...... .......|++.|+|||.+.+ ..++.++|||||||++|||++|++||...+..+.+.+|.
T Consensus 167 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~ 236 (350)
T d1q5ka_ 167 FGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236 (350)
T ss_dssp CTTCEECCTT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH
T ss_pred ccchhhccCC--cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHH
Confidence 9999876433 22334578999999998875 478999999999999999999999999887766666654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-40 Score=298.45 Aligned_cols=202 Identities=18% Similarity=0.227 Sum_probs=161.6
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCc-ceeeeeEEeeCCceEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSSPMMIVT 229 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~l~~~~~~~~~~~lv~ 229 (387)
+|+..+.||+|+||.||. +|+.||||++...... +++..|+.++++++|++ |+.+.+++......++||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 478889999999999874 4789999987654322 34778999999997665 555566667788899999
Q ss_pred EccCCCCHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCC---CCCEEEEeecCcccccc
Q 016544 230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTV 305 (387)
Q Consensus 230 e~~~~~sL~~~l~~-~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfg~~~~~~~ 305 (387)
||+ +++|...+.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++. +..++|+|||+|+.+..
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 999 5677666654 456999999999999999999999999 999999999999864 45699999999987654
Q ss_pred CCCC------CcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 016544 306 KEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366 (387)
Q Consensus 306 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i 366 (387)
.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...........+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~ 225 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH
Confidence 3221 223457899999999999999999999999999999999999999887665554443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-39 Score=290.99 Aligned_cols=207 Identities=23% Similarity=0.429 Sum_probs=177.0
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeCCceEEEEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 230 (387)
+|...+.||+|+||.|+. +|+.||||+++.... .....+++.+|+.+++.++||||+++++++......+++++
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 578889999999999874 578999999976543 34456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccccCCCCC
Q 016544 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP 310 (387)
Q Consensus 231 ~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 310 (387)
++.+++|..++...+.+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.+....... ..
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RC 157 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC-cc
Confidence 9999999998888888999999999999999999999999 9999999999999999999999999998765432 23
Q ss_pred cccCCCCCcccccccccCCC-CCCchhHHHHHHHHHHHHcCCCCCC-CCCCCcHHHHHH
Q 016544 311 LTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVPKAYA 367 (387)
Q Consensus 311 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~elltg~~pf~-~~~~~~~~~~i~ 367 (387)
.....+++.|+|||.+.+.. ++.++|||||||++|||++|+.||. +.+..+...++.
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~ 216 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHH
Confidence 33345678899999987764 6899999999999999999999864 444444555543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-39 Score=298.62 Aligned_cols=206 Identities=25% Similarity=0.340 Sum_probs=165.9
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC------Cc
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP 224 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~~ 224 (387)
+|...+.||+|+||.|+. +|+.||||++..... +......+.+|+.++++++||||++++++|... ..
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 588889999999999874 589999999976543 455667789999999999999999999999643 57
Q ss_pred eEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCccccc
Q 016544 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304 (387)
Q Consensus 225 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 304 (387)
+|+||||+.+ ++.+.+. ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.++++|||+++...
T Consensus 97 ~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccc
Confidence 8999999966 4444443 45899999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHccC
Q 016544 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370 (387)
Q Consensus 305 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~~ 370 (387)
.. .......+|+.|+|||++.+..+++++||||+||++|+|++|++||.+.+......++....
T Consensus 171 ~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~ 234 (355)
T d2b1pa1 171 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhc
Confidence 32 23344568999999999999999999999999999999999999999888777766665433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.5e-38 Score=288.29 Aligned_cols=190 Identities=23% Similarity=0.433 Sum_probs=162.7
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeC--CceEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS--SPMMI 227 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~--~~~~l 227 (387)
+|...+.||+|+||.|+. +|+.||||+++... .+++.+|+.+++.++ ||||++++++|... ..+++
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 588889999999999974 58999999987432 356788999999995 99999999999744 56999
Q ss_pred EEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCC-CEEEEeecCccccccC
Q 016544 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVK 306 (387)
Q Consensus 228 v~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 306 (387)
||||+.+++|..+. ..+++.++..++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+|......
T Consensus 110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999997653 35899999999999999999999999 99999999999998655 5899999999876433
Q ss_pred CCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 016544 307 EDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHD 359 (387)
Q Consensus 307 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~ 359 (387)
.......+|+.|+|||.+.+. .++.++|||||||++|+|++|+.||.....
T Consensus 184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 184 --QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp --CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred --CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 233445689999999998875 478999999999999999999999976543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=292.97 Aligned_cols=205 Identities=28% Similarity=0.408 Sum_probs=170.2
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcceeeeeEEeeC-----Cce
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM 225 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~-----~~~ 225 (387)
+|...+.||+|+||.|+. +|+.||||++..... +....+.+.+|+.++++++||||+++++++... ...
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 588889999999998874 589999999986543 445566788999999999999999999998643 334
Q ss_pred EEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecCcccccc
Q 016544 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305 (387)
Q Consensus 226 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 305 (387)
+++++++.+|+|.+++.. +.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++.....
T Consensus 98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc
Confidence 666777889999999865 46999999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCCCcccCCCCCcccccccccCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHcc
Q 016544 306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369 (387)
Q Consensus 306 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~elltg~~pf~~~~~~~~~~~i~~~ 369 (387)
......|++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+......+|...
T Consensus 174 ----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~ 234 (348)
T d2gfsa1 174 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234 (348)
T ss_dssp ----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 22345678899999987775 4688999999999999999999999988877777666544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=4.2e-32 Score=251.84 Aligned_cols=192 Identities=22% Similarity=0.359 Sum_probs=152.0
Q ss_pred CcccceeecccEEEEEEE-----cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-----------CCcceeeeeEE
Q 016544 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----------HPNVVQFLGAV 219 (387)
Q Consensus 156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~iv~l~~~~ 219 (387)
+|+..+.||+|+||.|+. +|+.||||+++.. ....+.+.+|+.+++.+. |+||+++++++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 488899999999999883 5899999999753 334466788988888775 57899999988
Q ss_pred eeC--CceEEEEEccCCCCH-HHHHH--HcCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCCEEeCCCCC--
Q 016544 220 TQS--SPMMIVTEYLPKGDL-RAFLK--RKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGN-- 291 (387)
Q Consensus 220 ~~~--~~~~lv~e~~~~~sL-~~~l~--~~~~l~~~~~~~i~~qi~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~-- 291 (387)
... ...+++++++..+.. ..... ....+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccc
Confidence 643 456666666655433 33332 23458899999999999999999998 77 999999999999986653
Q ss_pred ----EEEEeecCccccccCCCCCcccCCCCCcccccccccCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 016544 292 ----LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358 (387)
Q Consensus 292 ----~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~elltg~~pf~~~~ 358 (387)
++++|||.+...... .....+|+.|+|||++.+..++.++|+||+||++++|++|+.||....
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 899999998765422 233568999999999999999999999999999999999999997543
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.90 E-value=6.7e-24 Score=163.36 Aligned_cols=106 Identities=30% Similarity=0.393 Sum_probs=99.9
Q ss_pred chHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHH
Q 016544 41 EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120 (387)
Q Consensus 41 ~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~ 120 (387)
.|||++||..|+.++|++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..++.+
T Consensus 3 ~tpL~~A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~ 82 (118)
T d1myoa_ 3 DKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVS 82 (118)
T ss_dssp HHHHHHHHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCH
T ss_pred ChHHHHHHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchh
Confidence 58999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCccccccCCCC
Q 016544 121 VIKLLEKHGAKPLMAPMHVKHAREVP 146 (387)
Q Consensus 121 ~~~~L~~~g~~~~~~~~~~~~~~~~~ 146 (387)
++++|+++|+++........++....
T Consensus 83 ~v~~Ll~~Gad~~~~d~~G~t~l~~a 108 (118)
T d1myoa_ 83 CVKLLLSKGADKTVKGPDGLTALEAT 108 (118)
T ss_dssp HHHHHHTTCCCSSSSSSSTCCCCCTC
T ss_pred hhhhhhcccccceeeCCCCCCHHHHH
Confidence 99999999999988777766665444
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.88 E-value=5.8e-23 Score=165.26 Aligned_cols=99 Identities=20% Similarity=0.198 Sum_probs=92.8
Q ss_pred CCCcchHHHHHHhh---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccc
Q 016544 37 EIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113 (387)
Q Consensus 37 ~~~g~t~l~~a~~~---~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a 113 (387)
+..|+||||+|+.. |+.+++++|+++|+|+|.+|.+|+||||+||..|+.+++++|+++|++++.+|..|.||||+|
T Consensus 42 ~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A 121 (154)
T d1dcqa1 42 HEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIA 121 (154)
T ss_dssp SSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred CCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccccccccccccccccccCccccccCCCCCCHHHHH
Confidence 56799999999975 678999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccchHHHHHHHHhhCCCCCCC
Q 016544 114 IYYKNHEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 114 ~~~~~~~~~~~L~~~g~~~~~~ 135 (387)
+..++.+++++|++.++.....
T Consensus 122 ~~~~~~~i~~~L~~~~~~~~~~ 143 (154)
T d1dcqa1 122 KRLKHEHCEELLTQALSGRFNS 143 (154)
T ss_dssp HHTTCHHHHHHHHHHHTTCCCS
T ss_pred HHcCCHHHHHHHHHhCCCCCCc
Confidence 9999999999999988765443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=8.3e-23 Score=171.17 Aligned_cols=160 Identities=19% Similarity=0.136 Sum_probs=115.5
Q ss_pred cceeecccEEEEEEE----cCeEEEEEEcCcccCC---------------CHHHHHHHHHHHHHHHcCCCCcceeeeeEE
Q 016544 159 NSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---------------DDDRVRAFRDELALLQKIRHPNVVQFLGAV 219 (387)
Q Consensus 159 ~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~ 219 (387)
..+.||+|+||.||. +|+.||||+++..... ..........|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 467899999998874 6899999987542211 011223456688899999999999988663
Q ss_pred eeCCceEEEEEccCCCCHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCCEEeCCCCCEEEEeecC
Q 016544 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299 (387)
Q Consensus 220 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~i~~qi~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~ 299 (387)
..+++|||+++..+.+ ++...+..++.|++.++.|||+++ |+||||||+|||+++++ ++|+|||+
T Consensus 84 ----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDFG~ 148 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQ 148 (191)
T ss_dssp ----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCCTT
T ss_pred ----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEECCC
Confidence 2379999998765432 556677889999999999999999 99999999999999754 89999999
Q ss_pred ccccccCCCCCcccCCCCCccccc------ccccCCCCCCchhHHHHHHH
Q 016544 300 SKLLTVKEDRPLTCQDTSCRYVAP------EVFKNEEYDTKVDVFSFALI 343 (387)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~y~aP------E~~~~~~~~~~~Dv~slG~i 343 (387)
|........ ..|+.. +.+ ...++.++|+||+.--
T Consensus 149 a~~~~~~~~---------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 149 SVEVGEEGW---------REILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CEETTSTTH---------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred cccCCCCCc---------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 865432211 011111 111 3467888999997543
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=2.9e-22 Score=156.87 Aligned_cols=94 Identities=30% Similarity=0.364 Sum_probs=85.8
Q ss_pred hHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHH
Q 016544 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121 (387)
Q Consensus 42 t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~ 121 (387)
+.||.||..|+.++|++|+++|+|+|.+|.+|+||||+||..|+.+++++|+++|++++.+|.+|+||||+|+.+|+.++
T Consensus 3 ~lL~~A~~~G~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~ 82 (130)
T d1ycsb1 3 ALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQV 82 (130)
T ss_dssp HHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHH
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCC
Q 016544 122 IKLLEKHGAKPLMA 135 (387)
Q Consensus 122 ~~~L~~~g~~~~~~ 135 (387)
+++|+++|+++...
T Consensus 83 v~~Ll~~ga~v~~~ 96 (130)
T d1ycsb1 83 CKFLVESGAAVFAM 96 (130)
T ss_dssp HHHHHHTTCCTTCC
T ss_pred HHHHHHcCCCcccc
Confidence 99999999887643
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.85 E-value=3e-22 Score=154.00 Aligned_cols=87 Identities=30% Similarity=0.271 Sum_probs=81.9
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|++.++..|+||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|+|++.+|..|.|
T Consensus 24 ~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~~v~~Ll~~Gad~~~~d~~G~t 103 (118)
T d1myoa_ 24 KGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLT 103 (118)
T ss_dssp TTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCHHHHHHHTTCCCSSSSSSSTCC
T ss_pred hhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchhhhhhhhcccccceeeCCCCCC
Confidence 45667777788899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccc
Q 016544 109 PLGDAIY 115 (387)
Q Consensus 109 pl~~a~~ 115 (387)
|||+|..
T Consensus 104 ~l~~a~~ 110 (118)
T d1myoa_ 104 ALEATDN 110 (118)
T ss_dssp CCCTCSS
T ss_pred HHHHHhH
Confidence 9999954
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=1.7e-21 Score=152.45 Aligned_cols=102 Identities=23% Similarity=0.110 Sum_probs=90.9
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCc-CCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-WGS 107 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~-~g~ 107 (387)
++.|++.++.+|+||||+||..|+.+++++|++.|+++|.+|.+|+||||+|+..|+.+++++|+++|++++..+. .|.
T Consensus 23 ~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~v~~~~~~~~~ 102 (130)
T d1ycsb1 23 EVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQ 102 (130)
T ss_dssp TTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSSSCC
T ss_pred cCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHHHHHHHHcCCCcccccCCCCC
Confidence 4567777788899999999999999999999999999999999999999999999999999999999999998775 578
Q ss_pred Cccc--cccccchHHHHHHHHhhCC
Q 016544 108 TPLG--DAIYYKNHEVIKLLEKHGA 130 (387)
Q Consensus 108 tpl~--~a~~~~~~~~~~~L~~~g~ 130 (387)
||++ .|...|+.+++++|...+.
T Consensus 103 ~~~~~~~a~~~g~~eiv~~L~~~~~ 127 (130)
T d1ycsb1 103 TAADKCEEMEEGYTQCSQFLYGVQE 127 (130)
T ss_dssp CHHHHCCSSSTTCCCHHHHHHHHHH
T ss_pred CHHHHHHHHHcChHHHHHHHHhHHH
Confidence 8755 4567788999999987643
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1.6e-21 Score=151.49 Aligned_cols=97 Identities=23% Similarity=0.323 Sum_probs=72.4
Q ss_pred CCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCC-cHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNR-TALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~-t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
+.|++..+..|.||||+|+ .|+.+++++|+++|+++|.+|..|. ||||+|+..|+.+++++|+++|++++.+|..|+|
T Consensus 26 gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~G~T 104 (125)
T d1bi7b_ 26 GANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRL 104 (125)
T ss_dssp TCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTCCC
T ss_pred CCccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccCCCCC
Confidence 3445555566667777654 5778888888888888887777654 5788888888888888888888888888888888
Q ss_pred ccccccccchHHHHHHHHh
Q 016544 109 PLGDAIYYKNHEVIKLLEK 127 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~ 127 (387)
|||+|+.+|+.+++++|++
T Consensus 105 ~l~~A~~~g~~~~v~~Lls 123 (125)
T d1bi7b_ 105 PVDLAEELGHRDVARYLRA 123 (125)
T ss_dssp HHHHHHHHTCHHHHHHHSS
T ss_pred HHHHHHHcCCHHHHHHHHh
Confidence 8888888888888877764
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.81 E-value=2.3e-20 Score=163.18 Aligned_cols=100 Identities=33% Similarity=0.408 Sum_probs=93.4
Q ss_pred CCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCC-CCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcc
Q 016544 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (387)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~-d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl 110 (387)
+.+.++..|+||||+||..|+.+++++|++++++.+.. +..|+||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus 150 ~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~TpL~~A~~~~~~~~v~~Ll~~gadin~~d~~g~t~L 229 (255)
T d1oy3d_ 150 QLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPL 229 (255)
T ss_dssp GTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHH
T ss_pred ccccccccCcccccccccccccccccchhcccccccccccccccccccccccccHHHHHHHHHHCCCCCCCCCCCCCCHH
Confidence 34556677889999999999999999999999998865 67799999999999999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHhhCCC
Q 016544 111 GDAIYYKNHEVIKLLEKHGAK 131 (387)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~g~~ 131 (387)
|+|+..++.+++++|+++||+
T Consensus 230 ~~A~~~~~~~i~~~Ll~~Ga~ 250 (255)
T d1oy3d_ 230 GSALLRPNPILARLLRAHGAP 250 (255)
T ss_dssp HHHHTSSCHHHHHHHHHTTCC
T ss_pred HHHHHCCCHHHHHHHHHcCCC
Confidence 999999999999999999996
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=9.7e-20 Score=156.14 Aligned_cols=114 Identities=26% Similarity=0.259 Sum_probs=105.8
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|.+..+.+|.||||+|+..|+.+++++|+++|+|++.+|..|.||||+|+..++.+++++|++.|++++.+|..|+|
T Consensus 92 ~~~d~~~~d~~g~tpL~~A~~~~~~e~~~~Ll~~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d~~g~T 171 (223)
T d1uoha_ 92 KGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNT 171 (223)
T ss_dssp TTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTCCC
T ss_pred cCceeEeeCCCCCchhhHHHHcCCHHHHHHHHHCCCCCCCcCCCCCccchhhhhcCCcchhhhhccccceeeeccCCCCc
Confidence 45677788888999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
|||+|+..++.+++++|++.|+++........++
T Consensus 172 pL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~g~tp 205 (223)
T d1uoha_ 172 PLHLACDEERVEEAKLLVSQGASIYIENKEEKTP 205 (223)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCH
T ss_pred eeccccccCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence 9999999999999999999999987766554444
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=1.8e-20 Score=145.41 Aligned_cols=101 Identities=24% Similarity=0.249 Sum_probs=91.8
Q ss_pred cchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC-Cccccccccch
Q 016544 40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS-TPLGDAIYYKN 118 (387)
Q Consensus 40 g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~-tpl~~a~~~~~ 118 (387)
+.++||+||..|+.++|++|+++|+|+|.+|.+|.||||+|+ .|+.+++++|+++|++++.++..|. ||||+|+..|+
T Consensus 3 ~~~~L~~Aa~~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~ 81 (125)
T d1bi7b_ 3 SADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGF 81 (125)
T ss_dssp STTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTC
T ss_pred ChhHHHHHHHCCCHHHHHHHHHcCCccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc
Confidence 457899999999999999999999999999999999999775 7999999999999999999998876 69999999999
Q ss_pred HHHHHHHHhhCCCCCCCCccccc
Q 016544 119 HEVIKLLEKHGAKPLMAPMHVKH 141 (387)
Q Consensus 119 ~~~~~~L~~~g~~~~~~~~~~~~ 141 (387)
.+++++|++.|+++........+
T Consensus 82 ~~~v~~Ll~~ga~~~~~d~~G~T 104 (125)
T d1bi7b_ 82 LDTLVVLHRAGARLDVRDAWGRL 104 (125)
T ss_dssp HHHHHHHHHHTCCSSCCCTTCCC
T ss_pred ccccccccccccccccccCCCCC
Confidence 99999999999998766544443
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.77 E-value=2.6e-19 Score=156.29 Aligned_cols=97 Identities=23% Similarity=0.155 Sum_probs=90.3
Q ss_pred CCCCCcchHHHHHHhhCCHHHHHHHHHcCCC---CCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccc
Q 016544 35 GEEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (387)
Q Consensus 35 ~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~---~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~ 111 (387)
.-|.+|+||||+||..|+.+++++|+++|++ +|.+|..|.||||+||..|+.+++++|+++|++++.+|..|.||||
T Consensus 4 ~i~~~G~t~Lh~A~~~~~~~~v~~Ll~~~a~~~~i~~~~~~g~TpL~~A~~~g~~~iv~~Ll~~ga~i~~~d~~g~tpL~ 83 (255)
T d1oy3d_ 4 YVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALH 83 (255)
T ss_dssp CCCTTCCCHHHHHHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHH
T ss_pred cCCcCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCcCCCCCCccchHHhhcccccccccccccccccccccccchhhh
Confidence 3467899999999999999999999999998 6788999999999999999999999999999999999999999999
Q ss_pred cccccchHHHHHHHHhhCCC
Q 016544 112 DAIYYKNHEVIKLLEKHGAK 131 (387)
Q Consensus 112 ~a~~~~~~~~~~~L~~~g~~ 131 (387)
+|+..++.++++.|++.+..
T Consensus 84 ~A~~~~~~~~~~~Ll~~~~~ 103 (255)
T d1oy3d_ 84 LACRVRAHTCACVLLQPRPS 103 (255)
T ss_dssp HHTTTTCHHHHHHHSSSCCS
T ss_pred hhhccCchHHHHHHHhhccc
Confidence 99999999999999876543
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=8.5e-19 Score=148.25 Aligned_cols=98 Identities=22% Similarity=0.241 Sum_probs=93.1
Q ss_pred hcCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCC
Q 016544 28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107 (387)
Q Consensus 28 ~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~ 107 (387)
-.+.+.+..+..|+|||++|+..+..++++.|++.++++|.+|.+|+||||+||..|+.+++++|+++|+|++.+|..|+
T Consensus 111 ~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gad~n~~d~~g~ 190 (209)
T d1ot8a_ 111 TADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITDHMDR 190 (209)
T ss_dssp HTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred hhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHCCCCCCCcCCCCC
Confidence 35667777788899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccccchHHHHHHH
Q 016544 108 TPLGDAIYYKNHEVIKLL 125 (387)
Q Consensus 108 tpl~~a~~~~~~~~~~~L 125 (387)
||||+|+..|+.+++++|
T Consensus 191 Tpl~~A~~~~~~~iv~lL 208 (209)
T d1ot8a_ 191 LPRDVASERLHHDIVRLL 208 (209)
T ss_dssp CHHHHHHHTTCHHHHHHH
T ss_pred CHHHHHHHcCCHHHHhhc
Confidence 999999999999999986
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=9.2e-19 Score=141.20 Aligned_cols=96 Identities=25% Similarity=0.337 Sum_probs=46.0
Q ss_pred CCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcc
Q 016544 31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (387)
Q Consensus 31 ~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl 110 (387)
.|.+..+..|.+||++|+..++.++++.++++|+++|.+|.+|+||||+||..|+.+++++|+ .|++++.+|.+|.|||
T Consensus 59 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~~i~~~L~-~~~~~~~~d~~G~TpL 137 (156)
T d1bd8a_ 59 ASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLA-AESDLHRRDARGLTPL 137 (156)
T ss_dssp CCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHH-TTSCTTCCCTTSCCHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccCCCCeeecccccccccccccccc-ccccccccCCCCCCHH
Confidence 333333344444444444444444444444444444444444445555544444444444444 3444444444444555
Q ss_pred ccccccchHHHHHHHHh
Q 016544 111 GDAIYYKNHEVIKLLEK 127 (387)
Q Consensus 111 ~~a~~~~~~~~~~~L~~ 127 (387)
|+|+..|+.+++++|++
T Consensus 138 ~~A~~~g~~~iv~~Ll~ 154 (156)
T d1bd8a_ 138 ELALQRGAQDLVDILQG 154 (156)
T ss_dssp HHHHHSCCHHHHHHHHT
T ss_pred HHHHHcCCHHHHHHHHh
Confidence 54444444444444443
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.76 E-value=1.9e-18 Score=148.25 Aligned_cols=100 Identities=25% Similarity=0.250 Sum_probs=88.8
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcC-CCCCCCCCCCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCCcCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDRWG 106 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g-~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~~~~~~g 106 (387)
.+.+.+.++..|+||||+|+..|+.++++.|++.| .++|.+|.+|+||||+|+..|+.+++++|++ .|+|++.+|..|
T Consensus 127 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~gad~~~~d~~g 206 (229)
T d1ixva_ 127 NGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKG 206 (229)
T ss_dssp TTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCCCTTS
T ss_pred hcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCchhhhcccccHHHHHHHHHhcCCCCCCcCCCC
Confidence 56667777888999999999999999999999986 6889999999999999999999999999997 599999999999
Q ss_pred CCccccccccchHHHHHHHHhhCCC
Q 016544 107 STPLGDAIYYKNHEVIKLLEKHGAK 131 (387)
Q Consensus 107 ~tpl~~a~~~~~~~~~~~L~~~g~~ 131 (387)
.||||+|+. .+++++|++.|+|
T Consensus 207 ~t~l~~A~~---~~~~~~Ll~~g~d 228 (229)
T d1ixva_ 207 AKAEDVALN---EQVKKFFLNNVVD 228 (229)
T ss_dssp CCTGGGCSC---HHHHHHHHHHCCC
T ss_pred CCHHHHHhh---HHHHHHHHHcCCC
Confidence 999999974 4788999999986
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=2.1e-18 Score=147.62 Aligned_cols=98 Identities=22% Similarity=0.234 Sum_probs=92.6
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|++..+.+|.||||+|+..++.+++++|++.|+++|.+|.+|+||||+|+..|+.+++++|+++|||++.+|.+|+|
T Consensus 125 ~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d~~g~TpL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~g~t 204 (223)
T d1uoha_ 125 GGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIENKEEKT 204 (223)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCC
T ss_pred CCCCCCCcCCCCCccchhhhhcCCcchhhhhccccceeeeccCCCCceeccccccCcHHHHHHHHHCCCCCCCCCCCCCC
Confidence 56778888889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHh
Q 016544 109 PLGDAIYYKNHEVIKLLEK 127 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~ 127 (387)
|||+|. .++.++++.|++
T Consensus 205 pl~~A~-~~~~~i~~~Ll~ 222 (223)
T d1uoha_ 205 PLQVAK-GGLGLILKRMVE 222 (223)
T ss_dssp HHHHCC-TTHHHHHHHHHC
T ss_pred HHHHHH-CCCHHHHhcccC
Confidence 999985 689999998875
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.75 E-value=1.8e-18 Score=155.05 Aligned_cols=115 Identities=19% Similarity=0.193 Sum_probs=94.3
Q ss_pred cCCCCCCC-CCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCH-------HHHHHH--------
Q 016544 29 NGLDDDGE-EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT-------EVVSLL-------- 92 (387)
Q Consensus 29 ~~~~~~~~-~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~-------~~~~~L-------- 92 (387)
.+.|++.. |.+|+||||+||..|+.++|++||++|||++.+|..|+||||.||..++. +++++|
T Consensus 95 ~~~dvn~~~D~~G~T~LH~Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~~~d 174 (301)
T d1sw6a_ 95 TQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILED 174 (301)
T ss_dssp SCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEEC
T ss_pred cCCCcCcCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhhhcc
Confidence 34566655 78899999999999999999999999999999999999999999976541 233322
Q ss_pred ----------------------------------HHCCC-------------------------------------CCCC
Q 016544 93 ----------------------------------LERGA-------------------------------------DVDP 101 (387)
Q Consensus 93 ----------------------------------l~~ga-------------------------------------~~~~ 101 (387)
+..+. .+|.
T Consensus 175 ~~g~t~lh~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~ 254 (301)
T d1sw6a_ 175 SMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNA 254 (301)
T ss_dssp TTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTC
T ss_pred cccCCHHHHHHHHhCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcCccC
Confidence 22111 1688
Q ss_pred CCcCCCCccccccccchHHHHHHHHhhCCCCCCCCccccccC
Q 016544 102 KDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (387)
Q Consensus 102 ~~~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~~ 143 (387)
+|..|+||||+|+..|+.+++++|++.|+++........++.
T Consensus 255 ~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl 296 (301)
T d1sw6a_ 255 QDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPV 296 (301)
T ss_dssp CCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGG
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHH
Confidence 899999999999999999999999999999988776666554
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=1.1e-18 Score=162.78 Aligned_cols=93 Identities=31% Similarity=0.381 Sum_probs=89.7
Q ss_pred hHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHH
Q 016544 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121 (387)
Q Consensus 42 t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~ 121 (387)
||||+||..|+.++|+.|+++|+|+|.+|..|+||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.++
T Consensus 2 TpL~~Aa~~g~~~~v~~Ll~~g~~in~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gadi~~~~~~g~t~L~~A~~~g~~~~ 81 (408)
T d1n11a_ 2 TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNM 81 (408)
T ss_dssp CHHHHHHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHHHHHHHHTCHHH
T ss_pred ChHHHHHHCcCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCHHH
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCCC
Q 016544 122 IKLLEKHGAKPLM 134 (387)
Q Consensus 122 ~~~L~~~g~~~~~ 134 (387)
+++|+..+.++..
T Consensus 82 ~~~Ll~~~~~~~~ 94 (408)
T d1n11a_ 82 VKLLLENNANPNL 94 (408)
T ss_dssp HHHHHHHTCCTTC
T ss_pred HHHHHHhhhcccc
Confidence 9999998876543
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.74 E-value=3e-18 Score=137.45 Aligned_cols=63 Identities=35% Similarity=0.486 Sum_probs=30.8
Q ss_pred cCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHHHHH
Q 016544 62 SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKL 124 (387)
Q Consensus 62 ~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~~ 124 (387)
+|++++.+|.+|+||||+||..|+.+++++|+++|++++.+|.+|.||||+|+.+|+.+++++
T Consensus 89 ~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~Tpl~~A~~~g~~eiv~l 151 (153)
T d1awcb_ 89 HGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEI 151 (153)
T ss_dssp TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHH
T ss_pred cCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCCCHHHHHHHcCCHHHHHh
Confidence 344444444444555555555555555555444454444444445555555544444444443
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.74 E-value=5.2e-19 Score=156.11 Aligned_cols=91 Identities=22% Similarity=0.294 Sum_probs=84.8
Q ss_pred CcchHHHHHHhhCCHHHHHHH--------HHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcc
Q 016544 39 KPEFRLMFLANERDVEGIKEL--------LDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110 (387)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~L--------l~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl 110 (387)
+|+||||+||..|+.++|+.| +++|||||.+|.+|+||||+|+..|+.+++++|+++|+|++.+|.+|.||+
T Consensus 32 ~g~T~Lh~A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~d~~G~TpLh~A~~~g~~~iv~~Ll~~Gad~n~~~~~g~t~l 111 (277)
T d2fo1e1 32 HNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSAL 111 (277)
T ss_dssp SCCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHH
T ss_pred CCccHHHHHHHcCCHHHHHHHHhcchhHHHHcCCCccccCCCCCeeeccccccccccccccccccccccccccccccccc
Confidence 589999999999999998877 567999999999999999999999999999999999999999999999999
Q ss_pred ccccccchHHHHHHHHhhC
Q 016544 111 GDAIYYKNHEVIKLLEKHG 129 (387)
Q Consensus 111 ~~a~~~~~~~~~~~L~~~g 129 (387)
++|...++.++...+...+
T Consensus 112 ~~a~~~~~~~~~~~l~~~~ 130 (277)
T d2fo1e1 112 HQAAANRDFGMMVYMLNST 130 (277)
T ss_dssp HHHHHTTCHHHHHHHTTSH
T ss_pred cchhhhcchhhhhhhhhcc
Confidence 9999999999988876543
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=6.2e-18 Score=136.24 Aligned_cols=111 Identities=23% Similarity=0.244 Sum_probs=99.7
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|++..|..|+||||+|+. |+.+++++|++.++++|..+..|.+||+.|+..++.+++++++++|++++.+|..|.|
T Consensus 25 ~~~~~n~~d~~g~t~L~~A~~-~~~~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~t 103 (156)
T d1bd8a_ 25 ELVHPDALNRFGKTALQVMMF-GSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGAL 103 (156)
T ss_dssp TCCCTTCCCTTSCCHHHHSCT-TCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCC
T ss_pred CCCCCCccCCCCCcccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccCCCCe
Confidence 466778888899999999875 8899999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHhhCCCCCCCCccccc
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~ 141 (387)
|||+|+..|+.+++++|. .|+++........+
T Consensus 104 ~L~~A~~~~~~~i~~~L~-~~~~~~~~d~~G~T 135 (156)
T d1bd8a_ 104 PIHLAVQEGHTAVVSFLA-AESDLHRRDARGLT 135 (156)
T ss_dssp HHHHHHHHTCHHHHHHHH-TTSCTTCCCTTSCC
T ss_pred eecccccccccccccccc-ccccccccCCCCCC
Confidence 999999999999999887 67877655444433
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=8.8e-18 Score=156.49 Aligned_cols=99 Identities=29% Similarity=0.294 Sum_probs=88.5
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|++..+..+.||||.|+..++.++++.+++.|+++|.+|.+|.||||+|+..|+.+++++|+++|||++.+|..|.|
T Consensus 286 ~g~~~~~~~~~~~t~L~~~~~~~~~~~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g~~~iv~~Ll~~GAd~n~~d~~G~t 365 (408)
T d1n11a_ 286 HGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTT 365 (408)
T ss_dssp HTCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCSSSCC
T ss_pred CCCccccccccccccchhhcccCcceeeeeeccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Confidence 36667777777888899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHh
Q 016544 109 PLGDAIYYKNHEVIKLLEK 127 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~ 127 (387)
|||+|+..|+.+++++|..
T Consensus 366 ~L~~A~~~~~~~iv~~L~~ 384 (408)
T d1n11a_ 366 PLAIAKRLGYISVTDVLKV 384 (408)
T ss_dssp HHHHHHHTTCHHHHHHHHH
T ss_pred HHHHHHHcCCHHHHHHHHH
Confidence 9999999999998886654
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=5.1e-18 Score=136.57 Aligned_cols=92 Identities=32% Similarity=0.320 Sum_probs=75.4
Q ss_pred hHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHH
Q 016544 42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121 (387)
Q Consensus 42 t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~ 121 (387)
+|||+||..|+.++|+.|+++|+|+|.+|.+|+||||+|+ .|+.+++++|+++|++++.++..|.+|++.++..+..+.
T Consensus 3 ~~Lh~Aa~~g~~~~v~~Ll~~g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~ 81 (156)
T d1ihba_ 3 NELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDT 81 (156)
T ss_dssp HHHHHHHHHTCHHHHHHHTTSCCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHH
T ss_pred HHHHHHHHcCCHHHHHHHHHCCCCcCccCCcccccccccc-cccccccccccccccccccccccCccccccccccccccc
Confidence 6788888888888888888888888888888888888775 678888888888888888888888888888888888888
Q ss_pred HHHHHhhCCCCCC
Q 016544 122 IKLLEKHGAKPLM 134 (387)
Q Consensus 122 ~~~L~~~g~~~~~ 134 (387)
+..+...+.++..
T Consensus 82 ~~~l~~~~~~~~~ 94 (156)
T d1ihba_ 82 LQTLLEFQADVNI 94 (156)
T ss_dssp HHHHHHTTCCTTC
T ss_pred ccccccccccccc
Confidence 8888887766543
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.71 E-value=2.4e-17 Score=146.58 Aligned_cols=95 Identities=27% Similarity=0.327 Sum_probs=85.3
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
...+....+..|.||||+|+..|+.++++.|++.|+|+|.+|.+|+||||+|+..|+.++|++|+++|||++.+|..|.|
T Consensus 188 ~~~~~~~~~~~g~t~L~~a~~~~~~~~~~~Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~T 267 (291)
T d1s70b_ 188 GHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQT 267 (291)
T ss_dssp TCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred cccccccccCCCCChhhHHHHcCChhhhcccccceecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCC
Confidence 34455666778999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccchHHHHHHHHh
Q 016544 109 PLGDAIYYKNHEVIKLLEK 127 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~ 127 (387)
|||+|+. +++++|.+
T Consensus 268 aL~~A~e----~~~~~L~~ 282 (291)
T d1s70b_ 268 AFDVADE----DILGYLEE 282 (291)
T ss_dssp TTTSCCS----GGGHHHHH
T ss_pred HHHHHHH----HHHHHHHH
Confidence 9999986 34444444
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.70 E-value=1.8e-17 Score=132.76 Aligned_cols=107 Identities=32% Similarity=0.360 Sum_probs=99.5
Q ss_pred CCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccc
Q 016544 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115 (387)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~ 115 (387)
.+..|+||||+|+..++.++++.++......+..+..+.++++.++...+.+++++|+.+|++++.+|..|.||||+|+.
T Consensus 30 ~~~~g~t~L~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~T~L~~A~~ 109 (153)
T d1awcb_ 30 TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATE 109 (153)
T ss_dssp CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHH
T ss_pred cccCCCccccccccccccccccccccccccccccccccccccccccccccceeeecccccCCccccccccCchHHHhhhh
Confidence 47789999999999999999999999988888888999999999999999999999999999999999999999999999
Q ss_pred cchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 116 YKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 116 ~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
.|+.+++++|+++|+++........++
T Consensus 110 ~g~~~iv~~ll~~gad~~~~d~~g~Tp 136 (153)
T d1awcb_ 110 HNHQEVVELLIKYGADVHTQSKFCKTA 136 (153)
T ss_dssp TTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred cchhheeeeccccccCCcccCCCCCCH
Confidence 999999999999999998766655444
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=1.5e-17 Score=141.88 Aligned_cols=115 Identities=26% Similarity=0.244 Sum_probs=92.6
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHH---------------
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL--------------- 93 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll--------------- 93 (387)
++.+++.++.+|+||||+||..|+.+++++|+++|+|++.+|.+|.||||+|+..++.++++.|+
T Consensus 28 ~~~~in~~d~~g~TpLh~A~~~~~~~iv~~L~~~g~d~~~~d~~g~t~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 107 (221)
T d1iknd_ 28 DLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKAT 107 (221)
T ss_dssp -CCCCCCCCTTCCCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGCC
T ss_pred CCCCcccCCCCCCccccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccc
Confidence 45667777888899999999999999999999999999999999999998888777777666555
Q ss_pred ------------------------HCCCCCCCCC-cCCCCccccccccchHHHHHHHHhhCCCCCCCCccccccC
Q 016544 94 ------------------------ERGADVDPKD-RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAR 143 (387)
Q Consensus 94 ------------------------~~ga~~~~~~-~~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~~~~~~~~ 143 (387)
..|++++.++ .+|.||||+|+..|+.+++++|+++|+++........++.
T Consensus 108 ~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl 182 (221)
T d1iknd_ 108 NYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPY 182 (221)
T ss_dssp CTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGG
T ss_pred ccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCHH
Confidence 4455555544 5789999999999999999999999998876655555544
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.69 E-value=7.2e-19 Score=160.73 Aligned_cols=98 Identities=19% Similarity=0.071 Sum_probs=85.0
Q ss_pred CCCCCcchHHHHHHhhCCHHHHHH---HHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCC--cCCCCc
Q 016544 35 GEEIKPEFRLMFLANERDVEGIKE---LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGSTP 109 (387)
Q Consensus 35 ~~~~~g~t~l~~a~~~~~~~~~~~---Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~--~~g~tp 109 (387)
.++..|.||||+||.+|+.++++. |++.|+++|.+|.+|+||||+||..|+.++|++|+++|++++..+ ..|.||
T Consensus 85 ~~~~~~~t~L~~Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~ 164 (346)
T d2ajaa1 85 KKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHA 164 (346)
T ss_dssp HHTCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHH
T ss_pred hccCCCCcHHHHHHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCCh
Confidence 456678999999999999877665 788999999999999999999999999999999999999998876 468999
Q ss_pred cccccccchHHHHHHHHhhCCCC
Q 016544 110 LGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 110 l~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
||+|+..|+.+++++|++.|++.
T Consensus 165 L~~Aa~~g~~~iv~~Ll~~~~~~ 187 (346)
T d2ajaa1 165 FRLAAENGHLHVLNRLCELAPTE 187 (346)
T ss_dssp HHHHHHTTCHHHHHHHHHSCGGG
T ss_pred hHHHHHHhhHHHHHHHHHcCCcc
Confidence 99999999999999999988754
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1e-16 Score=136.71 Aligned_cols=96 Identities=25% Similarity=0.246 Sum_probs=88.5
Q ss_pred CCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccccc
Q 016544 36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (387)
Q Consensus 36 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d-~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~ 114 (387)
....|.||||+|+..++.+.+++|+..|++++..+ .+|+||||+|+..|+.+++++|+++|+|++.+|..|.||||+|+
T Consensus 107 ~~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl~~A~ 186 (221)
T d1iknd_ 107 TNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTW 186 (221)
T ss_dssp CCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGCT
T ss_pred cccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCHHHHHH
Confidence 34457889999999999999999999999998875 67999999999999999999999999999999999999999999
Q ss_pred ccchHHHHHHHHhhCCC
Q 016544 115 YYKNHEVIKLLEKHGAK 131 (387)
Q Consensus 115 ~~~~~~~~~~L~~~g~~ 131 (387)
..++.+++++|.+.+.+
T Consensus 187 ~~~~~~~~~~l~~~~~~ 203 (221)
T d1iknd_ 187 GRPSTRIQQQLGQLTLE 203 (221)
T ss_dssp TSSCHHHHHHHHTTSCG
T ss_pred HCCCHHHHHHHHHcCCc
Confidence 99999999999998765
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.67 E-value=9.9e-17 Score=128.33 Aligned_cols=99 Identities=25% Similarity=0.304 Sum_probs=88.3
Q ss_pred HHHHHhhCCHHHHHHHHHcCCCCCCC------CCCCCcHHHHHHHc---CCHHHHHHHHHCCCCCCCCCcCCCCcccccc
Q 016544 44 LMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (387)
Q Consensus 44 l~~a~~~~~~~~~~~Ll~~g~~~n~~------d~~g~t~Lh~A~~~---~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~ 114 (387)
|+.|++.+++..+..++..|+|++.+ +..|+||||+|+.. ++.+++++|+++|++++.+|..|.||||+|+
T Consensus 10 L~~Av~~~dl~~l~~~~~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~ 89 (154)
T d1dcqa1 10 LCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCC 89 (154)
T ss_dssp HHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHH
T ss_pred HHHHHHhCCHHHHHHHHHcCCCcCCCCCcccCCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhcccccccc
Confidence 45788999999999999999998765 77899999999974 6789999999999999999999999999999
Q ss_pred ccchHHHHHHHHhhCCCCCCCCcccccc
Q 016544 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHA 142 (387)
Q Consensus 115 ~~~~~~~~~~L~~~g~~~~~~~~~~~~~ 142 (387)
..|+.+++++|+++|+++........++
T Consensus 90 ~~~~~~~v~~Ll~~gad~~~~d~~g~tp 117 (154)
T d1dcqa1 90 LTDNAECLKLLLRGKASIEIANESGETP 117 (154)
T ss_dssp HTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred ccccccccccccccCccccccCCCCCCH
Confidence 9999999999999999987765554444
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=1.1e-16 Score=141.57 Aligned_cols=107 Identities=27% Similarity=0.234 Sum_probs=88.6
Q ss_pred CCCCCCCCCCcchHHHHHHh----hCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHH-CCCCCCCCCc
Q 016544 30 GLDDDGEEIKPEFRLMFLAN----ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDR 104 (387)
Q Consensus 30 ~~~~~~~~~~g~t~l~~a~~----~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~-~ga~~~~~~~ 104 (387)
+.|++..+..|.++++.+.. .+..+++++|+++|+++|.+|..|.||||+|+..|+.+++++|++ .|++++.+|.
T Consensus 172 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~i~~~Li~~ga~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d~ 251 (285)
T d1wdya_ 172 GADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDS 251 (285)
T ss_dssp CCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCT
T ss_pred CCCcccccCCCCcccccccccccchHHHHHHHHHHHCCCCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCCC
Confidence 34444555555555554433 223467888888889999999999999999999999999999998 4999999999
Q ss_pred CCCCccccccccchHHHHHHHHhhCCCCCCCC
Q 016544 105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP 136 (387)
Q Consensus 105 ~g~tpl~~a~~~~~~~~~~~L~~~g~~~~~~~ 136 (387)
+|.||||+|+.+++.+++++|+++||++..+.
T Consensus 252 ~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d 283 (285)
T d1wdya_ 252 DGKTALLLAVELKLKKIAELLCKRGASTDCGD 283 (285)
T ss_dssp TSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSS
T ss_pred CCCCHHHHHHHcCCHHHHHHHHHCCCCCCccc
Confidence 99999999999999999999999999987654
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.67 E-value=5.4e-19 Score=161.58 Aligned_cols=104 Identities=14% Similarity=0.003 Sum_probs=91.1
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCC--CCCCcHHHHHHHcCCHHHHHHHHHCCCCCC---CCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD--IDNRTALHVAACQGFTEVVSLLLERGADVD---PKD 103 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d--~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~---~~~ 103 (387)
.+.+++..+.+|+||||+||..|+.++|++|+++|++++..| .+|+||||+||..|+.+++++|+++|++.. ..+
T Consensus 115 ~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~L~~Aa~~g~~~iv~~Ll~~~~~~~~~~~~~ 194 (346)
T d2ajaa1 115 SDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQA 194 (346)
T ss_dssp CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHH
T ss_pred CCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCChhHHHHHHhhHHHHHHHHHcCCccccccccc
Confidence 567788888899999999999999999999999999999876 459999999999999999999999998753 344
Q ss_pred cCCCCccccccccchHHHHHHHHhhCCCC
Q 016544 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132 (387)
Q Consensus 104 ~~g~tpl~~a~~~~~~~~~~~L~~~g~~~ 132 (387)
..|.||++.|+..|+.+++++|++.|+++
T Consensus 195 ~~~~t~l~~A~~~g~~~iv~~Ll~~ga~~ 223 (346)
T d2ajaa1 195 ENYYAFRWAAVGRGHHNVINFLLDCPVML 223 (346)
T ss_dssp HHHHHHHHHHSTTCCHHHHHHHTTSHHHH
T ss_pred CCCcchhhHHhhcCHHHHHHHHHhCCCCc
Confidence 56778889999999999999999998765
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.67 E-value=2.4e-17 Score=139.12 Aligned_cols=106 Identities=31% Similarity=0.252 Sum_probs=91.9
Q ss_pred CCCcchHHHHHHhhCCHHHHHHHHHcCCCCC-------------------------------------------------
Q 016544 37 EIKPEFRLMFLANERDVEGIKELLDSGIDVN------------------------------------------------- 67 (387)
Q Consensus 37 ~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n------------------------------------------------- 67 (387)
|.+|.||||+||..|+.+++++|++.|+++|
T Consensus 20 d~~G~t~L~~A~~~g~~e~v~~Ll~~g~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (209)
T d1ot8a_ 20 DKTGETSLHLAARFARADAAKRLLDAGADANSQDNTGRTPLHAAVAADAMGVFQILLRNRATNLNARMHDGTTPLILAAR 99 (209)
T ss_dssp HHHCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTCTTCCTTCCCTTCCCHHHHHHH
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4567788999999999999999999888775
Q ss_pred ------------------CCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccchHHHHHHHHhhC
Q 016544 68 ------------------FRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129 (387)
Q Consensus 68 ------------------~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~~~~~~~L~~~g 129 (387)
.++..|+||||+|+..+..++++.|++++++++.+|..|.||||+|+..|+.+++++|+++|
T Consensus 100 ~~~~~~~~~L~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~g 179 (209)
T d1ot8a_ 100 LAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNF 179 (209)
T ss_dssp TTCTTHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTT
T ss_pred ccchhhhhhhhhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHCC
Confidence 35566778888888889999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccc
Q 016544 130 AKPLMAPMHVKHA 142 (387)
Q Consensus 130 ~~~~~~~~~~~~~ 142 (387)
+++........++
T Consensus 180 ad~n~~d~~g~Tp 192 (209)
T d1ot8a_ 180 ANREITDHMDRLP 192 (209)
T ss_dssp CCTTCCCTTSCCH
T ss_pred CCCCCcCCCCCCH
Confidence 9987665444433
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.66 E-value=7.5e-17 Score=141.99 Aligned_cols=96 Identities=26% Similarity=0.372 Sum_probs=89.0
Q ss_pred CCCCCCCcchHHHHHHhhCCHHHHHHHH-HcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccc
Q 016544 33 DDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll-~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~ 111 (387)
.+..+..|+||||+++..++.+++++++ ..+.+++.+|..|+||||+|+..|+.+++++|+++|+|++.+|..|.||||
T Consensus 180 ~~~~~~~g~t~L~~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~tpL~~A~~~g~~~iv~~Ll~~gadin~~d~~G~T~L~ 259 (277)
T d2fo1e1 180 KDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQ 259 (277)
T ss_dssp TSSSSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHHH
T ss_pred ccccccCCCCccccccccccccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCcCCCCCCHHH
Confidence 4556668899999999999999999866 568999999999999999999999999999999999999999999999999
Q ss_pred cccccchHHHHHHHHhh
Q 016544 112 DAIYYKNHEVIKLLEKH 128 (387)
Q Consensus 112 ~a~~~~~~~~~~~L~~~ 128 (387)
+|+..|+.+++++|++.
T Consensus 260 ~A~~~~~~~iv~lL~~c 276 (277)
T d2fo1e1 260 LAQANNHHNIVDIFDRC 276 (277)
T ss_dssp HHHHTTCHHHHHHHHTT
T ss_pred HHHHcCCHHHHHHHHHh
Confidence 99999999999999863
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.66 E-value=1.2e-16 Score=141.98 Aligned_cols=97 Identities=27% Similarity=0.393 Sum_probs=92.2
Q ss_pred CcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCccccccccch
Q 016544 39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118 (387)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~~~~~ 118 (387)
+|.||||.||..|+.++|++||++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++.+..+..+.|||++|+..++
T Consensus 39 ~~~t~l~~A~~~G~~~~v~~Ll~~Gadvn~~d~~G~T~L~~A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~~~ 118 (291)
T d1s70b_ 39 DDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGY 118 (291)
T ss_dssp CHHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTC
T ss_pred CCchHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCcHHHHHHhcCCceeeeeecccccccccccccccccccccccccc
Confidence 57799999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhCCCCCCC
Q 016544 119 HEVIKLLEKHGAKPLMA 135 (387)
Q Consensus 119 ~~~~~~L~~~g~~~~~~ 135 (387)
.++++.|+++|+.....
T Consensus 119 ~~~~~~l~~~~~~~~~~ 135 (291)
T d1s70b_ 119 LDIAEYLISQGAHVGAV 135 (291)
T ss_dssp HHHHHHHHHTTCCTTCC
T ss_pred cchhhcccccCcccccc
Confidence 99999999998775443
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=2.2e-16 Score=126.81 Aligned_cols=101 Identities=28% Similarity=0.308 Sum_probs=88.4
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCC
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t 108 (387)
++.|++.+|.+|+||||+|+ .|+.+++++|+++|+|++.++..|.|+|+.++..++.++++.|++.+.+++..|..|.+
T Consensus 23 ~g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 101 (156)
T d1ihba_ 23 NNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNL 101 (156)
T ss_dssp SCCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred CCCCcCccCCcccccccccc-cccccccccccccccccccccccCccccccccccccccccccccccccccccccccccc
Confidence 45666777778888999876 68899999999999999999999999999999999999999999999999988999999
Q ss_pred ccccccccchHHHHHHHHhhCC
Q 016544 109 PLGDAIYYKNHEVIKLLEKHGA 130 (387)
Q Consensus 109 pl~~a~~~~~~~~~~~L~~~g~ 130 (387)
|+++|+..++.+++++|+++++
T Consensus 102 ~l~~a~~~~~~~~~~~Ll~~~~ 123 (156)
T d1ihba_ 102 PLHLAAKEGHLRVVEFLVKHTA 123 (156)
T ss_dssp HHHHHHHTTCHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccc
Confidence 9999999999999998888876
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=2.2e-16 Score=133.57 Aligned_cols=93 Identities=22% Similarity=0.280 Sum_probs=86.8
Q ss_pred CcchHHHHHHhhCCHHHHHHHHH----cCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccccc
Q 016544 39 KPEFRLMFLANERDVEGIKELLD----SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (387)
Q Consensus 39 ~g~t~l~~a~~~~~~~~~~~Ll~----~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~ 114 (387)
+|+||||+||..|+.++++.|++ .|+++|.+|.+|+||||+|+..|+.+++++|+++|++++..+..|.++++.|.
T Consensus 2 dG~TpLh~A~~~g~~~~v~~Ll~~~~~~g~~in~~d~~g~TpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~a~ 81 (228)
T d1k1aa_ 2 DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLAC 81 (228)
T ss_dssp TTCCHHHHHHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred CCccHHHHHHHcCCHHHHHHHHHHHHHCCCCCCccCCCCCccceehhccccccccccccccccccccccccccccccccc
Confidence 69999999999999999999885 79999999999999999999999999999999999999999999999999999
Q ss_pred ccchHHHHHHHHhhCCC
Q 016544 115 YYKNHEVIKLLEKHGAK 131 (387)
Q Consensus 115 ~~~~~~~~~~L~~~g~~ 131 (387)
..++.++++.+......
T Consensus 82 ~~~~~~~~~~~~~~~~~ 98 (228)
T d1k1aa_ 82 EHRSPTCLRALLDSAAP 98 (228)
T ss_dssp HTTCHHHHHHHHHHSCT
T ss_pred ccccccchhhhhhcccc
Confidence 99999998887776543
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=4.5e-16 Score=131.63 Aligned_cols=91 Identities=24% Similarity=0.304 Sum_probs=85.4
Q ss_pred CCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccc
Q 016544 33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112 (387)
Q Consensus 33 ~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~ 112 (387)
.......|.+||+.|+..+...+++.++++|.+++.+|..|.||||+|+..|+.+++++|+++|+|++.+|.+|.||||+
T Consensus 137 ~~~~~~~~~~~l~~a~~~~~~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~TpL~~ 216 (228)
T d1k1aa_ 137 DAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMV 216 (228)
T ss_dssp TCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTT
T ss_pred ccccccchhhHHHHHHHhhhhhhhhhhhhhccccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHH
Confidence 33445578999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccchHHHHH
Q 016544 113 AIYYKNHEVIK 123 (387)
Q Consensus 113 a~~~~~~~~~~ 123 (387)
|+..++.|+++
T Consensus 217 A~~~~~~divk 227 (228)
T d1k1aa_ 217 ARSRRVIDILR 227 (228)
T ss_dssp CSSHHHHHHHT
T ss_pred HHhCCCccccC
Confidence 99999998874
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.59 E-value=3.6e-15 Score=127.38 Aligned_cols=113 Identities=25% Similarity=0.229 Sum_probs=101.1
Q ss_pred CCCCCCCCcchHHHHHHhhCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCC-CCCCCCCcCCCCcc
Q 016544 32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGSTPL 110 (387)
Q Consensus 32 ~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~g-a~~~~~~~~g~tpl 110 (387)
+....+..+.|||+.++..++.++++.|+..|.+.+.+|..|+||||+|+..|+.+++++|++.| .+++.+|..|+|||
T Consensus 97 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpL 176 (229)
T d1ixva_ 97 DLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPL 176 (229)
T ss_dssp CTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHH
T ss_pred cccccccccccccccccccchhhhhhhhhhhcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCch
Confidence 45556667899999999999999999999999999999999999999999999999999999987 78899999999999
Q ss_pred ccccccchHHHHHHHHh-hCCCCCCCCccccccCC
Q 016544 111 GDAIYYKNHEVIKLLEK-HGAKPLMAPMHVKHARE 144 (387)
Q Consensus 111 ~~a~~~~~~~~~~~L~~-~g~~~~~~~~~~~~~~~ 144 (387)
|+|+..++.+++++|++ .|+++........++..
T Consensus 177 h~A~~~~~~~~v~~Ll~~~gad~~~~d~~g~t~l~ 211 (229)
T d1ixva_ 177 FHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAED 211 (229)
T ss_dssp HHHHHTTCHHHHHHHHHHHCCCSCCCCTTSCCTGG
T ss_pred hhhcccccHHHHHHHHHhcCCCCCCcCCCCCCHHH
Confidence 99999999999999996 69998776655555543
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=2.2e-15 Score=132.96 Aligned_cols=76 Identities=26% Similarity=0.369 Sum_probs=71.1
Q ss_pred cCCCCCCCCCCcchHHHHHHhhCCHHHHHHHHHc-CCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCc
Q 016544 29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104 (387)
Q Consensus 29 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~-g~~~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~ 104 (387)
.+.|.+.++.+|.||||+||..|+.+++++|++. |+|+|.+|.+|.||||+|+..|+.+++++|+++|||+|.+|.
T Consensus 208 ~ga~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d~ 284 (285)
T d1wdya_ 208 HGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGDL 284 (285)
T ss_dssp TTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSSC
T ss_pred CCCCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcccC
Confidence 4667777888899999999999999999999985 999999999999999999999999999999999999999883
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.54 E-value=5.5e-15 Score=131.97 Aligned_cols=49 Identities=31% Similarity=0.376 Sum_probs=47.7
Q ss_pred CCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCcCCCCcccccc
Q 016544 66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114 (387)
Q Consensus 66 ~n~~d~~g~t~Lh~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~a~ 114 (387)
+|.+|.+|+||||+||..|+.+++++|+++|||++.+|+.|.|||++|+
T Consensus 252 in~~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl~~A~ 300 (301)
T d1sw6a_ 252 LNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 300 (301)
T ss_dssp TTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTC
T ss_pred ccCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHcC
Confidence 7889999999999999999999999999999999999999999999996
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.27 E-value=2.1e-06 Score=73.38 Aligned_cols=127 Identities=13% Similarity=0.031 Sum_probs=84.7
Q ss_pred EEEEEEcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEEccCCCCHHHHHHHcCC
Q 016544 168 FILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA 246 (387)
Q Consensus 168 ~~~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~ 246 (387)
++.+..++..+.+|......... ...+.+|...++.+. +--+++++.++..++..++||++++|.++.+....
T Consensus 30 v~rv~~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~--- 103 (263)
T d1j7la_ 30 VYKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED--- 103 (263)
T ss_dssp EEEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT---
T ss_pred EEEEEeCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc---
Confidence 45566678889999886543222 234567888887764 44467888888888899999999998777543321
Q ss_pred CChHHHHHHHHHHHHHHHHHHh-----------------------------------------------------C---C
Q 016544 247 LKPSTAVRFALDIARGMNYLHE-----------------------------------------------------N---K 270 (387)
Q Consensus 247 l~~~~~~~i~~qi~~~l~~LH~-----------------------------------------------------~---~ 270 (387)
......++.++.+.+..||+ . .
T Consensus 104 --~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 181 (263)
T d1j7la_ 104 --EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEE 181 (263)
T ss_dssp --CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCC
T ss_pred --cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcC
Confidence 11122234444444444543 1 1
Q ss_pred CCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
+..++|+|+.|.||++++++.+-|+||+.+..
T Consensus 182 ~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 182 ELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 22378999999999999876667999997654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.87 E-value=1.6e-05 Score=67.29 Aligned_cols=129 Identities=18% Similarity=0.128 Sum_probs=75.2
Q ss_pred EEEEEE-cCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC--CCcceeeeeEEeeCCceEEEEEccCCCCHHH-----
Q 016544 168 FILAFW-RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA----- 239 (387)
Q Consensus 168 ~~~v~~-~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~~iv~l~~~~~~~~~~~lv~e~~~~~sL~~----- 239 (387)
++.+.. .+..+++|....... ..+..|...++.+. .-.+++++.+..+++..+++|++++|.++.+
T Consensus 27 v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~~~~ 100 (255)
T d1nd4a_ 27 VFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAP 100 (255)
T ss_dssp EEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSCCCH
T ss_pred EEEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccccccH
Confidence 344444 355688898764432 23566777777663 2336778888888889999999998755421
Q ss_pred ---------HHHHcC-------CCC--hHHHHHHH--------------------HHHHHHHHHHHhCC----CCCeEeC
Q 016544 240 ---------FLKRKG-------ALK--PSTAVRFA--------------------LDIARGMNYLHENK----PVPIIHR 277 (387)
Q Consensus 240 ---------~l~~~~-------~l~--~~~~~~i~--------------------~qi~~~l~~LH~~~----~~~iiH~ 277 (387)
.+.+-. ++. ......-. ......+..+.... +..++|+
T Consensus 101 ~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHg 180 (255)
T d1nd4a_ 101 AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHG 180 (255)
T ss_dssp HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECS
T ss_pred HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCceEEeC
Confidence 111100 000 00000000 00122233333322 2237999
Q ss_pred CCCCCCEEeCCCCCEEEEeecCccc
Q 016544 278 DLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 278 Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
|+.|.||+++.+..+-|+||+.+..
T Consensus 181 D~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 181 DACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp SCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCcceEEeCCceEEEEEchhccc
Confidence 9999999999876677999987643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.72 E-value=6e-05 Score=68.12 Aligned_cols=31 Identities=26% Similarity=0.283 Sum_probs=26.3
Q ss_pred CCeEeCCCCCCCEEeCCCCCEEEEeecCcccc
Q 016544 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303 (387)
Q Consensus 272 ~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 303 (387)
..++|+|+.|.|||+++++ ++|+||..+...
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G 253 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFYG 253 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence 3589999999999999764 899999987653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.73 E-value=0.0018 Score=56.41 Aligned_cols=124 Identities=14% Similarity=0.108 Sum_probs=67.5
Q ss_pred EcCeEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCCCCcce--eeee-----EEeeCCceEEEEEccCCCCH-----HHH
Q 016544 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV--QFLG-----AVTQSSPMMIVTEYLPKGDL-----RAF 240 (387)
Q Consensus 173 ~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv--~l~~-----~~~~~~~~~lv~e~~~~~sL-----~~~ 240 (387)
.+|..+++|+.+..... .+++..|...+..+...++. ..+. .+...+..+.+++++.|..+ ..+
T Consensus 44 ~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~ 119 (325)
T d1zyla1 44 EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQM 119 (325)
T ss_dssp TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHH
T ss_pred CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHH
Confidence 36788999998754322 34566788887776422221 1111 22345668889999976332 111
Q ss_pred ------H---HH---cC-------------------------CCChHH---HHHHHHHHHHHHHHHH-hCCCCCeEeCCC
Q 016544 241 ------L---KR---KG-------------------------ALKPST---AVRFALDIARGMNYLH-ENKPVPIIHRDL 279 (387)
Q Consensus 241 ------l---~~---~~-------------------------~l~~~~---~~~i~~qi~~~l~~LH-~~~~~~iiH~Dl 279 (387)
+ +. .. .++... ....+.++...+.-+- +..+..++|+|+
T Consensus 120 ~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDl 199 (325)
T d1zyla1 120 EAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDC 199 (325)
T ss_dssp HHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSC
T ss_pred HHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCC
Confidence 1 00 00 011111 1122223333332221 223456899999
Q ss_pred CCCCEEeCCCCCEEEEeecCccc
Q 016544 280 EPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 280 kp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
.+.|||++++ ..++||+.+..
T Consensus 200 h~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 200 HAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SGGGEEESSS--EEECCCTTCCE
T ss_pred CcccEEEeCC--ceEEechhccc
Confidence 9999999743 56899997754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.99 E-value=0.0045 Score=55.35 Aligned_cols=53 Identities=13% Similarity=0.182 Sum_probs=34.3
Q ss_pred eEEEEEEcCcccCCCHHHHHHHHHHHHHHHcCC-CCcceeeeeEEeeCCceEEEEEccCCCCH
Q 016544 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237 (387)
Q Consensus 176 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~~~sL 237 (387)
..|.+++.... ... ....+|..+++.+. +.-.+++++++.. ++|+||++|.++
T Consensus 75 ~~vllRi~g~~--~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 75 NKVLLRVYFNP--ETE---SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp SEEEEEEECSC--CCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CcEEEEecCCc--chh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 56778877532 121 23456888888874 4445678887753 689999987443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.16 E-value=0.011 Score=50.90 Aligned_cols=32 Identities=25% Similarity=0.242 Sum_probs=27.5
Q ss_pred CCCeEeCCCCCCCEEeCCCCCEEEEeecCccc
Q 016544 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302 (387)
Q Consensus 271 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 302 (387)
|.++||+|+.++|++++.+...-++||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 44699999999999999887778999998753
|